

  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methylene]methanamine
C9H11NO
13114-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5488621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzaldehyde
C8H8O2
135-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Methoxyphenyl)methylene]methanamine
C9H11NO
1125-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 135-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1125-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31477794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 16898-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,4'-Trimethylenedipiperidine, a safe and greener alternative for
piperidine, catalyzed the synthesis of N-methyl imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorjian, Hayedeh; Khaligh, Nader Ghaffari
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2022), 48(5), 2035-2045

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenesulfonyl chloride
C6H4BrClO2S
2905-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
98192-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98192-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23306075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential
anti-inflammatory drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mengheres, Gabriel; Rice, Craig R.; Olajide, Olumayokun A.; Hemming, Karl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 34127761

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-fluoropyridine
C5H3BrFN
357927-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-4-pyridinamine
C6H7BrN2
847799-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357927-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847799-64-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19564697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-substituted aryl or heteroaryl compounds as EHMT1 and EHMT2
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Campbell, John Emmerson; Duncan, Kenneth William; Foley, Megan Alene;
Harvey, Darren Martin; Kuntz, Kevin Wayne; Mills, James Edward John;
Munchhof, Michael John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017181177 A1 2017-10-19

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9645597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: (4-Bromo-2-nitro-phenyl)-methyl-amine (24b) To a solution of 24a
(780 mg, 3.55 mmol) in MeCN (3 mL) under argon was slowly added
methylamine 33% in ethanol (1 mL, 7.8 mmol). The mixture was stirred at
room temperature for 1 hour and then heated at 40°C for 1 hour, upon
which complete dissolution is achieved. After cooling, water was added
and the resulting red solid was filtered, washed with water, dried under
vacuum and used without further purification. Yield 742 mg, 90%. LCMS
(ESI+) m/z 231/233 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of purine derivatives and their use as pharmaceuticals for
prevention or treatment of bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atamanyuk, Dmytro; Denis, Alexis; Gerusz, Vincent; Ledoussal, Benoit;
Bonvin, Yannick; Desroy, Nicolas; Gold, Johan; Moreau, Francois; Oxoby,
Mayalen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012172043 A1 2012-12-20

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-nitropyridine
C5H3ClN2O2
5470-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-2-pyridinamine
C6H7N3O2
4093-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 N 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5470-18-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4093-88-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7010141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and Selective Method for the Synthesis of
Dihydrodipyridopyrazines Based on the Pd-Catalysed Amination of
Halopyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patriciu, Oana-Irina; Finaru, Adriana-Luminita; Massip, Stephane; Leger,
Jean-Michel; Jarry, Christian; Guillaumet, Gerald
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2009), (22), 3753-3764,
S3753/1-S3753/35

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzaldehyde
C7H5NO3
552-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Nitrophenyl)methylene]methanamine
C8H8N2O2
57707-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57707-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-622045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methylene]methanamine
C8H8ClN
90434-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90434-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9763919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4144493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of volatile copper(II) complexes for deposition of copper films
by atomic layer deposition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bradley, Alexander Zak; Thorn, David Lincoln; Thompson, Jeffery Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003095701 A1 2003-11-20

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl β-(acetyloxy)-α-methylenebenzenepropanoate
C13H14O4
124957-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 C 5.3347 4.6200 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 C 5.3347 6.1600 0.0 0
M  V30 6 C 2.6674 1.5400 0.0 0
M  V30 7 O 8.0021 4.6200 0.0 0
M  V30 8 O 6.6684 2.3100 0.0 0
M  V30 9 C 2.6674 0.0000 0.0 0
M  V30 10 O 1.3336 2.3100 0.0 0
M  V30 11 C 9.3358 3.8500 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-2-[(methylamino)methyl]-3-phenyl-2-propenoate
C12H15NO2
1021167-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 O 7.7000 5.3347 0.0 0
M  V30 6 O 7.7000 2.6674 0.0 0
M  V30 7 N 5.3900 1.3338 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 10
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124957-36-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021167-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11242603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Baylis-Hillman reaction, key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective Synthesis of 3-Carboxy-4,5-dihydropyrroles via an
Intramolecular Iminium Ion Cyclization Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Jinbao; Xie, Hongxiang; Li, Zhuo; Dang, Qun; Bai, Xu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(15), 3818-3821

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-fluoro-3-nitrobenzene
C6H3ClFNO2
2106-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-6-nitrobenzenamine
C7H7ClN2O2
75438-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Cl 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2106-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 75438-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14559585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 191(A) 2-Chloro-N-methyl-6-nitrobenzenamine 2-Fluoro-3-chloronitrobenzene
(3.0 g, 17 mmol) was dissolved in EtOH (6 mL) and Methylamine 40% in
Water (6 mL) was added dropwise at 0°C and mixture was warmed up to RT
overnight. Mixture went to a dark orange precipitate within 10min. The
solid was isolated by filtration, rinsed with water (2*10 mL) and dried
in a desiccators under vacuum to afford 3 g of
2-chloro-N-methyl-6-nitrobenzenamine (Yield: 90%) as an orange
crystalline solid. Rf (Cyclohexane/EtOAc: 80/20) = 0.52 LCMS (RT) :
4.29min
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycle-containing alkynyl derivatives as modulators
of metabotropic glutamate receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bessis, Anne-Sophie; Bolea, Christelle; Bonnet, Beatrice; Epping-Jordan,
Mark; Poirier, Nicholas; Poli, Sonia-Maria; Rocher, Jean-Philippe;
Thollon, Yves
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005123703 A2 2005-12-29

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
4,5-Dibromo-2-furancarboxylic acid
C5H2Br2O3
2434-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 Br 0.0000 2.9016 0.0 0
M  V30 5 Br 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2587 0.0 0
M  V30 7 C 2.5620 3.8850 0.0 0
M  V30 8 O 3.8079 1.7271 0.0 0
M  V30 9 C 1.5316 2.7406 0.0 0
M  V30 10 C 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dibromo-N-methyl-2-furancarboxamide
C6H5Br2NO2
2411909-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 N 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 Br 1.6751 0.0000 0.0 0
M  V30 6 Br 0.0000 2.9016 0.0 0
M  V30 7 C 3.9690 3.2587 0.0 0
M  V30 8 C 3.8079 1.7271 0.0 0
M  V30 9 O 2.5620 3.8850 0.0 0
M  V30 10 C 2.3016 1.4070 0.0 0
M  V30 11 C 1.5316 2.7406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2434-03-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411909-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21853975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Furan derivatives as bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Demont, Emmanuel Hubert; Seal, Jonathan Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020043821 A1 2020-03-05

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3595433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of urea compounds containing fused tricycle moiety as Raf
kinase and/or Raf kinase dimer inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Changyou; Zhang, Guoliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014206343 A1 2014-12-31

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11626374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide compounds containing fused tricycle moiety as
multiple kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Changyou; Zhang, Guoliang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014206344 A1 2014-12-31

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Phenylalanine, methyl ester
C10H13NO2
2577-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methylbenzenepropanamide
C10H14N2O
35373-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2577-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35373-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10120627
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Hydantoins by Catalytic Oxidative Carbonylation of α-Amino
Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumbris, Seth M.; Diaz, Delmy J.; McElwee-White, Lisa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(22), 8862-8865

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19571099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their
use in the treatment of medical disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skerlj, Renato T.; Bourque, Elyse Marie Josee; Lansbury, Peter T.; Good,
Andrew C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017176960 A1 2017-10-12

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Methoxyphenyl)methylene]methanamine
C9H11NO
16928-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16928-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3396230
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl benzoylacetate
C10H10O3
614-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 4.6200 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C11H13NO2
2139332-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 N 4.0011 0.7700 0.0 0
M  V30 4 C 6.6684 2.3100 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 O 8.0022 3.0800 0.0 0
M  V30 7 O 6.6684 0.7700 0.0 0
M  V30 8 C 9.3359 2.3100 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3100 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 614-27-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139332-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethoxybenzaldehyde
C9H10O3
86-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 0.0000 3.0801 0.0 0
M  V30 5 O 6.6687 2.3101 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,3-Dimethoxyphenyl)methylene]methanamine
C10H13NO2
722495-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 N 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 1.3337 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-51-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 722495-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2760688
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-151703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-19-0
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 5: Synthesis of tadalafil in isobutyl acetate TDCl (10 g, 23.4
mmol), isobutylacetate (250 ml), and methylamine (8.8 ml, 8 M, 70 mmol,
33% EtOH) were combined in a 500 ml, 3 neck flask equipped with a
magnetic stirrer, thermometer, and condenser connected to a paraffin trap
in an oil bath, to form a reaction mixture. The reaction mixture was
stirred and heated at about 40°C for about 24 hours. The reaction mixture
was cooled in an ice bath and filtered. A solid was obtained, and was
slurried twice with methanol (25 ml). The solid was dried (8.22 g, 90%
yield) and determined to be tadalafil with a purity of 99.93%.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparations shown, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process of synthesizing tadalafil
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolitzky, Ben-Zion; Diller, Dov
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006091975 A1 2006-08-31

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloropyrimidine
C4H2BrClN2
32779-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Cl 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 N 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(methylamino)pyrimidine
C5H6BrN3
31402-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32779-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31402-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9309821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0437] Synthesis of
Methyl-[5-(4,4,5,5,-tetramethyl-[1,3,2]dioxaborolan-2-yl]amine: [0438]
Stage D: To 5-bromo-2-chloropyrimidine (2g, 10.34mmol) was added 1 M
methylamine solution in THF (20ml). The contents were stirred at 60 °C
for 6h after which TLC confirmed the absence of the reactant. The
contents were allowed to cool down. The volatiles were evaporated under
reduced pressure and the residue was subjected to flash chromatography
(hexane/ethyl acetate) to get (5-bromo-pyrimidin-2-yl)-methyl-amine
(1.75g, 90%).
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroarylmorpholinyltriazine derivatives for use as
kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Cheng Hsia Angeline; Nagaraj, Harish Kumar Mysore; William, Anthony
Deodaunia; Williams, Meredith; Xiong, Zhengchang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009093981 A1 2009-07-30

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
349-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 F 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzenesulfonamide
C7H8FNO2S
433-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 F 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 433-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19901212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition-Metal-Free One-Step Synthesis of Ynamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zeng, Xianzhu; Tu, Yongliang; Zhang, Zhenming; You, Changming; Wu, Jiao;
Ye, Zhiying; Zhao, Junfeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2019), 84(7), 4458-4466

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(chlorosulfonyl)-, methyl ester
C8H7ClO4S
63555-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 Cl 0.0000 3.8501 0.0 0
M  V30 7 O 2.1037 4.4137 0.0 0
M  V30 8 O 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[(methylamino)sulfonyl]benzoate
C9H11NO4S
1094752-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6673 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 3.4374 4.4137 0.0 0
M  V30 4 O 1.8973 1.7464 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 O 9.3360 2.3101 0.0 0
M  V30 8 O 8.0023 4.6201 0.0 0
M  V30 9 C 10.6697 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 5.3348 0.0000 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63555-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1094752-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-17786471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted amides as BACE-2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ankala, Sudha V.; Lilly, John C.; Peddabuddi, Gopal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017066742 A1 2017-04-20

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methyl 6-[2-[[[[2-methoxy-5-(trifluoromethyl)phenyl]amino]carbonyl]amino]ethy...
C20H19F3N4O4
863910-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.4528 4.6200 0.0 0
M  V30 2 O 18.2228 3.2864 0.0 0
M  V30 3 O 18.2228 5.9536 0.0 0
M  V30 4 C 19.7628 3.2864 0.0 0
M  V30 5 C 9.5420 6.1600 0.0 0
M  V30 6 C 8.2084 5.3900 0.0 0
M  V30 7 N 6.8747 6.1600 0.0 0
M  V30 8 C 5.5409 5.3900 0.0 0
M  V30 9 N 4.2073 6.1600 0.0 0
M  V30 10 O 5.5409 3.8500 0.0 0
M  V30 11 O 1.5400 7.7000 0.0 0
M  V30 12 C 0.2062 8.4700 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 F 3.0800 1.5400 0.0 0
M  V30 15 F 1.5400 0.0000 0.0 0
M  V30 16 F 0.0000 1.5400 0.0 0
M  V30 17 C 13.5431 3.8500 0.0 0
M  V30 18 C 13.5431 5.3900 0.0 0
M  V30 19 N 15.0076 3.3741 0.0 0
M  V30 20 C 12.2094 3.0800 0.0 0
M  V30 21 N 15.0076 5.8659 0.0 0
M  V30 22 C 12.2094 6.1600 0.0 0
M  V30 23 C 15.9128 4.6200 0.0 0
M  V30 24 C 10.8756 3.8500 0.0 0
M  V30 25 C 10.8756 5.3900 0.0 0
M  V30 26 C 2.8736 5.3900 0.0 0
M  V30 27 C 1.5400 6.1600 0.0 0
M  V30 28 C 2.8736 3.8500 0.0 0
M  V30 29 C 0.2062 5.3900 0.0 0
M  V30 30 C 1.5400 3.0800 0.0 0
M  V30 31 C 0.2062 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 30
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 23
M  V30 26 1 22 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-[[[[2-Methoxy-5-(trifluoromethyl)phenyl]amino]carbonyl]amino]ethyl]-N-me...
C20H20F3N5O3
863910-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.4528 4.6200 0.0 0
M  V30 2 N 18.2228 3.2864 0.0 0
M  V30 3 O 18.2228 5.9536 0.0 0
M  V30 4 C 19.7628 3.2864 0.0 0
M  V30 5 C 9.5420 6.1600 0.0 0
M  V30 6 C 8.2084 5.3900 0.0 0
M  V30 7 N 6.8747 6.1600 0.0 0
M  V30 8 C 5.5409 5.3900 0.0 0
M  V30 9 N 4.2073 6.1600 0.0 0
M  V30 10 O 5.5409 3.8500 0.0 0
M  V30 11 O 1.5400 7.7000 0.0 0
M  V30 12 C 0.2062 8.4700 0.0 0
M  V30 13 C 1.5400 1.5400 0.0 0
M  V30 14 F 0.0000 1.5400 0.0 0
M  V30 15 F 1.5400 0.0000 0.0 0
M  V30 16 F 3.0800 1.5400 0.0 0
M  V30 17 C 13.5431 3.8500 0.0 0
M  V30 18 C 13.5431 5.3900 0.0 0
M  V30 19 N 15.0076 3.3741 0.0 0
M  V30 20 C 12.2094 3.0800 0.0 0
M  V30 21 N 15.0076 5.8659 0.0 0
M  V30 22 C 12.2094 6.1600 0.0 0
M  V30 23 C 15.9128 4.6200 0.0 0
M  V30 24 C 10.8756 3.8500 0.0 0
M  V30 25 C 10.8756 5.3900 0.0 0
M  V30 26 C 2.8736 5.3900 0.0 0
M  V30 27 C 1.5400 6.1600 0.0 0
M  V30 28 C 2.8736 3.8500 0.0 0
M  V30 29 C 0.2062 5.3900 0.0 0
M  V30 30 C 1.5400 3.0800 0.0 0
M  V30 31 C 0.2062 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 30
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 23
M  V30 26 1 22 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 863910-74-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863910-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7479543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 50 mg (0.11 mmol) of the ester were dissolved in THF, and 5.5 mg (0.06
mmol) of anhydrous magnesium chloride were added. After 5 minutes, 0.34
ml (0.34 mmol) of methylamine solution (1M in THF) was added dropwise
over the course of 10 minutes, and the reaction mixture was stirred at
room temperature for 3 hours. The reaction mixture was poured into
ice-water, and the precipitate obtained was filtered off with suction,
washed with water and dried under reduced pressure. Yield: 45 mg (90%) of
12, beige solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ureidoalkyl-substituted benzimidazole derivatives as
kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchstaller, Hans-Peter; Burgdorf, Lars; Stieber, Frank; Amendt,
Christiane; Grell, Mathias; Sirrenberg, Christian; Zenke, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005082862 A2 2005-09-09

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-nitrobenzoic acid
C8H7NO4
5437-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 O 6.6687 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 13 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzamide
C9H10N2O3
600126-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 5.3900 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5437-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600126-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24003965
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of Chlorantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashwin, V; Pradhan, Ashok Kumar; Palimkar, Sanjay Sambhajirao; Mane,
Avinash Sheshrao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN201941033579 A 2021-02-26

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-nitrobenzoic acid
C8H7NO4
5437-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 O 6.6687 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 13 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzamide
C9H10N2O3
600126-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 5.3900 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5437-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600126-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23460343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of Chlorantraniliprole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashwin, V.; Pradhan, Ashok Kumar; Palimkar, Sanjay Sambhajirao; Mane,
Avinash Sheshrao; Kunhimon, Syam Kumar Unniaran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021033172 A1 2021-02-25

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-nitrobenzoic acid
C8H7NO4
5437-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 5.3348 3.0801 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 O 6.6687 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 2.6675 3.0801 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 13 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-nitrobenzamide
C9H10N2O3
600126-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 6 O 1.3336 5.3900 0.0 0
M  V30 7 O 4.0011 5.3900 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 14 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5437-38-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600126-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10572202
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Insecticidal anthranilic diamides: A new class of potent ryanodine
receptor activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lahm, George P.; Selby, Thomas P.; Freudenberger, John H.; Stevenson,
Thomas M.; Myers, Brian J.; Seburyamo, Gilles; Smith, Ben K.; Flexner,
Lindsey; Clark, Christopher E.; Cordova, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(22), 4898-4906

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3,5-dimethoxybenzene
C8H9ClO2
7051-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 Cl 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethoxy-N-methylbenzenamine
C9H13NO2
118684-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 4.0011 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 O 1.5400 6.6686 0.0 0
M  V30 4 C 0.0000 6.6686 0.0 0
M  V30 5 O 1.5400 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 5.3348 0.0 0
M  V30 9 C 3.8500 2.6675 0.0 0
M  V30 10 C 2.3100 5.3348 0.0 0
M  V30 11 C 2.3100 2.6675 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7051-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118684-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8166852
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1148148-01-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE TWENTY-FIVE: Synthesis of 3,5-Dimethoxy-N-methylaniline (Figure
11, Table 7, entry!) Following general procedure A, a mixture of
3,5-dimethoxychlorobenzene (173 mg, 1.0 mmol), 2M methylamine (1 mL, 2.0
mmol), NaO t-Bu (120 mg, 1.2 mmol), BrettPhos precatalyst 10 (8 mg, 0.01
mmol), and E-BuOH (1 mL) was stirred at room temperature for 2 h. The
crude product was purified via column chromatography (80:20 to 50:50
Hexanes/EtOAc gradient) to provide the title compound as a pale yellow
liquid (150 mg, 90%). 3,5-Dimethoxy-N-methylaniline, yield (150 mg, 90%)
1H NMR (400 MHz, CDCl3) δ: 5.89 (t, J = 2.2 Hz, 1H), 5.80 (t, J = 2.2 Hz,
2H), 3.76 (s,7H), 2.81 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ: 161.9,
151.5,91.4,89.7, 55.3, 30.9 ppm. Brown, F. J.; Bernstein, P. R.; Cronk,
L. A.; Dosset, D. L.; Hebbel, K. C; Maduskuie, T. P.; Shapiro, H. S.;
Vacek, E. P.; Yee, Y. K.; Willard, A. K.; Krell, R. D.; Snyder, D. W. J.
Med. Chem. 1989, 32, 807.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligands for transition-metal-catalyzed cross-couplings, and methods of
use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchwald, Stephen L.; Fors, Brett P.; Surry, David S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009076622 A2 2009-06-18

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-18013018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Long alkyl side-chains impede exciton interaction in organic light
harvesting crystals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nagarajan, Kalaivanan; Gopan, Gopika; Cheriya, Rijo T.; Hariharan, Mahesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2017), 53(53),
7409-7411

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-5630221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antiproliferative and apoptosis-inducing activities of novel
naphthalimide-cyclam conjugates through dual topoisomerase (topo) I/II
inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Shaoying; Sun, Deheng; Lyu, Jiankun; Sun, Xiao; Wu, Fangshu; Li,
Qiang; Yang, Yiqi; Liu, Jianxu; Wang, Xin; Chen, Zhuo; Li, Honglin; Qian,
Xuhong; Xu, Yufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(17), 5672-5680

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-11088944
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel metal complexes of naphthalimide-cyclam conjugates as potential
multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and
biological evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Shaoying; Han, Kun; Li, Qiang; Tong, Linjiang; Yang, Yiqi; Chen,
Zhuo; Xie, Hua; Ding, Jian; Qian, Xuhong; Xu, Yufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 85207-214

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-2951826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Effects of anionic surfactant SDS on the photophysical properties of two
fluorescent molecular sensors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Junhong; Xu, Yufang; Qian, Xuhong; Wang, Jiaobing; Zhang, Shenyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Photochemistry and Photobiology, A: Chemistry (2008),
200(2-3), 402-409

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-4-(Methylamino)-3-penten-2-one
C6H11NO
23652-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 N 1.5400 2.6673 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 6.1601 2.6673 0.0 0
M  V30 8 O 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23652-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13936725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photochromism of Rotation-Hindered Furylfulgides Influenced by Steric
Modifications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Struebe, Frank; Siewertsen, Ron; Soennichsen, Frank D.; Renth, Falk;
Temps, Friedrich; Mattay, Jochen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2011), (10), 1947-1955,
S1947/1-S1947/7

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-4-(Methylamino)-3-penten-2-one
C6H11NO
23652-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 N 1.5400 2.6673 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 6.1601 2.6673 0.0 0
M  V30 8 O 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23652-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3792684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalized Fulgides and Fluorophore-Photoswitch Conjugates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Struebe, Frank; Rath, Susann; Mattay, Jochen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2011), 2011(24), 4645-4653,
S4645/1-S4645/3

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-4-(Methylamino)-3-penten-2-one
C6H11NO
23652-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 N 1.5400 2.6673 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 6.1601 2.6673 0.0 0
M  V30 8 O 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23652-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10482722
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Formation of
Enaminones Iodine (20 mol%) was added to a mixture of ethyl acetoacetate
or acetylacetone (1.5 mmol) and amine (1.5 mmol) [but in the case of
aniline and ethylene diamine (entries 3, 6,9 and 12), iodine was first
added to the substrates, the mixture was cooled to 5°C, and then amine
was added dropwise]. When iodine was added, heat evolved (exothermic
reaction). Then, the reaction mixture was cooled under tap water. During
this period, the reaction completed, which was indicated by TLC. Then,
the reaction mixture was diluted with CH2Cl2 and washed with water. The
extract was dried (Na2SO4), filtered, and concentrated in vacuo. The
residue was purified by preparative TLC on silica gel using n-hexane/EtO
Ac (1 : 1), which gave the pure β -enaminones (79-99%).
(3Z)-4-(Methylamino)-3-penten-2-one (entry 4), yield 90%[22] IR (thin
film, CHCl3): 1610, 1572 cm-1. 1H NMR (300 MHz, CDCl3) δ (ppm): 10.64 (br
s, 1H, NH), 4.91 (s, 1H),2.86 (d, 3H, J = 5.4 Hz), 1.94 (s, 3H), 1.83 (s,
3H). 13C NMR (75MHz, CDCl3) δ (ppm): 194.4, 164.0, 94.7, 29.4, 28.4, 18.5
MS (ESI): m/z 136 (M+ + Na). Anal calcd. for C6H11NO: C, 63.62; H, 9.75;
N, 12.32. Found: C, 63.69; H, 9.80; N, 12.38.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iodine-catalyzed conversion of β-dicarbonyl compounds into β-enaminones
within a minute under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gogoi, Siddhartha; Bhuyan, Ranjana; Barua, Nabin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2005), 35(21), 2811-2818

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[5-formyl-3′-[(methylamino)sulfonyl][1,1′-biphenyl]-2-yl...
C20H23NO6S
1242846-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 6.6684 0.0 0
M  V30 2 C 10.7800 6.6684 0.0 0
M  V30 3 C 11.5500 8.0021 0.0 0
M  V30 4 O 13.0900 8.0021 0.0 0
M  V30 5 O 10.7800 9.3358 0.0 0
M  V30 6 C 13.8600 9.3358 0.0 0
M  V30 7 C 12.5264 10.1058 0.0 0
M  V30 8 C 14.6300 10.6694 0.0 0
M  V30 9 C 15.1936 8.5658 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 O 6.9300 0.0000 0.0 0
M  V30 12 S 2.3100 8.0020 0.0 0 VAL=6
M  V30 13 N 0.7700 8.0020 0.0 0
M  V30 14 O 2.3100 9.5421 0.0 0
M  V30 15 O 2.3100 6.4621 0.0 0
M  V30 16 C 0.0000 9.3358 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 8.4700 2.6673 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 4.6200 6.6684 0.0 0
M  V30 25 C 6.9300 8.0021 0.0 0
M  V30 26 C 3.8500 8.0020 0.0 0
M  V30 27 C 6.1600 9.3358 0.0 0
M  V30 28 C 4.6200 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 21
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 12 15
M  V30 15 1 12 26
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[5-[(methylamino)methyl]-3′-[(methylamino)sulfonyl][1,1′...
C21H28N2O5S
1242846-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2402 8.0022 0.0 0
M  V30 2 C 10.7802 8.0022 0.0 0
M  V30 3 C 11.5503 9.3360 0.0 0
M  V30 4 O 13.0903 9.3360 0.0 0
M  V30 5 O 10.7802 10.6697 0.0 0
M  V30 6 C 13.8603 10.6697 0.0 0
M  V30 7 C 15.1940 9.8996 0.0 0
M  V30 8 C 14.6303 12.0033 0.0 0
M  V30 9 C 12.5266 11.4397 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 N 6.9302 1.3337 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 S 2.3101 9.3360 0.0 0 VAL=6
M  V30 14 N 0.7700 9.3360 0.0 0
M  V30 15 O 2.3101 10.8760 0.0 0
M  V30 16 O 2.3101 7.7960 0.0 0
M  V30 17 C 0.0000 10.6697 0.0 0
M  V30 18 C 6.9302 6.6685 0.0 0
M  V30 19 C 8.4702 6.6685 0.0 0
M  V30 20 C 6.1601 5.3348 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 6.9302 4.0012 0.0 0
M  V30 23 C 8.4702 4.0012 0.0 0
M  V30 24 C 6.1601 8.0022 0.0 0
M  V30 25 C 4.6201 8.0022 0.0 0
M  V30 26 C 6.9302 9.3360 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 6.1601 10.6697 0.0 0
M  V30 29 C 4.6201 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 13 16
M  V30 16 1 13 27
M  V30 17 1 14 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 24
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242846-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242846-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3239636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 14: t-butyl
2-(2-(3-N-methylsulfamoylphenyl)-4-((methylamino)methyl)phenoxy)acetate
(14) To a solution of t-butyl
2-(2-(3-N-methylsulfamoylphenyl)-4-formylphenoxy)acetate (for example as
prepared for Intermediate 13) (280 mg, 0.69 mmol, 1 eq) and methylamine
(0.42 mL of a 2M solution in THF; 0.84 mmol, 1.2 eq.) in methanol (15 mL)
was stirred at rt for 2h. Sodium borohydride (13.1 mg, 0.35 mmol, 0.5
eq.) was added, and the resulting mixture was stirred at room temperature
for additional 2h. Water (3 mL) was added and the MeOH was removed in
vacuo. The resulting solution was extracted with EtOAc, and the combined
organic layers were dried (Na2SO4), filtered, and concentrated in vacuo
to afford 260 mg (89.7 %) of t-butyl
2-(2-(3-N-methylsulfamoylphenyl)-4-((methylamino)methyl)phenoxy)acetate
(14) as oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation biaryl oxyacetic acid compounds as inhibitors of CRTH2
receptor for treating inflammatory disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGuinness, Brian F.; Ho, Koc-Kan; Babu, Suresh; Dong, Guizhen; Duo,
Jingqi; Le, Thuy X. H.; Saionz, Kurt W.; Neeb, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011002814 A2 2011-01-06

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
1694-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 Cl 6.1600 4.0009 0.0 0
M  V30 3 O 4.6200 2.4609 0.0 0
M  V30 4 O 4.6200 5.5409 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 3.0800 4.0009 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenesulfonamide
C7H8N2O4S
23530-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 5.3900 5.3349 0.0 0
M  V30 3 O 5.9536 3.2311 0.0 0
M  V30 4 O 3.2864 4.7711 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 7 O 2.3100 5.3349 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 1.5400 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23530-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9128199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: N-methyl-2-nitrobenzenesulfonamide To a solution of
2-nitrobenzene-1-sulfonyl chloride (30 g, 0.14 mol) in dichloromethane
(500 mL) was slowly added a solution of methylamine in water (30 %, 15.3
g) and triethylamine (38 mL, 0.27 mol) respectively. The mixture was
stirred at room temperature for 1 hour and then evaporated. The residue
was subjected to silica gel chromatography to afford the product
N-methyl-2-nitrobenzenesulfonamide. Yield 26 g, 90 %.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine
derivatives as FAK and/or Pyk2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Dengming; Cheng, Liang; Liu, Xijie; Hu, Yuandong; Xu, Xinhe; Liu,
Zhihua; Zhang, Lipeng; Wu, Wei; Wang, Shulong; Shen, Yu; Li, Gen; Wang,
Yin; Zhao, Sheng; Li, Chonglong; Tang, Jia; Yu, Honghao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012092880 A1 2012-07-12

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-3-methyl-5-nitro-1,2-benzisoxazole
C8H5FN2O3
221559-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4294 0.3694 0.0 0
M  V30 2 N 6.3709 1.5400 0.0 0 VAL=5
M  V30 3 O 7.7047 2.3100 0.0 0
M  V30 4 O 6.3709 0.0000 0.0 0
M  V30 5 F 6.3709 4.6200 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 C 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 N 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-nitro-1,2-benzisoxazol-6-amine
C9H9N3O3
1983933-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0408 3.2907 0.0 0
M  V30 2 N 0.7700 4.0012 0.0 0
M  V30 3 C 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3337 0.0 0 VAL=5
M  V30 5 O 0.7700 1.3337 0.0 0
M  V30 6 O 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 5.3901 4.0012 0.0 0
M  V30 9 C 3.0801 5.3348 0.0 0
M  V30 10 O 5.6505 6.4792 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.8964 4.3213 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 N 7.0574 5.8529 0.0 0
M  V30 15 C 3.0801 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221559-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1983933-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23981065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate solvent (tetrahydrofuran) may be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile Synthesis of New Imidazo[4',5':4,5]benzo[1,2-d]isoxazol-6-one
Derivatives and In Silico Studies of Their Drug-like Profiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Maofeng; Yan, Xingli; Wang, Lizhong; Liu, Zhuyun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2021), 53(4), 413-421

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
2-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzamide
C8H7FN2O3
915087-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 403-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915087-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15908555
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-21-4
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for producing enzalutamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stach, Jan; Klecan, Ondrej; Lehnert, Petr; Rymes, Jan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015154730 A1 2015-10-15

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
2-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzamide
C8H7FN2O3
915087-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 403-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915087-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15094362
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 2-Fluoro-N-methyl-4-nitro-benzamide 21. Thionyl chloride
(15g, 130mmol) was added slowly to a solution of acid
2-fluoro-4-nitro-benzoic acid (20g, 110mmol) in DMF (20mL) at -5 °C. The
mixture was stirred for an additional 1h at -5 °C. At 0°C, a methylamine
solution (2M, 400mL, 800mmol) in tetrahydrafuran was added drop-wise to
the solution. The reaction mixture was slowly warmed to 25 °C and then
poured into ice-water (125mL). The suspension was extracted with ethyl
acetate (2x200mL) Combined organic phase was washed with brine (1x200mL),
dried (MgSO4) and concentrated to dryness in vacuo. The title compound 21
was obtained as a yellow solid (20g, 90%yield).
2-Fluoro-N-methyl-4-nitro-benzamide 21, yield (20g, 90%). MS: 163 (M+H)+.
1H NMR (acetone-d6, 500MHz): δ 7.66 (1H, dd, J=8.5, 8.5Hz), 6.41 (1H, dd,
J=8.6, 2.1Hz), 6.32 (1H, dd, J=13.6, 2.0Hz), 3.05 (3H, d, J=4.4Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Thioimidazolidinone derivatives as androgen receptor antagonists and
their preparation, pharmaceutical compositions and use in the treatment
of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tong, Youzhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011029392 A1 2011-03-17

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodobenzenesulfonyl chloride
C6H4ClIO2S
63059-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 I 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzenesulfonamide
C7H8INO2S
125259-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 I 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63059-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 125259-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-2578054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-iodo-N-methylbenzenesulfonamide:3a The title compound
was prepared in 90% yield from 2-iodo-benzenesulfonyl chloride2a and
methylamine in dioxane/THF according to the known procedure.3a
2-iodo-N-methylbenzenesulfonamide:, Yield 90%
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Remarkable Accelerating Effect of Ag-Salt on Intramolecular Cyclization
of o-(1-Alkynyl)benzenesulfonamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barange, Deepak Kumar; Nishad, T. C.; Swamy, N. Kumara; Bandameedi,
Venkanna; Kumar, Dinesh; Sreekanth, Bukkapattanam R.; Vyas, K.; Pal,
Manojit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(22), 8547-8550

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorocarbonyl)benzoate
C9H7ClO3
7377-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(methylamino)carbonyl]benzoate
C10H11NO3
23754-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7377-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23754-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2600709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aramidocalix[4]arenes as new anion receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Troisi, Francesco; Russo, Alessio; Gaeta, Carmine; Bifulco, Giuseppe;
Neri, Placido
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(45), 7986-7989

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
3-Methoxy-4-(2-propyn-1-ylamino)benzoic acid
C11H11NO3
2228938-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3349 0.0 0
M  V30 3 C 9.2400 5.3349 0.0 0
M  V30 4 C 10.7800 5.3349 0.0 0
M  V30 5 O 5.3900 1.3338 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 O 0.0000 5.3349 0.0 0
M  V30 9 O 0.0000 2.6674 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 3.0800 5.3349 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-4-(2-propyn-1-ylamino)benzamide
C12H14N2O2
2637450-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3349 0.0 0
M  V30 3 C 10.7800 5.3349 0.0 0
M  V30 4 C 12.3200 5.3349 0.0 0
M  V30 5 O 6.9300 1.3338 0.0 0
M  V30 6 C 6.1600 0.0000 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 1.5400 5.3349 0.0 0
M  V30 9 O 1.5400 2.6674 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 6.1600 5.3349 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 4.6200 5.3349 0.0 0
M  V30 16 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2228938-95-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2637450-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24572323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl compounds for restoring mutant p53 function
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vu, Binh; Dominique, Romyr; Li, Hongju; Fahr, Bruce; Good, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021061643 A1 2021-04-01

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloropurine
C5H2Cl2N4
5451-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-9H-purin-6-amine
C6H6ClN5
82499-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5451-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82499-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33553332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of aminobenzamides containing purine
moiety as class I histone deacetylases inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mao, Ping-Ting; He, Wei-Bao; Mai, Xi; Feng, Li-Hua; Li, Na; Liao,
Yi-Jing; Zhu, Cai-Sheng; Li, Jian; Chen, Ting; Liu, Shu-Hao; Zhang,
Qi-Ming; He, Ling
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2022), 56116599

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4-chloro-3-nitroquinoline
C9H4BrClN2O2
723281-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Br 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-3-nitro-4-quinolinamine
C10H8BrN3O2
1289187-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Br 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 723281-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289187-99-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36827203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of [1,2,3]Triazolo[4,5-c]quinoline Derivatives as a New Class
of Ataxia-Telangiectasia Mutated Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Shiyu; Zhou, Pei; Liu, Jingming; Xia, Anjie; Lin, Guifeng; Xiang,
Zhiyu; Fang, Zhen; Yang, Xin; Qiao, Jingxin; Hu, Qian; Zhang, Jiahao;
Zhao, Jinlong; Li, Linli
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2023), 14(6), 746-756

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4-chloro-3-nitroquinoline
C9H4BrClN2O2
723281-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Br 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-3-nitro-4-quinolinamine
C10H8BrN3O2
1289187-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Br 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 723281-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289187-99-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20947101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1,8-disubstituted-[1,2,3]triazolo[4,5-c]quinoline
derivatives as a new class of Hippo signaling pathway inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qiao, Jingxin; Lin, Guifeng; Xia, Anjie; Xiang, Zhiyu; Chen, Pei; Zhang,
Guo; Li, Linli; Yang, Shengyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2019), 29(18), 2595-2603

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-chloro-4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b...
C19H16ClFN2O2
1918182-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Chloro-4-fluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4...
C19H17ClFN3O
1918182-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19106433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biological Studies and Target Engagement of the 2-C-Methyl-D-Erythritol
4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent
(1R,3S)-MMV008138 and Analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghavami, Maryam; Merino, Emilio F.; Yao, Zhong-Ke; Elahi, Rubayet;
Simpson, Morgan E.; Fernandez-Murga, Maria L.; Butler, Joshua H.;
Casasanta, Michael A.; Krai, Priscilla M.; Totrov, Maxim M.; Slade,
Daniel J.; Carlier, Paul R.; Cassera, Maria Belen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2018), 4(4), 549-559

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dibromo-5-nitropyridine
C5H2Br2N2O2
4487-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Br 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-5-nitro-4-pyridinamine
C6H6BrN3O2
1234014-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4487-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1234014-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20204575
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole-6-carboxylic acids as GLP-1 receptor
agonists useful in treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aspnes, Gary Erik; Bagley, Scott W.; Curto, John M.; Dowling, Matthew S.;
Edmonds, David James; Flanagan, Mark E.; Futatsugi, Kentaro; Griffith,
David A.; Huard, Kim; Ingle, Gajendra; Jiao, Wenhua; Limberakis, Chris;
Mathiowetz, Alan M.; Piotrowski, David W.; Ruggeri, Roger B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2988721 A1 2018-06-16

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Bis(benzyloxy)benzaldehyde
C21H18O3
5447-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6685 0.0 0
M  V30 2 C 3.0801 6.6685 0.0 0
M  V30 3 O 7.7002 6.6685 0.0 0
M  V30 4 C 9.2402 6.6685 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 O 5.3901 0.0000 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 7.7002 4.0012 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 8.0023 0.0 0
M  V30 14 C 3.0801 9.3360 0.0 0
M  V30 15 C 0.7700 8.0023 0.0 0
M  V30 16 C 2.3101 10.6697 0.0 0
M  V30 17 C 0.0000 9.3360 0.0 0
M  V30 18 C 0.7700 10.6697 0.0 0
M  V30 19 C 10.0102 8.0023 0.0 0
M  V30 20 C 11.5503 8.0023 0.0 0
M  V30 21 C 9.2402 9.3360 0.0 0
M  V30 22 C 12.3203 9.3360 0.0 0
M  V30 23 C 10.0102 10.6697 0.0 0
M  V30 24 C 11.5503 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 4 19
M  V30 7 2 5 6
M  V30 8 1 5 11
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,4-bis(phenylmethoxy)benzenemethanamine
C22H23NO2
214424-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 5.3348 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 O 5.3901 8.0023 0.0 0
M  V30 4 C 4.6201 9.3360 0.0 0
M  V30 5 C 11.5503 8.0023 0.0 0
M  V30 6 N 12.3203 9.3360 0.0 0
M  V30 7 C 13.8603 9.3360 0.0 0
M  V30 8 C 7.7002 6.6685 0.0 0
M  V30 9 C 6.9302 8.0023 0.0 0
M  V30 10 C 9.2402 6.6685 0.0 0
M  V30 11 C 7.7002 9.3360 0.0 0
M  V30 12 C 10.0102 8.0023 0.0 0
M  V30 13 C 9.2402 9.3360 0.0 0
M  V30 14 C 6.9302 2.6673 0.0 0
M  V30 15 C 5.3901 2.6673 0.0 0
M  V30 16 C 7.7002 1.3337 0.0 0
M  V30 17 C 4.6201 1.3337 0.0 0
M  V30 18 C 6.9302 0.0000 0.0 0
M  V30 19 C 5.3901 0.0000 0.0 0
M  V30 20 C 3.0801 9.3360 0.0 0
M  V30 21 C 2.3101 10.6697 0.0 0
M  V30 22 C 2.3101 8.0023 0.0 0
M  V30 23 C 0.7700 10.6697 0.0 0
M  V30 24 C 0.7700 8.0023 0.0 0
M  V30 25 C 0.0000 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 1 5 12
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5447-02-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214424-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16613705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used (stage 1), product is further polymerized
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrocatechol-modified resins for boron recovery from water: Synthesis,
adsorption and isotopic separation studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lyu, Jiafei; Zeng, Zhouliangzi; Zhang, Nan; Liu, Hongxu; Bai, Peng; Guo,
Xianghai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Reactive & Functional Polymers (2017), 1121-8

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-chloro-3-pyridinecarboxylate
C10H12ClNO2
232951-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9301 4.0010 0.0 0
M  V30 5 C 6.9301 5.5410 0.0 0
M  V30 6 C 8.4701 4.0010 0.0 0
M  V30 7 C 6.9301 2.4609 0.0 0
M  V30 8 Cl 3.0800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 11 C 2.3100 4.0010 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 0.7700 4.0010 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-(methylamino)-3-pyridinecarboxylate
C11H16N2O2
338990-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.3900 5.3349 0.0 0
M  V30 3 O 5.3900 2.6674 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 C 6.9300 3.7949 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 6.9300 6.8749 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 N 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 232951-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 338990-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1136895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and antifungal activity of a novel water soluble
prodrug of antifungal triazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohwada, Jun; Tsukazaki, Masao; Hayase, Tadakatsu; Oikawa, Nobuhiro;
Isshiki, Yoshiaki; Fukuda, Hiroshi; Mizuguchi, Eisaku; Sakaitani,
Masahiro; Shiratori, Yasuhiko; Yamazaki, Toshikazu; Ichihara, Shigeyasu;
Umeda, Isao; Shimma, Nobuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(2), 191-196

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyanobenzaldehyde
C8H5NO
24964-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methyl]benzonitrile
C9H10N2
90389-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 0.0000 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24964-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90389-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3847830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. Table I, Entry 10, yield 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-5-pyrimidinecarboxaldehyde
C5H2Cl2N2O
5305-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 Cl 3.0800 5.3349 0.0 0
M  V30 4 Cl 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6675 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(methylamino)-5-pyrimidinecarboxaldehyde
C6H6ClN3O
14160-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6687 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 N 4.0012 4.6201 0.0 0
M  V30 9 C 1.3338 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 N 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5305-40-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14160-94-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9379806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as
dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Guozhang; Searle, Lily Lee; Hughes, Terry V.; Beck, Amanda K.;
Connolly, Peter J.; Abad, Marta C.; Neeper, Michael P.; Struble, Geoffrey
T.; Springer, Barry A.; Emanuel, Stuart L.; Gruninger, Robert H.; Pandey,
Niranjan; Adams, Mary; Moreno-Mazza, Sandra; Fuentes-Pesquera, Angel R.;
Middleton, Steven A.; Greenberger, Lee M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(12), 3495-3499

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl nitroacetate
C4H7NO4
626-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitroacetamide
C3H6N2O3
72078-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72078-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4064424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Organocatalyzed Knoevenagel Condensation/1,3-Dipolar Cycloaddition
towards Highly Functionalized Fused 1,2,3-Triazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM John, Jubi; Thomas, Joice; Parekh, Nikita; Dehaen, Wim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2015), 2015(22), 4922-4930

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl nitroacetate
C4H7NO4
626-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitroacetamide
C3H6N2O3
72078-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72078-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5609512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A metal-free three-component reaction for the regioselective synthesis of
1,4,5-trisubstituted 1,2,3-triazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomas, Joice; John, Jubi; Parekh, Nikita; Dehaen, Wim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2014), 53(38), 10155-10159

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-[4-(2-Bromoethoxy)phenyl]-2-phenyl-1-buten-1-yl]phenol
C24H23BrO2
147323-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 C 5.3900 8.0021 0.0 0
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 O 11.5500 5.3347 0.0 0
M  V30 6 C 12.3200 6.6684 0.0 0
M  V30 7 C 13.8600 6.6684 0.0 0
M  V30 8 Br 14.6300 8.0021 0.0 0
M  V30 9 O 2.3100 0.0000 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.0800 4.0011 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 2.3100 2.6674 0.0 0
M  V30 20 C 4.6200 1.3336 0.0 0
M  V30 21 C 3.0800 1.3336 0.0 0
M  V30 22 C 3.0800 6.6684 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 2.3100 8.0021 0.0 0
M  V30 25 C 0.7700 5.3347 0.0 0
M  V30 26 C 0.7700 8.0021 0.0 0
M  V30 27 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 2 22
M  V30 6 1 3 4
M  V30 7 1 5 6
M  V30 8 1 5 15
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 9 21
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
C25H27NO2
110025-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 C 5.3900 8.0021 0.0 0
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 O 11.5500 5.3347 0.0 0
M  V30 6 C 12.3200 6.6684 0.0 0
M  V30 7 C 13.8600 6.6684 0.0 0
M  V30 8 N 14.6300 8.0021 0.0 0
M  V30 9 C 16.1700 8.0021 0.0 0
M  V30 10 O 2.3100 0.0000 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 4.6200 1.3336 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 3.0800 1.3336 0.0 0
M  V30 23 C 3.0800 6.6684 0.0 0
M  V30 24 C 2.3100 8.0021 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 0.7700 8.0021 0.0 0
M  V30 27 C 0.7700 5.3347 0.0 0
M  V30 28 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 2 23
M  V30 6 1 3 4
M  V30 7 1 5 6
M  V30 8 1 5 16
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 10 22
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147323-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 110025-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9584102
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a
Novel Active Metabolite of Tamoxifen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Michael D.; Zuo, Hong; Lee, Kyung-Hoon; Trebley, Joseph P.; Rae,
James Michael; Weatherman, Ross V.; Desta, Zeruesanay; Flockhart, David
A.; Skaar, Todd C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Breast Cancer Research and Treatment (2004), 85(2), 151-159

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[(3aS,4R,6aS)-3a,6a-dihydro-2,2-dimethyl-6a-[(triphenylmethoxy)met...
C33H29ClN4O3
661463-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.8479 0.0 0
M  V30 2 O 6.1600 4.8479 0.0 0
M  V30 3 C 6.9300 3.5143 0.0 0
M  V30 4 C 8.2094 0.0000 0.0 0
M  V30 5 C 10.2704 0.0000 0.0 0
M  V30 6 Cl 16.2763 8.2532 0.0 0
M  V30 7 C 4.6200 3.3079 0.0 0
M  V30 8 C 5.9536 2.5379 0.0 0
M  V30 9 C 3.2862 2.5379 0.0 0
M  V30 10 C 5.9536 0.9979 0.0 0
M  V30 11 C 3.2862 0.9979 0.0 0
M  V30 12 C 4.6200 0.2279 0.0 0
M  V30 13 C 3.0800 4.8479 0.0 0
M  V30 14 C 2.3100 6.1817 0.0 0
M  V30 15 C 2.3100 3.5143 0.0 0
M  V30 16 C 0.7700 6.1817 0.0 0
M  V30 17 C 0.7700 3.5143 0.0 0
M  V30 18 C 0.0000 4.8479 0.0 0
M  V30 19 C 4.6200 6.3879 0.0 0
M  V30 20 C 3.2862 7.1579 0.0 0
M  V30 21 C 5.9536 7.1579 0.0 0
M  V30 22 C 3.2862 8.6979 0.0 0
M  V30 23 C 5.9536 8.6979 0.0 0
M  V30 24 C 4.6200 9.4679 0.0 0
M  V30 25 C 8.4700 3.5143 0.0 0 CFG=1
M  V30 26 C 10.0100 3.5143 0.0 0 CFG=1
M  V30 27 C 7.9940 4.9790 0.0 0
M  V30 28 O 7.9940 2.0496 0.0 0
M  V30 29 C 10.4859 4.9790 0.0 0 CFG=2
M  V30 30 O 10.4859 2.0496 0.0 0
M  V30 31 C 9.2400 5.8840 0.0 0
M  V30 32 C 9.2400 1.1445 0.0 0
M  V30 33 N 11.9504 5.4548 0.0 0
M  V30 34 C 12.4263 6.9194 0.0 0
M  V30 35 C 13.1963 4.5496 0.0 0
M  V30 36 C 13.9663 6.9194 0.0 0
M  V30 37 N 11.6563 8.2532 0.0 0
M  V30 38 N 14.4423 5.4548 0.0 0
M  V30 39 C 14.7363 8.2532 0.0 0
M  V30 40 C 12.4263 9.5868 0.0 0
M  V30 41 N 13.9663 9.5868 0.0 0
M  V30 42 H 11.5500 3.5143 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 3
M  V30 6 1 25 3 CFG=1
M  V30 7 1 4 32
M  V30 8 1 5 32
M  V30 9 1 6 39
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 1 26 42 CFG=1
M  V30 34 2 27 31
M  V30 35 1 28 32
M  V30 36 1 29 31
M  V30 37 1 29 33 CFG=1
M  V30 38 1 30 32
M  V30 39 1 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 34 37
M  V30 43 2 35 38
M  V30 44 1 36 38
M  V30 45 2 36 39
M  V30 46 1 37 40
M  V30 47 1 39 41
M  V30 48 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 26 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[(3aS,4R,6aS)-3a,6a-Dihydro-2,2-dimethyl-6a-[(triphenylmethoxy)methyl]-4H-c...
C34H33N5O3
661463-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 7.0238 0.0 0
M  V30 2 O 5.3348 6.2538 0.0 0
M  V30 3 C 5.3348 4.7137 0.0 0
M  V30 4 C 4.6857 1.0304 0.0 0
M  V30 5 C 6.4706 0.0000 0.0 0
M  V30 6 N 15.7986 4.1444 0.0 0
M  V30 7 C 17.1323 4.9144 0.0 0
M  V30 8 C 4.7710 8.3575 0.0 0
M  V30 9 C 4.0010 9.6911 0.0 0
M  V30 10 C 6.3111 8.3575 0.0 0
M  V30 11 C 4.7710 11.0248 0.0 0
M  V30 12 C 7.0811 9.6911 0.0 0
M  V30 13 C 6.3111 11.0248 0.0 0
M  V30 14 C 2.6673 7.7938 0.0 0
M  V30 15 C 2.6673 9.3338 0.0 0
M  V30 16 C 1.3337 7.0238 0.0 0
M  V30 17 C 1.3337 10.1039 0.0 0
M  V30 18 C 0.0000 7.7938 0.0 0
M  V30 19 C 0.0000 9.3338 0.0 0
M  V30 20 C 3.2310 5.6900 0.0 0
M  V30 21 C 4.0010 4.3563 0.0 0
M  V30 22 C 1.6910 5.6900 0.0 0
M  V30 23 C 3.2310 3.0226 0.0 0
M  V30 24 C 0.9209 4.3563 0.0 0
M  V30 25 C 1.6910 3.0226 0.0 0
M  V30 26 C 6.6685 3.9437 0.0 0 CFG=2
M  V30 27 C 8.0022 3.1737 0.0 0 CFG=1
M  V30 28 O 5.5239 2.9131 0.0 0
M  V30 29 C 6.9887 5.4500 0.0 0
M  V30 30 C 9.1467 4.2041 0.0 0 CFG=2
M  V30 31 O 7.6820 1.6672 0.0 0
M  V30 32 C 6.1504 1.5063 0.0 0
M  V30 33 C 8.5202 5.6111 0.0 0
M  V30 34 N 10.6530 3.8840 0.0 0
M  V30 35 C 11.7974 4.9144 0.0 0
M  V30 36 C 11.2794 2.4770 0.0 0
M  V30 37 C 13.1313 4.1444 0.0 0
M  V30 38 N 11.7974 6.4544 0.0 0
M  V30 39 N 12.8111 2.6381 0.0 0
M  V30 40 C 14.4649 4.9144 0.0 0
M  V30 41 C 13.1313 7.2245 0.0 0
M  V30 42 N 14.4649 6.4544 0.0 0
M  V30 43 H 9.3358 2.4037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 3
M  V30 6 1 26 3 CFG=1
M  V30 7 1 4 32
M  V30 8 1 5 32
M  V30 9 1 6 7
M  V30 10 1 6 40
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 43 CFG=1
M  V30 35 1 28 32
M  V30 36 2 29 33
M  V30 37 1 30 33
M  V30 38 1 30 34 CFG=1
M  V30 39 1 31 32
M  V30 40 1 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 2 35 38
M  V30 44 2 36 39
M  V30 45 1 37 39
M  V30 46 2 37 40
M  V30 47 1 38 41
M  V30 48 1 40 42
M  V30 49 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 27 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 661463-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 661463-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1141470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of apio analogues of neplanocin A as potential inhibitors of
S-adenosylhomocysteine hydrolase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Jeong A.; Yoo, Byul Nae; Choi, Won Jun; Moon, Hyung Ryong; Jeong,
Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Research Supplement (2003), 315-16

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
8-Bromo-4-quinolinecarboxylic acid
C10H6BrNO2
121490-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0800 0.0 0
M  V30 2 O 8.0021 2.3100 0.0 0
M  V30 3 O 6.6685 4.6200 0.0 0
M  V30 4 Br 0.0000 2.3100 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 N 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 0.7700 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-4-quinolinecarboxamide
C11H9BrN2O
1476076-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 Br 0.0000 2.3100 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 2.6675 0.7700 0.0 0
M  V30 11 C 1.3337 3.0800 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 4.0011 0.0000 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 121490-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1476076-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13469217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl-substituted propylaminopyrimidine derivatives
as DNA-PK inhibitors for the treatment cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charifson, Paul S.; Cottrell, Kevin Michael; Deng, Hongbo; Duffy, John
P.; Gao, Huai; Giroux, Simon; Green, Jeremy; Jackson, Katrina Lee;
Kennedy, Joseph M.; Lauffer, David J.; Ledeboer, Mark Willem; Li, Pan;
Maxwell, John Patrick; Morris, Mark A.; Pierce, Albert Charles; Waal,
Nathan D.; Xu, Jinwang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20140045869 A1 2014-02-13

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[5-[(1,1-Dimethylethoxy)carbonyl]-2-methylphenyl]-2-(4-fluorophenyl)furo[2,...
C26H22FNO5
1215107-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.9439 1.1444 0.0 0
M  V30 2 O 12.9133 0.0000 0.0 0
M  V30 3 O 15.4502 0.8242 0.0 0
M  V30 4 C 9.3358 0.0049 0.0 0
M  V30 5 C 4.0010 3.0850 0.0 0
M  V30 6 O 2.6673 2.3150 0.0 0
M  V30 7 O 4.0010 4.6250 0.0 0
M  V30 8 C 1.3337 3.0850 0.0 0
M  V30 9 C 2.1037 4.4187 0.0 0
M  V30 10 C 0.0000 3.8550 0.0 0
M  V30 11 C 0.5637 1.7513 0.0 0
M  V30 12 F 20.5333 3.8550 0.0 0
M  V30 13 C 12.0033 3.0850 0.0 0
M  V30 14 C 13.4679 2.6091 0.0 0
M  V30 15 C 12.0033 4.6250 0.0 0
M  V30 16 C 10.6697 2.3150 0.0 0
M  V30 17 C 14.3731 3.8550 0.0 0
M  V30 18 O 13.4679 5.1009 0.0 0
M  V30 19 N 10.6697 5.3950 0.0 0
M  V30 20 C 9.3358 3.0850 0.0 0
M  V30 21 C 9.3358 4.6250 0.0 0
M  V30 22 C 15.9132 3.8550 0.0 0
M  V30 23 C 16.6832 5.1887 0.0 0
M  V30 24 C 16.6832 2.5213 0.0 0
M  V30 25 C 18.2232 5.1887 0.0 0
M  V30 26 C 18.2232 2.5213 0.0 0
M  V30 27 C 18.9932 3.8550 0.0 0
M  V30 28 C 8.0022 2.3150 0.0 0
M  V30 29 C 6.6685 3.0850 0.0 0
M  V30 30 C 8.0022 0.7749 0.0 0
M  V30 31 C 5.3348 2.3150 0.0 0
M  V30 32 C 6.6685 0.0049 0.0 0
M  V30 33 C 5.3348 0.7749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 30
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 31
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 18
M  V30 21 1 17 22
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 20 28
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-(4-fluorophenyl)-3-[(methylamino)carbonyl]furo[2,3-b]p...
C27H25FN2O4
1215107-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5893 2.6091 0.0 0
M  V30 2 N 7.6199 1.4646 0.0 0
M  V30 3 O 5.0830 2.2890 0.0 0
M  V30 4 C 7.1439 0.0000 0.0 0
M  V30 5 C 11.1974 1.4695 0.0 0
M  V30 6 C 16.5323 4.5496 0.0 0
M  V30 7 O 17.8659 3.7796 0.0 0
M  V30 8 O 16.5323 6.0896 0.0 0
M  V30 9 C 19.1996 4.5496 0.0 0
M  V30 10 C 19.9696 3.2159 0.0 0
M  V30 11 C 20.5333 5.3196 0.0 0
M  V30 12 C 18.4296 5.8834 0.0 0
M  V30 13 F 0.0000 5.3196 0.0 0
M  V30 14 C 8.5299 4.5496 0.0 0
M  V30 15 C 7.0654 4.0737 0.0 0
M  V30 16 C 8.5299 6.0896 0.0 0
M  V30 17 C 9.8636 3.7796 0.0 0
M  V30 18 C 6.1601 5.3196 0.0 0
M  V30 19 O 7.0654 6.5656 0.0 0
M  V30 20 N 9.8636 6.8596 0.0 0
M  V30 21 C 11.1974 4.5496 0.0 0
M  V30 22 C 11.1974 6.0896 0.0 0
M  V30 23 C 4.6201 5.3196 0.0 0
M  V30 24 C 3.8501 3.9859 0.0 0
M  V30 25 C 3.8501 6.6534 0.0 0
M  V30 26 C 2.3101 3.9859 0.0 0
M  V30 27 C 2.3101 6.6534 0.0 0
M  V30 28 C 1.5400 5.3196 0.0 0
M  V30 29 C 12.5311 3.7796 0.0 0
M  V30 30 C 13.8648 4.5496 0.0 0
M  V30 31 C 12.5311 2.2395 0.0 0
M  V30 32 C 15.1984 3.7796 0.0 0
M  V30 33 C 13.8648 1.4695 0.0 0
M  V30 34 C 15.1984 2.2395 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 31
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 32
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 28
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 18 23
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1215107-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215107-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13065504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8: Preparation of tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate.
HATU (209 mg, 0.550 mmol) was added to a stirring solution of methanamine
(1.2 mL, 2.4 mmol, 2M in THF), DIEA (240 μL, 1.37 mmol) and
5-(5-(tert-butoxycarbonyl)-2-methylphenyl)-2-(4-fluorophenyl)furo[2,3-b]pyridine-3-carboxylic
acid (205 mg, 0.458 mmol) in DMF (4.5 mL) at rt. It was allowed to stir
for 1 hour. The mixture was diluted with EtOAc and washed with sat NaCl.
The organic phase was dried over Na2SO4, filtered and concentrated and
was purified on silica gel (Biotage, EtOAc/hexanes gradient, fraction
collection at λ = 254 nm) to give the expected product tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate
(190 mg, 0.413 mmol, 90% yield) consistent by LCMS and NMR. LC data was
recorded on a Shimadzu LC-10AS liquid chromatograph equipped with a
Waters SunFire 5u C18 4.6×50mm column using a SPD-10AV UV-Vis detector at
a detector wave length of 220nM. The elution conditions employed a flow
rate of 5 ml/min, a gradient of 100% solvent A / 0% solvent B to 0%
solvent A / 100% solvent B, a gradient time of 3 min, a hold time of 1
min, and an analysis time of 4 min where solvent A was 10% acetonitrile /
90% H2O / 0.1% trifluoroacetic acid and solvent B was 10% H2O / 90%
acetonitrile / 0.1% trifluoroacetic acid. M S data was determined using a
Micromass Platform for LC in electro spray mode. 1H NMR (400 MHz, MeOD) d
ppm 8.28 (1 H, d, J=2.26 Hz), 8.08 (1 H, d, J=2.01 Hz), 7.99 - 8.06 (2 H,
m), 7.92 (1 H, dd, J=8.03, 1.76 Hz), 7.86 (1 H, d, J=1.51 Hz), 7.45 (1 H,
d, J=8.03 Hz), 7.30 (2 H, t, J=8.78 Hz), 2.95 (3 H, s), 2.34 (3 H, s),
1.60 (9 H, s). LC-MS retention time: 2.70 min; m/z (MH+): 461.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine, imidazolopyridine, indole,
benzothiophene, and furopyridine compounds useful for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pracitto, Richard; Kadow, John F.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine; Han, Ying; Hewawasam, Piyasena; Nickel, Andrew;
Parcella, Kyle E.; Yeung, Kap-Sun; Chupak, Louis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011112186 A1 2011-09-15

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[5-[(1,1-Dimethylethoxy)carbonyl]-2-methylphenyl]-2-(4-fluorophenyl)furo[2,...
C26H22FNO5
1215107-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.9439 1.1444 0.0 0
M  V30 2 O 12.9133 0.0000 0.0 0
M  V30 3 O 15.4502 0.8242 0.0 0
M  V30 4 C 9.3358 0.0049 0.0 0
M  V30 5 C 4.0010 3.0850 0.0 0
M  V30 6 O 2.6673 2.3150 0.0 0
M  V30 7 O 4.0010 4.6250 0.0 0
M  V30 8 C 1.3337 3.0850 0.0 0
M  V30 9 C 2.1037 4.4187 0.0 0
M  V30 10 C 0.0000 3.8550 0.0 0
M  V30 11 C 0.5637 1.7513 0.0 0
M  V30 12 F 20.5333 3.8550 0.0 0
M  V30 13 C 12.0033 3.0850 0.0 0
M  V30 14 C 13.4679 2.6091 0.0 0
M  V30 15 C 12.0033 4.6250 0.0 0
M  V30 16 C 10.6697 2.3150 0.0 0
M  V30 17 C 14.3731 3.8550 0.0 0
M  V30 18 O 13.4679 5.1009 0.0 0
M  V30 19 N 10.6697 5.3950 0.0 0
M  V30 20 C 9.3358 3.0850 0.0 0
M  V30 21 C 9.3358 4.6250 0.0 0
M  V30 22 C 15.9132 3.8550 0.0 0
M  V30 23 C 16.6832 5.1887 0.0 0
M  V30 24 C 16.6832 2.5213 0.0 0
M  V30 25 C 18.2232 5.1887 0.0 0
M  V30 26 C 18.2232 2.5213 0.0 0
M  V30 27 C 18.9932 3.8550 0.0 0
M  V30 28 C 8.0022 2.3150 0.0 0
M  V30 29 C 6.6685 3.0850 0.0 0
M  V30 30 C 8.0022 0.7749 0.0 0
M  V30 31 C 5.3348 2.3150 0.0 0
M  V30 32 C 6.6685 0.0049 0.0 0
M  V30 33 C 5.3348 0.7749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 30
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 31
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 18
M  V30 21 1 17 22
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 20 28
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-(4-fluorophenyl)-3-[(methylamino)carbonyl]furo[2,3-b]p...
C27H25FN2O4
1215107-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5893 2.6091 0.0 0
M  V30 2 N 7.6199 1.4646 0.0 0
M  V30 3 O 5.0830 2.2890 0.0 0
M  V30 4 C 7.1439 0.0000 0.0 0
M  V30 5 C 11.1974 1.4695 0.0 0
M  V30 6 C 16.5323 4.5496 0.0 0
M  V30 7 O 17.8659 3.7796 0.0 0
M  V30 8 O 16.5323 6.0896 0.0 0
M  V30 9 C 19.1996 4.5496 0.0 0
M  V30 10 C 19.9696 3.2159 0.0 0
M  V30 11 C 20.5333 5.3196 0.0 0
M  V30 12 C 18.4296 5.8834 0.0 0
M  V30 13 F 0.0000 5.3196 0.0 0
M  V30 14 C 8.5299 4.5496 0.0 0
M  V30 15 C 7.0654 4.0737 0.0 0
M  V30 16 C 8.5299 6.0896 0.0 0
M  V30 17 C 9.8636 3.7796 0.0 0
M  V30 18 C 6.1601 5.3196 0.0 0
M  V30 19 O 7.0654 6.5656 0.0 0
M  V30 20 N 9.8636 6.8596 0.0 0
M  V30 21 C 11.1974 4.5496 0.0 0
M  V30 22 C 11.1974 6.0896 0.0 0
M  V30 23 C 4.6201 5.3196 0.0 0
M  V30 24 C 3.8501 3.9859 0.0 0
M  V30 25 C 3.8501 6.6534 0.0 0
M  V30 26 C 2.3101 3.9859 0.0 0
M  V30 27 C 2.3101 6.6534 0.0 0
M  V30 28 C 1.5400 5.3196 0.0 0
M  V30 29 C 12.5311 3.7796 0.0 0
M  V30 30 C 13.8648 4.5496 0.0 0
M  V30 31 C 12.5311 2.2395 0.0 0
M  V30 32 C 15.1984 3.7796 0.0 0
M  V30 33 C 13.8648 1.4695 0.0 0
M  V30 34 C 15.1984 2.2395 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 31
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 32
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 28
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 18 23
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1215107-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215107-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14522909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8: Preparation of tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate.
HATU (209 mg, 0.550 mmol) was added to a stirring solution of methanamine
(1.2 mL, 2.4 mmol, 2M in THF), DIEA (240 μL, 1.37 mmol) and
5-(5-(tert-butoxycarbonyl)-2-methylphenyl)-2-(4-fluorophenyl)furo[2,3-b]pyridine-3-carboxylic
acid (205 mg, 0.458 mmol) in DMF (4.5 mL) at rt. It was allowed to stir
for 1 hour. The mixture was diluted with EtOAc and washed with sat NaCl.
The organic phase was dried over Na2SO4, filtered and concentrated and
was purified on silica gel (Biotage, EtOAc/hexanes gradient, fraction
collection at λ =254nm) to give the expected product tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate
(190 mg, 0.413 mmol, 90% yield) consistent by LCMS and NMR. tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate,
yield 190 mg, 0.413 mmol, 90%. 1H NMR (400 MHz, MeOD) δ ppm 8.28 (1H, d,
J=2.26 Hz), 8.08 (1H, d, J=2.01 Hz), 7.99-8.06 (2H, m), 7.92 (1H, dd,
J=8.03, 1.76 Hz), 7.86 (1H, d, J=1.51 Hz), 7.45 (1H, d, J=8.03 Hz), 7.30
(2H, t, J=8.78 Hz), 2.95 (3H, s), 2.34 (3H, s), 1.60 (9H, s). LC-MS
retention time: 2.70 min; m/z (MH+): 461. LC data was recorded on a
Shimadzu LC-10AS liquid chromatograph equipped with a Waters SunFire 5 u
C18 4.6x50 mm column using a SPD-10AV UV-Vis detector at a detector wave
length of 220 nM. The elution conditions employed a flow rate of 5
ml/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100%
solvent B, a gradient time of 3 min, a hold time of 1 min, and an
analysis time of 4 min where solventA was 10% acetonitrile/90% H2O/0.1%
trifluoroacetic acid and solvent B was 10% H2O/90% acetonitrile/0.1%
trifluoroacetic acid. MS data was determined using a Micromass Platform
for LC in electrospray mode.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine, imidazolopyridine, indole,
benzothiophene, and furopyridine compounds useful for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pracitto, Richard; Kadow, John F.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Nickel,
Andrew; Parcella, Kyle E.; Yeung, Kap-Sun; Chupak, Louis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100184800 A1 2010-07-22

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[5-[(1,1-Dimethylethoxy)carbonyl]-2-methylphenyl]-2-(4-fluorophenyl)furo[2,...
C26H22FNO5
1215107-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.9439 1.1444 0.0 0
M  V30 2 O 12.9133 0.0000 0.0 0
M  V30 3 O 15.4502 0.8242 0.0 0
M  V30 4 C 9.3358 0.0049 0.0 0
M  V30 5 C 4.0010 3.0850 0.0 0
M  V30 6 O 2.6673 2.3150 0.0 0
M  V30 7 O 4.0010 4.6250 0.0 0
M  V30 8 C 1.3337 3.0850 0.0 0
M  V30 9 C 2.1037 4.4187 0.0 0
M  V30 10 C 0.0000 3.8550 0.0 0
M  V30 11 C 0.5637 1.7513 0.0 0
M  V30 12 F 20.5333 3.8550 0.0 0
M  V30 13 C 12.0033 3.0850 0.0 0
M  V30 14 C 13.4679 2.6091 0.0 0
M  V30 15 C 12.0033 4.6250 0.0 0
M  V30 16 C 10.6697 2.3150 0.0 0
M  V30 17 C 14.3731 3.8550 0.0 0
M  V30 18 O 13.4679 5.1009 0.0 0
M  V30 19 N 10.6697 5.3950 0.0 0
M  V30 20 C 9.3358 3.0850 0.0 0
M  V30 21 C 9.3358 4.6250 0.0 0
M  V30 22 C 15.9132 3.8550 0.0 0
M  V30 23 C 16.6832 5.1887 0.0 0
M  V30 24 C 16.6832 2.5213 0.0 0
M  V30 25 C 18.2232 5.1887 0.0 0
M  V30 26 C 18.2232 2.5213 0.0 0
M  V30 27 C 18.9932 3.8550 0.0 0
M  V30 28 C 8.0022 2.3150 0.0 0
M  V30 29 C 6.6685 3.0850 0.0 0
M  V30 30 C 8.0022 0.7749 0.0 0
M  V30 31 C 5.3348 2.3150 0.0 0
M  V30 32 C 6.6685 0.0049 0.0 0
M  V30 33 C 5.3348 0.7749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 30
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 31
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 27
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 18
M  V30 21 1 17 22
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 20 28
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-(4-fluorophenyl)-3-[(methylamino)carbonyl]furo[2,3-b]p...
C27H25FN2O4
1215107-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5893 2.6091 0.0 0
M  V30 2 N 7.6199 1.4646 0.0 0
M  V30 3 O 5.0830 2.2890 0.0 0
M  V30 4 C 7.1439 0.0000 0.0 0
M  V30 5 C 11.1974 1.4695 0.0 0
M  V30 6 C 16.5323 4.5496 0.0 0
M  V30 7 O 17.8659 3.7796 0.0 0
M  V30 8 O 16.5323 6.0896 0.0 0
M  V30 9 C 19.1996 4.5496 0.0 0
M  V30 10 C 19.9696 3.2159 0.0 0
M  V30 11 C 20.5333 5.3196 0.0 0
M  V30 12 C 18.4296 5.8834 0.0 0
M  V30 13 F 0.0000 5.3196 0.0 0
M  V30 14 C 8.5299 4.5496 0.0 0
M  V30 15 C 7.0654 4.0737 0.0 0
M  V30 16 C 8.5299 6.0896 0.0 0
M  V30 17 C 9.8636 3.7796 0.0 0
M  V30 18 C 6.1601 5.3196 0.0 0
M  V30 19 O 7.0654 6.5656 0.0 0
M  V30 20 N 9.8636 6.8596 0.0 0
M  V30 21 C 11.1974 4.5496 0.0 0
M  V30 22 C 11.1974 6.0896 0.0 0
M  V30 23 C 4.6201 5.3196 0.0 0
M  V30 24 C 3.8501 3.9859 0.0 0
M  V30 25 C 3.8501 6.6534 0.0 0
M  V30 26 C 2.3101 3.9859 0.0 0
M  V30 27 C 2.3101 6.6534 0.0 0
M  V30 28 C 1.5400 5.3196 0.0 0
M  V30 29 C 12.5311 3.7796 0.0 0
M  V30 30 C 13.8648 4.5496 0.0 0
M  V30 31 C 12.5311 2.2395 0.0 0
M  V30 32 C 15.1984 3.7796 0.0 0
M  V30 33 C 13.8648 1.4695 0.0 0
M  V30 34 C 15.1984 2.2395 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 31
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 32
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 28
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 18 23
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1215107-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215107-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7926040
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0123] Step 8: Preparation of tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate.
HATU (209 mg, 0.550 mmol) was added to a stirring solution of methanamine
(1.2 mL, 2.4 mmol, 2M in THF), DIEA (240 μL, 1.37 mmol) and
5-(5-(tert-butoxycarbonyl)-2-methylphenyl)-2-(4-fluorophenyl)furo[2,3-b]pyridine-3-carboxylic
acid (205 mg, 0.458 mmol) in DMF (4.5 mL) at rt. It was allowed to stir
for 1 hour. The mixture was diluted with EtOAc and washed with sat NaCl.
The organic phase was dried over Na2SO4, filtered and concentrated and
was purified on silica gel (Biotage, EtOAc/hexanes gradient, fraction
collection at λ=254 nm) to give the expected product tert-butyl
3-(2-(4-fluorophenyl)-3-(methylcarbamoyl)furo[2,3-b]pyridin-5-yl)-4-methylbenzoate
(190 mg, 0.413 mmol, 90% yield) consistent by LCMSand NMR. 1H NMR (400
MHz, MeOD) δ ppm 8.28 (1H, d, J=2.26 Hz), 8.08 (1H, d, J=2.01 Hz),
7.99-8.06 (2H, m), 7.92 (1H, dd, J=8.03, 1.76 Hz), 7.86 (1H, d, J=1.51
Hz), 7.45 (1H, d, J=8.03 Hz), 7.30 (2H, t, J=8.78 Hz), 2.95 (3H, s), 2.34
(3H, s), 1.60 (9H, s). LC-MS retention time: 2.70 min; m/z (MH+): 461. LC
data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped
with a Waters SunFire 5u C18 4.6×50 mm column using a SPD-10AV UV-Vis
detector at a detector wave length of 220 nM. The elution conditions
employed a flow rate of 5 ml/min, a gradient of 100% solvent A/0% solvent
B to 0% solvent A/100% solvent B, a gradient time of 3 min, a hold time
of 1 min, and an analysis time of 4 min where solvent A was 10%
acetonitrile/90% H2O/0.1% trifluoroacetic acid and solvent B was 10%
H2O/90% acetonitrile/0.1% trifluoroacetic acid. MS data was determined
using a Micromass Platform for LC in electrospray mode.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine, imidazolopyridine, indole,
benzothiophene, and furopyridine compounds useful for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pracitto, Richard; Kadow, John F.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Nickel,
Andrew; Parcella, Kyle E.; Yeung, Kap-Sun; Chupak, Louis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100063068 A1 2010-03-11

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
6-[Ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-5-(phenylmethoxy)pyrazolo[1...
C24H22FN3O5S
1215107-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9502 9.3192 0.0 0
M  V30 2 O 11.0948 10.3497 0.0 0
M  V30 3 O 8.4857 9.7952 0.0 0
M  V30 4 O 5.3900 5.3347 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 N 6.9300 2.6674 0.0 0
M  V30 7 S 7.7000 1.3338 0.0 0 VAL=6
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 8.4700 0.0000 0.0 0
M  V30 10 O 9.0336 2.1038 0.0 0
M  V30 11 O 6.3664 0.5638 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 F 17.0121 10.2666 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 N 10.0100 5.3347 0.0 0
M  V30 16 C 10.2704 7.8129 0.0 0
M  V30 17 C 7.7000 6.6685 0.0 0
M  V30 18 N 11.5164 5.6549 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 11.6774 7.1866 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 7.7000 4.0011 0.0 0
M  V30 23 C 13.0110 7.9566 0.0 0
M  V30 24 C 14.3446 7.1866 0.0 0
M  V30 25 C 13.0110 9.4966 0.0 0
M  V30 26 C 15.6784 7.9566 0.0 0
M  V30 27 C 14.3446 10.2666 0.0 0
M  V30 28 C 15.6784 9.4966 0.0 0
M  V30 29 C 3.0800 6.6685 0.0 0
M  V30 30 C 2.3100 5.3347 0.0 0
M  V30 31 C 2.3100 8.0021 0.0 0
M  V30 32 C 0.7700 5.3347 0.0 0
M  V30 33 C 0.7700 8.0021 0.0 0
M  V30 34 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 29
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[Ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-N-methyl-5-(phenylmethoxy)p...
C25H25FN4O4S
1215107-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9502 9.3192 0.0 0
M  V30 2 N 8.4857 9.7950 0.0 0
M  V30 3 O 11.0948 10.3497 0.0 0
M  V30 4 C 8.1655 11.3014 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 4.6200 6.6684 0.0 0
M  V30 7 N 6.9300 2.6674 0.0 0
M  V30 8 S 7.7000 1.3336 0.0 0 VAL=6
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 8.4700 0.0000 0.0 0
M  V30 11 O 9.0336 2.1036 0.0 0
M  V30 12 O 6.3664 0.5636 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 F 17.0121 10.2664 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 10.2704 7.8129 0.0 0
M  V30 17 N 10.0100 5.3347 0.0 0
M  V30 18 C 7.7000 6.6684 0.0 0
M  V30 19 C 11.6774 7.1864 0.0 0
M  V30 20 N 11.5164 5.6549 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 7.7000 4.0011 0.0 0
M  V30 24 C 13.0110 7.9564 0.0 0
M  V30 25 C 13.0110 9.4964 0.0 0
M  V30 26 C 14.3446 7.1864 0.0 0
M  V30 27 C 14.3446 10.2664 0.0 0
M  V30 28 C 15.6784 7.9564 0.0 0
M  V30 29 C 15.6784 9.4964 0.0 0
M  V30 30 C 3.0800 6.6684 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 2.3100 8.0021 0.0 0
M  V30 33 C 0.7700 5.3347 0.0 0
M  V30 34 C 0.7700 8.0021 0.0 0
M  V30 35 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 6 30
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 23
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 14 29
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 20
M  V30 24 1 19 24
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1215107-21-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215107-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7078559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-(benzyloxy)-6-(N-ethylmethylsulfonamido)-2-(4-fluorophenyl)-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide.
5-(Benzyloxy)-6-(N-ethylmethylsulfonamido)-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridine-3-carboxylic
acid (0.1 1 g,0.22mmol, 1 eq), EDCl.HCl (0.048 g, 0.25mmol, 1.1 eq), HOBT
(0.036 g,0.27mmol, 1.2 eq), DIPEA (0.12 ml, 0.68mmol, 3 eq) were
dissolved in dichloromethane and the reaction was stirred at room
temperature for 10 minutes. Then Methylamine (1 Min THF, 0.6 ml, 5 eq)
was added to the above solution and the reaction was stirred at room
temperature for 14 h. Finally, the mixture was diluted with water and the
product was extracted with dichloromethane. The organic layer was washed
with water, dried and concentrated. Yield: 0.1 g (90%). 1HNMR (400MHz,
DMSO-d6): δ 1.06 (t, J = 7.12 Hz, 3H), 2.77 (s, 3H), 3.00 (s, 3H), 3.62
(br m, 2H), 5.30 (s, 2H), 7.307.32 (m, 3H), 7.33 (d, J = 5.8 Hz , 1H),
7.40-7.43 (m,2H), 7.53-7.55 (m, 2H), 7.81 (t, J = 3.52 Hz, 1H), 7.95 (s,
2H), 8.88 (s, 1H). LCMS : (ES+) m/z = 497.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine, imidazolopyridine, indole,
benzothiophene, and furopyridine compounds useful for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pracitto, Richard; Kadow, John F.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine; Han, Ying; Hewawasam, Piyasena; Nickel, Andrew;
Parcella, Kyle E.; Yeung, Kap-Sun; Chupak, Louis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011112186 A1 2011-09-15

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
6-[Ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-5-(phenylmethoxy)pyrazolo[1...
C24H22FN3O5S
1215107-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9502 9.3192 0.0 0
M  V30 2 O 11.0948 10.3497 0.0 0
M  V30 3 O 8.4857 9.7952 0.0 0
M  V30 4 O 5.3900 5.3347 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 N 6.9300 2.6674 0.0 0
M  V30 7 S 7.7000 1.3338 0.0 0 VAL=6
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 8.4700 0.0000 0.0 0
M  V30 10 O 9.0336 2.1038 0.0 0
M  V30 11 O 6.3664 0.5638 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 F 17.0121 10.2666 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 N 10.0100 5.3347 0.0 0
M  V30 16 C 10.2704 7.8129 0.0 0
M  V30 17 C 7.7000 6.6685 0.0 0
M  V30 18 N 11.5164 5.6549 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 11.6774 7.1866 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 7.7000 4.0011 0.0 0
M  V30 23 C 13.0110 7.9566 0.0 0
M  V30 24 C 14.3446 7.1866 0.0 0
M  V30 25 C 13.0110 9.4966 0.0 0
M  V30 26 C 15.6784 7.9566 0.0 0
M  V30 27 C 14.3446 10.2666 0.0 0
M  V30 28 C 15.6784 9.4966 0.0 0
M  V30 29 C 3.0800 6.6685 0.0 0
M  V30 30 C 2.3100 5.3347 0.0 0
M  V30 31 C 2.3100 8.0021 0.0 0
M  V30 32 C 0.7700 5.3347 0.0 0
M  V30 33 C 0.7700 8.0021 0.0 0
M  V30 34 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 29
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[Ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-N-methyl-5-(phenylmethoxy)p...
C25H25FN4O4S
1215107-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9502 9.3192 0.0 0
M  V30 2 N 8.4857 9.7950 0.0 0
M  V30 3 O 11.0948 10.3497 0.0 0
M  V30 4 C 8.1655 11.3014 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 4.6200 6.6684 0.0 0
M  V30 7 N 6.9300 2.6674 0.0 0
M  V30 8 S 7.7000 1.3336 0.0 0 VAL=6
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 8.4700 0.0000 0.0 0
M  V30 11 O 9.0336 2.1036 0.0 0
M  V30 12 O 6.3664 0.5636 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 F 17.0121 10.2664 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 10.2704 7.8129 0.0 0
M  V30 17 N 10.0100 5.3347 0.0 0
M  V30 18 C 7.7000 6.6684 0.0 0
M  V30 19 C 11.6774 7.1864 0.0 0
M  V30 20 N 11.5164 5.6549 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 7.7000 4.0011 0.0 0
M  V30 24 C 13.0110 7.9564 0.0 0
M  V30 25 C 13.0110 9.4964 0.0 0
M  V30 26 C 14.3446 7.1864 0.0 0
M  V30 27 C 14.3446 10.2664 0.0 0
M  V30 28 C 15.6784 7.9564 0.0 0
M  V30 29 C 15.6784 9.4964 0.0 0
M  V30 30 C 3.0800 6.6684 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 2.3100 8.0021 0.0 0
M  V30 33 C 0.7700 5.3347 0.0 0
M  V30 34 C 0.7700 8.0021 0.0 0
M  V30 35 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 6 30
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 23
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 14 29
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 20
M  V30 24 1 19 24
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1215107-21-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215107-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10202860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-(benzyloxy)-6-(N-ethylmethylsulfonamido)-2-(4-fluorophenyl)-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide.
5-(Benzyloxy)-6-(N-ethylmethylsulfonamido)-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridine-3-carboxylic
acid (0.11 g, 0.22 mmol, 1 eq), EDCI.HCl (0.048 g, 0.25 mmol, 1.1 eq),
HOBT (0.036 g, 0.27 mmol, 1.2 eq), DIPEA (0.12 ml, 0.68 mmol, 3 eq) were
dissolved in dichloromethane and the reaction was stirred at room
temperature for 10 minutes. Then Methylamine (1 M in THF, 0.6 ml, 5 eq)
was added to the above solution and the reaction was stirred at room
temperature for 14 h. Finally, the mixture was diluted with water and the
product was extracted with dichloromethane. The organic layer was washed
with water, dried and concentrated. Yield: 0.1 g (90%).
5-(benzyloxy)-6-(N-ethylmethylsulfonamido)-2-(4-fluorophenyl)-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide,
yield 0.1 g, 90%. 1H NMR (400 MHz, DMSO-d6): δ 1.06 (t, J=7. 12 Hz, 3H),
2.77 (s, 3H), 3.00 (s, 3H), 3.62 (brm, 2H), 5.30 (s, 2H), 7.307.32 (m,
3H), 7.33 (d, J=5.8 Hz, 1H), 7.40-7.43 (m, 2H), 7.53-7.55 (m, 2H), 7.81
(t, J=3.52 Hz, 1H), 7.95 (s, 2H), 8.88 (s, 1H). LCMS: (ES+) m/z 497.0
(M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine, imidazolopyridine, indole,
benzothiophene, and furopyridine compounds useful for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pracitto, Richard; Kadow, John F.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Nickel,
Andrew; Parcella, Kyle E.; Yeung, Kap-Sun; Chupak, Louis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100184800 A1 2010-07-22

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
6-[Ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-5-(phenylmethoxy)pyrazolo[1...
C24H22FN3O5S
1215107-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9502 9.3192 0.0 0
M  V30 2 O 11.0948 10.3497 0.0 0
M  V30 3 O 8.4857 9.7952 0.0 0
M  V30 4 O 5.3900 5.3347 0.0 0
M  V30 5 C 4.6200 6.6685 0.0 0
M  V30 6 N 6.9300 2.6674 0.0 0
M  V30 7 S 7.7000 1.3338 0.0 0 VAL=6
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 8.4700 0.0000 0.0 0
M  V30 10 O 9.0336 2.1038 0.0 0
M  V30 11 O 6.3664 0.5638 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 F 17.0121 10.2666 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 N 10.0100 5.3347 0.0 0
M  V30 16 C 10.2704 7.8129 0.0 0
M  V30 17 C 7.7000 6.6685 0.0 0
M  V30 18 N 11.5164 5.6549 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 11.6774 7.1866 0.0 0
M  V30 21 C 6.9300 5.3347 0.0 0
M  V30 22 C 7.7000 4.0011 0.0 0
M  V30 23 C 13.0110 7.9566 0.0 0
M  V30 24 C 14.3446 7.1866 0.0 0
M  V30 25 C 13.0110 9.4966 0.0 0
M  V30 26 C 15.6784 7.9566 0.0 0
M  V30 27 C 14.3446 10.2666 0.0 0
M  V30 28 C 15.6784 9.4966 0.0 0
M  V30 29 C 3.0800 6.6685 0.0 0
M  V30 30 C 2.3100 5.3347 0.0 0
M  V30 31 C 2.3100 8.0021 0.0 0
M  V30 32 C 0.7700 5.3347 0.0 0
M  V30 33 C 0.7700 8.0021 0.0 0
M  V30 34 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 29
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[Ethyl(methylsulfonyl)amino]-2-(4-fluorophenyl)-N-methyl-5-(phenylmethoxy)p...
C25H25FN4O4S
1215107-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9502 9.3192 0.0 0
M  V30 2 N 8.4857 9.7950 0.0 0
M  V30 3 O 11.0948 10.3497 0.0 0
M  V30 4 C 8.1655 11.3014 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 4.6200 6.6684 0.0 0
M  V30 7 N 6.9300 2.6674 0.0 0
M  V30 8 S 7.7000 1.3336 0.0 0 VAL=6
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 8.4700 0.0000 0.0 0
M  V30 11 O 9.0336 2.1036 0.0 0
M  V30 12 O 6.3664 0.5636 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 F 17.0121 10.2664 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 10.2704 7.8129 0.0 0
M  V30 17 N 10.0100 5.3347 0.0 0
M  V30 18 C 7.7000 6.6684 0.0 0
M  V30 19 C 11.6774 7.1864 0.0 0
M  V30 20 N 11.5164 5.6549 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 7.7000 4.0011 0.0 0
M  V30 24 C 13.0110 7.9564 0.0 0
M  V30 25 C 13.0110 9.4964 0.0 0
M  V30 26 C 14.3446 7.1864 0.0 0
M  V30 27 C 14.3446 10.2664 0.0 0
M  V30 28 C 15.6784 7.9564 0.0 0
M  V30 29 C 15.6784 9.4964 0.0 0
M  V30 30 C 3.0800 6.6684 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 2.3100 8.0021 0.0 0
M  V30 33 C 0.7700 5.3347 0.0 0
M  V30 34 C 0.7700 8.0021 0.0 0
M  V30 35 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 6 30
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 23
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 14 29
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 20
M  V30 24 1 19 24
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1215107-21-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215107-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11849512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0142]
5-(benzyloxy)-6-(N-ethylmethylsulfonamido)-2-(4-fluorophenyl)-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide.
5-(Benzyloxy)-6-(N-ethyl
methylsulfonamido)-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridine-3-carboxylic
acid (0.11 g, 0.22 mmol, 1 eq), EDCI.HCl (0.048 g, 0.25 mmol, 1.1 eq),
HOBT (0.036 g, 0.27 mmol, 1.2 eq), DIPEA (0.12 ml, 0.68 mmol, 3 eq) were
dissolved in dichloromethane and the reaction was stirred at room
temperature for 10 minutes. Then Methylamine (1 M in THF, 0.6 ml, 5 eq)
was added to the above solution and the reaction was stirred at room
temperature for 14 h. Finally, the mixture was diluted with water and the
product was extracted with dichloromethane. The organic layer was washed
with water, dried and concentrated. Yield: 0.1 g (90%). 1HNMR (400 MHz,
DMSO-d6): δ 1.06 (t, J=7.12 Hz, 3H), 2.77 (s, 3H), 3.00 (s, 3H), 3.62 (br
m, 2H), 5.30 (s, 2H), 7307.32 (m, 3H), 7.33 (d, J=5.8 Hz, 1H), 7.40-7.43
(m, 21-1), 7.53-7.55 (m, 2H), 7.81 (t, J=3.52 Hz, 1H), 7.95 (s, 2H), 8.88
(s, 1H). LCMS: (ES+) m/z=497.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyridine, imidazolopyridine, indole,
benzothiophene, and furopyridine compounds useful for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pracitto, Richard; Kadow, John F.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Nickel,
Andrew; Parcella, Kyle E.; Yeung, Kap-Sun; Chupak, Louis S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100063068 A1 2010-03-11

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-4-Ethoxy-1,1,1-trifluoro-3-methyl-3-buten-2-one
C7H9F3O2
121781-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 O 6.6685 2.3101 0.0 0
M  V30 8 F 2.1037 3.6437 0.0 0
M  V30 9 F 0.0000 3.0801 0.0 0
M  V30 10 F 0.5637 0.9764 0.0 0
M  V30 11 C 8.0023 1.5400 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-1,1,1-Trifluoro-3-methyl-4-(methylamino)-3-buten-2-one
C6H8F3NO
2055665-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0
M  V30 8 F 2.1037 3.6437 0.0 0
M  V30 9 F 0.0000 3.0801 0.0 0
M  V30 10 F 0.5637 0.9764 0.0 0
M  V30 11 C 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121781-56-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055665-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16537870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The conformational analysis of push-pull enaminones using FTIR and NMR
spectroscopy, and quantum chemical calculations. VI.
β-N-Methyl-aminovinyl trifluoromethyl ketone and
α-methyl-β-N-methylaminovinyl trifluoromethyl ketone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vdovenko, Sergey I.; Gerus, Igor I.; Zhuk, Yuri I.; Kukhar, Valery P.;
Pagacz-Kostrzewa, Magdalena; Wierzejewska, Maria; Daniliuc,
Constantin-Gabriel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2017), 1128741-753

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzyloxy-4-oxo-4H-pyran-2-carboxylic acid
C13H10O5
1219-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 O 5.3900 0.0000 0.0 0
M  V30 4 C 0.7700 2.6674 0.0 0
M  V30 5 O 0.0000 4.0011 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 O 3.0800 4.0011 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 10.0100 5.3349 0.0 0
M  V30 15 C 10.0100 2.6674 0.0 0
M  V30 16 C 11.5500 5.3349 0.0 0
M  V30 17 C 11.5500 2.6674 0.0 0
M  V30 18 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dihydro-1-methyl-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid
C14H13NO4
119736-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 C 2.3100 5.3349 0.0 0
M  V30 5 O 5.3900 0.0000 0.0 0
M  V30 6 O 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 N 3.0800 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 10.0100 5.3349 0.0 0
M  V30 16 C 10.0100 2.6674 0.0 0
M  V30 17 C 11.5500 5.3349 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1219-33-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 119736-19-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-739427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A. Preparation of
5-benzyloxy-1-methyl-4-oxo-1,4-dihydro-pyridine-2-carboxylic acid A
mixture of 5-benzyloxy-4-oxo-4H-pyran-2-carboxylic acid (20.0 g, 81.2
mmol) and a solution of 2M MeNH2 in methanol (162.5 mL, 325 mmol) was
stirred at RT for 16 h. Volatiles were removed under reduced vacuum, and
the residue was dissolved in 70 ml. of de-ionized water. To the ice-cold
mixture was added a 6N HCl solution (13.5 mL, 81.0 mmol) dropwise. The
precipitated solid was collected via filtration, and washed with water
and acetone to give the title compound as a light yellow solid (18.9 g,
90% yield). 1H NMR (400MHz, DMSO-D6) δ (ppm): 7.82 (s, 1 H), 7.45-7.33
(m, 5H), 6.72 (s, 1 H), 5.05 (s, 2H) and 3.84 (s, 3H); MS-ESI (m/z):
259.8 [M+1]+, 91.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fluorinated derivatives of deferiprone as iron chelators
for treating iron-overload diseases including neurodegenerative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tam, Tim Fat; Leung-Toung, Regis; Wang, Yingsheng; Zhao, Yanquing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008116301 A1 2008-10-02

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzoyl chloride
C7H4ClNO3
122-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 Cl 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzamide
C8H8N2O3
2585-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2585-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-22415708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Convenient One-Pot Synthesis of 1,5-Disubstituted Tetrazoles Containing
an Amino or a Carboxy Group
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pokhodylo, N. T.; Shyyka, O. Ya.; Obushak, M. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2020), 56(5), 802-812

$RFMT $RIREG SCHEME52 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Triethyl phosphite
C6H15O3P
122-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0800 4.0011 0.0 0
M  V30 2 O 2.3100 5.3347 0.0 0
M  V30 3 O 4.6200 4.0011 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Euparin
C13H12O3
532-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2447 3.0800 0.0 0
M  V30 2 C 10.0147 4.4137 0.0 0
M  V30 3 C 10.0147 1.7464 0.0 0
M  V30 4 O 1.3338 4.6200 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 O 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 6.7994 1.8341 0.0 0
M  V30 14 C 7.7047 3.0800 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H26NO5P
2283382-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7711 5.3349 0.0 0
M  V30 2 P 4.0011 4.0011 0.0 0 VAL=5
M  V30 3 N 5.5411 4.0011 0.0 0
M  V30 4 C 3.4375 6.1050 0.0 0
M  V30 5 O 3.2311 2.6675 0.0 0
M  V30 6 O 2.6675 4.7711 0.0 0
M  V30 7 O 5.3348 3.2311 0.0 0
M  V30 8 C 7.0812 4.0011 0.0 0
M  V30 9 C 4.0011 1.3338 0.0 0
M  V30 10 C 1.3337 4.0011 0.0 0
M  V30 11 C 3.2311 0.0000 0.0 0
M  V30 12 C 0.0000 4.7711 0.0 0
M  V30 13 O 4.7711 8.4150 0.0 0
M  V30 14 C 12.6821 6.8750 0.0 0
M  V30 15 C 13.4521 8.2086 0.0 0
M  V30 16 C 13.4521 5.5411 0.0 0
M  V30 17 C 6.1048 6.1050 0.0 0
M  V30 18 C 6.1048 7.6450 0.0 0
M  V30 19 C 7.4385 5.3349 0.0 0
M  V30 20 C 7.4385 8.4150 0.0 0
M  V30 21 C 8.7723 6.1050 0.0 0
M  V30 22 C 8.7723 7.6450 0.0 0
M  V30 23 C 10.2368 5.6289 0.0 0
M  V30 24 O 10.2368 8.1208 0.0 0
M  V30 25 C 11.1421 6.8750 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 2 7
M  V30 8 1 3 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 13 18
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 25
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-52-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-48-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2283382-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28646677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-solvent, Kabachnik-Fields reaction, ZnO
nanoparticles used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of α-aminophosphonates using ZnO nanoparticles as an
efficient catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ezzatzadeh, Elham
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2018), 73(3-4), 179-184

$RFMT $RIREG SCHEME53 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenacyl bromide
C8H7BrO
70-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,2-Dimethyl-4-phenyl-1H-pyrrol-3-yl)ethanone
C14H15NO
127327-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 1.1444 0.0 0
M  V30 2 C 2.1559 0.0000 0.0 0
M  V30 3 O 4.6927 0.8242 0.0 0
M  V30 4 C 0.0000 2.1797 0.0 0
M  V30 5 C 0.0000 5.5302 0.0 0
M  V30 6 C 3.6156 3.8549 0.0 0
M  V30 7 C 2.7104 2.6091 0.0 0
M  V30 8 C 2.7104 5.1008 0.0 0
M  V30 9 C 1.2459 3.0849 0.0 0
M  V30 10 N 1.2459 4.6250 0.0 0
M  V30 11 C 5.1556 3.8549 0.0 0
M  V30 12 C 5.9256 5.1886 0.0 0
M  V30 13 C 5.9256 2.5213 0.0 0
M  V30 14 C 7.4657 5.1886 0.0 0
M  V30 15 C 7.4657 2.5213 0.0 0
M  V30 16 C 8.2357 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 127327-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22380910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, catalyst prepared and used, recyclable
catalyst, reusable catalyst used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic Liquid-assisted Preparation of Two-dimensional ZnO/Fe3O4
Nano-composites and their Application in Polysubstituted Pyrroles
Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karami, Hossein; Sabbaghan, Maryam; Hossaini, Zinatossadat;
Rostami-Charati, Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2020), 23(1), 55-65

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [[(4Z)-4,5-dihydro-5-oxo-4-(phenylmethylene)-2-oxazolyl]methyl...
C16H18N2O4
124194-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7844 2.9016 0.0 0
M  V30 2 O 4.4596 0.0000 0.0 0
M  V30 3 C 8.0870 4.0287 0.0 0
M  V30 4 N 9.4208 3.2587 0.0 0
M  V30 5 C 10.7545 4.0287 0.0 0
M  V30 6 O 12.0881 3.2587 0.0 0
M  V30 7 O 10.7545 5.5687 0.0 0
M  V30 8 C 13.4218 4.0287 0.0 0
M  V30 9 C 12.6518 5.3624 0.0 0
M  V30 10 C 14.7556 4.7987 0.0 0
M  V30 11 C 14.1918 2.6950 0.0 0
M  V30 12 C 4.3159 2.7406 0.0 0
M  V30 13 N 5.3465 3.8850 0.0 0
M  V30 14 C 5.0859 1.4070 0.0 0
M  V30 15 C 6.7533 3.2587 0.0 0
M  V30 16 O 6.5924 1.7271 0.0 0
M  V30 17 C 2.1580 4.3085 0.0 0
M  V30 18 C 3.0633 5.5544 0.0 0
M  V30 19 C 0.6265 4.4695 0.0 0
M  V30 20 C 2.4368 6.9612 0.0 0
M  V30 21 C 0.0000 5.8764 0.0 0
M  V30 22 C 0.9052 7.1223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 1 17
M  V30 3 2 2 14
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-[[1-[(methylamino)carbonyl]-2-phenylethenyl]amino]-2-oxoeth...
C17H23N3O4
124194-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 3.0801 4.0012 0.0 0
M  V30 3 N 5.3901 5.3348 0.0 0
M  V30 4 C 5.3901 2.6673 0.0 0
M  V30 5 C 6.9302 5.3348 0.0 0
M  V30 6 N 4.6201 1.3337 0.0 0
M  V30 7 O 6.9302 2.6673 0.0 0
M  V30 8 C 7.7002 6.6685 0.0 0
M  V30 9 O 7.7002 4.0012 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 N 9.2402 6.6685 0.0 0
M  V30 12 C 10.0102 8.0023 0.0 0
M  V30 13 O 11.5503 8.0023 0.0 0
M  V30 14 O 9.2402 9.3360 0.0 0
M  V30 15 C 12.3203 9.3360 0.0 0
M  V30 16 C 10.9866 10.1060 0.0 0
M  V30 17 C 13.0903 10.6697 0.0 0
M  V30 18 C 13.6539 8.5660 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0
M  V30 20 C 3.0801 6.6685 0.0 0
M  V30 21 C 0.7700 5.3348 0.0 0
M  V30 22 C 2.3101 8.0023 0.0 0
M  V30 23 C 0.0000 6.6685 0.0 0
M  V30 24 C 0.7700 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124194-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 124194-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19448093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general method for preparation of N-Boc-protected or N-Fmoc-protected
α,β-didehydropeptide building blocks and their use in the solid-phase
peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolczanski, Grzegorz; Lisowski, Marek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Peptide Science (2018), 24(8-9), n/a

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Difluoromethyl)-1-[4-[4-(ethenylsulfonyl)-1-piperazinyl]-6-(4-morpholinyl)...
C22H26F2N8O4S
1246201-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3984 5.5673 0.0 0
M  V30 2 F 3.5428 4.5369 0.0 0
M  V30 3 F 0.9337 5.0915 0.0 0
M  V30 4 O 0.4759 11.3367 0.0 0
M  V30 5 C 0.0000 12.8013 0.0 0
M  V30 6 S 13.4614 10.0102 0.0 0 VAL=6
M  V30 7 C 14.7950 10.7802 0.0 0
M  V30 8 O 14.2314 8.6763 0.0 0
M  V30 9 O 12.6913 11.3438 0.0 0
M  V30 10 C 16.1287 10.0102 0.0 0
M  V30 11 N 4.1254 7.7001 0.0 0
M  V30 12 C 3.9645 9.2317 0.0 0
M  V30 13 C 2.7186 7.0736 0.0 0
M  V30 14 C 2.4580 9.5518 0.0 0
M  V30 15 C 4.9949 10.3761 0.0 0
M  V30 16 N 1.6880 8.2182 0.0 0
M  V30 17 C 1.9822 11.0166 0.0 0
M  V30 18 C 4.5190 11.8408 0.0 0
M  V30 19 C 3.0127 12.1610 0.0 0
M  V30 20 C 5.4591 6.9301 0.0 0
M  V30 21 N 6.7929 7.7001 0.0 0
M  V30 22 N 5.4591 5.3901 0.0 0
M  V30 23 C 8.1266 6.9301 0.0 0
M  V30 24 C 6.7929 4.6201 0.0 0
M  V30 25 N 8.1266 5.3901 0.0 0
M  V30 26 N 9.4602 7.7001 0.0 0
M  V30 27 C 10.7939 6.9301 0.0 0
M  V30 28 C 9.4602 9.2401 0.0 0
M  V30 29 C 12.1277 7.7001 0.0 0
M  V30 30 C 10.7939 10.0102 0.0 0
M  V30 31 N 12.1277 9.2401 0.0 0
M  V30 32 N 6.7929 3.0800 0.0 0
M  V30 33 C 8.1266 2.3100 0.0 0
M  V30 34 C 5.4591 2.3100 0.0 0
M  V30 35 C 8.1266 0.7700 0.0 0
M  V30 36 C 5.4591 0.7700 0.0 0
M  V30 37 O 6.7929 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 31
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 1 24 32
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanamine, 2-[[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4...
C23H31F2N9O4S
1370416-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3984 5.5673 0.0 0
M  V30 2 F 0.9339 5.0914 0.0 0
M  V30 3 F 3.5429 4.5368 0.0 0
M  V30 4 O 0.4759 11.3366 0.0 0
M  V30 5 C 0.0000 12.8011 0.0 0
M  V30 6 S 13.4613 10.0100 0.0 0 VAL=6
M  V30 7 C 14.7949 10.7800 0.0 0
M  V30 8 O 14.2313 8.6762 0.0 0
M  V30 9 O 12.6913 11.3436 0.0 0
M  V30 10 C 16.1286 10.0100 0.0 0
M  V30 11 N 17.4622 10.7800 0.0 0
M  V30 12 C 18.7960 10.0100 0.0 0
M  V30 13 N 4.1255 7.7000 0.0 0
M  V30 14 C 3.9646 9.2315 0.0 0
M  V30 15 C 2.7186 7.0735 0.0 0
M  V30 16 C 2.4581 9.5517 0.0 0
M  V30 17 C 4.9950 10.3759 0.0 0
M  V30 18 N 1.6881 8.2181 0.0 0
M  V30 19 C 1.9823 11.0164 0.0 0
M  V30 20 C 4.5191 11.8406 0.0 0
M  V30 21 C 3.0127 12.1608 0.0 0
M  V30 22 C 5.4591 6.9300 0.0 0
M  V30 23 N 6.7928 7.7000 0.0 0
M  V30 24 N 5.4591 5.3900 0.0 0
M  V30 25 C 8.1266 6.9300 0.0 0
M  V30 26 C 6.7928 4.6200 0.0 0
M  V30 27 N 8.1266 5.3900 0.0 0
M  V30 28 N 9.4602 7.7000 0.0 0
M  V30 29 C 9.4602 9.2400 0.0 0
M  V30 30 C 10.7939 6.9300 0.0 0
M  V30 31 C 10.7939 10.0100 0.0 0
M  V30 32 C 12.1275 7.7000 0.0 0
M  V30 33 N 12.1275 9.2400 0.0 0
M  V30 34 N 6.7928 3.0800 0.0 0
M  V30 35 C 8.1266 2.3100 0.0 0
M  V30 36 C 5.4591 2.3100 0.0 0
M  V30 37 C 8.1266 0.7700 0.0 0
M  V30 38 C 5.4591 0.7700 0.0 0
M  V30 39 O 6.7928 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 33
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 1 26 34
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1246201-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1370416-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-20320887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of solubilized sulfonamide analogues
of the phosphatidylinositol 3-kinase inhibitor ZSTK474
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giddens, Anna C.; Gamage, Swarna A.; Kendall, Jackie D.; Lee, Woo-Jeong;
Baguley, Bruce C.; Buchanan, Christina M.; Jamieson, Stephen M. F.;
Dickson, James M. J.; Shepherd, Peter R.; Denny, William A.; Rewcastle,
Gordon W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2019), 27(8), 1529-1545

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Difluoromethyl)-1-[4-[4-(ethenylsulfonyl)-1-piperazinyl]-6-(4-morpholinyl)...
C22H26F2N8O4S
1246201-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3984 5.5673 0.0 0
M  V30 2 F 3.5428 4.5369 0.0 0
M  V30 3 F 0.9337 5.0915 0.0 0
M  V30 4 O 0.4759 11.3367 0.0 0
M  V30 5 C 0.0000 12.8013 0.0 0
M  V30 6 S 13.4614 10.0102 0.0 0 VAL=6
M  V30 7 C 14.7950 10.7802 0.0 0
M  V30 8 O 14.2314 8.6763 0.0 0
M  V30 9 O 12.6913 11.3438 0.0 0
M  V30 10 C 16.1287 10.0102 0.0 0
M  V30 11 N 4.1254 7.7001 0.0 0
M  V30 12 C 3.9645 9.2317 0.0 0
M  V30 13 C 2.7186 7.0736 0.0 0
M  V30 14 C 2.4580 9.5518 0.0 0
M  V30 15 C 4.9949 10.3761 0.0 0
M  V30 16 N 1.6880 8.2182 0.0 0
M  V30 17 C 1.9822 11.0166 0.0 0
M  V30 18 C 4.5190 11.8408 0.0 0
M  V30 19 C 3.0127 12.1610 0.0 0
M  V30 20 C 5.4591 6.9301 0.0 0
M  V30 21 N 6.7929 7.7001 0.0 0
M  V30 22 N 5.4591 5.3901 0.0 0
M  V30 23 C 8.1266 6.9301 0.0 0
M  V30 24 C 6.7929 4.6201 0.0 0
M  V30 25 N 8.1266 5.3901 0.0 0
M  V30 26 N 9.4602 7.7001 0.0 0
M  V30 27 C 10.7939 6.9301 0.0 0
M  V30 28 C 9.4602 9.2401 0.0 0
M  V30 29 C 12.1277 7.7001 0.0 0
M  V30 30 C 10.7939 10.0102 0.0 0
M  V30 31 N 12.1277 9.2401 0.0 0
M  V30 32 N 6.7929 3.0800 0.0 0
M  V30 33 C 8.1266 2.3100 0.0 0
M  V30 34 C 5.4591 2.3100 0.0 0
M  V30 35 C 8.1266 0.7700 0.0 0
M  V30 36 C 5.4591 0.7700 0.0 0
M  V30 37 O 6.7929 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 31
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 1 24 32
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanamine, 2-[[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4...
C23H31F2N9O4S
1370416-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3984 5.5673 0.0 0
M  V30 2 F 0.9339 5.0914 0.0 0
M  V30 3 F 3.5429 4.5368 0.0 0
M  V30 4 O 0.4759 11.3366 0.0 0
M  V30 5 C 0.0000 12.8011 0.0 0
M  V30 6 S 13.4613 10.0100 0.0 0 VAL=6
M  V30 7 C 14.7949 10.7800 0.0 0
M  V30 8 O 14.2313 8.6762 0.0 0
M  V30 9 O 12.6913 11.3436 0.0 0
M  V30 10 C 16.1286 10.0100 0.0 0
M  V30 11 N 17.4622 10.7800 0.0 0
M  V30 12 C 18.7960 10.0100 0.0 0
M  V30 13 N 4.1255 7.7000 0.0 0
M  V30 14 C 3.9646 9.2315 0.0 0
M  V30 15 C 2.7186 7.0735 0.0 0
M  V30 16 C 2.4581 9.5517 0.0 0
M  V30 17 C 4.9950 10.3759 0.0 0
M  V30 18 N 1.6881 8.2181 0.0 0
M  V30 19 C 1.9823 11.0164 0.0 0
M  V30 20 C 4.5191 11.8406 0.0 0
M  V30 21 C 3.0127 12.1608 0.0 0
M  V30 22 C 5.4591 6.9300 0.0 0
M  V30 23 N 6.7928 7.7000 0.0 0
M  V30 24 N 5.4591 5.3900 0.0 0
M  V30 25 C 8.1266 6.9300 0.0 0
M  V30 26 C 6.7928 4.6200 0.0 0
M  V30 27 N 8.1266 5.3900 0.0 0
M  V30 28 N 9.4602 7.7000 0.0 0
M  V30 29 C 9.4602 9.2400 0.0 0
M  V30 30 C 10.7939 6.9300 0.0 0
M  V30 31 C 10.7939 10.0100 0.0 0
M  V30 32 C 12.1275 7.7000 0.0 0
M  V30 33 N 12.1275 9.2400 0.0 0
M  V30 34 N 6.7928 3.0800 0.0 0
M  V30 35 C 8.1266 2.3100 0.0 0
M  V30 36 C 5.4591 2.3100 0.0 0
M  V30 37 C 8.1266 0.7700 0.0 0
M  V30 38 C 5.4591 0.7700 0.0 0
M  V30 39 O 6.7928 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 33
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 1 26 34
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1246201-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1370416-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10570272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reaction of
2-(difluoromethyl)-4-methoxy-1-{4-(4-morpholinyl)-6-[4-(vinylsulfonyl)-1-piperazinyl]-1,3,5-triazin-2-yl}-1H-benzimidazole
in THF with a solution of 40% aqueous methylamine at room temperature
gave
N-{4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}-2-(methylamino)ethanesulfonamide
2. Yield 90%.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, product further converted to methanesulfonate salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,3,5-triazinyl-benzimidazole sulfonamides for use in
cancer therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rewcastle, Gordon William; Giddens, Anna Claire; Gamage, Swarnalatha
Akuratiya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012044641 A1 2012-04-05

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-6-Deoxy-6-[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-glucopyranosyl-(1→4)-O-...
C57H97N5O23S
1247067-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  86 89 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 13.6536 8.0021 0.0 0
M  V30 2 N 10.5736 8.0021 0.0 0
M  V30 3 C 9.0336 8.0021 0.0 0
M  V30 4 C 8.2636 6.6684 0.0 0 CFG=1
M  V30 5 O 8.2636 9.3358 0.0 0
M  V30 6 C 6.7236 6.6685 0.0 0
M  V30 7 O 9.0336 5.3347 0.0 0
M  V30 8 C 5.9536 5.3347 0.0 0
M  V30 9 N 4.4136 5.3347 0.0 0
M  V30 10 C 3.6436 4.0011 0.0 0
M  V30 11 O 2.1036 4.0011 0.0 0
M  V30 12 O 4.4136 2.6674 0.0 0
M  V30 13 C 1.3336 2.6674 0.0 0
M  V30 14 C 2.6673 1.8974 0.0 0
M  V30 15 C 0.5636 1.3338 0.0 0
M  V30 16 C 0.0000 3.4374 0.0 0
M  V30 17 O 15.1936 10.6694 0.0 0
M  V30 18 O 13.6536 13.3369 0.0 0
M  V30 19 N 10.5736 13.3369 0.0 0
M  V30 20 C 9.0336 13.3369 0.0 0
M  V30 21 O 8.2636 12.0032 0.0 0
M  V30 22 O 8.2636 14.6705 0.0 0
M  V30 23 C 6.7236 12.0032 0.0 0
M  V30 24 C 6.7236 13.5432 0.0 0
M  V30 25 C 5.1836 12.0032 0.0 0
M  V30 26 C 6.7236 10.4632 0.0 0
M  V30 27 O 15.1936 5.3347 0.0 0
M  V30 28 N 18.2736 5.3347 0.0 0
M  V30 29 C 17.5036 4.0011 0.0 0
M  V30 30 O 18.2736 2.6674 0.0 0
M  V30 31 O 15.9636 4.0011 0.0 0
M  V30 32 C 17.5036 1.3336 0.0 0
M  V30 33 C 16.1700 2.1036 0.0 0
M  V30 34 C 16.7336 0.0000 0.0 0
M  V30 35 C 18.8373 0.5636 0.0 0
M  V30 36 C 18.2736 10.6694 0.0 0
M  V30 37 O 17.5036 12.0031 0.0 0
M  V30 38 S 18.2736 13.3369 0.0 0 VAL=6
M  V30 39 O 19.0436 14.6705 0.0 0
M  V30 40 O 16.9400 14.1069 0.0 0
M  V30 41 O 15.1936 16.0041 0.0 0
M  V30 42 O 19.8136 8.0021 0.0 0
M  V30 43 C 9.0336 16.0041 0.0 0
M  V30 44 N 8.2636 17.3379 0.0 0
M  V30 45 C 6.7236 17.3379 0.0 0
M  V30 46 O 5.9536 18.6716 0.0 0
M  V30 47 O 5.9536 16.0041 0.0 0
M  V30 48 C 4.4136 18.6716 0.0 0
M  V30 49 C 4.4136 20.2116 0.0 0
M  V30 50 C 2.8736 18.6716 0.0 0
M  V30 51 C 4.4136 17.1316 0.0 0
M  V30 52 O 13.6536 18.6716 0.0 0
M  V30 53 O 10.5736 18.6716 0.0 0
M  V30 54 C 20.9411 8.7169 0.0 0
M  V30 55 C 19.6073 9.4869 0.0 0
M  V30 56 C 20.9411 7.1769 0.0 0
M  V30 57 C 23.6084 13.3369 0.0 0
M  V30 58 C 24.9421 14.1069 0.0 0
M  V30 59 C 22.2747 14.1069 0.0 0
M  V30 60 C 26.2758 8.7169 0.0 0
M  V30 61 C 27.6094 9.4869 0.0 0
M  V30 62 C 26.2758 7.1769 0.0 0
M  V30 63 C 12.8836 9.3358 0.0 0 CFG=2
M  V30 64 C 11.3436 9.3358 0.0 0 CFG=2
M  V30 65 C 13.6536 10.6694 0.0 0 CFG=1
M  V30 66 C 10.5736 10.6694 0.0 0
M  V30 67 C 12.8836 12.0031 0.0 0 CFG=2
M  V30 68 C 11.3436 12.0032 0.0 0 CFG=2
M  V30 69 C 15.1936 8.0021 0.0 0 CFG=1
M  V30 70 C 15.9636 6.6684 0.0 0 CFG=2
M  V30 71 O 15.9636 9.3358 0.0 0
M  V30 72 C 17.5036 6.6684 0.0 0 CFG=1
M  V30 73 C 17.5036 9.3358 0.0 0 CFG=2
M  V30 74 C 18.2736 8.0021 0.0 0 CFG=2
M  V30 75 C 12.8836 14.6705 0.0 0 CFG=2
M  V30 76 O 11.3436 14.6705 0.0 0
M  V30 77 C 13.6536 16.0041 0.0 0 CFG=2
M  V30 78 C 10.5736 16.0041 0.0 0 CFG=2
M  V30 79 C 12.8836 17.3379 0.0 0 CFG=1
M  V30 80 C 11.3436 17.3379 0.0 0 CFG=1
M  V30 81 C 22.2747 11.0269 0.0 0
M  V30 82 C 22.2747 9.4869 0.0 0
M  V30 83 C 23.6084 11.7969 0.0 0
M  V30 84 C 23.6084 8.7169 0.0 0
M  V30 85 C 24.9421 11.0269 0.0 0
M  V30 86 C 24.9421 9.4869 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 63 1 CFG=1
M  V30 2 1 69 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 64 2 CFG=3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=1
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 65 17 CFG=3
M  V30 19 1 67 18 CFG=1
M  V30 20 1 75 18 CFG=1
M  V30 21 1 19 20
M  V30 22 1 68 19 CFG=3
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 70 27 CFG=1
M  V30 30 1 28 29
M  V30 31 1 72 28 CFG=3
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 32 35
M  V30 38 1 36 37
M  V30 39 1 73 36 CFG=3
M  V30 40 1 37 38
M  V30 41 2 38 39
M  V30 42 2 38 40
M  V30 43 1 38 81
M  V30 44 1 77 41 CFG=1
M  V30 45 1 74 42 CFG=1
M  V30 46 1 43 44
M  V30 47 1 78 43 CFG=3
M  V30 48 1 44 45
M  V30 49 1 45 46
M  V30 50 2 45 47
M  V30 51 1 46 48
M  V30 52 1 48 49
M  V30 53 1 48 50
M  V30 54 1 48 51
M  V30 55 1 79 52 CFG=3
M  V30 56 1 80 53 CFG=1
M  V30 57 1 54 55
M  V30 58 1 54 56
M  V30 59 1 54 82
M  V30 60 1 57 58
M  V30 61 1 57 59
M  V30 62 1 57 83
M  V30 63 1 60 61
M  V30 64 1 60 62
M  V30 65 1 60 86
M  V30 66 1 63 64
M  V30 67 1 63 65
M  V30 68 1 64 66
M  V30 69 1 65 67
M  V30 70 1 66 68
M  V30 71 1 67 68
M  V30 72 1 69 70
M  V30 73 1 69 71
M  V30 74 1 70 72
M  V30 75 1 71 73
M  V30 76 1 72 74
M  V30 77 1 73 74
M  V30 78 1 75 76
M  V30 79 1 75 77
M  V30 80 1 76 78
M  V30 81 1 77 79
M  V30 82 1 78 80
M  V30 83 1 79 80
M  V30 84 2 81 82
M  V30 85 1 81 83
M  V30 86 1 82 84
M  V30 87 2 83 85
M  V30 88 2 84 86
M  V30 89 1 85 86
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(16 4 63 64 65 67 68 69 70 72 73 74 75 77 78 79 80)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
O-6-Deoxy-6-[[(1,1-dimethylethoxy)carbonyl]amino]-α-D-glucopyranosyl-(1→4)-O-...
C43H78N6O20
1644444-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  69 71 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.6707 12.3203 0.0 0
M  V30 2 N 12.0033 10.7802 0.0 0
M  V30 3 C 10.6697 10.0102 0.0 0
M  V30 4 C 10.6697 8.4702 0.0 0 CFG=1
M  V30 5 O 9.3358 10.7802 0.0 0
M  V30 6 C 9.3358 7.7002 0.0 0
M  V30 7 O 12.0033 7.7002 0.0 0
M  V30 8 C 9.3358 6.1601 0.0 0
M  V30 9 N 8.0022 5.3901 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 O 6.6685 3.0801 0.0 0
M  V30 12 O 9.3358 3.0801 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 5.1285 1.5400 0.0 0
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 C 8.2085 1.5400 0.0 0
M  V30 17 O 14.6707 15.4003 0.0 0
M  V30 18 O 12.0033 16.9404 0.0 0
M  V30 19 N 9.3358 15.4003 0.0 0
M  V30 20 C 8.0022 14.6303 0.0 0
M  V30 21 O 8.0022 13.0903 0.0 0
M  V30 22 O 6.6685 15.4003 0.0 0
M  V30 23 C 6.6685 12.3203 0.0 0
M  V30 24 C 7.4385 10.9866 0.0 0
M  V30 25 C 5.3348 11.5503 0.0 0
M  V30 26 C 5.8985 13.6539 0.0 0
M  V30 27 O 17.3382 10.7802 0.0 0
M  V30 28 N 20.0055 12.3203 0.0 0
M  V30 29 C 21.3393 13.0903 0.0 0
M  V30 30 O 22.6730 12.3203 0.0 0
M  V30 31 O 21.3393 14.6303 0.0 0
M  V30 32 C 24.0067 13.0903 0.0 0
M  V30 33 C 23.2366 14.4240 0.0 0
M  V30 34 C 25.3403 13.8603 0.0 0
M  V30 35 C 24.7767 11.7566 0.0 0
M  V30 36 C 17.3382 16.9404 0.0 0
M  V30 37 N 18.6718 17.7104 0.0 0
M  V30 38 C 18.6718 19.2504 0.0 0
M  V30 39 O 12.0033 20.0204 0.0 0
M  V30 40 O 20.0055 15.4003 0.0 0
M  V30 41 C 6.6685 16.9404 0.0 0
M  V30 42 N 5.3348 17.7104 0.0 0
M  V30 43 C 4.0010 16.9404 0.0 0
M  V30 44 O 2.6673 17.7104 0.0 0
M  V30 45 O 4.0010 15.4003 0.0 0
M  V30 46 C 1.3337 16.9404 0.0 0
M  V30 47 C 0.5637 18.2740 0.0 0
M  V30 48 C 0.0000 16.1704 0.0 0
M  V30 49 C 2.1037 15.6067 0.0 0
M  V30 50 O 9.3358 21.5605 0.0 0
M  V30 51 O 6.6685 20.0204 0.0 0
M  V30 52 C 13.3370 13.0903 0.0 0 CFG=2
M  V30 53 C 12.0033 12.3203 0.0 0 CFG=2
M  V30 54 C 13.3370 14.6303 0.0 0 CFG=1
M  V30 55 C 10.6697 13.0903 0.0 0
M  V30 56 C 12.0033 15.4003 0.0 0 CFG=2
M  V30 57 C 10.6697 14.6303 0.0 0 CFG=2
M  V30 58 C 16.0045 13.0903 0.0 0 CFG=1
M  V30 59 C 17.3382 12.3203 0.0 0 CFG=2
M  V30 60 O 16.0045 14.6303 0.0 0
M  V30 61 C 18.6718 13.0903 0.0 0 CFG=1
M  V30 62 C 17.3382 15.4003 0.0 0 CFG=2
M  V30 63 C 18.6718 14.6303 0.0 0 CFG=2
M  V30 64 C 10.6697 17.7104 0.0 0 CFG=2
M  V30 65 O 9.3358 16.9404 0.0 0
M  V30 66 C 10.6697 19.2504 0.0 0 CFG=2
M  V30 67 C 8.0022 17.7104 0.0 0 CFG=2
M  V30 68 C 9.3358 20.0204 0.0 0 CFG=1
M  V30 69 C 8.0022 19.2504 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 52 1 CFG=1
M  V30 2 1 58 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 53 2 CFG=3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 4 7 CFG=1
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 54 17 CFG=3
M  V30 19 1 56 18 CFG=1
M  V30 20 1 64 18 CFG=1
M  V30 21 1 19 20
M  V30 22 1 57 19 CFG=3
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 59 27 CFG=1
M  V30 30 1 28 29
M  V30 31 1 61 28 CFG=3
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 32 35
M  V30 38 1 36 37
M  V30 39 1 62 36 CFG=3
M  V30 40 1 37 38
M  V30 41 1 66 39 CFG=1
M  V30 42 1 63 40 CFG=1
M  V30 43 1 41 42
M  V30 44 1 67 41 CFG=3
M  V30 45 1 42 43
M  V30 46 1 43 44
M  V30 47 2 43 45
M  V30 48 1 44 46
M  V30 49 1 46 47
M  V30 50 1 46 48
M  V30 51 1 46 49
M  V30 52 1 68 50 CFG=3
M  V30 53 1 69 51 CFG=1
M  V30 54 1 52 53
M  V30 55 1 52 54
M  V30 56 1 53 55
M  V30 57 1 54 56
M  V30 58 1 55 57
M  V30 59 1 56 57
M  V30 60 1 58 59
M  V30 61 1 58 60
M  V30 62 1 59 61
M  V30 63 1 60 62
M  V30 64 1 61 63
M  V30 65 1 62 63
M  V30 66 1 64 65
M  V30 67 1 64 66
M  V30 68 1 65 67
M  V30 69 1 66 68
M  V30 70 1 67 69
M  V30 71 1 68 69
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(16 4 52 53 54 56 57 58 59 61 62 63 64 66 67 68 69)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1247067-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1644444-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12480302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 11114-15-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used (stage 1), Dowex 550A (OH-) resin used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Singly Modified Amikacin and Tobramycin Derivatives Show Increased rRNA
A-Site Binding and Higher Potency against Resistant Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fair, Richard J.; McCoy, Lisa S.; Hensler, Mary E.; Aguilar, Bernice;
Nizet, Victor; Tor, Yitzhak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2014), 9(9), 2164-2171

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Ethyl-4-methyl-5-thiazolyl)ethanone
C8H11NOS
1249043-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 C 1.6839 4.8720 0.0 0
M  V30 5 C 6.6363 2.6672 0.0 0
M  V30 6 C 7.5415 3.9130 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 C 2.8284 3.8416 0.0 0
M  V30 9 S 4.0743 1.6836 0.0 0
M  V30 10 N 4.3347 4.1618 0.0 0
M  V30 11 C 5.1047 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-N,α,4-trimethyl-5-thiazolemethanamine
C9H16N2S
1248732-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.7104 0.0 0
M  V30 2 N 1.5400 4.0442 0.0 0
M  V30 3 C 1.5400 1.3768 0.0 0
M  V30 4 C 0.0000 4.0442 0.0 0
M  V30 5 C 4.2794 0.0000 0.0 0
M  V30 6 C 7.4658 4.3856 0.0 0
M  V30 7 C 8.8726 3.7593 0.0 0
M  V30 8 C 3.8500 2.7104 0.0 0
M  V30 9 C 4.7552 1.4645 0.0 0
M  V30 10 S 4.7552 3.9564 0.0 0
M  V30 11 N 6.2198 1.9404 0.0 0
M  V30 12 C 6.2198 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1249043-91-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1248732-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22801889
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine reactant and reagent stoichiometry dependent product
formation, incremental addition of agent in 3 portions stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Versatile approaches to a library of building blocks based on
5-acylthiazole skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulyk, Olesia G.; Biloborodov, Dmytro A.; Cherevatenko, Maksim A.;
Shyriakin, Yevhen Y.; Lyapunov, Alexander Yu.; Mazepa, Alexander V.;
Vashchenko, Valerii V.; Orlov, Valeriy D.; Kolosov, Maksim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2020), 50(23), 3616-3628

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxopentanoic acid pheny...
C26H24FNO3
125971-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 4.6200 6.6684 0.0 0
M  V30 6 O 6.9300 2.6674 0.0 0
M  V30 7 N 3.0800 4.0011 0.0 0
M  V30 8 O 5.3900 2.6674 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 O 5.3900 8.0021 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 2.3100 8.0021 0.0 0
M  V30 13 F 13.8600 4.0011 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 7.7000 9.3358 0.0 0
M  V30 18 C 10.0100 8.0021 0.0 0
M  V30 19 C 9.2400 9.3358 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.0100 2.6674 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 11.5500 2.6674 0.0 0
M  V30 25 C 12.3200 4.0011 0.0 0
M  V30 26 C 2.3100 2.6674 0.0 0
M  V30 27 C 3.0800 1.3336 0.0 0
M  V30 28 C 0.7700 2.6674 0.0 0
M  V30 29 C 2.3100 0.0000 0.0 0
M  V30 30 C 0.0000 1.3336 0.0 0
M  V30 31 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 3 20
M  V30 8 1 4 7
M  V30 9 2 4 8
M  V30 10 1 5 9
M  V30 11 2 5 10
M  V30 12 1 7 26
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 1 13 25
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Fluorophenyl)-1-methyl-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carbo...
C27H25FN2O
811864-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.8384 0.0 0
M  V30 2 N 4.0009 4.0684 0.0 0
M  V30 3 O 5.3347 6.3784 0.0 0
M  V30 4 C 8.9621 0.8097 0.0 0
M  V30 5 C 5.6849 1.5064 0.0 0
M  V30 6 C 6.0051 0.0000 0.0 0
M  V30 7 C 4.2202 1.9823 0.0 0
M  V30 8 F 15.2319 4.1942 0.0 0
M  V30 9 C 8.0752 4.6947 0.0 0
M  V30 10 C 9.1058 3.5503 0.0 0
M  V30 11 C 6.6684 4.0684 0.0 0
M  V30 12 N 8.3358 2.2167 0.0 0
M  V30 13 C 6.8293 2.5369 0.0 0
M  V30 14 C 8.3954 6.2011 0.0 0
M  V30 15 C 7.2510 7.2316 0.0 0
M  V30 16 C 9.8601 6.6770 0.0 0
M  V30 17 C 7.5711 8.7380 0.0 0
M  V30 18 C 10.1802 8.1834 0.0 0
M  V30 19 C 9.0358 9.2139 0.0 0
M  V30 20 C 10.6373 3.7113 0.0 0
M  V30 21 C 11.2636 5.1182 0.0 0
M  V30 22 C 11.5425 2.4654 0.0 0
M  V30 23 C 12.7952 5.2791 0.0 0
M  V30 24 C 13.0741 2.6263 0.0 0
M  V30 25 C 13.7004 4.0333 0.0 0
M  V30 26 C 2.6673 4.8384 0.0 0
M  V30 27 C 1.3336 4.0684 0.0 0
M  V30 28 C 2.6673 6.3784 0.0 0
M  V30 29 C 0.0000 4.8384 0.0 0
M  V30 30 C 1.3336 7.1484 0.0 0
M  V30 31 C 0.0000 6.3784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 26
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 13
M  V30 9 1 8 25
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 10 20
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 125971-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 811864-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4256083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-82-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient synthesis of highly substituted pyrrole and bis pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sagyam, Rajeshwar Reddy; Vurimidi, Himabindu; Padi, Pratap Reddy; Ghanta,
Mahesh Reddy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(4), 923-926

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(9R)-N-[[3,5-Bis(trifluoromethyl)phenyl]carbonimidoyl]-6′-methoxycinchonan-9-...
C29H26F6N4O
1260109-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 5.8555 0.0 0 CFG=2
M  V30 2 N 8.0022 5.0854 0.0 0
M  V30 3 C 9.3359 5.8555 0.0 0
M  V30 4 N 10.6695 6.6255 0.0 0
M  V30 5 C 3.3152 0.0000 0.0 0
M  V30 6 C 1.7767 0.0671 0.0 0
M  V30 7 O 1.3338 7.3955 0.0 0
M  V30 8 C 0.0000 8.1655 0.0 0
M  V30 9 C 13.3370 2.0054 0.0 0
M  V30 10 F 11.7970 2.0054 0.0 0
M  V30 11 F 13.3370 0.4654 0.0 0
M  V30 12 F 14.8770 2.0054 0.0 0
M  V30 13 C 16.0043 6.6255 0.0 0
M  V30 14 F 16.7743 5.2917 0.0 0
M  V30 15 F 17.3381 7.3955 0.0 0
M  V30 16 F 15.2343 7.9591 0.0 0
M  V30 17 C 5.3348 5.0854 0.0 0 CFG=1
M  V30 18 N 5.5673 3.4586 0.0 0 CFG=1
M  V30 19 C 4.9995 3.9360 0.0 0
M  V30 20 C 4.2814 2.7178 0.0 0
M  V30 21 C 7.0970 2.9639 0.0 0
M  V30 22 C 5.4438 2.0681 0.0 0 CFG=2
M  V30 23 C 4.1426 1.2989 0.0 0 CFG=2
M  V30 24 C 7.0396 1.5671 0.0 0
M  V30 25 C 6.6686 7.3955 0.0 0
M  V30 26 C 5.3348 8.1655 0.0 0
M  V30 27 C 8.0022 8.1655 0.0 0
M  V30 28 C 5.3348 9.7055 0.0 0
M  V30 29 C 4.0011 7.3955 0.0 0
M  V30 30 C 8.0022 9.7055 0.0 0
M  V30 31 N 6.6686 10.4755 0.0 0
M  V30 32 C 4.0011 10.4755 0.0 0
M  V30 33 C 2.6675 8.1655 0.0 0
M  V30 34 C 2.6675 9.7055 0.0 0
M  V30 35 C 12.0034 5.8555 0.0 0
M  V30 36 C 12.0034 4.3154 0.0 0
M  V30 37 C 13.3370 6.6255 0.0 0
M  V30 38 C 13.3370 3.5454 0.0 0
M  V30 39 C 14.6707 5.8555 0.0 0
M  V30 40 C 14.6707 4.3154 0.0 0
M  V30 41 H 4.1235 6.0364 0.0 0
M  V30 42 H 5.6203 0.5381 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 1 25 CFG=1
M  V30 4 2 2 3 CFG=2
M  V30 5 2 3 4 CFG=2
M  V30 6 1 4 35
M  V30 7 2 5 6
M  V30 8 1 23 5 CFG=1
M  V30 9 1 7 8
M  V30 10 1 7 33
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 38
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 39
M  V30 19 1 17 18
M  V30 20 1 17 19 CFG=3
M  V30 21 1 17 41 CFG=1
M  V30 22 1 18 20 CFG=1
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 22 42 CFG=1
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 26 29
M  V30 34 1 27 30
M  V30 35 1 28 31
M  V30 36 1 28 32
M  V30 37 2 29 33
M  V30 38 2 30 31
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 41 2 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 2 37 39
M  V30 45 2 38 40
M  V30 46 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 17 18 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[3,5-Bis(trifluoromethyl)phenyl]-N′-[(9R)-6′-methoxycinchonan-9-yl]-N′′-met...
C30H31F6N5O
1260177-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 6.9300 0.0 0 CFG=2
M  V30 2 N 9.3358 8.4700 0.0 0
M  V30 3 C 8.0020 9.2400 0.0 0
M  V30 4 N 6.6684 8.4700 0.0 0
M  V30 5 N 8.0020 10.7800 0.0 0
M  V30 6 C 9.3358 11.5500 0.0 0
M  V30 7 C 16.0831 6.9537 0.0 0
M  V30 8 C 16.7943 5.5877 0.0 0
M  V30 9 O 10.6694 1.5400 0.0 0
M  V30 10 C 10.6694 0.0000 0.0 0
M  V30 11 C 1.3336 8.4700 0.0 0
M  V30 12 F 0.5636 9.8036 0.0 0
M  V30 13 F 0.0000 7.7000 0.0 0
M  V30 14 F 2.1036 7.1364 0.0 0
M  V30 15 C 4.0011 13.0900 0.0 0
M  V30 16 F 2.4611 13.0900 0.0 0
M  V30 17 F 4.0011 14.6300 0.0 0
M  V30 18 F 5.5411 13.0900 0.0 0
M  V30 19 C 10.6694 6.1600 0.0 0 CFG=1
M  V30 20 N 11.9621 7.1749 0.0 0 CFG=1
M  V30 21 C 11.8324 6.4443 0.0 0
M  V30 22 C 13.2465 6.4315 0.0 0
M  V30 23 C 11.6256 8.7467 0.0 0
M  V30 24 C 13.2280 7.7631 0.0 0 CFG=2
M  V30 25 C 14.5447 7.0209 0.0 0 CFG=2
M  V30 26 C 12.8639 9.3955 0.0 0
M  V30 27 C 8.0020 6.1600 0.0 0
M  V30 28 C 8.0020 4.6200 0.0 0
M  V30 29 C 6.6684 6.9300 0.0 0
M  V30 30 C 6.6684 3.8500 0.0 0
M  V30 31 C 9.3358 3.8500 0.0 0
M  V30 32 C 5.3347 6.1600 0.0 0
M  V30 33 C 6.6684 2.3100 0.0 0
M  V30 34 N 5.3347 4.6200 0.0 0
M  V30 35 C 9.3358 2.3100 0.0 0
M  V30 36 C 8.0020 1.5400 0.0 0
M  V30 37 C 5.3347 9.2400 0.0 0
M  V30 38 C 4.0011 8.4700 0.0 0
M  V30 39 C 5.3347 10.7800 0.0 0
M  V30 40 C 2.6673 9.2400 0.0 0
M  V30 41 C 4.0011 11.5500 0.0 0
M  V30 42 C 2.6673 10.7800 0.0 0
M  V30 43 H 10.4515 4.6356 0.0 0
M  V30 44 H 14.4646 8.6808 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 27 CFG=1
M  V30 4 2 2 3 CFG=2
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 4 37
M  V30 8 1 5 6
M  V30 9 2 7 8
M  V30 10 1 25 7 CFG=1
M  V30 11 1 9 10
M  V30 12 1 9 35
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 40
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 41
M  V30 21 1 19 20
M  V30 22 1 19 21 CFG=3
M  V30 23 1 19 43 CFG=1
M  V30 24 1 20 22 CFG=1
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 24 44 CFG=1
M  V30 32 1 27 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 28 31
M  V30 36 1 29 32
M  V30 37 1 30 33
M  V30 38 1 30 34
M  V30 39 2 31 35
M  V30 40 2 32 34
M  V30 41 2 33 36
M  V30 42 1 35 36
M  V30 43 2 37 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 2 39 41
M  V30 47 2 40 42
M  V30 48 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 19 20 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1260109-06-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1260177-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-3702384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Enantioselective Amination Reactions of Fluorinated Keto Esters
Catalyzed by Novel Chiral Guanidines Derived from Cinchona Alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Xiao; Zhong, Fangrui; Lu, Yixin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2010), 352(16), 2778-2782

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3S)-2-acetyl-1,4-dihydro-α-methyl-2′-oxospiro[isoquinoline-3(2H),3...
C19H22N2O4
1262959-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3336 0.0 0
M  V30 2 C 6.9300 1.3336 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 5.3900 6.6685 0.0 0
M  V30 5 C 8.4700 6.6685 0.0 0 CFG=1
M  V30 6 C 10.0100 6.6685 0.0 0
M  V30 7 C 7.7000 8.0021 0.0 0
M  V30 8 O 10.7800 8.0021 0.0 0
M  V30 9 O 10.7800 5.3347 0.0 0
M  V30 10 C 12.3200 8.0021 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 12 N 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 N 7.7000 5.3347 0.0 0
M  V30 19 C 7.7000 2.6674 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 0.7700 4.0011 0.0 0
M  V30 24 C 0.7700 6.6685 0.0 0
M  V30 25 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12 CFG=3
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS,3S)-2-Acetyl-1,4-dihydro-N,α-dimethyl-2′-oxospiro[isoquinoline-3(2H),3′(2...
C19H23N3O3
1262959-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3336 0.0 0
M  V30 2 C 6.9300 1.3336 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 5.3900 6.6685 0.0 0
M  V30 5 C 8.4700 6.6685 0.0 0 CFG=1
M  V30 6 C 10.0100 6.6685 0.0 0
M  V30 7 C 7.7000 8.0021 0.0 0
M  V30 8 N 10.7800 8.0021 0.0 0
M  V30 9 O 10.7800 5.3347 0.0 0
M  V30 10 C 12.3200 8.0021 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 12 N 4.6200 2.6674 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 N 7.7000 5.3347 0.0 0
M  V30 19 C 7.7000 2.6674 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 0.7700 4.0011 0.0 0
M  V30 24 C 0.7700 6.6685 0.0 0
M  V30 25 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12 CFG=3
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1262959-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1262959-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9595402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 18. At 0°C, under N2 atmosphere, 17 (57 mg, 0.17 mmol) was
dissolved in a 8.0 M MeNH2 solution in EtOH (5 mL). The reaction mixture
was stirred for 4 h at rt, then evaporated in vacuo. The crude was
purified by flash chromatography (EtOAc/MeOH 9:1), affording 18 (51 mg,
90% yield) as a foam. Rf (EtOAc/MeOH 85:15) 0.38. [α]25D -146.5 (c 1.5,
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.60 (br s, 1H), 7.37-7.13 (m, 4H),
5.73 (dt, J = 10.2, 3.2 Hz, 1H), 5.49 (q, J = 7.4 Hz, 1H), 5.13 (dt, J =
10.2, 2.0 Hz, 1H), 4.72 (d, J = 14.2 Hz, 1H), 4.63 (d, J=14.2 Hz, 1H),
3.97 (dt, J=18.0, 2.6, 1H), 3.75 (dt, J=18.0, 2.6 Hz, 1H), 3.60 (d,
J=14.5, 1H), 2.90 (d, J=14.5 Hz, 1H), 2.80 (d, J=4.6 Hz, 3H), 2.24 (s,
3H), 1.47 (d, J = 7.4 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 170.4, 169.8,
168.5, 133.5, 133.5, 127.9-126.9 (4C), 125.4, 120.3, 59.2, 51.4, 48.3,
43.3, 40.5, 26.1, 22.9, 13.3. HRMS (EI) calcd for C19H23N3O3 341.1739,
found 341.1726.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phe-Ala-based diazaspirocyclic lactam as nucleator of type II' β-Turn
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sacchetti, Alessandro; Silvani, Alessandra; Lesma, Giordano; Pilati,
Tullio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(3), 833-839

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,5-Dimethyl-3-(methylamino)-2-cyclohexen-1-one
C9H15NO
701-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5178 4.6201 0.0 0
M  V30 2 C 6.8516 3.8501 0.0 0
M  V30 3 C 0.0000 3.5826 0.0 0
M  V30 4 C 0.9899 5.2971 0.0 0
M  V30 5 O 2.8504 0.0000 0.0 0
M  V30 6 C 4.1841 3.8501 0.0 0
M  V30 7 C 2.8504 4.6201 0.0 0
M  V30 8 C 4.1841 2.3101 0.0 0
M  V30 9 C 1.5168 3.8501 0.0 0
M  V30 10 C 2.8504 1.5400 0.0 0
M  V30 11 C 1.5168 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12259348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3-Aminocyclohex-2-enones 7; General Procedure.
Method A: A soln containing equimolar quantities of a primary amine and a
cyclohexane-1,3-dione 6 in benzene was refluxed at a Dean-Stark trap
until the separation of H2O had finished (ca. 3 h). The solvent was
removed in vacuo and the residual solid or viscous oil was triturated
(EtOAc) to give 7 as a crystalline solid. Compound 7A2, crystalline
solid, yield 40-90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Partially saturated indeno[1,2-b]indole derivatives via deoxygenation of
heterocyclic α-hydroxy-N,O-hemiaminals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hemmerling, Hans-Joerg; Reiss, Guido
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2009), (6), 985-999

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,5-Dimethyl-3-(methylamino)-2-cyclohexen-1-one
C9H15NO
701-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5178 4.6201 0.0 0
M  V30 2 C 6.8516 3.8501 0.0 0
M  V30 3 C 0.0000 3.5826 0.0 0
M  V30 4 C 0.9899 5.2971 0.0 0
M  V30 5 O 2.8504 0.0000 0.0 0
M  V30 6 C 4.1841 3.8501 0.0 0
M  V30 7 C 2.8504 4.6201 0.0 0
M  V30 8 C 4.1841 2.3101 0.0 0
M  V30 9 C 1.5168 3.8501 0.0 0
M  V30 10 C 2.8504 1.5400 0.0 0
M  V30 11 C 1.5168 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15512718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Environmentally benign one-pot multicomponent approaches to the synthesis
of novel unsymmetrical 4-arylacridinediones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Guan-Wu; Miao, Chun-Bao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2006), 8(12), 1080-1085

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-1H-indole-3-carboxaldehyde
C9H6FNO
126921-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.1457 3.3405 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 1.3338 2.3101 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-N-methyl-1H-indole-3-methanamine
C10H11FN2
620176-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126921-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6228002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole b)
7-Fluoro-3-(methylaminomethyl)-1H-indole [0806] According to the
procedure of Preparation 13 (c), except substituting
7-fluoro-1H-indole-3-carboxaldehyde (0.5 g, 3.1 mmole) for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (0.5 g, 90%)
was prepared as a viscous oil:. MS (ES) m/e 179 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-1H-indole-3-carboxaldehyde
C9H6FNO
126921-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.1457 3.3405 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 1.3338 2.3101 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-N-methyl-1H-indole-3-methanamine
C10H11FN2
620176-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126921-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13344562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-1H-indole-3-carboxaldehyde
C9H6FNO
126921-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6520 3.0203 0.0 0
M  V30 2 O 7.6826 4.1647 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.1457 3.3405 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 1.3338 2.3101 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 4.5192 4.7473 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-N-methyl-1H-indole-3-methanamine
C10H11FN2
620176-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 3.0203 0.0 0
M  V30 2 N 7.6825 4.1647 0.0 0
M  V30 3 C 9.1888 3.8445 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 5.1456 3.3405 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 N 2.9875 4.5864 0.0 0
M  V30 11 C 4.5192 4.7473 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126921-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8873031
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-pyridinecarboxaldehyde
C6H4BrNO
128071-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 N 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-3-pyridinemethanamine
C7H9BrN2
1236203-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 N 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 128071-75-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1236203-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12252103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular N-arylation in heterocyclization: synthesis of new
pyrido-fused pyrrolo[1,2-a][1,4]diazepinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Legeren, Loreto; Dominguez, Domingo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2010), 51(31), 4053-4057

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methyl β-(acetyloxy)-2-chloro-7-methyl-α-methylene-3-quinolinepropanoate
C17H16ClNO4
1296240-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.8501 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 8.0022 2.3101 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 2.3101 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 13.3370 3.8501 0.0 0
M  V30 12 Cl 8.0022 6.9302 0.0 0
M  V30 13 C 0.0000 6.9302 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 6.6685 6.1601 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 N 5.3348 6.9302 0.0 0
M  V30 19 C 4.0010 6.1601 0.0 0
M  V30 20 C 2.6673 3.8501 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 12 16
M  V30 13 1 13 23
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 17 20
M  V30 20 1 18 19
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,2-dihydro-1,8-dimethylbenzo[b][1,8]naphthyridine-3-carboxylate
C16H16N2O2
1296241-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 0.0000 0.0 0
M  V30 2 C 10.6697 4.6201 0.0 0
M  V30 3 O 12.0033 3.8501 0.0 0
M  V30 4 O 10.6697 6.1601 0.0 0
M  V30 5 C 13.3370 4.6201 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 N 5.3348 1.5400 0.0 0
M  V30 12 N 8.0022 1.5400 0.0 0
M  V30 13 C 4.0010 3.8501 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 1.5400 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1296240-86-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1296241-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7868308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction monitored by TLC; "base-free" one-pot two step amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Base-free amination of BH acetates of
2-chloroquinolinyl-3-carboxaldehydes: a facile route to the synthesis of
N-substituted-1,2-dihydrobenzo[b][1,8]naphthyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Bhawana; Chandra, Atish; Singh, Radhey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(13), 2441-2446

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbic anhydride
C9H8O3
129-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6460 2.7105 0.0 0
M  V30 2 O 1.9512 0.0000 0.0 0
M  V30 3 C 3.9952 3.4208 0.0 0 CFG=2
M  V30 4 C 2.6614 2.6508 0.0 0 CFG=1
M  V30 5 C 3.9998 4.9527 0.0 0 CFG=2
M  V30 6 C 5.1395 2.3904 0.0 0
M  V30 7 C 1.3324 3.4128 0.0 0 CFG=1
M  V30 8 C 2.9817 1.1445 0.0 0
M  V30 9 C 2.4301 4.5916 0.0 0
M  V30 10 C 2.6657 5.7235 0.0 0
M  V30 11 O 4.5132 0.9834 0.0 0
M  V30 12 C 1.3319 4.9535 0.0 0
M  V30 13 H 5.4029 4.0451 0.0 0
M  V30 14 H 1.4169 1.7437 0.0 0
M  V30 15 H 5.3347 5.7206 0.0 0
M  V30 16 H 0.0000 2.6406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 14 CFG=3
M  V30 10 1 5 9 CFG=3
M  V30 11 1 5 10
M  V30 12 1 5 15
M  V30 13 1 6 11
M  V30 14 1 7 9 CFG=3
M  V30 15 1 7 12
M  V30 16 1 7 16
M  V30 17 1 8 11
M  V30 18 2 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 5 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S,3R,4S)-3-[(Methylamino)carbonyl]bicyclo[2.2.1]hept-5-ene-2-carboxy...
C10H13NO3
32392-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3276 2.3160 0.0 0
M  V30 2 N 6.6612 3.0860 0.0 0
M  V30 3 O 5.3276 0.7760 0.0 0
M  V30 4 C 7.9949 2.3160 0.0 0
M  V30 5 C 2.6662 0.7740 0.0 0
M  V30 6 O 4.0021 0.0082 0.0 0
M  V30 7 O 1.3347 0.0000 0.0 0
M  V30 8 C 3.9939 3.0860 0.0 0 CFG=2
M  V30 9 C 2.6614 2.3140 0.0 0 CFG=1
M  V30 10 C 3.9962 4.6179 0.0 0 CFG=2
M  V30 11 C 1.3313 3.0739 0.0 0 CFG=1
M  V30 12 C 2.4270 4.2545 0.0 0
M  V30 13 C 2.6609 5.3867 0.0 0
M  V30 14 C 1.3285 4.6147 0.0 0
M  V30 15 H 5.3300 5.3878 0.0 0
M  V30 16 H 0.0000 2.2998 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 9 5 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12 CFG=3
M  V30 12 1 10 13
M  V30 13 1 10 15
M  V30 14 1 11 12 CFG=3
M  V30 15 1 11 14
M  V30 16 1 11 16
M  V30 17 2 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 8 9 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 129-64-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32392-72-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-8092930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Reaction of
bicyclo[2.2.1]-hept-5-ene-endo,endo-2,3-dicarboxylic acid anhydride (I)
with monoalkyl and dialkylamines. To 3.28 g (0.02 mol) of endic anhydride
(I) in 20–25 ml of anhydrous benzene was added at stirring 0.02 mol of an
appropriate amine (ammonia and methylamine were used as 25% water
solutions, dimethylamine, as 0.5 M benzene solution). The reaction
mixture was stirred at room temperature till completion of the reaction
(from 1 day to 3 weeks, TLC monitoring), the separated crystals were
filtered off, washed on the filter with benzene, and dried in air. The
products were additionally purified by recrystallization from benzene or
2-propanol. This procedure was applied to the synthesis of amido acids
IIa–IIj.
endo-3-(N-Methylcarbamoyl)bicyclo[2.2.1]-hept-5-ene-endo-2-carboxylic
acid (IIb), Yield 3.51 g (90%) mp 155–157°C (155°C [7]), Rf 0.06 (A),
0.73 (B). IR spectrum, cm–1: 3326, 3050, 1750, 1650, 1550, 1425, 1260,
714. 1H NMR spectrum (300 MHz, DMSO-d6), δ, ppm: 7.64 br.s (1H, NH), 6.16
d.d (1H, H6), 5.94 d.d (1H, H5, 3J5,6 5.5, 3J4,5 = 3J6,1 = 3.1 Hz), 3.13
d.d (1H, H2), 3.06 d.d (1H, H3, 3J2,3 10.2, 3J1,2 = 3J3,4 = 3.1 Hz), 3.01
m (1H, H1), 2.92 m (1H, H4), 2.48 s (3H, CH3), 1.26 d (1H, H7s), 1.20 d
(1H, H7an, 2J7s,7an 8.0 Hz). 13C NMR spectrum (DMSO-d6), δ, ppm: 173.4
(C=O), 171.5 (C=O), 134.8 (C6), 133.7 (C5), 48.3 (C2), 48.2 (C3), 48.1
(C7), 46.6 (C1), 45.3 (C4), 25.5 (CH3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lactonization of N-alkyl- and N,N-dialkylamido acids of norbornene series
in reactions with performic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal'chikov, V. A.; Tarabara, I. N.; Shishkina, S. V.; Shishkin, O. V.;
Kol'tsov, N. Yu.; Kas'yan, L. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2007), 43(5), 660-673

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-3-isocyanatopropane
C4H6ClNO
13010-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 N 2.6675 1.5400 0.0 0
M  V30 4 C 6.6687 0.7700 0.0 0
M  V30 5 C 1.3337 0.7700 0.0 0
M  V30 6 Cl 8.0023 1.5400 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloropropyl)-N′-methylurea
C5H11ClN2O
13107-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 Cl 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13010-19-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13107-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-19420498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Salt-Mediated Polyampholyte Hydrogels with High Mechanical Strength,
Excellent Self-Healing Property, and Satisfactory Electrical Conductivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Tangjie; Li, Yixuan; Fang, Xu; Sun, Junqi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Functional Materials (2018), 28(44), n/a

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[4-[3,4-dihydro-3-(2-methoxyethyl)-2-(methylsulfonyl)-...
C31H35N3O7S
1301611-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 2.3100 5.3347 0.0 0
M  V30 4 O 0.7700 5.3347 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 S 4.6200 1.3338 0.0 0 VAL=6
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 O 5.9536 0.5638 0.0 0
M  V30 9 O 3.2864 2.1038 0.0 0
M  V30 10 N 15.4721 7.5991 0.0 0
M  V30 11 C 17.0121 7.5991 0.0 0
M  V30 12 O 17.7821 6.2655 0.0 0
M  V30 13 O 17.7821 8.9328 0.0 0
M  V30 14 C 19.3221 6.2655 0.0 0
M  V30 15 C 19.3221 7.8055 0.0 0
M  V30 16 C 20.8621 6.2655 0.0 0
M  V30 17 C 19.3221 4.7255 0.0 0
M  V30 18 C 7.9604 6.4792 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 9.3674 5.8528 0.0 0
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 5.3900 5.3347 0.0 0
M  V30 23 O 9.2064 4.3212 0.0 0
M  V30 24 N 6.9300 2.6674 0.0 0
M  V30 25 N 4.6200 4.0011 0.0 0
M  V30 26 C 5.3900 2.6674 0.0 0
M  V30 27 C 7.6402 7.9855 0.0 0
M  V30 28 C 8.7848 9.0161 0.0 0
M  V30 29 C 6.1757 8.4614 0.0 0
M  V30 30 C 8.4646 10.5224 0.0 0
M  V30 31 C 5.8555 9.9678 0.0 0
M  V30 32 C 6.9999 10.9982 0.0 0
M  V30 33 C 10.7010 6.6228 0.0 0
M  V30 34 C 12.0346 5.8528 0.0 0
M  V30 35 C 10.7010 8.1628 0.0 0
M  V30 36 C 13.3684 6.6228 0.0 0
M  V30 37 C 12.0346 8.9328 0.0 0
M  V30 38 C 13.3684 8.1628 0.0 0
M  V30 39 C 14.7021 8.9328 0.0 0
M  V30 40 C 13.9321 10.2666 0.0 0
M  V30 41 C 16.0357 9.7028 0.0 0
M  V30 42 C 15.2657 11.0366 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 26
M  V30 10 1 10 11
M  V30 11 1 10 39
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 27
M  V30 21 2 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 20 33
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 1 38 39
M  V30 43 1 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[4-[3,4-dihydro-3-(2-methoxyethyl)-2-(methylamino)-4-o...
C31H36N4O5
1301611-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 O 0.7700 2.6674 0.0 0
M  V30 5 C 0.0000 1.3338 0.0 0
M  V30 6 N 4.6200 1.3338 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 N 15.4721 7.5991 0.0 0
M  V30 9 C 17.0121 7.5991 0.0 0
M  V30 10 O 17.7821 6.2655 0.0 0
M  V30 11 O 17.7821 8.9328 0.0 0
M  V30 12 C 19.3221 6.2655 0.0 0
M  V30 13 C 19.3221 7.8055 0.0 0
M  V30 14 C 20.8621 6.2655 0.0 0
M  V30 15 C 19.3221 4.7255 0.0 0
M  V30 16 C 7.9604 6.4792 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 9.3674 5.8528 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 5.3900 5.3347 0.0 0
M  V30 21 O 9.2064 4.3212 0.0 0
M  V30 22 N 6.9300 2.6674 0.0 0
M  V30 23 N 4.6200 4.0011 0.0 0
M  V30 24 C 5.3900 2.6674 0.0 0
M  V30 25 C 7.6402 7.9855 0.0 0
M  V30 26 C 6.1757 8.4614 0.0 0
M  V30 27 C 8.7848 9.0161 0.0 0
M  V30 28 C 5.8555 9.9678 0.0 0
M  V30 29 C 8.4646 10.5224 0.0 0
M  V30 30 C 6.9999 10.9982 0.0 0
M  V30 31 C 10.7010 6.6228 0.0 0
M  V30 32 C 10.7010 8.1628 0.0 0
M  V30 33 C 12.0346 5.8528 0.0 0
M  V30 34 C 12.0346 8.9328 0.0 0
M  V30 35 C 13.3684 6.6228 0.0 0
M  V30 36 C 13.3684 8.1628 0.0 0
M  V30 37 C 14.7021 8.9328 0.0 0
M  V30 38 C 13.9321 10.2666 0.0 0
M  V30 39 C 16.0357 9.7028 0.0 0
M  V30 40 C 15.2657 11.0366 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 8 9
M  V30 9 1 8 37
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 25
M  V30 19 2 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 31
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 1 36 37
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1301611-64-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1301611-68-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12946351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: tert-Butyl
1-(4-(3-(2-methoxyethyl)-2-(methylamino)-4-oxo-5-phenyl-3,4-dihydrofuro[2,3-d]pyrimidin-6-yl)phenyl)cyclobutylcarbamate:
A solution of tert-butyl
1-(4-(3-(2-methoxyethyl)-2-(methylsulfonyl)-4-oxo-5-phenyl-3,4-dihydrofuro[2,3-d]pyrimidin-6-yl)phenyl)cyclobutylcarbamate
(44 mg, 0.074 mmol) in methanamine (2.0M in THF) (3 ml, 6.00 mmol) was
stirred at RT for 2 h before analysis by LCMS - reaction complete. The
reaction mixture was concentrated in vacuo before purification by silica
gel chromatography (0 to 5% MeOH/DCM) affording ted-butyl
1-(4-(3-(2-methoxyethyl)-2-(methylamino)-4-oxo-5-phenyl-3,4-dihydrofuro[2,3-d]pyrimidin-6-yl)phenyl)cyclobutylcarbamate.
Oil, yield (29.4 mg, 0.054 mmol, 90%). LCMS (Method A) RT = 7.64 min,
M+H+ = 545.22.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furopyrimidine and furopyridine derivatives as AKT/PKB
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bell, Mark Peter; O'Dowd, Colin Roderick; Rountree, James Samuel Shane;
Trevitt, Graham Peter; Harrison, Timothy; McFarland, Mary Melissa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011055115 A1 2011-05-12

$RFMT $RIREG SCHEME68 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridineacetic acid
C7H7NO2
13115-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 N 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C29H27N5O5S
195444-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6363 8.5298 0.0 0 VAL=6
M  V30 2 N 5.3027 7.7598 0.0 0
M  V30 3 O 7.4063 7.1961 0.0 0
M  V30 4 O 5.8663 9.8634 0.0 0
M  V30 5 C 11.9710 6.9898 0.0 0
M  V30 6 N 13.3047 6.2198 0.0 0
M  V30 7 C 14.6383 6.9898 0.0 0
M  V30 8 C 13.3047 4.6798 0.0 0
M  V30 9 C 15.9721 6.2198 0.0 0
M  V30 10 O 14.6383 8.5298 0.0 0
M  V30 11 C 2.2419 6.3970 0.0 0
M  V30 12 C 0.0000 8.8869 0.0 0
M  V30 13 C 9.3036 8.5298 0.0 0
M  V30 14 C 7.9700 9.2998 0.0 0
M  V30 15 C 10.6374 9.2998 0.0 0
M  V30 16 C 7.9700 10.8398 0.0 0
M  V30 17 C 10.6374 10.8398 0.0 0
M  V30 18 C 9.3036 11.6098 0.0 0
M  V30 19 C 9.3036 6.9898 0.0 0
M  V30 20 C 10.6374 6.2198 0.0 0
M  V30 21 C 7.9700 6.2198 0.0 0
M  V30 22 C 10.6374 4.6798 0.0 0
M  V30 23 C 7.9700 4.6798 0.0 0
M  V30 24 C 9.3036 3.9098 0.0 0
M  V30 25 C 3.9689 8.5298 0.0 0
M  V30 26 C 2.5621 7.9034 0.0 0
M  V30 27 O 3.8080 10.0613 0.0 0
M  V30 28 C 1.5317 9.0478 0.0 0
M  V30 29 N 2.3017 10.3816 0.0 0
M  V30 30 C 9.3036 2.3698 0.0 0
M  V30 31 N 10.5496 1.4645 0.0 0
M  V30 32 O 8.0577 1.4645 0.0 0
M  V30 33 C 10.0736 0.0000 0.0 0
M  V30 34 C 8.5336 0.0000 0.0 0
M  V30 35 C 17.3057 6.9898 0.0 0
M  V30 36 C 18.6394 6.2198 0.0 0
M  V30 37 N 17.3057 8.5298 0.0 0
M  V30 38 C 19.9732 6.9898 0.0 0
M  V30 39 C 18.6394 9.2998 0.0 0
M  V30 40 C 19.9732 8.5298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 25
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 35
M  V30 13 1 11 26
M  V30 14 1 12 28
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 19
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 30
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13115-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7162935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5o
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-1-methyl-1H-indole-3-carboxaldehyde
C10H8INO
1313739-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 I 6.0810 1.3627 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N,1-dimethyl-1H-indole-3-methanamine
C11H13IN2
1313739-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 I 6.0810 1.3627 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313739-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313739-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8972711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular palladium-catalysed enolate arylation of 2- and
3-iodoindole derivatives for the synthesis of β-carbolines, γ-carbolines,
and pyrrolo[3,4-b]indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sole, Daniel; Bennasar, M.-Lluisa; Jimenez, Ivan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(12), 4535-4544

$RFMT $RIREG SCHEME70 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butoxycarbonyl-3-(2-naphthyl)-L-alanine
C18H21NO4
58438-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 4.0011 0.0 0
M  V30 2 C 7.7001 2.6675 0.0 0 CFG=1
M  V30 3 N 9.2401 2.6675 0.0 0
M  V30 4 C 6.9301 1.3338 0.0 0
M  V30 5 C 10.0101 4.0011 0.0 0
M  V30 6 O 7.7001 0.0000 0.0 0
M  V30 7 O 5.3901 1.3338 0.0 0
M  V30 8 O 11.5501 4.0011 0.0 0
M  V30 9 O 9.2401 5.3348 0.0 0
M  V30 10 C 12.3201 5.3348 0.0 0
M  V30 11 C 10.9865 6.1048 0.0 0
M  V30 12 C 13.0901 6.6686 0.0 0
M  V30 13 C 13.6538 4.5648 0.0 0
M  V30 14 C 3.0800 5.3348 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 2.3100 6.6686 0.0 0
M  V30 18 C 3.0800 2.6675 0.0 0
M  V30 19 C 0.7700 4.0011 0.0 0
M  V30 20 C 5.3901 4.0011 0.0 0
M  V30 21 C 0.7700 6.6686 0.0 0
M  V30 22 C 4.6201 2.6675 0.0 0
M  V30 23 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-leucine
C11H21NO4
13139-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Alaninamide, N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl-N2-(3-methoxy-3-oxop...
C29H41N3O6
408540-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 8.2638 0.0 0
M  V30 2 C 6.6685 9.0338 0.0 0 CFG=2
M  V30 3 C 5.3348 6.7238 0.0 0
M  V30 4 C 4.0010 9.0338 0.0 0
M  V30 5 C 8.0022 8.2638 0.0 0
M  V30 6 C 6.6685 10.5739 0.0 0
M  V30 7 C 4.0010 5.9538 0.0 0 CFG=2
M  V30 8 O 6.6685 5.9538 0.0 0
M  V30 9 C 4.0010 10.5739 0.0 0
M  V30 10 N 8.0022 11.3439 0.0 0
M  V30 11 O 5.3348 11.3439 0.0 0
M  V30 12 N 4.0010 4.4137 0.0 0
M  V30 13 C 2.6673 6.7238 0.0 0
M  V30 14 C 2.6673 11.3439 0.0 0
M  V30 15 C 8.0022 12.8839 0.0 0
M  V30 16 C 5.3348 3.6437 0.0 0
M  V30 17 C 1.3337 5.9538 0.0 0
M  V30 18 O 2.6673 12.8839 0.0 0
M  V30 19 O 1.3337 10.5739 0.0 0
M  V30 20 O 5.3348 2.1037 0.0 0
M  V30 21 O 6.6685 4.4137 0.0 0
M  V30 22 C 0.0000 6.7238 0.0 0
M  V30 23 C 1.3337 4.4137 0.0 0
M  V30 24 C 1.3337 13.6539 0.0 0
M  V30 25 C 6.6685 1.3337 0.0 0
M  V30 26 C 7.4385 2.6673 0.0 0
M  V30 27 C 8.0022 0.5637 0.0 0
M  V30 28 C 5.8985 0.0000 0.0 0
M  V30 29 C 9.3358 9.0338 0.0 0
M  V30 30 C 10.6697 8.2638 0.0 0
M  V30 31 C 9.3358 10.5739 0.0 0
M  V30 32 C 12.0033 9.0338 0.0 0
M  V30 33 C 10.6697 11.3439 0.0 0
M  V30 34 C 12.0033 10.5739 0.0 0
M  V30 35 C 13.3370 8.2638 0.0 0
M  V30 36 C 13.3370 11.3439 0.0 0
M  V30 37 C 14.6707 9.0338 0.0 0
M  V30 38 C 14.6707 10.5739 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 29
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13 CFG=1
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 16 20
M  V30 21 2 16 21
M  V30 22 1 17 22
M  V30 23 1 17 23
M  V30 24 1 18 24
M  V30 25 1 20 25
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 25 28
M  V30 29 2 29 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 2 31 33
M  V30 33 2 32 34
M  V30 34 1 32 35
M  V30 35 1 33 34
M  V30 36 1 34 36
M  V30 37 2 35 37
M  V30 38 2 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58438-04-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 13139-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 408540-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11997501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on reagents used in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wattanasin, Sompong; Kallen, Joerg; Myers, Stewart; Guo, Qin; Sabio,
Michael; Ehrhardt, Claus; Albert, Rainer; Hommel, Ulrich; Weckbecker,
Gisbert; Welzenbach, Karl; Weitz-Schmidt, Gabriele
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(4), 1217-1220

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dihydro-5,5-dimethyl-1-(1-piperidinylcarbonyl)pyrrolo[2,1-a]isoquinoline-...
C20H22N2O3
131527-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4079 3.2908 0.0 0
M  V30 2 O 6.0878 1.7844 0.0 0
M  V30 3 O 3.6974 7.9855 0.0 0
M  V30 4 C 0.0000 5.8614 0.0 0
M  V30 5 C 1.7146 6.8513 0.0 0
M  V30 6 O 6.7581 6.6228 0.0 0
M  V30 7 C 3.7571 4.0011 0.0 0
M  V30 8 N 2.9871 5.3347 0.0 0
M  V30 9 C 2.9871 2.6674 0.0 0
M  V30 10 C 5.2636 4.3212 0.0 0
M  V30 11 C 4.0176 6.4791 0.0 0
M  V30 12 C 1.4471 5.3347 0.0 0
M  V30 13 C 1.4471 2.6674 0.0 0
M  V30 14 C 3.7571 1.3336 0.0 0
M  V30 15 C 5.4245 5.8528 0.0 0
M  V30 16 C 0.6771 4.0011 0.0 0
M  V30 17 C 0.6771 1.3336 0.0 0
M  V30 18 C 2.9871 0.0000 0.0 0
M  V30 19 C 1.4471 0.0000 0.0 0
M  V30 20 N 7.8726 3.7667 0.0 0
M  V30 21 C 9.0170 2.7361 0.0 0
M  V30 22 C 8.1928 5.2730 0.0 0
M  V30 23 C 10.4817 3.2121 0.0 0
M  V30 24 C 9.6573 5.7488 0.0 0
M  V30 25 C 10.8019 4.7184 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 20
M  V30 4 2 3 11
M  V30 5 1 4 12
M  V30 6 1 5 12
M  V30 7 2 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 13 17
M  V30 20 1 14 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-(3,4-Dihydro-3,3-dimethyl-1(2H)-isoquinolinylidene)-N-methyl-α,γ-dioxo-1-pi...
C21H27N3O3
849149-17-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 5.3900 0.0 0
M  V30 2 C 6.8513 4.6200 0.0 0
M  V30 3 C 5.5177 6.9300 0.0 0
M  V30 4 O 6.8513 3.0800 0.0 0
M  V30 5 C 4.1840 7.7000 0.0 0
M  V30 6 O 6.8513 7.7000 0.0 0
M  V30 7 N 4.1840 9.2400 0.0 0
M  V30 8 O 2.8502 6.9300 0.0 0
M  V30 9 C 2.8502 10.0100 0.0 0
M  V30 10 C 0.0000 4.3527 0.0 0
M  V30 11 C 0.9899 6.0671 0.0 0
M  V30 12 C 4.1840 3.0800 0.0 0
M  V30 13 C 4.1840 4.6200 0.0 0
M  V30 14 C 2.8502 2.3100 0.0 0
M  V30 15 C 5.5177 2.3100 0.0 0
M  V30 16 N 2.8502 5.3900 0.0 0
M  V30 17 C 1.5166 3.0800 0.0 0
M  V30 18 C 2.8502 0.7700 0.0 0
M  V30 19 C 5.5177 0.7700 0.0 0
M  V30 20 C 1.5166 4.6200 0.0 0
M  V30 21 C 4.1840 0.0000 0.0 0
M  V30 22 N 8.1849 5.3900 0.0 0
M  V30 23 C 9.5187 4.6200 0.0 0
M  V30 24 C 8.1849 6.9300 0.0 0
M  V30 25 C 10.8524 5.3900 0.0 0
M  V30 26 C 9.5187 7.7000 0.0 0
M  V30 27 C 10.8524 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 13 CFG=2
M  V30 4 2 2 4
M  V30 5 1 2 22
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 1 10 20
M  V30 12 1 11 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 131527-19-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 849149-17-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-3678823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Amides of
[3,3-(R2)2-6,7-(R1)2-1,2,3,4-Tetrahydroisoquinolinidene-1]pyruvic Acids
(2a-c) and the Diamides of
3[3,3-(R2)2-1,2,3,4-Tetrahydroisoquinolinidene-1]-2-oxobutandioic Acids
(4a-h) (General Method). Gaseous ammonia or the corresponding amine was
bubbled through a solution of the corresponding dioxopyrroline 1a-c or
3a-h (10 mmol) in benzene (50-100 ml). The difficult to dissolve amides
2b,d dissolved on boiling and in these cases the syntheses were carried
out at 50-60°C. The reactions were carried out at 20° for all the other
substances. When the solution was decolorized the solvent was evaporated
in vacuum, the crystalline residue was filtered off, dried, and
recrystallized. Compound 4d, yield 90% mp: 146-148°C, Empirical formula:
C21H27N3O3; Found, (%): C 68.2, H 7.3, N 11.5; Calculated (%): C 68.3, H
7.4, N 11.4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of 2,3-dioxopyrrolo-[2,1-a]isoquinolines with ammonia and
aliphatic amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mikhailovskii, A. G.; Polygalova, N. N.; Turova, T. S.; Lobashova, G. A.;
Vahrin, M. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2004),
40(9), 1174-1178

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,5-dihydro-4,5,5-trimethyl-2-oxo-3-furancarboxylate
C10H14O4
13156-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0170 3.3320 0.0 0
M  V30 2 O 6.3506 2.5620 0.0 0
M  V30 3 O 5.0170 4.8720 0.0 0
M  V30 4 C 7.6844 3.3320 0.0 0
M  V30 5 C 9.0181 2.5620 0.0 0
M  V30 6 C 1.9561 4.6948 0.0 0
M  V30 7 O 4.6667 0.0000 0.0 0
M  V30 8 C 0.0000 1.1387 0.0 0
M  V30 9 C 0.2155 3.1885 0.0 0
M  V30 10 C 3.6833 2.5620 0.0 0
M  V30 11 C 2.2765 3.1885 0.0 0
M  V30 12 C 3.5224 1.0304 0.0 0
M  V30 13 C 1.2459 2.0439 0.0 0
M  V30 14 O 2.0159 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 2 7 12
M  V30 8 1 8 13
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dihydro-N,4,5,5-tetramethyl-2-oxo-3-furancarboxamide
C9H13NO3
34494-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4414 2.7106 0.0 0
M  V30 2 N 6.2114 1.3769 0.0 0
M  V30 3 O 6.2114 4.0442 0.0 0
M  V30 4 C 7.7514 1.3769 0.0 0
M  V30 5 C 3.4721 5.4211 0.0 0
M  V30 6 O 3.4721 0.0000 0.0 0
M  V30 7 C 0.0000 3.3196 0.0 0
M  V30 8 C 1.2114 4.9868 0.0 0
M  V30 9 C 3.9014 2.7106 0.0 0
M  V30 10 C 2.9962 3.9564 0.0 0
M  V30 11 C 2.9962 1.4647 0.0 0
M  V30 12 C 1.5315 3.4806 0.0 0
M  V30 13 O 1.5315 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 11
M  V30 7 1 7 12
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13156-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34494-98-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8451893
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1330-20-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new series of N5 derivatives of the 1,1,5-trimethyl
furo[3,4-c]pyridine-3,4-dione (cerpegin) selectively inhibits the
post-acid activity of mammalian 20S proteasomes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pham, The Hien; Hovhannisyan, Anna; Bouvier, Dominique; Tian, Lei;
Reboud-Ravaux, Michele; Melikyan, Gagik; Bouvier-Durand, Michelle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(11), 3822-3827

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
4-Chloro-2,5-difluorobenzoic acid
C7H3ClF2O2
132794-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 F 5.3901 5.3349 0.0 0
M  V30 6 Cl 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2,5-difluoro-N-methylbenzamide
C8H6ClF2NO
921213-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 Cl 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 132794-07-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 921213-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12312881
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl 2,5-difluoro-4-chloro-benzamide (10), from 2 on Kilogram Scale.
2,5-Difluoro-4-chloro-benzoic acid 2 (7.0 kg, 36.4 mol) was dissolved in
THF (175 L), and 105 L of THF was atmospherically distilled off.12 The
residual solution was cooled to 20 °C, and CDI (6.48 kg, 40 mol) was
added. The mixture was stirred at 20 °C for 2 h.13 Methylamine (11.3 kg,
145 mol, 40 wt % in water) was added, and the mixture was stirred at 20
°C for 2 h. Forty-two liters of solvent were distilled off under vacuum
(<30 °C, 0.1 bar), and water (140 L) was added. The resulting slurry was
cooled to 2 °C, stirred for 2 h, and filtered. The cake was washed with
water (14 L) and dried in a vacuum oven (35 °C) for 24 h to obtain 10.
White powder, yield: 85%, (6.33 kg, 30.8 mol). mp 127-128 °C. 1H NMR (400
MHz, CDCl3): δ 7.92 (dd, J= 9.2, 6.8 Hz, 1H), 7.24 (dd, J= 10.6, 5.6 Hz,
1H), 6.73 (brs, 1H), 3.05 (d, J= 4.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ
161.84, 155.61 (dd, JFC = 246, 3 Hz), 154.85 (dd, JFC = 247, 2 Hz),
125.21 (dd, JFC = 21, 2 Hz), 121.05 (dd, JFC = 15, 6 Hz), 118.98 (dd, JFC
= 26, 3 Hz), 118.31 (d, JFC = 31 Hz), 26.97. GCMS: 205.0 (M+). Elemental
Analysis: Calcd for C, 46.74; H, 2.94; N, 6.81; Found C, 46.94; H, 2.98;
N, 6.72.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Scalable Synthesis of CE-157119 HCl Salt, an SRI/5-HT2A Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Yong; Widlicka, Daniel W.; Hill, Paul D.; Couturier, Michel; Young,
Gregory R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2012), 16(11), 1805-1810

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-[(ethylamino)carbonyl]-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phe...
C35H35N3O7
1330736-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 8.7452 0.0 0
M  V30 2 N 2.6528 9.3716 0.0 0
M  V30 3 O 4.2207 7.2137 0.0 0
M  V30 4 C 1.4070 8.4663 0.0 0
M  V30 5 C 0.0000 9.0928 0.0 0
M  V30 6 O 9.2154 13.0878 0.0 0
M  V30 7 C 9.9854 14.4216 0.0 0
M  V30 8 C 12.2954 7.7530 0.0 0
M  V30 9 C 11.5254 6.4194 0.0 0
M  V30 10 C 13.8354 7.7530 0.0 0
M  V30 11 C 6.7702 3.7535 0.0 0
M  V30 12 O 7.8006 2.6091 0.0 0
M  V30 13 O 5.2639 3.4333 0.0 0
M  V30 14 C 7.3247 1.1444 0.0 0
M  V30 15 C 8.3552 0.0000 0.0 0
M  V30 16 O 13.8354 10.4205 0.0 0
M  V30 17 C 14.6054 11.7541 0.0 0
M  V30 18 C 7.6754 10.4205 0.0 0
M  V30 19 C 6.7702 9.1746 0.0 0
M  V30 20 O 6.7702 11.6663 0.0 0
M  V30 21 C 5.3055 9.6505 0.0 0
M  V30 22 N 5.3055 11.1905 0.0 0
M  V30 23 C 9.2154 10.4205 0.0 0
M  V30 24 C 9.9854 11.7541 0.0 0
M  V30 25 C 9.9854 9.0868 0.0 0
M  V30 26 C 11.5254 11.7541 0.0 0
M  V30 27 C 11.5254 9.0868 0.0 0
M  V30 28 C 12.2954 10.4205 0.0 0
M  V30 29 C 7.2460 7.7099 0.0 0
M  V30 30 C 6.3408 6.4640 0.0 0
M  V30 31 O 8.7107 7.2340 0.0 0
M  V30 32 C 7.2460 5.2182 0.0 0
M  V30 33 N 8.7107 5.6940 0.0 0
M  V30 34 C 9.2154 15.7552 0.0 0
M  V30 35 C 7.6754 15.7552 0.0 0
M  V30 36 C 9.9854 17.0889 0.0 0
M  V30 37 C 6.9054 17.0889 0.0 0
M  V30 38 C 9.2154 18.4225 0.0 0
M  V30 39 C 7.6754 18.4225 0.0 0
M  V30 40 C 16.1454 11.7541 0.0 0
M  V30 41 C 16.9154 13.0878 0.0 0
M  V30 42 C 16.9154 10.4205 0.0 0
M  V30 43 C 18.4555 13.0878 0.0 0
M  V30 44 C 18.4555 10.4205 0.0 0
M  V30 45 C 19.2255 11.7541 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 7 34
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 27
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 32
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 28
M  V30 19 1 17 40
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 23
M  V30 23 1 19 21
M  V30 24 1 19 29
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[4,5′-Biisoxazole]-3,3′-dicarboxamide, N3-ethyl-N3′-methyl-5-[5-(1-methylethy...
C34H34N4O6
1330738-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 7.6008 0.0 0
M  V30 2 N 2.6528 8.2273 0.0 0
M  V30 3 O 4.2207 6.0693 0.0 0
M  V30 4 C 1.4069 7.3221 0.0 0
M  V30 5 C 0.0000 7.9484 0.0 0
M  V30 6 O 9.2154 11.9435 0.0 0
M  V30 7 C 9.9854 13.2771 0.0 0
M  V30 8 C 12.2954 6.6088 0.0 0
M  V30 9 C 13.8354 6.6088 0.0 0
M  V30 10 C 11.5254 5.2750 0.0 0
M  V30 11 C 6.7701 2.6091 0.0 0
M  V30 12 N 7.8006 1.4647 0.0 0
M  V30 13 O 5.2639 2.2889 0.0 0
M  V30 14 C 7.3247 0.0000 0.0 0
M  V30 15 O 13.8354 9.2760 0.0 0
M  V30 16 C 14.6054 10.6097 0.0 0
M  V30 17 C 7.6754 9.2760 0.0 0
M  V30 18 C 6.7701 8.0302 0.0 0
M  V30 19 O 6.7701 10.5219 0.0 0
M  V30 20 C 5.3055 8.5060 0.0 0
M  V30 21 N 5.3055 10.0460 0.0 0
M  V30 22 C 9.2154 9.2760 0.0 0
M  V30 23 C 9.9854 10.6097 0.0 0
M  V30 24 C 9.9854 7.9424 0.0 0
M  V30 25 C 11.5254 10.6097 0.0 0
M  V30 26 C 11.5254 7.9424 0.0 0
M  V30 27 C 12.2954 9.2760 0.0 0
M  V30 28 C 7.2460 6.5655 0.0 0
M  V30 29 C 6.3408 5.3196 0.0 0
M  V30 30 O 8.7107 6.0896 0.0 0
M  V30 31 C 7.2460 4.0738 0.0 0
M  V30 32 N 8.7107 4.5496 0.0 0
M  V30 33 C 9.2154 14.6108 0.0 0
M  V30 34 C 7.6754 14.6108 0.0 0
M  V30 35 C 9.9854 15.9444 0.0 0
M  V30 36 C 6.9054 15.9444 0.0 0
M  V30 37 C 9.2154 17.2782 0.0 0
M  V30 38 C 7.6754 17.2782 0.0 0
M  V30 39 C 16.1454 10.6097 0.0 0
M  V30 40 C 16.9154 9.2760 0.0 0
M  V30 41 C 16.9154 11.9435 0.0 0
M  V30 42 C 18.4554 9.2760 0.0 0
M  V30 43 C 18.4554 11.9435 0.0 0
M  V30 44 C 19.2254 10.6097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 7 33
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 27
M  V30 18 1 16 39
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 17 22
M  V30 22 1 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1330736-76-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330738-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41294343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel heat shock protein (Hsp90) inhibitors based on
luminespib with potent antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Juyoung; Kwon, Jinsun; Hong, Soojung; Moon, An-Na; Jeong, Jinah;
Kwon, Sungwook; Kim, Jeong-ah; Lee, Myoungjae; Lee, Hongsub; Lee, Jin
Hee; Lee, Jeewoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(12), 127165

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-[(ethylamino)carbonyl]-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phe...
C35H35N3O7
1330736-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 8.7452 0.0 0
M  V30 2 N 2.6528 9.3716 0.0 0
M  V30 3 O 4.2207 7.2137 0.0 0
M  V30 4 C 1.4070 8.4663 0.0 0
M  V30 5 C 0.0000 9.0928 0.0 0
M  V30 6 O 9.2154 13.0878 0.0 0
M  V30 7 C 9.9854 14.4216 0.0 0
M  V30 8 C 12.2954 7.7530 0.0 0
M  V30 9 C 11.5254 6.4194 0.0 0
M  V30 10 C 13.8354 7.7530 0.0 0
M  V30 11 C 6.7702 3.7535 0.0 0
M  V30 12 O 7.8006 2.6091 0.0 0
M  V30 13 O 5.2639 3.4333 0.0 0
M  V30 14 C 7.3247 1.1444 0.0 0
M  V30 15 C 8.3552 0.0000 0.0 0
M  V30 16 O 13.8354 10.4205 0.0 0
M  V30 17 C 14.6054 11.7541 0.0 0
M  V30 18 C 7.6754 10.4205 0.0 0
M  V30 19 C 6.7702 9.1746 0.0 0
M  V30 20 O 6.7702 11.6663 0.0 0
M  V30 21 C 5.3055 9.6505 0.0 0
M  V30 22 N 5.3055 11.1905 0.0 0
M  V30 23 C 9.2154 10.4205 0.0 0
M  V30 24 C 9.9854 11.7541 0.0 0
M  V30 25 C 9.9854 9.0868 0.0 0
M  V30 26 C 11.5254 11.7541 0.0 0
M  V30 27 C 11.5254 9.0868 0.0 0
M  V30 28 C 12.2954 10.4205 0.0 0
M  V30 29 C 7.2460 7.7099 0.0 0
M  V30 30 C 6.3408 6.4640 0.0 0
M  V30 31 O 8.7107 7.2340 0.0 0
M  V30 32 C 7.2460 5.2182 0.0 0
M  V30 33 N 8.7107 5.6940 0.0 0
M  V30 34 C 9.2154 15.7552 0.0 0
M  V30 35 C 7.6754 15.7552 0.0 0
M  V30 36 C 9.9854 17.0889 0.0 0
M  V30 37 C 6.9054 17.0889 0.0 0
M  V30 38 C 9.2154 18.4225 0.0 0
M  V30 39 C 7.6754 18.4225 0.0 0
M  V30 40 C 16.1454 11.7541 0.0 0
M  V30 41 C 16.9154 13.0878 0.0 0
M  V30 42 C 16.9154 10.4205 0.0 0
M  V30 43 C 18.4555 13.0878 0.0 0
M  V30 44 C 18.4555 10.4205 0.0 0
M  V30 45 C 19.2255 11.7541 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 7 34
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 27
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 32
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 28
M  V30 19 1 17 40
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 18 23
M  V30 23 1 19 21
M  V30 24 1 19 29
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[4,5′-Biisoxazole]-3,3′-dicarboxamide, N3-ethyl-N3′-methyl-5-[5-(1-methylethy...
C34H34N4O6
1330738-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 7.6008 0.0 0
M  V30 2 N 2.6528 8.2273 0.0 0
M  V30 3 O 4.2207 6.0693 0.0 0
M  V30 4 C 1.4069 7.3221 0.0 0
M  V30 5 C 0.0000 7.9484 0.0 0
M  V30 6 O 9.2154 11.9435 0.0 0
M  V30 7 C 9.9854 13.2771 0.0 0
M  V30 8 C 12.2954 6.6088 0.0 0
M  V30 9 C 13.8354 6.6088 0.0 0
M  V30 10 C 11.5254 5.2750 0.0 0
M  V30 11 C 6.7701 2.6091 0.0 0
M  V30 12 N 7.8006 1.4647 0.0 0
M  V30 13 O 5.2639 2.2889 0.0 0
M  V30 14 C 7.3247 0.0000 0.0 0
M  V30 15 O 13.8354 9.2760 0.0 0
M  V30 16 C 14.6054 10.6097 0.0 0
M  V30 17 C 7.6754 9.2760 0.0 0
M  V30 18 C 6.7701 8.0302 0.0 0
M  V30 19 O 6.7701 10.5219 0.0 0
M  V30 20 C 5.3055 8.5060 0.0 0
M  V30 21 N 5.3055 10.0460 0.0 0
M  V30 22 C 9.2154 9.2760 0.0 0
M  V30 23 C 9.9854 10.6097 0.0 0
M  V30 24 C 9.9854 7.9424 0.0 0
M  V30 25 C 11.5254 10.6097 0.0 0
M  V30 26 C 11.5254 7.9424 0.0 0
M  V30 27 C 12.2954 9.2760 0.0 0
M  V30 28 C 7.2460 6.5655 0.0 0
M  V30 29 C 6.3408 5.3196 0.0 0
M  V30 30 O 8.7107 6.0896 0.0 0
M  V30 31 C 7.2460 4.0738 0.0 0
M  V30 32 N 8.7107 4.5496 0.0 0
M  V30 33 C 9.2154 14.6108 0.0 0
M  V30 34 C 7.6754 14.6108 0.0 0
M  V30 35 C 9.9854 15.9444 0.0 0
M  V30 36 C 6.9054 15.9444 0.0 0
M  V30 37 C 9.2154 17.2782 0.0 0
M  V30 38 C 7.6754 17.2782 0.0 0
M  V30 39 C 16.1454 10.6097 0.0 0
M  V30 40 C 16.9154 9.2760 0.0 0
M  V30 41 C 16.9154 11.9435 0.0 0
M  V30 42 C 18.4554 9.2760 0.0 0
M  V30 43 C 18.4554 11.9435 0.0 0
M  V30 44 C 19.2254 10.6097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 7 33
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 31
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 27
M  V30 18 1 16 39
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 17 22
M  V30 22 1 18 20
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1330736-76-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330738-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7706054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1:
5-(2,4-Bis(benzyloxy)-5-isopropylphenyl)-N3,N3'-diethyl-4,5'-biisoxazole-3.3'-dicarboxamide.
2 M-ethylamine solution (3.99ml) was added to a ethyl
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-3-(ethylcarbamoyl)-4,5'-biisoxazole-3'-carboxylate
(486.7mg, 0.798mmol) in EtOH (4.89ml), and the reaction mixture was
heated to reflux for 2 h. The mixture was cooled to ambient temperature,
solvent was evaporated in vacuo, and the residue was extracted between
methylene chloride and water. The organic phase was dried with magnesium
sulfate, and evaporated in vacuo. The residue was purified by silica gel
column chromatography. ethyl
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-3-(ethylcarbamoyl)-4,5'-biisoxazole-3'-carboxylate
(37.4mg, 0.061mmol) was reacted with aqueous 40% methylamine (47.6μl,
0.061mmol).
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N3-ethyl-N3'-methyl-4,5'-biisoxazole-3,3'-dicarboxamide
(32.6mg, 0.055mmol,) in a yield of 90%. 1H-NMR (400 MHz, CDCl3) δ
7.41-7.25 (m, 9H), 7.09-7.06 (m, 2H), 7.00 (s, 1H), 6.86-6.80 (m, 2H),
6.50 (s, 1H), 5.01 (s, 2H), 4.81 (s, 2H), 3.49-3.42 (m, 2H), 3.31 (sept,
1H), 2.94 (d, 3H), 1.28-1.20 (m, 9H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Five-membered heterocycle derivatives as HSP90 inhibitors and and their
preparation, pharmaceutical compositions and use in the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kang, Jae-Hoon; Lee, Hong-Sub; Kwon, Jin-Sun; Park, Joon-Tae; Hong,
Chang-Sung; Shin, Dong-Hyung; Hong, Soo-Jung; Moon, An-Na; Jeong, Jin-Ah;
Kwon, Sung-Wook
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011102660 A2 2011-08-25

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate
C9H12N2O2
133261-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7095 1.5400 0.0 0
M  V30 2 O 8.0433 2.3101 0.0 0
M  V30 3 O 6.7095 0.0000 0.0 0
M  V30 4 C 9.3770 1.5400 0.0 0
M  V30 5 C 10.7106 2.3101 0.0 0
M  V30 6 C 2.9384 2.8281 0.0 0
M  V30 7 C 3.9690 1.6836 0.0 0
M  V30 8 N 3.7084 4.1618 0.0 0
M  V30 9 C 5.3758 2.3101 0.0 0
M  V30 10 N 5.2149 3.8416 0.0 0
M  V30 11 C 1.4068 2.6672 0.0 0
M  V30 12 C 0.0000 3.2935 0.0 0
M  V30 13 C 0.1609 1.7620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyclopropyl-N-methyl-1H-pyrazole-3-carboxamide
C8H11N3O
1291012-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7096 1.5400 0.0 0
M  V30 2 N 8.0433 2.3101 0.0 0
M  V30 3 O 6.7096 0.0000 0.0 0
M  V30 4 C 9.3770 1.5400 0.0 0
M  V30 5 C 2.9385 2.8281 0.0 0
M  V30 6 C 3.9690 1.6836 0.0 0
M  V30 7 N 3.7086 4.1618 0.0 0
M  V30 8 C 5.3758 2.3101 0.0 0
M  V30 9 N 5.2149 3.8416 0.0 0
M  V30 10 C 1.4068 2.6672 0.0 0
M  V30 11 C 0.0000 3.2935 0.0 0
M  V30 12 C 0.1609 1.7620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133261-06-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1291012-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8460416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5-tert-Butyl-1H-pyrazole-3-carboxamide (IVa).
The ammonolysis of 167 g (0.85 mol) of ester IIIa was carried out in 1
liter of a mixture of ethanol with 25% aqueous ammonia, 1:1, at room
temperature over 7 days. Then the reaction mixture was boiled for 5 h,
ethanol and excess ammonia were removed, 0.5 liter of petroleum ether was
added, the white precipitate was filtered off and dried in a vacuum.
5-Cyclopropyl-1H-pyrazole-3-(N-methyl)-carboxamide (IVb) was obtained
from 146 g (0.81 mol) of ester IIIb. Yield: 120 g (90%). mp 176-178°C. 1H
NMR spectrum, δ, ppm: 0.68 m, 0.92 m (4H, 2CH2cyclopropyl), 1.89 m (1H,
CH cyclopropyl), 2.71 s (3H, CH3), 6.28 s (1H, CH═), 7.89 br.s (1H, NH
amide), 12.87 br.s (1H, NH). Found, %: C 57.97; H 6.60; N 25.50.
C8H11N3O. Calculated, %: C 58.17; H 6.71; N 25.44.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-aminomethyl-substituted pyrazoles and isoxazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Musatov, D. M.; Starodubtseva, E. V.; Rakishev, A. K.; Turova, O. V.;
Vinogradov, M. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2011), 47(8), 1199-1203

$RFMT $RIREG SCHEME76 STEP1
$RXN



  3  1
$MOL
6-Iodoquinoline
C9H6IN
13327-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl propiolate
C4H4O2
922-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(6-quinolinyl)-2-propynamide
C13H10N2O
2370974-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 C 8.4702 2.6673 0.0 0
M  V30 3 C 10.0102 2.6673 0.0 0
M  V30 4 N 10.7802 4.0010 0.0 0
M  V30 5 O 10.7802 1.3337 0.0 0
M  V30 6 C 12.3203 4.0010 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 3.0801 4.0010 0.0 0
M  V30 12 N 0.7700 2.6673 0.0 0
M  V30 13 C 5.3901 2.6673 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 4.6201 4.0010 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13327-31-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 922-67-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2370974-96-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-180-CAS-20518651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13965-03-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM trans-Hydroboration of Propiolamides: Access to Primary and Secondary
(E)-β-Borylacrylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grams, R. Justin; Fritzemeier, Russell G.; Slebodnick, Carla; Santos,
Webster L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(17), 6795-6799

$RFMT $RIREG SCHEME77 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxybenzaldehyde
C10H12O4
86-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 6.6686 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-4,5-diphenyl-2-(3,4,5-trimethoxyphenyl)-1H-imidazole
C25H24N2O3
1627168-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3051 8.2051 0.0 0
M  V30 2 O 9.6995 10.6924 0.0 0
M  V30 3 C 8.3659 11.4624 0.0 0
M  V30 4 O 12.3670 6.0723 0.0 0
M  V30 5 C 12.3670 4.5323 0.0 0
M  V30 6 O 12.3670 9.1524 0.0 0
M  V30 7 C 13.7007 8.3824 0.0 0
M  V30 8 C 4.5948 5.5543 0.0 0
M  V30 9 C 5.3648 4.2206 0.0 0
M  V30 10 N 5.6252 6.6988 0.0 0
M  V30 11 N 6.8711 4.5408 0.0 0
M  V30 12 C 7.0322 6.0723 0.0 0
M  V30 13 C 3.0633 5.7153 0.0 0
M  V30 14 C 2.4368 7.1221 0.0 0
M  V30 15 C 2.1580 4.4693 0.0 0
M  V30 16 C 0.9052 7.2831 0.0 0
M  V30 17 C 0.6265 4.6304 0.0 0
M  V30 18 C 0.0000 6.0372 0.0 0
M  V30 19 C 4.7383 2.8138 0.0 0
M  V30 20 C 3.2068 2.6527 0.0 0
M  V30 21 C 5.6436 1.5677 0.0 0
M  V30 22 C 2.5805 1.2459 0.0 0
M  V30 23 C 5.0172 0.1609 0.0 0
M  V30 24 C 3.4857 0.0000 0.0 0
M  V30 25 C 8.3659 6.8423 0.0 0
M  V30 26 C 8.3659 8.3824 0.0 0
M  V30 27 C 9.6995 6.0723 0.0 0
M  V30 28 C 9.6995 9.1524 0.0 0
M  V30 29 C 11.0332 6.8423 0.0 0
M  V30 30 C 11.0332 8.3824 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 28
M  V30 4 1 4 5
M  V30 5 1 4 29
M  V30 6 1 6 7
M  V30 7 1 6 30
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 9 19
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 12 25
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-81-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1627168-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17274423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 1,2,4,5-tetrasubstituted
imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Yue; Yuan, Rui; Ge, Wen-hui; Wang, Yuan-jiang; Liu, Gui-xiang; Li,
Ming-qi; Xu, Jiang-biao; Wan, Yu; Zhou, Sheng-liang; Han, Xi-guang;
Zhang, Peng; Liu, Jin-juan; Wu, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(8), 4413-4421

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-2-[[(3,4,8-trimethyl-2-oxo-2H-1-benzopyran-7-yl)...
C23H23NO6
1352564-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0
M  V30 2 C 2.6674 0.7700 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 O 0.0000 5.3900 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 12.0032 3.0800 0.0 0
M  V30 8 C 10.6696 2.3100 0.0 0
M  V30 9 N 13.3369 2.3100 0.0 0
M  V30 10 O 10.6696 0.7700 0.0 0
M  V30 11 O 9.3358 3.0800 0.0 0
M  V30 12 O 14.6705 3.0800 0.0 0
M  V30 13 C 9.3358 0.0000 0.0 0
M  V30 14 C 16.0043 2.3100 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 O 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 2.3100 0.0 0
M  V30 20 C 2.6674 2.3100 0.0 0
M  V30 21 C 6.6685 4.6200 0.0 0
M  V30 22 C 1.3338 4.6200 0.0 0
M  V30 23 C 6.6685 3.0800 0.0 0
M  V30 24 C 1.3338 3.0800 0.0 0
M  V30 25 C 10.6696 5.3900 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0
M  V30 27 C 10.6696 6.9300 0.0 0
M  V30 28 C 13.3369 5.3900 0.0 0
M  V30 29 C 12.0032 7.7000 0.0 0
M  V30 30 C 13.3369 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 4 25
M  V30 6 2 5 22
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methoxyimino)-N-methyl-2-[[(3,4,8-trimethyl-2-oxo-2H-1-benzopyran-7-y...
C23H24N2O5
1352564-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0
M  V30 2 C 2.6674 0.7700 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 O 0.0000 5.3900 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 12.0032 3.0800 0.0 0
M  V30 8 C 10.6696 2.3100 0.0 0
M  V30 9 N 13.3369 2.3100 0.0 0
M  V30 10 N 10.6696 0.7700 0.0 0
M  V30 11 O 9.3358 3.0800 0.0 0
M  V30 12 O 14.6705 3.0800 0.0 0
M  V30 13 C 9.3358 0.0000 0.0 0
M  V30 14 C 16.0043 2.3100 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 O 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 2.3100 0.0 0
M  V30 20 C 2.6674 2.3100 0.0 0
M  V30 21 C 6.6685 4.6200 0.0 0
M  V30 22 C 1.3338 4.6200 0.0 0
M  V30 23 C 6.6685 3.0800 0.0 0
M  V30 24 C 1.3338 3.0800 0.0 0
M  V30 25 C 10.6696 5.3900 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0
M  V30 27 C 10.6696 6.9300 0.0 0
M  V30 28 C 13.3369 5.3900 0.0 0
M  V30 29 C 12.0032 7.7000 0.0 0
M  V30 30 C 13.3369 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 4 25
M  V30 6 2 5 22
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352564-77-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352564-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3542684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and structure-activity relationship of novel coumarin
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guan, Ai-Ying; Liu, Chang-Ling; Li, Miao; Zhang, Hong; Li, Zhi-Nian; Li,
Zheng-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pest Management Science (2011), 67(6), 647-655

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(7-chloro-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)...
C18H25ClN4O2
1353628-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 4.6200 0.0 0
M  V30 2 O 1.5400 5.3900 0.0 0
M  V30 3 O 4.2074 5.3900 0.0 0
M  V30 4 C 1.5400 6.9300 0.0 0
M  V30 5 C 0.0000 6.9300 0.0 0
M  V30 6 C 1.5400 8.4700 0.0 0
M  V30 7 C 3.0800 6.9300 0.0 0
M  V30 8 Cl 10.2884 2.2644 0.0 0
M  V30 9 C 10.2884 7.5991 0.0 0
M  V30 10 C 11.8284 4.9317 0.0 0
M  V30 11 C 5.5411 3.0800 0.0 0
M  V30 12 C 5.7020 4.6115 0.0 0
M  V30 13 N 6.9479 2.4537 0.0 0
M  V30 14 C 7.2084 4.9317 0.0 0
M  V30 15 N 7.9784 3.5981 0.0 0
M  V30 16 N 7.9784 6.2655 0.0 0
M  V30 17 C 9.5184 3.5981 0.0 0
M  V30 18 C 9.5184 6.2655 0.0 0
M  V30 19 C 10.2884 4.9317 0.0 0
M  V30 20 C 4.2074 2.3100 0.0 0 CFG=2
M  V30 21 N 2.8736 3.0800 0.0 0
M  V30 22 C 4.2074 0.7700 0.0 0
M  V30 23 C 1.5400 2.3100 0.0 0
M  V30 24 C 2.8736 0.0000 0.0 0
M  V30 25 C 1.5400 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 17
M  V30 9 1 9 18
M  V30 10 1 10 19
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 20 11 CFG=3
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[5,6-dimethyl-7-(methylamino)pyrazolo[1,5-a]pyrimidi...
C19H29N5O2
1353628-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.2430 4.6201 0.0 0
M  V30 2 C 12.5768 3.8501 0.0 0
M  V30 3 C 11.2430 1.5400 0.0 0
M  V30 4 C 8.5757 0.0000 0.0 0
M  V30 5 C 3.6439 6.2875 0.0 0
M  V30 6 O 2.1038 6.2875 0.0 0
M  V30 7 O 4.4139 4.9538 0.0 0
M  V30 8 C 1.3338 4.9538 0.0 0
M  V30 9 C 0.0000 5.7238 0.0 0
M  V30 10 C 0.5638 3.6200 0.0 0
M  V30 11 C 2.6675 4.1838 0.0 0
M  V30 12 N 8.5757 4.6201 0.0 0
M  V30 13 C 7.2420 3.8501 0.0 0
M  V30 14 N 8.2555 6.1265 0.0 0
M  V30 15 C 9.9093 3.8501 0.0 0
M  V30 16 C 6.0974 4.8807 0.0 0
M  V30 17 N 7.2420 2.3100 0.0 0
M  V30 18 C 6.7239 6.2875 0.0 0
M  V30 19 C 9.9093 2.3100 0.0 0
M  V30 20 C 8.5757 1.5400 0.0 0
M  V30 21 C 5.9539 7.6211 0.0 0 CFG=2
M  V30 22 N 4.4139 7.6211 0.0 0
M  V30 23 C 6.7239 8.9550 0.0 0
M  V30 24 C 3.6439 8.9550 0.0 0
M  V30 25 C 5.9539 10.2886 0.0 0
M  V30 26 C 4.4139 10.2886 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 19
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 2 17 20
M  V30 21 1 21 18 CFG=1
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353628-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353628-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4067343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methylamine (40% in H2O, 2 mL) was added to a solution of 19 (110 mg,
0.301 mmol) in dioxane (5 mL). The reaction mixture was stirred for 2 h
and concentrated under reduced pressure. The resulting residue was
purified via silica gel column chromatography (0-80% EtOAc in hexanes).
(S)-tert-butyl
2-(5,6-dimethyl-7-(methylamino)pyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carboxylate
(98 mg, 90%). 1H NMR (CD3CN, 300 MHz): δ 1.45 (m, 11H), 1.60 (m, 2H),
1.82 (m, 1H), 2.30 (s, 3H), 2.40 (m, 1H, 2.42 (s, 3H), 2.95 (t, 1H), 3.35
(d, 3H), 4.01 (d, 1H), 5.49 (m, 1H), 6.00 (s, 1H), 6.29 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor
(GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mackman, Richard L.; Sangi, Michael; Sperandio, David; Parrish, Jay P.;
Eisenberg, Eugene; Perron, Michel; Hui, Hon; Zhang, Lijun; Siegel,
Dustin; Yang, Hai; Saunders, Oliver; Boojamra, Constantine; Lee, Gary;
Samuel, Dharmaraj; Babaoglu, Kerim; Carey, Anne; Gilbert, Brian E.;
Piedra, Pedro A.; Strickley, Robert; Iwata, Quynh; Hayes, Jaclyn; Stray,
Kirsten; Kinkade, April; Theodore, Dorothy; Jordan, Robert; Desai, Manoj;
Cihlar, Tomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(4), 1630-1643

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(7-chloro-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)...
C18H25ClN4O2
1353628-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 4.6200 0.0 0
M  V30 2 O 1.5400 5.3900 0.0 0
M  V30 3 O 4.2074 5.3900 0.0 0
M  V30 4 C 1.5400 6.9300 0.0 0
M  V30 5 C 0.0000 6.9300 0.0 0
M  V30 6 C 1.5400 8.4700 0.0 0
M  V30 7 C 3.0800 6.9300 0.0 0
M  V30 8 Cl 10.2884 2.2644 0.0 0
M  V30 9 C 10.2884 7.5991 0.0 0
M  V30 10 C 11.8284 4.9317 0.0 0
M  V30 11 C 5.5411 3.0800 0.0 0
M  V30 12 C 5.7020 4.6115 0.0 0
M  V30 13 N 6.9479 2.4537 0.0 0
M  V30 14 C 7.2084 4.9317 0.0 0
M  V30 15 N 7.9784 3.5981 0.0 0
M  V30 16 N 7.9784 6.2655 0.0 0
M  V30 17 C 9.5184 3.5981 0.0 0
M  V30 18 C 9.5184 6.2655 0.0 0
M  V30 19 C 10.2884 4.9317 0.0 0
M  V30 20 C 4.2074 2.3100 0.0 0 CFG=2
M  V30 21 N 2.8736 3.0800 0.0 0
M  V30 22 C 4.2074 0.7700 0.0 0
M  V30 23 C 1.5400 2.3100 0.0 0
M  V30 24 C 2.8736 0.0000 0.0 0
M  V30 25 C 1.5400 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 17
M  V30 9 1 9 18
M  V30 10 1 10 19
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 20 11 CFG=3
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[5,6-dimethyl-7-(methylamino)pyrazolo[1,5-a]pyrimidi...
C19H29N5O2
1353628-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.2430 4.6201 0.0 0
M  V30 2 C 12.5768 3.8501 0.0 0
M  V30 3 C 11.2430 1.5400 0.0 0
M  V30 4 C 8.5757 0.0000 0.0 0
M  V30 5 C 3.6439 6.2875 0.0 0
M  V30 6 O 2.1038 6.2875 0.0 0
M  V30 7 O 4.4139 4.9538 0.0 0
M  V30 8 C 1.3338 4.9538 0.0 0
M  V30 9 C 0.0000 5.7238 0.0 0
M  V30 10 C 0.5638 3.6200 0.0 0
M  V30 11 C 2.6675 4.1838 0.0 0
M  V30 12 N 8.5757 4.6201 0.0 0
M  V30 13 C 7.2420 3.8501 0.0 0
M  V30 14 N 8.2555 6.1265 0.0 0
M  V30 15 C 9.9093 3.8501 0.0 0
M  V30 16 C 6.0974 4.8807 0.0 0
M  V30 17 N 7.2420 2.3100 0.0 0
M  V30 18 C 6.7239 6.2875 0.0 0
M  V30 19 C 9.9093 2.3100 0.0 0
M  V30 20 C 8.5757 1.5400 0.0 0
M  V30 21 C 5.9539 7.6211 0.0 0 CFG=2
M  V30 22 N 4.4139 7.6211 0.0 0
M  V30 23 C 6.7239 8.9550 0.0 0
M  V30 24 C 3.6439 8.9550 0.0 0
M  V30 25 C 5.9539 10.2886 0.0 0
M  V30 26 C 4.4139 10.2886 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 19
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 2 17 20
M  V30 21 1 21 18 CFG=1
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353628-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353628-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13762339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Intermediate 23 The intermediate 19 (0.110 g, 0.301 mmol),
was dissolved in 1,4-dioxane 5 ml. Methyl amine (40% in water) (2 mL) was
added and the reaction was stirred for 2 hr. Solvents were removed by
rotary evaporation. The residue was taken up in DCM and loaded onto a
silica gel column. Intermediate 23 was eluted with a 0 to 80% EtOAc in
hexanes gradient (98 mg, 0.272 mmol, 90%). 1H-NMR (CD3CN, 300 MHz): δ
1.45 (m, 11H), 1.60 (m, 2H), 1.82 (m, 1H), 2.30 (s, 3H), 2.40 (m, 1H,
2.42 (s, 3H), 2.95 (t, 1H), 3.35 (d, 3H), 4.01 (d, 1H), 5.49 (m, 1H),
6.00 (s, 1H), 6.29 (bs, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[1,5-a]pyrimidines and analogs as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siegel, Dustin; Sperandio, David; Yang, Hai; Sangi, Michael; Parrish, Jay
P.; Hui, Hon Chung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130273037 A1 2013-10-17

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(7-chloro-5,6-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)...
C18H25ClN4O2
1353628-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 4.6200 0.0 0
M  V30 2 O 1.5400 5.3900 0.0 0
M  V30 3 O 4.2074 5.3900 0.0 0
M  V30 4 C 1.5400 6.9300 0.0 0
M  V30 5 C 0.0000 6.9300 0.0 0
M  V30 6 C 1.5400 8.4700 0.0 0
M  V30 7 C 3.0800 6.9300 0.0 0
M  V30 8 Cl 10.2884 2.2644 0.0 0
M  V30 9 C 10.2884 7.5991 0.0 0
M  V30 10 C 11.8284 4.9317 0.0 0
M  V30 11 C 5.5411 3.0800 0.0 0
M  V30 12 C 5.7020 4.6115 0.0 0
M  V30 13 N 6.9479 2.4537 0.0 0
M  V30 14 C 7.2084 4.9317 0.0 0
M  V30 15 N 7.9784 3.5981 0.0 0
M  V30 16 N 7.9784 6.2655 0.0 0
M  V30 17 C 9.5184 3.5981 0.0 0
M  V30 18 C 9.5184 6.2655 0.0 0
M  V30 19 C 10.2884 4.9317 0.0 0
M  V30 20 C 4.2074 2.3100 0.0 0 CFG=2
M  V30 21 N 2.8736 3.0800 0.0 0
M  V30 22 C 4.2074 0.7700 0.0 0
M  V30 23 C 1.5400 2.3100 0.0 0
M  V30 24 C 2.8736 0.0000 0.0 0
M  V30 25 C 1.5400 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 17
M  V30 9 1 9 18
M  V30 10 1 10 19
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 20 11 CFG=3
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[5,6-dimethyl-7-(methylamino)pyrazolo[1,5-a]pyrimidi...
C19H29N5O2
1353628-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.2430 4.6201 0.0 0
M  V30 2 C 12.5768 3.8501 0.0 0
M  V30 3 C 11.2430 1.5400 0.0 0
M  V30 4 C 8.5757 0.0000 0.0 0
M  V30 5 C 3.6439 6.2875 0.0 0
M  V30 6 O 2.1038 6.2875 0.0 0
M  V30 7 O 4.4139 4.9538 0.0 0
M  V30 8 C 1.3338 4.9538 0.0 0
M  V30 9 C 0.0000 5.7238 0.0 0
M  V30 10 C 0.5638 3.6200 0.0 0
M  V30 11 C 2.6675 4.1838 0.0 0
M  V30 12 N 8.5757 4.6201 0.0 0
M  V30 13 C 7.2420 3.8501 0.0 0
M  V30 14 N 8.2555 6.1265 0.0 0
M  V30 15 C 9.9093 3.8501 0.0 0
M  V30 16 C 6.0974 4.8807 0.0 0
M  V30 17 N 7.2420 2.3100 0.0 0
M  V30 18 C 6.7239 6.2875 0.0 0
M  V30 19 C 9.9093 2.3100 0.0 0
M  V30 20 C 8.5757 1.5400 0.0 0
M  V30 21 C 5.9539 7.6211 0.0 0 CFG=2
M  V30 22 N 4.4139 7.6211 0.0 0
M  V30 23 C 6.7239 8.9550 0.0 0
M  V30 24 C 3.6439 8.9550 0.0 0
M  V30 25 C 5.9539 10.2886 0.0 0
M  V30 26 C 4.4139 10.2886 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 19
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 2 17 20
M  V30 21 1 21 18 CFG=1
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353628-17-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353628-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5412004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 27. The intermediate 26 (0.110 g, 0.301 mmol), was dissolved
in 1,4-dioxane 5 mL Methyl amine (40% in water) (2 mL) was added and the
reaction was stirred for 2 hr. Solvents were removed by rotary
evaporation. The residue was taken up in DCM and loaded onto a silica gel
column. The product, intermediate 27, was eluted with a 0 to 80% EtOAc in
hexanes gradient. (98 mg, 0.272 mmol, 90%). 1H-NMR (CD3CN, 300 MHz): δ
1.45 (m, 11H), 1.60 (m, 2H), 1.82 (m, 1H), 2.30 (s, 3H), 2.40 (m, 1H,
2.42 (s, 3H), 2.95 (t, 1H), 3.35 (d, 3H), 4.01 (d, 1H), 5.49 (m, 1H),
6.00 (s, 1H), 6.29 (bs, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[1,5-a]pyrimidines as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babaoglu, Kerim; Boojamra, Constantine G.; Eisenberg, Eugene J.; Hui, Hon
Chung; Mackman, Richard L.; Parrish, Jay P.; Sangi, Michael; Saunders,
Oliver L.; Siegel, Dustin; Sperandio, David; Yang, Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011163518 A1 2011-12-29

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (βE)-β-(methoxyimino)-2-[[(4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]met...
C22H21NO6
1354771-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 O 4.6200 6.6684 0.0 0
M  V30 6 O 0.7700 5.3347 0.0 0
M  V30 7 O 3.0800 6.6684 0.0 0
M  V30 8 C 5.3900 8.0021 0.0 0
M  V30 9 C 0.0000 6.6684 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 O 9.2400 4.0011 0.0 0
M  V30 12 C 11.5500 10.6694 0.0 0
M  V30 13 O 16.1700 8.0021 0.0 0
M  V30 14 C 5.3900 2.6673 0.0 0
M  V30 15 C 6.9300 2.6673 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 C 7.7000 1.3336 0.0 0
M  V30 18 C 5.3900 0.0000 0.0 0
M  V30 19 C 6.9300 0.0000 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 9.2400 6.6684 0.0 0
M  V30 23 C 12.3200 6.6684 0.0 0
M  V30 24 C 10.0100 8.0021 0.0 0
M  V30 25 C 11.5500 8.0021 0.0 0
M  V30 26 O 13.8600 6.6684 0.0 0
M  V30 27 C 12.3200 9.3358 0.0 0
M  V30 28 C 14.6300 8.0021 0.0 0
M  V30 29 C 13.8600 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 1 11 20
M  V30 13 1 12 27
M  V30 14 2 13 28
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 23 26
M  V30 27 2 24 25
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αZ)-α-(Methoxyimino)-N-methyl-2-[[(4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]m...
C21H20N2O5
1354771-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6684 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 N 1.5400 5.3347 0.0 0
M  V30 5 O 1.5400 8.0021 0.0 0
M  V30 6 O 3.8500 4.0011 0.0 0
M  V30 7 C 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 6.9300 6.6684 0.0 0
M  V30 10 O 8.4700 6.6684 0.0 0
M  V30 11 C 10.7800 0.0000 0.0 0
M  V30 12 O 15.4000 2.6673 0.0 0
M  V30 13 C 4.6200 8.0021 0.0 0
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 3.8500 9.3358 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 4.6200 10.6694 0.0 0
M  V30 18 C 6.1600 10.6694 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 11.5500 4.0011 0.0 0
M  V30 23 C 9.2400 2.6673 0.0 0
M  V30 24 C 10.7800 2.6673 0.0 0
M  V30 25 O 13.0900 4.0011 0.0 0
M  V30 26 C 11.5500 1.3336 0.0 0
M  V30 27 C 13.8600 2.6673 0.0 0
M  V30 28 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 26
M  V30 13 2 12 27
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 2 23 24
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354771-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354771-88-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30711838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and bioactivity of novel coumarin derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guan, Ai-Ying; Liu, Chang-Ling; Li, Miao; Li, Zhi-Nian; Zhang, Ming-Xing;
Zhang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Communications (2011), 6(12), 1917-1920

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Anhydro-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2,3-bis-O-[(1...
C26H45N3O7Si2
1355340-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.8973 4.6200 0.0 0
M  V30 2 Si 9.8973 3.0800 0.0 0
M  V30 3 C 9.8973 1.5400 0.0 0
M  V30 4 C 8.3573 3.0800 0.0 0
M  V30 5 C 11.4373 3.0800 0.0 0
M  V30 6 C 8.3573 1.5400 0.0 0
M  V30 7 C 9.8973 0.0000 0.0 0
M  V30 8 C 11.4373 1.5400 0.0 0
M  V30 9 C 11.4840 7.8854 0.0 0
M  V30 10 N 12.7608 8.7466 0.0 0
M  V30 11 O 11.5915 6.3491 0.0 0
M  V30 12 C 14.1449 8.0715 0.0 0
M  V30 13 C 15.4216 8.9326 0.0 0
M  V30 14 C 16.8058 8.2577 0.0 0
M  V30 15 O 6.8365 3.2573 0.0 0
M  V30 16 Si 5.3720 2.7814 0.0 0
M  V30 17 C 3.9073 2.3055 0.0 0
M  V30 18 C 4.8960 4.2459 0.0 0
M  V30 19 C 5.8479 1.3167 0.0 0
M  V30 20 C 3.4314 3.7701 0.0 0
M  V30 21 C 2.4426 1.8295 0.0 0
M  V30 22 C 4.3832 0.8408 0.0 0
M  V30 23 O 4.3159 8.3998 0.0 0
M  V30 24 O 0.0000 5.2642 0.0 0
M  V30 25 C 8.4026 6.9215 0.0 0 CFG=1
M  V30 26 C 8.5637 5.3900 0.0 0 CFG=1
M  V30 27 O 6.8963 7.2417 0.0 0
M  V30 28 C 7.1567 4.7635 0.0 0 CFG=1
M  V30 29 C 6.1263 5.9081 0.0 0 CFG=1
M  V30 30 C 8.5637 8.4531 0.0 0 CFG=1
M  V30 31 C 10.0998 8.5606 0.0 0 CFG=1
M  V30 32 O 9.2386 9.8372 0.0 0
M  V30 33 N 4.5948 5.7471 0.0 0
M  V30 34 C 3.6895 6.9930 0.0 0
M  V30 35 C 3.9683 4.3402 0.0 0
M  V30 36 N 2.1580 6.8321 0.0 0
M  V30 37 C 2.4367 4.1793 0.0 0
M  V30 38 C 1.5315 5.4251 0.0 0
M  V30 39 H 9.9426 6.9215 0.0 0
M  V30 40 H 7.0832 8.8777 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 26 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 31 9 CFG=3
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 15 16
M  V30 16 1 28 15 CFG=1
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 2 23 34
M  V30 24 2 24 38
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 25 30
M  V30 28 1 25 39 CFG=1
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 29 33 CFG=3
M  V30 33 1 30 31
M  V30 34 1 30 32 CFG=1
M  V30 35 1 30 40
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 25 26 28 29 30 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,6-Dideoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-2,3-bis-O-[(1,1-dimet...
C27H50N4O7Si2
1355340-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.9173 4.3513 0.0 0
M  V30 2 Si 3.4110 4.6715 0.0 0
M  V30 3 C 1.9045 4.9917 0.0 0
M  V30 4 C 3.0907 3.1651 0.0 0
M  V30 5 C 3.7312 6.1778 0.0 0
M  V30 6 C 2.2247 6.4980 0.0 0
M  V30 7 C 0.3982 5.3118 0.0 0
M  V30 8 C 1.5844 3.4854 0.0 0
M  V30 9 O 8.2494 4.0011 0.0 0
M  V30 10 Si 7.4794 2.6673 0.0 0
M  V30 11 C 6.7094 1.3337 0.0 0
M  V30 12 C 8.8131 1.8973 0.0 0
M  V30 13 C 6.1456 3.4373 0.0 0
M  V30 14 C 5.3756 2.1037 0.0 0
M  V30 15 C 5.9394 0.0000 0.0 0
M  V30 16 C 8.0431 0.5636 0.0 0
M  V30 17 C 9.4394 5.9716 0.0 0 CFG=1
M  V30 18 C 10.7731 6.7416 0.0 0 CFG=1
M  V30 19 O 9.4394 4.4316 0.0 0
M  V30 20 C 12.1069 5.9716 0.0 0
M  V30 21 N 10.7731 8.2816 0.0 0
M  V30 22 N 13.4406 6.7416 0.0 0
M  V30 23 O 12.1069 4.4316 0.0 0
M  V30 24 C 12.1069 9.0516 0.0 0
M  V30 25 C 14.7742 5.9716 0.0 0
M  V30 26 C 16.1079 6.7416 0.0 0
M  V30 27 C 17.4417 5.9716 0.0 0
M  V30 28 O 5.3057 10.0653 0.0 0
M  V30 29 O 0.0000 9.5076 0.0 0
M  V30 30 C 5.9477 5.4957 0.0 0 CFG=2
M  V30 31 C 5.6276 7.0022 0.0 0 CFG=2
M  V30 32 C 7.4794 5.3348 0.0 0 CFG=2
M  V30 33 O 6.9612 7.7722 0.0 0
M  V30 34 C 8.1058 6.7416 0.0 0 CFG=1
M  V30 35 N 4.2207 7.6285 0.0 0
M  V30 36 C 4.0597 9.1601 0.0 0
M  V30 37 C 2.9749 6.7233 0.0 0
M  V30 38 N 2.6528 9.7865 0.0 0
M  V30 39 C 1.5679 7.3498 0.0 0
M  V30 40 C 1.4070 8.8813 0.0 0
M  V30 41 H 9.0110 7.9876 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 30 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 32 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 17 18
M  V30 18 1 17 19 CFG=3
M  V30 19 1 17 34
M  V30 20 1 18 20
M  V30 21 1 18 21 CFG=1
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 25 26
M  V30 27 2 26 27
M  V30 28 2 28 36
M  V30 29 2 29 40
M  V30 30 1 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 31 35 CFG=3
M  V30 34 1 32 34
M  V30 35 1 33 34
M  V30 36 1 34 41 CFG=1
M  V30 37 1 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 1 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 17 18 30 31 32 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1355340-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1355340-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-12858340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Amino Alcohol 32. To a solution of epoxy amide 31 (61 mg, 0.107 mmol, 1.0
equiv) in MeOH (3 mL) was added an aqueous MeNH2 solution (40% w/v
solution, 0.17 mL, 2.15 mmol, 20.0 equiv). Then, the reaction mixture was
heated at 60 °C for 36 h. After this time, the crude mixture was allowed
to reach room temperature and concentrated under reduced pressure. The
resulting crude product was subjected to purification by flash column
chromatography (silica gel, 45% EtOAc, 5% MeOH in hexanes) to obtain
amino alcohol 32. (58 mg, 90%) as a colorless oil. Rf = 0.31 (silica gel,
60% EtOAc, 5% MeOH in hexanes); [α]D22 +3.3 (c 0.12, CH2Cl2); 1H NMR (400
MHz, CDCl3) δ = 0.02 (s, 3 H), 0.03 (s, 3 H), 0.05 (s, 3 H), 0.06 (s, 3
H), 0.85 (s, 9 H), 0.87 (s, 9 H), 2.43 (s, 3 H), 3.25 (bs, 1 H),
3.88−3.93 (m, 3 H), 4.12 (d, J = 3.8 Hz, 1H), 4.17 (dd, J = 4.3, 3.8 Hz,
1H), 4.29 (d, J = 4.8, 4.3 Hz, 1 H), 5.12−5.21 (m, 2 H), 5.72 (d, J = 8.1
Hz, 1 H), 5.76 (d, J = 4.8 Hz, 1 H), 5.77−5.87 (m, 1 H), 7.69 (bs, 1 H),
8.03 (d, J = 8.1 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ = −4.8, −4.7, −4.6,
−4.5, 17.9, 18.0, 25.8, 34.5, 41.5, 63.1, 70.5, 72.2, 74.7, 84.1, 90.2,
102.3, 116.6, 133.6, 141.6, 150.5, 163.3, 174.0; FAB HRMS (NBA) m/ e
599.3293, M + H+ calcd for C27H50N4O7Si2 599.3296.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the Chemistry of Epoxy Amides for the Synthesis of the
2''-epi-Diazepanone Core of Liposidomycins and Caprazamycins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sarabia, Francisco; Vivar-Garcia, Carlos; Garcia-Ruiz, Cristina;
Martin-Ortiz, Laura; Romero-Carrasco, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(3), 1328-1339

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
cis-4-[2-[(4-Fluorobenzoyl)amino]-6-(1-piperidinylmethyl)-1H-benzimidazol-1-y...
C27H31FN4O3
1357924-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.9119 8.2489 0.0 0
M  V30 2 C 12.6819 9.5825 0.0 0
M  V30 3 O 11.9119 10.9161 0.0 0
M  V30 4 C 4.0011 6.7089 0.0 0
M  V30 5 C 11.3703 1.1444 0.0 0
M  V30 6 O 10.3397 0.0000 0.0 0
M  V30 7 O 12.8766 0.8242 0.0 0
M  V30 8 F 18.8419 9.5825 0.0 0
M  V30 9 N 9.4667 7.0030 0.0 0
M  V30 10 C 8.0021 7.4789 0.0 0
M  V30 11 C 10.3719 8.2489 0.0 0
M  V30 12 C 8.0021 9.0189 0.0 0
M  V30 13 C 6.6684 6.7089 0.0 0
M  V30 14 N 9.4667 9.4947 0.0 0
M  V30 15 C 6.6684 9.7889 0.0 0
M  V30 16 C 5.3347 7.4789 0.0 0
M  V30 17 C 5.3347 9.0189 0.0 0
M  V30 18 C 9.9426 5.5383 0.0 0 CFG=2
M  V30 19 C 11.4490 5.2181 0.0 0
M  V30 20 C 8.9121 4.3939 0.0 0
M  V30 21 C 11.9248 3.7534 0.0 0
M  V30 22 C 9.3880 2.9292 0.0 0
M  V30 23 C 10.8944 2.6091 0.0 0 CFG=1
M  V30 24 C 14.2219 9.5825 0.0 0
M  V30 25 C 14.9919 8.2489 0.0 0
M  V30 26 C 14.9919 10.9161 0.0 0
M  V30 27 C 16.5319 8.2489 0.0 0
M  V30 28 C 16.5319 10.9161 0.0 0
M  V30 29 C 17.3019 9.5825 0.0 0
M  V30 30 N 2.6674 7.4789 0.0 0
M  V30 31 C 2.6674 9.0189 0.0 0
M  V30 32 C 1.3336 6.7089 0.0 0
M  V30 33 C 1.3336 9.7889 0.0 0
M  V30 34 C 0.0000 7.4789 0.0 0
M  V30 35 C 0.0000 9.0189 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 16
M  V30 6 1 4 30
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 23 5 CFG=1
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 18 9 CFG=1
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 14
M  V30 18 2 12 15
M  V30 19 1 13 16
M  V30 20 1 15 17
M  V30 21 2 16 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 18 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-[1-[cis-4-[(methylamino)carbonyl]cyclohexyl]-6-(1-piperidinylmethy...
C28H34FN5O2
1357918-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.9120 9.7134 0.0 0
M  V30 2 C 12.6820 11.0471 0.0 0
M  V30 3 O 11.9120 12.3807 0.0 0
M  V30 4 C 4.0011 8.1734 0.0 0
M  V30 5 C 11.3703 2.6091 0.0 0
M  V30 6 N 10.3398 1.4645 0.0 0
M  V30 7 O 12.8766 2.2888 0.0 0
M  V30 8 C 10.8158 0.0000 0.0 0
M  V30 9 F 18.8420 11.0471 0.0 0
M  V30 10 N 9.4667 8.4676 0.0 0
M  V30 11 C 8.0022 8.9434 0.0 0
M  V30 12 C 10.3720 9.7134 0.0 0
M  V30 13 C 8.0022 10.4834 0.0 0
M  V30 14 C 6.6684 8.1734 0.0 0
M  V30 15 N 9.4667 10.9593 0.0 0
M  V30 16 C 6.6684 11.2535 0.0 0
M  V30 17 C 5.3347 8.9434 0.0 0
M  V30 18 C 5.3347 10.4834 0.0 0
M  V30 19 C 9.9426 7.0029 0.0 0 CFG=2
M  V30 20 C 11.4490 6.6827 0.0 0
M  V30 21 C 8.9122 5.8585 0.0 0
M  V30 22 C 11.9249 5.2182 0.0 0
M  V30 23 C 9.3880 4.3938 0.0 0
M  V30 24 C 10.8945 4.0736 0.0 0 CFG=1
M  V30 25 C 14.2220 11.0471 0.0 0
M  V30 26 C 14.9920 9.7134 0.0 0
M  V30 27 C 14.9920 12.3807 0.0 0
M  V30 28 C 16.5320 9.7134 0.0 0
M  V30 29 C 16.5320 12.3807 0.0 0
M  V30 30 C 17.3020 11.0471 0.0 0
M  V30 31 N 2.6674 8.9434 0.0 0
M  V30 32 C 2.6674 10.4834 0.0 0
M  V30 33 C 1.3336 8.1734 0.0 0
M  V30 34 C 1.3336 11.2535 0.0 0
M  V30 35 C 0.0000 8.9434 0.0 0
M  V30 36 C 0.0000 10.4834 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 25
M  V30 5 1 4 17
M  V30 6 1 4 31
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 24 5 CFG=1
M  V30 10 1 6 8
M  V30 11 1 9 30
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 19 10 CFG=1
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 2 12 15
M  V30 18 1 13 15
M  V30 19 2 13 16
M  V30 20 1 14 17
M  V30 21 1 16 18
M  V30 22 2 17 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1357924-35-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357918-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4393648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(E)-N-(1-(cis-4-(Ethylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1H-benzo[d]imidazol-2(3H)-ylidene)-4-fluorobenzamide.
cis-4-((E)-2-(4-Fluorobenzoylimino)-6-(piperidin-1-ylmethyl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)cyclohexanecarboxylic
acid (0.025 g, 0.052 mmol) was cooled to 0°C under nitrogen. To this
mixture was added thionyl chloride (0.381 mL, 5.22 mmol), and the
resulting reaction mixture was stirred for 10 minutes. The mixture was
concentrated under reduced pressure and dried under high vacuum. The
residue was suspended in THF (0.5 mL) and cooled to 0°C under a nitrogen
atmosphere. To this mixture was added ethanamine (2M in THF) (0.059 mL,
1.045 mmol) dropwise, and the reaction was stirred at 0°C for 30 minutes.
The reaction mixture was diluted with water (10 mL) and DCM (20 mL), and
the layers were separated. The organic phase was dried over sodium
sulfate, filtered, and solvent was concentrated under reduced pressure to
afford
(E)-N-(1-(cis-4-(ethylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1H-benzo[d]imidazol-2(3H)-ylidene)-4-fluorobenzamide.
(E)-N-(1-(cis-4-(Methylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1H-benzo[d]imidazol-2(3H)-ylidene)-4-fluorobenzamide.
The title compound was prepared from
cis-4-((E)-2-(4-fluorobenzoylimino)-6-(piperidin-1-ylmethyl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)cyclohexanecarboxylic
acid using a method analogous to the preparation of
(E)-N-(1-(cis-4-(ethylcarbamoyl)cyclohexyl)-6-(piperidin-1-ylmethyl)-1H-benzo[d]imidazol-2(3H)-ylidene)-4-fluorobenzamide
(23 mg, 90 % yield). MS m/z = 492.2 [M+H]. Calc'd for C28H34FN5O2: 491.3.
1H NMR (400 MHz, DMSO-d6) δ ppm 1.42 - 1.50 (m, 2 H) 1.52 - 1.62 (m, 4 H)
1.64 - 1.74 (m, 2 H) 1.71 - 1.87 (m, 2 H) 2.16 - 2.28 (m, 2 H) 2.35 -
2.47 (m, 4 H) 2.59 - 2.66 (m, 1 H) 2.77 (d, J=4.60 Hz, 3 H) 2.78 - 2.85
(m, 2 H) 3.57 (s, 2 H) 4.68 - 5.04 (m, 1 H) 7.13 - 7.24 (m, 1 H) 7.25 -
7.36 (m, 2 H) 7.53 (d, J=8.12 Hz, 1 H) 7.64 (s, 1 H) 7.76 - 7.87 (m, 1 H)
8.27 - 8.41 (m, 2 H) 12.80 (s, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabenzimidazole derivatives and analogs for use as
anaplastic lymphoma kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bode, Christiane M.; Cheng, Alan C.; Choquette, Deborah; Lewis, Richard
T.; Potashman, Michele H.; Romero, Karina; Stellwagen, John C.;
Whittington, Douglas A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012018668 A1 2012-02-09

$RFMT $RIREG SCHEME83 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acenaphthenequinone
C12H6O2
82-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5501 3.3821 0.0 0
M  V30 2 O 4.8784 6.2775 0.0 0
M  V30 3 C 2.6315 3.0500 0.0 0
M  V30 4 C 3.9780 2.3751 0.0 0
M  V30 5 C 2.7203 4.5535 0.0 0
M  V30 6 C 1.3158 2.2904 0.0 0
M  V30 7 C 5.0179 3.5399 0.0 0
M  V30 8 C 4.0223 0.8215 0.0 0
M  V30 9 C 4.2490 4.8717 0.0 0
M  V30 10 C 1.3971 5.3688 0.0 0
M  V30 11 C 0.0000 3.1125 0.0 0
M  V30 12 C 1.3700 0.7399 0.0 0
M  V30 13 C 2.7204 0.0000 0.0 0
M  V30 14 C 0.0345 4.6520 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 9
M  V30 13 2 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Bis(methylthio)-2-nitroethylene
C4H7NO2S2
13623-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 S 1.5400 1.3338 0.0 0
M  V30 4 S 1.5400 4.0011 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0 VAL=5
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 O 6.1600 4.0011 0.0 0
M  V30 9 O 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chlorophenyl)-3-methyl-5-pyrazolone
C10H9ClN2O
14580-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0492 0.0000 0.0 0
M  V30 2 Cl 3.0800 5.3780 0.0 0
M  V30 3 C 8.2357 4.3858 0.0 0
M  V30 4 N 4.6200 2.7106 0.0 0
M  V30 5 C 5.5252 1.4647 0.0 0
M  V30 6 N 5.5252 3.9564 0.0 0
M  V30 7 C 6.9898 1.9406 0.0 0
M  V30 8 C 6.9898 3.4806 0.0 0
M  V30 9 C 3.0800 2.7106 0.0 0
M  V30 10 C 2.3100 4.0442 0.0 0
M  V30 11 C 2.3100 1.3769 0.0 0
M  V30 12 C 0.7700 4.0442 0.0 0
M  V30 13 C 0.7700 1.3769 0.0 0
M  V30 14 C 0.0000 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-(2-Chlorophenyl)-3′-methyl-6′-(methylamino)-5′-nitrospiro[acenaphthylene-1...
C25H17ClN4O4
2138461-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7137 1.2299 0.0 0 VAL=5
M  V30 2 O 5.6404 0.0000 0.0 0
M  V30 3 O 3.1850 1.0421 0.0 0
M  V30 4 O 5.4335 6.8593 0.0 0
M  V30 5 C 4.8937 7.6295 0.0 0
M  V30 6 N 7.1002 0.6651 0.0 0
M  V30 7 C 8.5649 0.1893 0.0 0
M  V30 8 Cl 10.0495 8.6216 0.0 0
M  V30 9 C 4.9952 4.1539 0.0 0
M  V30 10 C 6.1397 5.1843 0.0 0
M  V30 11 C 3.7339 3.2334 0.0 0
M  V30 12 C 5.3153 2.6474 0.0 0
M  V30 13 C 4.5230 5.6172 0.0 0
M  V30 14 C 7.6043 4.7084 0.0 0
M  V30 15 C 6.1397 6.7243 0.0 0
M  V30 16 C 2.5595 4.1759 0.0 0
M  V30 17 C 3.4513 1.7054 0.0 0
M  V30 18 C 6.7800 2.1716 0.0 0
M  V30 19 C 2.9617 5.6270 0.0 0
M  V30 20 N 8.5095 5.9543 0.0 0
M  V30 21 O 7.9244 3.2020 0.0 0
M  V30 22 N 7.6043 7.2002 0.0 0
M  V30 23 C 1.1136 3.7094 0.0 0
M  V30 24 C 2.0060 1.1755 0.0 0
M  V30 25 C 1.8394 6.7018 0.0 0
M  V30 26 C 0.8412 2.1822 0.0 0
M  V30 27 C 0.0000 4.7894 0.0 0
M  V30 28 C 0.3568 6.2871 0.0 0
M  V30 29 C 10.0495 5.9543 0.0 0
M  V30 30 C 10.8195 7.2879 0.0 0
M  V30 31 C 10.8195 4.6206 0.0 0
M  V30 32 C 12.3595 7.2879 0.0 0
M  V30 33 C 12.3595 4.6206 0.0 0
M  V30 34 C 13.1295 5.9543 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 13
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 30
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 2 15 22
M  V30 22 1 16 19
M  V30 23 2 16 23
M  V30 24 1 17 24
M  V30 25 1 18 21
M  V30 26 2 19 25
M  V30 27 1 20 22
M  V30 28 1 20 29
M  V30 29 1 23 26
M  V30 30 1 23 27
M  V30 31 2 24 26
M  V30 32 1 25 28
M  V30 33 2 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-86-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 13623-94-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 14580-22-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138461-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18008000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, combinatorial, green chemistry-solvent, optimization
study, optimized on reaction conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective synthesis of novel spiropyrano acenaphthylene derivatives
via one-pot four-component reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bayat, Mohammad; Amiri, Zeinab
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2017), 58(45), 4260-4263

$RFMT $RIREG SCHEME84 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acenaphthenequinone
C12H6O2
82-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5501 3.3821 0.0 0
M  V30 2 O 4.8784 6.2775 0.0 0
M  V30 3 C 2.6315 3.0500 0.0 0
M  V30 4 C 3.9780 2.3751 0.0 0
M  V30 5 C 2.7203 4.5535 0.0 0
M  V30 6 C 1.3158 2.2904 0.0 0
M  V30 7 C 5.0179 3.5399 0.0 0
M  V30 8 C 4.0223 0.8215 0.0 0
M  V30 9 C 4.2490 4.8717 0.0 0
M  V30 10 C 1.3971 5.3688 0.0 0
M  V30 11 C 0.0000 3.1125 0.0 0
M  V30 12 C 1.3700 0.7399 0.0 0
M  V30 13 C 2.7204 0.0000 0.0 0
M  V30 14 C 0.0345 4.6520 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 9
M  V30 13 2 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylbarbituric acid
C6H8N2O3
769-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 O 6.1600 2.6674 0.0 0
M  V30 6 N 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Bis(methylthio)-2-nitroethylene
C4H7NO2S2
13623-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6674 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 S 1.5400 1.3338 0.0 0
M  V30 4 S 1.5400 4.0011 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0 VAL=5
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 O 6.1600 4.0011 0.0 0
M  V30 9 O 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′,3′-Dimethyl-7′-(methylamino)-6′-nitrospiro[acenaphthylene-1(2H),5′-[5H]pyr...
C21H16N4O6
2138461-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.2406 3.3503 0.0 0 VAL=5
M  V30 2 O 2.1063 1.8161 0.0 0
M  V30 3 O 0.9791 4.2337 0.0 0
M  V30 4 O 6.4097 7.4318 0.0 0
M  V30 5 O 6.5822 8.2028 0.0 0
M  V30 6 N 3.6363 1.3338 0.0 0
M  V30 7 C 4.4063 0.0000 0.0 0
M  V30 8 C 9.0264 2.6675 0.0 0
M  V30 9 C 9.0264 8.0023 0.0 0
M  V30 10 O 10.5664 5.3348 0.0 0
M  V30 11 C 4.4063 5.3348 0.0 0
M  V30 12 C 2.8532 5.4948 0.0 0
M  V30 13 C 5.9463 5.3348 0.0 0
M  V30 14 C 3.6363 4.0011 0.0 0
M  V30 15 C 5.0346 6.7384 0.0 0
M  V30 16 C 2.6110 6.9811 0.0 0
M  V30 17 C 1.6207 4.5483 0.0 0
M  V30 18 C 6.7163 4.0011 0.0 0
M  V30 19 C 6.7163 6.6686 0.0 0
M  V30 20 C 4.4063 2.6675 0.0 0
M  V30 21 C 3.8810 7.7904 0.0 0
M  V30 22 C 1.2243 7.6019 0.0 0
M  V30 23 C 0.1920 5.1217 0.0 0
M  V30 24 O 5.9463 2.6675 0.0 0
M  V30 25 N 8.2564 4.0011 0.0 0
M  V30 26 N 8.2564 6.6686 0.0 0
M  V30 27 C 3.7660 9.3401 0.0 0
M  V30 28 C 0.0000 6.6494 0.0 0
M  V30 29 C 1.1194 9.1497 0.0 0
M  V30 30 C 9.0264 5.3348 0.0 0
M  V30 31 C 2.3869 10.0240 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 4 15
M  V30 5 2 5 19
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 1 8 25
M  V30 9 1 9 26
M  V30 10 2 10 30
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 2 13 18
M  V30 18 1 13 19
M  V30 19 2 14 20
M  V30 20 1 15 21
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 23
M  V30 24 1 18 24
M  V30 25 1 18 25
M  V30 26 1 19 26
M  V30 27 1 20 24
M  V30 28 2 21 27
M  V30 29 1 22 28
M  V30 30 1 22 29
M  V30 31 2 23 28
M  V30 32 1 25 30
M  V30 33 1 26 30
M  V30 34 1 27 31
M  V30 35 2 29 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82-86-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 769-42-6
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 13623-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2138461-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18009936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, combinatorial, green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective synthesis of novel spiropyrano acenaphthylene derivatives
via one-pot four-component reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bayat, Mohammad; Amiri, Zeinab
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2017), 58(45), 4260-4263

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
3-(1,1-Dimethylethyl) 3-azabicyclo[3.1.0]hexane-1,3-dicarboxylate
C11H17NO4
1363381-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4070 2.2389 0.0 0
M  V30 2 O 1.5679 3.7705 0.0 0
M  V30 3 O 0.0000 1.6126 0.0 0
M  V30 4 C 6.4239 2.6218 0.0 0
M  V30 5 O 7.7576 1.8517 0.0 0
M  V30 6 O 6.4239 4.1618 0.0 0
M  V30 7 C 9.0913 2.6218 0.0 0
M  V30 8 C 8.3213 3.9554 0.0 0
M  V30 9 C 10.4251 3.3918 0.0 0
M  V30 10 C 9.8613 1.2881 0.0 0
M  V30 11 C 2.6529 1.3337 0.0 0
M  V30 12 C 3.4229 0.0000 0.0 0
M  V30 13 C 1.8828 0.0000 0.0 0
M  V30 14 C 3.6833 2.4782 0.0 0
M  V30 15 C 4.9292 0.3202 0.0 0
M  V30 16 N 5.0903 1.8517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 13
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 1-[(methylamino)carbonyl]-3-azabicyclo[3.1.0]hexane-3-carbo...
C12H20N2O3
2386778-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0181 2.2389 0.0 0
M  V30 2 N 10.4251 1.6126 0.0 0
M  V30 3 O 8.8572 3.7705 0.0 0
M  V30 4 C 11.6710 2.5176 0.0 0
M  V30 5 C 4.0012 2.6218 0.0 0
M  V30 6 O 2.6675 1.8517 0.0 0
M  V30 7 O 4.0012 4.1618 0.0 0
M  V30 8 C 1.3337 2.6218 0.0 0
M  V30 9 C 0.5637 1.2881 0.0 0
M  V30 10 C 0.0000 3.3918 0.0 0
M  V30 11 C 2.1037 3.9554 0.0 0
M  V30 12 C 7.7722 1.3337 0.0 0
M  V30 13 C 7.0022 0.0000 0.0 0
M  V30 14 C 8.5423 0.0000 0.0 0
M  V30 15 C 6.7418 2.4782 0.0 0
M  V30 16 C 5.4959 0.3202 0.0 0
M  V30 17 N 5.3348 1.8517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 14
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1363381-55-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2386778-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22294215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridine-3-sulfonamide derivatives as amine oxidase copper
containing 3 (AOC3) inhibitors and pharmaceutical compositions and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hehn, Joerg P.; Blum, Andreas; Hucke, Oliver; Peters, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020089026 A1 2020-05-07

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
3-(1,1-Dimethylethyl) 3-azabicyclo[3.1.0]hexane-1,3-dicarboxylate
C11H17NO4
1363381-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4070 2.2389 0.0 0
M  V30 2 O 1.5679 3.7705 0.0 0
M  V30 3 O 0.0000 1.6126 0.0 0
M  V30 4 C 6.4239 2.6218 0.0 0
M  V30 5 O 7.7576 1.8517 0.0 0
M  V30 6 O 6.4239 4.1618 0.0 0
M  V30 7 C 9.0913 2.6218 0.0 0
M  V30 8 C 8.3213 3.9554 0.0 0
M  V30 9 C 10.4251 3.3918 0.0 0
M  V30 10 C 9.8613 1.2881 0.0 0
M  V30 11 C 2.6529 1.3337 0.0 0
M  V30 12 C 3.4229 0.0000 0.0 0
M  V30 13 C 1.8828 0.0000 0.0 0
M  V30 14 C 3.6833 2.4782 0.0 0
M  V30 15 C 4.9292 0.3202 0.0 0
M  V30 16 N 5.0903 1.8517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 13
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 1-[(methylamino)carbonyl]-3-azabicyclo[3.1.0]hexane-3-carbo...
C12H20N2O3
2386778-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0181 2.2389 0.0 0
M  V30 2 N 10.4251 1.6126 0.0 0
M  V30 3 O 8.8572 3.7705 0.0 0
M  V30 4 C 11.6710 2.5176 0.0 0
M  V30 5 C 4.0012 2.6218 0.0 0
M  V30 6 O 2.6675 1.8517 0.0 0
M  V30 7 O 4.0012 4.1618 0.0 0
M  V30 8 C 1.3337 2.6218 0.0 0
M  V30 9 C 0.5637 1.2881 0.0 0
M  V30 10 C 0.0000 3.3918 0.0 0
M  V30 11 C 2.1037 3.9554 0.0 0
M  V30 12 C 7.7722 1.3337 0.0 0
M  V30 13 C 7.0022 0.0000 0.0 0
M  V30 14 C 8.5423 0.0000 0.0 0
M  V30 15 C 6.7418 2.4782 0.0 0
M  V30 16 C 5.4959 0.3202 0.0 0
M  V30 17 N 5.3348 1.8517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 14
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1363381-55-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2386778-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22445815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridine-3-sulfonamide derivatives as amine oxidase copper
containing 3 (AOC3) inhibitors and pharmaceutical compositions and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hehn, Joerg P.; Blum, Andreas; Hucke, Oliver; Peters, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020089025 A1 2020-05-07

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-[4-(4-fluorophenoxy)phenyl]quinazoline
C20H12ClFN2O
1371596-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6673 0.0000 0.0 0
M  V30 2 O 9.3358 6.9302 0.0 0
M  V30 3 F 14.6707 3.8501 0.0 0
M  V30 4 C 4.0010 3.8501 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 N 4.0010 2.3101 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 2.6673 6.1601 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 N 1.3337 2.3101 0.0 0
M  V30 11 C 0.0000 4.6201 0.0 0
M  V30 12 C 1.3337 6.9302 0.0 0
M  V30 13 C 0.0000 6.1601 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 6.6685 6.9302 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 12.0033 6.9302 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 12.0033 3.8501 0.0 0
M  V30 25 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 19
M  V30 3 1 2 20
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 2 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 2 9 10
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(4-Fluorophenoxy)phenyl]-N-methyl-2-quinazolinamine
C21H16FN3O
1371596-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 0.7700 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 O 9.3358 7.7002 0.0 0
M  V30 4 F 14.6707 4.6201 0.0 0
M  V30 5 C 2.6673 5.3901 0.0 0
M  V30 6 C 4.0010 4.6201 0.0 0
M  V30 7 C 1.3337 4.6201 0.0 0
M  V30 8 C 2.6673 6.9302 0.0 0
M  V30 9 N 4.0010 3.0801 0.0 0
M  V30 10 N 1.3337 3.0801 0.0 0
M  V30 11 C 0.0000 5.3901 0.0 0
M  V30 12 C 1.3337 7.7002 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 0.0000 6.9302 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 5.3348 6.9302 0.0 0
M  V30 18 C 8.0022 5.3901 0.0 0
M  V30 19 C 6.6685 7.7002 0.0 0
M  V30 20 C 8.0022 6.9302 0.0 0
M  V30 21 C 10.6697 6.9302 0.0 0
M  V30 22 C 10.6697 5.3901 0.0 0
M  V30 23 C 12.0033 7.7002 0.0 0
M  V30 24 C 12.0033 4.6201 0.0 0
M  V30 25 C 13.3370 6.9302 0.0 0
M  V30 26 C 13.3370 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 20
M  V30 4 1 3 21
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 15
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 2 10 13
M  V30 16 2 11 14
M  V30 17 1 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1371596-31-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1371596-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7110942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of
compounds 13a-z: A mixture of compound 11 (0.2 g, 1.0 eq.), RH (12a-z,
1.05 eq.), wherein R is NR5R6 or OR9, K2CO3 (2 eq.) and TEA (2 eq.) in 3
mL of DMF was shaken at 100 °C for 24 hours. Water (5 mL) and EtOAc (30
mL) were added to the reaction mixture. The organic layer was separated,
concentrated and purified by column (TCM/MeOH 10/0.2 to 10/5) to obtain
compounds 13a-z in 20 to 90% yield. .
4-(4-(4-Fluorophenoxy)phenyl)-N-methylquinazolin-2-amine (13n, yellow
solid): Yield 90%. 1H-NMR (400 MHz, DMSO-d6): δ 7.6 - 7.7 (m, 4H), 7.49
(d, 1H, 8.5Hz), 7.21 - 7.29 (m, 3H), 7.12 - 7.16 (m, 3H), 7.08 (d, 2H,
8.7Hz), 2.85 (d, 3H, 4.8Hz); LC/MS: m/z = 346.1 [M + H]+ (Calc: 345.4).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl and heteroaryl substituted quinazoline compounds as
sodium channel blockers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goehring, R. Richard; Tafesse, Laykea; Yao, Jiangchao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012046132 A1 2012-04-12

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Allofuranose, 6-O-[(1,1-dimethylethyl)dimethylsilyl]-1,2-O-(1-methylethyl...
C17H28F6O10S2Si
1372631-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.6091 6.6847 0.0 0 CFG=2
M  V30 2 C 8.9428 5.9146 0.0 0
M  V30 3 O 7.6091 8.2247 0.0 0
M  V30 4 O 10.2765 6.6847 0.0 0
M  V30 5 S 8.9428 8.9947 0.0 0 VAL=6
M  V30 6 Si 11.6103 5.9146 0.0 0
M  V30 7 C 8.1728 10.3284 0.0 0
M  V30 8 O 10.2765 9.7647 0.0 0
M  V30 9 O 9.7128 7.6609 0.0 0
M  V30 10 C 12.9439 5.1446 0.0 0
M  V30 11 C 10.8403 4.5808 0.0 0
M  V30 12 C 12.3803 7.2483 0.0 0
M  V30 13 F 8.9428 11.6620 0.0 0
M  V30 14 F 7.4028 11.6620 0.0 0
M  V30 15 F 6.6328 10.3284 0.0 0
M  V30 16 C 12.1739 3.8108 0.0 0
M  V30 17 C 14.2776 4.3746 0.0 0
M  V30 18 C 13.7140 6.4783 0.0 0
M  V30 19 O 3.5649 6.3438 0.0 0
M  V30 20 S 2.1579 5.7175 0.0 0 VAL=6
M  V30 21 C 1.5316 7.1243 0.0 0
M  V30 22 O 0.7511 5.0912 0.0 0
M  V30 23 O 2.7844 4.3107 0.0 0
M  V30 24 F 0.0000 7.2854 0.0 0
M  V30 25 F 0.9052 8.5313 0.0 0
M  V30 26 F 2.4368 8.3704 0.0 0
M  V30 27 C 3.4771 0.6368 0.0 0
M  V30 28 C 5.4371 0.0000 0.0 0
M  V30 29 C 6.2755 5.9146 0.0 0 CFG=1
M  V30 30 C 4.8107 5.4388 0.0 0 CFG=1
M  V30 31 O 7.1805 4.6688 0.0 0
M  V30 32 C 4.8107 3.8987 0.0 0 CFG=1
M  V30 33 C 6.2755 3.4227 0.0 0 CFG=2
M  V30 34 O 3.9055 2.6527 0.0 0
M  V30 35 O 6.2755 1.8827 0.0 0
M  V30 36 C 4.8107 1.4068 0.0 0
M  V30 37 H 5.6490 7.3215 0.0 0
M  V30 38 H 3.3462 4.3746 0.0 0
M  V30 39 H 7.7400 2.9468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 7 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 10 18
M  V30 19 1 19 20
M  V30 20 1 30 19 CFG=3
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 27 36
M  V30 28 1 28 36
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 1 29 37 CFG=3
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 32 38 CFG=1
M  V30 37 1 33 35
M  V30 38 1 33 39 CFG=1
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 29 30 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,4aR,5S,6aS,6bR)-5-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]hexahyd...
C16H31NO4Si
1372631-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6836 2.1037 0.0 0
M  V30 2 O 10.0174 2.8737 0.0 0
M  V30 3 Si 11.3511 2.1037 0.0 0
M  V30 4 C 12.6847 1.3336 0.0 0
M  V30 5 C 10.5811 0.7700 0.0 0
M  V30 6 C 12.1211 3.4375 0.0 0
M  V30 7 C 11.9147 0.0000 0.0 0
M  V30 8 C 14.0184 0.5636 0.0 0
M  V30 9 C 13.4547 2.6674 0.0 0
M  V30 10 C 7.7214 5.6949 0.0 0
M  V30 11 C 0.7384 5.5459 0.0 0
M  V30 12 C 0.0000 3.6218 0.0 0
M  V30 13 C 5.8625 2.4751 0.0 0 CFG=2
M  V30 14 C 5.4639 3.9626 0.0 0 CFG=2
M  V30 15 C 7.3500 2.8737 0.0 0 CFG=2
M  V30 16 O 4.5709 1.6364 0.0 0
M  V30 17 C 3.9259 4.0433 0.0 0 CFG=1
M  V30 18 N 6.9514 4.3613 0.0 0
M  V30 19 C 3.3742 2.6055 0.0 0 CFG=2
M  V30 20 O 2.7292 5.0124 0.0 0
M  V30 21 O 1.8362 2.6861 0.0 0
M  V30 22 C 1.4376 4.1737 0.0 0
M  V30 23 H 6.4888 1.0683 0.0 0
M  V30 24 H 5.3029 5.4943 0.0 0
M  V30 25 H 4.4779 5.4810 0.0 0
M  V30 26 H 2.8222 1.1678 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 18
M  V30 11 1 11 22
M  V30 12 1 12 22
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 23 CFG=3
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 24 CFG=3
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 17 19
M  V30 23 1 17 20
M  V30 24 1 17 25 CFG=1
M  V30 25 1 19 21
M  V30 26 1 19 26 CFG=1
M  V30 27 1 20 22
M  V30 28 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 13 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1372631-84-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1372631-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10813309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method B: The amine (1.1 eq) and
diisopropylethylamine (2.5 eq) were added simultaneously to a stirred
solution of the di-triflate (1 eq) in acetonitrile (35-75 mg/mL) and the
mixture heated to 40-50 ºC. After 15-25 h TLC analysis (toluene/acetone
or cyclohexane/ethyl acetate) showed consumption of starting material.
The mixture was concentrated in vacuo and the resulting crude material
purified via flash column chromatography on silica gel (cyclohexane/ethyl
acetate). The title compounds.
N-Benzyl-6-O-tert-butyldimethylsilyl-3,5-dideoxy-3,5-imino-1,2-O-isopropylidene-β-Lidofuranose
4L Procedure 1, Method B (0.63 mmol scale, 25 h reaction time, 50 ºC
temperature).
N-Methyl-6-O-tert-butyldimethylsilyl-3,5-dideoxy-3,5-imino-1,2-O-isopropylidene-β-L-idofuranose
20L Procedure 1, Method B (0.30 mmol scale, 15 h reaction time, 40 ºC).
The title compound as a clear, colourless oil (89 mg, 90%). Rf 0.42 (3:1
cyclohexane/ethyl acetate); [α] D 25 +47.6 (c 0.94 in CHCl3); δH (CDCl3,
400 MHz): 0.05, 0.05 (6H, 2 x s, OSi(CH3)2C(CH3)3), 0.87 (9H, s,
OSi(CH3)2C(CH3)3), 1.34, 1.42 (6H, 2 x s, C(CH3)2), 2.40 (3H, s, H7),
2.93-2.98 (1H, adt, H5, J 5,4 4.7, J 5,6/5,6´ 6.4), 3.50-3.52 (1H, d, H3,
J 3,4 4.7), 3.52-3.56 (1H, dd, H6, J 6,5 6.5, J gem 10.5), 3.73-3.77 (1H,
dd, H6′, J 6´,5 6.3, J gem 10.5), 4.52-4.53 (1H, d, H2, J 2,1 3.7),
4.87-4.89 (1H, t, H4, J 4,3/J 4,5 4.7), 6.06-6.07 (1H, d, H1, J 1,2 3.7);
δC (CDCl3, 100 MHz): -5.2, -5.2 (OSi(CH3)2C(CH3)3), 18.4
(OSi(CH3)2C(CH3)3), 26.1 (OSi(CH3)2C(CH3)3), 27.4, 27.9 (C(CH3)2), 43.3
(C7), 62.2 (C6), 70.3 (C5), 71.4 (C3), 75.9 (C4), 84.0 (C2), 110.1 (C1),
113.5 (C(CH3)2); m/z (ESI+ve): 320 ([M + H]+, 91%), 681 [2M + Na]+,
100%); HRMS m/z (ESI+ve): found 352.1904 ([M + Na]+); C16H31NNaO4Si
requires 352.1915.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine Iminosugars from the Cyclization of 3,5-Di-O-triflates of
α-Furanosides and of 2,4-Di-O-triflates of β-Pyranosides Derived from
Glucose
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lenagh-Snow, Gabriel M. J.; Araujo, Noelia; Jenkinson, Sarah F.;
Martinez, R. Fernando; Shimada, Yousuke; Yu, Chu-Yi; Kato, Atsushi;
Fleet, George W. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(8), 2142-2145

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-L-Allofuranose, 6-O-[(1,1-dimethylethyl)dimethylsilyl]-1,2-O-(1-methylethyl...
C17H28F6O10S2Si
1372631-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.6091 6.6847 0.0 0 CFG=1
M  V30 2 C 8.9428 5.9146 0.0 0
M  V30 3 O 7.6091 8.2247 0.0 0
M  V30 4 O 10.2765 6.6847 0.0 0
M  V30 5 S 8.9428 8.9947 0.0 0 VAL=6
M  V30 6 Si 11.6103 5.9146 0.0 0
M  V30 7 C 8.1728 10.3284 0.0 0
M  V30 8 O 10.2765 9.7647 0.0 0
M  V30 9 O 9.7128 7.6609 0.0 0
M  V30 10 C 12.9439 5.1446 0.0 0
M  V30 11 C 10.8403 4.5808 0.0 0
M  V30 12 C 12.3803 7.2483 0.0 0
M  V30 13 F 8.9428 11.6620 0.0 0
M  V30 14 F 7.4028 11.6620 0.0 0
M  V30 15 F 6.6328 10.3284 0.0 0
M  V30 16 C 12.1739 3.8108 0.0 0
M  V30 17 C 14.2776 4.3746 0.0 0
M  V30 18 C 13.7140 6.4783 0.0 0
M  V30 19 O 3.5649 6.3438 0.0 0
M  V30 20 S 2.1579 5.7175 0.0 0 VAL=6
M  V30 21 C 1.5316 7.1243 0.0 0
M  V30 22 O 0.7511 5.0912 0.0 0
M  V30 23 O 2.7844 4.3107 0.0 0
M  V30 24 F 0.0000 7.2854 0.0 0
M  V30 25 F 0.9052 8.5313 0.0 0
M  V30 26 F 2.4368 8.3704 0.0 0
M  V30 27 C 3.4771 0.6368 0.0 0
M  V30 28 C 5.4371 0.0000 0.0 0
M  V30 29 C 6.2755 5.9146 0.0 0 CFG=2
M  V30 30 C 4.8107 5.4388 0.0 0 CFG=2
M  V30 31 O 7.1805 4.6688 0.0 0
M  V30 32 C 4.8107 3.8987 0.0 0 CFG=2
M  V30 33 C 6.2755 3.4227 0.0 0 CFG=1
M  V30 34 O 3.9055 2.6527 0.0 0
M  V30 35 O 6.2755 1.8827 0.0 0
M  V30 36 C 4.8107 1.4068 0.0 0
M  V30 37 H 5.6490 7.3215 0.0 0
M  V30 38 H 3.3462 4.3746 0.0 0
M  V30 39 H 7.7400 2.9468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 29
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 7 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 10 18
M  V30 19 1 19 20
M  V30 20 1 30 19 CFG=1
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 27 36
M  V30 28 1 28 36
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 1 29 37 CFG=1
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 32 38 CFG=3
M  V30 37 1 33 35
M  V30 38 1 33 39 CFG=3
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 29 30 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aS,4aS,5R,6aR,6bS)-5-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]hexahyd...
C16H31NO4Si
1372631-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6836 2.1037 0.0 0
M  V30 2 O 10.0174 2.8737 0.0 0
M  V30 3 Si 11.3511 2.1037 0.0 0
M  V30 4 C 12.6847 1.3336 0.0 0
M  V30 5 C 10.5811 0.7700 0.0 0
M  V30 6 C 12.1211 3.4375 0.0 0
M  V30 7 C 11.9147 0.0000 0.0 0
M  V30 8 C 14.0184 0.5636 0.0 0
M  V30 9 C 13.4547 2.6674 0.0 0
M  V30 10 C 7.7214 5.6949 0.0 0
M  V30 11 C 0.7384 5.5459 0.0 0
M  V30 12 C 0.0000 3.6218 0.0 0
M  V30 13 C 5.8625 2.4751 0.0 0 CFG=1
M  V30 14 C 5.4639 3.9626 0.0 0 CFG=1
M  V30 15 C 7.3500 2.8737 0.0 0 CFG=1
M  V30 16 O 4.5709 1.6364 0.0 0
M  V30 17 C 3.9259 4.0433 0.0 0 CFG=2
M  V30 18 N 6.9514 4.3613 0.0 0
M  V30 19 C 3.3742 2.6055 0.0 0 CFG=1
M  V30 20 O 2.7292 5.0124 0.0 0
M  V30 21 O 1.8362 2.6861 0.0 0
M  V30 22 C 1.4376 4.1737 0.0 0
M  V30 23 H 6.4888 1.0683 0.0 0
M  V30 24 H 5.3029 5.4943 0.0 0
M  V30 25 H 4.4779 5.4810 0.0 0
M  V30 26 H 2.8222 1.1678 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 18
M  V30 11 1 11 22
M  V30 12 1 12 22
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 23 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 24 CFG=1
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 17 19
M  V30 23 1 17 20
M  V30 24 1 17 25 CFG=3
M  V30 25 1 19 21
M  V30 26 1 19 26 CFG=3
M  V30 27 1 20 22
M  V30 28 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 13 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1372631-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1372631-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12951059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method B: The amine (1.1 eq) and
diisopropylethylamine (2.5 eq) were added simultaneously to a stirred
solution of the di-triflate (1 eq) in acetonitrile (35-75 mg/mL) and the
mixture heated to 40-50 ºC. After 15-25 h TLC analysis (toluene/acetone
or cyclohexane/ethyl acetate) showed consumption of starting material.
The mixture was concentrated in vacuo and the resulting crude material
purified via flash column chromatography on silica gel (cyclohexane/ethyl
acetate). The title compounds.
N-Benzyl-6-O-tert-butyldimethylsilyl-3,5-dideoxy-3,5-imino-1,2-O-isopropylidene-β-Lidofuranose
4L Procedure 1, Method B (0.63 mmol scale, 25 h reaction time, 50 ºC
temperature). D-Enantiomer 20D: Procedure 1, Method B (0.5 mmol scale, 24
h reaction time, 40 ºC). The title compound as a clear, colourless oil
(107 mg, 65%). [α] D 25 -41.4 (c 0.50 in CHCl3).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine Iminosugars from the Cyclization of 3,5-Di-O-triflates of
α-Furanosides and of 2,4-Di-O-triflates of β-Pyranosides Derived from
Glucose
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lenagh-Snow, Gabriel M. J.; Araujo, Noelia; Jenkinson, Sarah F.;
Martinez, R. Fernando; Shimada, Yousuke; Yu, Chu-Yi; Kato, Atsushi;
Fleet, George W. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(8), 2142-2145

$RFMT $RIREG SCHEME89 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3R,4S)-3,4-Dihydro-3-hydroxy-6-[4-(3-oxetanyl)-1-piperazinyl]-2H-1-benzop...
C23H26FN3O4
1373215-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 6.9300 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 6.9300 0.0 0
M  V30 4 O 0.0000 8.4700 0.0 0
M  V30 5 F 1.3336 0.0000 0.0 0
M  V30 6 C 4.0011 9.2400 0.0 0
M  V30 7 C 2.6674 8.4700 0.0 0 CFG=2
M  V30 8 C 4.0011 10.7800 0.0 0
M  V30 9 C 5.3347 8.4700 0.0 0
M  V30 10 C 1.3336 9.2400 0.0 0 CFG=1
M  V30 11 C 5.3347 11.5500 0.0 0
M  V30 12 O 2.6674 11.5500 0.0 0
M  V30 13 C 6.6684 9.2400 0.0 0
M  V30 14 C 1.3336 10.7800 0.0 0
M  V30 15 C 6.6684 10.7800 0.0 0
M  V30 16 N 8.0022 8.4700 0.0 0
M  V30 17 C 9.3358 9.2400 0.0 0
M  V30 18 C 8.0022 6.9300 0.0 0
M  V30 19 C 10.6695 8.4700 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0
M  V30 21 N 10.6695 6.9300 0.0 0
M  V30 22 C 1.3336 4.6200 0.0 0
M  V30 23 C 2.6674 3.8500 0.0 0
M  V30 24 C 0.0000 3.8500 0.0 0
M  V30 25 C 2.6674 2.3100 0.0 0
M  V30 26 C 0.0000 2.3100 0.0 0
M  V30 27 C 1.3336 1.5400 0.0 0
M  V30 28 C 12.0031 6.1600 0.0 0
M  V30 29 C 13.4908 6.5586 0.0 0
M  V30 30 C 12.4018 4.6725 0.0 0
M  V30 31 O 13.8893 5.0711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 22
M  V30 5 1 10 4 CFG=1
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 1 13 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 21 28
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3R,4S)-3,4-Dihydro-3-[[(methylamino)carbonyl]oxy]-6-[4-(3-oxetanyl)-1-pip...
C25H29FN4O5
1373215-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.9302 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 O 4.0012 8.4702 0.0 0
M  V30 5 C 2.6673 9.2402 0.0 0
M  V30 6 N 1.3337 8.4702 0.0 0
M  V30 7 O 2.6673 10.7802 0.0 0
M  V30 8 C 0.0000 9.2402 0.0 0
M  V30 9 F 5.3348 0.0000 0.0 0
M  V30 10 C 8.0022 9.2402 0.0 0
M  V30 11 C 6.6685 8.4702 0.0 0 CFG=2
M  V30 12 C 8.0022 10.7802 0.0 0
M  V30 13 C 9.3360 8.4702 0.0 0
M  V30 14 C 5.3348 9.2402 0.0 0 CFG=1
M  V30 15 O 6.6685 11.5503 0.0 0
M  V30 16 C 9.3360 11.5503 0.0 0
M  V30 17 C 10.6697 9.2402 0.0 0
M  V30 18 C 5.3348 10.7802 0.0 0
M  V30 19 C 10.6697 10.7802 0.0 0
M  V30 20 N 12.0033 8.4702 0.0 0
M  V30 21 C 12.0033 6.9302 0.0 0
M  V30 22 C 13.3370 9.2402 0.0 0
M  V30 23 C 13.3370 6.1601 0.0 0
M  V30 24 C 14.6708 8.4702 0.0 0
M  V30 25 N 14.6708 6.9302 0.0 0
M  V30 26 C 5.3348 4.6201 0.0 0
M  V30 27 C 4.0012 3.8501 0.0 0
M  V30 28 C 6.6685 3.8501 0.0 0
M  V30 29 C 4.0012 2.3101 0.0 0
M  V30 30 C 6.6685 2.3101 0.0 0
M  V30 31 C 5.3348 1.5400 0.0 0
M  V30 32 C 16.0045 6.1601 0.0 0
M  V30 33 C 16.4031 4.6726 0.0 0
M  V30 34 C 17.4920 6.5587 0.0 0
M  V30 35 O 17.8906 5.0712 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 14 4 CFG=1
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 31
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 1 17 20
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 1 25 32
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1373215-45-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1373215-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-18210479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3R,4S)-4-(4-fluorobenzamido)-6-(4-(oxetan-3-yl)piperazin-1-yl
methylcarbamate (5). To a solution of
4-fluoro-N-((3R,4S)-3-hydroxy-6-(4-oxetan-3-yl)piperazin-1-yl)chroman-4-yl)benzamide
(SI-5, 22.8 kg, 53.3 mol) in THF (456 L) was added
1,1’-carbonyldiimidazole (11.2 kg, 69.3 mol). The resulting mixture was
stirred at 15-25°C for 2 h. After cooling to 0°C, a solution of
methylamine (2.0 M in THF, 46.3 kg, 95.9 mol) was added over 0.5 h, and
the mixture was stirred for 4 h. 2 N aqueous NaOH (228 L) was added, and
stirring was continued for 0.5 h. The layers were separated, and the
organics were washed with 2 N NaOH (3 × 228 L). Water (456 L) was added,
and the mixture was concentrated under reduced pressure to 25 L/kg of 5.
THF (45 L) was added, and the mixture was cooled to 10°C and stirred for
3 h. After filtration, the crude solids were re-dissolved in THF (456 L).
Water (456 L) was added and the mixture was re-concentrated to 25 L/kg of
5. THF (45 L) was added and the mixture stirred at 10°C for 3 h. After
filtration, 5 was isolated as a white crystalline solid (22.8 kg, 90 %
yield). HPLC purity = 98.6% (tR = 24.2 min) by HPLC method 3. ee = 99.9%
(tR = 23.6 min) by Chiral HPLC method 4. HPLC Method 3. Shimadzu LC-20 A
HPLC, Waters Sunfire C18 (4.6 mm × 150 mm × 3.5 µm) column; Solvent A:
0.01% (v/v) TFA in Water; Solvent B: 0.01% (v/v) TFA in acetonitrile;
gradient 10-50% B in 15 min, 50-95% B in 5 min, then hold at 95% B for 2
min; λ 235 nm. Chiral HPLC Method 4. Shimadzu LC-20 A HPLC, Chiralpak IC
(4.6 mm × 250 mm × 5 µm) eluting with 3:7 EtOH: hexanes); λ 235 nm.
Specific rotation: [α]D 25 = 55.19 (c = 10, DMSO). 1H NMR (400 MHz,
DMSO-d 6) δ 8.92 (d, J = 7.8 Hz, 1H), 8.01 - 7.90 (m, 2H), 7.34 - 7.23
(m, 2H), 7.19 (q, J = 4.5 Hz, 1H), 6.87 (dd, J = 9.0, 2.9 Hz, 1H), 6.78 -
6.69 (m, 2H), 5.03 (dd, J = 8.1, 3.7 Hz, 1H), 4.86 (td, J = 4.1, 1.8 Hz,
1H), 4.52 (t, J = 6.5 Hz, 2H), 4.41 (t, J = 6.0 Hz, 2H), 4.23 (dd, J =
11.8, 1.9 Hz, 1H), 4.13 (ddd, J = 11.8, 4.4, 1.6 Hz, 1H), 3.39 (p, J =
6.3 Hz, 1H), 2.96 (t, J = 4.9 Hz, 4H), 2.52 (d, J = 4.5 Hz, 3H), 2.34 (t,
J = 4.9 Hz, 4H). 13C NMR (DMSO-d 6, 100 MHz): δ 165.4, 164.5 (d, J =
248.7 Hz), 156.1, 148.2, 146.2, 131.0, 130.8 (d, J = 9.5 Hz), 120.9,
118.6, 117.6, 117.2, 115.6 (d, J = 21.3 Hz), 74.8, 68.7, 64.3, 58.9,
49.8, 49.5, 47.7, 27.4. HRMS (ESI+): calcd. for C25H30FN4O5 (M+1):
485.2195, found 485.2188.
$DTYPE RXN:VAR(1):NOTES
$DATUM ee = 99.9%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of
Abdominal Aortic Aneurysm
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jadhav, Prabhakar K.; Schiffler, Matthew A.; Gavardinas, Kostas; Kim,
Euibong J.; Matthews, Donald P.; Staszak, Michael A.; Coffey, D. Scott;
Shaw, Bruce W.; Cassidy, Kenneth C.; Brier, Richard A.; Zhang, Yuke;
Christie, Robert M.; Matter, William F.; Qing, Keyun; Durbin, Jim D.;
Wang, Yong; Deng, Gary G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(10), 1138-1142

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Ethyl 2-(4-fluorophenyl)-10,11-dihydro-5-methyl-11-(methylsulfonyl)-5H-benzo[...
C27H24FNO5S
1374235-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3847 3.7536 0.0 0
M  V30 2 O 9.3541 2.6091 0.0 0
M  V30 3 O 11.8910 3.4334 0.0 0
M  V30 4 C 9.8300 1.1445 0.0 0
M  V30 5 C 8.7996 0.0000 0.0 0
M  V30 6 C 4.9154 3.2325 0.0 0
M  V30 7 S 4.9154 9.6957 0.0 0 VAL=6
M  V30 8 C 5.2580 11.1970 0.0 0
M  V30 9 O 6.4169 9.3529 0.0 0
M  V30 10 O 3.4140 10.0383 0.0 0
M  V30 11 F 16.9739 6.4640 0.0 0
M  V30 12 C 8.4441 5.6940 0.0 0
M  V30 13 C 8.4441 7.2340 0.0 0
M  V30 14 C 9.9087 5.2181 0.0 0
M  V30 15 C 7.1105 4.9240 0.0 0
M  V30 16 C 7.1105 8.0040 0.0 0
M  V30 17 O 9.9087 7.7100 0.0 0
M  V30 18 C 10.8139 6.4640 0.0 0
M  V30 19 C 5.7767 5.6940 0.0 0
M  V30 20 C 5.7767 7.2340 0.0 0
M  V30 21 C 4.5727 4.7338 0.0 0
M  V30 22 N 4.5727 8.1942 0.0 0
M  V30 23 C 3.0714 5.0766 0.0 0
M  V30 24 C 3.0714 7.8515 0.0 0
M  V30 25 C 2.4032 6.4640 0.0 0
M  V30 26 C 2.2039 3.8041 0.0 0
M  V30 27 C 0.8675 6.5792 0.0 0
M  V30 28 C 0.6682 3.9193 0.0 0
M  V30 29 C 0.0000 5.3067 0.0 0
M  V30 30 C 12.3539 6.4640 0.0 0
M  V30 31 C 13.1239 7.7978 0.0 0
M  V30 32 C 13.1239 5.1304 0.0 0
M  V30 33 C 14.6639 7.7978 0.0 0
M  V30 34 C 14.6639 5.1304 0.0 0
M  V30 35 C 15.4339 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 22
M  V30 11 1 11 35
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 18
M  V30 21 1 18 30
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 25
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-10,11-dihydro-N,5-dimethyl-11-(methylsulfonyl)-5H-benzo[c]...
C26H23FN2O4S
1374230-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3848 2.6091 0.0 0
M  V30 2 N 9.3542 1.4646 0.0 0
M  V30 3 O 11.8910 2.2889 0.0 0
M  V30 4 C 9.8301 0.0000 0.0 0
M  V30 5 C 4.9154 2.0879 0.0 0
M  V30 6 S 4.9154 8.5512 0.0 0 VAL=6
M  V30 7 C 5.2581 10.0526 0.0 0
M  V30 8 O 6.4169 8.2086 0.0 0
M  V30 9 O 3.4141 8.8939 0.0 0
M  V30 10 F 16.9740 5.3197 0.0 0
M  V30 11 C 8.4442 4.5497 0.0 0
M  V30 12 C 8.4442 6.0897 0.0 0
M  V30 13 C 9.9087 4.0736 0.0 0
M  V30 14 C 7.1105 3.7797 0.0 0
M  V30 15 C 7.1105 6.8597 0.0 0
M  V30 16 O 9.9087 6.5655 0.0 0
M  V30 17 C 10.8140 5.3197 0.0 0
M  V30 18 C 5.7767 4.5497 0.0 0
M  V30 19 C 5.7767 6.0897 0.0 0
M  V30 20 C 4.5728 3.5895 0.0 0
M  V30 21 N 4.5728 7.0499 0.0 0
M  V30 22 C 3.0714 3.9321 0.0 0
M  V30 23 C 3.0714 6.7071 0.0 0
M  V30 24 C 2.4032 5.3197 0.0 0
M  V30 25 C 2.2039 2.6598 0.0 0
M  V30 26 C 0.8675 5.4347 0.0 0
M  V30 27 C 0.6682 2.7748 0.0 0
M  V30 28 C 0.0000 4.1623 0.0 0
M  V30 29 C 12.3540 5.3197 0.0 0
M  V30 30 C 13.1240 6.6533 0.0 0
M  V30 31 C 13.1240 3.9859 0.0 0
M  V30 32 C 14.6640 6.6533 0.0 0
M  V30 33 C 14.6640 3.9859 0.0 0
M  V30 34 C 15.4340 5.3197 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 21
M  V30 10 1 10 34
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 17
M  V30 20 1 17 29
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 22 25
M  V30 28 1 23 24
M  V30 29 2 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1374235-05-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374230-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11556003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 7. To a solution of compound 4-7 (50 mg,
0.12 mmol) in MeOH/THF (2 mL/4 mL) was added LiOH (2.0 N, 0.46 mmol). The
resulting mixture was stirred at 70°C. for 2 hrs, cooled to rt and
acidified with 1 N aq. HCl (5 mL). Subsequently, the suspension was
filtered and the solid was washed with waster and dried in vacuo. Crude
compound 4-8 (46 mg, 95% yield) as a white solid, which was used directly
for the next step without further purification. Step 8. To a solution of
compound 4-8 (46 mg, 0.12 mmol) in DMF (2 mL) was added HATU (54 mg, 0.14
mmol). The resulting mixture was stirred at rt for 30 min and added DIEA
(154 mg, 1.20 mmol) and MeNH2.HCl (41 mg, 0.60 mmol). After stirring at
rt for 20 min, the reaction mixture was poured into ice water (50 mL).
The suspension was filtered and the solid was purified by silica gel
column chromatography (Petroleum ether/acetone=3/1 (v/v)). Compound 4-9
(30 mg, 61% yield) as a white solid. Synthesis of Compound 28-9a.
Following the same procedure as that for the preparation of 1-16
described in Scheme 1 (WO2012/058125) and replacing compound 1-14 with
28-8a. Step 7. Following the same procedure as that for the preparation
of compound 1-16 described in Scheme 1 and replacing compound 1-14 with
29-6. Compound 29-7 was obtained (130 mg, 90% yield) as a pale brown
solid. LC-MS (ESI): m/z 479.1 [M+H]+; 1H NMR (500 MHz, CDCl3): δ
7.85-7.88 (m, 2H), 7.78 (s, 1H), 7.71 (s, 1H), 7.30 (d, 2H), 7.15-7.24
(m, 5H), 5.76 (brs, 2H), 5.12 (d, J=16 Hz, 2H), 4.95 (d, J=16 Hz, 5H),
4.57-4.62 (dd, J1 =15 Hz, J2 =7 Hz, 1H), 2.72 (d, J=5 Hz, 3H), 2.73 (s,
3H), 1.80 (d, J=8 Hz, 3H) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Furanobenzoxazepine derivatives as inhibitors of hepatitis C virus and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhong, Min; Li, Leping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013163466 A1 2013-10-31

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Ethyl 2-(4-fluorophenyl)-10,11-dihydro-5-methyl-11-(methylsulfonyl)-5H-benzo[...
C27H24FNO5S
1374235-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3847 3.7536 0.0 0
M  V30 2 O 9.3541 2.6091 0.0 0
M  V30 3 O 11.8910 3.4334 0.0 0
M  V30 4 C 9.8300 1.1445 0.0 0
M  V30 5 C 8.7996 0.0000 0.0 0
M  V30 6 C 4.9154 3.2325 0.0 0
M  V30 7 S 4.9154 9.6957 0.0 0 VAL=6
M  V30 8 C 5.2580 11.1970 0.0 0
M  V30 9 O 6.4169 9.3529 0.0 0
M  V30 10 O 3.4140 10.0383 0.0 0
M  V30 11 F 16.9739 6.4640 0.0 0
M  V30 12 C 8.4441 5.6940 0.0 0
M  V30 13 C 8.4441 7.2340 0.0 0
M  V30 14 C 9.9087 5.2181 0.0 0
M  V30 15 C 7.1105 4.9240 0.0 0
M  V30 16 C 7.1105 8.0040 0.0 0
M  V30 17 O 9.9087 7.7100 0.0 0
M  V30 18 C 10.8139 6.4640 0.0 0
M  V30 19 C 5.7767 5.6940 0.0 0
M  V30 20 C 5.7767 7.2340 0.0 0
M  V30 21 C 4.5727 4.7338 0.0 0
M  V30 22 N 4.5727 8.1942 0.0 0
M  V30 23 C 3.0714 5.0766 0.0 0
M  V30 24 C 3.0714 7.8515 0.0 0
M  V30 25 C 2.4032 6.4640 0.0 0
M  V30 26 C 2.2039 3.8041 0.0 0
M  V30 27 C 0.8675 6.5792 0.0 0
M  V30 28 C 0.6682 3.9193 0.0 0
M  V30 29 C 0.0000 5.3067 0.0 0
M  V30 30 C 12.3539 6.4640 0.0 0
M  V30 31 C 13.1239 7.7978 0.0 0
M  V30 32 C 13.1239 5.1304 0.0 0
M  V30 33 C 14.6639 7.7978 0.0 0
M  V30 34 C 14.6639 5.1304 0.0 0
M  V30 35 C 15.4339 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 22
M  V30 11 1 11 35
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 18
M  V30 21 1 18 30
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 25
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-10,11-dihydro-N,5-dimethyl-11-(methylsulfonyl)-5H-benzo[c]...
C26H23FN2O4S
1374230-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3848 2.6091 0.0 0
M  V30 2 N 9.3542 1.4646 0.0 0
M  V30 3 O 11.8910 2.2889 0.0 0
M  V30 4 C 9.8301 0.0000 0.0 0
M  V30 5 C 4.9154 2.0879 0.0 0
M  V30 6 S 4.9154 8.5512 0.0 0 VAL=6
M  V30 7 C 5.2581 10.0526 0.0 0
M  V30 8 O 6.4169 8.2086 0.0 0
M  V30 9 O 3.4141 8.8939 0.0 0
M  V30 10 F 16.9740 5.3197 0.0 0
M  V30 11 C 8.4442 4.5497 0.0 0
M  V30 12 C 8.4442 6.0897 0.0 0
M  V30 13 C 9.9087 4.0736 0.0 0
M  V30 14 C 7.1105 3.7797 0.0 0
M  V30 15 C 7.1105 6.8597 0.0 0
M  V30 16 O 9.9087 6.5655 0.0 0
M  V30 17 C 10.8140 5.3197 0.0 0
M  V30 18 C 5.7767 4.5497 0.0 0
M  V30 19 C 5.7767 6.0897 0.0 0
M  V30 20 C 4.5728 3.5895 0.0 0
M  V30 21 N 4.5728 7.0499 0.0 0
M  V30 22 C 3.0714 3.9321 0.0 0
M  V30 23 C 3.0714 6.7071 0.0 0
M  V30 24 C 2.4032 5.3197 0.0 0
M  V30 25 C 2.2039 2.6598 0.0 0
M  V30 26 C 0.8675 5.4347 0.0 0
M  V30 27 C 0.6682 2.7748 0.0 0
M  V30 28 C 0.0000 4.1623 0.0 0
M  V30 29 C 12.3540 5.3197 0.0 0
M  V30 30 C 13.1240 6.6533 0.0 0
M  V30 31 C 13.1240 3.9859 0.0 0
M  V30 32 C 14.6640 6.6533 0.0 0
M  V30 33 C 14.6640 3.9859 0.0 0
M  V30 34 C 15.4340 5.3197 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 21
M  V30 10 1 10 34
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 17
M  V30 20 1 17 29
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 22 25
M  V30 28 1 23 24
M  V30 29 2 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1374235-05-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374230-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13121025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of compound 1-14 (70 mg, 0.16
mmol) in MeOH/THF (1 mL/2 mL) was added LiOH (0.65 mmol). After stirring
at 70 °C for 2 hr, the reaction mixture was cooled to rt and acidified by
adding 1N aq. HCl (7 mL). The resulting mixture was filtered and the
solid was dried in vacuo. To a solution of compound 1-15 (60 mg, 0.14
mmol) in DMF (1.5 mL) was added HATU (66 mg, 0.17 mmol). After stirring
at rt for 30 min, the mixture were added DIPEA (181 mg, 1.40 mmol) and
MeNH2·HCl (47 mg, 0.70 mmol). The resulting mixture was stined at rt for
20 min and poured into water (50 mL). The suspension was filtered and the
obtained solid was purified by silica gel column chromatography (DCM/MeOH
= 600/1 (v/v)). Step 7. Following the same procedure as that for for the
praparation of compound 1-16 described in Scheme 1 and replacing compound
1-14 with 29-6, compound 29-7 was obtained (130 mg, 90% yield) as a pale
brown solid. LC-MS (ESI): m/z 479.1 [M+H]+; 1H NMR (500 MHz, CDCl3) : δ
7.85-7.88 (m, 2H), 7.78 (s, 1H), 7.71 (s, 1H), 7.30 (d, 2H), 7.15-7.24
(m, 5H), 5.76 (brs, 2H), 5.12 (d,J = 16 Hz, 2H), 4.95 (d, J = 16 Hz, 5H),
4.57-4.62 (dd, J= 15 Hz, J2= 7 Hz, 1H), 2.72 (d, J= 5 Hz, 3H), 2.73 (s,
3H), 1.80 (d,J = 8 Hz, 3H) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused benzofuran derivatives as inhibitors of hepatitis C virus and their
preparation and use for the treatment of HCV infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhong, Min; Li, Leping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012058125 A1 2012-05-03

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-thiazolecarboxaldehyde
C5H5NOS
13750-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-2-thiazolemethanamine
C6H10N2S
644950-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13750-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644950-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5204824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0285] Ti(OiPR)4 (1.3 eq) was added with stirring to MeNH2 (2.0 M in
MeOH, 3 eq) at 0 °C under Ar. After 15 min.
4-methylthiazole-2-carbaldehyde (1eq) was added and the solution was
stirred for 2-3 h. NaBH4 (1.4 eq, in batches if large scale) was added
and stirred at 0° C to RT overnight, followed by solvent removal in
vacuo. The residue was diluted with water/CH2Cl2 and a white ppt formed.
The mixture was then filtered through Celite to remove the white ppt and
the layers were separated. The aqueous layer was extracted with CH2Cl2
(x3) and the combined organics were dried over Na2SO4. The inorganics
were filtered off and the solvent was removed in vacuo to give the crude
product. Purification via column chromatography yielded the pure product.
80-90% yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolidine derivatives which inhibit beta-secretase activity and and
their preparation and use for the treatment of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bilcer, Geoffrey M.; Lilly, John C.; Swanson, Lisa M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011130383 A1 2011-10-20

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-thiazolecarboxaldehyde
C5H5NOS
13750-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-2-thiazolemethanamine
C6H10N2S
644950-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13750-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644950-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7961543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1.1.2: N-methyl-1-(4-methylthiazol-2-yl)methanamine Ti(OipR)4
(1.3 eq) was added with stirring to MeNH2 (2.0 M in MeOH, 3 eq) at 0 °C
under Ar. After 15 min. 4-methylthiazole-2-carbaldehyde (1 eq) was added,
and the solution was stirred for 2-3 h. NaBH4 (1.4 eq, in batches if
large scale) was added and stirred at 0°C to RT overnight, followed by
solvent removal in vacuo. The residue was diluted with water/CH2Cl2, and
a white ppt formed. The mixture was then filtered through Celite to
remove the white ppt and the layers were separated. The aqueous layer was
extracted with CH2Cl2 (x3) and the combined organics were dried over
Na2SO4. The inorganics were filtered off, and the solvent was removed in
vacuo to give the crude product. Purification via column chromatography
yielded the pure product. Yield 80-90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolidine compounds which inhibit beta-secretase activity and their
preparation and use in the treatment of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bilcer, Geoffrey M.; Ankala, Sudha V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011044057 A1 2011-04-14

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-thiazolecarboxaldehyde
C5H5NOS
13750-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-2-thiazolemethanamine
C6H10N2S
644950-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13750-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644950-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1553478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1.1.2: N-methyl-1-(4-methylthiazol-2-yl)methanamine Ti(O i PR)4
(1.3 eq) was added with stirring to MeNH2 (2.0 M in MeOH, 3 eq) at 0 °C
under Ar. After 15 min. 4-methylthiazole-2-carbaldehyde (1 eq) was added,
and the solution was stirred for 2-3 h. NaBH4 (1.4 eq, in batches if
large scale) was added and stirred at 0° C to RT overnight, followed by
solvent removal in vacuo. The residue was diluted with water/CH2Cl2, and
a white ppt formed. The mixture was then filtered through Celite to
remove the white ppt and the layers were separated. The aqueous layer was
extracted with CH2Cl2 (x3) and the combined organics were dried over
Na2SO4. The inorganics were filtered off, and the solvent was removed in
vacuo to give the crude product. Purification via column chromatography
yielded the pure product in 80-90% yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolidine compounds as inhibitors of beta-secretase activity and their
preparation and use in the treatment of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bilcer, Geoffrey M.; Devasamudram, Thippeswamy; Ankala, Sudha V.; Lilly,
John C.; Liu, Chunfeng; Lei, Hui; Ghosh, Arun K.; Inoue, Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010110817 A1 2010-09-30

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-thiazolecarboxaldehyde
C5H5NOS
13750-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-2-thiazolemethanamine
C6H10N2S
644950-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13750-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644950-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7131822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1.1.2: N-methyl-1-(4-methylthiazol-2-yl)methanamine [0268]
Ti(O'PR)4 (1.3 eq) was added with stirring to MeNH2 (2.0 M in MeOH, 3 eq)
at 0°C under Ar. After 15 min. 4-methylthiazole-2-carbaldehyde (1 eq) was
added, and the solution was stirred for 2-3 h. NaBH4 (1.4 eq, in batches
if large scale) was added and stirred at 0°C to RT overnight, followed by
solvent removal in vacuo. The residue was diluted with water/CH2Cl2, and
a white ppt formed. The mixture was then filtered through Celite to
remove the white ppt and the layers were separated. The aqueous layer was
extracted with CH2Cl2 (x3) and the combined organics were dried over
Na2SO4. The inorganics were filtered off, and the solvent was removed in
vacuo to give the crude product. Purification via column chromatography
yielded the pure product in 80-90% yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolidine compounds which inhibit beta-secretase activity and their
preparation and use in the treatment of Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bilcer, Geoffrey M.; Devasamudram, Thippeswamy; Ankala, Sudha V.; Lilly,
John C.; Liu, Chunfeng; Lei, Hui; Ghosh, Arun K.; Inoue, Makoto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010042892 A1 2010-04-15

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-thiazolecarboxaldehyde
C5H5NOS
13750-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-2-thiazolemethanamine
C6H10N2S
644950-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13750-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644950-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10394158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1.1.55: N-methyl-1-(-t-methylthiarol-2-yl)methanamine.
Ti(OipR)4(1.3 eq) was added with stirring to MeNH2 (2.0 M in MeOH, 3 eq)
at 0 °C under Ar. After 15 min. 4-methylthiazole-2-carbaldehyde (1 eq)
was added, and the solution was stirred for 2-3 h. NaBH4 (1.4 eq, in
batches iflarge scale) was added and stirred at 0°C to RT overnight,
followed by solvent removal in vacuo. The residue was diluted with
water/CH2Cl2, and a white ppt formed. The mixture was then filtered
through Celite to remove the white ppt and the layers were separated. The
aqueous layer was extracted with CH2Cl2 (×3) and the combined organics
were dried over Na2SO4. The inorganics were filtered off, and the solvent
was removed in vacuo to give the crude product. Purification via column
chromatography yielded the pure product in 80-90% yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
(3-hydroxy-4-amino-butan-2-yl)-3-[2-(thiazol-2-yl)pyrrolidine-1-carbonyl]benzamide
derivatives and related compounds as selective beta-secretase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghosh, Arun K.; Liu, Chunfeng; Devasamudram, Thippeswamy; Lei, Hui;
Swanson, Lisa M.; Ankala, Sudha V.; Lilly, John C.; Bilcer, Geoffrey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009042694 A1 2009-04-02

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-2-thiazolecarboxaldehyde
C5H5NOS
13750-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 C 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 N 2.5620 2.4782 0.0 0
M  V30 6 S 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-2-thiazolemethanamine
C6H10N2S
644950-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 N 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 C 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 N 2.5620 2.4782 0.0 0
M  V30 7 S 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13750-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 644950-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14077207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1.1.55: N-methyl-1-(4-methylthiazol-2-yl)methanamine Ti(OiPR)4
(1.3 eq) was added with stirring to MeNH2 (2.0 M in MeOH, 3 eq) at 0 °C
under Ar. After 15 min. 4-methylthiazole-2-carbaldehyde (1 eq) was added,
and the solution was stirred for 2-3 h. NaBH4 (1.4 eq, in batches if
large scale) was added and stirred at 0°C to RT overnight, followed by
solvent removal in vacuo. The residue was diluted with water/CH2Cl2, and
a white ppt formed. The mixture was then filtered through Celite to
remove the white ppt and the layers were separated. The aqueous layer was
extracted with CH2Cl2 (x3) and the combined organics were dried over
Na2SO4. The inorganics were filtered off, and the solvent was removed in
vacuo to give the crude product. Purification via column chromatography
yielded the pure product in 80-90% yield.
N-methyl-1-(4-methylthiazol-2-yl)methanamine, Yield 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isophthalamide compounds which inhibit beta-secretase activity and their
preparation, pharmaceutical compositions and use in the treatment of
Alzheimer's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghosh, Arun K.; Liu, Chunfeng; Devasamudram, Thippeswamy; Lei, Hui;
Swanson, Lisa M.; Ankala, Sudha V.; Lilly, John C.; Bilcer, Geoffrey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009015369 A2 2009-01-29

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-3-[(3R)-3-Hydroxy-1-oxo-3-phenylpropyl]-4-(1-methylethyl)-1-[(1R)-1-phen...
C23H28N2O3
1375257-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2221 2.3932 0.0 0
M  V30 2 C 9.5559 3.1632 0.0 0
M  V30 3 O 8.2221 0.8532 0.0 0
M  V30 4 C 10.8895 2.3932 0.0 0 CFG=2
M  V30 5 O 10.8895 0.8532 0.0 0
M  V30 6 C 5.1615 1.0304 0.0 0
M  V30 7 C 3.6968 0.5546 0.0 0
M  V30 8 C 6.3059 0.0000 0.0 0
M  V30 9 O 7.8719 5.7253 0.0 0
M  V30 10 C 4.5948 6.4218 0.0 0 CFG=2
M  V30 11 C 5.5000 7.6677 0.0 0
M  V30 12 N 6.8884 3.1632 0.0 0
M  V30 13 C 5.4816 2.5368 0.0 0 CFG=1
M  V30 14 C 6.7275 4.6947 0.0 0
M  V30 15 C 4.4511 3.6812 0.0 0
M  V30 16 N 5.2211 5.0150 0.0 0
M  V30 17 C 3.0632 6.5827 0.0 0
M  V30 18 C 2.4367 7.9897 0.0 0
M  V30 19 C 2.1580 5.3369 0.0 0
M  V30 20 C 0.9052 8.1506 0.0 0
M  V30 21 C 0.6265 5.4978 0.0 0
M  V30 22 C 0.0000 6.9048 0.0 0
M  V30 23 C 12.2232 3.1632 0.0 0
M  V30 24 C 13.5568 2.3932 0.0 0
M  V30 25 C 12.2232 4.7032 0.0 0
M  V30 26 C 14.8906 3.1632 0.0 0
M  V30 27 C 13.5568 5.4732 0.0 0
M  V30 28 C 14.8906 4.7032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=3
M  V30 6 1 4 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 13 6 CFG=1
M  V30 10 2 9 14
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 16
M  V30 13 1 10 17
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(βR)-β-Hydroxy-N-methylbenzenepropanamide
C10H13NO2
210546-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 4.6200 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1375257-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 210546-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-1162167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
(S)/(R)-3-hydroxy-N-methyl-3-phenylpropanamide (12/15). To a solution of
8a(i) or 9a(i) (3.0 g, 7.88 mmol, 1.0 equiv) in methanol (50 mL) was
added aq methylamine (1.8 mL, 23.6 mmol, 3.0 equiv; 40% in H2O), and
refluxed for 5 h. After completion of the reaction the solvent was
removed under vacuum, and the reaction mixture was extracted with ethyl
acetate, dried, concentrated and purified by column chromatography[silica
gel (60-120 mesh), eluent EtOAc:hexanes = 3:7] to afford the chiral
auxiliary and the corresponding hydroxy amide (eluent EtOAc:hexanes =
4:6;). (R)-3-Hydroxy-N-methyl-3-phenylpropanamide (15). yield 1.26 g,
90%). White solid. Mp 133-137 °C;[α]D20 +75.8 (c 0.5, CHCl3). All the
other analytical data were found to be identical with its isomer 12.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown for 2-Imidazolidinone,
4-(1-methylethyl)-1-[(1R)-1-phenylethyl]-, (4S)-
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reversal of selectivity in acetate aldol reactions of
N-acetyl-(S)-4-isopropyl-1-[(R)-1-phenylethyl]imidazolidin-2-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khatik, Gopal L.; Kumar, Varun; Nair, Vipin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(10), 2442-2445

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(4-chloro-8-methoxy-2-quinolinyl)oxy]acetate
C14H14ClNO4
1380598-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 6.1601 0.0 0
M  V30 2 C 0.0000 6.9302 0.0 0
M  V30 3 Cl 4.0010 0.0000 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 O 10.6697 3.8501 0.0 0
M  V30 8 O 9.3360 6.1601 0.0 0
M  V30 9 C 12.0033 4.6201 0.0 0
M  V30 10 C 13.3370 3.8501 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 N 4.0010 4.6201 0.0 0
M  V30 15 C 4.0010 1.5400 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-8-methoxy-N-methyl-2-quinolinamine
C11H11ClN2O
1380598-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 1.3338 0.0 0
M  V30 2 C 8.4700 1.3338 0.0 0
M  V30 3 Cl 1.5400 5.3349 0.0 0
M  V30 4 N 1.5400 0.0000 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 N 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 15 C 6.1600 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1380598-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380598-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13266145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Smiles rearrangement (2nd stage), alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel one pot synthesis of 2-amino-4-chloroquinolines via Smiles
rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Devadoss Karthik; Rajendran, Subramaniam Parameswaran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(26), 3230-3232

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
3-Ethenyl-2,3-dihydro-5-methoxy-1-methyl-2-oxo-1H-indole-3-acetic acid
C14H15NO4
1396316-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2938 2.6528 0.0 0
M  V30 2 C 2.3886 1.4068 0.0 0
M  V30 3 O 3.0149 0.0000 0.0 0
M  V30 4 O 0.8570 1.5679 0.0 0
M  V30 5 C 1.3337 3.2896 0.0 0
M  V30 6 C 0.0000 4.0597 0.0 0
M  V30 7 O 0.2222 5.3055 0.0 0
M  V30 8 C 2.1915 8.0161 0.0 0
M  V30 9 O 8.1332 3.7655 0.0 0
M  V30 10 C 9.4668 4.5355 0.0 0
M  V30 11 C 2.6673 4.0597 0.0 0
M  V30 12 C 4.1320 4.5355 0.0 0
M  V30 13 C 1.7622 5.3055 0.0 0
M  V30 14 C 4.1320 6.0755 0.0 0
M  V30 15 C 5.4657 3.7655 0.0 0
M  V30 16 N 2.6673 6.5514 0.0 0
M  V30 17 C 5.4657 6.8456 0.0 0
M  V30 18 C 6.7995 4.5355 0.0 0
M  V30 19 C 6.7995 6.0755 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 13
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethenyl-2,3-dihydro-5-methoxy-N,1-dimethyl-2-oxo-1H-indole-3-acetamide
C15H18N2O3
1396316-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2938 3.8987 0.0 0
M  V30 2 C 2.3886 2.6528 0.0 0
M  V30 3 N 3.0149 1.2459 0.0 0
M  V30 4 O 0.8570 2.8137 0.0 0
M  V30 5 C 2.1097 0.0000 0.0 0
M  V30 6 C 1.3336 4.5355 0.0 0
M  V30 7 C 0.0000 5.3055 0.0 0
M  V30 8 O 0.2222 6.5513 0.0 0
M  V30 9 C 2.1914 9.2619 0.0 0
M  V30 10 O 8.1331 5.0113 0.0 0
M  V30 11 C 9.4667 5.7813 0.0 0
M  V30 12 C 2.6673 5.3055 0.0 0
M  V30 13 C 4.1320 5.7813 0.0 0
M  V30 14 C 1.7622 6.5513 0.0 0
M  V30 15 C 4.1320 7.3214 0.0 0
M  V30 16 C 5.4656 5.0113 0.0 0
M  V30 17 N 2.6673 7.7974 0.0 0
M  V30 18 C 5.4656 8.0914 0.0 0
M  V30 19 C 6.7994 5.7813 0.0 0
M  V30 20 C 6.7994 7.3214 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 2 8 14
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1396316-64-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396316-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4601495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of phenserine analogues and evaluation of their cholinesterase
inhibitory activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shinada, Masashi; Narumi, Fuminori; Osada, Yuji; Matsumoto, Koji;
Yoshida, Takayasu; Higuchi, Kazuhiro; Kawasaki, Tomomi; Tanaka, Hiroyuki;
Satoh, Mitsutoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2012), 20(16), 4901-4914

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Aminophenyl)sulfonyl]-2-methylalanine methyl ester
C11H16N2O4S
1401065-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 8.2636 3.2311 0.0 0
M  V30 7 C 5.5962 4.7711 0.0 0
M  V30 8 C 7.7000 5.3349 0.0 0
M  V30 9 O 9.5973 4.0011 0.0 0
M  V30 10 O 8.2636 1.6911 0.0 0
M  V30 11 C 10.9309 3.2311 0.0 0
M  V30 12 N 3.0800 0.0000 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 0.7700 1.3338 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 12 14
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(2-Aminophenyl)sulfonyl]amino]-N,2-dimethylpropanamide
C11H17N3O3S
1424328-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 8.2636 3.2311 0.0 0
M  V30 7 C 5.5962 4.7711 0.0 0
M  V30 8 C 7.7000 5.3349 0.0 0
M  V30 9 N 9.5973 4.0011 0.0 0
M  V30 10 O 8.2636 1.6911 0.0 0
M  V30 11 C 10.9309 3.2311 0.0 0
M  V30 12 N 3.0800 0.0000 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 0.7700 1.3338 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 12 14
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401065-86-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1424328-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13840313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Orthanilic acid-promoted reverse turn formation in peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kale, Sangram S.; Priya, Gowri; Kotmale, Amol S.; Gawade, Rupesh L.;
Puranik, Vedavati G.; Rajamohanan, P. R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2013), 49(22),
2222-2224

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-[[2-[(4S,4aS,10bS)-10b-[(4-chlorophenyl)sulfonyl]-7,10-difluoro-1,...
C23H25ClF2O9S3
1402428-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 5.5828 7.2871 0.0 0 VAL=6
M  V30 2 O 4.9320 5.8914 0.0 0
M  V30 3 O 6.2338 8.6830 0.0 0
M  V30 4 F 6.6901 5.3347 0.0 0
M  V30 5 C 13.6201 6.6684 0.0 0
M  V30 6 C 14.3901 8.0020 0.0 0
M  V30 7 S 15.9301 8.0020 0.0 0 VAL=6
M  V30 8 C 17.4701 8.0020 0.0 0
M  V30 9 O 15.9301 6.4620 0.0 0
M  V30 10 O 15.9301 9.5420 0.0 0
M  V30 11 C 18.2401 9.3358 0.0 0
M  V30 12 O 19.7801 9.3358 0.0 0
M  V30 13 S 20.5501 10.6694 0.0 0 VAL=6
M  V30 14 C 21.8837 9.8994 0.0 0
M  V30 15 O 21.3201 12.0031 0.0 0
M  V30 16 O 19.2163 11.4394 0.0 0
M  V30 17 F 9.7701 0.0000 0.0 0
M  V30 18 Cl 0.0000 9.8905 0.0 0
M  V30 19 C 9.7701 5.3347 0.0 0 CFG=1
M  V30 20 C 9.0001 4.0011 0.0 0
M  V30 21 C 11.3101 5.3347 0.0 0 CFG=1
M  V30 22 C 9.0001 6.6684 0.0 0
M  V30 23 C 9.7701 2.6673 0.0 0
M  V30 24 C 7.4601 4.0011 0.0 0
M  V30 25 C 12.0801 6.6684 0.0 0 CFG=2
M  V30 26 C 12.0801 4.0011 0.0 0
M  V30 27 C 9.7701 8.0020 0.0 0
M  V30 28 O 11.3101 2.6673 0.0 0
M  V30 29 C 9.0001 1.3336 0.0 0
M  V30 30 C 6.6901 2.6673 0.0 0
M  V30 31 O 11.3101 8.0020 0.0 0
M  V30 32 C 7.4601 1.3336 0.0 0
M  V30 33 C 4.1871 7.9381 0.0 0
M  V30 34 C 2.9257 7.0547 0.0 0
M  V30 35 C 4.0530 9.4722 0.0 0
M  V30 36 C 1.5300 7.7055 0.0 0
M  V30 37 C 2.6573 10.1230 0.0 0
M  V30 38 C 1.3957 9.2397 0.0 0
M  V30 39 H 12.8501 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=1
M  V30 4 1 1 33
M  V30 5 1 4 24
M  V30 6 1 5 6
M  V30 7 1 25 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 13 16
M  V30 18 1 17 29
M  V30 19 1 18 38
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 21 39 CFG=1
M  V30 28 1 22 27
M  V30 29 1 23 28
M  V30 30 2 23 29
M  V30 31 1 24 30
M  V30 32 1 25 31
M  V30 33 1 26 28
M  V30 34 1 27 31
M  V30 35 1 29 32
M  V30 36 2 30 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 19 21 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[2-[(4S,4aS,10bS)-10b-[(4-Chlorophenyl)sulfonyl]-7,10-difluoro-1,4a,5,10b-...
C23H26ClF2NO6S2
1402427-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 5.5830 7.2873 0.0 0 VAL=6
M  V30 2 O 6.2338 8.6830 0.0 0
M  V30 3 O 4.9320 5.8914 0.0 0
M  V30 4 F 6.6901 5.3347 0.0 0
M  V30 5 C 13.6201 6.6684 0.0 0
M  V30 6 C 14.3901 8.0021 0.0 0
M  V30 7 S 15.9301 8.0021 0.0 0 VAL=6
M  V30 8 C 17.4701 8.0021 0.0 0
M  V30 9 O 15.9301 9.5421 0.0 0
M  V30 10 O 15.9301 6.4621 0.0 0
M  V30 11 C 18.2401 9.3358 0.0 0
M  V30 12 N 19.7801 9.3358 0.0 0
M  V30 13 C 20.5501 10.6694 0.0 0
M  V30 14 F 9.7701 0.0000 0.0 0
M  V30 15 Cl 0.0000 9.8905 0.0 0
M  V30 16 C 9.7701 5.3347 0.0 0 CFG=1
M  V30 17 C 9.0001 4.0011 0.0 0
M  V30 18 C 11.3101 5.3347 0.0 0 CFG=1
M  V30 19 C 9.0001 6.6684 0.0 0
M  V30 20 C 9.7701 2.6673 0.0 0
M  V30 21 C 7.4601 4.0011 0.0 0
M  V30 22 C 12.0801 6.6684 0.0 0 CFG=2
M  V30 23 C 12.0801 4.0011 0.0 0
M  V30 24 C 9.7701 8.0020 0.0 0
M  V30 25 O 11.3101 2.6673 0.0 0
M  V30 26 C 9.0001 1.3336 0.0 0
M  V30 27 C 6.6901 2.6673 0.0 0
M  V30 28 O 11.3101 8.0020 0.0 0
M  V30 29 C 7.4601 1.3336 0.0 0
M  V30 30 C 4.1871 7.9381 0.0 0
M  V30 31 C 4.0530 9.4722 0.0 0
M  V30 32 C 2.9257 7.0547 0.0 0
M  V30 33 C 2.6573 10.1230 0.0 0
M  V30 34 C 1.5300 7.7055 0.0 0
M  V30 35 C 1.3957 9.2397 0.0 0
M  V30 36 H 12.8501 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 1 30
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 14 26
M  V30 16 1 15 35
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 18 36 CFG=1
M  V30 25 1 19 24
M  V30 26 1 20 25
M  V30 27 2 20 26
M  V30 28 1 21 27
M  V30 29 1 22 28
M  V30 30 1 23 25
M  V30 31 1 24 28
M  V30 32 1 26 29
M  V30 33 2 27 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 18 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1402428-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1402427-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16967825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of water soluble β-aminosulfone analogues of SCH
900229 as γ-secretase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Wen-Lian; Burnett, Duane A.; Clader, John; Greenlee, William J.;
Jiang, Qin; Hyde, Lynn A.; Del Vecchio, Robert A.; Cohen-Williams, Mary
E.; Song, Lixin; Lee, Julie; Terracina, Giuseppe; Zhang, Qi; Nomeir,
Amin; Parker, Eric M.; Zhang, Lili
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(23), 5836-5841

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-5-nitrobenzoic acid
C7H4FNO4
14027-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 5 O 6.6685 6.1600 0.0 0
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methyl-5-nitrobenzamide
C8H7FN2O3
1239596-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 F 4.0011 0.0000 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14027-75-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239596-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5969844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. To a roundbottom flask charged with 3-fluoro-5-nitrobenzoic acid
(1.00 g, 5.40 mmol) was added DMF (6.75 mL), followed by Hunig's base
(1.13 mL, 6.48 mmol), and HATU (2.157 g, 5.67 mmol). The flask was sealed
with a septum and methanamine (2.0 M in THF) (13.5 mL, 27.0 mmol) was
added via syringe. The resulting orange reaction mixture was stirred
overnight at RT. After 16 h, the reaction reaction mixture was diluted
with CH2Cl2 (70 mL) and the resulting mixture was transferred to a
separatory funnel and extracted with sat. aq. NaHCO3 (3 × 30 mL). The
organic layer was dried with Na2SO4, filtered and concentrated under
reduced pressure. Purification with medium pressure silica gel
chromatography using 70:30 Hex:EtOAc as the eluent afforded
3-fluoro-N-methyl-5-nitrobenzamide (961 mg, 4.85 mmol, 90 %) as a yellow
solid.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl carboxamide derivatives as sodium channel inhibitors
for treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bregman, Howard; Buchanan, John L.; Chakka, Nagasree; Dimauro, Erin F.;
Du, Bingfan; Nguyen, Hanh Nho; Zheng, Xiao Mei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011103196 A1 2011-08-25

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Methoxymethyl)-3,4,5-trinitro-1H-pyrazole
C5H5N5O7
1415924-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8549 6.5626 0.0 0 VAL=5
M  V30 2 O 5.1886 7.3326 0.0 0
M  V30 3 O 2.5211 7.3326 0.0 0
M  V30 4 N 1.1444 4.5932 0.0 0 VAL=5
M  V30 5 O 0.8242 6.0997 0.0 0
M  V30 6 O 0.0000 3.5628 0.0 0
M  V30 7 C 6.5654 4.5932 0.0 0
M  V30 8 O 7.7099 3.5628 0.0 0
M  V30 9 C 9.1744 4.0387 0.0 0
M  V30 10 N 2.1797 1.4068 0.0 0 VAL=5
M  V30 11 O 0.6482 1.5679 0.0 0
M  V30 12 O 2.8060 0.0000 0.0 0
M  V30 13 C 3.8549 5.0226 0.0 0
M  V30 14 C 2.6091 4.1174 0.0 0
M  V30 15 N 5.1008 4.1174 0.0 0
M  V30 16 C 3.0849 2.6528 0.0 0
M  V30 17 N 4.6250 2.6528 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Methoxymethyl)-N-methyl-3,4-dinitro-1H-pyrazol-5-amine
C6H9N5O5
1415924-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.8384 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0684 0.0 0
M  V30 3 O 1.3337 6.3784 0.0 0
M  V30 4 N 4.3944 6.2012 0.0 0
M  V30 5 C 5.8591 6.6772 0.0 0
M  V30 6 N 1.6840 1.5064 0.0 0 VAL=5
M  V30 7 O 2.0042 0.0000 0.0 0
M  V30 8 O 0.2193 1.9823 0.0 0
M  V30 9 C 6.6364 3.7114 0.0 0
M  V30 10 O 7.5416 2.4656 0.0 0
M  V30 11 C 9.0732 2.6265 0.0 0
M  V30 12 C 2.6675 4.0684 0.0 0
M  V30 13 C 4.0743 4.6949 0.0 0
M  V30 14 C 2.8284 2.5369 0.0 0
M  V30 15 N 5.1047 3.5504 0.0 0
M  V30 16 N 4.3347 2.2167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1415924-63-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1415924-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-196-CAS-10928438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Reaction of
1-methoxymethyl-3,4,5-trinitropyrazole (2) with N-nucleophiles (general
procedure). A 25% aqueous NH3 (5 mL) (for 4a), or 40% aq. MeNH2 (2 mL)
(for 4b), or the corresponding amine or hydrazine (2.25 mmol) (for 4c—e)
was added to a solution of 1-methoxymethyl-3,4,5-trinitropyrazole (2)
(0.5 g, 2.02 mmol) in MeOH (3 mL) at room temperature. The reaction
mixture was stirred for 3 h, a precipitate formed was filtered off,
washed with water, and recrystallized from EtOH—H2O (5 : 1). In the case
of 4c, the solvent was evaporated at reduced pressure, the residue was
subjected to chromatography on silica gel (eluent CHCl3—MeOH (10 : 1)).
1-Methoxymethyl-5-(methylamino)-3,4-dinitro-1H-pyrazole (4b). The yield
was 90% m.p. 98—100 °C. Found (%): C, 31.33; H, 4.07; N, 30.58. C6H9N5O5.
Calculated (%): C, 31.17; H, 3.92; N, 30.30. 1H NMR (CDCl3), δ: 3.36 (d,
2 H, NHCH3, J = 5.5 Hz); 3.49 (s, 3 H, CH3); 5.48 (s, 2 H, CH2); 7.26
(br.s, 1 H, NH). 13C NMR, δ: 30.46 (MeNH); 56.39 (OCH3); 81.84 (CH2);
109.02 (br.s, C(4)); 147.48 (C(5)); 148.04 (br.s, C(3)). MS: m/z = 231
[M]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitropyrazoles 20. Synthesis and transformations of
1-methoxymethyl-3,4,5-trinitropyrazole
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dalinger, I. L.; Vatsadze, I. A.; Shkineva, T. K.; Popova, G. P.;
Shevelev, S. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2012), 61(2), 464-466

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentacarbonyl[1-ethoxy-3-(4′-ethynyl[1,1′-biphenyl]-4-yl)-2-propyn-...
C24H14O6W
1422755-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 W 4.2634 2.8449 0.0 0 CHG=2 VAL=7
M  V30 2 C 6.7243 4.2673 0.0 0 CHG=-2 VAL=4
M  V30 3 C 1.4224 2.8449 0.0 0
M  V30 4 C 7.1083 2.8449 0.0 0
M  V30 5 C 4.2634 0.0000 0.0 0
M  V30 6 C 1.8025 1.4224 0.0 0
M  V30 7 C 4.2634 5.6859 0.0 0
M  V30 8 C 8.5503 4.2673 0.0 0
M  V30 9 O 6.7243 5.6859 0.0 0
M  V30 10 O 0.0000 2.8449 0.0 0 VAL=3
M  V30 11 O 8.5268 2.8449 0.0 0 VAL=3
M  V30 12 O 2.8410 0.0000 0.0 0 VAL=3
M  V30 13 O 0.3801 1.4224 0.0 0 VAL=3
M  V30 14 O 2.8410 5.6859 0.0 0 VAL=3
M  V30 15 C 9.9728 4.2673 0.0 0
M  V30 16 C 7.9586 6.3990 0.0 0
M  V30 17 C 9.1773 5.6663 0.0 0
M  V30 18 C 19.2010 8.7737 0.0 0
M  V30 19 C 20.4315 9.4830 0.0 0
M  V30 20 C 11.3952 4.2673 0.0 0
M  V30 21 C 11.3952 5.8073 0.0 0
M  V30 22 C 12.7315 3.4954 0.0 0
M  V30 23 C 12.7315 6.5793 0.0 0
M  V30 24 C 14.0677 4.2673 0.0 0
M  V30 25 C 14.0677 5.8073 0.0 0
M  V30 26 C 15.2981 6.5205 0.0 0
M  V30 27 C 15.2981 8.0605 0.0 0
M  V30 28 C 16.6344 5.7485 0.0 0
M  V30 29 C 16.6344 8.8325 0.0 0
M  V30 30 C 17.9706 6.5205 0.0 0
M  V30 31 C 17.9706 8.0605 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 9
M  V30 9 3 3 10
M  V30 10 3 4 11
M  V30 11 3 5 12
M  V30 12 3 6 13
M  V30 13 3 7 14
M  V30 14 3 8 15
M  V30 15 1 9 16
M  V30 16 1 15 20
M  V30 17 1 16 17
M  V30 18 3 18 19
M  V30 19 1 18 31
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentacarbonyl[3-(4′-ethynyl[1,1′-biphenyl]-4-yl)-1-(methylamino)-2-...
C23H13NO5W
1422755-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 W 4.2546 2.8390 0.0 0 CHG=2 VAL=7
M  V30 2 C 6.7104 4.2585 0.0 0 CHG=-2 VAL=4
M  V30 3 C 1.4195 2.8390 0.0 0
M  V30 4 C 7.0936 2.8390 0.0 0
M  V30 5 C 4.2546 0.0000 0.0 0
M  V30 6 C 1.7988 1.4195 0.0 0
M  V30 7 C 4.2546 5.6741 0.0 0
M  V30 8 C 8.5326 4.2585 0.0 0
M  V30 9 N 6.7104 5.6741 0.0 0
M  V30 10 O 0.0000 2.8390 0.0 0 VAL=3
M  V30 11 O 8.5092 2.8390 0.0 0 VAL=3
M  V30 12 O 2.8351 0.0000 0.0 0 VAL=3
M  V30 13 O 0.3793 1.4195 0.0 0 VAL=3
M  V30 14 O 2.8351 5.6741 0.0 0 VAL=3
M  V30 15 C 9.9521 4.2585 0.0 0
M  V30 16 C 5.1032 6.6048 0.0 0
M  V30 17 C 19.1613 8.7555 0.0 0
M  V30 18 C 20.3892 9.4633 0.0 0
M  V30 19 C 11.3716 4.2585 0.0 0
M  V30 20 C 11.3716 5.7953 0.0 0
M  V30 21 C 12.7051 3.4881 0.0 0
M  V30 22 C 12.7051 6.5657 0.0 0
M  V30 23 C 14.0386 4.2585 0.0 0
M  V30 24 C 14.0386 5.7953 0.0 0
M  V30 25 C 15.2665 6.5070 0.0 0
M  V30 26 C 15.2665 8.0438 0.0 0
M  V30 27 C 16.5999 5.7367 0.0 0
M  V30 28 C 16.5999 8.8142 0.0 0
M  V30 29 C 17.9334 6.5070 0.0 0
M  V30 30 C 17.9334 8.0438 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 9
M  V30 9 3 3 10
M  V30 10 3 4 11
M  V30 11 3 5 12
M  V30 12 3 6 13
M  V30 13 3 7 14
M  V30 14 3 8 15
M  V30 15 1 9 16
M  V30 16 1 15 19
M  V30 17 3 17 18
M  V30 18 1 17 30
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1422755-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1422755-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-8783899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM tlc control of consumption, 1.1 eq. of amine used, electrochemistry
studied
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A click approach to polymetallic chromium(0) and tungsten(0)
Fischer-carbene complexes and their use in the synthesis of
functionalized polymetallic metal-carbene complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Beatriz; Casarrubios, Luis; Sierra, Miguel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(4), 1429-1435

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[C(E)]-2-[5-(3-Chloro-2-pyridinyl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]-...
C21H15ClF3N5O3
1423030-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8137 3.9646 0.0 0
M  V30 2 C 1.4069 4.5909 0.0 0
M  V30 3 F 2.0333 5.9977 0.0 0
M  V30 4 F 0.0000 5.2172 0.0 0
M  V30 5 F 0.7805 3.1841 0.0 0
M  V30 6 Cl 3.4633 2.1049 0.0 0
M  V30 7 O 11.0495 2.9724 0.0 0
M  V30 8 C 10.2795 9.6407 0.0 0
M  V30 9 C 14.8995 6.9734 0.0 0
M  V30 10 N 15.6695 8.3071 0.0 0
M  V30 11 O 17.2095 8.3071 0.0 0
M  V30 12 C 17.9795 9.6407 0.0 0
M  V30 13 C 5.5243 4.3938 0.0 0
M  V30 14 C 6.4295 5.6398 0.0 0
M  V30 15 N 4.0596 4.8698 0.0 0
M  V30 16 C 5.5243 6.8856 0.0 0
M  V30 17 N 4.0596 6.4098 0.0 0
M  V30 18 C 6.0001 2.9292 0.0 0
M  V30 19 C 4.9697 1.7847 0.0 0
M  V30 20 N 7.5066 2.6091 0.0 0
M  V30 21 C 5.4456 0.3202 0.0 0
M  V30 22 C 7.9824 1.1444 0.0 0
M  V30 23 C 6.9519 0.0000 0.0 0
M  V30 24 C 7.9695 5.6398 0.0 0
M  V30 25 N 8.7395 6.9734 0.0 0
M  V30 26 O 8.7395 4.3060 0.0 0
M  V30 27 C 10.2795 6.9734 0.0 0
M  V30 28 C 10.2795 4.3060 0.0 0
M  V30 29 C 11.0495 5.6398 0.0 0
M  V30 30 C 11.0495 8.3071 0.0 0
M  V30 31 C 12.5895 5.6398 0.0 0
M  V30 32 C 12.5895 8.3071 0.0 0
M  V30 33 C 13.3595 6.9734 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 19
M  V30 7 2 7 28
M  V30 8 1 8 30
M  V30 9 2 9 10
M  V30 10 1 9 33
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 14 24
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 27 30
M  V30 32 1 28 29
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Chloro-2-pyridinyl)-N-[4-[(E)-(methoxyimino)methyl]-2-methyl-6-[(methyla...
C22H20ClF3N6O3
1423030-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9695 6.6685 0.0 0
M  V30 2 N 8.7395 5.3347 0.0 0
M  V30 3 O 8.7395 8.0021 0.0 0
M  V30 4 C 2.8137 8.3437 0.0 0
M  V30 5 C 1.4069 7.7172 0.0 0
M  V30 6 F 0.7805 9.1242 0.0 0
M  V30 7 F 0.0000 7.0909 0.0 0
M  V30 8 F 2.0333 6.3105 0.0 0
M  V30 9 Cl 3.4633 10.2033 0.0 0
M  V30 10 C 10.2795 2.6674 0.0 0
M  V30 11 N 11.0495 1.3338 0.0 0
M  V30 12 O 8.7395 2.6674 0.0 0
M  V30 13 C 10.2795 0.0000 0.0 0
M  V30 14 C 10.2795 8.0021 0.0 0
M  V30 15 C 14.8995 5.3347 0.0 0
M  V30 16 N 15.6695 4.0011 0.0 0
M  V30 17 O 17.2095 4.0011 0.0 0
M  V30 18 C 17.9795 2.6674 0.0 0
M  V30 19 C 5.5243 7.9144 0.0 0
M  V30 20 C 6.4295 6.6685 0.0 0
M  V30 21 N 4.0596 7.4385 0.0 0
M  V30 22 C 5.5243 5.4226 0.0 0
M  V30 23 N 4.0596 5.8985 0.0 0
M  V30 24 C 6.0001 9.3789 0.0 0
M  V30 25 C 4.9697 10.5234 0.0 0
M  V30 26 N 7.5066 9.6992 0.0 0
M  V30 27 C 5.4456 11.9880 0.0 0
M  V30 28 C 7.9824 11.1638 0.0 0
M  V30 29 C 6.9519 12.3083 0.0 0
M  V30 30 C 10.2795 5.3347 0.0 0
M  V30 31 C 11.0495 4.0011 0.0 0
M  V30 32 C 11.0495 6.6685 0.0 0
M  V30 33 C 12.5895 4.0011 0.0 0
M  V30 34 C 12.5895 6.6685 0.0 0
M  V30 35 C 13.3595 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 30
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 31
M  V30 14 1 11 13
M  V30 15 1 14 32
M  V30 16 2 15 16
M  V30 17 1 15 35
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1423030-61-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1423030-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15092060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 10: Synthesis of
5-(3-chloro-2-pyridyl)-N-[4-[(E)-methoxyiminomethyl]-2-methyl-6-
(methylcarbamoyl)phenyl]-1-(2 ,
2,2-trifluoroethyl)pyrazole-4-carboxamide, To a solution of
2-[5-(3-chloro-2-pyridyl)-1-(2 ,2, 2-trifluoroethyl)pyrazol-4-yl]-6-[(E)-
methoxyiminomethyl]-8-methyl-3,1-benzoxazin-4-one (i.e. the product of
Step 9, 120 mg, 0.25 mmol) in THF (8 mL) was added a solution of
methylamine (0.8 mL of a 2 M solution in THF, 1.6 mmol, 6.4 equiv.) at
room temperature. After 4 h, the mixture was concentrated in vacuo and
the residue was triturated with diethyl ether. (115 mg, 90%).
Characterization by HPLC-MS (method A): 2.849 min M = 509.00
Characterization by 1H-NMR (500 MHz, DMSO-d6):δ[delta] = 2.20 (s, 3H),
2.66 (s, 3H), 3.91 (s, 3H), 4.95-5.32 (m, 2H), 7.54 (m, 3H), 8.07 (m, 1
H), 8.20 (s, 1H), 8.24 (m, 1H), 8.35 (s, 1H), 8.68 (m, 1H), 9.89 (s, 1H)
ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of anthranilamide compounds and their use as pesticides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deshmukh, Prashant; Koerber, Karsten; Kaiser, Florian; Kordes, Markus;
Dickhaut, Joachim; Narine, Arun; Bandur, Nina Gertrud; Veitch, Gemma;
Culbertson, Deborah L.; Neese, Paul; Gunjima, Koshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013024006 A1 2013-02-21

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(3-Chloro-2-pyridinyl)-4-(trifluoromethyl)phenyl]-8-methyl-6-(1H-1,2,4-t...
C23H13ClF3N5O2
1423167-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.8500 1.3336 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 F 1.5400 3.7947 0.0 0
M  V30 4 F 0.0000 5.3347 0.0 0
M  V30 5 F 1.5400 6.8747 0.0 0
M  V30 6 O 10.7800 2.6674 0.0 0
M  V30 7 C 10.0100 9.3358 0.0 0
M  V30 8 C 6.1600 5.3347 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 5.3900 6.6684 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 3.8500 6.6684 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 7.7000 5.3347 0.0 0
M  V30 15 N 8.4700 6.6684 0.0 0
M  V30 16 O 8.4700 4.0011 0.0 0
M  V30 17 C 10.0100 6.6684 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 10.7800 8.0021 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 22 C 12.3200 8.0021 0.0 0
M  V30 23 C 13.0900 6.6684 0.0 0
M  V30 24 C 6.1600 2.6674 0.0 0
M  V30 25 C 5.3900 1.3336 0.0 0
M  V30 26 N 7.7000 2.6674 0.0 0
M  V30 27 C 6.1600 0.0000 0.0 0
M  V30 28 C 8.4700 1.3336 0.0 0
M  V30 29 C 7.7000 0.0000 0.0 0
M  V30 30 N 14.6300 6.6684 0.0 0
M  V30 31 C 15.5352 5.4225 0.0 0
M  V30 32 N 15.5352 7.9144 0.0 0
M  V30 33 N 16.9998 5.8984 0.0 0
M  V30 34 C 16.9998 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 13
M  V30 6 2 6 18
M  V30 7 1 7 20
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 9 24
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 19
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 23 30
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(3-Chloro-2-pyridinyl)-4-(trifluoromethyl)benzoyl]amino]-N,3-dimethyl-5...
C24H18ClF3N6O2
1423167-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0
M  V30 2 N 8.4700 5.3347 0.0 0
M  V30 3 O 8.4700 8.0020 0.0 0
M  V30 4 Cl 3.8500 10.6695 0.0 0
M  V30 5 C 1.5400 6.6684 0.0 0
M  V30 6 F 1.5400 8.2084 0.0 0
M  V30 7 F 0.0000 6.6684 0.0 0
M  V30 8 F 1.5400 5.1284 0.0 0
M  V30 9 C 10.0101 2.6673 0.0 0
M  V30 10 N 10.7801 1.3336 0.0 0
M  V30 11 O 8.4700 2.6673 0.0 0
M  V30 12 C 10.0101 0.0000 0.0 0
M  V30 13 C 10.0101 8.0020 0.0 0
M  V30 14 C 5.3900 8.0020 0.0 0
M  V30 15 C 6.1600 6.6684 0.0 0
M  V30 16 C 3.8500 8.0020 0.0 0
M  V30 17 C 5.3900 5.3347 0.0 0
M  V30 18 C 3.0800 6.6684 0.0 0
M  V30 19 C 3.8500 5.3347 0.0 0
M  V30 20 C 6.1600 9.3358 0.0 0
M  V30 21 C 5.3900 10.6695 0.0 0
M  V30 22 N 7.7000 9.3358 0.0 0
M  V30 23 C 6.1600 12.0031 0.0 0
M  V30 24 C 8.4700 10.6695 0.0 0
M  V30 25 C 7.7000 12.0031 0.0 0
M  V30 26 C 10.0101 5.3347 0.0 0
M  V30 27 C 10.7801 4.0011 0.0 0
M  V30 28 C 10.7801 6.6684 0.0 0
M  V30 29 C 12.3201 4.0011 0.0 0
M  V30 30 C 12.3201 6.6684 0.0 0
M  V30 31 C 13.0901 5.3347 0.0 0
M  V30 32 N 14.6301 5.3347 0.0 0
M  V30 33 C 15.5353 4.0889 0.0 0
M  V30 34 N 15.5353 6.5806 0.0 0
M  V30 35 N 16.9998 4.5647 0.0 0
M  V30 36 C 16.9998 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 26
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 1 13 28
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 31 32
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1423167-86-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1423167-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5058290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 8: Synthesis of
2-[[2-(3-chloro-2-pyridyl)-4-(trifluoromethyl)benzoyl]amino]-N,3-dimethyl-5-(1,2,4-triazol-1-yl)benzamide
To a solution of
2-[2-(3-chloro-2-pyridyl)-4-(trifluoromethyl)phenyl]-8-methyl-6-(1,2,4-triazol-1-yl)-3,1-benzoxazin-4-one
(i.e. the product of Step 7, 300 mg, 0.620 mmol) in THF (12 mL) was added
a solution of methylamine (1.0 mL of a 2 M solution in THF, 2 mmol, 3.2
equiv.) at room temperature. After 2 h, the mixture was concentrated in
vacuo and the residue was triturated with ethyl acetate/ diethyl ether to
obtain the title compound. Yield 287 mg, 90%. Characterization by HPLC-MS
(method A): 2.951 min, M = 514.95.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of anthranilamide compounds and their use as pesticides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaiser, Florian; Deshmukh, Prashant; Koerber, Karsten; Von Deyn,
Wolfgang; Kordes, Markus; Dickhaut, Joachim; Narine, Arun; Bandur, Nina
Gertrud; Veitch, Gemma; Culbertson, Deborah L.; Neese, Paul; Gunjima,
Koshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013024005 A1 2013-02-21

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[C(E)]-2-[2-(3-Chloro-2-pyridinyl)-4-(trifluoromethyl)phenyl]-8-methyl-4-oxo-...
C23H15ClF3N3O3
1423167-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.8500 1.3336 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 F 1.5400 6.8747 0.0 0
M  V30 4 F 0.0000 5.3347 0.0 0
M  V30 5 F 1.5400 3.7947 0.0 0
M  V30 6 O 10.7800 2.6674 0.0 0
M  V30 7 C 10.0100 9.3358 0.0 0
M  V30 8 C 14.6300 6.6684 0.0 0
M  V30 9 N 15.4000 8.0021 0.0 0
M  V30 10 O 16.9400 8.0021 0.0 0
M  V30 11 C 17.7100 9.3358 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 6.6684 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.8500 6.6684 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 N 8.4700 6.6684 0.0 0
M  V30 20 O 8.4700 4.0011 0.0 0
M  V30 21 C 10.0100 6.6684 0.0 0
M  V30 22 C 10.0100 4.0011 0.0 0
M  V30 23 C 10.7800 5.3347 0.0 0
M  V30 24 C 10.7800 8.0021 0.0 0
M  V30 25 C 12.3200 5.3347 0.0 0
M  V30 26 C 12.3200 8.0021 0.0 0
M  V30 27 C 13.0900 6.6684 0.0 0
M  V30 28 C 6.1600 2.6674 0.0 0
M  V30 29 C 5.3900 1.3336 0.0 0
M  V30 30 N 7.7000 2.6674 0.0 0
M  V30 31 C 6.1600 0.0000 0.0 0
M  V30 32 C 8.4700 1.3336 0.0 0
M  V30 33 C 7.7000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 17
M  V30 6 2 6 22
M  V30 7 1 7 24
M  V30 8 2 8 9
M  V30 9 1 8 27
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 13 28
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 23
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(3-Chloro-2-pyridinyl)-4-(trifluoromethyl)benzoyl]amino]-5-[(E)-(methox...
C24H20ClF3N4O3
1423167-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0
M  V30 2 N 8.4700 5.3347 0.0 0
M  V30 3 O 8.4700 8.0020 0.0 0
M  V30 4 Cl 3.8500 10.6694 0.0 0
M  V30 5 C 1.5400 6.6684 0.0 0
M  V30 6 F 1.5400 8.2084 0.0 0
M  V30 7 F 0.0000 6.6684 0.0 0
M  V30 8 F 1.5400 5.1284 0.0 0
M  V30 9 C 10.0100 2.6673 0.0 0
M  V30 10 N 10.7800 1.3336 0.0 0
M  V30 11 O 8.4700 2.6673 0.0 0
M  V30 12 C 10.0100 0.0000 0.0 0
M  V30 13 C 10.0100 8.0020 0.0 0
M  V30 14 C 14.6300 5.3347 0.0 0
M  V30 15 N 15.4000 4.0011 0.0 0
M  V30 16 O 16.9400 4.0011 0.0 0
M  V30 17 C 17.7100 2.6673 0.0 0
M  V30 18 C 5.3900 8.0020 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0
M  V30 20 C 3.8500 8.0020 0.0 0
M  V30 21 C 5.3900 5.3347 0.0 0
M  V30 22 C 3.0800 6.6684 0.0 0
M  V30 23 C 3.8500 5.3347 0.0 0
M  V30 24 C 6.1600 9.3358 0.0 0
M  V30 25 C 5.3900 10.6694 0.0 0
M  V30 26 N 7.7000 9.3358 0.0 0
M  V30 27 C 6.1600 12.0031 0.0 0
M  V30 28 C 8.4700 10.6694 0.0 0
M  V30 29 C 7.7000 12.0031 0.0 0
M  V30 30 C 10.0100 5.3347 0.0 0
M  V30 31 C 10.7800 4.0011 0.0 0
M  V30 32 C 10.7800 6.6684 0.0 0
M  V30 33 C 12.3200 4.0011 0.0 0
M  V30 34 C 12.3200 6.6684 0.0 0
M  V30 35 C 13.0900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 30
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 22
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 31
M  V30 13 1 10 12
M  V30 14 1 13 32
M  V30 15 2 14 15
M  V30 16 1 14 35
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1423167-87-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1423167-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12416573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4: Synthesis of
2-[[2-(3-chloro-2-pyridyl)-4-(trifluoromethyl)benzoyl]amino]-5-[(E)-methoxyiminomethyl]-N,3-dimethyl-benzamide
To a solution of
2-[2-(3-chloro-2-pyridyl)-4-(trifluoromethyl)phenyl]-6-[(E)-methoxyiminomethyl]-8-methyl-3,1-benzoxazin-4-one
(i.e. the product of Step 3, 0.33 mg, 0.70 mmol) in THF (8 mL) was added
a solution of methylamine (1.0 mL of a 2 M solution in THF, 2.0 mmol,
2.87 equiv.) at room temperature. After 4 h, the mixture was concentrated
in vacuo and the residue was triturated with diethyl ether to obtain the
title compound. Yield 18 mg, 90%. Characterization by HPLC-MS (method A):
3.417 min, M = 505.00.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of anthranilamide compounds and their use as pesticides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaiser, Florian; Deshmukh, Prashant; Koerber, Karsten; Von Deyn,
Wolfgang; Kordes, Markus; Dickhaut, Joachim; Narine, Arun; Bandur, Nina
Gertrud; Veitch, Gemma; Culbertson, Deborah L.; Neese, Paul; Gunjima,
Koshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013024005 A1 2013-02-21

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-oxo-2H-1-benzopyran-7-yl 4-nitrobenzenesulfonate
C16H10ClNO7S
1427203-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 O 8.4702 4.0012 0.0 0
M  V30 4 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 5 O 10.0102 6.6687 0.0 0
M  V30 6 O 7.9065 6.1048 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 N 14.5750 2.2548 0.0 0 VAL=5
M  V30 9 O 15.9089 3.0248 0.0 0
M  V30 10 O 14.5750 0.7147 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 3.8501 4.0012 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 6.9302 4.0012 0.0 0
M  V30 18 C 2.3101 1.3338 0.0 0
M  V30 19 C 1.5400 2.6675 0.0 0
M  V30 20 C 6.1601 5.3348 0.0 0
M  V30 21 C 10.5740 4.5648 0.0 0
M  V30 22 C 10.5740 3.0248 0.0 0
M  V30 23 C 11.9077 5.3348 0.0 0
M  V30 24 C 11.9077 2.2548 0.0 0
M  V30 25 C 13.2414 4.5648 0.0 0
M  V30 26 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 2 7 18
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 1 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl 4-nitrobe...
C17H14N2O7S
1427203-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2890 3.9967 0.0 0
M  V30 2 C 2.6091 5.5030 0.0 0
M  V30 3 N 1.4647 6.5334 0.0 0
M  V30 4 O 4.0739 5.9789 0.0 0
M  V30 5 C 0.0000 6.0576 0.0 0
M  V30 6 O 9.5599 3.2863 0.0 0
M  V30 7 S 10.3299 4.6201 0.0 0 VAL=6
M  V30 8 O 11.0999 5.9538 0.0 0
M  V30 9 O 8.9963 5.3901 0.0 0
M  V30 10 N 15.6648 1.5400 0.0 0 VAL=5
M  V30 11 O 16.9986 2.3101 0.0 0
M  V30 12 O 15.6648 0.0000 0.0 0
M  V30 13 C 5.7098 1.9526 0.0 0
M  V30 14 C 4.9398 3.2863 0.0 0
M  V30 15 C 7.2499 1.9526 0.0 0
M  V30 16 O 4.6794 0.8082 0.0 0
M  V30 17 C 3.4335 2.9661 0.0 0
M  V30 18 C 5.7098 4.6201 0.0 0
M  V30 19 C 8.0199 3.2863 0.0 0
M  V30 20 C 3.2726 1.4345 0.0 0
M  V30 21 C 7.2499 4.6201 0.0 0
M  V30 22 C 11.6638 3.8501 0.0 0
M  V30 23 C 11.6638 2.3101 0.0 0
M  V30 24 C 12.9974 4.6201 0.0 0
M  V30 25 C 12.9974 1.5400 0.0 0
M  V30 26 C 14.3311 3.8501 0.0 0
M  V30 27 C 14.3311 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14660609
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-3-[2-(Methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
4-Nitrobenzenesulfonate (26). 26 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 20% → 80%). Yield: 90%. 1H
NMR (300 MHz, DMSO-d6) δ: 2.64 (d, J = 4.7 Hz, 3H), 5.24 (d, J = 2.5 Hz,
2H), 5.86 (t, J = 2.5 Hz, 1H), 6.56 (dd, J1 = 2.2 Hz, J2 = 8.5 Hz, 1H),
6.74 (d, J = 2.2 Hz, 1H), 8.04 (br q, J = 4.7 Hz, 1H, disappears with
D2O), 8.13-8.18 (m, 2H), 8.41-8.45 (m, 2H), 8.87 (d, J = 8.5 Hz, 1H).
IC50 ± SD (nM), MAO-A: 37 ± 2.9; MAO-B: 13%. Calculated: C 52.30, H 3.61,
N 7.18; Found: C 52.59, H 3.68, N 7.32.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-8-methyl-2-oxo-2H-1-benzopyran-7-yl 4-cyanobenzenesulfonate
C18H12ClNO5S
1427203-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 C 6.9302 1.3338 0.0 0
M  V30 4 O 8.4702 4.0012 0.0 0
M  V30 5 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 6 O 10.0102 6.6687 0.0 0
M  V30 7 O 7.9065 6.1048 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 C 14.5750 2.2548 0.0 0
M  V30 10 N 15.9089 1.4847 0.0 0
M  V30 11 C 3.8501 4.0012 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 6.1601 2.6675 0.0 0
M  V30 16 O 3.8501 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 18 C 6.1601 5.3348 0.0 0
M  V30 19 C 6.9302 4.0012 0.0 0
M  V30 20 C 2.3101 1.3338 0.0 0
M  V30 21 C 10.5740 4.5648 0.0 0
M  V30 22 C 10.5740 3.0248 0.0 0
M  V30 23 C 11.9077 5.3348 0.0 0
M  V30 24 C 11.9077 2.2548 0.0 0
M  V30 25 C 13.2414 4.5648 0.0 0
M  V30 26 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 2 8 20
M  V30 10 3 9 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-7-methyl-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl ...
C19H16N2O5S
1427203-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0127 1.7270 0.0 0
M  V30 2 C 2.5367 3.1917 0.0 0
M  V30 3 N 1.0304 3.5118 0.0 0
M  V30 4 O 3.5673 4.3360 0.0 0
M  V30 5 C 0.0000 2.3673 0.0 0
M  V30 6 C 9.6644 1.6672 0.0 0
M  V30 7 O 9.6644 4.7472 0.0 0
M  V30 8 S 9.6644 6.2872 0.0 0 VAL=6
M  V30 9 O 9.6644 7.8272 0.0 0
M  V30 10 O 8.1244 6.2872 0.0 0
M  V30 11 C 15.8244 6.2872 0.0 0
M  V30 12 N 17.3644 6.2872 0.0 0
M  V30 13 C 5.6635 2.4372 0.0 0
M  V30 14 C 6.9971 1.6672 0.0 0
M  V30 15 C 4.5190 1.4068 0.0 0
M  V30 16 C 5.6635 3.9772 0.0 0
M  V30 17 C 8.3308 2.4372 0.0 0
M  V30 18 O 6.6770 0.1609 0.0 0
M  V30 19 C 5.1453 0.0000 0.0 0
M  V30 20 C 6.9971 4.7472 0.0 0
M  V30 21 C 8.3308 3.9772 0.0 0
M  V30 22 C 11.2044 6.2872 0.0 0
M  V30 23 C 11.9744 4.9536 0.0 0
M  V30 24 C 11.9744 7.6210 0.0 0
M  V30 25 C 13.5144 4.9536 0.0 0
M  V30 26 C 13.5144 7.6210 0.0 0
M  V30 27 C 14.2844 6.2872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 21
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 3 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14050322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-7-Methyl-3-[2-(methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
4-Cyanobenzenesulfonate (33). 33 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 20% → 90%). Yield: 90%. 1H
NMR (300 MHz, DMSO-d6) δ: 1.88 (s, 3H), 2.64 (d, J = 4.7 Hz, 3H), 5.25
(d, J = 2.5 Hz, 2H), 5.85 (t, J = 2.5 Hz, 1H), 6.49 (d, J = 8.8 Hz, 1H),
8.02 (br q, J = 4.7 Hz, 1H, disappears with D2O), 8.08 (d, J = 8.5 Hz,
2H), 8.17 (d, J = 8.5 Hz, 2H), 8.69 (d, J = 8.8 Hz, 1H). IC50 ± SD (nM),
MAO-A: 15 ± 2.7; MAO-B: 6 ± 0.5%. Calculated: C 59.37, H 4.20, N 7.29;
Found: C 59.50, H 4.44, N 7.32.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS)-4-(diethoxyphosphinyl)-α-[[(1,1-dimethylethoxy)carbonyl]amino]-1H...
C15H27N4O7P
1427557-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 3.3420 7.0100 0.0 0 VAL=5
M  V30 2 O 2.0961 7.9152 0.0 0
M  V30 3 O 2.4368 5.7641 0.0 0
M  V30 4 O 4.2472 8.2558 0.0 0
M  V30 5 C 2.2570 9.4467 0.0 0
M  V30 6 C 0.9052 5.9250 0.0 0
M  V30 7 C 1.0112 10.3519 0.0 0
M  V30 8 C 0.0000 4.6792 0.0 0
M  V30 9 C 8.4978 5.3347 0.0 0
M  V30 10 C 9.2678 4.0011 0.0 0 CFG=1
M  V30 11 N 10.8078 4.0011 0.0 0
M  V30 12 C 8.4978 2.6674 0.0 0
M  V30 13 C 11.5778 5.3347 0.0 0
M  V30 14 O 9.2678 1.3336 0.0 0
M  V30 15 O 6.9578 2.6674 0.0 0
M  V30 16 O 13.1178 5.3347 0.0 0
M  V30 17 O 10.8078 6.6684 0.0 0
M  V30 18 C 8.4978 0.0000 0.0 0
M  V30 19 C 13.8878 6.6684 0.0 0
M  V30 20 C 15.2214 5.8984 0.0 0
M  V30 21 C 14.6578 8.0022 0.0 0
M  V30 22 C 12.5540 7.4384 0.0 0
M  V30 23 C 4.5878 6.1047 0.0 0
M  V30 24 C 6.0525 6.5806 0.0 0
M  V30 25 N 4.5878 4.5647 0.0 0
M  V30 26 N 6.9578 5.3347 0.0 0
M  V30 27 N 6.0525 4.0889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 23
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[[4-(diethoxyphosphinyl)-1H-1,2,3-triazol-1-yl]me...
C15H28N5O6P
1427557-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 3.3420 7.0100 0.0 0 VAL=5
M  V30 2 O 2.0961 7.9152 0.0 0
M  V30 3 O 2.4368 5.7641 0.0 0
M  V30 4 O 4.2472 8.2558 0.0 0
M  V30 5 C 2.2570 9.4467 0.0 0
M  V30 6 C 0.9052 5.9250 0.0 0
M  V30 7 C 1.0112 10.3519 0.0 0
M  V30 8 C 0.0000 4.6792 0.0 0
M  V30 9 C 8.4978 5.3347 0.0 0
M  V30 10 C 9.2678 4.0011 0.0 0 CFG=1
M  V30 11 N 10.8078 4.0011 0.0 0
M  V30 12 C 8.4978 2.6674 0.0 0
M  V30 13 C 11.5778 5.3347 0.0 0
M  V30 14 N 9.2678 1.3336 0.0 0
M  V30 15 O 6.9578 2.6674 0.0 0
M  V30 16 O 13.1178 5.3347 0.0 0
M  V30 17 O 10.8078 6.6684 0.0 0
M  V30 18 C 8.4978 0.0000 0.0 0
M  V30 19 C 13.8878 6.6684 0.0 0
M  V30 20 C 15.2214 5.8984 0.0 0
M  V30 21 C 14.6578 8.0022 0.0 0
M  V30 22 C 12.5540 7.4384 0.0 0
M  V30 23 C 4.5878 6.1047 0.0 0
M  V30 24 C 6.0525 6.5806 0.0 0
M  V30 25 N 4.5878 4.5647 0.0 0
M  V30 26 N 6.9578 5.3347 0.0 0
M  V30 27 N 6.0525 4.0889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 23
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 1 10 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 16 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427557-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427557-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10887584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-t-Butyl
3-(4-(diethoxyphosphoryl)-1H-1,2,3-triazol-1-yl)-1-(methylamino)-1-oxopropan-2-ylcarbamate
[Boc-4-PO(OEt)2Tza-NHMe] (14) Thirty-three percentage aqueous methylamine
(3.0 mL, 31 mmol) was added to a solution of triazole 12a (0.30 g, 0.74
mmol) in MeOH (5 mL). The solution was stirred at room temperature for 4
h, then the volatiles were evaporated, and the residue was subjected to
flash chromatography. Elution withMeOH/DCM (1:10) gave 14. Pale yellow
oil, yield 270 mg, 90%. Rf = 0.20 (MeOH/DCM 1:9). IR (thin film) cm-1:
3,305 (NH), 1,712 (OC=O), 1,666 (NC=O). 1H NMR (500 MHz, CD3OD): δ 8.39
(s, 1H, triazolyl), 4.92 (dd, 1H,J = 12.5 Hz, 3.0 Hz, α -H), 4.63 (m, 2H,
β -H), 4.14 (m, 4H, 2 x OCH2CH3), 2.70 (s, 1H, CONHCH3), 1.32 (s, 9H,
t-Bu), 1.288 (t, 3H, J = 7.0 Hz, OCH2CH3a), 1.287 (t, 3H, J = 7.0 Hz,
OCH2CH3b). 13C NMR (125 MHz, CD3OD): δ 171.3 (CO2), 157.1 (NCO2), 137.4
(d, JC,P = 242.2 Hz, CP), 133.5 (d, JC,P = 33.2 Hz, triazolyl CH), 81.0,
64.45 (d, JC,P = 4.2 Hz, OCH2CH3a), 64.50 (d, JC,P = 4.2 Hz, OCH2CH3b),
55.7, 52.3, 28.6, 26.5, 16.6 (d, JC,P = 6.5 Hz, OCH2CH3). 31P NMR (120
MHz, CD3OD): δ 8.73.MS (ESI) m/z: 406[M+H]+, 428[M+Na]+. HRMS (ESI):
observed, 406.1855, [C15H28N5O6P+H]+ requires 406.1850. [α]D = -5.4° (c
1.0, MeOH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable triazolylphosphonate analogues of phosphohistidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mukai, Shin; Flematti, Gavin R.; Byrne, Lindsay T.; Besant, Paul G.;
Attwood, Paul V.; Piggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2012), 43(2), 857-874

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl [C(Z)]-N′-cyano-N-[[(1S,3R,5S,6R)-3-(5-oxazolyl)-2-oxabicyclo[3.1.0]he...
C12H14N4O2S
1440426-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.1535 4.0011 0.0 0
M  V30 2 N 9.9235 2.6673 0.0 0
M  V30 3 C 11.4635 2.6673 0.0 0
M  V30 4 N 12.2335 4.0011 0.0 0
M  V30 5 S 12.2335 1.3336 0.0 0
M  V30 6 C 13.7735 4.0011 0.0 0
M  V30 7 C 11.4635 0.0000 0.0 0
M  V30 8 N 15.3135 4.0011 0.0 0
M  V30 9 C 6.2797 3.2311 0.0 0 CFG=1
M  V30 10 C 6.2797 4.7711 0.0 0 CFG=2
M  V30 11 C 7.6135 4.0011 0.0 0 CFG=2
M  V30 12 C 4.8151 2.7551 0.0 0
M  V30 13 O 4.8151 5.2469 0.0 0
M  V30 14 C 3.9099 4.0011 0.0 0 CFG=2
M  V30 15 C 2.3699 4.0011 0.0 0
M  V30 16 C 1.4647 2.7551 0.0 0
M  V30 17 O 1.4647 5.2469 0.0 0
M  V30 18 N 0.0000 3.2311 0.0 0
M  V30 19 C 0.0000 4.7711 0.0 0
M  V30 20 H 6.9061 1.8241 0.0 0
M  V30 21 H 6.9061 6.1779 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 20 CFG=1
M  V30 13 1 10 11
M  V30 14 1 10 13
M  V30 15 1 10 21 CFG=1
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 14 15 CFG=3
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[C(E)]-N′′-Cyano-N-methyl-N′-[[(1S,3R,5S,6R)-3-(5-oxazolyl)-2-oxabicyclo[3.1....
C12H15N5O2
1440426-20-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.1535 4.0011 0.0 0
M  V30 2 N 9.9235 2.6673 0.0 0
M  V30 3 C 11.4635 2.6673 0.0 0
M  V30 4 N 12.2335 4.0011 0.0 0
M  V30 5 N 12.2335 1.3336 0.0 0
M  V30 6 C 13.7735 4.0011 0.0 0
M  V30 7 C 11.4635 0.0000 0.0 0
M  V30 8 N 15.3135 4.0011 0.0 0
M  V30 9 C 6.2797 3.2311 0.0 0 CFG=1
M  V30 10 C 6.2797 4.7711 0.0 0 CFG=2
M  V30 11 C 7.6135 4.0011 0.0 0 CFG=2
M  V30 12 C 4.8151 2.7551 0.0 0
M  V30 13 O 4.8151 5.2469 0.0 0
M  V30 14 C 3.9099 4.0011 0.0 0 CFG=2
M  V30 15 C 2.3699 4.0011 0.0 0
M  V30 16 C 1.4647 2.7551 0.0 0
M  V30 17 O 1.4647 5.2469 0.0 0
M  V30 18 N 0.0000 3.2311 0.0 0
M  V30 19 C 0.0000 4.7711 0.0 0
M  V30 20 H 6.9061 1.8241 0.0 0
M  V30 21 H 6.9061 6.1779 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 3 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 20 CFG=1
M  V30 13 1 10 11
M  V30 14 1 10 13
M  V30 15 1 10 21 CFG=1
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 14 15 CFG=3
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1440426-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1440426-20-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13999538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and pharmacological characterization of new tetrahydrofuran
based compounds as conformationally constrained histamine receptor
ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bodensteiner, Julian; Baumeister, Paul; Geyer, Roland; Buschauer, Armin;
Reiser, Oliver
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(24), 4040-4055

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(5-Amino-2,4-difluorophenyl)-7-chloro-1-(1-methylethyl)-1,6-naphthyridin-2(...
C17H14ClF2N3O
1442470-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 1.3338 0.0 0
M  V30 2 C 2.3100 1.3338 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 6.9300 1.3338 0.0 0
M  V30 5 Cl 0.0000 5.3347 0.0 0
M  V30 6 F 8.4700 6.6685 0.0 0
M  V30 7 N 11.5500 1.3338 0.0 0
M  V30 8 F 13.0900 4.0011 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 N 4.6200 2.6674 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 3.8500 6.6685 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 1.5400 5.3347 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 N 2.3100 6.6685 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 9.2400 2.6674 0.0 0
M  V30 22 C 10.7800 5.3347 0.0 0
M  V30 23 C 10.7800 2.6674 0.0 0
M  V30 24 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 4 15
M  V30 5 1 5 16
M  V30 6 1 6 20
M  V30 7 1 7 23
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(5-Amino-2,4-difluorophenyl)-7-(methylamino)-1-(1-methylethyl)-1,6-naphthyr...
C18H18F2N4O
1442470-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 C 3.0800 1.3338 0.0 0
M  V30 3 C 5.3900 0.0000 0.0 0
M  V30 4 O 7.7000 1.3338 0.0 0
M  V30 5 N 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 F 9.2400 6.6685 0.0 0
M  V30 8 N 12.3200 1.3338 0.0 0
M  V30 9 F 13.8600 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 5.3900 5.3347 0.0 0
M  V30 12 N 5.3900 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 4.6200 6.6685 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 N 3.0800 6.6685 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.0100 2.6674 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 11.5500 2.6674 0.0 0
M  V30 25 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 2 4 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 21
M  V30 8 1 8 24
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1442470-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1442470-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6077119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydronaphthyridines and related compounds useful as
kinase inhibitors for the treatment of proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Kaufman, Michael D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013184119 A1 2013-12-12

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(5-Amino-2,4-difluorophenyl)-7-chloro-1-(1-methylethyl)-1,6-naphthyridin-2(...
C17H14ClF2N3O
1442470-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 1.3338 0.0 0
M  V30 2 C 2.3100 1.3338 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 6.9300 1.3338 0.0 0
M  V30 5 Cl 0.0000 5.3347 0.0 0
M  V30 6 F 8.4700 6.6685 0.0 0
M  V30 7 N 11.5500 1.3338 0.0 0
M  V30 8 F 13.0900 4.0011 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 N 4.6200 2.6674 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 3.8500 6.6685 0.0 0
M  V30 15 C 6.1600 2.6674 0.0 0
M  V30 16 C 1.5400 5.3347 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 N 2.3100 6.6685 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 9.2400 2.6674 0.0 0
M  V30 22 C 10.7800 5.3347 0.0 0
M  V30 23 C 10.7800 2.6674 0.0 0
M  V30 24 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 4 15
M  V30 5 1 5 16
M  V30 6 1 6 20
M  V30 7 1 7 23
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(5-Amino-2,4-difluorophenyl)-7-(methylamino)-1-(1-methylethyl)-1,6-naphthyr...
C18H18F2N4O
1442470-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 C 3.0800 1.3338 0.0 0
M  V30 3 C 5.3900 0.0000 0.0 0
M  V30 4 O 7.7000 1.3338 0.0 0
M  V30 5 N 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 F 9.2400 6.6685 0.0 0
M  V30 8 N 12.3200 1.3338 0.0 0
M  V30 9 F 13.8600 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 5.3900 5.3347 0.0 0
M  V30 12 N 5.3900 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 4.6200 6.6685 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 N 3.0800 6.6685 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.0100 2.6674 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 11.5500 2.6674 0.0 0
M  V30 25 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 2 4 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 21
M  V30 8 1 8 24
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1442470-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1442470-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4750447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A mixture of Example A24 (4 g, 11.5 mmol) and methylamine (30 mL) was
heated to 100°C. in a sealed vessel for 12 h, then cooled to RT. The
mixture was concentrated and residue was washed with EtOAc to give
3-(5-amino-2,4-difluorophenyl)-1-isopropy7-(methylamino)-1,6-naphthyridin-2(1H)-one.
Yield (3.5 g, 90%). 1H NMR (400 MHz, DMSO-d6), δ 8.40 (s, 1H), 7.70 (s,
1H), 7.05 (t, J=10 Hz, 1H), 6.98 (m, 1H), 6.81 (t, J=7.6 Hz, 1H), 6.45
(s, 1H), 5.10 (br s, 1H), 5.06 (s, 2H), 2.87 (d, J=4.8 Hz, 3H), 1.53 (d,
J=6.8 Hz, 6H); MS (ESI) m/z: 345.1 [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dihydronaphthyridines and related compounds useful as
kinase inhibitors for the treatment of proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Kaufman, Michael D.; Petillo, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US8461179 B1 2013-06-11

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-1,3-diphenyl-2,4(1H,3H)-quinolinedione
C21H14ClNO2
144603-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6513 6.6685 0.0 0
M  V30 2 Cl 4.6088 6.8513 0.0 0
M  V30 3 O 2.0313 4.0011 0.0 0
M  V30 4 N 6.6513 4.0011 0.0 0
M  V30 5 C 5.8813 2.6674 0.0 0
M  V30 6 C 5.8813 5.3347 0.0 0
M  V30 7 C 4.3413 2.6674 0.0 0
M  V30 8 C 6.6513 1.3338 0.0 0
M  V30 9 C 4.3413 5.3347 0.0 0
M  V30 10 C 3.5713 4.0011 0.0 0
M  V30 11 C 3.5713 1.3338 0.0 0
M  V30 12 C 5.8813 0.0000 0.0 0
M  V30 13 C 4.3413 0.0000 0.0 0
M  V30 14 C 8.1913 4.0011 0.0 0
M  V30 15 C 8.9613 5.3347 0.0 0
M  V30 16 C 8.9613 2.6674 0.0 0
M  V30 17 C 10.5013 5.3347 0.0 0
M  V30 18 C 10.5013 2.6674 0.0 0
M  V30 19 C 11.2713 4.0011 0.0 0
M  V30 20 C 2.8941 5.8614 0.0 0
M  V30 21 C 1.7145 4.8716 0.0 0
M  V30 22 C 2.6268 7.3781 0.0 0
M  V30 23 C 0.2673 5.3983 0.0 0
M  V30 24 C 1.1796 7.9048 0.0 0
M  V30 25 C 0.0000 6.9149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 9
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 9 20
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-1,3-diphenyl-2,4(1H,3H)-quinolinedione
C22H18N2O2
2035485-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6088 6.8513 0.0 0
M  V30 2 C 6.0559 7.3781 0.0 0
M  V30 3 O 6.6513 6.6685 0.0 0
M  V30 4 O 2.0313 4.0011 0.0 0
M  V30 5 C 4.3413 5.3347 0.0 0
M  V30 6 C 5.8813 5.3347 0.0 0
M  V30 7 C 3.5713 4.0011 0.0 0
M  V30 8 N 6.6513 4.0011 0.0 0
M  V30 9 C 4.3413 2.6674 0.0 0
M  V30 10 C 5.8813 2.6674 0.0 0
M  V30 11 C 3.5713 1.3338 0.0 0
M  V30 12 C 6.6513 1.3338 0.0 0
M  V30 13 C 4.3413 0.0000 0.0 0
M  V30 14 C 5.8813 0.0000 0.0 0
M  V30 15 C 2.8941 5.8614 0.0 0
M  V30 16 C 2.6268 7.3781 0.0 0
M  V30 17 C 1.7145 4.8716 0.0 0
M  V30 18 C 1.1796 7.9048 0.0 0
M  V30 19 C 0.2673 5.3983 0.0 0
M  V30 20 C 0.0000 6.9149 0.0 0
M  V30 21 C 8.1913 4.0011 0.0 0
M  V30 22 C 8.9613 2.6674 0.0 0
M  V30 23 C 8.9613 5.3347 0.0 0
M  V30 24 C 10.5013 2.6674 0.0 0
M  V30 25 C 10.5013 5.3347 0.0 0
M  V30 26 C 11.2713 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 21
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144603-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2035485-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16453123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,4-Benzodiazepine-2,5-diones by Base Promoted Ring
Expansion of 3-Aminoquinoline-2,4-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kremen, Filip; Gazvoda, Martin; Kafka, Stanislav; Proisl, Karel;
Srholcova, Anna; Klasek, Antonin; Urankar, Damijana; Kosmrlj, Janez
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(1), 715-722

$RFMT $RIREG SCHEME109 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1R)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6675 1.5400 0.0 0
M  V30 5 Cl 2.6675 0.0000 0.0 0
M  V30 6 C 6.6686 3.8500 0.0 0
M  V30 7 C 8.0022 4.6200 0.0 0
M  V30 8 C 6.6686 2.3100 0.0 0
M  V30 9 C 9.3359 3.8500 0.0 0
M  V30 10 C 8.3224 6.1263 0.0 0
M  V30 11 C 8.0022 1.5400 0.0 0
M  V30 12 S 10.4804 4.8804 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 9.8539 6.2874 0.0 0
M  V30 15 C 2.6675 4.6200 0.0 0
M  V30 16 C 1.3338 3.8500 0.0 0
M  V30 17 C 2.6675 6.1600 0.0 0
M  V30 18 C 0.0000 4.6200 0.0 0
M  V30 19 C 1.3338 6.9300 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Oxalic acid
C2H2O4
144-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamine, γ-(benzo[b]thien-4-yloxy)-N-methyl-, ethanedioate (1:1), ...
C18H19NOS.C2H2O4
476200-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 9.3912 0.0 0
M  V30 2 C 4.6200 9.3912 0.0 0 CFG=1
M  V30 3 C 3.8500 10.7248 0.0 0
M  V30 4 C 2.3100 10.7248 0.0 0
M  V30 5 N 1.5400 12.0586 0.0 0
M  V30 6 C 0.0000 12.0586 0.0 0
M  V30 7 C 6.9300 10.7248 0.0 0
M  V30 8 C 8.4700 10.7248 0.0 0
M  V30 9 C 6.1600 12.0586 0.0 0
M  V30 10 C 9.2400 12.0586 0.0 0
M  V30 11 C 9.5004 9.5804 0.0 0
M  V30 12 C 6.9300 13.3922 0.0 0
M  V30 13 S 10.7463 11.7383 0.0 0
M  V30 14 C 8.4700 13.3922 0.0 0
M  V30 15 C 10.9072 10.2067 0.0 0
M  V30 16 C 3.8500 8.0575 0.0 0
M  V30 17 C 2.3100 8.0575 0.0 0
M  V30 18 C 4.6200 6.7237 0.0 0
M  V30 19 C 1.5400 6.7237 0.0 0
M  V30 20 C 3.8500 5.3901 0.0 0
M  V30 21 C 2.3100 5.3901 0.0 0
M  V30 22 C 6.1204 1.5400 0.0 0
M  V30 23 C 4.7868 2.3101 0.0 0
M  V30 24 O 7.4541 2.3101 0.0 0
M  V30 25 O 6.1204 0.0000 0.0 0
M  V30 26 O 4.7868 3.8501 0.0 0
M  V30 27 O 3.4531 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 23 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-63-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 144-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476200-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1844083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-(heteroaryloxy)propanamines as serotonin and
norepinephrine reuptake inhibitors for treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallagher, Peter Thaddeus; Rathmell, Richard Edmund; Fagan, Maria Ann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002094262 A1 2002-11-28

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-cyclopropyl-4H-3,1-benzoxazin-4-one
C11H8BrNO2
1447250-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9536 0.0000 0.0 0
M  V30 2 Br 9.8036 4.0011 0.0 0
M  V30 3 C 2.8736 2.6674 0.0 0
M  V30 4 N 3.6436 4.0011 0.0 0
M  V30 5 O 3.6436 1.3338 0.0 0
M  V30 6 C 5.1836 4.0011 0.0 0
M  V30 7 C 5.1836 1.3338 0.0 0
M  V30 8 C 5.9536 2.6674 0.0 0
M  V30 9 C 5.9536 5.3349 0.0 0
M  V30 10 C 7.4936 2.6674 0.0 0
M  V30 11 C 7.4936 5.3349 0.0 0
M  V30 12 C 8.2636 4.0011 0.0 0
M  V30 13 C 1.3336 2.6674 0.0 0
M  V30 14 C 0.0000 1.8974 0.0 0
M  V30 15 C 0.0000 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 8
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 5-bromo-2-[(cyclopropylcarbonyl)amino]-N-methyl-
C12H13BrN2O2
2919020-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.6436 5.3347 0.0 0
M  V30 2 C 2.8736 6.6685 0.0 0
M  V30 3 O 3.6436 8.0021 0.0 0
M  V30 4 C 5.1836 2.6674 0.0 0
M  V30 5 N 5.9536 1.3336 0.0 0
M  V30 6 O 3.6436 2.6674 0.0 0
M  V30 7 C 5.1836 0.0000 0.0 0
M  V30 8 Br 9.8036 5.3347 0.0 0
M  V30 9 C 5.1836 5.3347 0.0 0
M  V30 10 C 5.9536 4.0011 0.0 0
M  V30 11 C 5.9536 6.6685 0.0 0
M  V30 12 C 7.4936 4.0011 0.0 0
M  V30 13 C 7.4936 6.6685 0.0 0
M  V30 14 C 8.2636 5.3347 0.0 0
M  V30 15 C 1.3336 6.6685 0.0 0
M  V30 16 C 0.0000 5.8985 0.0 0
M  V30 17 C 0.0000 7.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 1 5 7
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447250-61-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919020-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35751410
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of New Quinazolin-4-one Derivatives with Negative
mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaczorowska, Katarzyna; Stankiewicz, Anna; Bugno, Ryszard; Paluchowska,
Maria H.; Burnat, Grzegorz; Branski, Piotr; Cieslik, Paulina; Wieronska,
Joanna M.; Milik, Mariusz; Nowak, Mateusz; Przybylowicz, Agnieszka;
Koziol, Aneta; Hogendorf, Agata; Hogendorf, Adam S.; Kalinowska-Tluscik,
Justyna; Duszynska, Beata; Pilc, Andrzej; Bojarski, Andrzej J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2023), 24(3), 1981

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1-Bromo-2,2-diethoxyethyl)benzene
C12H17BrO2
14492-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 O 4.6200 2.6674 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 Br 5.3900 6.6685 0.0 0
M  V30 6 C 5.3900 1.3338 0.0 0
M  V30 7 C 7.7000 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 0.7700 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 10
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(Diethoxymethyl)-N-methylbenzenemethanamine
C13H21NO2
1503643-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 3.8500 0.0 0
M  V30 3 N 4.0011 6.1601 0.0 0
M  V30 4 O 6.6684 4.6201 0.0 0
M  V30 5 O 5.3348 2.3100 0.0 0
M  V30 6 C 2.6675 6.9301 0.0 0
M  V30 7 C 8.0022 3.8500 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 C 9.3359 4.6201 0.0 0
M  V30 10 C 6.6684 0.0000 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14492-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1503643-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16433821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kohn, Leonard D.; Curley, Robert W.; Rice, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000012175 A2 2000-03-09

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-c]pyridine-2-carboxylic acid, 4-bromo-, methyl ester
C9H6BrNO2S
145325-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.5772 3.0801 0.0 0
M  V30 3 O 7.3472 4.4137 0.0 0
M  V30 4 O 7.3472 1.7464 0.0 0
M  V30 5 C 8.8872 4.4137 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 S 4.1321 4.3260 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 4.1321 1.8342 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 5.0371 3.0801 0.0 0
M  V30 13 N 0.0000 3.8501 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylthieno[2,3-c]pyridine-2-carboxamide
C9H7BrN2OS
1009104-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.5772 3.0801 0.0 0
M  V30 3 N 7.3472 4.4137 0.0 0
M  V30 4 O 7.3472 1.7464 0.0 0
M  V30 5 C 8.8872 4.4137 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 S 4.1321 4.3260 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 4.1321 1.8342 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 5.0371 3.0801 0.0 0
M  V30 13 N 0.0000 3.8501 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 145325-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009104-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14616422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile and general synthesis of 2,4-Di- and 2,4,7-trisubstituted
thieno[2,3-c]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Gui-Dong; Gunawardana, Indrani W.; Boyd, Steven A.; Melcher, Laura
M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2008), 45(1), 91-96

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-(bromomethyl)-1-(2,2-difluoroethyl)-1H-pyrazole-5-carbonitrile
C7H5Br2F2N3
1454849-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.7281 0.0 0
M  V30 2 N 0.0000 6.0483 0.0 0
M  V30 3 C 2.8691 2.6673 0.0 0
M  V30 4 C 3.6391 1.3337 0.0 0
M  V30 5 F 2.8691 0.0000 0.0 0
M  V30 6 F 5.1791 1.3337 0.0 0
M  V30 7 Br 3.9962 7.9700 0.0 0
M  V30 8 C 6.8978 6.2949 0.0 0
M  V30 9 Br 8.1437 5.3896 0.0 0
M  V30 10 C 3.0128 5.4080 0.0 0
M  V30 11 N 3.6391 4.0010 0.0 0
M  V30 12 C 4.1572 6.4384 0.0 0
M  V30 13 N 5.1706 4.1621 0.0 0
M  V30 14 C 5.4910 5.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-(2,2-difluoroethyl)-3-[(methylamino)methyl]-1H-pyrazole-5-carbonitrile
C8H9BrF2N4
1454849-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5064 5.7281 0.0 0
M  V30 2 N 0.0000 6.0483 0.0 0
M  V30 3 C 2.8691 2.6673 0.0 0
M  V30 4 C 3.6391 1.3337 0.0 0
M  V30 5 F 2.8691 0.0000 0.0 0
M  V30 6 F 5.1791 1.3337 0.0 0
M  V30 7 Br 3.9962 7.9699 0.0 0
M  V30 8 C 6.8978 6.2948 0.0 0
M  V30 9 N 8.1436 5.3896 0.0 0
M  V30 10 C 9.5506 6.0159 0.0 0
M  V30 11 C 3.0127 5.4079 0.0 0
M  V30 12 N 3.6391 4.0010 0.0 0
M  V30 13 C 4.1573 6.4384 0.0 0
M  V30 14 N 5.1708 4.1621 0.0 0
M  V30 15 C 5.4909 5.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1454849-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454849-33-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2582180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 7: A solution of compound 221 (18 g, 27.4 mmol) in EtOH (50 mL) was
slowly added to a solution of MeNH2 (40% in MeOH, 56 mL, 0.55 mol) in
additional EtOH (50 mL) at 0 °C over 15 mins. After complete addition the
reaction was stirred at 0 °C for 2 hours. The mixture was then
concentrated under vacuo to approx 50 mL in volume. EtOH (50 mL) was
added and the mixture was again concentrated under vacuo to approx 40 mL
volume. 1M aq HCl (90 mL) was added, followed by TBME (150 mL) and the
mixture was stirred vigorously for 5 minutes. The aqueous Iayerwas
collected and washed once more with TBME (100 mL). The aqueous Iayerwas
collected and basified to approx pH 12-13 (pH paper) using conc aq NH3.
The resulting mixture was extracted into DCM (3 x 150 mL). The organics
were dried (Na2SO4) and evaporated. Compound 222 (6.8 g, 90%) as a pale
brown oil which solidified on standing. 1H NMR (400 MHz, DMSO-d6) δ 6.44
(tt, J = 53.8, 2.8 Hz, 1H), 4.84 (td, J = 15.9, 2.8 Hz, 2H), 3.63 (s,
2H), 2.24 (s, 3H), [MH]+ 279.0 and 281.0 (60%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,3,5,8-tetrahydro-1-methyl-8-oxo-1H-pyrrolo[2,3-g]quinoline-6-carboxy...
C14H14N2O3
1456697-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9606 0.0000 0.0 0
M  V30 2 C 9.5806 2.6673 0.0 0
M  V30 3 O 10.3506 1.3336 0.0 0
M  V30 4 O 10.3506 4.0011 0.0 0
M  V30 5 C 11.8906 1.3336 0.0 0
M  V30 6 C 0.0000 3.2907 0.0 0
M  V30 7 C 4.9606 2.6673 0.0 0
M  V30 8 C 5.7306 4.0011 0.0 0
M  V30 9 C 3.4206 2.6673 0.0 0
M  V30 10 C 5.7306 1.3336 0.0 0
M  V30 11 C 4.9606 5.3347 0.0 0
M  V30 12 N 7.2706 4.0011 0.0 0
M  V30 13 C 2.6506 4.0011 0.0 0
M  V30 14 C 7.2706 1.3336 0.0 0
M  V30 15 C 3.4206 5.3347 0.0 0
M  V30 16 C 8.0406 2.6673 0.0 0
M  V30 17 N 1.1444 4.3212 0.0 0
M  V30 18 C 2.3902 6.4791 0.0 0
M  V30 19 C 0.9834 5.8528 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 17
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,8-Tetrahydro-N,1-dimethyl-8-oxo-1H-pyrrolo[2,3-g]quinoline-6-carboxamide
C14H15N3O2
1456697-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9606 0.0000 0.0 0
M  V30 2 C 9.5806 2.6673 0.0 0
M  V30 3 N 10.3506 1.3336 0.0 0
M  V30 4 O 10.3506 4.0011 0.0 0
M  V30 5 C 11.8906 1.3336 0.0 0
M  V30 6 C 0.0000 3.2907 0.0 0
M  V30 7 C 4.9606 2.6673 0.0 0
M  V30 8 C 5.7306 4.0011 0.0 0
M  V30 9 C 3.4206 2.6673 0.0 0
M  V30 10 C 5.7306 1.3336 0.0 0
M  V30 11 C 4.9606 5.3347 0.0 0
M  V30 12 N 7.2706 4.0011 0.0 0
M  V30 13 C 2.6506 4.0011 0.0 0
M  V30 14 C 7.2706 1.3336 0.0 0
M  V30 15 C 3.4206 5.3347 0.0 0
M  V30 16 C 8.0406 2.6673 0.0 0
M  V30 17 N 1.1444 4.3212 0.0 0
M  V30 18 C 2.3902 6.4791 0.0 0
M  V30 19 C 0.9834 5.8528 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 6 17
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1456697-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456697-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8243130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 4 A solution of compound 3 (0.26 g, 1 mmol) and methylamine (10
mL) was stirred for 4 h at r.t. under N2. Then the solvent was
evaporated, and the crude product was further purified by flash
chromatography (silica gel, CH2Cl2/0-2% MeOH). Pure compound 4 (0.23 g).
Yellow solid, yield: 90%. M.P: > 300 ºC. 1H NMR (400 MHz, DMSO, ppm):
isomer1+isomer2: δ 11.61 (1H, s), 11.07 (1H, s), 8.87 (1H, q), 8,53(1H,
q), 7.64 (1H, s), 7.53 (1H, s), 7.384 (1H, s), 6.88 (1H, s), 6.74 (1H,
s), 6.53 (1H, s), 3.49 (2H, t, J = 7.6 Hz), 3.37 (2H, t, J = 7.6 Hz),
3.13 (2H, t, J = 8.0 Hz), 3.04 (2H, t, J = 8.0 Hz), 2.85 (3H, s), 2.84
(6H, m), 2.78 (3H, s). HRMS (ESI) for C14H16N3O2 (M+H+): calcd: 258.1243,
found: 258.1236.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinoline-Based Fluorescent Probe for Ratiometric Detection of Lysosomal
pH
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Guoping; Zhu, Dongjian; Xue, Lin; Jiang, Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2013), 15(19), 5020-5023

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[4-(3-Methoxyphenyl)-5-(2-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]acetic acid
C16H14N4O3S
1459687-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.3503 6.5892 0.0 0
M  V30 2 C 9.4947 7.6198 0.0 0
M  V30 3 C 10.9594 7.1439 0.0 0
M  V30 4 O 12.1038 8.1743 0.0 0
M  V30 5 O 11.2796 5.6375 0.0 0
M  V30 6 O 8.3071 1.5400 0.0 0
M  V30 7 C 8.3071 0.0000 0.0 0
M  V30 8 N 5.6398 6.1600 0.0 0
M  V30 9 C 4.3939 7.0652 0.0 0
M  V30 10 C 6.8856 7.0652 0.0 0
M  V30 11 N 4.8698 8.5298 0.0 0
M  V30 12 N 6.4098 8.5298 0.0 0
M  V30 13 C 5.6398 4.6200 0.0 0
M  V30 14 C 6.9734 3.8500 0.0 0
M  V30 15 C 4.3061 3.8500 0.0 0
M  V30 16 C 6.9734 2.3100 0.0 0
M  V30 17 C 4.3061 2.3100 0.0 0
M  V30 18 C 5.6398 1.5400 0.0 0
M  V30 19 C 2.9292 6.5892 0.0 0
M  V30 20 C 2.6091 5.0829 0.0 0
M  V30 21 N 1.7849 7.6198 0.0 0
M  V30 22 C 1.1444 4.6071 0.0 0
M  V30 23 C 0.3202 7.1439 0.0 0
M  V30 24 C 0.0000 5.6375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[4-(3-Methoxyphenyl)-5-(2-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-N-methyla...
C17H17N5O2S
1459687-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.3502 6.5892 0.0 0
M  V30 2 C 9.4947 7.6198 0.0 0
M  V30 3 C 10.9593 7.1439 0.0 0
M  V30 4 N 12.1038 8.1743 0.0 0
M  V30 5 O 11.2794 5.6375 0.0 0
M  V30 6 C 13.5683 7.6985 0.0 0
M  V30 7 O 8.3071 1.5400 0.0 0
M  V30 8 C 8.3071 0.0000 0.0 0
M  V30 9 N 5.6398 6.1600 0.0 0
M  V30 10 C 4.3938 7.0652 0.0 0
M  V30 11 C 6.8856 7.0652 0.0 0
M  V30 12 N 4.8698 8.5298 0.0 0
M  V30 13 N 6.4098 8.5298 0.0 0
M  V30 14 C 5.6398 4.6200 0.0 0
M  V30 15 C 6.9734 3.8500 0.0 0
M  V30 16 C 4.3060 3.8500 0.0 0
M  V30 17 C 6.9734 2.3100 0.0 0
M  V30 18 C 4.3060 2.3100 0.0 0
M  V30 19 C 5.6398 1.5400 0.0 0
M  V30 20 C 2.9292 6.5892 0.0 0
M  V30 21 C 1.7847 7.6198 0.0 0
M  V30 22 N 2.6091 5.0829 0.0 0
M  V30 23 C 0.3202 7.1439 0.0 0
M  V30 24 C 1.1444 4.6071 0.0 0
M  V30 25 C 0.0000 5.6375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1459687-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1459687-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3254848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A New Series of Small Molecular Weight Compounds Induce Read Through of
All Three Types of Nonsense Mutations in the ATM Gene
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Du, Liutao; Jung, Michael E.; Damoiseaux, Robert; Completo, Gladys; Fike,
Francesca; Ku, Jin-Mo; Nahas, Shareef; Piao, Cijing; Hu, Hailiang; Gatti,
Richard A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Therapy (2013), 21(9), 1653-1660

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[4-(3-Methoxyphenyl)-5-(2-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]acetic acid
C16H14N4O3S
1459687-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.3503 6.5892 0.0 0
M  V30 2 C 9.4947 7.6198 0.0 0
M  V30 3 C 10.9594 7.1439 0.0 0
M  V30 4 O 12.1038 8.1743 0.0 0
M  V30 5 O 11.2796 5.6375 0.0 0
M  V30 6 O 8.3071 1.5400 0.0 0
M  V30 7 C 8.3071 0.0000 0.0 0
M  V30 8 N 5.6398 6.1600 0.0 0
M  V30 9 C 4.3939 7.0652 0.0 0
M  V30 10 C 6.8856 7.0652 0.0 0
M  V30 11 N 4.8698 8.5298 0.0 0
M  V30 12 N 6.4098 8.5298 0.0 0
M  V30 13 C 5.6398 4.6200 0.0 0
M  V30 14 C 6.9734 3.8500 0.0 0
M  V30 15 C 4.3061 3.8500 0.0 0
M  V30 16 C 6.9734 2.3100 0.0 0
M  V30 17 C 4.3061 2.3100 0.0 0
M  V30 18 C 5.6398 1.5400 0.0 0
M  V30 19 C 2.9292 6.5892 0.0 0
M  V30 20 C 2.6091 5.0829 0.0 0
M  V30 21 N 1.7849 7.6198 0.0 0
M  V30 22 C 1.1444 4.6071 0.0 0
M  V30 23 C 0.3202 7.1439 0.0 0
M  V30 24 C 0.0000 5.6375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[4-(3-Methoxyphenyl)-5-(2-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-N-methyla...
C17H17N5O2S
1459687-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.3502 6.5892 0.0 0
M  V30 2 C 9.4947 7.6198 0.0 0
M  V30 3 C 10.9593 7.1439 0.0 0
M  V30 4 N 12.1038 8.1743 0.0 0
M  V30 5 O 11.2794 5.6375 0.0 0
M  V30 6 C 13.5683 7.6985 0.0 0
M  V30 7 O 8.3071 1.5400 0.0 0
M  V30 8 C 8.3071 0.0000 0.0 0
M  V30 9 N 5.6398 6.1600 0.0 0
M  V30 10 C 4.3938 7.0652 0.0 0
M  V30 11 C 6.8856 7.0652 0.0 0
M  V30 12 N 4.8698 8.5298 0.0 0
M  V30 13 N 6.4098 8.5298 0.0 0
M  V30 14 C 5.6398 4.6200 0.0 0
M  V30 15 C 6.9734 3.8500 0.0 0
M  V30 16 C 4.3060 3.8500 0.0 0
M  V30 17 C 6.9734 2.3100 0.0 0
M  V30 18 C 4.3060 2.3100 0.0 0
M  V30 19 C 5.6398 1.5400 0.0 0
M  V30 20 C 2.9292 6.5892 0.0 0
M  V30 21 C 1.7847 7.6198 0.0 0
M  V30 22 N 2.6091 5.0829 0.0 0
M  V30 23 C 0.3202 7.1439 0.0 0
M  V30 24 C 1.1444 4.6071 0.0 0
M  V30 25 C 0.0000 5.6375 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1459687-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1459687-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5777146
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Compounds 1b-1j. To a solution of triazole 1a (100 mg, 0.30 mmol) and the
appropriate amine, NHR6R6a, e.g. aniline (34 mg, 0.36 mmol) in
dichoromethane (2 mL),
O-benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU)
(120 mL, 0.36 mmol), and triethylamine (0.05 mL, 0.36 mmol) were added.
The reaction mixture was stirred for 4 h. After removal of solvent under
reduced pressure, the residue was dissolved in ethyl acetate, washed with
water, aqueous NaHCO3, and brine solution. The organic layers were
combined, dried over anhydrous MgSO4, and then concentrated in vacuo. The
crude mixture was purified by column chromatography on silica gel (ethyl
acetate:hexane.
2-(4-(3-Methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-ylthio)-N-methylacetamide
(1h). Yield: 70-90%. 1H NMR (300 MHz, CDCl3): δ 8.34 (d, J = 4.2 Hz, 1H),
8.05 (d, J = 7.8 Hz, 1H), 7.75 (t, J = 7.5 Hz, 1H), 7.35 (t, J = 7.5 Hz,
1H), 7.22 (d, J = 9.0 Hz, 1H), 7.02 (dd, J = 8.7, 2.4 Hz, 1H), 6.83-6.78
(m, 2H), 4.28 (s, 2H), 3.79 (s, 3H), 2.77 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Premature-termination-codons readthrough compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gatti, Richard A.; Du, Liutao; Hu, Hailiang; Damoiseaux, Robert; Jung,
Michael E.; Ku, Jin-Mo; Completo, Gladys
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013142346 A1 2013-09-26

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-5-nitroso-N4-[4-(trifluoromethyl)phenyl]-2,4-pyrimidinediamine
C12H10F3N5O2
1460293-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 2.3101 0.0 0
M  V30 2 N 9.3360 0.7700 0.0 0
M  V30 3 O 10.6697 0.0000 0.0 0
M  V30 4 O 12.0033 2.3101 0.0 0
M  V30 5 C 13.3370 3.0801 0.0 0
M  V30 6 N 9.3360 6.9302 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 F 0.5637 4.0564 0.0 0
M  V30 9 F 0.0000 6.1601 0.0 0
M  V30 10 F 2.1037 6.7238 0.0 0
M  V30 11 C 8.0022 3.0801 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 N 8.0022 4.6201 0.0 0
M  V30 14 C 10.6697 3.0801 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 N 10.6697 4.6201 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 4.0010 5.3901 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-Methyl-5-nitroso-N6-[4-(trifluoromethyl)phenyl]-2,4,6-pyrimidinetriamine
C12H11F3N6O
1460293-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 2.3101 0.0 0
M  V30 2 N 9.3360 0.7700 0.0 0
M  V30 3 O 10.6697 0.0000 0.0 0
M  V30 4 N 12.0033 2.3101 0.0 0
M  V30 5 C 13.3370 3.0801 0.0 0
M  V30 6 N 9.3360 6.9302 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 F 0.5637 4.0564 0.0 0
M  V30 9 F 0.0000 6.1601 0.0 0
M  V30 10 F 2.1037 6.7238 0.0 0
M  V30 11 C 8.0022 3.0801 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 N 8.0022 4.6201 0.0 0
M  V30 14 C 10.6697 3.0801 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 N 10.6697 4.6201 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 4.0010 5.3901 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1460293-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1460293-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8918399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure B: Synthesis of
N4,N6-Disubstituted 5-Nitrosopyrimidine- 2,4,6-triamines 4-6 . The
corresponding amine (1.1 equiv) or an excess of aq. ammonia was added
dropwise to the mixture of the corresponding compound 3a-i (1.0 equiv) in
DMF (20 mL per 1 mmol of 3), and the reaction mixture was stirred at room
temperature (rt) or under conventional heating (conv.) for 3-24 h. The
solvents were evaporated, and the corresponding product 4a-h, 5a-h, or
6a-i was obtained by silica gel column chromatography (3- 20% MeOH in
CHCl3).
N4-Methyl-5-nitroso-N6-[4-(trifluoromethyl)phenyl]pyrimidine-2,4,6-triamine
(4b). Treatment of 3b (100 mg, 0.32 mmol) with methylamine (33% ethanolic
solution, 15 μL) in DMF by general procedure B (rt, 16 h) gave 4b (90 mg,
90%) as an orange solid. mp = 220 °C. 1H NMR (DMSO-d6 ): δ 14.16 (1H, s,
6-NH, A), 11.39 (1H, q, J NH-CH3 = 5.0 Hz, 4-NH, B), 10.62 (1H, s, 6-NH,
B), 9.02 (1H, q, J NH-CH3 = 4.9 Hz, 4-NH, A), 8.26 (2H, m, H2′, B), 8.07
(2H, m, H2′, A), 7.96 and 7.94 (2H, bs, 2-NH2, A), 7.84 (2H, bs, 2-NH2,
B), 7.64-7.68 (4H, m, H3′, A and B), 2.97 (3H, d, J CH3-NH = 4.9 Hz, CH3,
A), 2.90 (3H, d, J CH3-NH = 5.0 Hz, CH3, B). 13C NMR (DMSO-d6 ): Rotamer
A: δ 164.4 (C2), 163.2 (C4), 148.4 (C6), 141.9 (C1′, J C1′-F = 1.3 Hz),
136.0 (C5), 126.0 (C3′, J C3′-F = 3.8 Hz), 124.4 (CF3, J C-F = 271.5 Hz),
124.2 (C4′, J C4′-F = 32.4 Hz), 122.8 (C2′), 27.6 (NH- CH3). Rotamer B: δ
164.0 (C2), 162.0 (C6), 151.2 (C4), 142.9 (C1′, J C1′-F =J C1′-F = 1.2
Hz), 136.5 (C5), 125.6 (C3′, J C3′-F = 3.8 Hz), 124.6 (CF3, J C-F = 271.5
Hz), 123.3 (C4′, J C4′-F = 32.8 Hz), 122.2 (C2′) 26.2 (NH-CH3). UV/vis
(DMSO): λ max = 570 nm. ESI MS m/z: 335.1 [M + Na]+, 313.1 [M + H]+. HRMS
(ESI) m/z: calcd for C12H12F3N6O [M + H]+ 313.1019, found 313.1018.
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of ethanolic amine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Switchable Intramolecular Hydrogen Bond in Polysubstituted 5
Nitrosopyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prochazkova, Eliska; Cechova, Lucie; Janeba, Zlatko; Dracinsky, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(20), 10121-10133

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
(3S)-2,3-Dihydro-3-(3-methyl-3-buten-1-yl)-2-oxo-1-(phenylmethyl)-1H-indole-3...
C22H23NO3
1464060-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.2896 4.0011 0.0 0
M  V30 2 C 4.0596 2.6673 0.0 0
M  V30 3 C 3.2896 1.3336 0.0 0
M  V30 4 C 1.7496 1.3336 0.0 0
M  V30 5 C 4.0596 0.0000 0.0 0
M  V30 6 C 2.6528 5.9610 0.0 0
M  V30 7 C 1.4069 5.0558 0.0 0
M  V30 8 O 1.5679 3.5243 0.0 0
M  V30 9 O 0.0000 5.6823 0.0 0
M  V30 10 O 5.3056 2.8895 0.0 0
M  V30 11 C 8.0160 4.8589 0.0 0
M  V30 12 C 4.0596 5.3347 0.0 0 CFG=1
M  V30 13 C 4.5356 6.7994 0.0 0
M  V30 14 C 5.3056 4.4295 0.0 0
M  V30 15 C 6.0756 6.7994 0.0 0
M  V30 16 C 3.7656 8.1331 0.0 0
M  V30 17 N 6.5515 5.3347 0.0 0
M  V30 18 C 6.8456 8.1331 0.0 0
M  V30 19 C 4.5356 9.4667 0.0 0
M  V30 20 C 6.0756 9.4667 0.0 0
M  V30 21 C 9.1606 5.8893 0.0 0
M  V30 22 C 8.8404 7.3957 0.0 0
M  V30 23 C 10.6251 5.4134 0.0 0
M  V30 24 C 9.9848 8.4261 0.0 0
M  V30 25 C 11.7696 6.4438 0.0 0
M  V30 26 C 11.4495 7.9503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 12 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 14
M  V30 11 1 11 17
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-2,3-Dihydro-N-methyl-3-(3-methyl-2-buten-1-yl)-2-oxo-1-(phenylmethyl)-1H...
C23H26N2O2
1464060-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.1168 5.9611 0.0 0
M  V30 2 C 10.3627 5.0558 0.0 0
M  V30 3 N 11.7697 5.6823 0.0 0
M  V30 4 O 10.2018 3.5243 0.0 0
M  V30 5 C 13.0155 4.7771 0.0 0
M  V30 6 C 8.4801 4.0011 0.0 0
M  V30 7 C 7.7100 2.6673 0.0 0
M  V30 8 C 8.4801 1.3336 0.0 0
M  V30 9 C 7.7100 0.0000 0.0 0
M  V30 10 C 10.0201 1.3336 0.0 0
M  V30 11 O 6.4640 2.8895 0.0 0
M  V30 12 C 3.7536 4.8589 0.0 0
M  V30 13 C 7.7100 5.3347 0.0 0 CFG=2
M  V30 14 C 7.2340 6.7994 0.0 0
M  V30 15 C 6.4640 4.4295 0.0 0
M  V30 16 C 5.6940 6.7994 0.0 0
M  V30 17 C 8.0040 8.1331 0.0 0
M  V30 18 N 5.2182 5.3347 0.0 0
M  V30 19 C 4.9240 8.1331 0.0 0
M  V30 20 C 7.2340 9.4667 0.0 0
M  V30 21 C 5.6940 9.4667 0.0 0
M  V30 22 C 2.6091 5.8893 0.0 0
M  V30 23 C 2.9292 7.3957 0.0 0
M  V30 24 C 1.1445 5.4134 0.0 0
M  V30 25 C 1.7849 8.4262 0.0 0
M  V30 26 C 0.0000 6.4439 0.0 0
M  V30 27 C 0.3202 7.9503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 13 6 CFG=1
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 15
M  V30 12 1 12 18
M  V30 13 1 12 22
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1464060-48-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1464060-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-117-CAS-10641143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective synthesis of spirocyclic oxindoles based on a one-pot
Ullmann coupling/Claisen rearrangement and its application to the
synthesis of a hexahydropyrrolo[2,3-b]indole alkaloid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miyamoto, Hiroshi; Hirano, Tomohiro; Okawa, Yoichiro; Nakazaki, Atsuo;
Kobayashi, Susumu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(45), 9481-9493

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-4-nitro-L-tryptophan methyl ester
C18H23N3O6
1476031-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 3.9302 0.0 0
M  V30 2 C 7.0871 4.7002 0.0 0 CFG=1
M  V30 3 N 8.4208 3.9302 0.0 0
M  V30 4 C 7.0871 6.2402 0.0 0
M  V30 5 C 9.7544 4.7002 0.0 0
M  V30 6 C 8.4208 2.3901 0.0 0
M  V30 7 O 8.4208 7.0102 0.0 0
M  V30 8 O 5.7534 7.0102 0.0 0
M  V30 9 O 11.0882 3.9302 0.0 0
M  V30 10 O 9.7544 6.2402 0.0 0
M  V30 11 C 8.4208 8.5503 0.0 0
M  V30 12 C 12.4219 4.7002 0.0 0
M  V30 13 C 11.6519 6.0339 0.0 0
M  V30 14 C 13.7556 5.4702 0.0 0
M  V30 15 C 13.1919 3.3665 0.0 0
M  V30 16 N 3.5673 1.4647 0.0 0 VAL=5
M  V30 17 O 3.0915 0.0000 0.0 0
M  V30 18 O 5.0736 1.7849 0.0 0
M  V30 19 C 3.0128 4.0739 0.0 0
M  V30 20 C 4.4196 4.7002 0.0 0
M  V30 21 C 1.9823 5.2183 0.0 0
M  V30 22 C 2.5369 2.6091 0.0 0
M  V30 23 C 4.2587 6.2317 0.0 0
M  V30 24 N 2.7523 6.5519 0.0 0
M  V30 25 C 0.4759 4.8981 0.0 0
M  V30 26 C 1.0304 2.2890 0.0 0
M  V30 27 C 0.0000 3.4334 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 22
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 23 24
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-N-Methyl-α-(methylamino)-4-nitro-1H-indole-3-propanamide
C13H16N4O3
1476031-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 3.9301 0.0 0
M  V30 2 C 7.0870 4.7001 0.0 0 CFG=2
M  V30 3 C 8.4207 3.9301 0.0 0
M  V30 4 N 7.0870 6.2402 0.0 0
M  V30 5 N 9.7545 4.7001 0.0 0
M  V30 6 O 8.4207 2.3901 0.0 0
M  V30 7 C 8.4207 7.0102 0.0 0
M  V30 8 C 11.0882 3.9301 0.0 0
M  V30 9 N 3.5673 1.4647 0.0 0 VAL=5
M  V30 10 O 3.0914 0.0000 0.0 0
M  V30 11 O 5.0738 1.7849 0.0 0
M  V30 12 C 3.0127 4.0738 0.0 0
M  V30 13 C 4.4197 4.7001 0.0 0
M  V30 14 C 1.9823 5.2182 0.0 0
M  V30 15 C 2.5369 2.6091 0.0 0
M  V30 16 C 4.2586 6.2317 0.0 0
M  V30 17 N 2.7523 6.5519 0.0 0
M  V30 18 C 0.4759 4.8980 0.0 0
M  V30 19 C 1.0304 2.2889 0.0 0
M  V30 20 C 0.0000 3.4333 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1476031-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1476031-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-13644437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of compound 6: A solution of 5 (6.4 g, 33.9 mmol) and the
MeNH2 (300 mmol) in anhydrous methanol (150 mL) was stirred at room
temperature for 7 days. The reaction mixture was concentrated, follow by
addition of a mixture of dichloromethane (80 mL) and trifluroacetic acid
(20 mL), and stirring was continued at room temperature for another
30min. The reaction mixture was concentrated, the product 6 was obtained
after recrystallization from methanol (4.2 g, 90% yield) as yellowish
powder. 6: mp 134-136°C; TLC (CH2Cl2:CH3OH, 75:25 v/v): Rf = 0.40; [α]25
D = +124.0° (c = 1.0, CH3OH); 1H-NMR ( CD3OD, 400Mz ) δ 7.87 (d, J = 8.0
Hz, 1H), 7.73 (d, J = 8.0 Hz, 1H), 7.36 (s, 1H), 7.20 (t, J = 8.0 Hz,
1H), 3.40 (m, 2H), 3.12 (m, 1H), 2.58 (s, 3H), 2.40 (s, 3H); 13C NMR (100
MHz, CD3OD) δ 26.0, 31.6, 33.9, 66.5, 110.1, 118.7, 119.3, 120.1, 121.2,
131.3, 141.2, 143.7, 174.4; HRMS: Calcd for C13H16N4O3 (M + H)+ 277.1295,
found 277.1293.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Thaxtomin A and Its Stereoisomers and Findings of
Their Biological Activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Hongbo; Ning, Xin; Hang, Hang; Ru, Xuyan; Li, Haichen; Li,
Yonghong; Wang, Lizhong; Zhang, Xiao; Yu, Shujing; Qiao, Yuanyuan; Wang,
Xin; Wang, Peng George
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2013), 15(22), 5670-5673

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[5-formyl-2-(methylthio)-4-pyrimidinyl]amino]-1-pyr...
C15H22N4O3S
1478019-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 6.6684 0.0 0
M  V30 2 C 1.5400 6.6684 0.0 0
M  V30 3 O 0.0000 6.6684 0.0 0
M  V30 4 S 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 9.7757 8.3436 0.0 0
M  V30 7 O 11.1826 7.7173 0.0 0
M  V30 8 O 9.6147 9.8751 0.0 0
M  V30 9 C 12.4285 8.6223 0.0 0
M  V30 10 C 11.5233 9.8684 0.0 0
M  V30 11 C 13.6743 9.5276 0.0 0
M  V30 12 C 13.3337 7.3765 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 N 4.6200 4.0011 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 N 2.3100 2.6673 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0 CFG=1
M  V30 20 C 7.0652 7.9143 0.0 0
M  V30 21 C 7.0652 5.4225 0.0 0
M  V30 22 N 8.5298 7.4384 0.0 0
M  V30 23 C 8.5298 5.8984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 19 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 14
M  V30 5 1 4 5
M  V30 6 1 4 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 22
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[5-[(methylamino)methyl]-2-(methylthio)-4-pyrimidin...
C16H27N5O2S
1478019-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 N 0.7700 6.6684 0.0 0
M  V30 4 C 0.0000 8.0020 0.0 0
M  V30 5 S 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 10.5457 8.3436 0.0 0
M  V30 8 O 11.9526 7.7173 0.0 0
M  V30 9 O 10.3847 9.8751 0.0 0
M  V30 10 C 13.1985 8.6224 0.0 0
M  V30 11 C 12.2933 9.8684 0.0 0
M  V30 12 C 14.4444 9.5276 0.0 0
M  V30 13 C 14.1037 7.3765 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 N 5.3900 4.0011 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 4.6200 2.6673 0.0 0
M  V30 19 N 3.0800 2.6673 0.0 0
M  V30 20 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 21 C 7.8353 7.9143 0.0 0
M  V30 22 C 7.8353 5.4225 0.0 0
M  V30 23 N 9.2998 7.4384 0.0 0
M  V30 24 C 9.2998 5.8984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 20 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1478019-25-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1478019-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8671254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: tert-Butyl
4-(5-((Benzylamino)methyl)-2-(methylthio)-pyrimidin-4-ylamino)cyclohexylcarbamate
(8a). General procedure for syntheses of 8a-v. Benzylamine (1 g, 9.25
mmol) and AcOH (0.1 mL) were added at room temperature to a solution of
7a (2.26 g, 6.17 mmol) in MeOH (50 mL). After the amine was converted
completely to the imine, NaBH4 (469 mg, 12.34 mmol) was added to the
reaction mixture at 0°C. The resulting mixture was concentrated in vacuo,
partitioned between CH2Cl2 and saturated NaHCO3, and extracted with
CH2Cl2. The organic layer was separated, washed with brine, dried with
Na2SO4, filtered, and concentrated in vacuo. The resulting crude material
was subjected to flash column chromatography (SiO2, petroleum
ether/EtOAc, 3:1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of
2-Oxo-3,4-dihydropyrimido[4,5 d]pyrimidinyl Derivatives as New
Irreversible Epidermal Growth Factor Receptor Inhibitors with Improved
Pharmacokinetic Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Shilin; Xu, Tianfeng; Zhang, Lianwen; Zhang, Zhang; Luo, Jinfeng;
Liu, Yingxue; Lu, Xiaoyun; Tu, Zhengchao; Ren, Xiaomei; Ding, Ke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(21), 8803-8813

$RFMT $RIREG SCHEME120 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bisphenol AF
C15H10F6O2
1478-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 C 3.8500 8.0021 0.0 0
M  V30 4 F 0.0000 5.3347 0.0 0
M  V30 5 F 1.5400 3.7947 0.0 0
M  V30 6 F 1.5400 6.8747 0.0 0
M  V30 7 F 3.0800 9.3358 0.0 0
M  V30 8 F 2.5164 7.2321 0.0 0
M  V30 9 F 5.1836 8.7721 0.0 0
M  V30 10 O 11.5500 5.3347 0.0 0
M  V30 11 O 2.3100 0.0000 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6684 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6684 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 5.3900 2.6674 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 4.6200 1.3336 0.0 0
M  V30 23 C 3.0800 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 1 18
M  V30 5 1 2 4
M  V30 6 1 2 5
M  V30 7 1 2 6
M  V30 8 1 3 7
M  V30 9 1 3 8
M  V30 10 1 3 9
M  V30 11 1 10 17
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1,3-Benzoxazine, 6,6′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[3...
C21H20F6N2O2
267420-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.6680 0.0 0
M  V30 2 C 5.0051 1.3337 0.0 0
M  V30 3 C 8.4702 2.0005 0.0 0
M  V30 4 F 6.3388 0.5637 0.0 0
M  V30 5 F 4.2351 0.0000 0.0 0
M  V30 6 F 3.6714 2.1037 0.0 0
M  V30 7 F 7.1365 1.2305 0.0 0
M  V30 8 F 9.2402 0.6668 0.0 0
M  V30 9 F 9.8039 2.7705 0.0 0
M  V30 10 C 13.8603 8.6692 0.0 0
M  V30 11 C 0.0000 8.6692 0.0 0
M  V30 12 C 7.7002 6.0017 0.0 0
M  V30 13 C 9.2402 6.0017 0.0 0
M  V30 14 C 6.9302 7.3353 0.0 0
M  V30 15 C 10.0102 7.3353 0.0 0
M  V30 16 C 7.7002 8.6692 0.0 0
M  V30 17 C 9.2402 8.6692 0.0 0
M  V30 18 C 11.5503 7.3353 0.0 0
M  V30 19 O 10.0102 10.0028 0.0 0
M  V30 20 N 12.3203 8.6692 0.0 0
M  V30 21 C 11.5503 10.0028 0.0 0
M  V30 22 C 5.3901 4.6680 0.0 0
M  V30 23 C 4.6201 6.0017 0.0 0
M  V30 24 C 4.6201 3.3343 0.0 0
M  V30 25 C 3.0801 6.0017 0.0 0
M  V30 26 C 3.0801 3.3343 0.0 0
M  V30 27 C 2.3101 4.6680 0.0 0
M  V30 28 C 2.3101 7.3353 0.0 0
M  V30 29 O 0.7700 4.6680 0.0 0
M  V30 30 N 0.7700 7.3353 0.0 0
M  V30 31 C 0.0000 6.0017 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 1 22
M  V30 5 1 2 4
M  V30 6 1 2 5
M  V30 7 1 2 6
M  V30 8 1 3 7
M  V30 9 1 3 8
M  V30 10 1 3 9
M  V30 11 1 10 20
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 16 17
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1478-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 267420-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-2599886
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic examination of thermal, mechanical and dielectrical properties
of aromatic polybenzoxazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamerton, Ian; Howlin, Brendan J.; Mitchell, Amy L.; McNamara, Lisa T.;
Takeda, Shinji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Reactive & Functional Polymers (2012), 72(10), 736-744

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Trimethyl 2-fluoro-1,3,5-benzenetricarboxylate
C12H11FO6
1494-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.9302 0.0 0
M  V30 2 O 9.3360 6.1601 0.0 0
M  V30 3 O 8.0023 8.4702 0.0 0
M  V30 4 C 10.6697 6.9302 0.0 0
M  V30 5 F 5.3348 8.4702 0.0 0
M  V30 6 C 2.6673 6.9302 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 O 2.6673 8.4702 0.0 0
M  V30 9 C 0.0000 6.9302 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 O 4.0012 1.5400 0.0 0
M  V30 12 O 6.6685 1.5400 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 6.6685 6.1601 0.0 0
M  V30 15 C 5.3348 6.9302 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 4.0012 6.1601 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Trimethyl 2-(methylamino)-1,3,5-benzenetricarboxylate
C13H15NO6
1801158-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 8.4702 0.0 0
M  V30 2 C 6.6685 9.2402 0.0 0
M  V30 3 C 2.6673 6.9302 0.0 0
M  V30 4 O 1.3337 6.1601 0.0 0
M  V30 5 O 2.6673 8.4702 0.0 0
M  V30 6 C 0.0000 6.9302 0.0 0
M  V30 7 C 8.0023 6.9302 0.0 0
M  V30 8 O 9.3360 6.1601 0.0 0
M  V30 9 O 8.0023 8.4702 0.0 0
M  V30 10 C 10.6697 6.9302 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 O 4.0012 1.5400 0.0 0
M  V30 13 O 6.6685 1.5400 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 5.3348 6.9302 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 6.6685 6.1601 0.0 0
M  V30 18 C 4.0012 4.6201 0.0 0
M  V30 19 C 6.6685 4.6201 0.0 0
M  V30 20 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1494-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1801158-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8918153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, HF generated (handle with extreme care)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tuning the nitric oxide release behavior of amino functionalized HKUST-1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peikert, Katharina; McCormick, Laura J.; Cattaneo, Damiano; Duncan,
Morven J.; Hoffmann, Frank; Khan, Arafat H.; Bertmer, Marko; Morris,
Russell E.; Froeba, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Microporous and Mesoporous Materials (2015), 216118-126

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl]benzoate
C23H24N4O2
1510714-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 7.1821 0.0 0
M  V30 2 C 6.0810 3.8500 0.0 0
M  V30 3 C 6.0810 2.3100 0.0 0
M  V30 4 C 7.4148 1.5400 0.0 0
M  V30 5 C 7.4148 0.0000 0.0 0
M  V30 6 N 0.0000 3.8044 0.0 0
M  V30 7 C 11.5894 5.2785 0.0 0
M  V30 8 O 12.7338 6.3091 0.0 0
M  V30 9 O 11.9096 3.7722 0.0 0
M  V30 10 C 14.1985 5.8331 0.0 0
M  V30 11 C 3.0800 6.4719 0.0 0
M  V30 12 N 4.5864 6.1517 0.0 0
M  V30 13 C 2.3100 7.8055 0.0 0
M  V30 14 C 2.3100 5.1382 0.0 0
M  V30 15 C 4.7474 4.6200 0.0 0
M  V30 16 C 0.7700 7.8055 0.0 0
M  V30 17 C 3.0800 9.1391 0.0 0
M  V30 18 N 3.3406 3.9937 0.0 0
M  V30 19 C 0.7700 5.1382 0.0 0
M  V30 20 N 0.0000 6.4719 0.0 0
M  V30 21 C 0.0000 9.1391 0.0 0
M  V30 22 C 2.3100 10.4729 0.0 0
M  V30 23 C 0.7700 10.4729 0.0 0
M  V30 24 C 7.1955 6.7062 0.0 0
M  V30 25 C 7.5157 5.1998 0.0 0
M  V30 26 C 8.3399 7.7367 0.0 0
M  V30 27 C 8.9804 4.7240 0.0 0
M  V30 28 C 9.8046 7.2608 0.0 0
M  V30 29 C 10.1247 5.7544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 29
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 2 15 18
M  V30 21 1 16 20
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 4-[(4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl]-N-methyl-
C23H25N5O
3029694-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 7.1821 0.0 0
M  V30 2 C 6.0810 3.8500 0.0 0
M  V30 3 C 6.0810 2.3100 0.0 0
M  V30 4 C 7.4148 1.5400 0.0 0
M  V30 5 C 7.4148 0.0000 0.0 0
M  V30 6 N 0.0000 3.8044 0.0 0
M  V30 7 C 11.5894 5.2785 0.0 0
M  V30 8 N 12.7338 6.3091 0.0 0
M  V30 9 O 11.9096 3.7722 0.0 0
M  V30 10 C 14.1985 5.8331 0.0 0
M  V30 11 C 3.0800 6.4719 0.0 0
M  V30 12 N 4.5864 6.1517 0.0 0
M  V30 13 C 2.3100 7.8055 0.0 0
M  V30 14 C 2.3100 5.1382 0.0 0
M  V30 15 C 4.7474 4.6200 0.0 0
M  V30 16 C 0.7700 7.8055 0.0 0
M  V30 17 C 3.0800 9.1391 0.0 0
M  V30 18 N 3.3406 3.9937 0.0 0
M  V30 19 C 0.7700 5.1382 0.0 0
M  V30 20 N 0.0000 6.4719 0.0 0
M  V30 21 C 0.0000 9.1391 0.0 0
M  V30 22 C 2.3100 10.4729 0.0 0
M  V30 23 C 0.7700 10.4729 0.0 0
M  V30 24 C 7.1955 6.7062 0.0 0
M  V30 25 C 7.5157 5.1998 0.0 0
M  V30 26 C 8.3399 7.7367 0.0 0
M  V30 27 C 8.9804 4.7240 0.0 0
M  V30 28 C 9.8046 7.2608 0.0 0
M  V30 29 C 10.1247 5.7544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 29
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 2 15 18
M  V30 21 1 16 20
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1510714-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3029694-99-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40921827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Relationships toward the Identification of a
High-Potency Selective Human Toll-like Receptor-7 Agonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaushik, Deepender; Kaur, Arshpreet; Patil, Madhuri T.; Sihag, Binita;
Piplani, Sakshi; Sakala, Isaac; Honda-Okubo, Yoshikazu; Ramakrishnan,
Saravanan; Petrovsky, Nikolai; Salunke, Deepak B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(10), 8346-8360

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Fructopyranose, 2,3-O-(1-methylethylidene)-, cyclic 4,5-sulfate 1-chloros...
C9H13ClO10S2
152192-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2931 3.6832 0.0 0
M  V30 2 O 8.0631 5.0169 0.0 0
M  V30 3 S 9.6031 5.0169 0.0 0 VAL=6
M  V30 4 Cl 9.6031 6.5569 0.0 0
M  V30 5 O 11.1431 5.0169 0.0 0
M  V30 6 O 9.6031 3.4769 0.0 0
M  V30 7 C 6.3795 0.2154 0.0 0
M  V30 8 C 4.3299 0.0000 0.0 0
M  V30 9 O 0.0000 5.9595 0.0 0
M  V30 10 O 0.8382 7.8423 0.0 0
M  V30 11 C 5.7531 3.6832 0.0 0 CFG=2
M  V30 12 C 4.2216 3.5223 0.0 0 CFG=1
M  V30 13 O 6.3795 2.2763 0.0 0
M  V30 14 O 6.3795 5.0900 0.0 0
M  V30 15 C 3.3164 4.7681 0.0 0 CFG=2
M  V30 16 O 3.9014 2.0159 0.0 0
M  V30 17 C 5.2351 1.2459 0.0 0
M  V30 18 C 5.4744 6.3360 0.0 0
M  V30 19 C 3.9427 6.1749 0.0 0 CFG=2
M  V30 20 O 1.7849 4.9291 0.0 0
M  V30 21 O 2.7983 7.2055 0.0 0
M  V30 22 S 1.4647 6.4355 0.0 0 VAL=6
M  V30 23 H 2.8495 2.8231 0.0 0
M  V30 24 H 2.0548 3.8848 0.0 0
M  V30 25 H 4.4186 7.6396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 17
M  V30 8 1 8 17
M  V30 9 2 9 22
M  V30 10 2 10 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 23 CFG=3
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 15 24 CFG=1
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 1 19 21
M  V30 25 1 19 25 CFG=1
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 11 12 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Sulfamic acid, N-methyl-, [(3aR,5aS,8aS,8bS)-tetrahydro-7,7-dimethyl-2,2-diox...
C10H17NO10S2
152192-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2931 3.6832 0.0 0
M  V30 2 O 8.0631 5.0169 0.0 0
M  V30 3 S 9.6031 5.0169 0.0 0 VAL=6
M  V30 4 N 9.6031 6.5569 0.0 0
M  V30 5 O 11.1431 5.0169 0.0 0
M  V30 6 O 9.6031 3.4769 0.0 0
M  V30 7 C 10.9368 7.3269 0.0 0
M  V30 8 C 6.3795 0.2154 0.0 0
M  V30 9 C 4.3299 0.0000 0.0 0
M  V30 10 O 0.0000 5.9595 0.0 0
M  V30 11 O 0.8382 7.8423 0.0 0
M  V30 12 C 5.7531 3.6832 0.0 0 CFG=1
M  V30 13 C 4.2216 3.5223 0.0 0 CFG=1
M  V30 14 O 6.3795 5.0900 0.0 0
M  V30 15 O 6.3795 2.2763 0.0 0
M  V30 16 C 3.3164 4.7682 0.0 0 CFG=2
M  V30 17 O 3.9014 2.0159 0.0 0
M  V30 18 C 5.4744 6.3360 0.0 0
M  V30 19 C 5.2351 1.2459 0.0 0
M  V30 20 C 3.9427 6.1749 0.0 0 CFG=2
M  V30 21 O 1.7849 4.9291 0.0 0
M  V30 22 O 2.7983 7.2055 0.0 0
M  V30 23 S 1.4647 6.4355 0.0 0 VAL=6
M  V30 24 H 2.8495 2.8231 0.0 0
M  V30 25 H 2.0548 3.8848 0.0 0
M  V30 26 H 4.4186 7.6396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 8 19
M  V30 9 1 9 19
M  V30 10 2 10 23
M  V30 11 2 11 23
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 24 CFG=3
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 16 25 CFG=1
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 20 22
M  V30 26 1 20 26 CFG=1
M  V30 27 1 21 23
M  V30 28 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 152192-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 152192-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-21044624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic monosaccharide derivatives useful in treating
acute ischemia-induced neurodegeneration
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Costanzo, Michael; Maryanoff, Bruce E.; Shank, Richard P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001007453 A1 2001-02-01

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-1,10-phenanthrolin-5-ylacetamide
C14H10BrN3O
154030-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 O 6.9300 6.6685 0.0 0
M  V30 5 Br 10.0100 6.6685 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 5.3900 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 N 0.7700 4.0011 0.0 0
M  V30 16 C 3.0800 0.0000 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 2 11 16
M  V30 16 2 12 14
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-1,10-phenanthrolin-5-ylacetamide
C15H14N4O
1628447-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 O 6.9300 6.6685 0.0 0
M  V30 5 N 10.0100 6.6685 0.0 0
M  V30 6 C 11.5500 6.6685 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 N 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 N 0.7700 4.0011 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 C 2.3100 6.6685 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 2 13 15
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 154030-81-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628447-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5540244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hierarchical Self-Assembly of Luminescent EuIII Complexes on Silicon
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Misztal, Kasjan; Tudisco, Cristina; Sartori, Andrea; Malicka, Joanna M.;
Castelli, Riccardo; Condorelli, Guglielmo G.; Dalcanale, Enrico
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2014), 2014(16), 2687-2694

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(benzoylamino)-1,6-dihydro-1-[2-(1H-indol-3-yl)ethyl]-6-oxo-2-pyrimi...
C23H20N4O4
1542130-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 6.6684 0.0 0
M  V30 2 C 5.8244 5.3348 0.0 0
M  V30 3 C 7.3644 2.6673 0.0 0
M  V30 4 O 8.1344 1.3337 0.0 0
M  V30 5 O 5.8244 2.6673 0.0 0
M  V30 6 C 7.3644 0.0000 0.0 0
M  V30 7 O 7.3644 8.0021 0.0 0
M  V30 8 N 10.4444 8.0021 0.0 0
M  V30 9 C 11.9844 8.0021 0.0 0
M  V30 10 O 12.7545 6.6684 0.0 0
M  V30 11 C 2.6091 7.9143 0.0 0
M  V30 12 C 3.5143 6.6684 0.0 0
M  V30 13 C 1.1445 7.4385 0.0 0
M  V30 14 C 2.9293 9.4208 0.0 0
M  V30 15 C 2.6091 5.4226 0.0 0
M  V30 16 N 1.1445 5.8984 0.0 0
M  V30 17 C 0.0000 8.4689 0.0 0
M  V30 18 C 1.7849 10.4512 0.0 0
M  V30 19 C 0.3202 9.9753 0.0 0
M  V30 20 N 7.3644 5.3348 0.0 0
M  V30 21 C 8.1344 4.0011 0.0 0
M  V30 22 C 8.1344 6.6684 0.0 0
M  V30 23 N 9.6744 4.0011 0.0 0
M  V30 24 C 9.6744 6.6684 0.0 0
M  V30 25 C 10.4444 5.3348 0.0 0
M  V30 26 C 12.7545 9.3359 0.0 0
M  V30 27 C 11.9844 10.6696 0.0 0
M  V30 28 C 14.2945 9.3359 0.0 0
M  V30 29 C 12.7545 12.0032 0.0 0
M  V30 30 C 15.0645 10.6696 0.0 0
M  V30 31 C 14.2945 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 2 7 22
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 2 9 10
M  V30 12 1 9 26
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Benzoylamino)-1,6-dihydro-1-[2-(1H-indol-3-yl)ethyl]-N-methyl-6-oxo-2-pyri...
C23H21N5O3
1542130-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 6.6684 0.0 0
M  V30 2 C 5.8244 5.3348 0.0 0
M  V30 3 C 7.3644 2.6673 0.0 0
M  V30 4 N 8.1344 1.3337 0.0 0
M  V30 5 O 5.8244 2.6673 0.0 0
M  V30 6 C 7.3644 0.0000 0.0 0
M  V30 7 O 7.3644 8.0021 0.0 0
M  V30 8 N 10.4444 8.0021 0.0 0
M  V30 9 C 11.9844 8.0021 0.0 0
M  V30 10 O 12.7545 6.6684 0.0 0
M  V30 11 C 2.6091 7.9143 0.0 0
M  V30 12 C 3.5143 6.6684 0.0 0
M  V30 13 C 1.1445 7.4385 0.0 0
M  V30 14 C 2.9293 9.4208 0.0 0
M  V30 15 C 2.6091 5.4226 0.0 0
M  V30 16 N 1.1445 5.8984 0.0 0
M  V30 17 C 0.0000 8.4689 0.0 0
M  V30 18 C 1.7849 10.4512 0.0 0
M  V30 19 C 0.3202 9.9753 0.0 0
M  V30 20 N 7.3644 5.3348 0.0 0
M  V30 21 C 8.1344 4.0011 0.0 0
M  V30 22 C 8.1344 6.6684 0.0 0
M  V30 23 N 9.6744 4.0011 0.0 0
M  V30 24 C 9.6744 6.6684 0.0 0
M  V30 25 C 10.4444 5.3348 0.0 0
M  V30 26 C 12.7545 9.3359 0.0 0
M  V30 27 C 11.9844 10.6696 0.0 0
M  V30 28 C 14.2945 9.3359 0.0 0
M  V30 29 C 12.7545 12.0032 0.0 0
M  V30 30 C 15.0645 10.6696 0.0 0
M  V30 31 C 14.2945 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 2 7 22
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 2 9 10
M  V30 12 1 9 26
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1542130-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1542130-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4008757
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of
5-Benzamido-N-methyl-6-oxo-1,6-dihydropyrimidine-2-carboxamide 4a,b. An
aqueous solution of methylamine (40 wt %, 2 mL) was added dropwise to a
cooled mixture of the corresponding ester 3b,c (1 mmol) in ethanol (2
mL). The ice bath was removed, and the reaction was stirred at room
temperature until TLC (1:1 ethyl acetate: n-hexane) showed complete
conversion of the starting material. Water (10 mL) was added, and the
crude amide was filtered off and recrystallized from an appropriate
solvent to afford amides 4a,b.
1-(2-(1H-Indol-3-yl)ethyl)-5-benzamido-N-methyl-6-oxo-1,6-di-hydropyrimidine-2-carboxamide
(4a). Yield 90%, 373 mg, pale white solid. Rf = 0.32 (n-hexane/ethyl
acetate 1:1); mp 270°C (from THF); 1H NMR (500 MHz, DMSO-d6) δ 10.89 (s,
1H), 9.58 (s, 1H), 8.84 (d, J = 4.6, 1H), 8.78 (s, 1H), 8.00 (d, J = 7.4
Hz, 2H), 7.71 (d, J = 7.8 Hz, 1H), 7.65 (t, J = 7.3 Hz, 1H), 7.57 (t, J =
7.5 Hz, 2H), 7.36 (d, J = 8.0 Hz, 1H), 7.16 (s, 1H), 7.09 (t, J = 7.4 Hz,
1H), 7.02 (t, J = 7.3 Hz, 1H), 4.57-4.28 (m, 2H), 3.20-3.06 (m, 2H), 2.73
(d, J = 4.6 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) δ 165.4, 161.3, 157.1,
147.9, 137.2, 136.2, 133.2, 132.2, 128.6, 127.5, 126.9, 126.5, 123.1,
121.0, 118.3, 118.2, 111.4, 110.0, 46.0, 25.8, 24.5. Anal. Calcd. for
C23H21N5O3 : C, 66.49; H, 5.09; N, 16.86. Found: C, 66.32; H, 4.86; N
16.69
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Conformational Analysis of Trispyrimidonamides as
α-Helix Mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spanier, Lukas; Ciglia, Emanuele; Hansen, Finn K.; Kuna, Krystina; Frank,
Walter; Gohlke, Holger; Kurz, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(4), 1582-1593

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-(3-cyano-1-methyl-4,5-diphenyl-1H-pyrrol-2-yl)methanimidate
C21H19N3O
155194-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 8.3503 0.0 0
M  V30 2 N 4.5735 9.8150 0.0 0
M  V30 3 C 8.2358 3.9646 0.0 0
M  V30 4 N 8.2358 7.3150 0.0 0
M  V30 5 C 9.6426 6.6887 0.0 0
M  V30 6 O 10.8884 7.5939 0.0 0
M  V30 7 C 12.2954 6.9674 0.0 0
M  V30 8 C 13.5412 7.8726 0.0 0
M  V30 9 C 4.6200 5.6398 0.0 0
M  V30 10 C 5.5252 4.3939 0.0 0
M  V30 11 C 5.5252 6.8856 0.0 0
M  V30 12 N 6.9898 4.8698 0.0 0
M  V30 13 C 6.9898 6.4098 0.0 0
M  V30 14 C 3.0800 5.6398 0.0 0
M  V30 15 C 2.3100 4.3061 0.0 0
M  V30 16 C 2.3100 6.9736 0.0 0
M  V30 17 C 0.7700 4.3061 0.0 0
M  V30 18 C 0.7700 6.9736 0.0 0
M  V30 19 C 0.0000 5.6398 0.0 0
M  V30 20 C 5.0494 2.9294 0.0 0
M  V30 21 C 6.0798 1.7849 0.0 0
M  V30 22 C 3.5429 2.6091 0.0 0
M  V30 23 C 5.6039 0.3203 0.0 0
M  V30 24 C 3.0671 1.1445 0.0 0
M  V30 25 C 4.0975 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 12
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 20
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Dihydro-3,7-dimethyl-5,6-diphenyl-4H-pyrrolo[2,3-d]pyrimidin-4-imine
C20H18N4
2139241-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.3235 2.5598 0.0 0
M  V30 2 C 5.0494 8.3502 0.0 0
M  V30 3 C 10.9910 4.0998 0.0 0
M  V30 4 C 5.5252 4.3938 0.0 0
M  V30 5 C 6.9899 4.8698 0.0 0
M  V30 6 C 4.6200 5.6398 0.0 0
M  V30 7 C 6.9899 6.4098 0.0 0
M  V30 8 C 8.3235 4.0998 0.0 0
M  V30 9 N 5.5252 6.8856 0.0 0
M  V30 10 N 8.3235 7.1798 0.0 0
M  V30 11 N 9.6572 4.8698 0.0 0
M  V30 12 C 9.6572 6.4098 0.0 0
M  V30 13 C 5.0494 2.9292 0.0 0
M  V30 14 C 3.5431 2.6091 0.0 0
M  V30 15 C 6.0798 1.7847 0.0 0
M  V30 16 C 3.0671 1.1444 0.0 0
M  V30 17 C 5.6039 0.3202 0.0 0
M  V30 18 C 4.0976 0.0000 0.0 0
M  V30 19 C 3.0800 5.6398 0.0 0
M  V30 20 C 2.3100 6.9734 0.0 0
M  V30 21 C 2.3100 4.3060 0.0 0
M  V30 22 C 0.7700 6.9734 0.0 0
M  V30 23 C 0.7700 4.3060 0.0 0
M  V30 24 C 0.0000 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 19
M  V30 11 1 7 9
M  V30 12 1 7 10
M  V30 13 1 8 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155194-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139241-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-21347299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Two new pyrrolo[2,3-d]pyrimidines (7-deazapurines): ultrasonic-assisted
synthesis, experimental and theoretical characterizations as well as
antibacterial evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vazirimehr, Simin; Davoodnia, Abolghasem; Beyramabadi, S. Ali;
Nakhaei-Moghaddam, Mahboobeh; Tavakoli-Hoseini, Niloofar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2017), 72(7), 481-487

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-1-[(2S)-2-oxiranyl]-2-phenylethyl]carbamate
C15H21NO3
156474-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8502 0.0 0 CFG=2
M  V30 2 C 3.0800 2.8502 0.0 0
M  V30 3 N 5.3900 4.1839 0.0 0
M  V30 4 C 6.9300 4.1839 0.0 0
M  V30 5 O 7.7000 5.5175 0.0 0
M  V30 6 O 7.7000 2.8502 0.0 0
M  V30 7 C 9.2400 5.5175 0.0 0
M  V30 8 C 9.2400 3.9775 0.0 0
M  V30 9 C 10.7800 5.5175 0.0 0
M  V30 10 C 9.2400 7.0575 0.0 0
M  V30 11 C 5.3900 1.5166 0.0 0 CFG=2
M  V30 12 C 4.2104 0.5267 0.0 0
M  V30 13 O 5.6573 0.0000 0.0 0
M  V30 14 C 2.3100 4.1839 0.0 0
M  V30 15 C 0.7700 4.1839 0.0 0
M  V30 16 C 3.0800 5.5175 0.0 0
M  V30 17 C 0.0000 5.5175 0.0 0
M  V30 18 C 2.3100 6.8513 0.0 0
M  V30 19 C 0.7700 6.8513 0.0 0
M  V30 20 H 6.8371 2.0433 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 11 20
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1R,2R)-2-hydroxy-3-(methylamino)-1-(phenylmethyl)propyl]-, 1...
C16H26N2O3
853904-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 N 6.9300 5.3347 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 5 C 7.7000 6.6684 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 O 3.0800 4.0011 0.0 0
M  V30 8 O 9.2400 6.6684 0.0 0
M  V30 9 O 6.9300 8.0021 0.0 0
M  V30 10 N 4.6200 1.3336 0.0 0
M  V30 11 C 10.0100 8.0021 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 8.6764 8.7721 0.0 0
M  V30 14 C 10.7800 9.3358 0.0 0
M  V30 15 C 11.3436 7.2321 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156474-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853904-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-3569656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM However, for the reaction leading to analogue 21, methylamine was bubbled
into the solution to saturation and the reaction was carried out in a
pressured vessel. The solution was diluted with ethyl acetate and washed
consecutively with water, aqueous 1 N HCl, and saturated NaHCO3, and the
organic phase was dried over Na2SO4, filtered, and concentrated to
provide the amino alcohol 9.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction carried out in pressurized vessel
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereochemical Analysis of (Hydroxyethyl)urea Peptidomimetic Inhibitors
of γ-Secretase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bakshi, Pancham; Wolfe, Michael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(26), 6485-6489

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-[(2-Azido-2-methyl-1-oxopropyl)amino]phenyl]sulfonyl]-2-methylalanyl-2-...
C29H40N8O9S2
1568826-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 7.8512 0.0 0
M  V30 2 C 6.6685 8.6213 0.0 0
M  V30 3 C 8.0022 7.8512 0.0 0
M  V30 4 O 6.6685 10.1613 0.0 0
M  V30 5 N 8.7722 9.1849 0.0 0
M  V30 6 C 9.3358 7.0812 0.0 0
M  V30 7 C 7.2322 6.5176 0.0 0
M  V30 8 C 10.3122 9.1849 0.0 0
M  V30 9 C 11.0822 10.5187 0.0 0
M  V30 10 O 11.0822 7.8512 0.0 0
M  V30 11 N 12.4159 9.7487 0.0 0
M  V30 12 C 11.8523 11.8524 0.0 0
M  V30 13 C 9.7486 11.2888 0.0 0
M  V30 14 S 13.7497 10.5187 0.0 0 VAL=6
M  V30 15 O 12.9797 11.8524 0.0 0
M  V30 16 O 14.5197 9.1849 0.0 0
M  V30 17 S 2.6673 6.3112 0.0 0 VAL=6
M  V30 18 N 2.6673 4.7712 0.0 0
M  V30 19 O 1.1273 6.3112 0.0 0
M  V30 20 O 4.2074 6.3112 0.0 0
M  V30 21 C 1.3337 4.0012 0.0 0
M  V30 22 C 2.1037 2.6675 0.0 0
M  V30 23 C 0.0000 3.2311 0.0 0
M  V30 24 C 0.5637 5.3348 0.0 0
M  V30 25 O 1.3337 1.3338 0.0 0
M  V30 26 O 3.6437 2.6675 0.0 0
M  V30 27 C 2.1037 0.0000 0.0 0
M  V30 28 N 16.4171 8.9787 0.0 0
M  V30 29 C 17.7507 8.2087 0.0 0
M  V30 30 C 17.7507 6.6687 0.0 0
M  V30 31 O 19.0846 8.9787 0.0 0
M  V30 32 N 19.2908 6.6687 0.0 0
M  V30 33 C 17.7507 5.1286 0.0 0
M  V30 34 C 16.2107 6.6687 0.0 0
M  V30 35 N 20.0608 5.3348 0.0 0 CHG=1 VAL=4
M  V30 36 N 20.8308 4.0012 0.0 0 CHG=-1
M  V30 37 C 4.0010 8.6213 0.0 0
M  V30 38 C 2.6673 7.8512 0.0 0
M  V30 39 C 4.0010 10.1613 0.0 0
M  V30 40 C 1.3337 8.6213 0.0 0
M  V30 41 C 2.6673 10.9313 0.0 0
M  V30 42 C 1.3337 10.1613 0.0 0
M  V30 43 C 15.0834 11.2888 0.0 0
M  V30 44 C 16.4171 10.5187 0.0 0
M  V30 45 C 15.0834 12.8288 0.0 0
M  V30 46 C 17.7507 11.2888 0.0 0
M  V30 47 C 16.4171 13.5988 0.0 0
M  V30 48 C 17.7507 12.8288 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 37
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 14 15
M  V30 16 2 14 16
M  V30 17 1 14 43
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 17 20
M  V30 21 1 17 38
M  V30 22 1 18 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 1 25 27
M  V30 29 1 28 29
M  V30 30 1 28 44
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 1 30 34
M  V30 36 2 32 35
M  V30 37 2 35 36
M  V30 38 2 37 38
M  V30 39 1 37 39
M  V30 40 1 38 40
M  V30 41 2 39 41
M  V30 42 2 40 42
M  V30 43 1 41 42
M  V30 44 2 43 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 2 45 47
M  V30 48 2 46 48
M  V30 49 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-[(2-Azido-2-methyl-1-oxopropyl)amino]phenyl]sulfonyl]-2-methylalanyl-2-...
C29H41N9O8S2
1568826-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 7.8512 0.0 0
M  V30 2 C 6.6685 8.6213 0.0 0
M  V30 3 C 8.0022 7.8512 0.0 0
M  V30 4 O 6.6685 10.1613 0.0 0
M  V30 5 N 8.7722 9.1849 0.0 0
M  V30 6 C 9.3358 7.0812 0.0 0
M  V30 7 C 7.2322 6.5176 0.0 0
M  V30 8 C 10.3122 9.1849 0.0 0
M  V30 9 C 11.0822 10.5187 0.0 0
M  V30 10 O 11.0822 7.8512 0.0 0
M  V30 11 N 12.4159 9.7487 0.0 0
M  V30 12 C 11.8523 11.8524 0.0 0
M  V30 13 C 9.7486 11.2888 0.0 0
M  V30 14 S 13.7497 10.5187 0.0 0 VAL=6
M  V30 15 O 12.9797 11.8524 0.0 0
M  V30 16 O 14.5197 9.1849 0.0 0
M  V30 17 S 2.6673 6.3112 0.0 0 VAL=6
M  V30 18 N 2.6673 4.7712 0.0 0
M  V30 19 O 4.2074 6.3112 0.0 0
M  V30 20 O 1.1273 6.3112 0.0 0
M  V30 21 C 1.3337 4.0012 0.0 0
M  V30 22 C 2.1037 2.6675 0.0 0
M  V30 23 C 0.0000 3.2311 0.0 0
M  V30 24 C 0.5637 5.3348 0.0 0
M  V30 25 N 1.3337 1.3338 0.0 0
M  V30 26 O 3.6437 2.6675 0.0 0
M  V30 27 C 2.1037 0.0000 0.0 0
M  V30 28 N 16.4171 8.9787 0.0 0
M  V30 29 C 17.7507 8.2087 0.0 0
M  V30 30 C 17.7507 6.6687 0.0 0
M  V30 31 O 19.0846 8.9787 0.0 0
M  V30 32 N 19.2908 6.6687 0.0 0
M  V30 33 C 17.7507 5.1286 0.0 0
M  V30 34 C 16.2107 6.6687 0.0 0
M  V30 35 N 20.0608 5.3348 0.0 0 CHG=1 VAL=4
M  V30 36 N 20.8308 4.0012 0.0 0 CHG=-1
M  V30 37 C 4.0010 8.6213 0.0 0
M  V30 38 C 2.6673 7.8512 0.0 0
M  V30 39 C 4.0010 10.1613 0.0 0
M  V30 40 C 1.3337 8.6213 0.0 0
M  V30 41 C 2.6673 10.9313 0.0 0
M  V30 42 C 1.3337 10.1613 0.0 0
M  V30 43 C 15.0834 11.2888 0.0 0
M  V30 44 C 16.4171 10.5187 0.0 0
M  V30 45 C 15.0834 12.8288 0.0 0
M  V30 46 C 17.7507 11.2888 0.0 0
M  V30 47 C 16.4171 13.5988 0.0 0
M  V30 48 C 17.7507 12.8288 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 37
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 14 15
M  V30 16 2 14 16
M  V30 17 1 14 43
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 17 20
M  V30 21 1 17 38
M  V30 22 1 18 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 2 22 26
M  V30 28 1 25 27
M  V30 29 1 28 29
M  V30 30 1 28 44
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 30 32
M  V30 34 1 30 33
M  V30 35 1 30 34
M  V30 36 2 32 35
M  V30 37 2 35 36
M  V30 38 2 37 38
M  V30 39 1 37 39
M  V30 40 1 38 40
M  V30 41 2 39 41
M  V30 42 2 40 42
M  V30 43 1 41 42
M  V30 44 2 43 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 2 45 47
M  V30 48 2 46 48
M  V30 49 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1568826-40-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1568826-69-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13334340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational modulation of peptide secondary structures using
β-aminobenzenesulfonic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kale, Sangram S.; Kunjir, Shrikant M.; Gawade, Rupesh L.; Puranik,
Vedavati G.; Rajamohanan, P. R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(22),
2886-2888

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(4-chlorophenyl)phosphine oxide
C12H9Cl2OP
15948-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 5.3347 1.5400 0.0 0 VAL=5
M  V30 2 O 5.3347 0.0000 0.0 0
M  V30 3 Cl 10.6694 4.6200 0.0 0
M  V30 4 Cl 0.0000 4.6200 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 C 6.6684 3.8500 0.0 0
M  V30 7 C 8.0021 1.5400 0.0 0
M  V30 8 C 8.0021 4.6200 0.0 0
M  V30 9 C 9.3358 2.3100 0.0 0
M  V30 10 C 9.3358 3.8500 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 2.6673 4.6200 0.0 0
M  V30 15 C 1.3336 2.3100 0.0 0
M  V30 16 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 10
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
P,P-Bis(4-chlorophenyl)-N-methylphosphinic amide
C13H12Cl2NOP
1251821-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 6.1600 2.3100 0.0 0 VAL=5
M  V30 2 N 6.1600 0.7700 0.0 0
M  V30 3 O 6.1600 3.8500 0.0 0
M  V30 4 C 4.8264 0.0000 0.0 0
M  V30 5 Cl 12.3200 2.3100 0.0 0
M  V30 6 Cl 0.0000 2.3100 0.0 0
M  V30 7 C 7.7000 2.3100 0.0 0
M  V30 8 C 8.4700 0.9764 0.0 0
M  V30 9 C 8.4700 3.6436 0.0 0
M  V30 10 C 10.0100 0.9764 0.0 0
M  V30 11 C 10.0100 3.6436 0.0 0
M  V30 12 C 10.7800 2.3100 0.0 0
M  V30 13 C 4.6200 2.3100 0.0 0
M  V30 14 C 3.8500 0.9764 0.0 0
M  V30 15 C 3.8500 3.6436 0.0 0
M  V30 16 C 2.3100 0.9764 0.0 0
M  V30 17 C 2.3100 3.6436 0.0 0
M  V30 18 C 1.5400 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 1 2 4
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15948-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251821-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-568-CAS-5520731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 56-23-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Phosphorylation of primary amines,
dimethylamine, and N-(2-hydroxyethyl)-N-methylamine. Diethylphosphoric
and diaryl- and dibutylphosphinic alkyl- and dialkylamides 2a-n and 3a-c
(general procedures). Method A. A 27% aqueous solution of methylamine (15
mmol) and a 50% aqueous solution of NaOH (11 mmol) were successively
added dropwise at 0-5°C to a stirred solution of acid 1 (10 mmol) in
CH2Cl2 (10 mL) and CCl4 (30 mmol). The reaction mixture was stirred at
20-25°C for 0.5-1 h, the organic layer was separated, washed with a
saturated solution of K2CO3 (2×5 mL) and water (3×5 mL), dried with
Na2SO4, and concentrated in vacuo. The residue was distilled,
recrystallized or chromatographed on silica gel (see Tables 1 and 2).
Compound: 2m; Yield: 90%. M.p. (solvent): 130-133°C (C6H6-MeOH);
molecular formula: C13H12Cl2NOP; elemental analysis Found, (%): C, 51.82;
H, 3.94; N, 4.5; P, 10.19; Calculated, (%): 52.02; H, 4.03; N, 4.67; P,
10.32; 31P NMR δP: 23.7; 1H NMR spectra δH (J/Hz): 2.69 (dd, 3H, NMe, 3 J
H,P = 12.2, 3 J H,H = 2.4); 3.07-3.29 (m, 1H, NH); 7.42-7.50 (m, 4H,
p-ClC6H4); 7.78-7.88 (m, 4H, p-ClC6H4).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of nonsymmetrical dialkylamines on the basis of
diphenylphosphinic amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bondarenko, N. A.; Kharlamov, A. V.; Vendilo, A. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2009), 58(9), 1872-1885

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-leucyl-2-methylalanyl-2-aminobenzenesulfon...
C37H60N6O10S
1596346-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 11.3774 9.1847 0.0 0 VAL=6
M  V30 2 O 12.1474 7.8511 0.0 0
M  V30 3 O 10.6074 10.5184 0.0 0
M  V30 4 C 8.3166 10.5475 0.0 0
M  V30 5 N 6.8521 11.0233 0.0 0
M  V30 6 O 9.4611 11.5779 0.0 0
M  V30 7 C 6.5319 12.5297 0.0 0 CFG=1
M  V30 8 C 5.0672 13.0056 0.0 0
M  V30 9 C 7.6763 13.5602 0.0 0
M  V30 10 N 3.9228 11.9752 0.0 0
M  V30 11 O 4.7471 14.5119 0.0 0
M  V30 12 C 7.3561 15.0664 0.0 0
M  V30 13 C 2.4581 12.4511 0.0 0
M  V30 14 C 5.8914 15.5425 0.0 0
M  V30 15 C 8.5005 16.0970 0.0 0
M  V30 16 C 1.9823 10.9864 0.0 0
M  V30 17 C 0.9935 12.9269 0.0 0
M  V30 18 C 2.9340 13.9156 0.0 0
M  V30 19 O 0.4759 10.6662 0.0 0
M  V30 20 O 3.0127 9.8420 0.0 0
M  V30 21 C 0.0000 9.2015 0.0 0
M  V30 22 N 14.0448 7.6447 0.0 0
M  V30 23 C 15.3784 6.8747 0.0 0
M  V30 24 C 15.3784 5.3347 0.0 0
M  V30 25 O 16.7121 7.6447 0.0 0
M  V30 26 N 16.9184 5.3347 0.0 0
M  V30 27 C 13.8384 5.3347 0.0 0
M  V30 28 C 15.3784 3.7947 0.0 0
M  V30 29 C 17.6884 4.0011 0.0 0
M  V30 30 C 19.2284 4.0011 0.0 0 CFG=2
M  V30 31 O 16.9184 2.6674 0.0 0
M  V30 32 N 19.9984 5.3347 0.0 0
M  V30 33 C 19.9984 2.6674 0.0 0
M  V30 34 C 21.5384 5.3347 0.0 0
M  V30 35 C 19.2284 1.3336 0.0 0
M  V30 36 O 22.3084 6.6684 0.0 0
M  V30 37 O 22.3084 4.0011 0.0 0
M  V30 38 C 17.6884 1.3336 0.0 0
M  V30 39 C 19.9984 0.0000 0.0 0
M  V30 40 C 23.8484 6.6684 0.0 0
M  V30 41 C 23.8484 5.1284 0.0 0
M  V30 42 C 25.3884 6.6684 0.0 0
M  V30 43 C 23.8484 8.2084 0.0 0
M  V30 44 N 10.0437 8.4147 0.0 0
M  V30 45 C 8.6368 9.0412 0.0 0 CFG=2
M  V30 46 C 9.8828 6.8832 0.0 0
M  V30 47 C 7.6064 7.8967 0.0 0
M  V30 48 C 8.3764 6.5630 0.0 0
M  V30 49 C 12.7110 9.9547 0.0 0
M  V30 50 C 14.0448 9.1847 0.0 0
M  V30 51 C 12.7110 11.4947 0.0 0
M  V30 52 C 15.3784 9.9547 0.0 0
M  V30 53 C 14.0448 12.2647 0.0 0
M  V30 54 C 15.3784 11.4947 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 44
M  V30 4 1 1 49
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 45 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 19 21
M  V30 23 1 22 23
M  V30 24 1 22 50
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 26 29
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 30 32
M  V30 34 1 30 33 CFG=1
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 34 37
M  V30 39 1 35 38
M  V30 40 1 35 39
M  V30 41 1 36 40
M  V30 42 1 40 41
M  V30 43 1 40 42
M  V30 44 1 40 43
M  V30 45 1 44 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 1 47 48
M  V30 50 2 49 50
M  V30 51 1 49 51
M  V30 52 1 50 52
M  V30 53 2 51 53
M  V30 54 2 52 54
M  V30 55 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 30 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-leucyl-2-methylalanyl-2-aminobenzenesulfon...
C37H61N7O9S
1596346-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  54 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 11.3774 9.1847 0.0 0 VAL=6
M  V30 2 O 12.1474 7.8511 0.0 0
M  V30 3 O 10.6074 10.5184 0.0 0
M  V30 4 C 8.3166 10.5475 0.0 0
M  V30 5 N 6.8521 11.0233 0.0 0
M  V30 6 O 9.4611 11.5779 0.0 0
M  V30 7 C 6.5319 12.5297 0.0 0 CFG=1
M  V30 8 C 5.0672 13.0056 0.0 0
M  V30 9 C 7.6763 13.5602 0.0 0
M  V30 10 N 3.9228 11.9752 0.0 0
M  V30 11 O 4.7471 14.5119 0.0 0
M  V30 12 C 7.3561 15.0664 0.0 0
M  V30 13 C 2.4581 12.4511 0.0 0
M  V30 14 C 5.8914 15.5425 0.0 0
M  V30 15 C 8.5005 16.0970 0.0 0
M  V30 16 C 1.9823 10.9864 0.0 0
M  V30 17 C 0.9935 12.9269 0.0 0
M  V30 18 C 2.9340 13.9156 0.0 0
M  V30 19 N 0.4759 10.6662 0.0 0
M  V30 20 O 3.0127 9.8420 0.0 0
M  V30 21 C 0.0000 9.2015 0.0 0
M  V30 22 N 14.0448 7.6447 0.0 0
M  V30 23 C 15.3784 6.8747 0.0 0
M  V30 24 C 15.3784 5.3347 0.0 0
M  V30 25 O 16.7121 7.6447 0.0 0
M  V30 26 N 16.9184 5.3347 0.0 0
M  V30 27 C 15.3784 3.7947 0.0 0
M  V30 28 C 13.8384 5.3347 0.0 0
M  V30 29 C 17.6884 4.0011 0.0 0
M  V30 30 C 19.2284 4.0011 0.0 0 CFG=2
M  V30 31 O 16.9184 2.6674 0.0 0
M  V30 32 N 19.9984 5.3347 0.0 0
M  V30 33 C 19.9984 2.6674 0.0 0
M  V30 34 C 21.5384 5.3347 0.0 0
M  V30 35 C 19.2284 1.3336 0.0 0
M  V30 36 O 22.3084 6.6684 0.0 0
M  V30 37 O 22.3084 4.0011 0.0 0
M  V30 38 C 17.6884 1.3336 0.0 0
M  V30 39 C 19.9984 0.0000 0.0 0
M  V30 40 C 23.8484 6.6684 0.0 0
M  V30 41 C 23.8484 8.2084 0.0 0
M  V30 42 C 25.3884 6.6684 0.0 0
M  V30 43 C 23.8484 5.1284 0.0 0
M  V30 44 N 10.0437 8.4147 0.0 0
M  V30 45 C 8.6368 9.0412 0.0 0 CFG=2
M  V30 46 C 9.8828 6.8832 0.0 0
M  V30 47 C 7.6064 7.8967 0.0 0
M  V30 48 C 8.3764 6.5630 0.0 0
M  V30 49 C 12.7110 9.9547 0.0 0
M  V30 50 C 14.0448 9.1847 0.0 0
M  V30 51 C 12.7110 11.4947 0.0 0
M  V30 52 C 15.3784 9.9547 0.0 0
M  V30 53 C 14.0448 12.2647 0.0 0
M  V30 54 C 15.3784 11.4947 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 44
M  V30 4 1 1 49
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 45 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 19 21
M  V30 23 1 22 23
M  V30 24 1 22 50
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 26 29
M  V30 31 1 29 30
M  V30 32 2 29 31
M  V30 33 1 30 32
M  V30 34 1 30 33 CFG=1
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 34 37
M  V30 39 1 35 38
M  V30 40 1 35 39
M  V30 41 1 36 40
M  V30 42 1 40 41
M  V30 43 1 40 42
M  V30 44 1 40 43
M  V30 45 1 44 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 1 47 48
M  V30 50 2 49 50
M  V30 51 1 49 51
M  V30 52 1 50 52
M  V30 53 2 51 53
M  V30 54 2 52 54
M  V30 55 1 53 54
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 30 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1596346-40-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1596346-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15584220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Probing the folding induction ability of orthanilic acid in peptides:
some observations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roy, Arup; Kotmale, Amol S.; Gawade, Rupesh L.; Puranik, Vedavati G.;
Rajamohanan, P. R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(25), 13018-13025

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6-phenyl-4-(trifluoromethyl)furo[2,3-b]pyridine-2-carboxylate
C17H13F3N2O3
160436-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 F 3.7947 1.5400 0.0 0
M  V30 3 F 5.3347 0.0000 0.0 0
M  V30 4 F 6.8747 1.5400 0.0 0
M  V30 5 N 8.6089 1.9094 0.0 0
M  V30 6 C 10.5783 4.6200 0.0 0
M  V30 7 O 11.3483 5.9536 0.0 0
M  V30 8 O 11.3483 3.2864 0.0 0
M  V30 9 C 12.8883 5.9536 0.0 0
M  V30 10 C 13.6583 7.2874 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 6.6684 5.3900 0.0 0
M  V30 13 C 5.3347 3.0800 0.0 0
M  V30 14 C 8.1330 3.3741 0.0 0
M  V30 15 N 5.3347 6.1600 0.0 0
M  V30 16 O 8.1330 5.8659 0.0 0
M  V30 17 C 4.0011 3.8500 0.0 0
M  V30 18 C 9.0383 4.6200 0.0 0
M  V30 19 C 4.0011 5.3900 0.0 0
M  V30 20 C 2.6674 6.1600 0.0 0
M  V30 21 C 2.6674 7.7000 0.0 0
M  V30 22 C 1.3336 5.3900 0.0 0
M  V30 23 C 1.3336 8.4700 0.0 0
M  V30 24 C 0.0000 6.1600 0.0 0
M  V30 25 C 0.0000 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 19 20
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N-methyl-6-phenyl-4-(trifluoromethyl)furo[2,3-b]pyridine-2-carboxamide
C16H12F3N3O2
2228865-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 F 3.7947 1.5400 0.0 0
M  V30 3 F 5.3347 0.0000 0.0 0
M  V30 4 F 6.8747 1.5400 0.0 0
M  V30 5 N 8.6089 1.9094 0.0 0
M  V30 6 C 10.5783 4.6200 0.0 0
M  V30 7 N 11.3483 5.9536 0.0 0
M  V30 8 O 11.3483 3.2864 0.0 0
M  V30 9 C 12.8883 5.9536 0.0 0
M  V30 10 C 6.6684 3.8500 0.0 0
M  V30 11 C 5.3347 3.0800 0.0 0
M  V30 12 C 6.6684 5.3900 0.0 0
M  V30 13 C 8.1330 3.3741 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 O 8.1330 5.8659 0.0 0
M  V30 16 N 5.3347 6.1600 0.0 0
M  V30 17 C 9.0383 4.6200 0.0 0
M  V30 18 C 4.0011 5.3900 0.0 0
M  V30 19 C 2.6674 6.1600 0.0 0
M  V30 20 C 1.3336 5.3900 0.0 0
M  V30 21 C 2.6674 7.7000 0.0 0
M  V30 22 C 0.0000 6.1600 0.0 0
M  V30 23 C 1.3336 8.4700 0.0 0
M  V30 24 C 0.0000 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160436-48-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2228865-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20154782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Novel Alkyl Amide Functionalized Trifluoromethyl Substituted
Furo/thieno Pyridine Derivatives: Their Anticancer Activity and CoMFA and
CoMSIA Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhoomandla, Srinu; Gunda, Shravan Kumar; Kotoori, Srawanthi; Kanuparthy,
Phani Raja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2019), 56(7), 1986-1998

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-2-(trifluoromethoxy)benzaldehyde
C8H4F3NO4
160503-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 1.3337 3.0801 0.0 0
M  V30 3 F 0.0000 2.3101 0.0 0
M  V30 4 F 0.0000 3.8501 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 O 6.6685 0.0000 0.0 0
M  V30 8 N 8.0023 5.3901 0.0 0 VAL=5
M  V30 9 O 8.0023 6.9302 0.0 0
M  V30 10 O 9.3360 4.6201 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-2-(trifluoromethoxy)benzenemethanamine
C9H9F3N2O3
1037359-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 F 8.0023 6.1601 0.0 0
M  V30 7 F 9.3360 5.3901 0.0 0
M  V30 8 F 9.3360 3.8501 0.0 0
M  V30 9 N 1.3337 6.9302 0.0 0 VAL=5
M  V30 10 O 1.3337 8.4702 0.0 0
M  V30 11 O 0.0000 6.1601 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160503-78-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037359-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16054046
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Potent, Selective, and Orally Bioavailable
Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor
Complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Johnson, James A.; Jiang, Wen;
Jacutin-Porte, Swanee; Ladziata, Vladimir; Zou, Yan; Phillips, Monique
S.; Wurtz, Nicholas R.; Parkhurst, Brandon; Rendina, Alan R.; Harper,
Timothy M.; Cheney, Daniel L.; Luettgen, Joseph M.; Wong, Pancras C.;
Seiffert, Dietmar; Wexler, Ruth R.; Priestley, E. Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(15), 7125-7137

$RFMT $RIREG SCHEME133 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis[[(1-methylethyl)thio]methyl]urea
C9H20N2OS2
1610032-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 N 8.0022 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 S 2.6673 2.3101 0.0 0
M  V30 8 S 10.6697 2.3101 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 12.0033 0.0000 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-5-methyl-1,3-bis[[(1-methylethyl)thio]methyl]-1,3,5-triazin-2(1H)-one
C12H25N3OS2
2758881-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 S 2.6673 3.8501 0.0 0
M  V30 3 C 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 O 6.6685 6.1601 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 S 10.6697 3.8501 0.0 0
M  V30 9 C 12.0033 4.6201 0.0 0
M  V30 10 C 12.0033 6.1601 0.0 0
M  V30 11 C 13.3370 3.8501 0.0 0
M  V30 12 C 6.6685 0.0000 0.0 0
M  V30 13 N 5.3348 3.8501 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 N 8.0022 3.8501 0.0 0
M  V30 17 N 6.6685 1.5400 0.0 0
M  V30 18 C 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 6 14
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 12 17
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1610032-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2758881-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31104005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction, alternative reaction conditions gave lower yield,
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multicomponent Synthesis of
1,3-Bis[(alkylsulfanyl)methyl]-1,3,5-triazinan-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeva, L. A.; Biktasheva, L. F.; Nugumanov, T. R.; Fatykhov, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2021), 57(12), 1948-1954

$RFMT $RIREG SCHEME134 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-2-carboxylic acid
C10H9NO2
16136-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0205 0.1773 0.0 0
M  V30 2 C 6.0811 1.5400 0.0 0
M  V30 3 O 7.4149 2.3100 0.0 0
M  V30 4 O 6.0811 0.0000 0.0 0
M  V30 5 C 2.3100 2.8281 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 N 3.3406 1.6836 0.0 0
M  V30 8 C 0.7700 2.8281 0.0 0
M  V30 9 C 4.5865 3.8416 0.0 0
M  V30 10 C 2.3100 5.4954 0.0 0
M  V30 11 C 4.7474 2.3100 0.0 0
M  V30 12 C 0.0000 4.1618 0.0 0
M  V30 13 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C32H29N5O5S
195444-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 14.0833 8.5298 0.0 0 VAL=6
M  V30 2 N 15.4169 7.7598 0.0 0
M  V30 3 O 13.3133 7.1962 0.0 0
M  V30 4 O 14.8533 9.8635 0.0 0
M  V30 5 C 8.7485 6.9898 0.0 0
M  V30 6 N 7.4149 6.2198 0.0 0
M  V30 7 C 6.0812 6.9898 0.0 0
M  V30 8 C 7.4149 4.6798 0.0 0
M  V30 9 O 6.0812 8.5298 0.0 0
M  V30 10 C 18.4777 6.3971 0.0 0
M  V30 11 C 20.7197 8.8870 0.0 0
M  V30 12 C 3.0204 8.3526 0.0 0
M  V30 13 C 11.4160 8.5298 0.0 0
M  V30 14 C 12.7496 9.2998 0.0 0
M  V30 15 C 10.0822 9.2998 0.0 0
M  V30 16 C 12.7496 10.8399 0.0 0
M  V30 17 C 10.0822 10.8399 0.0 0
M  V30 18 C 11.4160 11.6099 0.0 0
M  V30 19 C 11.4160 6.9898 0.0 0
M  V30 20 C 10.0822 6.2198 0.0 0
M  V30 21 C 12.7496 6.2198 0.0 0
M  V30 22 C 10.0822 4.6798 0.0 0
M  V30 23 C 12.7496 4.6798 0.0 0
M  V30 24 C 11.4160 3.9098 0.0 0
M  V30 25 C 16.7508 8.5298 0.0 0
M  V30 26 C 18.1576 7.9035 0.0 0
M  V30 27 O 16.9117 10.0614 0.0 0
M  V30 28 C 19.1880 9.0479 0.0 0
M  V30 29 N 18.4180 10.3817 0.0 0
M  V30 30 C 11.4160 2.3698 0.0 0
M  V30 31 N 10.1700 1.4646 0.0 0
M  V30 32 O 12.6619 1.4646 0.0 0
M  V30 33 C 10.6460 0.0000 0.0 0
M  V30 34 C 12.1860 0.0000 0.0 0
M  V30 35 C 4.7474 6.2198 0.0 0
M  V30 36 N 3.3406 6.8463 0.0 0
M  V30 37 C 4.5865 4.6883 0.0 0
M  V30 38 C 2.3100 5.7018 0.0 0
M  V30 39 C 3.0800 4.3681 0.0 0
M  V30 40 C 0.7700 5.7018 0.0 0
M  V30 41 C 2.3100 3.0344 0.0 0
M  V30 42 C 0.0000 4.3681 0.0 0
M  V30 43 C 0.7700 3.0344 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 25
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 7 35
M  V30 12 1 10 26
M  V30 13 1 11 28
M  V30 14 1 12 36
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 19
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 30
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 39 1 35 36
M  V30 40 2 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16136-58-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5303634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5p
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]-α-(methoxyimi...
C20H18ClN3O4
1620283-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 2.6675 2.3100 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6686 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 Cl 17.8997 4.7459 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 2.6675 5.3901 0.0 0
M  V30 15 C 5.3348 6.9301 0.0 0
M  V30 16 C 2.6675 6.9301 0.0 0
M  V30 17 C 4.0011 7.7001 0.0 0
M  V30 18 C 9.3359 4.6201 0.0 0
M  V30 19 N 10.7429 5.2464 0.0 0
M  V30 20 C 9.4968 3.0885 0.0 0
M  V30 21 N 11.7733 4.1020 0.0 0
M  V30 22 C 11.0033 2.7683 0.0 0
M  V30 23 C 13.3049 4.2629 0.0 0
M  V30 24 C 13.9312 5.6699 0.0 0
M  V30 25 C 14.2101 3.0171 0.0 0
M  V30 26 C 15.4629 5.8308 0.0 0
M  V30 27 C 15.7416 3.1780 0.0 0
M  V30 28 C 16.3680 4.5849 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 13
M  V30 11 1 10 18
M  V30 12 1 11 28
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[1-(4-Chlorophenyl)-1H-pyrazol-3-yl]oxy]methyl]-α-(methoxyimino)-N-m...
C20H19ClN4O3
1637478-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 2.6675 2.3100 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 O 6.6686 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6686 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6686 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 Cl 17.8997 4.7459 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 2.6675 5.3901 0.0 0
M  V30 15 C 5.3348 6.9301 0.0 0
M  V30 16 C 2.6675 6.9301 0.0 0
M  V30 17 C 4.0011 7.7001 0.0 0
M  V30 18 C 9.3359 4.6201 0.0 0
M  V30 19 N 10.7429 5.2464 0.0 0
M  V30 20 C 9.4968 3.0885 0.0 0
M  V30 21 N 11.7733 4.1020 0.0 0
M  V30 22 C 11.0033 2.7683 0.0 0
M  V30 23 C 13.3049 4.2629 0.0 0
M  V30 24 C 13.9312 5.6699 0.0 0
M  V30 25 C 14.2101 3.0171 0.0 0
M  V30 26 C 15.4629 5.8308 0.0 0
M  V30 27 C 15.7416 3.1780 0.0 0
M  V30 28 C 16.3680 4.5849 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 13
M  V30 11 1 10 18
M  V30 12 1 11 28
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620283-74-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1637478-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4307178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and fungicidal activity of novel chloro-containing
1-aryl-3-oxypyrazoles with an oximino ester or oximino amide moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yuanyuan; Li, Yi; Chen, Nanqing; Lv, Kunzhi; Zhou, Chao; Xiong,
Xiaohui; Li, Fangshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2014), 19(6), 8140-8150, 11 pp.

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hepten-2-ol, 6-methyl-, 2-methanesulfonate, (2S)-
C9H18O3S
1620401-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0 CFG=1
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 4.0012 0.0000 0.0 0
M  V30 5 S 1.3337 1.5400 0.0 0 VAL=6
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 O 0.0000 0.7700 0.0 0
M  V30 9 O 2.1037 0.2064 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Isometheptene
C9H19N
503-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 7 8
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620401-61-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503-01-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16295748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Teflon lined sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazoline receptor type 1 ligands for use as therapeutics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rideout, Darryl; Lederman, Seth; Daugherty, Bruce; Gershell, Leland J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016105448 A1 2016-06-30

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-cyano-4-(methoxycarbonyl)phenyl]-1-piperazinecarboxylate
C18H23N3O4
1620775-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 N 9.2400 0.0000 0.0 0
M  V30 3 C 14.6300 4.0011 0.0 0
M  V30 4 O 15.4000 5.3349 0.0 0
M  V30 5 O 15.4000 2.6674 0.0 0
M  V30 6 C 16.9400 5.3349 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 O 3.0800 5.3349 0.0 0
M  V30 9 O 3.0800 2.6674 0.0 0
M  V30 10 C 1.5400 5.3349 0.0 0
M  V30 11 C 1.5400 6.8749 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 1.5400 3.7949 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 10.7800 2.6674 0.0 0
M  V30 16 C 10.7800 5.3349 0.0 0
M  V30 17 C 12.3200 2.6674 0.0 0
M  V30 18 C 12.3200 5.3349 0.0 0
M  V30 19 C 13.0900 4.0011 0.0 0
M  V30 20 N 8.4700 4.0011 0.0 0
M  V30 21 C 7.7000 5.3349 0.0 0
M  V30 22 C 7.7000 2.6674 0.0 0
M  V30 23 C 6.1600 5.3349 0.0 0
M  V30 24 C 6.1600 2.6674 0.0 0
M  V30 25 N 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-cyano-4-[(methylamino)carbonyl]phenyl]-1-piperazinecar...
C18H24N4O3
2855981-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 N 9.2400 0.0000 0.0 0
M  V30 3 C 14.6300 4.0011 0.0 0
M  V30 4 N 15.4000 5.3349 0.0 0
M  V30 5 O 15.4000 2.6674 0.0 0
M  V30 6 C 16.9400 5.3349 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 O 3.0800 5.3349 0.0 0
M  V30 9 O 3.0800 2.6674 0.0 0
M  V30 10 C 1.5400 5.3349 0.0 0
M  V30 11 C 1.5400 6.8749 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 C 1.5400 3.7949 0.0 0
M  V30 14 C 10.0100 4.0011 0.0 0
M  V30 15 C 10.7800 2.6674 0.0 0
M  V30 16 C 10.7800 5.3349 0.0 0
M  V30 17 C 12.3200 2.6674 0.0 0
M  V30 18 C 12.3200 5.3349 0.0 0
M  V30 19 C 13.0900 4.0011 0.0 0
M  V30 20 N 8.4700 4.0011 0.0 0
M  V30 21 C 7.7000 2.6674 0.0 0
M  V30 22 C 7.7000 5.3349 0.0 0
M  V30 23 C 6.1600 2.6674 0.0 0
M  V30 24 C 6.1600 5.3349 0.0 0
M  V30 25 N 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620775-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855981-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35013784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine derivatives as PARP1 inhibitors useful in
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trzoss, Lynnie; Dong, Qing; Kaldor, Stephen W.; Hoffman, Robert L.; Va,
Porino Jinjo; Pinchman, Joseph Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022225934 A1 2022-10-27

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 4-[5-carboxy-4-(4-phenoxyphenyl)-2-thiazolyl]-1-piperaz...
C25H27N3O5S
1628356-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6692 1.1444 0.0 0
M  V30 2 O 10.6998 0.0000 0.0 0
M  V30 3 O 8.1630 0.8242 0.0 0
M  V30 4 O 3.0800 3.8549 0.0 0
M  V30 5 C 16.5934 8.2457 0.0 0
M  V30 6 O 18.0002 7.6193 0.0 0
M  V30 7 O 16.4323 9.7772 0.0 0
M  V30 8 C 19.2461 8.5246 0.0 0
M  V30 9 C 20.1513 7.2787 0.0 0
M  V30 10 C 20.4920 9.4298 0.0 0
M  V30 11 C 18.3409 9.7704 0.0 0
M  V30 12 C 9.2400 3.8549 0.0 0
M  V30 13 C 10.1451 2.6091 0.0 0
M  V30 14 N 10.1451 5.1008 0.0 0
M  V30 15 S 11.6098 3.0849 0.0 0
M  V30 16 C 11.6098 4.6250 0.0 0
M  V30 17 C 7.7000 3.8549 0.0 0
M  V30 18 C 6.9300 2.5213 0.0 0
M  V30 19 C 6.9300 5.1886 0.0 0
M  V30 20 C 5.3900 2.5213 0.0 0
M  V30 21 C 5.3900 5.1886 0.0 0
M  V30 22 C 4.6200 3.8549 0.0 0
M  V30 23 N 12.8557 5.5302 0.0 0
M  V30 24 C 14.2626 4.9037 0.0 0
M  V30 25 C 12.6947 7.0617 0.0 0
M  V30 26 C 15.5085 5.8089 0.0 0
M  V30 27 C 13.9406 7.9669 0.0 0
M  V30 28 N 15.3474 7.3404 0.0 0
M  V30 29 C 2.3100 5.1886 0.0 0
M  V30 30 C 0.7700 5.1886 0.0 0
M  V30 31 C 3.0800 6.5222 0.0 0
M  V30 32 C 0.0000 6.5222 0.0 0
M  V30 33 C 2.3100 7.8560 0.0 0
M  V30 34 C 0.7700 7.8560 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 22
M  V30 5 1 4 29
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 16 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-[(methylamino)carbonyl]-4-(4-phenoxyphenyl)-2-thiazoly...
C26H30N4O4S
1688666-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6692 2.6091 0.0 0
M  V30 2 N 10.6998 1.4647 0.0 0
M  V30 3 O 8.1630 2.2889 0.0 0
M  V30 4 C 10.2238 0.0000 0.0 0
M  V30 5 O 3.0800 5.3196 0.0 0
M  V30 6 C 16.5934 9.7104 0.0 0
M  V30 7 O 18.0002 9.0840 0.0 0
M  V30 8 O 16.4323 11.2421 0.0 0
M  V30 9 C 19.2461 9.9893 0.0 0
M  V30 10 C 18.3409 11.2351 0.0 0
M  V30 11 C 20.4920 10.8945 0.0 0
M  V30 12 C 20.1513 8.7434 0.0 0
M  V30 13 C 9.2400 5.3196 0.0 0
M  V30 14 C 10.1451 4.0738 0.0 0
M  V30 15 N 10.1451 6.5655 0.0 0
M  V30 16 S 11.6098 4.5496 0.0 0
M  V30 17 C 11.6098 6.0897 0.0 0
M  V30 18 C 7.7000 5.3196 0.0 0
M  V30 19 C 6.9300 3.9860 0.0 0
M  V30 20 C 6.9300 6.6533 0.0 0
M  V30 21 C 5.3900 3.9860 0.0 0
M  V30 22 C 5.3900 6.6533 0.0 0
M  V30 23 C 4.6200 5.3196 0.0 0
M  V30 24 N 12.8557 6.9949 0.0 0
M  V30 25 C 12.6947 8.5264 0.0 0
M  V30 26 C 14.2626 6.3685 0.0 0
M  V30 27 C 13.9406 9.4316 0.0 0
M  V30 28 C 15.5085 7.2736 0.0 0
M  V30 29 N 15.3474 8.8053 0.0 0
M  V30 30 C 2.3100 6.6533 0.0 0
M  V30 31 C 0.7700 6.6533 0.0 0
M  V30 32 C 3.0800 7.9871 0.0 0
M  V30 33 C 0.0000 7.9871 0.0 0
M  V30 34 C 2.3100 9.3207 0.0 0
M  V30 35 C 0.7700 9.3207 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 5 30
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 29
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 17 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628356-20-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1688666-85-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11555249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted nicotinamide inhibitors of BTK useful in the
treatment of cancer, inflammation and autoimmune disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Xiangyang; Gao, Yingxiang; Liu, Chong; Ni, Haihong; Mulvihill, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015048662 A2 2015-04-02

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-2-aminobenzenesulfonylglycyl-L-prol...
C32H42N6O11S2
1642577-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.5264 4.5190 0.0 0
M  V30 2 C 7.0619 4.9949 0.0 0
M  V30 3 O 5.9173 3.9644 0.0 0
M  V30 4 S 11.4558 3.5673 0.0 0 VAL=6
M  V30 5 N 12.6002 4.5977 0.0 0
M  V30 6 O 12.4862 2.4229 0.0 0
M  V30 7 O 10.4252 4.7117 0.0 0
M  V30 8 C 14.0649 4.1218 0.0 0
M  V30 9 C 15.2093 5.1523 0.0 0
M  V30 10 O 14.8891 6.6587 0.0 0
M  V30 11 C 4.0011 6.3576 0.0 0
M  V30 12 O 2.6674 7.1276 0.0 0
M  V30 13 O 4.0011 4.8176 0.0 0
M  V30 14 C 1.3336 6.3576 0.0 0
M  V30 15 C 2.1037 5.0240 0.0 0
M  V30 16 C 0.0000 5.5876 0.0 0
M  V30 17 C 0.5636 7.6914 0.0 0
M  V30 18 C 17.9198 7.1216 0.0 0
M  V30 19 N 19.2535 7.8916 0.0 0
M  V30 20 O 16.5860 7.8916 0.0 0
M  V30 21 S 21.9208 9.4316 0.0 0 VAL=6
M  V30 22 N 23.2546 8.6616 0.0 0
M  V30 23 O 21.1508 8.0980 0.0 0
M  V30 24 O 22.6908 10.7653 0.0 0
M  V30 25 C 24.5882 9.4316 0.0 0
M  V30 26 C 25.9219 8.6616 0.0 0
M  V30 27 O 27.2555 9.4316 0.0 0
M  V30 28 O 25.9219 7.1216 0.0 0
M  V30 29 C 28.5893 8.6616 0.0 0
M  V30 30 C 8.8467 3.0127 0.0 0
M  V30 31 C 10.3113 2.5369 0.0 0
M  V30 32 C 7.7022 1.9823 0.0 0
M  V30 33 C 10.6314 1.0304 0.0 0
M  V30 34 C 8.0224 0.4759 0.0 0
M  V30 35 C 9.4871 0.0000 0.0 0
M  V30 36 C 6.7417 6.5013 0.0 0 CFG=2
M  V30 37 N 5.3347 7.1276 0.0 0
M  V30 38 C 7.7721 7.6457 0.0 0
M  V30 39 C 5.4958 8.6593 0.0 0
M  V30 40 C 7.0021 8.9795 0.0 0
M  V30 41 N 16.6740 4.6764 0.0 0
M  V30 42 C 17.9198 5.5816 0.0 0 CFG=2
M  V30 43 C 17.1498 3.2118 0.0 0
M  V30 44 C 19.1657 4.6764 0.0 0
M  V30 45 C 18.6898 3.2118 0.0 0
M  V30 46 C 19.2535 9.4316 0.0 0
M  V30 47 C 20.5871 10.2016 0.0 0
M  V30 48 C 17.9198 10.2016 0.0 0
M  V30 49 C 20.5871 11.7416 0.0 0
M  V30 50 C 17.9198 11.7416 0.0 0
M  V30 51 C 19.2535 12.5116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 2 2 3
M  V30 4 1 36 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 31
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 9 41
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 37
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 42 18 CFG=3
M  V30 23 1 19 46
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 21 24
M  V30 27 1 21 47
M  V30 28 1 22 25
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 44 1 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 1 43 45
M  V30 48 1 44 45
M  V30 49 2 46 47
M  V30 50 1 46 48
M  V30 51 1 47 49
M  V30 52 2 48 50
M  V30 53 2 49 51
M  V30 54 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 36 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-2-aminobenzenesulfonylglycyl-L-prol...
C32H43N7O10S2
1642577-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  51 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.5264 4.5190 0.0 0
M  V30 2 C 7.0619 4.9949 0.0 0
M  V30 3 O 5.9173 3.9644 0.0 0
M  V30 4 S 11.4558 3.5673 0.0 0 VAL=6
M  V30 5 N 12.6002 4.5977 0.0 0
M  V30 6 O 12.4862 2.4229 0.0 0
M  V30 7 O 10.4252 4.7117 0.0 0
M  V30 8 C 14.0649 4.1218 0.0 0
M  V30 9 C 15.2093 5.1523 0.0 0
M  V30 10 O 14.8891 6.6587 0.0 0
M  V30 11 C 4.0011 6.3576 0.0 0
M  V30 12 O 2.6674 7.1276 0.0 0
M  V30 13 O 4.0011 4.8176 0.0 0
M  V30 14 C 1.3338 6.3576 0.0 0
M  V30 15 C 0.5636 7.6914 0.0 0
M  V30 16 C 0.0000 5.5876 0.0 0
M  V30 17 C 2.1038 5.0240 0.0 0
M  V30 18 C 17.9198 7.1216 0.0 0
M  V30 19 N 19.2535 7.8916 0.0 0
M  V30 20 O 16.5860 7.8916 0.0 0
M  V30 21 S 21.9208 9.4316 0.0 0 VAL=6
M  V30 22 N 23.2546 8.6616 0.0 0
M  V30 23 O 22.6908 10.7653 0.0 0
M  V30 24 O 21.1508 8.0980 0.0 0
M  V30 25 C 24.5882 9.4316 0.0 0
M  V30 26 C 25.9219 8.6616 0.0 0
M  V30 27 N 27.2557 9.4316 0.0 0
M  V30 28 O 25.9219 7.1216 0.0 0
M  V30 29 C 28.5893 8.6616 0.0 0
M  V30 30 C 8.8467 3.0127 0.0 0
M  V30 31 C 10.3113 2.5369 0.0 0
M  V30 32 C 7.7022 1.9823 0.0 0
M  V30 33 C 10.6314 1.0304 0.0 0
M  V30 34 C 8.0224 0.4759 0.0 0
M  V30 35 C 9.4871 0.0000 0.0 0
M  V30 36 C 6.7417 6.5013 0.0 0 CFG=2
M  V30 37 N 5.3347 7.1276 0.0 0
M  V30 38 C 7.7721 7.6457 0.0 0
M  V30 39 C 5.4958 8.6593 0.0 0
M  V30 40 C 7.0021 8.9795 0.0 0
M  V30 41 N 16.6740 4.6764 0.0 0
M  V30 42 C 17.9198 5.5816 0.0 0 CFG=2
M  V30 43 C 17.1498 3.2118 0.0 0
M  V30 44 C 19.1657 4.6764 0.0 0
M  V30 45 C 18.6898 3.2118 0.0 0
M  V30 46 C 19.2535 9.4316 0.0 0
M  V30 47 C 20.5871 10.2016 0.0 0
M  V30 48 C 17.9198 10.2016 0.0 0
M  V30 49 C 20.5871 11.7416 0.0 0
M  V30 50 C 17.9198 11.7416 0.0 0
M  V30 51 C 19.2535 12.5116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 2 2 3
M  V30 4 1 36 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 31
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 9 41
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 37
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 42 18 CFG=3
M  V30 23 1 19 46
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 21 24
M  V30 27 1 21 47
M  V30 28 1 22 25
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 44 1 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 1 43 45
M  V30 48 1 44 45
M  V30 49 2 46 47
M  V30 50 1 46 48
M  V30 51 1 47 49
M  V30 52 2 48 50
M  V30 53 2 49 51
M  V30 54 1 50 51
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 36 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1642577-19-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1642577-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11616972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational modulation of peptides using β-amino benzenesulfonic acid
(SAnt)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priya, Gowri; Kotmale, Amol S.; Chakravarty, Debamitra; Puranik, Vedavati
G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(7), 2087-2091

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(6H-[2]Benzopyrano[3,4-c]pyridin-8-ylcarbonyl)amino]methyl]benzoic acid
C21H16N2O4
1643976-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 9.3359 4.6201 0.0 0
M  V30 3 O 8.0022 6.9301 0.0 0
M  V30 4 C 10.6695 5.3901 0.0 0
M  V30 5 C 16.0043 5.3901 0.0 0
M  V30 6 O 16.0043 6.9301 0.0 0
M  V30 7 O 17.3381 4.6201 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 1.3338 3.0800 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 2.6675 5.3901 0.0 0
M  V30 16 C 6.6686 3.0800 0.0 0
M  V30 17 O 1.3338 4.6201 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 19 C 1.3338 0.0000 0.0 0
M  V30 20 C 6.6686 4.6201 0.0 0
M  V30 21 N 0.0000 0.7700 0.0 0
M  V30 22 C 12.0034 4.6201 0.0 0
M  V30 23 C 13.3370 5.3901 0.0 0
M  V30 24 C 12.0034 3.0800 0.0 0
M  V30 25 C 14.6707 4.6201 0.0 0
M  V30 26 C 13.3370 2.3100 0.0 0
M  V30 27 C 14.6707 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 25
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 15 17
M  V30 22 2 16 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[3-[(Methylamino)carbonyl]phenyl]methyl]-6H-[2]benzopyrano[3,4-c]pyridine-...
C22H19N3O3
1643976-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 5.3901 0.0 0
M  V30 2 N 9.3360 4.6201 0.0 0
M  V30 3 O 8.0023 6.9302 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 C 16.0045 5.3901 0.0 0
M  V30 6 N 17.3383 4.6201 0.0 0
M  V30 7 O 16.0045 6.9302 0.0 0
M  V30 8 C 18.6720 5.3901 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 2.6675 5.3901 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 O 1.3337 4.6201 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 20 C 1.3337 0.0000 0.0 0
M  V30 21 C 6.6687 4.6201 0.0 0
M  V30 22 N 0.0000 0.7700 0.0 0
M  V30 23 C 12.0035 4.6201 0.0 0
M  V30 24 C 13.3372 5.3901 0.0 0
M  V30 25 C 12.0035 3.0801 0.0 0
M  V30 26 C 14.6708 4.6201 0.0 0
M  V30 27 C 13.3372 2.3101 0.0 0
M  V30 28 C 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 2 13 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 1 16 18
M  V30 23 2 17 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1643976-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643976-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41763360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of 5H-chromeno[3,4-c]pyridine and
6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual
ROCK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Zilun; Wang, Cailan; Sitkoff, Doree; Cheadle, Nathan L.; Xu, Songmei;
Muckelbauer, Jodi K.; Adam, Leonard P.; Wexler, Ruth R.; Quan, Mimi L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(21), 127474

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-(phenylthio)-7-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-7H-pyrrolo[...
C38H28ClN3O7S
1648589-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.3594 11.7836 0.0 0
M  V30 2 C 5.8531 12.1038 0.0 0
M  V30 3 O 4.8225 10.9594 0.0 0
M  V30 4 O 5.3900 9.0731 0.0 0
M  V30 5 C 4.6200 7.7394 0.0 0
M  V30 6 O 5.3900 6.4058 0.0 0
M  V30 7 C 7.3594 6.3627 0.0 0
M  V30 8 O 8.3898 5.2181 0.0 0
M  V30 9 C 7.9139 3.7536 0.0 0
M  V30 10 O 6.4076 3.4333 0.0 0
M  V30 11 S 14.4557 11.5183 0.0 0
M  V30 12 Cl 13.7952 14.7464 0.0 0
M  V30 13 C 9.2999 9.8431 0.0 0 CFG=2
M  V30 14 C 7.8352 10.3189 0.0 0 CFG=2
M  V30 15 O 9.2999 8.3031 0.0 0
M  V30 16 C 6.9302 9.0731 0.0 0 CFG=2
M  V30 17 C 7.8352 7.8272 0.0 0 CFG=2
M  V30 18 N 10.5458 10.7483 0.0 0
M  V30 19 C 10.5458 12.2883 0.0 0
M  V30 20 C 12.0105 10.2724 0.0 0
M  V30 21 C 12.0105 12.7641 0.0 0
M  V30 22 N 9.4014 13.3187 0.0 0
M  V30 23 C 12.9157 11.5183 0.0 0
M  V30 24 C 12.3306 14.2706 0.0 0
M  V30 25 C 9.7216 14.8251 0.0 0
M  V30 26 N 11.1861 15.3010 0.0 0
M  V30 27 C 5.3772 13.5685 0.0 0
M  V30 28 C 3.8708 13.8886 0.0 0
M  V30 29 C 6.4076 14.7129 0.0 0
M  V30 30 C 3.3949 15.3532 0.0 0
M  V30 31 C 5.9318 16.1775 0.0 0
M  V30 32 C 4.4253 16.4977 0.0 0
M  V30 33 C 15.2255 10.1846 0.0 0
M  V30 34 C 16.7657 10.1846 0.0 0
M  V30 35 C 14.4557 8.8510 0.0 0
M  V30 36 C 17.5357 8.8510 0.0 0
M  V30 37 C 15.2255 7.5172 0.0 0
M  V30 38 C 16.7657 7.5172 0.0 0
M  V30 39 C 3.0800 7.7394 0.0 0
M  V30 40 C 2.3100 9.0731 0.0 0
M  V30 41 C 2.3100 6.4058 0.0 0
M  V30 42 C 0.7702 9.0731 0.0 0
M  V30 43 C 0.7700 6.4058 0.0 0
M  V30 44 C 0.0000 7.7394 0.0 0
M  V30 45 C 8.9445 2.6091 0.0 0
M  V30 46 C 8.4685 1.1445 0.0 0
M  V30 47 C 10.4507 2.9292 0.0 0
M  V30 48 C 9.4990 0.0000 0.0 0
M  V30 49 C 11.4812 1.7849 0.0 0
M  V30 50 C 11.0053 0.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 27
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 2 5 6
M  V30 8 1 5 39
M  V30 9 1 7 8
M  V30 10 1 17 7 CFG=3
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 9 45
M  V30 14 1 11 23
M  V30 15 1 11 33
M  V30 16 1 12 24
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 1 13 18 CFG=3
M  V30 20 1 14 16
M  V30 21 1 15 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 19 22
M  V30 27 2 20 23
M  V30 28 1 21 23
M  V30 29 2 21 24
M  V30 30 1 22 25
M  V30 31 1 24 26
M  V30 32 2 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 39 2 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 2 35 37
M  V30 43 2 36 38
M  V30 44 1 37 38
M  V30 45 2 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 43
M  V30 49 2 42 44
M  V30 50 1 43 44
M  V30 51 2 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 2 48 50
M  V30 56 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 13 14 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(phenylthio)-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
C18H20N4O4S
1648589-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 3.0800 4.7344 0.0 0
M  V30 2 N 3.7405 1.5064 0.0 0
M  V30 3 C 3.4203 0.0000 0.0 0
M  V30 4 O 6.9899 8.8549 0.0 0
M  V30 5 C 12.1457 7.1797 0.0 0
M  V30 6 O 12.9157 5.8460 0.0 0
M  V30 7 O 10.1763 9.8902 0.0 0
M  V30 8 C 5.5252 3.4886 0.0 0
M  V30 9 C 6.9899 3.9644 0.0 0
M  V30 10 C 4.6200 4.7344 0.0 0
M  V30 11 C 5.2051 1.9823 0.0 0
M  V30 12 N 6.9899 5.5044 0.0 0
M  V30 13 N 8.1343 2.9340 0.0 0
M  V30 14 C 5.5252 5.9805 0.0 0
M  V30 15 N 6.3496 0.9517 0.0 0
M  V30 16 C 7.8141 1.4277 0.0 0
M  V30 17 C 8.2358 6.4097 0.0 0 CFG=1
M  V30 18 O 9.7005 5.9338 0.0 0
M  V30 19 C 8.2358 7.9497 0.0 0 CFG=2
M  V30 20 C 10.6057 7.1797 0.0 0 CFG=2
M  V30 21 C 9.7005 8.4255 0.0 0 CFG=2
M  V30 22 C 2.3100 6.0682 0.0 0
M  V30 23 C 0.7700 6.0682 0.0 0
M  V30 24 C 3.0800 7.4019 0.0 0
M  V30 25 C 0.0000 7.4019 0.0 0
M  V30 26 C 2.3100 8.7355 0.0 0
M  V30 27 C 0.7700 8.7355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 19 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 20 5 CFG=1
M  V30 8 1 21 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 17 12 CFG=1
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1648589-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1648589-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2049301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and cytostatic activity of 7-arylsulfanyl-7-deazapurine bases
and ribonucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klecka, Martin; Slavetinska, Lenka Postova; Tloustova, Eva; Dzubak, Petr;
Hajduch, Marian; Hocek, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2015), 6(4), 576-580

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Oxo-N-phenylhexanamide
C12H15NO2
16682-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 0.7700 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-N-phenyl-2-hexenamide
C13H18N2O
2754314-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 4.6200 2.6674 0.0 0
M  V30 5 C 7.7000 2.6674 0.0 0
M  V30 6 C 9.2400 2.6674 0.0 0
M  V30 7 N 6.9300 1.3338 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 7.7000 0.0000 0.0 0
M  V30 10 C 11.5500 4.0011 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 14 C 0.7700 4.0011 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16682-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754314-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24906883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1643-19-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Tandem Hofmann-Type Rearrangement and Cyclization Reaction
of α-Acyl-β-aminoacrylamides: Access to Polysubstituted Oxazol-2(3H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baibin; Yuan, Jingwen; Ye, Xuebei; Zhang, Rui; Li, Jiacheng; Wang,
Yu; Hu, Jiana; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(24), 17944-17954

$RFMT $RIREG SCHEME143 STEP1
$RXN



  4  1
$MOL
4-Chlorobenzoic acid
C7H5ClO2
74-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azidobenzaldehyde
C7H5N3O
16714-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 4.0010 0.0 0
M  V30 2 N 6.1601 4.0010 0.0 0 CHG=1 VAL=4
M  V30 3 N 7.7002 4.0010 0.0 0 CHG=-1
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 1.5400 1.3337 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-α-[(4-chlorobenzoyl)methylamino]-N-(1,1-dimethylethyl)benzeneacetamide
C20H22ClN5O2
1220272-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4136 5.3347 0.0 0
M  V30 2 N 5.9536 5.3347 0.0 0
M  V30 3 C 3.6436 6.6684 0.0 0
M  V30 4 C 6.7236 6.6684 0.0 0
M  V30 5 C 6.7236 4.0011 0.0 0
M  V30 6 N 2.1036 6.6684 0.0 0
M  V30 7 O 4.4136 8.0021 0.0 0
M  V30 8 O 5.9536 8.0021 0.0 0
M  V30 9 C 1.3336 8.0021 0.0 0
M  V30 10 C 0.0000 7.2321 0.0 0
M  V30 11 C 0.5636 9.3358 0.0 0
M  V30 12 C 2.6673 8.7721 0.0 0
M  V30 13 N 5.9536 2.6674 0.0 0
M  V30 14 N 6.7236 1.3336 0.0 0 CHG=1 VAL=4
M  V30 15 N 7.4936 0.0000 0.0 0 CHG=-1
M  V30 16 Cl 12.8836 6.6684 0.0 0
M  V30 17 C 3.6436 4.0011 0.0 0
M  V30 18 C 4.4136 2.6674 0.0 0
M  V30 19 C 2.1036 4.0011 0.0 0
M  V30 20 C 3.6436 1.3336 0.0 0
M  V30 21 C 1.3336 2.6674 0.0 0
M  V30 22 C 2.1036 1.3336 0.0 0
M  V30 23 C 8.2636 6.6684 0.0 0
M  V30 24 C 9.0336 5.3347 0.0 0
M  V30 25 C 9.0336 8.0021 0.0 0
M  V30 26 C 10.5736 5.3347 0.0 0
M  V30 27 C 10.5736 8.0021 0.0 0
M  V30 28 C 11.3436 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 2 4 8
M  V30 9 1 4 23
M  V30 10 1 6 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 2 13 14
M  V30 15 1 13 18
M  V30 16 2 14 15
M  V30 17 1 16 28
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-11-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 16714-25-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1220272-98-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12651132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sequential Ugi four component condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unexpected Synthesis of Rearranged 3,4-Dihydroquinazolines by a
Sequential Ugi 4CC/Aza-Wittig/Carbodiimide-Mediated Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Ping; Wu, Jing; Nie, Yi-Bo; Ding, Ming-Wu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2010), (6), 1088-1095,
S1088/1-S1088/33

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-[5-methoxy-2-(3,4,5-trimethoxybenzoyl)phenyl]acetamide
C19H20BrNO6
1674432-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0100 6.6684 0.0 0
M  V30 2 C 11.5500 6.6684 0.0 0
M  V30 3 C 12.3200 8.0021 0.0 0
M  V30 4 O 12.3200 5.3347 0.0 0
M  V30 5 Br 13.8600 8.0021 0.0 0
M  V30 6 C 6.9300 6.6684 0.0 0
M  V30 7 O 7.7000 8.0021 0.0 0
M  V30 8 O 10.0100 1.3336 0.0 0
M  V30 9 C 9.2400 0.0000 0.0 0
M  V30 10 O 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 O 2.3100 9.3358 0.0 0
M  V30 13 C 3.0800 10.6694 0.0 0
M  V30 14 O 0.7700 6.6684 0.0 0
M  V30 15 C 0.0000 8.0021 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 9.2400 2.6673 0.0 0
M  V30 21 C 7.7000 2.6673 0.0 0
M  V30 22 C 5.3900 6.6684 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0
M  V30 24 C 4.6200 8.0021 0.0 0
M  V30 25 C 3.0800 5.3347 0.0 0
M  V30 26 C 3.0800 8.0021 0.0 0
M  V30 27 C 2.3100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 17
M  V30 8 1 6 22
M  V30 9 1 8 9
M  V30 10 1 8 20
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-Methoxy-2-(3,4,5-trimethoxybenzoyl)phenyl]-2-(methylamino)acetamide
C20H24N2O6
1674432-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9302 0.0 0
M  V30 2 O 8.0022 7.7002 0.0 0
M  V30 3 N 9.3358 5.3901 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0033 5.3901 0.0 0
M  V30 6 O 10.6697 3.0801 0.0 0
M  V30 7 N 13.3370 4.6201 0.0 0
M  V30 8 C 14.6707 5.3901 0.0 0
M  V30 9 O 6.6685 0.7700 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 O 4.0010 11.5503 0.0 0
M  V30 12 C 5.3348 12.3203 0.0 0
M  V30 13 O 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 7.7002 0.0 0
M  V30 15 O 1.3337 10.0102 0.0 0
M  V30 16 C 1.3337 11.5503 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 8.0022 3.0801 0.0 0
M  V30 21 C 5.3348 3.0801 0.0 0
M  V30 22 C 6.6685 2.3101 0.0 0
M  V30 23 C 5.3348 7.7002 0.0 0
M  V30 24 C 5.3348 9.2402 0.0 0
M  V30 25 C 4.0010 6.9302 0.0 0
M  V30 26 C 4.0010 10.0102 0.0 0
M  V30 27 C 2.6673 7.7002 0.0 0
M  V30 28 C 2.6673 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 12
M  V30 13 1 11 26
M  V30 14 1 13 14
M  V30 15 1 13 27
M  V30 16 1 15 16
M  V30 17 1 15 28
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1674432-68-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1674432-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10726404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The convenient aqueous synthesis and biological evaluation of
ortho-(3,4,5-trimethoxybenzoyl)-acetanilides as novel anti-cancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Jianfei; Mao, Fei; Yan, Jun; Huang, Ling; Li, Xingshu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(78), 41510-41520

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S)-1-(2-chloro-4-methylphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b...
C20H19ClN2O2
1679333-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-1-(2-Chloro-4-methylphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4...
C20H20ClN3O
1918182-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 C 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=2
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1679333-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15944004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Difluoro-4-iodo-1-phenyl-4-(trimethylsilyl)-1-butanone
C13H17F2IOSi
169385-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 F 4.5648 3.6437 0.0 0
M  V30 6 F 6.1048 0.9764 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 Si 9.3360 3.0801 0.0 0
M  V30 9 I 8.0023 0.7700 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 10.1060 1.7464 0.0 0
M  V30 12 C 8.5660 4.4137 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-1-methyl-2-phenyl-1H-pyrrole
C11H10FN
340696-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.9406 5.4211 0.0 0
M  V30 2 C 1.9406 0.0000 0.0 0
M  V30 3 C 2.3698 2.7106 0.0 0
M  V30 4 C 1.4645 3.9564 0.0 0
M  V30 5 N 1.4645 1.4647 0.0 0
M  V30 6 C 0.0000 3.4806 0.0 0
M  V30 7 C 0.0000 1.9406 0.0 0
M  V30 8 C 3.9098 2.7106 0.0 0
M  V30 9 C 4.6798 4.0442 0.0 0
M  V30 10 C 4.6798 1.3769 0.0 0
M  V30 11 C 6.2198 4.0442 0.0 0
M  V30 12 C 6.2198 1.3769 0.0 0
M  V30 13 C 6.9898 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 169385-20-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 340696-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6769744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A study on the synthesis of β-fluoro-α-phenylpyrrole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwak, Kyung Chell; Oh, Hyuncheol; Chung, Duk-Sang; Lee, Young-Haeng;
Baik, Seung-Hwa; Kim, Jong-Soo; Chai, Kyu Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Korean Chemical Society (2001), 45(1), 100-103

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Benzyloxybenzaldehyde
C14H12O2
1700-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 C 10.6697 2.3101 0.0 0
M  V30 4 O 12.0033 3.0801 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 C 8.0022 5.3901 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 2 3 4
M  V30 5 1 3 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(phenylmethoxy)benzenemethanamine
C15H17NO
214424-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 N 12.0033 2.3101 0.0 0
M  V30 5 C 13.3370 3.0801 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0022 0.0000 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1700-37-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214424-24-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12646893
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. Table I, Entry 14, yield 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,3R)-2,3-Oxiranedicarboxylic acid
C4H4O5
17015-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 2.1036 0.0 0
M  V30 2 O 0.0000 1.3336 0.0 0
M  V30 3 O 1.3338 3.6436 0.0 0
M  V30 4 C 5.5411 2.1036 0.0 0
M  V30 5 O 5.5411 3.6436 0.0 0
M  V30 6 O 6.8749 1.3336 0.0 0
M  V30 7 C 2.6674 1.3336 0.0 0 CFG=2
M  V30 8 C 4.2074 1.3336 0.0 0 CFG=2
M  V30 9 O 3.4374 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 8 4 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-3-Hydroxy-N-methyl-L-aspartic acid
C5H9NO5
1931912-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 2 C 4.0011 3.0800 0.0 0 CFG=1
M  V30 3 C 1.3338 3.0800 0.0 0
M  V30 4 N 2.6674 0.7700 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 4.0011 4.6200 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 4.6200 0.0 0
M  V30 9 C 1.3338 0.0000 0.0 0
M  V30 10 O 6.6685 3.0800 0.0 0
M  V30 11 O 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17015-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1931912-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32024882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternate reaction conditions also shown,alternative
preparation shown,94% overall yield over two steps starting from
diethyl-(2R,3R)-epoxysuccinate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic peptides as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luesch, Hendrik; Paul, Valerie J.; Matthew, Susan; Chen, Qi-Yin;
Ratnayake, Ranjala
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022076563 A1 2022-04-14

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,3R)-2,3-Oxiranedicarboxylic acid
C4H4O5
17015-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 2.1036 0.0 0
M  V30 2 O 0.0000 1.3336 0.0 0
M  V30 3 O 1.3338 3.6436 0.0 0
M  V30 4 C 5.5411 2.1036 0.0 0
M  V30 5 O 5.5411 3.6436 0.0 0
M  V30 6 O 6.8749 1.3336 0.0 0
M  V30 7 C 2.6674 1.3336 0.0 0 CFG=2
M  V30 8 C 4.2074 1.3336 0.0 0 CFG=2
M  V30 9 O 3.4374 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 8 4 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-3-Hydroxy-N-methyl-L-aspartic acid
C5H9NO5
1931912-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 2 C 4.0011 3.0800 0.0 0 CFG=1
M  V30 3 C 1.3338 3.0800 0.0 0
M  V30 4 N 2.6674 0.7700 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 4.0011 4.6200 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 4.6200 0.0 0
M  V30 9 C 1.3338 0.0000 0.0 0
M  V30 10 O 6.6685 3.0800 0.0 0
M  V30 11 O 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17015-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1931912-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26172721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternative preparation shown,alternate reaction
conditions also shown,% overall yield over 2 steps starting from diester
= 94
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh
tubulin pharmacological site
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matthew, Susan; Chen, Qi-Yin; Ratnayake, Ranjala; Fermaintt, Charles S.;
Lucena-Agell, Daniel; Bonato, Francesca; Prota, Andrea E.; Lim, Seok
Ting; Wang, Xiaomeng; Diaz, J. Fernando; Risinger, April L.; Paul,
Valerie J.; Oliva, Maria Angela; Luesch, Hendrik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences of the United States of
America (2021), 118(9), e2021847118

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloropyrimidine
C4H3ClN2
1722-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 N 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-pyrimidinamine
C5H7N3
931-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 N 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1722-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 931-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34483282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hit-to-lead optimization of novel phenyl imidazole carboxamides that are
active against Leishmania donovani
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McNamara, Nicole; Saunders, Eleanor; Varghese, Swapna; Zheng, Rebecca;
Simpson, Kaylene; Varma, Devika M.; Johnson, Monica M.; Hasan Zahid, M.
Shamim; Bachelder, Eric M.; Ainslie, Kristy M.; No, Joo Hwan; Koh, Dahae;
Shum, David; Das, Nirmal; Patra, Binita; Roy, Jayasree; Talukdar,
Arindam; Ganguly, Dipyman; McConville, Malcolm; Baell, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 240114577

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloropyrimidine
C4H3ClN2
1722-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 N 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-pyrimidinamine
C5H7N3
931-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 N 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1722-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 931-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17691628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Methylamino Pyrimidyl Amides (MAPA): Highly Reactive,
Electronically-Activated Amides in Catalytic N-C(O) Cleavage
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meng, Guangrong; Lalancette, Roger; Szostak, Roman; Szostak, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(17), 4656-4659

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Fluoro-2H-3,1-benzoxazine-2,4(1H)-dione
C8H4FNO3
174463-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 6.6686 0.0 0
M  V30 2 F 3.0800 0.0000 0.0 0
M  V30 3 O 6.9301 4.0011 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 3.0800 2.6675 0.0 0
M  V30 6 C 3.0800 5.3348 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 N 4.6201 2.6675 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 O 4.6201 5.3348 0.0 0
M  V30 11 C 0.0000 2.6675 0.0 0
M  V30 12 C 5.3901 4.0011 0.0 0
M  V30 13 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 9
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-fluoro-N-methylbenzamide
C8H9FN2O
1017789-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 2.6674 4.6200 0.0 0
M  V30 6 F 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 174463-53-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1017789-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10414787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 308a) 5-Methyl isatoic anhydride (10.1 g, 57.2
mmol) was dissolved in 100 mL THF and treated with a solution (aqeous or
THF) of methylamine (120 mmol). The mixture was stirred for 2 hours and
then concentrated in vacuo and azeotroped with benzene. Trituration from
ether twice afforded 2-amino-5,N-dimethyl-benzamide (5.25 g, 56%). 311a)
Analagous to Example 308a, 2-amino-3-fluoro-N-methyl-benzamide was
prepared from 3-fluoro isatoic anhydride in 90% yield, m.p. = 94-97 °C;
LCMS (m/e) 169 (M+1); 1H-NMR (DMSO-d6, 400 MHz) δ 8.30 (s, 1H), 7.32 (d,
1H, J = 8.0 Hz), 7.12 (m, 1H), 6.52 (m, 1H), 6.32 (s, 2H), 2.73 (d, 3H, J
= 4.5 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK
and c-Met kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmed, Gulzar; Bohnstedt, Adolph; Breslin, Henry Joseph; Burke, Jason;
Curry, Matthew A.; Diebold, James L.; Dorsey, Bruce; Dugan, Benjamin J.;
Feng, Daming; Gingrich, Diane E.; Guo, Tao; Ho, Koc-Kan; Learn, Keith S.;
Lisko, Joseph G.; Liu, Rong-Qiang; Mesaros, Eugen F.; Milkiewicz, Karen;
Ott, Gregory R.; Parrish, Jonathan; Theroff, Jay P.; Thieu, Tho V.;
Tripathy, Rabindranath; Underiner, Theodore L.; Wagner, Jason C.;
Weinberg, Linda; Wells, Gregory J.; You, Ming; Zificsak, Craig A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008051547 A1 2008-05-02

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-[(methylsulfonyl)oxy]butyl]carbamate
C10H21NO5S
174626-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 1.3337 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 C 4.0010 2.1037 0.0 0
M  V30 4 C 0.5637 0.7700 0.0 0
M  V30 5 C 0.0000 2.8737 0.0 0
M  V30 6 C 2.1037 3.4374 0.0 0
M  V30 7 N 5.3348 1.3337 0.0 0
M  V30 8 O 4.0010 3.6437 0.0 0
M  V30 9 C 6.6685 2.1037 0.0 0
M  V30 10 C 8.0022 1.3337 0.0 0
M  V30 11 C 9.3358 2.1037 0.0 0
M  V30 12 C 10.6697 1.3337 0.0 0
M  V30 13 O 12.0033 2.1037 0.0 0
M  V30 14 S 13.3370 1.3337 0.0 0 VAL=6
M  V30 15 C 14.1070 2.6673 0.0 0
M  V30 16 O 14.6707 0.5637 0.0 0
M  V30 17 O 12.5670 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-(methylamino)butyl]carbamate
C10H22N2O2
874831-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5637 2.8737 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 N 12.0033 1.5400 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 174626-25-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 874831-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9802664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of (4-tert-butyloxycarbonylamino)-butyl
methanesulfonate (5 g, 18.7 mmol) in ethanol (25 mL) was added
methylamine (25 mL) at 0 °C. The reaction mixture was stirred for 18 h at
RT. After the completion of reaction (monitored by TLC), the volatiles
were removed under reduced presure to afford tert-butyl
4-(methylamino)butylcarbamate as colorless viscous liquid, yield 3.4 g,
90%. 1H NMR (CDCl3, 200 MHz): δ 5.15 (bs, 2H), 3.22 - 3.10 (m, 2H), 2.95
(t, J = 7.0 Hz, 2H), 2.70 (s, 3H), 1.90 - 1.70 (m, 2H), 1.88 - 1.50 (m,
2H), 1.43 (s, 9H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidinamines as protein kinase inhibitors, their preparation,
pharmaceutical compositions, and their use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Juswinder; Ghosh, Shomir; Kluge, Arthur F.; Petter, Russell C.;
Tester, Richland Wayne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010123870 A1 2010-10-28

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-[(methylsulfonyl)oxy]butyl]carbamate
C10H21NO5S
174626-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 1.3337 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 C 4.0010 2.1037 0.0 0
M  V30 4 C 0.5637 0.7700 0.0 0
M  V30 5 C 0.0000 2.8737 0.0 0
M  V30 6 C 2.1037 3.4374 0.0 0
M  V30 7 N 5.3348 1.3337 0.0 0
M  V30 8 O 4.0010 3.6437 0.0 0
M  V30 9 C 6.6685 2.1037 0.0 0
M  V30 10 C 8.0022 1.3337 0.0 0
M  V30 11 C 9.3358 2.1037 0.0 0
M  V30 12 C 10.6697 1.3337 0.0 0
M  V30 13 O 12.0033 2.1037 0.0 0
M  V30 14 S 13.3370 1.3337 0.0 0 VAL=6
M  V30 15 C 14.1070 2.6673 0.0 0
M  V30 16 O 14.6707 0.5637 0.0 0
M  V30 17 O 12.5670 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-(methylamino)butyl]carbamate
C10H22N2O2
874831-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 C 0.5637 2.8737 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 N 12.0033 1.5400 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 174626-25-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 874831-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14030265
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step-3 To a stirred solution of (4-tert-butyloxycarbonylamino)-butyl
methanesulfonate (5 g, 18.7 mmol) in ethanol (25 mL) was added
methylamine (25 mL) at 0° C. The reaction mixture was stirred for 18 h at
RT. After the completion of reaction (monitored by TLC), the volatiles
were removed under reduced pressure to afford tert-butyl
4-(methylamino)butylcarbamate (4) (3.4 g, 89.9%) as colorless viscous
liquid. The crude compound was used in the next step without further
purification. 1H NMR (CDCl3, 200 MHz): δ 5.15 (bs, 2H), 3.22-3.10 (m,
2H), 2.95 (t, J=7.0 Hz, 2H), 2.70 (s, 3H), 1.90-1.70 (m, 2H), 1.88-1.50
(m, 2H), 1.43 (s, 9H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidinamines as protein kinase inhibitors, their preparation,
pharmaceutical compositions, and their use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Juswinder; Ghosh, Shomir; Kluge, Arthur F.; Petter, Russell C.;
Tester, Richland W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100016296 A1 2010-01-21

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-(trifluoromethyl)benzenesulfonyl chloride
C7H3BrClF3O2S
176225-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3957 5.0529 0.0 0 VAL=6
M  V30 2 Cl 0.0000 5.7037 0.0 0
M  V30 3 O 2.0465 6.4486 0.0 0
M  V30 4 O 0.7449 3.6572 0.0 0
M  V30 5 C 3.4273 1.5341 0.0 0
M  V30 6 F 3.2930 0.0000 0.0 0
M  V30 7 F 4.9613 1.4000 0.0 0
M  V30 8 F 1.8931 1.6684 0.0 0
M  V30 9 Br 7.4114 4.4019 0.0 0
M  V30 10 C 2.7914 4.4019 0.0 0
M  V30 11 C 3.5614 3.0683 0.0 0
M  V30 12 C 3.5614 5.7357 0.0 0
M  V30 13 C 5.1014 3.0683 0.0 0
M  V30 14 C 5.1014 5.7357 0.0 0
M  V30 15 C 5.8714 4.4019 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 11
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-(trifluoromethyl)benzenesulfonamide
C8H7BrF3NO2S
1055995-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.5353 3.4273 0.0 0 VAL=6
M  V30 2 N 7.0693 3.2930 0.0 0
M  V30 3 O 5.6694 4.9613 0.0 0
M  V30 4 O 5.4010 1.8931 0.0 0
M  V30 5 C 7.9527 4.5545 0.0 0
M  V30 6 C 2.0165 1.3957 0.0 0
M  V30 7 F 3.4122 0.7449 0.0 0
M  V30 8 F 1.3657 0.0000 0.0 0
M  V30 9 F 0.6208 2.0465 0.0 0
M  V30 10 Br 0.0000 5.8715 0.0 0
M  V30 11 C 4.0011 3.5615 0.0 0
M  V30 12 C 2.6673 2.7914 0.0 0
M  V30 13 C 4.0011 5.1015 0.0 0
M  V30 14 C 1.3337 3.5615 0.0 0
M  V30 15 C 2.6673 5.8715 0.0 0
M  V30 16 C 1.3337 5.1015 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 12
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176225-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1055995-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-11634475
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1: General Procedure C for formation of
sulfonamides from sulfonyl chlorides 4-Bromobenzene sulfonyl chloride
(0.40 g, 1.5mmol) and propylamine (0.32 mL, 3.90 mmol) were dissolved in
dry dichloromethane (5 mL) in a sealed tube. The mixture was stirred for
16 hours then concentrated in vacuo onto the Celite® reagent. The crude
product was purified via Isco chromatography (the RedisepTM column,
silica, gradient 0-3% ethyl acetate-dichloromethane) to provide
4-bromo-N-propylbenzenesulfonamide (0.12 g, 28%). Step 1: In an analogous
manner to General Procedure A, 4-Bromo-2-trifluoromethylbenzenesulfonyl
chloride (0.50 g, 1.54 mmol) and methylamine (10 mL, 33% in ethanol) were
stirred in sealed tube for 16 hours. 4-bromo-N-methyl-2
(trifluoromethyl)benzenesulfonamide (0.44 g, 90%) was provided after
purification. MS (ESI) m/z 318. HPLC purity 100.0% at 210-370 nm, 8.5
min.; the Xterra® RP18 column, 3.5μ, 150x4.6 mm column, 1.2 mL/min,
85/15-5/95 (ammonium formate buffer pH=3.5/ACN+ MeOH) for 10 min, hold 4
min.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-(4-cyano-1H-pyrrol-2-yl)benzenesulfonamide useful for
modulation of the progesterone receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Fensome, Andrew; Marella, Michael Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080221201 A1 2008-09-11

$RFMT $RIREG SCHEME153 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3,3-Trifluoropropanoic acid
C3H3F3O2
2516-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 C 3.8500 2.8736 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 F 1.5400 3.0800 0.0 0
M  V30 7 O 3.0800 4.2073 0.0 0
M  V30 8 O 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C25H23F3N4O5S
195444-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9899 0.0 0
M  V30 2 N 5.3348 6.2199 0.0 0
M  V30 3 C 4.0010 6.9899 0.0 0
M  V30 4 C 5.3348 4.6799 0.0 0
M  V30 5 C 2.6673 6.2199 0.0 0
M  V30 6 O 4.0010 8.5299 0.0 0
M  V30 7 C 1.3337 6.9899 0.0 0
M  V30 8 F 0.0000 7.7599 0.0 0
M  V30 9 F 0.5637 5.6562 0.0 0
M  V30 10 F 2.1037 8.3236 0.0 0
M  V30 11 S 12.0033 8.5299 0.0 0 VAL=6
M  V30 12 N 13.3370 7.7599 0.0 0
M  V30 13 O 11.2333 7.1963 0.0 0
M  V30 14 O 12.7733 9.8636 0.0 0
M  V30 15 C 16.3978 6.3971 0.0 0
M  V30 16 C 18.6396 8.8871 0.0 0
M  V30 17 C 9.3358 6.9899 0.0 0
M  V30 18 C 8.0022 6.2199 0.0 0
M  V30 19 C 10.6697 6.2199 0.0 0
M  V30 20 C 8.0022 4.6799 0.0 0
M  V30 21 C 10.6697 4.6799 0.0 0
M  V30 22 C 9.3358 3.9098 0.0 0
M  V30 23 C 9.3358 8.5299 0.0 0
M  V30 24 C 10.6697 9.3000 0.0 0
M  V30 25 C 8.0022 9.3000 0.0 0
M  V30 26 C 10.6697 10.8400 0.0 0
M  V30 27 C 8.0022 10.8400 0.0 0
M  V30 28 C 9.3358 11.6100 0.0 0
M  V30 29 C 9.3358 2.3698 0.0 0
M  V30 30 N 8.0900 1.4646 0.0 0
M  V30 31 O 10.5819 1.4646 0.0 0
M  V30 32 C 8.5658 0.0000 0.0 0
M  V30 33 C 10.1059 0.0000 0.0 0
M  V30 34 C 14.6707 8.5299 0.0 0
M  V30 35 C 16.0776 7.9036 0.0 0
M  V30 36 O 14.8318 10.0615 0.0 0
M  V30 37 C 17.1081 9.0480 0.0 0
M  V30 38 N 16.3381 10.3818 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 24
M  V30 15 1 12 34
M  V30 16 1 15 35
M  V30 17 1 16 37
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 22 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2516-99-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7827512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5h
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME154 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzeneacetic acid
C9H7F3O2
32857-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 O 7.7000 0.0000 0.0 0
M  V30 8 O 10.0100 1.3336 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C31H27F3N4O5S
195444-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6365 8.5299 0.0 0 VAL=6
M  V30 2 N 5.3026 7.7599 0.0 0
M  V30 3 O 7.4065 7.1963 0.0 0
M  V30 4 O 5.8665 9.8636 0.0 0
M  V30 5 C 11.9713 6.9899 0.0 0
M  V30 6 N 13.3050 6.2199 0.0 0
M  V30 7 C 14.6386 6.9899 0.0 0
M  V30 8 C 13.3050 4.6799 0.0 0
M  V30 9 C 15.9723 6.2199 0.0 0
M  V30 10 O 14.6386 8.5299 0.0 0
M  V30 11 C 2.2420 6.3971 0.0 0
M  V30 12 C 0.0000 8.8871 0.0 0
M  V30 13 C 21.3073 9.3000 0.0 0
M  V30 14 F 22.0772 7.9663 0.0 0
M  V30 15 F 22.6410 10.0700 0.0 0
M  V30 16 F 20.5373 10.6336 0.0 0
M  V30 17 C 9.3038 8.5299 0.0 0
M  V30 18 C 7.9701 9.3000 0.0 0
M  V30 19 C 10.6375 9.3000 0.0 0
M  V30 20 C 7.9701 10.8400 0.0 0
M  V30 21 C 10.6375 10.8400 0.0 0
M  V30 22 C 9.3038 11.6100 0.0 0
M  V30 23 C 9.3038 6.9899 0.0 0
M  V30 24 C 10.6375 6.2199 0.0 0
M  V30 25 C 7.9701 6.2199 0.0 0
M  V30 26 C 10.6375 4.6799 0.0 0
M  V30 27 C 7.9701 4.6799 0.0 0
M  V30 28 C 9.3038 3.9098 0.0 0
M  V30 29 C 3.9690 8.5299 0.0 0
M  V30 30 C 2.5622 7.9036 0.0 0
M  V30 31 O 3.8080 10.0615 0.0 0
M  V30 32 C 1.5316 9.0480 0.0 0
M  V30 33 N 2.3016 10.3818 0.0 0
M  V30 34 C 9.3038 2.3698 0.0 0
M  V30 35 N 8.0579 1.4646 0.0 0
M  V30 36 O 10.5497 1.4646 0.0 0
M  V30 37 C 8.5338 0.0000 0.0 0
M  V30 38 C 10.0738 0.0000 0.0 0
M  V30 39 C 17.3061 6.9899 0.0 0
M  V30 40 C 17.3061 8.5299 0.0 0
M  V30 41 C 18.6398 6.2199 0.0 0
M  V30 42 C 18.6398 9.3000 0.0 0
M  V30 43 C 19.9735 6.9899 0.0 0
M  V30 44 C 19.9735 8.5299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 18
M  V30 5 1 2 29
M  V30 6 1 5 6
M  V30 7 1 5 24
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 39
M  V30 13 1 11 30
M  V30 14 1 12 32
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 44
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 17 23
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 28 34
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 32857-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9906062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5m
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME155 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanoic acid
C9H10O2
501-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C31H30N4O5S
195444-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6363 8.5298 0.0 0 VAL=6
M  V30 2 N 5.3027 7.7598 0.0 0
M  V30 3 O 7.4063 7.1961 0.0 0
M  V30 4 O 5.8663 9.8634 0.0 0
M  V30 5 C 11.9710 6.9898 0.0 0
M  V30 6 N 13.3047 6.2198 0.0 0
M  V30 7 C 14.6383 6.9898 0.0 0
M  V30 8 C 13.3047 4.6798 0.0 0
M  V30 9 C 15.9721 6.2198 0.0 0
M  V30 10 O 14.6383 8.5298 0.0 0
M  V30 11 C 17.3057 6.9898 0.0 0
M  V30 12 C 2.2419 6.3970 0.0 0
M  V30 13 C 0.0000 8.8869 0.0 0
M  V30 14 C 9.3036 8.5298 0.0 0
M  V30 15 C 7.9700 9.2998 0.0 0
M  V30 16 C 10.6374 9.2998 0.0 0
M  V30 17 C 7.9700 10.8398 0.0 0
M  V30 18 C 10.6374 10.8398 0.0 0
M  V30 19 C 9.3036 11.6098 0.0 0
M  V30 20 C 9.3036 6.9898 0.0 0
M  V30 21 C 10.6374 6.2198 0.0 0
M  V30 22 C 7.9700 6.2198 0.0 0
M  V30 23 C 10.6374 4.6798 0.0 0
M  V30 24 C 7.9700 4.6798 0.0 0
M  V30 25 C 9.3036 3.9098 0.0 0
M  V30 26 C 3.9689 8.5298 0.0 0
M  V30 27 C 2.5621 7.9034 0.0 0
M  V30 28 O 3.8080 10.0613 0.0 0
M  V30 29 C 1.5317 9.0478 0.0 0
M  V30 30 N 2.3017 10.3816 0.0 0
M  V30 31 C 9.3036 2.3698 0.0 0
M  V30 32 N 10.5496 1.4645 0.0 0
M  V30 33 O 8.0577 1.4645 0.0 0
M  V30 34 C 10.0736 0.0000 0.0 0
M  V30 35 C 8.5336 0.0000 0.0 0
M  V30 36 C 18.6394 6.2198 0.0 0
M  V30 37 C 18.6394 4.6798 0.0 0
M  V30 38 C 19.9730 6.9898 0.0 0
M  V30 39 C 19.9730 3.9098 0.0 0
M  V30 40 C 21.3068 6.2198 0.0 0
M  V30 41 C 21.3068 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 2 26
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 11
M  V30 13 1 11 36
M  V30 14 1 12 27
M  V30 15 1 13 29
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 25 31
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 501-52-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3224814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5k
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichlorobenzoic acid
C7H4Cl2O2
51-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 Cl 0.0000 4.6200 0.0 0
M  V30 5 Cl 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichloro-N-[[2′-[[(3,4-dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazoly...
C29H24Cl2N4O5S
195444-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.9710 6.9898 0.0 0
M  V30 2 N 13.3047 6.2198 0.0 0
M  V30 3 C 14.6383 6.9898 0.0 0
M  V30 4 C 13.3047 4.6798 0.0 0
M  V30 5 O 14.6383 8.5298 0.0 0
M  V30 6 S 6.6363 8.5298 0.0 0 VAL=6
M  V30 7 N 5.3027 7.7598 0.0 0
M  V30 8 O 5.8663 9.8634 0.0 0
M  V30 9 O 7.4063 7.1961 0.0 0
M  V30 10 C 2.2419 6.3970 0.0 0
M  V30 11 C 0.0000 8.8869 0.0 0
M  V30 12 Cl 17.3057 2.3698 0.0 0
M  V30 13 Cl 19.9732 6.9898 0.0 0
M  V30 14 C 9.3036 6.9898 0.0 0
M  V30 15 C 10.6374 6.2198 0.0 0
M  V30 16 C 7.9700 6.2198 0.0 0
M  V30 17 C 10.6374 4.6798 0.0 0
M  V30 18 C 7.9700 4.6798 0.0 0
M  V30 19 C 9.3036 3.9098 0.0 0
M  V30 20 C 9.3036 8.5298 0.0 0
M  V30 21 C 7.9700 9.2998 0.0 0
M  V30 22 C 10.6374 9.2998 0.0 0
M  V30 23 C 7.9700 10.8398 0.0 0
M  V30 24 C 10.6374 10.8398 0.0 0
M  V30 25 C 9.3036 11.6098 0.0 0
M  V30 26 C 9.3036 2.3698 0.0 0
M  V30 27 N 10.5496 1.4645 0.0 0
M  V30 28 O 8.0577 1.4645 0.0 0
M  V30 29 C 10.0736 0.0000 0.0 0
M  V30 30 C 8.5336 0.0000 0.0 0
M  V30 31 C 3.9689 8.5298 0.0 0
M  V30 32 C 2.5621 7.9034 0.0 0
M  V30 33 O 3.8080 10.0613 0.0 0
M  V30 34 C 1.5317 9.0478 0.0 0
M  V30 35 N 2.3017 10.3816 0.0 0
M  V30 36 C 15.9721 6.2198 0.0 0
M  V30 37 C 15.9721 4.6798 0.0 0
M  V30 38 C 17.3057 6.9898 0.0 0
M  V30 39 C 17.3057 3.9098 0.0 0
M  V30 40 C 18.6394 6.2198 0.0 0
M  V30 41 C 18.6394 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 1 3 36
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 6 21
M  V30 11 1 7 31
M  V30 12 1 10 32
M  V30 13 1 11 34
M  V30 14 1 12 39
M  V30 15 1 13 40
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 19 26
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 51-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-77-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11757098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5l
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME157 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexaneacetic acid
C8H14O2
5292-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C30H34N4O5S
195444-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6363 8.5298 0.0 0 VAL=6
M  V30 2 N 5.3027 7.7598 0.0 0
M  V30 3 O 7.4063 7.1961 0.0 0
M  V30 4 O 5.8663 9.8634 0.0 0
M  V30 5 C 11.9710 6.9898 0.0 0
M  V30 6 N 13.3047 6.2198 0.0 0
M  V30 7 C 14.6383 6.9898 0.0 0
M  V30 8 C 13.3047 4.6798 0.0 0
M  V30 9 C 15.9721 6.2198 0.0 0
M  V30 10 O 14.6383 8.5298 0.0 0
M  V30 11 C 2.2419 6.3970 0.0 0
M  V30 12 C 0.0000 8.8869 0.0 0
M  V30 13 C 9.3036 8.5298 0.0 0
M  V30 14 C 7.9700 9.2998 0.0 0
M  V30 15 C 10.6374 9.2998 0.0 0
M  V30 16 C 7.9700 10.8398 0.0 0
M  V30 17 C 10.6374 10.8398 0.0 0
M  V30 18 C 9.3036 11.6098 0.0 0
M  V30 19 C 9.3036 6.9898 0.0 0
M  V30 20 C 10.6374 6.2198 0.0 0
M  V30 21 C 7.9700 6.2198 0.0 0
M  V30 22 C 10.6374 4.6798 0.0 0
M  V30 23 C 7.9700 4.6798 0.0 0
M  V30 24 C 9.3036 3.9098 0.0 0
M  V30 25 C 3.9689 8.5298 0.0 0
M  V30 26 C 2.5621 7.9034 0.0 0
M  V30 27 O 3.8080 10.0613 0.0 0
M  V30 28 C 1.5317 9.0478 0.0 0
M  V30 29 N 2.3017 10.3816 0.0 0
M  V30 30 C 9.3036 2.3698 0.0 0
M  V30 31 N 10.5496 1.4645 0.0 0
M  V30 32 O 8.0577 1.4645 0.0 0
M  V30 33 C 10.0736 0.0000 0.0 0
M  V30 34 C 8.5336 0.0000 0.0 0
M  V30 35 C 17.3057 6.9898 0.0 0
M  V30 36 C 18.6394 6.2198 0.0 0
M  V30 37 C 17.3057 8.5298 0.0 0
M  V30 38 C 19.9732 6.9898 0.0 0
M  V30 39 C 18.6394 9.2998 0.0 0
M  V30 40 C 19.9732 8.5298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 25
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 35
M  V30 13 1 11 26
M  V30 14 1 12 28
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 19
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 24 30
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 5292-21-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-773997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5n
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME158 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid
C2H4O2
64-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C24H24N4O5S
176960-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.3360 8.5299 0.0 0 VAL=6
M  V30 2 N 10.6697 7.7599 0.0 0
M  V30 3 O 10.1060 9.8636 0.0 0
M  V30 4 O 8.5660 7.1963 0.0 0
M  V30 5 C 4.0012 6.9899 0.0 0
M  V30 6 N 2.6673 6.2199 0.0 0
M  V30 7 C 1.3337 6.9899 0.0 0
M  V30 8 C 2.6673 4.6799 0.0 0
M  V30 9 C 1.3337 8.5299 0.0 0
M  V30 10 O 0.0000 6.2199 0.0 0
M  V30 11 C 13.7305 6.3971 0.0 0
M  V30 12 C 15.9723 8.8871 0.0 0
M  V30 13 C 6.6685 8.5299 0.0 0
M  V30 14 C 8.0022 9.3000 0.0 0
M  V30 15 C 5.3348 9.3000 0.0 0
M  V30 16 C 8.0022 10.8400 0.0 0
M  V30 17 C 5.3348 10.8400 0.0 0
M  V30 18 C 6.6685 11.6100 0.0 0
M  V30 19 C 6.6685 6.9899 0.0 0
M  V30 20 C 5.3348 6.2199 0.0 0
M  V30 21 C 8.0022 6.2199 0.0 0
M  V30 22 C 5.3348 4.6799 0.0 0
M  V30 23 C 8.0022 4.6799 0.0 0
M  V30 24 C 6.6685 3.9098 0.0 0
M  V30 25 C 12.0033 8.5299 0.0 0
M  V30 26 C 13.4103 7.9036 0.0 0
M  V30 27 O 12.1643 10.0615 0.0 0
M  V30 28 C 14.4407 9.0480 0.0 0
M  V30 29 N 13.6707 10.3818 0.0 0
M  V30 30 C 6.6685 2.3698 0.0 0
M  V30 31 N 5.4226 1.4646 0.0 0
M  V30 32 O 7.9144 1.4646 0.0 0
M  V30 33 C 5.8985 0.0000 0.0 0
M  V30 34 C 7.4385 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 25
M  V30 6 1 5 6
M  V30 7 1 5 20
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 11 26
M  V30 13 1 12 28
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 24 30
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 176960-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10056254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5a
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME159 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid
C7H6O2
65-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C29H26N4O5S
176960-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 12.0032 8.5299 0.0 0 VAL=6
M  V30 2 N 13.3369 7.7599 0.0 0
M  V30 3 O 11.2332 7.1962 0.0 0
M  V30 4 O 12.7733 9.8635 0.0 0
M  V30 5 C 6.6684 6.9899 0.0 0
M  V30 6 N 5.3348 6.2198 0.0 0
M  V30 7 C 4.0010 6.9899 0.0 0
M  V30 8 C 5.3348 4.6798 0.0 0
M  V30 9 O 4.0010 8.5299 0.0 0
M  V30 10 C 16.3977 6.3971 0.0 0
M  V30 11 C 18.6395 8.8870 0.0 0
M  V30 12 C 9.3358 8.5299 0.0 0
M  V30 13 C 10.6696 9.2999 0.0 0
M  V30 14 C 8.0021 9.2999 0.0 0
M  V30 15 C 10.6696 10.8399 0.0 0
M  V30 16 C 8.0021 10.8399 0.0 0
M  V30 17 C 9.3358 11.6099 0.0 0
M  V30 18 C 9.3358 6.9899 0.0 0
M  V30 19 C 8.0021 6.2198 0.0 0
M  V30 20 C 10.6696 6.2198 0.0 0
M  V30 21 C 8.0021 4.6798 0.0 0
M  V30 22 C 10.6696 4.6798 0.0 0
M  V30 23 C 9.3358 3.9098 0.0 0
M  V30 24 C 14.6706 8.5299 0.0 0
M  V30 25 C 16.0775 7.9035 0.0 0
M  V30 26 O 14.8316 10.0614 0.0 0
M  V30 27 C 17.1080 9.0479 0.0 0
M  V30 28 N 16.3379 10.3817 0.0 0
M  V30 29 C 9.3358 2.3698 0.0 0
M  V30 30 N 10.5818 1.4646 0.0 0
M  V30 31 O 8.0899 1.4646 0.0 0
M  V30 32 C 10.1058 0.0000 0.0 0
M  V30 33 C 8.5658 0.0000 0.0 0
M  V30 34 C 2.6673 6.2198 0.0 0
M  V30 35 C 2.6673 4.6798 0.0 0
M  V30 36 C 1.3337 6.9899 0.0 0
M  V30 37 C 1.3337 3.9098 0.0 0
M  V30 38 C 0.0000 6.2198 0.0 0
M  V30 39 C 0.0000 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 24
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 7 34
M  V30 12 1 10 25
M  V30 13 1 11 27
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 18
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 23 29
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 65-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 176960-89-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14207621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5i
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME160 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pivalic acid
C5H10O2
75-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 C 0.5637 0.9764 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 C 2.1037 3.6437 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C27H30N4O5S
176960-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 10.6696 8.5299 0.0 0 VAL=6
M  V30 2 N 12.0033 7.7599 0.0 0
M  V30 3 O 11.4396 9.8636 0.0 0
M  V30 4 O 9.8996 7.1962 0.0 0
M  V30 5 C 5.3348 6.9899 0.0 0
M  V30 6 N 4.0011 6.2199 0.0 0
M  V30 7 C 2.6673 6.9899 0.0 0
M  V30 8 C 4.0011 4.6798 0.0 0
M  V30 9 C 1.3337 6.2199 0.0 0
M  V30 10 O 2.6673 8.5299 0.0 0
M  V30 11 C 0.5637 7.5535 0.0 0
M  V30 12 C 0.0000 5.4499 0.0 0
M  V30 13 C 2.1037 4.8862 0.0 0
M  V30 14 C 15.0641 6.3971 0.0 0
M  V30 15 C 17.3059 8.8870 0.0 0
M  V30 16 C 8.0021 8.5299 0.0 0
M  V30 17 C 9.3360 9.2999 0.0 0
M  V30 18 C 6.6685 9.2999 0.0 0
M  V30 19 C 9.3360 10.8399 0.0 0
M  V30 20 C 6.6685 10.8399 0.0 0
M  V30 21 C 8.0021 11.6100 0.0 0
M  V30 22 C 8.0021 6.9899 0.0 0
M  V30 23 C 6.6685 6.2199 0.0 0
M  V30 24 C 9.3360 6.2199 0.0 0
M  V30 25 C 6.6685 4.6798 0.0 0
M  V30 26 C 9.3360 4.6798 0.0 0
M  V30 27 C 8.0021 3.9098 0.0 0
M  V30 28 C 13.3369 8.5299 0.0 0
M  V30 29 C 14.7439 7.9036 0.0 0
M  V30 30 O 13.4980 10.0615 0.0 0
M  V30 31 C 15.7744 9.0480 0.0 0
M  V30 32 N 15.0043 10.3818 0.0 0
M  V30 33 C 8.0021 2.3698 0.0 0
M  V30 34 N 9.2480 1.4646 0.0 0
M  V30 35 O 6.7563 1.4646 0.0 0
M  V30 36 C 8.7722 0.0000 0.0 0
M  V30 37 C 7.2321 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 28
M  V30 6 1 5 6
M  V30 7 1 5 23
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 14 29
M  V30 16 1 15 31
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 22
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 27 33
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-98-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 176960-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10286681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5e
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME161 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3,4-Dimethyl-5-isoxazolyl)-2′-formyl-4′-(2-oxazolyl)[1,1′-biphenyl]-2-sulf...
C21H17N3O5S
176961-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 8.5299 0.0 0 VAL=6
M  V30 2 N 8.0023 7.7599 0.0 0
M  V30 3 O 7.4385 9.8636 0.0 0
M  V30 4 O 5.8985 7.1963 0.0 0
M  V30 5 C 1.3337 6.9899 0.0 0
M  V30 6 O 0.0000 6.2199 0.0 0
M  V30 7 C 11.0630 6.3971 0.0 0
M  V30 8 C 13.3050 8.8871 0.0 0
M  V30 9 C 4.0012 8.5299 0.0 0
M  V30 10 C 5.3348 9.3000 0.0 0
M  V30 11 C 2.6675 9.3000 0.0 0
M  V30 12 C 5.3348 10.8400 0.0 0
M  V30 13 C 2.6675 10.8400 0.0 0
M  V30 14 C 4.0012 11.6100 0.0 0
M  V30 15 C 4.0012 6.9899 0.0 0
M  V30 16 C 2.6675 6.2199 0.0 0
M  V30 17 C 5.3348 6.2199 0.0 0
M  V30 18 C 2.6675 4.6799 0.0 0
M  V30 19 C 5.3348 4.6799 0.0 0
M  V30 20 C 4.0012 3.9098 0.0 0
M  V30 21 C 9.3360 8.5299 0.0 0
M  V30 22 C 10.7428 7.9036 0.0 0
M  V30 23 O 9.4969 10.0615 0.0 0
M  V30 24 C 11.7734 9.0480 0.0 0
M  V30 25 N 11.0034 10.3818 0.0 0
M  V30 26 C 4.0012 2.3698 0.0 0
M  V30 27 N 2.7553 1.4646 0.0 0
M  V30 28 O 5.2470 1.4646 0.0 0
M  V30 29 C 3.2311 0.0000 0.0 0
M  V30 30 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 21
M  V30 6 2 5 6
M  V30 7 1 5 16
M  V30 8 1 7 22
M  V30 9 1 8 24
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 26
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isobutyric acid
C4H8O2
79-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2′-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphe...
C26H28N4O5S
195444-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 10.6695 8.5298 0.0 0 VAL=6
M  V30 2 N 12.0031 7.7598 0.0 0
M  V30 3 O 9.8995 7.1961 0.0 0
M  V30 4 O 11.4395 9.8634 0.0 0
M  V30 5 C 5.3347 6.9898 0.0 0
M  V30 6 N 4.0011 6.2198 0.0 0
M  V30 7 C 2.6673 6.9898 0.0 0
M  V30 8 C 4.0011 4.6798 0.0 0
M  V30 9 C 1.3336 6.2198 0.0 0
M  V30 10 O 2.6673 8.5298 0.0 0
M  V30 11 C 0.0000 6.9898 0.0 0
M  V30 12 C 1.3336 4.6798 0.0 0
M  V30 13 C 15.0639 6.3970 0.0 0
M  V30 14 C 17.3057 8.8869 0.0 0
M  V30 15 C 8.0020 8.5298 0.0 0
M  V30 16 C 9.3358 9.2998 0.0 0
M  V30 17 C 6.6684 9.2998 0.0 0
M  V30 18 C 9.3358 10.8398 0.0 0
M  V30 19 C 6.6684 10.8398 0.0 0
M  V30 20 C 8.0020 11.6098 0.0 0
M  V30 21 C 8.0020 6.9898 0.0 0
M  V30 22 C 6.6684 6.2198 0.0 0
M  V30 23 C 9.3358 6.2198 0.0 0
M  V30 24 C 6.6684 4.6798 0.0 0
M  V30 25 C 9.3358 4.6798 0.0 0
M  V30 26 C 8.0020 3.9098 0.0 0
M  V30 27 C 13.3368 8.5298 0.0 0
M  V30 28 C 14.7437 7.9035 0.0 0
M  V30 29 O 13.4979 10.0613 0.0 0
M  V30 30 C 15.7741 9.0479 0.0 0
M  V30 31 N 15.0041 10.3817 0.0 0
M  V30 32 C 8.0020 2.3698 0.0 0
M  V30 33 N 9.2479 1.4645 0.0 0
M  V30 34 O 6.7562 1.4645 0.0 0
M  V30 35 C 8.7720 0.0000 0.0 0
M  V30 36 C 7.2320 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 27
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 28
M  V30 15 1 14 30
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 26 32
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176961-45-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 79-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195444-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5162443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Representative Procedure for Compounds 5a-p.
N-[[2'-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(5g). To a solution of 0.15 g (0.35 mmol) of 417 in 15 mL of
dichloromethane, methylamine (33% solution in absolute ethanol, 0.13 mL,
1.06 mmol), glacial acetic acid (0.12 g, 2 mmol), and 1 g of 3 Å
molecular sieves were added. The mixture was stirred at room temperature
for 1 h. Sodium triacetoxyboro-hydride (0.22 g, 1.06 mmol) was added, and
the mixture was stirred overnight. The solution was then filtered, washed
once with water, dried, and evaporated to afford 0.15 g of
2'-[(methylamino)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-
4'-(2-oxazolyl)[1,1'-biphenyl]-2-sulfonamide as a colorless gum. To a
solution of this material (32.9 mg, 0.075 mmol) and tertbutylacetic acid
(0.075 mol) in 0.3 mL of CH2Cl2 was added 0.1 mL of DMF followed by a
solution of 1,3-diisopropylcarbodiimide in CH2Cl2 (0.28N, 0.320 mL, 0.09
mmol). The reaction mixture was vortexed for 3 min and then let stand at
room temperature for 24 h. The mixture was then loaded onto 1.5 g of a
Strong Anion Exchange (Quaternary Amine) resin and eluted with 20 mL of
CH2Cl2 followed by 10 mL of 3% TFA in CH2Cl2 to give 5g as a white solid.
Compound 5c
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, first stage mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biphenylsulfonamide Endothelin Receptor Antagonists. 4. Discovery of
N-[[2'-[[(4,5-Dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide
(BMS-207940), a Highly Potent and Orally Active ETA Selective Antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Gu, Zhengxiang; Spergel, Steven; Young, Marian; Chen,
Ping; Mathur, Arvind; Leith, Leslie; Hermsmeier, Mark; Liu, Eddie C.-K.;
Zhang, Rongan; Bird, Eileen; Waldron, Tom; Marino, Anthony; Koplowitz,
Barry; Humphreys, W. Griffith; Chong, Saeho; Morrison, Richard A.; Webb,
Maria L.; Moreland, Suzanne; Trippodo, Nick; Barrish, Joel C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(1), 125-137

$RFMT $RIREG SCHEME162 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-1-(4-methylbenzoyl)-5H-1-benzazepin-5-one
C18H17NO2
1778386-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1760 2.6464 0.0 0
M  V30 2 O 6.1760 1.1064 0.0 0
M  V30 3 O 0.0000 4.5516 0.0 0
M  V30 4 C 11.5108 5.7265 0.0 0
M  V30 5 C 3.5700 2.5489 0.0 0
M  V30 6 N 4.8423 3.4164 0.0 0
M  V30 7 C 2.0983 3.0029 0.0 0
M  V30 8 C 3.9126 1.0475 0.0 0
M  V30 9 C 4.9574 4.9521 0.0 0
M  V30 10 C 1.5357 4.4364 0.0 0
M  V30 11 C 0.9695 1.9554 0.0 0
M  V30 12 C 2.7836 0.0000 0.0 0
M  V30 13 C 3.8285 5.9997 0.0 0
M  V30 14 C 2.3057 5.7702 0.0 0
M  V30 15 C 1.3121 0.4540 0.0 0
M  V30 16 C 7.5098 3.4164 0.0 0
M  V30 17 C 8.8435 2.6464 0.0 0
M  V30 18 C 7.5098 4.9564 0.0 0
M  V30 19 C 10.1772 3.4164 0.0 0
M  V30 20 C 8.8435 5.7265 0.0 0
M  V30 21 C 10.1772 4.9564 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 16
M  V30 4 2 3 10
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl](4-methylphenyl)me...
C20H24N2O
1902970-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0435 2.6463 0.0 0
M  V30 2 O 7.0435 1.1063 0.0 0
M  V30 3 N 0.8675 4.5515 0.0 0
M  V30 4 C 0.1993 5.9389 0.0 0
M  V30 5 C 0.0000 3.2790 0.0 0
M  V30 6 C 12.3782 5.7263 0.0 0
M  V30 7 C 4.4374 2.5489 0.0 0
M  V30 8 C 2.9659 3.0028 0.0 0
M  V30 9 N 5.7099 3.4163 0.0 0
M  V30 10 C 4.7802 1.0475 0.0 0
M  V30 11 C 2.4032 4.4363 0.0 0
M  V30 12 C 1.8369 1.9553 0.0 0
M  V30 13 C 5.8249 4.9520 0.0 0
M  V30 14 C 3.6512 0.0000 0.0 0
M  V30 15 C 3.1732 5.7701 0.0 0
M  V30 16 C 2.1796 0.4540 0.0 0
M  V30 17 C 4.6961 5.9995 0.0 0
M  V30 18 C 8.3771 3.4163 0.0 0
M  V30 19 C 9.7109 2.6463 0.0 0
M  V30 20 C 8.3771 4.9563 0.0 0
M  V30 21 C 11.0446 3.4163 0.0 0
M  V30 22 C 9.7109 5.7263 0.0 0
M  V30 23 C 11.0446 4.9563 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 11
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1778386-31-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1902970-04-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5717339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used (4 A - stages 1-2), anti/syn diastereomer ratio
observed solvent dependent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereochemistry of N-Benzoyl-5-substituted-1-benzazepines Revisited:
Synthesis of the Conformationally Biased Derivatives and Revision of the
Reported Structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tabata, Hidetsugu; Yoneda, Tetsuya; Tasaka, Tomohiko; Ito, Shigekazu;
Oshitari, Tetsuta; Takahashi, Hideyo; Natsugari, Hideaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(8), 3136-3148

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
6H-Pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyridine-7-carboxylic acid, 1-methyl-6...
C17H14N4O2.C2HF3O2
1799727-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3561 9.0387 0.0 0
M  V30 2 C 5.3867 6.3281 0.0 0
M  V30 3 O 6.8930 6.0079 0.0 0
M  V30 4 O 4.3563 5.1837 0.0 0
M  V30 5 C 0.0000 9.3444 0.0 0
M  V30 6 C 4.9108 10.2846 0.0 0
M  V30 7 C 3.4461 9.8087 0.0 0
M  V30 8 N 5.8160 9.0387 0.0 0
M  V30 9 C 5.2310 11.7909 0.0 0
M  V30 10 N 2.3017 10.8391 0.0 0
M  V30 11 C 3.4461 8.2687 0.0 0
M  V30 12 C 4.9108 7.7928 0.0 0
M  V30 13 C 4.0864 12.8215 0.0 0
M  V30 14 C 2.6219 12.3454 0.0 0
M  V30 15 C 0.7700 10.6782 0.0 0
M  V30 16 N 1.2882 13.1154 0.0 0
M  V30 17 N 0.1437 12.0850 0.0 0
M  V30 18 C 8.1261 10.3724 0.0 0
M  V30 19 C 9.6661 10.3724 0.0 0
M  V30 20 C 7.3561 11.7060 0.0 0
M  V30 21 C 10.4361 11.7060 0.0 0
M  V30 22 C 8.1261 13.0397 0.0 0
M  V30 23 C 9.6661 13.0397 0.0 0
M  V30 24 C 4.5512 2.3101 0.0 0
M  V30 25 C 5.8849 1.5400 0.0 0
M  V30 26 F 5.3212 3.6437 0.0 0
M  V30 27 F 3.2175 3.0801 0.0 0
M  V30 28 F 3.7812 0.9764 0.0 0
M  V30 29 O 7.2186 2.3101 0.0 0
M  V30 30 O 5.8849 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 2 11 12
M  V30 17 1 13 14
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 1 24 28
M  V30 31 1 25 29
M  V30 32 2 25 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-6-(phenylmethyl)-6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyridine...
C18H17N5O
1799722-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3560 5.3196 0.0 0
M  V30 2 C 0.0000 5.6255 0.0 0
M  V30 3 C 5.3866 2.6091 0.0 0
M  V30 4 N 4.3562 1.4647 0.0 0
M  V30 5 O 6.8929 2.2889 0.0 0
M  V30 6 C 4.8321 0.0000 0.0 0
M  V30 7 C 3.4461 6.0896 0.0 0
M  V30 8 C 4.9108 6.5655 0.0 0
M  V30 9 N 2.3017 7.1200 0.0 0
M  V30 10 C 3.4461 4.5496 0.0 0
M  V30 11 N 5.8160 5.3196 0.0 0
M  V30 12 C 5.2309 8.0719 0.0 0
M  V30 13 C 2.6218 8.6265 0.0 0
M  V30 14 C 0.7700 6.9591 0.0 0
M  V30 15 C 4.9108 4.0738 0.0 0
M  V30 16 C 4.0864 9.1023 0.0 0
M  V30 17 N 1.2882 9.3965 0.0 0
M  V30 18 N 0.1437 8.3659 0.0 0
M  V30 19 C 8.1260 6.6533 0.0 0
M  V30 20 C 7.3560 7.9869 0.0 0
M  V30 21 C 9.6660 6.6533 0.0 0
M  V30 22 C 8.1260 9.3207 0.0 0
M  V30 23 C 10.4360 7.9869 0.0 0
M  V30 24 C 9.6660 9.3207 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 16
M  V30 19 2 13 17
M  V30 20 2 14 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1799727-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799722-35-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9879123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tricyclic heterocycles as BET protein inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Haisheng; Shao, Lixin; Rodgers, James D.; Shepard, Stacey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015095492 A1 2015-06-25

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-[[(2S)-2-[[[2-[bis(phenylmethyl)amino]-2-oxoethyl]amin...
C32H36N4O5
1801588-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.6536 2.6674 0.0 0
M  V30 2 C 15.1936 2.6674 0.0 0 CFG=2
M  V30 3 O 12.8836 1.3336 0.0 0
M  V30 4 N 15.9636 4.0011 0.0 0
M  V30 5 C 15.9636 1.3336 0.0 0
M  V30 6 C 17.5036 4.0011 0.0 0
M  V30 7 C 15.1936 0.0000 0.0 0
M  V30 8 C 17.5036 1.3336 0.0 0
M  V30 9 O 18.2736 5.3347 0.0 0
M  V30 10 O 18.2736 2.6674 0.0 0
M  V30 11 C 19.8136 5.3347 0.0 0
M  V30 12 C 10.0100 4.7711 0.0 0
M  V30 13 N 9.2400 6.1047 0.0 0
M  V30 14 O 9.2400 3.4374 0.0 0
M  V30 15 C 7.7000 6.1047 0.0 0
M  V30 16 C 6.9300 4.7711 0.0 0
M  V30 17 N 5.3900 4.7711 0.0 0
M  V30 18 O 7.7000 3.4374 0.0 0
M  V30 19 C 4.6200 6.1047 0.0 0
M  V30 20 C 4.6200 3.4374 0.0 0
M  V30 21 N 12.8836 4.0011 0.0 0
M  V30 22 C 11.5500 4.7711 0.0 0 CFG=2
M  V30 23 C 12.8836 5.5411 0.0 0
M  V30 24 C 20.5836 6.6684 0.0 0
M  V30 25 C 22.1236 6.6684 0.0 0
M  V30 26 C 19.8136 8.0021 0.0 0
M  V30 27 C 22.8936 8.0021 0.0 0
M  V30 28 C 20.5836 9.3358 0.0 0
M  V30 29 C 22.1236 9.3358 0.0 0
M  V30 30 C 5.3900 7.4384 0.0 0
M  V30 31 C 4.6200 8.7721 0.0 0
M  V30 32 C 6.9300 7.4384 0.0 0
M  V30 33 C 5.3900 10.1058 0.0 0
M  V30 34 C 7.7000 8.7721 0.0 0
M  V30 35 C 6.9300 10.1058 0.0 0
M  V30 36 C 3.0800 3.4374 0.0 0
M  V30 37 C 2.3100 2.1036 0.0 0
M  V30 38 C 2.3100 4.7711 0.0 0
M  V30 39 C 0.7700 2.1036 0.0 0
M  V30 40 C 0.7700 4.7711 0.0 0
M  V30 41 C 0.0000 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 22 12 CFG=3
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 19 30
M  V30 23 1 20 36
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-valyl-3-(methylamino)-L-alanyl-N,N-bis(phenylme...
C33H41N5O5
1801588-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 4.6201 0.0 0
M  V30 2 C 4.0010 3.0801 0.0 0
M  V30 3 C 2.6673 5.3901 0.0 0
M  V30 4 C 5.3348 5.3901 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 O 5.3348 6.9302 0.0 0
M  V30 7 N 8.0022 5.3901 0.0 0
M  V30 8 C 9.3358 4.6201 0.0 0
M  V30 9 C 10.6697 5.3901 0.0 0 CFG=2
M  V30 10 O 9.3360 3.0801 0.0 0
M  V30 11 N 12.0033 4.6201 0.0 0
M  V30 12 C 10.6697 6.9302 0.0 0
M  V30 13 C 13.3370 5.3901 0.0 0
M  V30 14 N 9.3358 7.7002 0.0 0
M  V30 15 C 14.6708 4.6201 0.0 0 CFG=2
M  V30 16 O 13.3370 6.9302 0.0 0
M  V30 17 C 9.3358 9.2402 0.0 0
M  V30 18 N 16.0045 5.3901 0.0 0
M  V30 19 C 14.6708 3.0801 0.0 0
M  V30 20 C 17.3382 4.6201 0.0 0
M  V30 21 C 13.3370 2.3101 0.0 0
M  V30 22 C 16.0045 2.3101 0.0 0
M  V30 23 O 18.6718 5.3901 0.0 0
M  V30 24 O 17.3382 3.0801 0.0 0
M  V30 25 C 20.0057 4.6201 0.0 0
M  V30 26 C 2.6673 2.3101 0.0 0
M  V30 27 C 1.3337 3.0801 0.0 0
M  V30 28 C 2.6673 0.7700 0.0 0
M  V30 29 C 0.0000 2.3101 0.0 0
M  V30 30 C 1.3337 0.0000 0.0 0
M  V30 31 C 0.0000 0.7700 0.0 0
M  V30 32 C 2.6673 6.9302 0.0 0
M  V30 33 C 1.3337 7.7002 0.0 0
M  V30 34 C 4.0010 7.7002 0.0 0
M  V30 35 C 1.3337 9.2402 0.0 0
M  V30 36 C 4.0010 9.2402 0.0 0
M  V30 37 C 2.6673 10.0102 0.0 0
M  V30 38 C 21.3393 5.3901 0.0 0
M  V30 39 C 21.3393 6.9302 0.0 0
M  V30 40 C 22.6730 4.6201 0.0 0
M  V30 41 C 22.6730 7.7002 0.0 0
M  V30 42 C 24.0067 5.3901 0.0 0
M  V30 43 C 24.0067 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 26
M  V30 5 1 3 32
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12 CFG=3
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 2 20 24
M  V30 26 1 23 25
M  V30 27 1 25 38
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1801588-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1801588-74-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-038-CAS-3209326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aziridine electrophiles in the functionalization of peptide chains with
amine nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spork, Anatol P.; Donohoe, Timothy J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(31), 8545-8549

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-(Benzoylamino)-4-(2-bromoethoxy)-N-[(1S)-1-(hydroxymethyl)-2-phenyleth...
C27H29BrN2O4
1801645-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 8.0020 0.0 0 CFG=1
M  V30 2 C 7.7000 9.3358 0.0 0
M  V30 3 N 5.3900 8.0020 0.0 0
M  V30 4 C 7.7000 6.6684 0.0 0
M  V30 5 C 4.6200 9.3358 0.0 0
M  V30 6 N 6.9300 5.3347 0.0 0
M  V30 7 O 9.2400 6.6684 0.0 0
M  V30 8 O 5.3900 10.6694 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0 CFG=2
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 6.9300 2.6673 0.0 0
M  V30 12 O 5.3900 2.6673 0.0 0
M  V30 13 O 13.8600 9.3358 0.0 0
M  V30 14 C 14.6300 10.6694 0.0 0
M  V30 15 C 16.1700 10.6694 0.0 0
M  V30 16 Br 16.9400 12.0031 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 C 10.0100 8.0020 0.0 0
M  V30 19 C 10.0100 10.6694 0.0 0
M  V30 20 C 11.5500 8.0020 0.0 0
M  V30 21 C 11.5500 10.6694 0.0 0
M  V30 22 C 12.3200 9.3358 0.0 0
M  V30 23 C 3.0800 9.3358 0.0 0
M  V30 24 C 2.3100 8.0020 0.0 0
M  V30 25 C 2.3100 10.6694 0.0 0
M  V30 26 C 0.7700 8.0020 0.0 0
M  V30 27 C 0.7700 10.6694 0.0 0
M  V30 28 C 0.0000 9.3358 0.0 0
M  V30 29 C 10.0100 2.6673 0.0 0
M  V30 30 C 11.5500 2.6673 0.0 0
M  V30 31 C 9.2400 1.3336 0.0 0
M  V30 32 C 12.3200 1.3336 0.0 0
M  V30 33 C 10.0100 0.0000 0.0 0
M  V30 34 C 11.5500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 23
M  V30 10 1 6 9
M  V30 11 1 9 10
M  V30 12 1 9 11 CFG=1
M  V30 13 1 10 29
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 22
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-(Benzoylamino)-N-[(1S)-1-(hydroxymethyl)-2-phenylethyl]-4-[2-(methylam...
C28H33N3O4
1918170-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 8.0020 0.0 0 CFG=2
M  V30 2 C 7.7000 9.3358 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 5.3900 8.0020 0.0 0
M  V30 5 N 6.9300 5.3347 0.0 0
M  V30 6 O 9.2400 6.6684 0.0 0
M  V30 7 C 4.6200 9.3358 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0 CFG=2
M  V30 9 O 5.3900 10.6694 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 6.9300 2.6673 0.0 0
M  V30 12 O 5.3900 2.6673 0.0 0
M  V30 13 O 13.8600 9.3358 0.0 0
M  V30 14 C 14.6300 10.6694 0.0 0
M  V30 15 C 16.1700 10.6694 0.0 0
M  V30 16 N 16.9400 12.0031 0.0 0
M  V30 17 C 18.4800 12.0031 0.0 0
M  V30 18 C 9.2400 9.3358 0.0 0
M  V30 19 C 10.0100 10.6694 0.0 0
M  V30 20 C 10.0100 8.0020 0.0 0
M  V30 21 C 11.5500 10.6694 0.0 0
M  V30 22 C 11.5500 8.0020 0.0 0
M  V30 23 C 12.3200 9.3358 0.0 0
M  V30 24 C 3.0800 9.3358 0.0 0
M  V30 25 C 2.3100 10.6694 0.0 0
M  V30 26 C 2.3100 8.0020 0.0 0
M  V30 27 C 0.7700 10.6694 0.0 0
M  V30 28 C 0.7700 8.0020 0.0 0
M  V30 29 C 0.0000 9.3358 0.0 0
M  V30 30 C 10.0100 2.6673 0.0 0
M  V30 31 C 9.2400 1.3336 0.0 0
M  V30 32 C 11.5500 2.6673 0.0 0
M  V30 33 C 10.0100 0.0000 0.0 0
M  V30 34 C 12.3200 1.3336 0.0 0
M  V30 35 C 11.5500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 24
M  V30 11 1 8 10
M  V30 12 1 8 11 CFG=1
M  V30 13 1 10 30
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 23
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1801645-25-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918170-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15588449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process development of clinical anti-HBV drug Y101: identification and
synthesis of novel impurities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Zhanxing; Liao, HaiJian; An, Qiao; Pan, Weidong; Cao, Peixue; Liu,
Changxiao; Huang, Zhengming; Xia, Wen; Xu, Bixue; Liang, Guangyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2016), 42(3), 2577-2595

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylsulfony...
C26H30Cl2N4O8S
1802932-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 9.0337 6.6684 0.0 0
M  V30 2 Cl 4.4137 4.0010 0.0 0
M  V30 3 O 8.2637 8.0021 0.0 0
M  V30 4 O 10.5737 4.0010 0.0 0
M  V30 5 C 11.3437 2.6673 0.0 0
M  V30 6 O 5.9537 1.3337 0.0 0
M  V30 7 C 6.7237 0.0000 0.0 0
M  V30 8 C 6.7237 10.6695 0.0 0
M  V30 9 C 8.2637 10.6695 0.0 0
M  V30 10 O 9.0337 12.0032 0.0 0
M  V30 11 S 1.3337 12.0032 0.0 0 VAL=6
M  V30 12 C 0.5636 13.3368 0.0 0
M  V30 13 O 2.6673 12.7732 0.0 0
M  V30 14 O 0.0000 11.2332 0.0 0
M  V30 15 C 14.2916 12.0032 0.0 0
M  V30 16 O 15.0617 13.3368 0.0 0
M  V30 17 O 15.0617 10.6695 0.0 0
M  V30 18 C 16.6017 13.3368 0.0 0
M  V30 19 C 16.6017 11.7968 0.0 0
M  V30 20 C 18.1417 13.3368 0.0 0
M  V30 21 C 16.6017 14.8768 0.0 0
M  V30 22 C 6.7237 5.3348 0.0 0
M  V30 23 C 8.2637 5.3348 0.0 0
M  V30 24 C 5.9537 4.0010 0.0 0
M  V30 25 C 9.0337 4.0010 0.0 0
M  V30 26 C 6.7237 2.6673 0.0 0
M  V30 27 C 8.2637 2.6673 0.0 0
M  V30 28 C 5.9537 6.6684 0.0 0
M  V30 29 C 6.7237 8.0021 0.0 0
M  V30 30 C 4.4137 6.6684 0.0 0
M  V30 31 N 5.9537 9.3359 0.0 0
M  V30 32 C 3.6437 8.0021 0.0 0
M  V30 33 C 4.4137 9.3359 0.0 0
M  V30 34 C 2.1037 8.0021 0.0 0
M  V30 35 N 3.6437 10.6695 0.0 0
M  V30 36 N 1.3337 9.3359 0.0 0
M  V30 37 C 2.1037 10.6695 0.0 0
M  V30 38 C 10.5737 12.0032 0.0 0
M  V30 39 C 11.6627 13.0921 0.0 0
M  V30 40 C 11.6627 10.9142 0.0 0
M  V30 41 N 12.7516 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 23
M  V30 2 1 2 24
M  V30 3 2 3 29
M  V30 4 1 4 5
M  V30 5 1 4 25
M  V30 6 1 6 7
M  V30 7 1 6 26
M  V30 8 1 8 9
M  V30 9 1 8 31
M  V30 10 1 9 10
M  V30 11 1 10 38
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 37
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 41
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 22 28
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 37
M  V30 41 1 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-...
C26H31Cl2N5O6
1802932-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 3.0801 0.0 0
M  V30 2 Cl 6.6687 2.3101 0.0 0
M  V30 3 Cl 4.0012 6.9302 0.0 0
M  V30 4 C 10.6697 4.6201 0.0 0
M  V30 5 C 12.0035 5.3901 0.0 0
M  V30 6 O 13.3372 4.6201 0.0 0
M  V30 7 O 4.0012 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 O 1.3338 5.3901 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 N 12.0035 10.0102 0.0 0
M  V30 12 C 12.0035 11.5503 0.0 0
M  V30 13 C 17.8907 7.2491 0.0 0
M  V30 14 O 19.2244 6.4791 0.0 0
M  V30 15 O 17.8907 8.7891 0.0 0
M  V30 16 C 20.5581 7.2491 0.0 0
M  V30 17 C 19.7880 8.5828 0.0 0
M  V30 18 C 21.8919 8.0191 0.0 0
M  V30 19 C 21.3281 5.9154 0.0 0
M  V30 20 C 6.6687 5.3901 0.0 0
M  V30 21 C 8.0023 4.6201 0.0 0
M  V30 22 C 6.6687 6.9302 0.0 0
M  V30 23 N 9.3360 5.3901 0.0 0
M  V30 24 C 8.0023 7.7002 0.0 0
M  V30 25 C 9.3360 6.9302 0.0 0
M  V30 26 C 8.0023 9.2402 0.0 0
M  V30 27 N 10.6697 7.7002 0.0 0
M  V30 28 N 9.3360 10.0102 0.0 0
M  V30 29 C 10.6697 9.2402 0.0 0
M  V30 30 C 5.3348 4.6201 0.0 0
M  V30 31 C 5.3348 3.0801 0.0 0
M  V30 32 C 4.0012 5.3901 0.0 0
M  V30 33 C 4.0012 2.3101 0.0 0
M  V30 34 C 2.6675 4.6201 0.0 0
M  V30 35 C 2.6675 3.0801 0.0 0
M  V30 36 C 14.6708 5.3901 0.0 0
M  V30 37 C 16.1583 4.9916 0.0 0
M  V30 38 C 15.0694 6.8776 0.0 0
M  V30 39 N 16.5571 6.4791 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 31
M  V30 3 1 3 32
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 6 36
M  V30 8 1 7 8
M  V30 9 1 7 33
M  V30 10 1 9 10
M  V30 11 1 9 34
M  V30 12 1 11 12
M  V30 13 1 11 29
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 39
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 30
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1802932-92-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802932-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18234643
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinolone derivatives as fibroblast growth factor receptor
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verner, Erik; Brameld, Kenneth Albert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015120049 A1 2015-08-13

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanyl-(βR,γS)-γ-amino-β-(nitromethy...
C39H56N6O11
1809035-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 57 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.6784 7.2321 0.0 0 CFG=1
M  V30 2 C 15.3447 8.0021 0.0 0 CFG=1
M  V30 3 C 16.6784 5.6921 0.0 0
M  V30 4 N 18.0121 8.0021 0.0 0
M  V30 5 C 14.0111 7.2321 0.0 0
M  V30 6 C 15.3447 9.5421 0.0 0
M  V30 7 C 19.3458 7.2321 0.0 0
M  V30 8 C 12.6773 8.0021 0.0 0
M  V30 9 N 16.6784 10.3121 0.0 0 VAL=5
M  V30 10 C 20.6794 8.0021 0.0 0
M  V30 11 O 19.3458 5.6921 0.0 0
M  V30 12 N 11.3436 7.2321 0.0 0
M  V30 13 O 12.6773 9.5421 0.0 0
M  V30 14 O 18.0121 9.5421 0.0 0
M  V30 15 O 16.6784 11.8521 0.0 0
M  V30 16 N 21.4494 6.6685 0.0 0
M  V30 17 C 19.9094 9.3358 0.0 0
M  V30 18 C 22.0131 8.7721 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 22.9894 6.6685 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 8.6764 8.7721 0.0 0
M  V30 23 C 10.7800 9.3358 0.0 0
M  V30 24 O 23.7594 5.3347 0.0 0
M  V30 25 O 23.7594 8.0021 0.0 0
M  V30 26 N 7.7000 6.6685 0.0 0
M  V30 27 O 10.0100 5.3347 0.0 0
M  V30 28 C 25.2994 5.3347 0.0 0
M  V30 29 C 6.9300 5.3347 0.0 0 CFG=1
M  V30 30 C 25.2994 6.8747 0.0 0
M  V30 31 C 26.8394 5.3347 0.0 0
M  V30 32 C 25.2994 3.7947 0.0 0
M  V30 33 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 34 C 7.7000 4.0011 0.0 0
M  V30 35 C 4.6200 4.0011 0.0 0
M  V30 36 C 4.6200 6.6685 0.0 0
M  V30 37 C 3.0800 4.0011 0.0 0
M  V30 38 N 5.3900 8.0021 0.0 0 VAL=5
M  V30 39 O 2.3100 2.6674 0.0 0
M  V30 40 O 2.3100 5.3347 0.0 0
M  V30 41 O 6.9300 8.0021 0.0 0
M  V30 42 O 4.6200 9.3358 0.0 0
M  V30 43 C 0.7700 2.6674 0.0 0
M  V30 44 C 0.0000 1.3336 0.0 0
M  V30 45 C 15.3447 4.9221 0.0 0
M  V30 46 C 15.3447 3.3821 0.0 0
M  V30 47 C 14.0111 5.6921 0.0 0
M  V30 48 C 14.0111 2.6121 0.0 0
M  V30 49 C 12.6773 4.9221 0.0 0
M  V30 50 C 12.6773 3.3821 0.0 0
M  V30 51 C 6.9300 2.6674 0.0 0
M  V30 52 C 5.3900 2.6674 0.0 0
M  V30 53 C 7.7000 1.3336 0.0 0
M  V30 54 C 4.6200 1.3336 0.0 0
M  V30 55 C 6.9300 0.0000 0.0 0
M  V30 56 C 5.3900 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 45
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 10 18
M  V30 19 1 12 19
M  V30 20 1 16 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 20 25
M  V30 26 1 21 26
M  V30 27 2 21 27
M  V30 28 1 24 28
M  V30 29 1 26 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 1 29 34 CFG=1
M  V30 35 1 33 35
M  V30 36 1 33 36 CFG=3
M  V30 37 1 34 51
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 37 40
M  V30 42 2 38 41
M  V30 43 2 38 42
M  V30 44 1 39 43
M  V30 45 1 43 44
M  V30 46 2 45 46
M  V30 47 1 45 47
M  V30 48 1 46 48
M  V30 49 2 47 49
M  V30 50 2 48 50
M  V30 51 1 49 50
M  V30 52 2 51 52
M  V30 53 1 51 53
M  V30 54 1 52 54
M  V30 55 2 53 55
M  V30 56 2 54 56
M  V30 57 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanyl-(βR,γS)-γ-amino-β-(nitromethy...
C38H55N7O10
1809035-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 56 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.9084 7.2321 0.0 0 CFG=1
M  V30 2 C 14.5747 8.0021 0.0 0 CFG=1
M  V30 3 C 15.9084 5.6921 0.0 0
M  V30 4 N 17.2420 8.0021 0.0 0
M  V30 5 C 13.2411 7.2321 0.0 0
M  V30 6 C 14.5747 9.5421 0.0 0
M  V30 7 C 18.5758 7.2321 0.0 0
M  V30 8 C 11.9073 8.0021 0.0 0
M  V30 9 N 15.9084 10.3121 0.0 0 VAL=5
M  V30 10 C 19.9094 8.0021 0.0 0
M  V30 11 O 18.5758 5.6921 0.0 0
M  V30 12 N 10.5736 7.2321 0.0 0
M  V30 13 O 11.9073 9.5421 0.0 0
M  V30 14 O 17.2420 9.5421 0.0 0
M  V30 15 O 15.9084 11.8521 0.0 0
M  V30 16 N 20.6794 6.6685 0.0 0
M  V30 17 C 21.2431 8.7721 0.0 0
M  V30 18 C 19.1394 9.3358 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 22.2194 6.6685 0.0 0
M  V30 21 C 8.4700 6.6685 0.0 0
M  V30 22 C 10.0100 9.3358 0.0 0
M  V30 23 C 7.9064 8.7721 0.0 0
M  V30 24 O 22.9894 5.3347 0.0 0
M  V30 25 O 22.9894 8.0021 0.0 0
M  V30 26 N 6.9300 6.6685 0.0 0
M  V30 27 O 9.2400 5.3347 0.0 0
M  V30 28 C 24.5294 5.3347 0.0 0
M  V30 29 C 6.1600 5.3347 0.0 0 CFG=1
M  V30 30 C 24.5294 6.8747 0.0 0
M  V30 31 C 26.0694 5.3347 0.0 0
M  V30 32 C 24.5294 3.7947 0.0 0
M  V30 33 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 34 C 6.9300 4.0011 0.0 0
M  V30 35 C 3.8500 4.0011 0.0 0
M  V30 36 C 3.8500 6.6685 0.0 0
M  V30 37 C 2.3100 4.0011 0.0 0
M  V30 38 N 4.6200 8.0021 0.0 0 VAL=5
M  V30 39 N 1.5400 2.6674 0.0 0
M  V30 40 O 1.5400 5.3347 0.0 0
M  V30 41 O 3.8500 9.3358 0.0 0
M  V30 42 O 6.1600 8.0021 0.0 0
M  V30 43 C 0.0000 2.6674 0.0 0
M  V30 44 C 14.5747 4.9221 0.0 0
M  V30 45 C 14.5747 3.3821 0.0 0
M  V30 46 C 13.2411 5.6921 0.0 0
M  V30 47 C 13.2411 2.6121 0.0 0
M  V30 48 C 11.9073 4.9221 0.0 0
M  V30 49 C 11.9073 3.3821 0.0 0
M  V30 50 C 6.1600 2.6674 0.0 0
M  V30 51 C 6.9300 1.3336 0.0 0
M  V30 52 C 4.6200 2.6674 0.0 0
M  V30 53 C 6.1600 0.0000 0.0 0
M  V30 54 C 3.8500 1.3336 0.0 0
M  V30 55 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 44
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 10 18
M  V30 19 1 12 19
M  V30 20 1 16 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 20 25
M  V30 26 1 21 26
M  V30 27 2 21 27
M  V30 28 1 24 28
M  V30 29 1 26 29
M  V30 30 1 28 30
M  V30 31 1 28 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 1 29 34 CFG=1
M  V30 35 1 33 35
M  V30 36 1 33 36 CFG=3
M  V30 37 1 34 50
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 37 40
M  V30 42 2 38 41
M  V30 43 2 38 42
M  V30 44 1 39 43
M  V30 45 2 44 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 2 46 48
M  V30 49 2 47 49
M  V30 50 1 48 49
M  V30 51 2 50 51
M  V30 52 1 50 52
M  V30 53 1 51 53
M  V30 54 2 52 54
M  V30 55 2 53 55
M  V30 56 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 29 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1809035-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809035-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9187363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM γ- and β-Peptide Foldamers from Common Multifaceted Building Blocks:
Synthesis and Structural Characterization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ganesh Kumar, Mothukuri; Gopi, Hosahudya N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(19), 4738-4741

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-chloroquinoline
C9H5BrClN
1810-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6673 0.0 0
M  V30 2 Cl 8.4702 1.3337 0.0 0
M  V30 3 C 3.8501 1.3337 0.0 0
M  V30 4 C 4.6201 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 N 6.1601 2.6673 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 1.5400 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-2-quinolinamine
C10H9BrN2
1201845-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 Br 0.0000 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 N 5.3348 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1810-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1201845-11-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17454124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, reaction in a stainless steel autoclave
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolidinone derivatives as inhibitors of PERK
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Axten, Jeffrey Michael; Faucher, Nicolas Eric; Daugan, Alain Claude-Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017046739 A1 2017-03-23

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
2-[2-[4-[[[3-[4-[[4-(Aminocarbonyl)phenyl]methyl]-1-piperidinyl]propyl](3-chl...
C33H43ClN4O6
1816317-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8603 5.3348 0.0 0
M  V30 2 C 15.4003 5.3348 0.0 0
M  V30 3 C 13.0903 6.6685 0.0 0
M  V30 4 O 16.1704 4.0010 0.0 0
M  V30 5 C 11.5503 6.6685 0.0 0
M  V30 6 C 10.7802 8.0022 0.0 0
M  V30 7 Cl 13.8603 0.0000 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 18.4804 10.6697 0.0 0
M  V30 10 C 20.0204 10.6697 0.0 0
M  V30 11 O 17.7104 12.0033 0.0 0
M  V30 12 O 20.7905 12.0033 0.0 0
M  V30 13 C 22.3305 12.0033 0.0 0
M  V30 14 C 23.1005 13.3370 0.0 0
M  V30 15 O 22.3305 14.6707 0.0 0
M  V30 16 O 24.6405 13.3370 0.0 0
M  V30 17 C 4.6201 8.0022 0.0 0
M  V30 18 C 1.5400 13.3370 0.0 0
M  V30 19 N 2.3101 14.6707 0.0 0
M  V30 20 O 0.0000 13.3370 0.0 0
M  V30 21 C 13.0903 4.0010 0.0 0
M  V30 22 C 13.8603 2.6673 0.0 0
M  V30 23 C 11.5503 4.0010 0.0 0
M  V30 24 C 13.0903 1.3337 0.0 0
M  V30 25 C 10.7802 2.6673 0.0 0
M  V30 26 C 11.5503 1.3337 0.0 0
M  V30 27 C 16.1704 6.6685 0.0 0
M  V30 28 C 15.4003 8.0022 0.0 0
M  V30 29 C 17.7104 6.6685 0.0 0
M  V30 30 C 16.1704 9.3358 0.0 0
M  V30 31 C 18.4804 8.0022 0.0 0
M  V30 32 N 17.7104 9.3358 0.0 0
M  V30 33 N 9.2402 8.0022 0.0 0
M  V30 34 C 8.4702 9.3358 0.0 0
M  V30 35 C 8.4702 6.6685 0.0 0
M  V30 36 C 6.9302 9.3358 0.0 0
M  V30 37 C 6.9302 6.6685 0.0 0
M  V30 38 C 6.1601 8.0022 0.0 0
M  V30 39 C 3.8501 9.3358 0.0 0
M  V30 40 C 4.6201 10.6697 0.0 0
M  V30 41 C 2.3101 9.3358 0.0 0
M  V30 42 C 3.8501 12.0033 0.0 0
M  V30 43 C 1.5400 10.6697 0.0 0
M  V30 44 C 2.3101 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 2 4
M  V30 5 1 2 27
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 33
M  V30 9 1 7 24
M  V30 10 1 8 26
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 32
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 17 38
M  V30 20 1 17 39
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 44
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-[[4-(Aminocarbonyl)phenyl]methyl]-1-piperidinyl]propyl]-N-(3-chloro-4...
C34H46ClN5O5
1816317-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8603 5.3348 0.0 0
M  V30 2 C 15.4003 5.3348 0.0 0
M  V30 3 C 13.0903 6.6685 0.0 0
M  V30 4 O 16.1704 4.0010 0.0 0
M  V30 5 C 11.5503 6.6685 0.0 0
M  V30 6 C 10.7802 8.0022 0.0 0
M  V30 7 Cl 13.8603 0.0000 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 18.4804 10.6697 0.0 0
M  V30 10 C 20.0204 10.6697 0.0 0
M  V30 11 O 17.7104 12.0033 0.0 0
M  V30 12 O 20.7905 12.0033 0.0 0
M  V30 13 C 22.3305 12.0033 0.0 0
M  V30 14 C 23.1005 13.3370 0.0 0
M  V30 15 N 24.6405 13.3370 0.0 0
M  V30 16 O 22.3305 14.6707 0.0 0
M  V30 17 C 25.4106 14.6707 0.0 0
M  V30 18 C 4.6201 8.0022 0.0 0
M  V30 19 C 1.5400 13.3370 0.0 0
M  V30 20 N 2.3101 14.6707 0.0 0
M  V30 21 O 0.0000 13.3370 0.0 0
M  V30 22 C 13.0903 4.0010 0.0 0
M  V30 23 C 13.8603 2.6673 0.0 0
M  V30 24 C 11.5503 4.0010 0.0 0
M  V30 25 C 13.0903 1.3337 0.0 0
M  V30 26 C 10.7802 2.6673 0.0 0
M  V30 27 C 11.5503 1.3337 0.0 0
M  V30 28 C 16.1704 6.6685 0.0 0
M  V30 29 C 17.7104 6.6685 0.0 0
M  V30 30 C 15.4003 8.0022 0.0 0
M  V30 31 C 18.4804 8.0022 0.0 0
M  V30 32 C 16.1704 9.3358 0.0 0
M  V30 33 N 17.7104 9.3358 0.0 0
M  V30 34 N 9.2402 8.0022 0.0 0
M  V30 35 C 8.4702 6.6685 0.0 0
M  V30 36 C 8.4702 9.3358 0.0 0
M  V30 37 C 6.9302 6.6685 0.0 0
M  V30 38 C 6.9302 9.3358 0.0 0
M  V30 39 C 6.1601 8.0022 0.0 0
M  V30 40 C 3.8501 9.3358 0.0 0
M  V30 41 C 4.6201 10.6697 0.0 0
M  V30 42 C 2.3101 9.3358 0.0 0
M  V30 43 C 3.8501 12.0033 0.0 0
M  V30 44 C 1.5400 10.6697 0.0 0
M  V30 45 C 2.3101 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22
M  V30 4 2 2 4
M  V30 5 1 2 28
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 34
M  V30 9 1 7 25
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 33
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 18 39
M  V30 21 1 18 40
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 45
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1816317-81-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1816317-82-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16644404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Analgesic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Portoghese, Philip S.; Akgun, Eyup
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016138142 A1 2016-09-01

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
2-[2-[4-[[[3-[4-[[4-(Aminocarbonyl)phenyl]methyl]-1-piperidinyl]propyl](3-chl...
C33H43ClN4O6
1816317-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8603 5.3348 0.0 0
M  V30 2 C 15.4003 5.3348 0.0 0
M  V30 3 C 13.0903 6.6685 0.0 0
M  V30 4 O 16.1704 4.0010 0.0 0
M  V30 5 C 11.5503 6.6685 0.0 0
M  V30 6 C 10.7802 8.0022 0.0 0
M  V30 7 Cl 13.8603 0.0000 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 18.4804 10.6697 0.0 0
M  V30 10 C 20.0204 10.6697 0.0 0
M  V30 11 O 17.7104 12.0033 0.0 0
M  V30 12 O 20.7905 12.0033 0.0 0
M  V30 13 C 22.3305 12.0033 0.0 0
M  V30 14 C 23.1005 13.3370 0.0 0
M  V30 15 O 22.3305 14.6707 0.0 0
M  V30 16 O 24.6405 13.3370 0.0 0
M  V30 17 C 4.6201 8.0022 0.0 0
M  V30 18 C 1.5400 13.3370 0.0 0
M  V30 19 N 2.3101 14.6707 0.0 0
M  V30 20 O 0.0000 13.3370 0.0 0
M  V30 21 C 13.0903 4.0010 0.0 0
M  V30 22 C 13.8603 2.6673 0.0 0
M  V30 23 C 11.5503 4.0010 0.0 0
M  V30 24 C 13.0903 1.3337 0.0 0
M  V30 25 C 10.7802 2.6673 0.0 0
M  V30 26 C 11.5503 1.3337 0.0 0
M  V30 27 C 16.1704 6.6685 0.0 0
M  V30 28 C 15.4003 8.0022 0.0 0
M  V30 29 C 17.7104 6.6685 0.0 0
M  V30 30 C 16.1704 9.3358 0.0 0
M  V30 31 C 18.4804 8.0022 0.0 0
M  V30 32 N 17.7104 9.3358 0.0 0
M  V30 33 N 9.2402 8.0022 0.0 0
M  V30 34 C 8.4702 9.3358 0.0 0
M  V30 35 C 8.4702 6.6685 0.0 0
M  V30 36 C 6.9302 9.3358 0.0 0
M  V30 37 C 6.9302 6.6685 0.0 0
M  V30 38 C 6.1601 8.0022 0.0 0
M  V30 39 C 3.8501 9.3358 0.0 0
M  V30 40 C 4.6201 10.6697 0.0 0
M  V30 41 C 2.3101 9.3358 0.0 0
M  V30 42 C 3.8501 12.0033 0.0 0
M  V30 43 C 1.5400 10.6697 0.0 0
M  V30 44 C 2.3101 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 2 4
M  V30 5 1 2 27
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 33
M  V30 9 1 7 24
M  V30 10 1 8 26
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 32
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 17 38
M  V30 20 1 17 39
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 44
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 42 2 39 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-[[4-(Aminocarbonyl)phenyl]methyl]-1-piperidinyl]propyl]-N-(3-chloro-4...
C34H46ClN5O5
1816317-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.8603 5.3348 0.0 0
M  V30 2 C 15.4003 5.3348 0.0 0
M  V30 3 C 13.0903 6.6685 0.0 0
M  V30 4 O 16.1704 4.0010 0.0 0
M  V30 5 C 11.5503 6.6685 0.0 0
M  V30 6 C 10.7802 8.0022 0.0 0
M  V30 7 Cl 13.8603 0.0000 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 18.4804 10.6697 0.0 0
M  V30 10 C 20.0204 10.6697 0.0 0
M  V30 11 O 17.7104 12.0033 0.0 0
M  V30 12 O 20.7905 12.0033 0.0 0
M  V30 13 C 22.3305 12.0033 0.0 0
M  V30 14 C 23.1005 13.3370 0.0 0
M  V30 15 N 24.6405 13.3370 0.0 0
M  V30 16 O 22.3305 14.6707 0.0 0
M  V30 17 C 25.4106 14.6707 0.0 0
M  V30 18 C 4.6201 8.0022 0.0 0
M  V30 19 C 1.5400 13.3370 0.0 0
M  V30 20 N 2.3101 14.6707 0.0 0
M  V30 21 O 0.0000 13.3370 0.0 0
M  V30 22 C 13.0903 4.0010 0.0 0
M  V30 23 C 13.8603 2.6673 0.0 0
M  V30 24 C 11.5503 4.0010 0.0 0
M  V30 25 C 13.0903 1.3337 0.0 0
M  V30 26 C 10.7802 2.6673 0.0 0
M  V30 27 C 11.5503 1.3337 0.0 0
M  V30 28 C 16.1704 6.6685 0.0 0
M  V30 29 C 17.7104 6.6685 0.0 0
M  V30 30 C 15.4003 8.0022 0.0 0
M  V30 31 C 18.4804 8.0022 0.0 0
M  V30 32 C 16.1704 9.3358 0.0 0
M  V30 33 N 17.7104 9.3358 0.0 0
M  V30 34 N 9.2402 8.0022 0.0 0
M  V30 35 C 8.4702 6.6685 0.0 0
M  V30 36 C 8.4702 9.3358 0.0 0
M  V30 37 C 6.9302 6.6685 0.0 0
M  V30 38 C 6.9302 9.3358 0.0 0
M  V30 39 C 6.1601 8.0022 0.0 0
M  V30 40 C 3.8501 9.3358 0.0 0
M  V30 41 C 4.6201 10.6697 0.0 0
M  V30 42 C 2.3101 9.3358 0.0 0
M  V30 43 C 3.8501 12.0033 0.0 0
M  V30 44 C 1.5400 10.6697 0.0 0
M  V30 45 C 2.3101 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 22
M  V30 4 2 2 4
M  V30 5 1 2 28
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 34
M  V30 9 1 7 25
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 33
M  V30 14 1 10 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 18 39
M  V30 21 1 18 40
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 45
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 43 2 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 2 42 44
M  V30 47 2 43 45
M  V30 48 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1816317-81-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1816317-82-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-964749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, activated reactant from stage 1 added
stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid
Receptor/Chemokine Receptor 5 Heteromer (MOR-CCR5)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akgun, Eyup; Javed, Muhammad I.; Lunzer, Mary M.; Powers, Michael D.;
Sham, Yuk Y.; Watanabe, Yoshikazu; Portoghese, Philip S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(21), 8647-8657

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2,2-Dimethyl-1-oxopropoxy)methyl]uridine
C15H22N2O8
1820702-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5789 0.6966 0.0 0
M  V30 2 O 4.5955 6.3388 0.0 0
M  V30 3 C 0.6265 2.9016 0.0 0
M  V30 4 O 0.0000 4.3086 0.0 0
M  V30 5 O 2.3017 0.0000 0.0 0
M  V30 6 C 9.9303 3.2587 0.0 0
M  V30 7 O 11.2640 4.0287 0.0 0
M  V30 8 C 12.5976 3.2587 0.0 0
M  V30 9 C 13.9313 4.0287 0.0 0
M  V30 10 O 12.5976 1.7187 0.0 0
M  V30 11 C 13.1613 5.3624 0.0 0
M  V30 12 C 15.2651 4.7987 0.0 0
M  V30 13 C 14.7013 2.6951 0.0 0
M  V30 14 O 9.9303 6.3388 0.0 0
M  V30 15 C 4.5955 3.2587 0.0 0 CFG=1
M  V30 16 O 3.1885 3.8850 0.0 0
M  V30 17 C 4.4344 1.7271 0.0 0 CFG=2
M  V30 18 C 2.1580 2.7406 0.0 0 CFG=2
M  V30 19 C 2.9281 1.4070 0.0 0 CFG=2
M  V30 20 N 5.9291 4.0287 0.0 0
M  V30 21 C 7.2628 3.2587 0.0 0
M  V30 22 C 5.9291 5.5688 0.0 0
M  V30 23 C 8.5965 4.0287 0.0 0
M  V30 24 N 7.2628 6.3388 0.0 0
M  V30 25 C 8.5965 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 2 2 22
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=1
M  V30 5 1 19 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 14 25
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20 CFG=1
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-[(Methylamino)methyl]uridine
C11H17N3O6
72667-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9646 6.6363 0.0 0
M  V30 2 O 6.6374 2.2418 0.0 0
M  V30 3 C 9.1247 6.6363 0.0 0
M  V30 4 N 9.8947 5.3026 0.0 0
M  V30 5 C 11.4348 5.3026 0.0 0
M  V30 6 C 1.2459 1.6751 0.0 0
M  V30 7 O 0.0000 2.5803 0.0 0
M  V30 8 O 4.1475 0.0000 0.0 0
M  V30 9 O 7.5847 9.3037 0.0 0
M  V30 10 N 5.2746 5.3026 0.0 0
M  V30 11 C 6.8147 5.3026 0.0 0
M  V30 12 C 4.5046 6.6363 0.0 0
M  V30 13 C 7.5847 6.6363 0.0 0
M  V30 14 N 5.2746 7.9700 0.0 0
M  V30 15 C 6.8147 7.9700 0.0 0
M  V30 16 C 4.5046 3.9688 0.0 0 CFG=1
M  V30 17 O 2.9730 3.8079 0.0 0
M  V30 18 C 5.1309 2.5620 0.0 0 CFG=2
M  V30 19 C 2.6529 2.3016 0.0 0 CFG=2
M  V30 20 C 3.9865 1.5316 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 18 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 19 6 CFG=1
M  V30 8 1 20 8 CFG=3
M  V30 9 2 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 16 10 CFG=1
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1820702-19-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72667-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26798996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on time, temperature and solvent, rubber
septum sealed flask used, literature preparation, alternative preparation
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of various substituted 5-methyluridines (xm5U) and
2-thiouridines (xm5s2U) via nucleophilic substitution of
5-pivaloyloxymethyluridine/2-thiouridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartosik, Karolina; Leszczynska, Grazyna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(47), 6593-6597

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(2,2-Dimethyl-1-oxopropoxy)methyl]-2-thiouridine
C15H22N2O7S
1820702-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5789 0.6966 0.0 0
M  V30 2 S 4.5955 6.3388 0.0 0
M  V30 3 C 0.6265 2.9016 0.0 0
M  V30 4 O 0.0000 4.3086 0.0 0
M  V30 5 O 2.3017 0.0000 0.0 0
M  V30 6 C 9.9303 3.2587 0.0 0
M  V30 7 O 11.2640 4.0287 0.0 0
M  V30 8 C 12.5976 3.2587 0.0 0
M  V30 9 C 13.9313 4.0287 0.0 0
M  V30 10 O 12.5976 1.7187 0.0 0
M  V30 11 C 13.1613 5.3624 0.0 0
M  V30 12 C 15.2651 4.7987 0.0 0
M  V30 13 C 14.7013 2.6951 0.0 0
M  V30 14 O 9.9303 6.3388 0.0 0
M  V30 15 C 4.5955 3.2587 0.0 0 CFG=1
M  V30 16 O 3.1885 3.8850 0.0 0
M  V30 17 C 4.4344 1.7271 0.0 0 CFG=2
M  V30 18 C 2.1580 2.7406 0.0 0 CFG=2
M  V30 19 C 2.9281 1.4070 0.0 0 CFG=2
M  V30 20 N 5.9291 4.0287 0.0 0
M  V30 21 C 7.2628 3.2587 0.0 0
M  V30 22 C 5.9291 5.5688 0.0 0
M  V30 23 C 8.5965 4.0287 0.0 0
M  V30 24 N 7.2628 6.3388 0.0 0
M  V30 25 C 8.5965 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 2 2 22
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=1
M  V30 5 1 19 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 14 25
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20 CFG=1
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Methylaminomethyl-2-thiouridine
C11H17N3O5S
32860-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 2.9646 6.6363 0.0 0
M  V30 2 O 6.6374 2.2418 0.0 0
M  V30 3 C 9.1247 6.6363 0.0 0
M  V30 4 N 9.8947 5.3026 0.0 0
M  V30 5 C 11.4348 5.3026 0.0 0
M  V30 6 C 1.2459 1.6751 0.0 0
M  V30 7 O 0.0000 2.5803 0.0 0
M  V30 8 O 4.1475 0.0000 0.0 0
M  V30 9 O 7.5847 9.3037 0.0 0
M  V30 10 N 5.2746 5.3026 0.0 0
M  V30 11 C 6.8147 5.3026 0.0 0
M  V30 12 C 4.5046 6.6363 0.0 0
M  V30 13 C 7.5847 6.6363 0.0 0
M  V30 14 N 5.2746 7.9700 0.0 0
M  V30 15 C 6.8147 7.9700 0.0 0
M  V30 16 C 4.5046 3.9688 0.0 0 CFG=1
M  V30 17 O 2.9730 3.8079 0.0 0
M  V30 18 C 5.1309 2.5620 0.0 0 CFG=2
M  V30 19 C 2.6529 2.3016 0.0 0 CFG=2
M  V30 20 C 3.9865 1.5316 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 18 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 19 6 CFG=1
M  V30 8 1 20 8 CFG=3
M  V30 9 2 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 16 10 CFG=1
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1820702-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32860-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26902504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on solvent, time and temperature, rubber
septum sealed flask used, literature preparation, alternative preparation
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of various substituted 5-methyluridines (xm5U) and
2-thiouridines (xm5s2U) via nucleophilic substitution of
5-pivaloyloxymethyluridine/2-thiouridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartosik, Karolina; Leszczynska, Grazyna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(47), 6593-6597

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-3,4-dihydro-2-(1-methylethyl)-3-oxo-2H-1,4-benzoxazine-6-carboxylic acid
C12H12BrNO4
1820889-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.6684 6.1600 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 C 1.3336 6.1600 0.0 0
M  V30 5 C 9.3358 1.5400 0.0 0
M  V30 6 O 10.6694 2.3100 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 O 1.3336 1.5400 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 O 4.0011 4.6200 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 N 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 18 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 2 8 18
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-3,4-dihydro-N-methyl-2-(1-methylethyl)-3-oxo-2H-1,4-benzoxazine-6-car...
C13H15BrN2O3
1820889-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.6685 6.1601 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 C 1.3337 6.1601 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 N 10.6697 2.3101 0.0 0
M  V30 7 O 9.3360 0.0000 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 O 4.0012 4.6201 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 N 4.0012 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 8.0022 3.8501 0.0 0
M  V30 18 C 8.0022 2.3101 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 18
M  V30 8 1 6 8
M  V30 9 2 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1820889-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1820889-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9779012
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and
pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Combs, Andrew P.; Maduskuie, Thomas P., Jr.; Falahatpisheh, Nikoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015164480 A1 2015-10-29

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-nitro-N′-[(tetrahydro-3-furanyl)methyl]carbamimidothioate
C7H13N3O3S
184848-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 N 5.1048 3.0801 0.0 0
M  V30 3 C 6.4384 2.3101 0.0 0
M  V30 4 N 7.7722 3.0801 0.0 0
M  V30 5 S 6.4384 0.7700 0.0 0
M  V30 6 N 9.1059 2.3101 0.0 0 VAL=5
M  V30 7 C 5.1048 0.0000 0.0 0
M  V30 8 O 9.1059 0.7700 0.0 0
M  V30 9 O 10.4396 3.0801 0.0 0
M  V30 10 C 2.4374 3.0801 0.0 0
M  V30 11 C 1.0304 2.4536 0.0 0
M  V30 12 C 2.2763 4.6116 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 14 O 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dinotefuran
C7H14N4O3
165252-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 N 5.1048 3.0801 0.0 0
M  V30 3 C 6.4384 2.3101 0.0 0
M  V30 4 N 7.7722 3.0801 0.0 0
M  V30 5 N 6.4384 0.7700 0.0 0
M  V30 6 N 9.1059 2.3101 0.0 0 VAL=5
M  V30 7 C 5.1048 0.0000 0.0 0
M  V30 8 O 9.1059 0.7700 0.0 0
M  V30 9 O 10.4396 3.0801 0.0 0
M  V30 10 C 2.4374 3.0801 0.0 0
M  V30 11 C 2.2763 4.6116 0.0 0
M  V30 12 C 1.0304 2.4536 0.0 0
M  V30 13 C 0.7700 4.9318 0.0 0
M  V30 14 O 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 184848-82-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 165252-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4229888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationships of dinotefuran
derivatives: Modification in the nitroguanidine part
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakita, Takeo; Kinoshita, Katsutoshi; Yasui, Naoko; Yamada, Eiichi;
Kawahara, Nobuyuki; Kodaka, Kenji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Pesticide Science (Tokyo, Japan) (2004), 29(4), 348-355

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 6′-chloro-2′-methylursa-2,12-dieno[3,2-d]pyrimidin-28-oate
C40H53ClN2O2
1849649-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6300 6.6684 0.0 0
M  V30 2 O 16.1700 6.6684 0.0 0
M  V30 3 O 13.8600 8.0021 0.0 0
M  V30 4 C 16.9400 8.0021 0.0 0
M  V30 5 C 13.0900 1.3336 0.0 0
M  V30 6 C 10.6457 6.8689 0.0 0
M  V30 7 C 16.1700 1.3336 0.0 0
M  V30 8 C 9.3743 6.8689 0.0 0
M  V30 9 C 7.0643 2.4669 0.0 0
M  V30 10 C 3.1729 5.8614 0.0 0
M  V30 11 C 4.8873 6.8513 0.0 0
M  V30 12 Cl 4.6200 0.0000 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 13.8600 5.3347 0.0 0 CFG=1
M  V30 15 C 13.0900 4.0011 0.0 0 CFG=1
M  V30 16 C 13.0900 6.6684 0.0 0
M  V30 17 C 15.4000 5.3347 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 13.8600 2.6674 0.0 0 CFG=1
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 16.1700 4.0011 0.0 0
M  V30 22 C 10.7800 5.3347 0.0 0 CFG=1
M  V30 23 C 10.7800 2.6674 0.0 0
M  V30 24 C 15.4000 2.6674 0.0 0 CFG=2
M  V30 25 C 9.2400 5.3347 0.0 0 CFG=1
M  V30 26 C 9.2400 2.6674 0.0 0
M  V30 27 C 8.4700 4.0011 0.0 0 CFG=1
M  V30 28 C 8.4700 6.6684 0.0 0
M  V30 29 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 30 C 6.9300 6.6684 0.0 0
M  V30 31 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 32 C 6.1600 2.6674 0.0 0
M  V30 33 C 4.6200 5.3347 0.0 0
M  V30 34 C 4.6200 2.6674 0.0 0
M  V30 35 C 3.8500 4.0011 0.0 0
M  V30 36 C 3.8500 1.3336 0.0 0
M  V30 37 N 2.3100 4.0011 0.0 0
M  V30 38 N 2.3100 1.3336 0.0 0
M  V30 39 C 1.5400 2.6674 0.0 0
M  V30 40 C 18.4800 8.0021 0.0 0
M  V30 41 C 19.2500 6.6684 0.0 0
M  V30 42 C 19.2500 9.3358 0.0 0
M  V30 43 C 20.7900 6.6684 0.0 0
M  V30 44 C 20.7900 9.3358 0.0 0
M  V30 45 C 21.5600 8.0021 0.0 0
M  V30 46 H 12.3200 2.6674 0.0 0
M  V30 47 H 8.3357 2.4669 0.0 0
M  V30 48 H 5.3900 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 40
M  V30 6 1 19 5 CFG=3
M  V30 7 1 22 6 CFG=1
M  V30 8 1 24 7 CFG=1
M  V30 9 1 25 8 CFG=3
M  V30 10 1 29 9 CFG=3
M  V30 11 1 10 33
M  V30 12 1 11 33
M  V30 13 1 12 36
M  V30 14 1 13 39
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 46 CFG=3
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 18 23
M  V30 25 1 19 24
M  V30 26 1 20 22
M  V30 27 1 21 24
M  V30 28 1 22 25
M  V30 29 1 23 26
M  V30 30 1 25 27
M  V30 31 1 25 28
M  V30 32 1 26 27
M  V30 33 1 27 29
M  V30 34 1 27 47 CFG=1
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 1 29 32
M  V30 38 1 30 31
M  V30 39 1 31 33
M  V30 40 1 31 48 CFG=1
M  V30 41 1 32 34
M  V30 42 1 33 35
M  V30 43 1 34 35
M  V30 44 2 34 36
M  V30 45 2 35 37
M  V30 46 1 36 38
M  V30 47 1 37 39
M  V30 48 2 38 39
M  V30 49 2 40 41
M  V30 50 1 40 42
M  V30 51 1 41 43
M  V30 52 2 42 44
M  V30 53 2 43 45
M  V30 54 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 14 15 19 22 24 25 27 29 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 6′-(methylamino)-2′-methylursa-2,12-dieno[3,2-d]pyrimidin-28-oate
C41H57N3O2
1849649-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 14.6300 8.0021 0.0 0
M  V30 2 O 16.1700 8.0021 0.0 0
M  V30 3 O 13.8600 9.3358 0.0 0
M  V30 4 C 16.9400 9.3358 0.0 0
M  V30 5 C 13.0900 2.6673 0.0 0
M  V30 6 C 10.3814 8.1560 0.0 0
M  V30 7 C 16.1700 2.6673 0.0 0
M  V30 8 C 9.6386 8.1560 0.0 0
M  V30 9 C 7.3286 3.8472 0.0 0
M  V30 10 C 3.1729 7.1950 0.0 0
M  V30 11 C 4.8873 8.1849 0.0 0
M  V30 12 N 4.6200 1.3336 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 13.8600 6.6684 0.0 0 CFG=1
M  V30 16 C 13.0900 5.3347 0.0 0 CFG=1
M  V30 17 C 13.0900 8.0021 0.0 0
M  V30 18 C 15.4000 6.6684 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0 CFG=1
M  V30 21 C 11.5500 8.0021 0.0 0
M  V30 22 C 16.1700 5.3347 0.0 0
M  V30 23 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 24 C 10.7800 4.0011 0.0 0
M  V30 25 C 15.4000 4.0011 0.0 0 CFG=2
M  V30 26 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 27 C 9.2400 4.0011 0.0 0
M  V30 28 C 8.4700 5.3347 0.0 0 CFG=1
M  V30 29 C 8.4700 8.0021 0.0 0
M  V30 30 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 31 C 6.9300 8.0021 0.0 0
M  V30 32 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 33 C 6.1600 4.0011 0.0 0
M  V30 34 C 4.6200 6.6684 0.0 0
M  V30 35 C 4.6200 4.0011 0.0 0
M  V30 36 C 3.8500 5.3347 0.0 0
M  V30 37 C 3.8500 2.6673 0.0 0
M  V30 38 N 2.3100 5.3347 0.0 0
M  V30 39 N 2.3100 2.6673 0.0 0
M  V30 40 C 1.5400 4.0011 0.0 0
M  V30 41 C 18.4800 9.3358 0.0 0
M  V30 42 C 19.2500 10.6694 0.0 0
M  V30 43 C 19.2500 8.0021 0.0 0
M  V30 44 C 20.7900 10.6694 0.0 0
M  V30 45 C 20.7900 8.0021 0.0 0
M  V30 46 C 21.5600 9.3358 0.0 0
M  V30 47 H 12.3200 4.0011 0.0 0
M  V30 48 H 8.3357 3.8006 0.0 0
M  V30 49 H 5.3900 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 41
M  V30 6 1 20 5 CFG=3
M  V30 7 1 23 6 CFG=1
M  V30 8 1 25 7 CFG=1
M  V30 9 1 26 8 CFG=3
M  V30 10 1 30 9 CFG=3
M  V30 11 1 10 34
M  V30 12 1 11 34
M  V30 13 1 12 13
M  V30 14 1 12 37
M  V30 15 1 14 40
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 47 CFG=3
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 1 21 23
M  V30 28 1 22 25
M  V30 29 1 23 26
M  V30 30 1 24 27
M  V30 31 1 26 28
M  V30 32 1 26 29
M  V30 33 1 27 28
M  V30 34 1 28 30
M  V30 35 1 28 48 CFG=1
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 30 33
M  V30 39 1 31 32
M  V30 40 1 32 34
M  V30 41 1 32 49 CFG=1
M  V30 42 1 33 35
M  V30 43 1 34 36
M  V30 44 1 35 36
M  V30 45 2 35 37
M  V30 46 2 36 38
M  V30 47 1 37 39
M  V30 48 1 38 40
M  V30 49 2 39 40
M  V30 50 2 41 42
M  V30 51 1 41 43
M  V30 52 1 42 44
M  V30 53 2 43 45
M  V30 54 2 44 46
M  V30 55 1 45 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 15 16 20 23 25 26 28 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1849649-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1849649-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15604016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused triterpene compounds and use as retinoid-related
orphan receptors gamma (RORγ) modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Rajiv; Borhade, Namdev Narayan; Chakor, Narayan Subhash; Mistry,
Hitesh Devchandbhai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015198232 A1 2015-12-30

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
(2Z)-2-Fluoro-3-[3-[[1-[(4-methoxyphenyl)methyl]-4-(4-phenoxyphenoxy)-1H-pyra...
C35H27FN4O5
1854972-87-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7135 8.6410 0.0 0
M  V30 2 O 12.7338 9.9582 0.0 0
M  V30 3 C 7.0029 13.3358 0.0 0
M  V30 4 C 8.0649 3.5674 0.0 0
M  V30 5 C 6.9205 2.5369 0.0 0
M  V30 6 C 7.2407 1.0306 0.0 0
M  V30 7 F 5.4558 3.0127 0.0 0
M  V30 8 O 8.7054 0.5547 0.0 0
M  V30 9 O 6.0963 0.0000 0.0 0
M  V30 10 O 18.8939 9.9582 0.0 0
M  V30 11 O 1.1444 11.4323 0.0 0
M  V30 12 C 0.0000 12.4627 0.0 0
M  V30 13 C 10.4238 11.2919 0.0 0
M  V30 14 C 9.6537 12.6255 0.0 0
M  V30 15 C 9.3933 10.1475 0.0 0
M  V30 16 C 11.9638 11.2919 0.0 0
M  V30 17 N 8.1475 12.3054 0.0 0
M  V30 18 N 10.4238 13.9593 0.0 0
M  V30 19 N 7.9865 10.7738 0.0 0
M  V30 20 C 12.7338 12.6255 0.0 0
M  V30 21 C 11.9638 13.9593 0.0 0
M  V30 22 C 8.5691 7.6106 0.0 0
M  V30 23 C 8.8893 6.1042 0.0 0
M  V30 24 C 7.1044 8.0865 0.0 0
M  V30 25 C 7.7447 5.0737 0.0 0
M  V30 26 C 5.9600 7.0560 0.0 0
M  V30 27 C 6.2802 5.5496 0.0 0
M  V30 28 C 14.2738 9.9582 0.0 0
M  V30 29 C 15.0438 8.6246 0.0 0
M  V30 30 C 15.0438 11.2919 0.0 0
M  V30 31 C 16.5838 8.6246 0.0 0
M  V30 32 C 16.5838 11.2919 0.0 0
M  V30 33 C 17.3538 9.9582 0.0 0
M  V30 34 C 5.5384 12.8599 0.0 0
M  V30 35 C 5.2182 11.3536 0.0 0
M  V30 36 C 4.3938 13.8905 0.0 0
M  V30 37 C 3.7535 10.8778 0.0 0
M  V30 38 C 2.9293 13.4145 0.0 0
M  V30 39 C 2.6091 11.9082 0.0 0
M  V30 40 C 19.6639 8.6246 0.0 0
M  V30 41 C 21.2039 8.6246 0.0 0
M  V30 42 C 18.8939 7.2907 0.0 0
M  V30 43 C 21.9739 7.2907 0.0 0
M  V30 44 C 19.6639 5.9571 0.0 0
M  V30 45 C 21.2039 5.9571 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 22
M  V30 3 1 2 16
M  V30 4 1 2 28
M  V30 5 1 3 17
M  V30 6 1 3 34
M  V30 7 2 4 5
M  V30 8 1 4 25
M  V30 9 1 5 6
M  V30 10 1 5 7
M  V30 11 1 6 8
M  V30 12 2 6 9
M  V30 13 1 10 33
M  V30 14 1 10 40
M  V30 15 1 11 12
M  V30 16 1 11 39
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 2 13 16
M  V30 20 1 14 17
M  V30 21 2 14 18
M  V30 22 2 15 19
M  V30 23 1 16 20
M  V30 24 1 17 19
M  V30 25 1 18 21
M  V30 26 2 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-Fluoro-3-[3-[[1-[(4-methoxyphenyl)methyl]-4-(4-phenoxyphenoxy)-1H-pyra...
C36H30FN5O4
1854972-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.7135 10.1474 0.0 0
M  V30 2 O 12.7338 11.4646 0.0 0
M  V30 3 C 7.0030 14.8421 0.0 0
M  V30 4 C 8.0650 5.0736 0.0 0
M  V30 5 C 6.9206 4.0432 0.0 0
M  V30 6 C 7.2407 2.5367 0.0 0
M  V30 7 F 5.4558 4.5190 0.0 0
M  V30 8 N 6.0963 1.5063 0.0 0
M  V30 9 O 8.7054 2.0609 0.0 0
M  V30 10 C 6.4165 0.0000 0.0 0
M  V30 11 O 18.8939 11.4646 0.0 0
M  V30 12 O 1.1444 12.9387 0.0 0
M  V30 13 C 0.0000 13.9691 0.0 0
M  V30 14 C 10.4238 12.7982 0.0 0
M  V30 15 C 9.6538 14.1319 0.0 0
M  V30 16 C 9.3934 11.6537 0.0 0
M  V30 17 C 11.9638 12.7982 0.0 0
M  V30 18 N 8.1475 13.8117 0.0 0
M  V30 19 N 10.4238 15.4655 0.0 0
M  V30 20 N 7.9866 12.2802 0.0 0
M  V30 21 C 12.7338 14.1319 0.0 0
M  V30 22 C 11.9638 15.4655 0.0 0
M  V30 23 C 8.5692 9.1169 0.0 0
M  V30 24 C 8.8893 7.6105 0.0 0
M  V30 25 C 7.1044 9.5928 0.0 0
M  V30 26 C 7.7448 6.5801 0.0 0
M  V30 27 C 5.9600 8.5622 0.0 0
M  V30 28 C 6.2802 7.0559 0.0 0
M  V30 29 C 14.2739 11.4646 0.0 0
M  V30 30 C 15.0439 10.1307 0.0 0
M  V30 31 C 15.0439 12.7982 0.0 0
M  V30 32 C 16.5839 10.1307 0.0 0
M  V30 33 C 16.5839 12.7982 0.0 0
M  V30 34 C 17.3539 11.4646 0.0 0
M  V30 35 C 5.5384 14.3663 0.0 0
M  V30 36 C 4.3938 15.3967 0.0 0
M  V30 37 C 5.2182 12.8600 0.0 0
M  V30 38 C 2.9293 14.9208 0.0 0
M  V30 39 C 3.7535 12.3840 0.0 0
M  V30 40 C 2.6091 13.4145 0.0 0
M  V30 41 C 19.6640 10.1307 0.0 0
M  V30 42 C 21.2040 10.1307 0.0 0
M  V30 43 C 18.8939 8.7971 0.0 0
M  V30 44 C 21.9740 8.7971 0.0 0
M  V30 45 C 19.6640 7.4634 0.0 0
M  V30 46 C 21.2040 7.4634 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 23
M  V30 3 1 2 17
M  V30 4 1 2 29
M  V30 5 1 3 18
M  V30 6 1 3 35
M  V30 7 2 4 5
M  V30 8 1 4 26
M  V30 9 1 5 6
M  V30 10 1 5 7
M  V30 11 1 6 8
M  V30 12 2 6 9
M  V30 13 1 8 10
M  V30 14 1 11 34
M  V30 15 1 11 41
M  V30 16 1 12 13
M  V30 17 1 12 40
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 2 14 17
M  V30 21 1 15 18
M  V30 22 2 15 19
M  V30 23 2 16 20
M  V30 24 1 17 21
M  V30 25 1 18 20
M  V30 26 1 19 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1854972-87-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1854972-89-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15921554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolopyridines as inhibitors of Bruton's
tyrosine kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei; Wang, Longcheng; Yan, Shunqi; Loury, David J.; Jia, Zhaozhong
J.; Frye, Leah Lynn; Greenwood, Jeremy Robert; Shelley, Mee Yoo; Atallah,
Gordana Babic; Zanaletti, Riccardo; Catalani, Maria Pia; Raveglia, Luca
Francesco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016004272 A1 2016-01-07

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1-Methyl-4-piperidinyl)oxy]benzaldehyde
C13H17NO2
186191-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 O 12.0033 2.3101 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 8.0022 3.0801 0.0 0
M  V30 7 C 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 8.0022 0.0000 0.0 0
M  V30 10 C 9.3360 0.7700 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[(1-methyl-4-piperidinyl)oxy]benzenemethanamine
C14H22N2O
916217-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 N 12.0033 2.3101 0.0 0
M  V30 4 C 13.3370 3.0801 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0022 0.0000 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 186191-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916217-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6808937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The aldehyde was dissolved in 50 mL of 2.0M methyl amine in MeOH. A
catalytic amount of 10% Pd/C was added and mixture hydrogenated for 4 h
at 3 atm. LC/MS monitoring ofreaction indicated reaction completion.
Reaction mixture was filtered and concentrated. Purification via SiO2
chromatography using (9/0.9/0.1) mixture of (CH2Cl2/CH3OH/NH3OH) afforded
4.0 g of Intermediate E (90% yield).
Methyl-[3-(1-methyl-piperidin-4-yloxy)-benzyl]-amine, yield 4.0 g, 90% 1H
NMR (300 MHz, CDCl3, 300K) δ 7.25 (t, 1H), 7.06 (s, 1H), 6.98 (d, 1H),
6.86 (d, 1H), 5.06 (s, 1H), 4.40 (m, 1H), 3.87 (d, 2H), 2.82 (m, 2H),
2.49 (m, 5H), 2.40 (s, 3H), 2.14 (m,2H), 1.91 (m,2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabicyclooctyloxy- and piperidinyloxybenzylamides and
related compounds as modulators of melanin concentrating hormone (MCH1)
receptor modulators.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Urbanek, Rebecca; Brown, Dean; Steelman, Gary; Blackwell, William;
Wesolowski, Steven; Wang, Xia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007078251 A1 2007-07-12

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1-Methyl-4-piperidinyl)oxy]benzaldehyde
C13H17NO2
186191-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 O 12.0033 2.3101 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 8.0022 3.0801 0.0 0
M  V30 7 C 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 8.0022 0.0000 0.0 0
M  V30 10 C 9.3360 0.7700 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[(1-methyl-4-piperidinyl)oxy]benzenemethanamine
C14H22N2O
916217-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 N 12.0033 2.3101 0.0 0
M  V30 4 C 13.3370 3.0801 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 8.0022 3.0801 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0022 0.0000 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 186191-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916217-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1911282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Product was used without further purification. The aldehyde was dissolved
in 50 ml of 2.0M methyl amine in methanol. A catalytic amount of 10% Pd/C
was added and mixture hydrogenated for 4 h at 3 atm. LC/MS monitoring of
reaction indicated reaction completion. Reaction mixture was filtered and
concentrated. Purification via silica gel chromatography using
(9/0.9/0.1) mixture of (CH2Cl2/CH3OH/NH3OH) afforded 4.0 g of methyl
-[3-(1-methyl-piperidin-4-yloxy)- benzyl]-amine, (90%).
Methyl-[3-(1-methyl-piperidin-4-yloxy)-benzyl]-amine,yield 90% 1H NMR
(300 MHz, CDCl3, 300K) δ 7.25 (t, 1H), 7.06 (s, 1H), 6.98 (d, 1H), 6.86
(d, 1H), 5.06 (s, 1H), 4.40 (m, 1H), 3.87 (d, 2H), 2.82 (m, 2H), 2.49 (m,
5H), 2.40 (s, 3H), 2.14 (m, 2H), 1.91 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic amides as novel MCHR1 antagonists and their
use for treatment of MCHR1 mediated conditions and disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Dean; Blackwell, William C.; Mclaren, Frances M.; Schnecke,
Volker; Smith, Reed W.; Steelman, Gary; Wang, Xia; Urbanek, Rebecca A.;
Wesolowski, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006130075 A1 2006-12-07

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-oxo-6-(2-thienyl)-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidine-3-ca...
C16H11F3N2O3S
1883691-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 2.3698 0.0 0
M  V30 2 C 9.3360 3.9098 0.0 0
M  V30 3 O 10.6697 4.6799 0.0 0
M  V30 4 O 9.3360 2.3698 0.0 0
M  V30 5 C 12.0033 3.9098 0.0 0
M  V30 6 C 13.3370 4.6799 0.0 0
M  V30 7 C 1.3337 6.9899 0.0 0
M  V30 8 F 0.5637 5.6562 0.0 0
M  V30 9 F 0.0000 7.7599 0.0 0
M  V30 10 F 2.1037 8.3236 0.0 0
M  V30 11 N 5.3348 4.6799 0.0 0
M  V30 12 C 4.0010 3.9098 0.0 0
M  V30 13 C 5.3348 6.2199 0.0 0
M  V30 14 C 6.6685 3.9098 0.0 0
M  V30 15 C 2.6673 4.6799 0.0 0
M  V30 16 C 4.0010 6.9899 0.0 0
M  V30 17 N 6.6685 6.9899 0.0 0
M  V30 18 C 8.0022 4.6799 0.0 0
M  V30 19 C 2.6673 6.2199 0.0 0
M  V30 20 C 8.0022 6.2199 0.0 0
M  V30 21 C 4.0010 2.3698 0.0 0
M  V30 22 C 5.2470 1.4646 0.0 0
M  V30 23 S 2.7551 1.4646 0.0 0
M  V30 24 C 4.7710 0.0000 0.0 0
M  V30 25 C 3.2310 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 21
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-oxo-6-(2-thienyl)-8-(trifluoromethyl)-4H-pyrido[1,2-a]pyrimidine-3...
C15H10F3N3O2S
1883691-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8500 3.7710 0.0 0
M  V30 2 C 2.3100 6.4384 0.0 0
M  V30 3 N 1.5400 7.7721 0.0 0
M  V30 4 O 1.5400 5.1046 0.0 0
M  V30 5 C 0.0000 7.7721 0.0 0
M  V30 6 C 10.7800 5.1046 0.0 0
M  V30 7 F 10.7800 6.6446 0.0 0
M  V30 8 F 12.3200 5.1046 0.0 0
M  V30 9 F 10.7800 3.5646 0.0 0
M  V30 10 N 6.1600 5.1046 0.0 0
M  V30 11 C 6.9300 3.7710 0.0 0
M  V30 12 C 6.9300 6.4384 0.0 0
M  V30 13 C 4.6200 5.1046 0.0 0
M  V30 14 C 8.4700 3.7710 0.0 0
M  V30 15 C 8.4700 6.4384 0.0 0
M  V30 16 N 6.1600 7.7721 0.0 0
M  V30 17 C 3.8500 6.4384 0.0 0
M  V30 18 C 9.2400 5.1046 0.0 0
M  V30 19 C 4.6200 7.7721 0.0 0
M  V30 20 C 6.1600 2.4374 0.0 0
M  V30 21 C 6.7863 1.0304 0.0 0
M  V30 22 S 4.6285 2.2764 0.0 0
M  V30 23 C 5.6419 0.0000 0.0 0
M  V30 24 C 4.3083 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 20
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1883691-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1883691-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7390367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel pyrido[1,2-a]pyrimidine-3-carboxamide derivatives and
their anticancer activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Gautham Santhosh; Dev, Gaddameedi Jitender; Kumar, Nagiri Ravi;
Swaroop, Desireddy Krishna; Chandra, Yedla Poorna; Kumar, Chityala
Ganesh; Narsaiah, Banda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2015), 63(8), 584-590

$RFMT $RIREG SCHEME178 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[1H-indene-1,5′-oxazolidine]-3′-acetamide, 5-amino-N-[(4-fluorophenyl)me...
C23H21F4N3O4
1889290-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.1292 10.7126 0.0 0
M  V30 2 C 6.1600 8.0022 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 N 3.8500 6.6684 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 3.0800 8.0022 0.0 0 CFG=1
M  V30 8 C 1.5400 8.0022 0.0 0
M  V30 9 C 3.8500 9.3358 0.0 0
M  V30 10 F 0.0000 8.0022 0.0 0
M  V30 11 F 1.5400 6.4622 0.0 0
M  V30 12 F 1.5400 9.5422 0.0 0
M  V30 13 O 8.1292 5.2916 0.0 0
M  V30 14 N 16.1291 7.8134 0.0 0
M  V30 15 F 6.1600 0.0000 0.0 0
M  V30 16 C 10.0698 8.7722 0.0 0 CFG=1
M  V30 17 C 11.5345 8.2963 0.0 0
M  V30 18 C 8.6053 9.2481 0.0 0
M  V30 19 O 10.0698 7.2322 0.0 0
M  V30 20 C 10.0698 10.3122 0.0 0
M  V30 21 C 12.4397 9.5422 0.0 0
M  V30 22 C 12.1608 6.8894 0.0 0
M  V30 23 N 7.7000 8.0022 0.0 0
M  V30 24 C 8.6053 6.7563 0.0 0
M  V30 25 C 11.5345 10.7881 0.0 0
M  V30 26 C 13.9713 9.3811 0.0 0
M  V30 27 C 13.6924 6.7284 0.0 0
M  V30 28 C 14.5976 7.9743 0.0 0
M  V30 29 C 3.8500 4.0011 0.0 0
M  V30 30 C 3.0800 2.6674 0.0 0
M  V30 31 C 5.3900 4.0011 0.0 0
M  V30 32 C 3.8500 1.3336 0.0 0
M  V30 33 C 6.1600 2.6674 0.0 0
M  V30 34 C 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 29
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 2 13 24
M  V30 15 1 14 28
M  V30 16 1 15 34
M  V30 17 1 16 17 CFG=1
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 21 25
M  V30 27 2 21 26
M  V30 28 1 22 27
M  V30 29 1 23 24
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R)-N-[(4-Fluorophenyl)methyl]-2,3-dihydro-5-[[(methylamino)carbonyl]amino]-...
C25H24F4N4O5
1889279-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.1294 10.7126 0.0 0
M  V30 2 C 6.1600 8.0022 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 N 3.8500 6.6684 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 3.0800 8.0022 0.0 0 CFG=1
M  V30 8 C 1.5400 8.0022 0.0 0
M  V30 9 C 3.8500 9.3358 0.0 0
M  V30 10 F 0.0000 8.0022 0.0 0
M  V30 11 F 1.5400 9.5422 0.0 0
M  V30 12 F 1.5400 6.4622 0.0 0
M  V30 13 O 8.1294 5.2916 0.0 0
M  V30 14 N 16.1293 7.8134 0.0 0
M  V30 15 C 17.0345 9.0592 0.0 0
M  V30 16 N 18.5660 8.8983 0.0 0
M  V30 17 O 16.4080 10.4660 0.0 0
M  V30 18 C 19.4712 10.1442 0.0 0
M  V30 19 F 6.1600 0.0000 0.0 0
M  V30 20 C 10.0700 8.7722 0.0 0 CFG=2
M  V30 21 C 11.5345 8.2963 0.0 0
M  V30 22 C 8.6053 9.2481 0.0 0
M  V30 23 C 10.0700 10.3122 0.0 0
M  V30 24 O 10.0700 7.2322 0.0 0
M  V30 25 C 12.4397 9.5422 0.0 0
M  V30 26 C 12.1610 6.8894 0.0 0
M  V30 27 N 7.7000 8.0022 0.0 0
M  V30 28 C 11.5345 10.7881 0.0 0
M  V30 29 C 8.6053 6.7563 0.0 0
M  V30 30 C 13.9713 9.3811 0.0 0
M  V30 31 C 13.6925 6.7284 0.0 0
M  V30 32 C 14.5977 7.9743 0.0 0
M  V30 33 C 3.8500 4.0011 0.0 0
M  V30 34 C 3.0800 2.6674 0.0 0
M  V30 35 C 5.3900 4.0011 0.0 0
M  V30 36 C 3.8500 1.3336 0.0 0
M  V30 37 C 6.1600 2.6674 0.0 0
M  V30 38 C 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 1 2 27
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 2 13 29
M  V30 15 1 14 15
M  V30 16 1 14 32
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 19 38
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23 CFG=3
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 1 22 27
M  V30 28 1 23 28
M  V30 29 1 24 29
M  V30 30 1 25 28
M  V30 31 2 25 30
M  V30 32 1 26 31
M  V30 33 1 27 29
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1889290-04-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1889279-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-19392014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable
Inhibitors of p300/CBP Histone Acetyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Michaelides, Michael R.; Kluge, Arthur; Patane, Michael; Van Drie, John
H.; Wang, Ce; Hansen, T. Matthew; Risi, Roberto M.; Mantei, Robert;
Hertel, Carmen; Karukurichi, Kannan; Nesterov, Alexandre; McElligott,
David; de Vries, Peter; Langston, J. William; Cole, Philip A.;
Marmorstein, Ronen; Liu, Hong; Lasko, Loren; Bromberg, Kenneth D.; Lai,
Albert; Kesicki, Edward A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2018), 9(1), 28-33

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
2-Chloro-1-(2,4,5-trimethoxyphenyl)ethanone
C11H13ClO4
19278-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 Cl 9.3360 5.3901 0.0 0
M  V30 5 O 4.0012 6.9302 0.0 0
M  V30 6 C 2.6675 7.7002 0.0 0
M  V30 7 O 4.0012 0.7700 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 O 1.3337 2.3101 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylammonium methyldithiocarbamate
C2H5NS2.CH5N
21160-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 S 1.3337 1.5400 0.0 0
M  V30 4 S 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-methyl-4-(2,4,5-trimethoxyphenyl)-2-thiazolidinethione
C13H17NO4S2
243636-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.7690 2.4696 0.0 0
M  V30 2 O 5.3901 1.3337 0.0 0
M  V30 3 C 4.6201 0.0000 0.0 0
M  V30 4 C 9.0627 2.2740 0.0 0
M  V30 5 O 2.3100 6.6686 0.0 0
M  V30 6 C 3.0800 8.0023 0.0 0
M  V30 7 S 10.7380 5.1756 0.0 0
M  V30 8 O 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 2.6675 0.0 0
M  V30 10 C 5.3901 4.0011 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 3.0800 2.6675 0.0 0
M  V30 14 C 3.0800 5.3348 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 6.9301 4.0011 0.0 0
M  V30 17 N 8.4364 3.6810 0.0 0
M  V30 18 C 6.7690 5.5327 0.0 0
M  V30 19 C 9.2064 5.0146 0.0 0
M  V30 20 S 8.1760 6.1592 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 2 7 19
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 19278-85-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21160-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 243636-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10569419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and spectroscopy of new 4-aryl-2(3H)-thiazolethiones and
derived thiazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanchez-Viesca, F.; Berros, Martha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocyclic Communications (2004), 10(6), 435-440

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidineethanethioamide
C7H9N3O2S
195819-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 6.1600 5.3349 0.0 0
M  V30 4 S 8.4700 4.0011 0.0 0
M  V30 5 O 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 N 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 9
M  V30 6 1 6 12
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-N,5-dimethyl-2,4-dioxo-1(2H)-pyrimidineethanethioamide
C8H11N3O2S
897392-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 N 8.0021 4.6200 0.0 0
M  V30 4 S 6.6684 2.3100 0.0 0
M  V30 5 C 9.3358 3.8500 0.0 0
M  V30 6 O 2.6674 6.1600 0.0 0
M  V30 7 C 2.6674 0.0000 0.0 0
M  V30 8 O 0.0000 1.5400 0.0 0
M  V30 9 N 4.0011 3.8500 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 N 1.3336 3.8500 0.0 0
M  V30 13 C 2.6674 1.5400 0.0 0
M  V30 14 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 13
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 195819-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 897392-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-1745997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
N-methylthioamide 6. Primary thioamide 5 (0.005 mol) was dissolved in 33%
methylamine in absolute ethanol (10 mL) and the solution allowed to stand
for three days at room temperature until the substrate was consumed, as
followed by TLC, and then the solution was concentrated in vacuo. The
oily residue was solidified upon treatment of ice-water or keeping the
flask in the refrigerator until encrustation occurred to give pure sample
6. It can be also purified by column chromatography on silica gel
(100-200 mesh, 18:1 chloroform-methanol) and recrystallized from aqueous
isopropanol. Considerable recovery of starting material 5a was observed
when the reaction was carried out in 33% dimethylamine in absolute
ethanol under conditions analogous to those used above.
(N-Methyl(1-thyminyl)thioacetamide (6f). 90%. mp 308 °C (with
sublimation); IR v (cm-1): 3268, 3141, 3092, 2986, 2831, 1683, 1571,
1488, 1475, 1433, 1427, 1398, 1384, 1360, 1334; 1H NMR δ (ppm): 1.76 (d,
3H, J = 1.1 Hz, C5CH3), 2.99 (s, 3H, NCH3), 4.58 (s, 2H, CH2), 7.42 (d,
1H, J = 1.2Hz, C6H), 10.12 (br s, 1H, CSNH...O = C2, no coupling with the
CH3 protons), 11.26 (br s, 1H, N3H); 13C NMR δ (ppm): 12.0, 32.3, 56.0,
108.1, 142.4, 151.0, 164.6, 197.2; LRMS (EI): 213 (100), 182 (36), 140
(70), 127 (11), 111 (7); HRMS (EI): M+•, found 213.0584. C8H11N3O2S
requires 213.0572.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient syntheses of N-methylthioamides: a migration of the H2S
molecule in the thioamide-nitrile system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spychala, Jaroslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Sulfur Chemistry (2006), 27(3), 203-212

$RFMT $RIREG SCHEME181 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-methoxybenzyl bromide
C8H8Br2O
19614-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 Br 4.6200 0.0000 0.0 0
M  V30 4 O 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2-bromo-5-methoxyphenyl)methyl]-N-methylcarbamate
C14H20BrNO3
205676-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 C 6.1600 5.3349 0.0 0
M  V30 5 O 9.2400 5.3349 0.0 0
M  V30 6 O 9.2400 2.6674 0.0 0
M  V30 7 C 10.7800 5.3349 0.0 0
M  V30 8 C 10.7800 6.8749 0.0 0
M  V30 9 C 12.3200 5.3349 0.0 0
M  V30 10 C 10.7800 3.7949 0.0 0
M  V30 11 Br 4.6200 0.0000 0.0 0
M  V30 12 O 1.5400 5.3349 0.0 0
M  V30 13 C 0.0000 5.3349 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.8500 1.3338 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 16
M  V30 12 1 12 13
M  V30 13 1 12 17
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19614-12-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205676-67-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1877534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 3-[N-(tert-Butoxycarbonyl)-N-methylamino]methyl-4-bromoanisole 40%
aqueous methylamine (49 mL, 563 mmole) was added rapidly to a solution of
4-bromo-3-bromomethylanisole (15.76 g, 56.29 mmole) in THF (280 mL) at
RT. After 2.5 hr, the reaction was concentrated, and the residue was
partitioned between Et2O (560 mL) and 1.0 N NaOH (100 mL). The layers
were separated, and the organic layer was dried (MgSO4) and concentrated
to a yellow oil: The oil was dissolved in CHCl3 (280 mL), and
di-tert-butyl dicarbonate (1.29 g, 56.29 mmole) was added. The reaction
was stirred at RT for 45 min, then was concentrated. Silica gel
chromatography (5% EtOAc/toluene) gave the title compound (16.81 g, 90%)
as a light yellow oil: TLC (5% MeOH/CHCl3) Rf 0.32. TLC (5%
EtOAc/toluene) Rf 0.43; 1H NMR (400, CDCl3) mixture of rotamers; 7.42 (d,
J=8.7 Hz, 1 H, 6.65-6.80 (m, 2 H), 4.40-4.55 (m, 2 H), 3.77 (s, 3 H),
2.81-2.97 (m, 3 H), 1.37-1.60 (m, 9 H); MS (ES) m/e 352/354 (M+Na)+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM method for treatment of an ocular neovascular disorder by administration
of
5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide
and
(S)-3-oxo-8-[3-(pyridin-2-ylamino)-1-propyloxy]-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic
acid.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brigandi, Richard Anthony; Levick, Mark; Miller, William Henry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007064752 A2 2007-06-07

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(4-formylphenyl)-1-piperazinecarboxylate
C16H22N2O3
197638-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 N 8.4701 2.8737 0.0 0
M  V30 11 C 7.7001 1.5400 0.0 0
M  V30 12 C 7.7001 4.2073 0.0 0
M  V30 13 C 6.1601 1.5400 0.0 0
M  V30 14 C 6.1601 4.2073 0.0 0
M  V30 15 N 5.3901 2.8737 0.0 0
M  V30 16 C 10.0101 2.8737 0.0 0
M  V30 17 C 10.7801 1.5400 0.0 0
M  V30 18 C 10.7801 4.2073 0.0 0
M  V30 19 C 12.3201 1.5400 0.0 0
M  V30 20 C 12.3201 4.2073 0.0 0
M  V30 21 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[4-[(methylamino)methyl]phenyl]-1-piperazinecarboxylate
C17H27N3O2
681508-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6300 2.8736 0.0 0
M  V30 9 N 15.4000 4.2073 0.0 0
M  V30 10 C 16.9400 4.2073 0.0 0
M  V30 11 N 8.4700 2.8736 0.0 0
M  V30 12 C 7.7000 4.2073 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 6.1600 4.2073 0.0 0
M  V30 15 C 6.1600 1.5400 0.0 0
M  V30 16 N 5.3900 2.8736 0.0 0
M  V30 17 C 10.0100 2.8736 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 10.7800 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 12.3200 1.5400 0.0 0
M  V30 22 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 197638-83-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 681508-91-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15316600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development and in Vitro Evaluation of a Microbicide Gel Formulation for
a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the
N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tintori, Cristina; Brai, Annalaura; Dasso Lang, Maria Chiara; Deodato,
Davide; Greco, Antonia Michela; Bizzarri, Bruno Mattia; Cascone, Lorena;
Casian, Alexandru; Zamperini, Claudio; Dreassi, Elena; Crespan,
Emmanuele; Maga, Giovanni; Vanham, Guido; Ceresola, Elisa; Canducci,
Filippo; Arien, Kevin K.; Botta, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2747-2759

$RFMT $RIREG SCHEME183 STEP1
$RXN



  6  1
$MOL
Glycine ethyl ester
C4H9NO2
459-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromophenyl isothiocyanate
C7H4BrNS
1985-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 S 8.0022 1.5400 0.0 0
M  V30 4 Br 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxy-1,2-benzenedicarboxaldehyde
C8H6O3
73289-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 O 6.6687 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 1.3338 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 7-[(4-bromophenyl)imino]-14-hydroxy-2-(1-methylethenyl)-5-[1-(methylimi...
C33H28BrN3O5
2754289-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0147 6.1601 0.0 0
M  V30 2 C 8.6810 3.8501 0.0 0
M  V30 3 O 8.6810 2.3101 0.0 0
M  V30 4 O 10.0147 4.6201 0.0 0
M  V30 5 C 10.0147 1.5400 0.0 0
M  V30 6 C 10.0147 0.0000 0.0 0
M  V30 7 O 3.9970 8.3259 0.0 0
M  V30 8 C 8.6810 11.5503 0.0 0
M  V30 9 N 8.6810 13.0903 0.0 0
M  V30 10 C 10.0147 10.7802 0.0 0
M  V30 11 C 10.0147 13.8603 0.0 0
M  V30 12 C 0.7700 10.0102 0.0 0
M  V30 13 C 0.0000 8.6765 0.0 0
M  V30 14 C 0.0000 11.3439 0.0 0
M  V30 15 Br 15.3495 9.2402 0.0 0
M  V30 16 C 6.0135 6.9302 0.0 0
M  V30 17 C 6.0135 8.4702 0.0 0
M  V30 18 N 7.3473 6.1601 0.0 0
M  V30 19 C 4.6799 6.1601 0.0 0
M  V30 20 C 7.3473 9.2402 0.0 0
M  V30 21 C 4.6799 9.2402 0.0 0
M  V30 22 C 8.6810 6.9302 0.0 0
M  V30 23 C 7.3473 4.6201 0.0 0
M  V30 24 C 4.6799 4.6201 0.0 0
M  V30 25 C 3.3462 6.9302 0.0 0
M  V30 26 C 7.3473 10.7802 0.0 0
M  V30 27 O 8.6810 8.4702 0.0 0
M  V30 28 C 4.6799 10.7802 0.0 0
M  V30 29 O 3.2153 8.7643 0.0 0
M  V30 30 C 6.0135 3.8501 0.0 0
M  V30 31 C 3.3462 3.8501 0.0 0
M  V30 32 C 2.0125 6.1601 0.0 0
M  V30 33 C 6.0135 11.5503 0.0 0
M  V30 34 C 3.2153 11.2561 0.0 0
M  V30 35 C 2.3101 10.0102 0.0 0
M  V30 36 C 2.0125 4.6201 0.0 0
M  V30 37 C 11.3484 6.9302 0.0 0
M  V30 38 C 11.3484 8.4702 0.0 0
M  V30 39 C 12.6822 6.1601 0.0 0
M  V30 40 C 12.6822 9.2402 0.0 0
M  V30 41 C 14.0158 6.9302 0.0 0
M  V30 42 C 14.0158 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22 CFG=2
M  V30 2 1 1 37
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 23
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 25
M  V30 9 2 8 9 CFG=2
M  V30 10 1 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 35
M  V30 16 1 15 42
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 19 25
M  V30 26 1 20 26
M  V30 27 1 20 27
M  V30 28 2 21 28
M  V30 29 1 21 29
M  V30 30 1 22 27
M  V30 31 2 23 30
M  V30 32 1 24 30
M  V30 33 2 24 31
M  V30 34 1 25 32
M  V30 35 2 26 33
M  V30 36 1 28 33
M  V30 37 1 28 34
M  V30 38 1 29 35
M  V30 39 1 31 36
M  V30 40 2 32 36
M  V30 41 2 34 35
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 459-73-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1985-12-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 73289-89-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754289-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24903600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 12173-10-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst can be
recycled and reused, catalyst prepared and used, MWCNTs nanocomposite
support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biosynthesis of Cu/KF/Clinoptilolite@MWCNTs nanocomposite and its
application as a recyclable nanocatalyst for the synthesis of new Schiff
base of benzoxazine derivatives and reduction of organic pollutants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamedani, Naghmeh Faal; Hargalani, Fariba Zamani; Rostami-Charati,
Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2022), 26(4), 2069-2083

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1E)-3-[1-(1,3-Benzodioxol-5-yl)-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-...
C28H22N2O4
199675-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5289 6.2874 0.0 0
M  V30 2 C 9.8625 7.0574 0.0 0
M  V30 3 O 8.5289 4.7474 0.0 0
M  V30 4 C 11.1963 6.2874 0.0 0
M  V30 5 C 16.5311 9.3674 0.0 0
M  V30 6 O 17.8647 8.5974 0.0 0
M  V30 7 C 5.8614 6.2874 0.0 0 CFG=3
M  V30 8 C 4.5278 7.0574 0.0 0
M  V30 9 N 7.1952 7.0574 0.0 0
M  V30 10 C 4.5278 8.5974 0.0 0
M  V30 11 N 3.0632 6.5815 0.0 0
M  V30 12 C 7.1952 8.5974 0.0 0
M  V30 13 C 3.0632 9.0733 0.0 0
M  V30 14 C 5.8614 9.3674 0.0 0
M  V30 15 C 2.1580 7.8274 0.0 0
M  V30 16 C 2.4368 10.4802 0.0 0
M  V30 17 C 0.6265 7.9883 0.0 0
M  V30 18 C 0.9052 10.6411 0.0 0
M  V30 19 C 0.0000 9.3953 0.0 0
M  V30 20 C 5.8614 4.7474 0.0 0
M  V30 21 C 4.5278 3.9774 0.0 0
M  V30 22 C 7.1952 3.9774 0.0 0
M  V30 23 C 4.5278 2.4374 0.0 0
M  V30 24 C 7.1952 2.4374 0.0 0
M  V30 25 C 5.8614 1.6674 0.0 0
M  V30 26 O 3.3834 1.4070 0.0 0
M  V30 27 O 5.5413 0.1609 0.0 0
M  V30 28 C 4.0097 0.0000 0.0 0
M  V30 29 C 12.5300 7.0574 0.0 0
M  V30 30 C 12.5300 8.5974 0.0 0
M  V30 31 C 13.8636 6.2874 0.0 0
M  V30 32 C 13.8636 9.3674 0.0 0
M  V30 33 C 15.1973 7.0574 0.0 0
M  V30 34 C 15.1973 8.5974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 1 4 29
M  V30 6 2 5 6
M  V30 7 1 5 34
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 20
M  V30 11 2 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 2 13 16
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 1 20 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 23 26
M  V30 30 2 24 25
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 28
M  V30 34 2 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-[1-(1,3-Benzodioxol-5-yl)-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-y...
C29H27N3O3
199676-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5289 6.2874 0.0 0
M  V30 2 C 9.8625 7.0574 0.0 0
M  V30 3 O 8.5289 4.7474 0.0 0
M  V30 4 C 11.1962 6.2874 0.0 0
M  V30 5 C 16.5309 9.3674 0.0 0
M  V30 6 N 17.8647 8.5974 0.0 0
M  V30 7 C 19.1984 9.3674 0.0 0
M  V30 8 C 4.5278 7.0574 0.0 0
M  V30 9 C 5.8614 6.2874 0.0 0 CFG=3
M  V30 10 C 4.5278 8.5974 0.0 0
M  V30 11 N 3.0632 6.5815 0.0 0
M  V30 12 N 7.1952 7.0574 0.0 0
M  V30 13 C 3.0632 9.0733 0.0 0
M  V30 14 C 5.8614 9.3674 0.0 0
M  V30 15 C 2.1580 7.8274 0.0 0
M  V30 16 C 7.1952 8.5974 0.0 0
M  V30 17 C 2.4368 10.4802 0.0 0
M  V30 18 C 0.6263 7.9883 0.0 0
M  V30 19 C 0.9052 10.6411 0.0 0
M  V30 20 C 0.0000 9.3953 0.0 0
M  V30 21 C 5.8614 4.7474 0.0 0
M  V30 22 C 4.5278 3.9774 0.0 0
M  V30 23 C 7.1952 3.9774 0.0 0
M  V30 24 C 4.5278 2.4374 0.0 0
M  V30 25 C 7.1952 2.4374 0.0 0
M  V30 26 C 5.8614 1.6674 0.0 0
M  V30 27 O 3.3834 1.4070 0.0 0
M  V30 28 O 5.5413 0.1609 0.0 0
M  V30 29 C 4.0097 0.0000 0.0 0
M  V30 30 C 12.5300 7.0574 0.0 0
M  V30 31 C 12.5300 8.5974 0.0 0
M  V30 32 C 13.8636 6.2874 0.0 0
M  V30 33 C 13.8636 9.3674 0.0 0
M  V30 34 C 15.1973 7.0574 0.0 0
M  V30 35 C 15.1973 8.5974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 4 30
M  V30 6 1 5 6
M  V30 7 1 5 35
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 21
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 13 15
M  V30 19 2 13 17
M  V30 20 1 14 16
M  V30 21 2 15 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 24 27
M  V30 31 2 25 26
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 199675-51-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 199676-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7523463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A stirred solution of Example 23 (0.5 g, 1.0 mmol) in MeOH was refluxed
with methylamine (1.6 mL, 1.5 equiv., 33% in EtOH) for one hour.
Evaporation in vacuo gave
(E)-1-[1-(3,4-methylenedioxyphenyl)-1,3,4,9-tetrahydro-β
-carbolin-2-yl]-3-(4-methylimine methylphenyl)propenelone, Yield 0.46 g,
90%. 1H NMR (CDCl3, 250 MHz) δ 8.2 (d, 1H), 8.1 (s, 1H), 7.8-7.65 (m,
3H), 7.55-7.5 (m, 3H), 7.4-7.1 (m, 3H), 7.0-6.85 (m, 2H), 6.8-6.6 (dd,
2H), 5.9 (s, 2H), 4.2-4.1 (br d, 1H), 3.5 (s+m, 4H), 3.05-2.85 (m, 2H).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of carbolines as potent and selective inhibitors of cyclic
guanosine 3',5'-monophosphate specific phosphodiesterase (cGMP-specific
PDE)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bombrun, Agnes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6043252 A 2000-03-28

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetyl-2,5-dihydro-2-(2-methylpropyl)-1H-pyrrole-2-carboxylic acid
C11H17NO3
203051-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3202 1.7623 0.0 0
M  V30 2 C 6.7272 2.3886 0.0 0
M  V30 3 C 6.8881 3.9202 0.0 0
M  V30 4 C 7.9731 1.4834 0.0 0
M  V30 5 C 3.3043 1.3337 0.0 0
M  V30 6 O 1.7643 1.3337 0.0 0
M  V30 7 O 4.0743 0.0000 0.0 0
M  V30 8 C 1.3337 2.5238 0.0 0
M  V30 9 C 1.3337 0.9838 0.0 0
M  V30 10 O 0.0000 3.2938 0.0 0
M  V30 11 C 4.0743 2.6673 0.0 0
M  V30 12 N 2.6675 3.2938 0.0 0
M  V30 13 C 5.1047 3.8119 0.0 0
M  V30 14 C 2.8284 4.8254 0.0 0
M  V30 15 C 4.3347 5.1456 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 12
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Acetyl-2,5-dihydro-N-methyl-2-(2-methylpropyl)-1H-pyrrole-2-carboxamide
C12H20N2O2
908075-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3043 2.6673 0.0 0
M  V30 2 N 4.0743 1.3337 0.0 0
M  V30 3 O 1.7643 2.6673 0.0 0
M  V30 4 C 3.3043 0.0000 0.0 0
M  V30 5 C 5.3202 3.0959 0.0 0
M  V30 6 C 6.7272 3.7223 0.0 0
M  V30 7 C 7.9731 2.8170 0.0 0
M  V30 8 C 6.8881 5.2538 0.0 0
M  V30 9 C 1.3337 3.8575 0.0 0
M  V30 10 C 1.3337 2.3174 0.0 0
M  V30 11 O 0.0000 4.6275 0.0 0
M  V30 12 C 4.0743 4.0012 0.0 0
M  V30 13 N 2.6675 4.6275 0.0 0
M  V30 14 C 5.1047 5.1456 0.0 0
M  V30 15 C 2.8284 6.1591 0.0 0
M  V30 16 C 4.3347 6.4792 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 13
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 203051-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 908075-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1930794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Amide Coupling of
16{1- 5,1-3} (Protocol F). A 5 mL microwave tube was charged with
3,4-dehydroproline 16{1,2} (20 mg, 0.073 mmol, 1 equiv), PS-carbodiimide
(11 mg, 0.15 mmol, 2 equiv), 1-hydroxybenzotriazole (9.9 mg, 0.073 mmol,
1 equiv), and methylamine 13{1} (33 wt % in water) (0.021 mL, 0.22 mmol,
3 equiv) in dichloromethane (1 mL) and capped. The suspension was
irradiated in an Emrys Optimizer microwave reactor (250 W) at 60 °C for
30 min (for nonvolatile amines irradiation was performed at 100 °C for 10
min). After it was cool to room temperature, the reaction mixture was
filtered through an SPE-cartridge (prepacked with 500 mg silica-bound
carbonate and preconditioned with 2 mL of CH2Cl2) and washed with
dichloromethane (3 x 2 mL). The eluants were collected via gravity
filtration. Evaporation of all volatile components in a centrifugal
vacuum evaporator (Genevac HT-4) provided the desired amide 10{1,2,1}
(21.0 mg, 99%). 10{1,1,1}, yield 90%. Purity 99%.
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME187 STEP1
$RXN



  3  1
$MOL
Bis(1-methylethyl) P-acetylphosphonate
C8H17O4P
20526-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 2.3100 0.0 0 VAL=5
M  V30 2 O 2.3100 2.3100 0.0 0
M  V30 3 O 5.3901 2.3100 0.0 0
M  V30 4 C 3.8500 0.7700 0.0 0
M  V30 5 O 3.8500 3.8500 0.0 0
M  V30 6 C 1.5400 3.6437 0.0 0
M  V30 7 C 6.1601 3.6437 0.0 0
M  V30 8 C 5.1837 0.0000 0.0 0
M  V30 9 O 2.5164 0.0000 0.0 0
M  V30 10 C 2.3100 4.9773 0.0 0
M  V30 11 C 0.0000 3.6437 0.0 0
M  V30 12 C 5.3901 4.9773 0.0 0
M  V30 13 C 7.7001 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Triphenylmethyl)isatin
C27H19NO2
41128-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0010 0.0 0
M  V30 2 O 4.3514 7.3332 0.0 0
M  V30 3 O 7.6286 8.0297 0.0 0
M  V30 4 N 5.3348 4.7710 0.0 0
M  V30 5 C 6.7418 4.1447 0.0 0
M  V30 6 C 5.4959 6.3027 0.0 0
M  V30 7 C 7.7722 5.2892 0.0 0
M  V30 8 C 7.2177 2.6801 0.0 0
M  V30 9 C 7.0022 6.6229 0.0 0
M  V30 10 C 9.2787 4.9689 0.0 0
M  V30 11 C 8.7240 2.3598 0.0 0
M  V30 12 C 9.7546 3.5043 0.0 0
M  V30 13 C 4.7712 2.6673 0.0 0
M  V30 14 C 4.0012 1.3337 0.0 0
M  V30 15 C 6.3112 2.6673 0.0 0
M  V30 16 C 4.7712 0.0000 0.0 0
M  V30 17 C 7.0812 1.3337 0.0 0
M  V30 18 C 6.3112 0.0000 0.0 0
M  V30 19 C 3.2311 5.3348 0.0 0
M  V30 20 C 4.0012 6.6685 0.0 0
M  V30 21 C 1.6911 5.3348 0.0 0
M  V30 22 C 3.2311 8.0022 0.0 0
M  V30 23 C 0.9211 6.6685 0.0 0
M  V30 24 C 1.6911 8.0022 0.0 0
M  V30 25 C 2.6675 3.2310 0.0 0
M  V30 26 C 1.3338 4.0010 0.0 0
M  V30 27 C 2.6675 1.6910 0.0 0
M  V30 28 C 0.0000 3.2310 0.0 0
M  V30 29 C 1.3338 0.9209 0.0 0
M  V30 30 C 0.0000 1.6910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 1 25
M  V30 5 2 2 6
M  V30 6 2 3 9
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 2 5 8
M  V30 11 1 6 9
M  V30 12 1 7 9
M  V30 13 2 7 10
M  V30 14 1 8 11
M  V30 15 1 10 12
M  V30 16 2 11 12
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-2,3-Dihydro-3-hydroxy-N-methyl-2-oxo-1-(triphenylmethyl)-1H-indole-3-ace...
C30H26N2O3
1380341-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.5892 7.3306 0.0 0
M  V30 3 C 10.0613 5.2291 0.0 0
M  V30 4 C 10.9665 6.4749 0.0 0
M  V30 5 N 12.4980 6.3140 0.0 0
M  V30 6 O 10.3402 7.8817 0.0 0
M  V30 7 C 13.4032 7.5599 0.0 0
M  V30 8 O 8.8499 6.8963 0.0 0
M  V30 9 N 6.1600 4.6200 0.0 0
M  V30 10 C 7.0652 3.3741 0.0 0
M  V30 11 C 7.0652 5.8659 0.0 0
M  V30 12 C 8.5298 3.8500 0.0 0
M  V30 13 C 6.7449 1.8677 0.0 0
M  V30 14 C 8.5298 5.3900 0.0 0 CFG=1
M  V30 15 C 9.6743 2.8196 0.0 0
M  V30 16 C 7.8894 0.8373 0.0 0
M  V30 17 C 9.3540 1.3132 0.0 0
M  V30 18 C 4.6200 6.1600 0.0 0
M  V30 19 C 5.9536 6.9300 0.0 0
M  V30 20 C 3.2862 6.9300 0.0 0
M  V30 21 C 5.9536 8.4700 0.0 0
M  V30 22 C 3.2862 8.4700 0.0 0
M  V30 23 C 4.6200 9.2400 0.0 0
M  V30 24 C 3.0800 4.6200 0.0 0
M  V30 25 C 2.3100 5.9536 0.0 0
M  V30 26 C 2.3100 3.2864 0.0 0
M  V30 27 C 0.7700 5.9536 0.0 0
M  V30 28 C 0.7700 3.2864 0.0 0
M  V30 29 C 0.0000 4.6200 0.0 0
M  V30 30 C 4.6200 3.0800 0.0 0
M  V30 31 C 5.9536 2.3100 0.0 0
M  V30 32 C 3.2862 2.3100 0.0 0
M  V30 33 C 5.9536 0.7700 0.0 0
M  V30 34 C 3.2862 0.7700 0.0 0
M  V30 35 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 2 2 11
M  V30 6 1 3 4
M  V30 7 1 14 3 CFG=1
M  V30 8 1 4 5
M  V30 9 2 4 6
M  V30 10 1 5 7
M  V30 11 1 14 8 CFG=3
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 12 14
M  V30 18 2 12 15
M  V30 19 1 13 16
M  V30 20 1 15 17
M  V30 21 2 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20526-22-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41128-14-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380341-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25911907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1101869-04-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Experimental Procedure for the Synthesis of the Acetamide Aldol Product 7
(Scheme 1) A solution of catalyst 4j (2.3 mg, 5.0 μmol, 5.0 mol %) and
N-tritylisatin 2a (38.9 mg, 0.10 mmol) in THF (2.0 ml) were stirred at
-15 °C for 15 min. Then diisopropyl acetylphosphonate 1c (104.1 mg, 0.50
mmol) was added in one portion to the above mixture. The reaction mixture
was further stirred at the above temperature for 6 h (monitored by TLC).
Upon the completion of the reaction, the reaction mixture was allowed to
warm to room temperature and then MeNH2 solution in THF (2.0 M, 1.0 mL,
2.0 mmol) was added. After stirring for an additional 15 min, the
volatile components were removed under reduced pressure. The residue was
purified by column chromatography on silica gel (EtOAc/hexane=1:2) to
afford acetamide aldol product 7.
(R)-2-(3-hydroxy-2-oxo-1-tritylindolin-3-yl)-N-methylacetamide (7) White
solid; Yield 41.6 mg (90%). m.p. 218-220 °C; 1H (300 MHz, CDCl3): δ 2.43
(d, J = 14.7 Hz, 1H), 2.59-2.64 (m, 4H), 5.09 (s, 1H), 6.18 (d, J = 6.6
Hz, 1H), 6.82 (d, J = 3.6 Hz, 1H), 7.01-7.33 (m, 15H); 13C (75 MHz,
CDCl3): δ 26.4, 42.9, 74.2, 74.4, 116.1, 122.8, 123.5, 126.9, 127.7,
128.4, 129.1, 130.1, 141.7, 142.5, 170.2, 178.1; ν max: 1002, 1033, 1154,
1314, 1449, 1534, 1597, 1649, 1670, 1720, 3418, 3639 cm-1. [α ]D25 =
-0.94 (c 0.10, CH2Cl2, 96% ee). Enantiomeric excess of the product was
determined by chiral stationary phase HPLC analysis using a ChiralPak
AD-H column (hexanes/i-PrOH 85:15 at 1.0 mL/min), major enantiomer: tR =
10.3 min, minor enantiomer: tR = 9.0 min. Anal. calcd. for C30H26N2O3: C,
77.90; H, 5.67; N, 6.06. Found: C, 77.70; H, 6.27; N, 5.58.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 96% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acetylphosphonate as a Surrogate of Acetate or Acetamide in
Organocatalyzed Enantioselective Aldol Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Guo, Qunsheng; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(12), 3174-3177

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-7-methoxy-6-quinolinecarboxylate
C12H10ClNO3
205448-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 O 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-7-methoxy-N-methyl-6-quinolinecarboxamide
C12H11ClN2O2
417723-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205448-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417723-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37421532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of crystalline forms and salt forms of a kinase inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Phizackerley, Kirsten; Cao, Yizheng; Pcion, Dominika
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023122739 A1 2023-06-29

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-7-methoxy-6-quinolinecarboxylate
C12H10ClNO3
205448-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 O 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-7-methoxy-N-methyl-6-quinolinecarboxamide
C12H11ClN2O2
417723-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205448-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417723-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36511255
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinoline compounds for the treatment of kinase-dependent disorders and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shah, Khalid; Demorin, Frenel; Shakya, Sagar; Wang, Yong; Xu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023081253 A1 2023-05-11

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-7-methoxy-6-quinolinecarboxylate
C12H10ClNO3
205448-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 O 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-7-methoxy-N-methyl-6-quinolinecarboxamide
C12H11ClN2O2
417723-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205448-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417723-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24530199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinoline derivative as kinase inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Demorin, Frenel; Shah, Khalid; Shakya, Sagar; Wang, Yong; Xu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021222673 A1 2021-11-04

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-7-methoxy-6-quinolinecarboxylate
C12H10ClNO3
205448-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 O 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-7-methoxy-N-methyl-6-quinolinecarboxamide
C12H11ClN2O2
417723-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205448-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417723-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23822559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridone compounds and methods of use in the modulation of a protein
kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bannen, Lynne; Bui, Minna; Jiang, Faming; Maung, Jack; Raub, Andrew;
Salvant, Justin; Spangler, Benjamin; Tso, Kin; Wang, Yong; Xu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021062245 A1 2021-04-01

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-7-methoxy-6-quinolinecarboxylate
C12H10ClNO3
205448-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 O 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-7-methoxy-N-methyl-6-quinolinecarboxamide
C12H11ClN2O2
417723-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205448-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417723-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21564229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted
N-phenyl-N'-(pyridin-3-yl)cyclopropane-1,1-dicarboxamides for the
treatment of Axl and Mer receptor tyrosine kinase-dependent disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bannen, Lynne Canne; Bui, Minna; Jiang, Faming; Wang, Yong; Xu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019148043 A1 2019-08-01

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-7-methoxy-6-quinolinecarboxylate
C12H10ClNO3
205448-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 O 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-7-methoxy-N-methyl-6-quinolinecarboxamide
C12H11ClN2O2
417723-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 8.0022 0.0 0
M  V30 2 C 6.9301 4.0011 0.0 0
M  V30 3 N 7.7001 5.3348 0.0 0
M  V30 4 O 7.7001 2.6675 0.0 0
M  V30 5 C 9.2401 5.3348 0.0 0
M  V30 6 O 5.3901 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 5.3348 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 3.0800 2.6675 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205448-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417723-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21545290
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted
N-[(quinolin-4-yl)-phenyl]-N'-phenylcyclopropane-1,1-dicarboxamide for
the treatment of Axl and Mer receptor tyrosine kinase-dependent disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bannen, Lynne Canne; Bui, Minna; Jiang, Faming; Tso, Kin; Wang, Yong; Xu,
Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019148044 A1 2019-08-01

$RFMT $RIREG SCHEME189 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sulfoxonium, dimethyl(2-oxo-2-phenylethyl)-, inner salt
C10H12O2S
20718-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8736 0.0 0
M  V30 2 C 5.3900 1.5400 0.0 0 CHG=-1
M  V30 3 O 5.3900 4.2073 0.0 0
M  V30 4 S 6.9300 1.5400 0.0 0 CHG=1 VAL=5
M  V30 5 C 8.4700 1.5400 0.0 0
M  V30 6 C 6.9300 3.0800 0.0 0
M  V30 7 O 6.9300 0.0000 0.0 0
M  V30 8 C 3.0800 2.8736 0.0 0
M  V30 9 C 2.3100 4.2073 0.0 0
M  V30 10 C 2.3100 1.5400 0.0 0
M  V30 11 C 0.7700 4.2073 0.0 0
M  V30 12 C 0.7700 1.5400 0.0 0
M  V30 13 C 0.0000 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-4-phenyl-2(3H)-thiazolethione
C10H9NS2
21402-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0493 0.0000 0.0 0
M  V30 2 S 8.2357 1.0352 0.0 0
M  V30 3 C 4.6201 2.7104 0.0 0
M  V30 4 N 5.5253 1.4646 0.0 0
M  V30 5 C 5.5253 3.9563 0.0 0
M  V30 6 C 6.9898 1.9404 0.0 0
M  V30 7 S 6.9898 3.4804 0.0 0
M  V30 8 C 3.0800 2.7104 0.0 0
M  V30 9 C 2.3100 1.3768 0.0 0
M  V30 10 C 2.3100 4.0441 0.0 0
M  V30 11 C 0.7700 1.3768 0.0 0
M  V30 12 C 0.7700 4.0441 0.0 0
M  V30 13 C 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 20718-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21402-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36089832
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multicomponent Reaction of CS2, Amines and Sulfoxonium Ylides in Water:
Straightforward Access to β-Keto Dithiocarbamates, Thiazolidine-2-thiones
and Thiazole-2-thiones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Naveen; Sharma, Ajay; Kumar, Upendra; Pandey, Satyendra Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2023), 88(9), 6120-6125

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Oxo-2-naphthaleneacetaldehyde 2-oxime
C12H9NO2
20862-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 N 9.3360 1.5400 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(Methylimino)-2-naphthaleneacetaldehyde oxime
C13H12N2O
867251-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 7.7000 1.3338 0.0 0
M  V30 4 N 9.2400 4.0011 0.0 0
M  V30 5 C 6.9300 0.0000 0.0 0
M  V30 6 O 10.0100 5.3349 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 4.6200 1.3338 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 13
M  V30 4 2 2 4 CFG=2
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20862-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867251-35-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5352583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of Schiff Base Ligand.
Methyliminoisonitroso-2-acetylnaphthalene [HL1] was prepared by a
condensation method. Methylamine (0.18 g, 6 mmol) was dissolved in MeOH
(10 mL) and was added to a solution of isonitroso-2-acetylnaphthalene
(1.19g, 6mmol) in 20 mL of MeOH. The reaction mixture was stirred for 2h
and then left overnight at room temperature.The solid reaction product
was filtered and washed with cold ethanol. The ligand was recrystallized
from dichloromethane/ethanol (1:1) and dried in a vacuum desiccator over
CaCl2. Benzyliminoisonitroso-2-acetylnaphthalene was prepared in a
similar fashion. Compound: HL1, Color: Yellow, Yield: 90%. M.p: 84°C,
Molecular formula: C13H12N2O, FW.: 212.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Characterization of New Schiff Bases and Their Cobalt(II),
Nickel(II), Copper(II), Zinc(II), Cadmium(II) and Mercury(II) Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ucan, Selma Y.; Ucan, Mustafa; Mercimek, Bedrettin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal
Chemistry (2005), 35(5), 417-421

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 5-bromo-4-hydroxydecanedioate
C11H19BrO5
2089221-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 5.3348 2.3100 0.0 0
M  V30 4 O 6.6686 0.0000 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 Br 8.0022 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 10.6697 2.3100 0.0 0
M  V30 9 C 2.6675 2.3100 0.0 0
M  V30 10 C 12.0034 1.5400 0.0 0
M  V30 11 O 1.3338 1.5400 0.0 0
M  V30 12 O 2.6675 3.8500 0.0 0
M  V30 13 C 13.3370 2.3100 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 14.6707 1.5400 0.0 0
M  V30 16 O 14.6707 0.0000 0.0 0
M  V30 17 O 16.0045 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl 4-hydroxy-5-(methylamino)decanedioate
C12H23NO5
341925-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 2.3101 0.0 0
M  V30 2 C 9.3360 3.0801 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 N 8.0023 0.7700 0.0 0
M  V30 5 C 10.6698 2.3101 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 6.6687 0.0000 0.0 0
M  V30 9 C 12.0035 3.0801 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 13.3372 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 O 14.6708 3.0801 0.0 0
M  V30 14 O 13.3372 0.7700 0.0 0
M  V30 15 C 1.3338 3.0801 0.0 0
M  V30 16 C 16.0046 2.3101 0.0 0
M  V30 17 O 1.3338 4.6201 0.0 0
M  V30 18 O 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2089221-97-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 341925-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16875706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methylammonium Groups at the Solid Walls of Nanometer-Sized, Water-Filled
Monolayer Gaps as Binding Sites for a Tetraanionic Porphyrin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skupin, Marc; Li, Guangtao; Fudickar, Werner; Zimmermann, Joerg; Roeder,
Beate; Fuhrhop, Juergen-Hinrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2001), 123(15), 3454-3461

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[1-(2-Chloro-4-pyrimidinyl)cyclopropyl]carbonyl]amino]-4-methyl-N-[4-(4-m...
C28H28ClF3N6O2
2097023-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0237 8.0023 0.0 0
M  V30 2 N 7.5637 8.0023 0.0 0
M  V30 3 O 5.2536 6.6685 0.0 0
M  V30 4 Cl 0.0000 10.2623 0.0 0
M  V30 5 C 6.0237 5.3348 0.0 0
M  V30 6 C 12.1838 5.3348 0.0 0
M  V30 7 N 12.9538 4.0011 0.0 0
M  V30 8 O 12.9538 6.6685 0.0 0
M  V30 9 C 17.5738 1.3337 0.0 0
M  V30 10 F 18.9077 2.1037 0.0 0
M  V30 11 F 18.3438 0.0000 0.0 0
M  V30 12 F 16.2402 0.5636 0.0 0
M  V30 13 C 23.7339 4.0011 0.0 0
M  V30 14 C 5.2536 9.3359 0.0 0
M  V30 15 C 6.4335 10.3259 0.0 0
M  V30 16 C 4.9863 10.8526 0.0 0
M  V30 17 C 3.8065 8.8092 0.0 0
M  V30 18 N 2.6268 9.7992 0.0 0
M  V30 19 C 3.5391 7.2926 0.0 0
M  V30 20 C 1.1797 9.2723 0.0 0
M  V30 21 C 2.0920 6.7658 0.0 0
M  V30 22 N 0.9123 7.7557 0.0 0
M  V30 23 C 8.3337 6.6685 0.0 0
M  V30 24 C 9.8737 6.6685 0.0 0
M  V30 25 C 7.5637 5.3348 0.0 0
M  V30 26 C 10.6437 5.3348 0.0 0
M  V30 27 C 8.3337 4.0011 0.0 0
M  V30 28 C 9.8737 4.0011 0.0 0
M  V30 29 C 14.4938 4.0011 0.0 0
M  V30 30 C 15.2638 2.6675 0.0 0
M  V30 31 C 15.2638 5.3348 0.0 0
M  V30 32 C 16.8038 2.6675 0.0 0
M  V30 33 C 16.8038 5.3348 0.0 0
M  V30 34 C 17.5738 4.0011 0.0 0
M  V30 35 N 19.1139 4.0011 0.0 0
M  V30 36 C 19.8839 5.3348 0.0 0
M  V30 37 C 19.8839 2.6675 0.0 0
M  V30 38 C 21.4239 5.3348 0.0 0
M  V30 39 C 21.4239 2.6675 0.0 0
M  V30 40 N 22.1939 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 23
M  V30 5 1 4 20
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 29
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 32
M  V30 15 1 13 40
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 1 34 35
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-3-[[[1-[2-(methylamino)-4-pyrimidinyl]cyclopropyl]carbonyl]amino]-N-...
C29H32F3N7O2
2095851-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.7100 8.0021 0.0 0
M  V30 2 N 16.1700 8.0021 0.0 0
M  V30 3 O 18.4800 6.6684 0.0 0
M  V30 4 N 23.7337 10.2621 0.0 0
M  V30 5 C 25.1808 9.7354 0.0 0
M  V30 6 C 17.7100 5.3347 0.0 0
M  V30 7 C 11.5500 5.3347 0.0 0
M  V30 8 N 10.7800 4.0011 0.0 0
M  V30 9 O 10.7800 6.6684 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 F 4.8264 2.1036 0.0 0
M  V30 12 F 5.3900 0.0000 0.0 0
M  V30 13 F 7.4936 0.5636 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 18.4800 9.3358 0.0 0
M  V30 16 C 17.3004 10.3257 0.0 0
M  V30 17 C 18.7475 10.8524 0.0 0
M  V30 18 C 19.9271 8.8091 0.0 0
M  V30 19 N 21.1069 9.7990 0.0 0
M  V30 20 C 20.1946 7.2925 0.0 0
M  V30 21 C 22.5539 9.2722 0.0 0
M  V30 22 C 21.6416 6.7657 0.0 0
M  V30 23 N 22.8214 7.7556 0.0 0
M  V30 24 C 15.4000 6.6684 0.0 0
M  V30 25 C 13.8600 6.6684 0.0 0
M  V30 26 C 16.1700 5.3347 0.0 0
M  V30 27 C 13.0900 5.3347 0.0 0
M  V30 28 C 15.4000 4.0011 0.0 0
M  V30 29 C 13.8600 4.0011 0.0 0
M  V30 30 C 9.2400 4.0011 0.0 0
M  V30 31 C 8.4700 2.6674 0.0 0
M  V30 32 C 8.4700 5.3347 0.0 0
M  V30 33 C 6.9300 2.6674 0.0 0
M  V30 34 C 6.9300 5.3347 0.0 0
M  V30 35 C 6.1600 4.0011 0.0 0
M  V30 36 N 4.6200 4.0011 0.0 0
M  V30 37 C 3.8500 5.3347 0.0 0
M  V30 38 C 3.8500 2.6674 0.0 0
M  V30 39 C 2.3100 5.3347 0.0 0
M  V30 40 C 2.3100 2.6674 0.0 0
M  V30 41 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 27
M  V30 11 1 8 30
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 33
M  V30 16 1 14 41
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 35 36
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097023-24-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095851-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17233427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design, synthesis, and biological evaluation of Pan-Raf
inhibitors to overcome resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lu; Zhu, Gaoyuan; Zhang, Qing; Duan, Chunqi; Zhang, Yanmin; Zhang,
Zhimin; Zhou, Yujun; Lu, Tao; Tang, Weifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(16), 3455-3465

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4-Trimethoxybenzaldehyde
C10H12O4
2103-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 O 4.0011 6.1601 0.0 0
M  V30 4 C 5.3348 6.9301 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 6.6686 4.6201 0.0 0
M  V30 8 C 8.0022 3.8500 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,3,4-Trimethoxyphenyl)methylene]methanamine
C11H15NO3
485842-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2103-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 485842-37-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14307754
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Sobetirome
C20H24O4
211110-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 9.3360 0.0000 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 3.8501 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 O 16.0046 3.8501 0.0 0
M  V30 9 C 1.3338 1.5400 0.0 0
M  V30 10 C 1.3338 0.0000 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 O 1.3338 4.6201 0.0 0
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 10.6698 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6698 3.8501 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 4.0012 1.5400 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 2.3101 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0
M  V30 24 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 22
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[[4-Hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-N-methy...
C21H27NO3
2128258-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 9.3360 0.0000 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 3.8501 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 N 16.0045 3.8501 0.0 0
M  V30 8 O 14.6708 6.1601 0.0 0
M  V30 9 C 17.3383 4.6201 0.0 0
M  V30 10 C 1.3338 1.5400 0.0 0
M  V30 11 C 1.3338 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 1.3338 4.6201 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 9.3360 1.5400 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 1.5400 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 23 C 2.6675 2.3101 0.0 0
M  V30 24 C 4.0012 4.6201 0.0 0
M  V30 25 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 23
M  V30 14 1 13 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 211110-63-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2128258-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19926823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryloxyacetamides for the treatment of neurodegenerative
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scanlan, Thomas S.; Meinig, James Matthew; Ferrara, Skylar J.; Banerji,
Tapasree; Banerji, Tania
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018032012 A1 2018-02-15

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Sobetirome
C20H24O4
211110-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 9.3360 0.0000 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 3.8501 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 O 16.0046 3.8501 0.0 0
M  V30 9 C 1.3338 1.5400 0.0 0
M  V30 10 C 1.3338 0.0000 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 O 1.3338 4.6201 0.0 0
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 10.6698 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6698 3.8501 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 4.0012 1.5400 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 2.3101 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0
M  V30 24 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 22
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[[4-Hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-N-methy...
C21H27NO3
2128258-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 C 9.3360 0.0000 0.0 0
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 3.8501 0.0 0
M  V30 6 C 14.6708 4.6201 0.0 0
M  V30 7 N 16.0045 3.8501 0.0 0
M  V30 8 O 14.6708 6.1601 0.0 0
M  V30 9 C 17.3383 4.6201 0.0 0
M  V30 10 C 1.3338 1.5400 0.0 0
M  V30 11 C 1.3338 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 O 1.3338 4.6201 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 9.3360 1.5400 0.0 0
M  V30 16 C 8.0023 3.8501 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 1.5400 0.0 0
M  V30 22 C 5.3348 3.8501 0.0 0
M  V30 23 C 2.6675 2.3101 0.0 0
M  V30 24 C 4.0012 4.6201 0.0 0
M  V30 25 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 23
M  V30 14 1 13 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 211110-63-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2128258-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17954608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeting Fatty-Acid Amide Hydrolase with Prodrugs for CNS-Selective
Therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meinig, J. Matthew; Ferrara, Skylar J.; Banerji, Tania; Banerji,
Tapasree; Sanford-Crane, Hannah S.; Bourdette, Dennis; Scanlan, Thomas S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Neuroscience (2017), 8(11), 2468-2476

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-α,α-dimethylbenzeneacetaldehyde
C10H11BrO
212626-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6675 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 2.6675 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 Br 3.0800 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 5.3901 4.0011 0.0 0
M  V30 11 C 5.3901 1.3338 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N,β,β-trimethylbenzeneethanamine
C11H16BrN
1069114-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 4.0012 0.0 0
M  V30 2 C 4.4137 3.2311 0.0 0
M  V30 3 C 3.8501 5.3350 0.0 0
M  V30 4 C 1.7462 4.7712 0.0 0
M  V30 5 N 5.7474 4.0012 0.0 0
M  V30 6 C 7.0811 3.2311 0.0 0
M  V30 7 Br 0.0000 4.0012 0.0 0
M  V30 8 C 2.3101 2.6675 0.0 0
M  V30 9 C 0.7700 2.6675 0.0 0
M  V30 10 C 3.0801 1.3338 0.0 0
M  V30 11 C 0.0000 1.3338 0.0 0
M  V30 12 C 2.3101 0.0000 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 212626-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1069114-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14461880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(2-bromophenyl)-N, 2-dimethylpropan-1-amine: To a solution of the
aldehyde4 (1.28 g, 5.65 mmol, 1 equiv.) in MeOH (15 mL) was added a 40%
aq. solution of methylamine (640 μL, 16.9 mmol, 3 equiv.). After stirring
at 20°C for 3h, the solution was cooled to 0°C prior to adding sodium
borohydride (200 mg, 5.65 mmol, 1 equiv.) portion wise. The resulting
solution was stirred at 20°C for 1.5 h. After addition of water (30 mL),
MeOH was evaporated under vacuum and the resulting aqueous phase
extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were
dried over MgSO4 and the solvent was evaporated. It afforded the title
product as a colorless oil (1.25 g, 90%). 2-(2-bromophenyl)-N,
2-dimethylpropan-1-amine, yield (1.25 g, 90%). 1H NMR (300 MHz, CDCl3): δ
= 7.58 (dd, J = 7.9, 1.4 Hz, 1H), 7.43 (dd, J = 7.9, 1.6 Hz, 1H), 7.25
(ddd, J = 7.9, 7.9, 1.4 Hz, 1H), 7.04 (ddd, J = 7.9, 7.9, 1.6 Hz, 1H),
3.13 (s, 2H), 2.38 (s, 3H), 1.93 (s, 1H, NH), 1.61 (s, 6H) ppm; 13C NMR
(75 MHz, CDCl3): δ =144.6, 135.9, 130.0, 128.0, 127.5, 122.3, 60.6, 40.9,
37.2, 27.4 ppm; IR (neat): ν = 2961, 2872, 1466, 1015, 752 cm-1; HRMS
(ESI): calculated for C11H17N79Br+ [M+H]+ : 242.0544, found: 242.0543.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Benzocyclobutenes by Palladium-Catalyzed C-H Activation of
Methyl Groups: Method and Mechanistic Study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chaumontet, Manon; Piccardi, Riccardo; Audic, Nicolas; Hitce, Julien;
Peglion, Jean-Louis; Clot, Eric; Baudoin, Olivier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(45), 15157-15166

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3R,6′R)-5-bromo-1,2,5′,6′-tetrahydro-6′-(2-hydroxyphenyl)-1-methyl-2-o...
C22H20BrNO5
2133827-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4178 9.7292 0.0 0
M  V30 2 C 4.5150 4.0011 0.0 0
M  V30 3 O 5.2850 2.6675 0.0 0
M  V30 4 O 2.9750 4.0011 0.0 0
M  V30 5 C 4.5150 1.3338 0.0 0
M  V30 6 C 5.2850 0.0000 0.0 0
M  V30 7 C 4.9280 11.9711 0.0 0
M  V30 8 Br 0.0000 6.5782 0.0 0
M  V30 9 O 9.1350 4.0011 0.0 0
M  V30 10 C 5.2850 8.0022 0.0 0 CFG=2
M  V30 11 C 3.7535 8.1631 0.0 0
M  V30 12 C 6.8250 8.0022 0.0 0
M  V30 13 C 4.5150 6.6686 0.0 0
M  V30 14 C 5.9115 9.4090 0.0 0
M  V30 15 C 3.4333 9.6696 0.0 0
M  V30 16 C 2.6091 7.1327 0.0 0
M  V30 17 C 7.5950 6.6686 0.0 0 CFG=2
M  V30 18 C 5.2850 5.3348 0.0 0
M  V30 19 N 4.7670 10.4396 0.0 0
M  V30 20 C 1.9686 10.1454 0.0 0
M  V30 21 C 1.1444 7.6086 0.0 0
M  V30 22 O 6.8250 5.3348 0.0 0
M  V30 23 C 0.8242 9.1149 0.0 0
M  V30 24 C 9.1350 6.6686 0.0 0
M  V30 25 C 9.9050 5.3348 0.0 0
M  V30 26 C 9.9050 8.0022 0.0 0
M  V30 27 C 11.4451 5.3348 0.0 0
M  V30 28 C 11.4451 8.0022 0.0 0
M  V30 29 C 12.2151 6.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 19
M  V30 8 1 8 21
M  V30 9 1 9 25
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14 CFG=3
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 15 19
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 17 22
M  V30 23 1 17 24 CFG=3
M  V30 24 1 18 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,6′R)-5-Bromo-1,2,5′,6′-tetrahydro-6′-(2-hydroxyphenyl)-N,1-dimethyl-2-oxo...
C21H19BrN2O4
2636793-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4177 8.3955 0.0 0
M  V30 2 C 4.5150 2.6674 0.0 0
M  V30 3 N 5.2850 1.3338 0.0 0
M  V30 4 O 2.9750 2.6674 0.0 0
M  V30 5 C 4.5150 0.0000 0.0 0
M  V30 6 C 4.9280 10.6374 0.0 0
M  V30 7 Br 0.0000 5.2443 0.0 0
M  V30 8 O 9.1350 2.6674 0.0 0
M  V30 9 C 5.2850 6.6685 0.0 0 CFG=2
M  V30 10 C 3.7534 6.8294 0.0 0
M  V30 11 C 6.8250 6.6685 0.0 0
M  V30 12 C 4.5150 5.3347 0.0 0
M  V30 13 C 5.9114 8.0753 0.0 0
M  V30 14 C 3.4333 8.3357 0.0 0
M  V30 15 C 2.6091 5.7990 0.0 0
M  V30 16 C 7.5950 5.3347 0.0 0 CFG=2
M  V30 17 C 5.2850 4.0011 0.0 0
M  V30 18 N 4.7669 9.1057 0.0 0
M  V30 19 C 1.9686 8.8117 0.0 0
M  V30 20 C 1.1444 6.2749 0.0 0
M  V30 21 O 6.8250 4.0011 0.0 0
M  V30 22 C 0.8242 7.7812 0.0 0
M  V30 23 C 9.1350 5.3347 0.0 0
M  V30 24 C 9.9050 4.0011 0.0 0
M  V30 25 C 9.9050 6.6685 0.0 0
M  V30 26 C 11.4450 4.0011 0.0 0
M  V30 27 C 11.4450 6.6685 0.0 0
M  V30 28 C 12.2150 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 6 18
M  V30 7 1 7 20
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13 CFG=3
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 16 23 CFG=3
M  V30 23 1 17 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2133827-21-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2636793-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23385522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee 99%, dr = 96:4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Box-copper catalyzed asymmetric inverse-electron-demand
oxa-hetero-Diels-Alder reaction for efficient synthesis of spiro
pyranyl-oxindole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Nai-Kai; Sun, Bing-Bing; Chen, Jun-Bo; Yang, Hao-Di; Wang, Bai-Lin;
Yu, Jie-Qiang; Wang, Xing-Wang; Wang, Zheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(9), 2009-2018

$RFMT $RIREG SCHEME197 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(4-Methylphenyl)methyl]thio]benzaldehyde
C15H14OS
85825-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 7
M  V30 6 1 5 17
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methoxyethylidene)glycine ethyl ester
C7H13NO3
2135836-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 1.3337 1.5400 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4 CFG=2
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3,5-Dihydro-2,3-dimethyl-5-[[2-[[(4-methylphenyl)methyl]thio]phenyl]meth...
C20H20N2OS
2848680-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 S 7.9701 5.5688 0.0 0
M  V30 3 C 9.3038 6.3388 0.0 0
M  V30 4 O 4.9524 0.6966 0.0 0
M  V30 5 C 1.6752 0.0000 0.0 0
M  V30 6 C 0.0000 2.9016 0.0 0
M  V30 7 C 14.6386 3.2587 0.0 0
M  V30 8 C 5.3026 5.5688 0.0 0
M  V30 9 C 6.6363 6.3388 0.0 0
M  V30 10 C 3.9690 6.3388 0.0 0
M  V30 11 C 6.6363 7.8788 0.0 0
M  V30 12 C 3.9690 7.8788 0.0 0
M  V30 13 C 5.3026 8.6488 0.0 0
M  V30 14 C 3.9690 3.2587 0.0 0
M  V30 15 C 3.8080 1.7271 0.0 0
M  V30 16 N 2.5622 3.8850 0.0 0
M  V30 17 N 2.3016 1.4070 0.0 0
M  V30 18 C 1.5316 2.7406 0.0 0
M  V30 19 C 10.6375 5.5688 0.0 0
M  V30 20 C 11.9711 6.3388 0.0 0
M  V30 21 C 10.6375 4.0287 0.0 0
M  V30 22 C 13.3050 5.5688 0.0 0
M  V30 23 C 11.9711 3.2587 0.0 0
M  V30 24 C 13.3050 4.0287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 19
M  V30 6 2 4 15
M  V30 7 1 5 17
M  V30 8 1 6 18
M  V30 9 1 7 24
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85825-83-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2135836-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2848680-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34407638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of spiro[imidazole-4,3'-thiochroman]ones from
[2-(benzylsulfanyl)benzylidene]imidazolones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zaitseva, Elvira R.; Sokolov, Anatolii I.; Mikhaylov, Andrey A.; Baleeva,
Nadezhda S.; Baranov, Mikhail S.; Smirnov, Alexander Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2022),
58(8-9), 477-480

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methyl-7-nitro-1H-indole-5-carboxylate
C11H10N2O4
2139228-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0011 1.3338 0.0 0 VAL=5
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 O 1.4610 1.3338 0.0 0
M  V30 4 C 0.0000 6.6231 0.0 0
M  V30 5 C 7.6212 4.0012 0.0 0
M  V30 6 O 8.3912 5.3348 0.0 0
M  V30 7 O 8.3912 2.6675 0.0 0
M  V30 8 C 9.9311 5.3348 0.0 0
M  V30 9 C 3.0011 4.0012 0.0 0
M  V30 10 C 3.7711 5.3348 0.0 0
M  V30 11 C 3.7711 2.6675 0.0 0
M  V30 12 N 1.4946 4.3213 0.0 0
M  V30 13 C 5.3111 5.3348 0.0 0
M  V30 14 C 2.7405 6.4794 0.0 0
M  V30 15 C 5.3111 2.6675 0.0 0
M  V30 16 C 1.3337 5.8531 0.0 0
M  V30 17 C 6.0811 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-7-nitro-1H-indole-5-carboxamide
C11H11N3O3
2448481-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0012 1.3338 0.0 0 VAL=5
M  V30 2 O 3.7712 0.0000 0.0 0
M  V30 3 O 1.4612 1.3338 0.0 0
M  V30 4 C 0.0000 6.6229 0.0 0
M  V30 5 C 7.6212 4.0011 0.0 0
M  V30 6 N 8.3912 5.3347 0.0 0
M  V30 7 O 8.3912 2.6674 0.0 0
M  V30 8 C 9.9312 5.3347 0.0 0
M  V30 9 C 3.0012 4.0011 0.0 0
M  V30 10 C 3.7712 5.3347 0.0 0
M  V30 11 C 3.7712 2.6674 0.0 0
M  V30 12 N 1.4947 4.3212 0.0 0
M  V30 13 C 5.3112 5.3347 0.0 0
M  V30 14 C 2.7406 6.4792 0.0 0
M  V30 15 C 5.3112 2.6674 0.0 0
M  V30 16 C 1.3338 5.8529 0.0 0
M  V30 17 C 6.0812 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2139228-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2448481-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38468794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of 3-acetylindole derivatives that selectively target BRPF1
as new inhibitors of receptor activator of NF-κB ligand (RANKL)-Induced
osteoclastogenesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wenqiang; Ning, Ruonan; Ran, Ting; Peng, Qi; Liu, Yong; Lu, Tao;
Chen, Yadong; Jiang, Min; Jiao, Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2023), 96117440

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-3-pyridinesulfonyl chloride
C5H2BrCl2NO2S
216394-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 Cl 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-N-methyl-3-pyridinesulfonamide
C6H6BrClN2O2S
622814-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216394-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 622814-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34228224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of a 3-(imidazol-4-yl)-4-(amino)-benzenesulfonamide TEAD
inhibitor with an EGFR inhibitor and/or MEK inhibitor for use in the
treatment of lung cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro, Alfredo C.; Burke, Michael; Amidon, Benjamin; Frosch, Hyejin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022159986 A1 2022-07-28

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-3-pyridinesulfonyl chloride
C5H2BrCl2NO2S
216394-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 Cl 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-N-methyl-3-pyridinesulfonamide
C6H6BrClN2O2S
622814-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216394-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 622814-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33185568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as TEAD degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro, Alfredo C.; Burke, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022120355 A1 2022-06-09

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-3-pyridinesulfonyl chloride
C5H2BrCl2NO2S
216394-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 4.2073 0.0 0
M  V30 4 O 1.5400 1.1273 0.0 0
M  V30 5 Br 6.1600 0.0000 0.0 0
M  V30 6 Cl 7.7000 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-6-chloro-N-methyl-3-pyridinesulfonamide
C6H6BrClN2O2S
622814-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 4.0011 0.0 0
M  V30 6 Br 1.5400 0.0000 0.0 0
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 216394-05-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 622814-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33114192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as TEAD inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro, Alfredo C.; Burke, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022120353 A1 2022-06-09

$RFMT $RIREG SCHEME200 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Itaconic anhydride
C5H4O3
2170-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.3320 0.0 0
M  V30 2 O 0.3502 0.0000 0.0 0
M  V30 3 O 5.3026 2.2049 0.0 0
M  V30 4 C 1.3337 2.5620 0.0 0
M  V30 5 C 1.4946 1.0304 0.0 0
M  V30 6 C 2.7406 3.1885 0.0 0
M  V30 7 O 3.0011 0.7103 0.0 0
M  V30 8 C 3.7711 2.0439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-3-methyl-4-oxo-2-thioxo-2H-1,3-thiazine-5-acetic acid
C7H9NO3S2
2129653-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 6.1600 5.3349 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 O 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 S 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 N 2.3100 1.3338 0.0 0
M  V30 12 S 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 9
M  V30 6 1 6 11
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2170-03-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2129653-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27090926
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, thia-Michael addition (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigation of the Reaction of In Situ Prepared Dithiocarbamic Acids
with Itaconic Anhydride in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halimehjani, Azim Ziyaei; Nosood, Yazdanbakhsh Lotfi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2017), 54(6), 3372-3376

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H14BrClO2
2173254-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 O 9.3360 0.0000 0.0 0
M  V30 8 Br 4.0010 4.6201 0.0 0
M  V30 9 Cl 1.3337 0.0000 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 12.0033 1.5400 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 13.3370 2.3101 0.0 0
M  V30 21 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 6 7
M  V30 8 1 6 16
M  V30 9 1 8 11
M  V30 10 1 9 12
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H17BrClNO
2173253-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 N 6.6685 0.7700 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 9.3360 0.7700 0.0 0
M  V30 9 Br 1.3337 0.7700 0.0 0
M  V30 10 Cl 4.0010 5.3901 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 13.3370 3.0801 0.0 0
M  V30 21 C 12.0033 5.3901 0.0 0
M  V30 22 C 13.3370 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 6 17
M  V30 10 1 9 12
M  V30 11 1 10 13
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173254-13-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173253-90-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18703501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-Substituted Condensed Tetrahydropyridine-Based Enaminones
via Palladium-Catalyzed Intramolecular C-N Cross-coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dousova, Hana; Ruzickova, Zdenka; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2018), 55(3), 670-684

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[[4-(2-Bromoethoxy)phenyl][4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]me...
C28H39BrO2Si
2173514-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 4.9136 0.0 0
M  V30 2 O 4.0012 7.9937 0.0 0
M  V30 3 Si 2.6675 7.2237 0.0 0
M  V30 4 C 1.3337 6.4537 0.0 0
M  V30 5 C 3.4375 5.8900 0.0 0
M  V30 6 C 1.8975 8.5574 0.0 0
M  V30 7 C 0.5637 7.7873 0.0 0
M  V30 8 C 0.0000 5.6836 0.0 0
M  V30 9 C 2.1037 5.1200 0.0 0
M  V30 10 O 14.6708 7.9937 0.0 0
M  V30 11 C 16.0045 7.2237 0.0 0
M  V30 12 C 17.3383 7.9937 0.0 0
M  V30 13 Br 18.6720 7.2237 0.0 0
M  V30 14 C 8.0023 5.6836 0.0 0
M  V30 15 C 6.6685 4.9136 0.0 0
M  V30 16 C 8.0023 7.2237 0.0 0
M  V30 17 C 5.3348 5.6836 0.0 0
M  V30 18 C 6.6685 7.9937 0.0 0
M  V30 19 C 5.3348 7.2237 0.0 0
M  V30 20 C 10.6697 5.6836 0.0 0
M  V30 21 C 12.0035 4.9136 0.0 0
M  V30 22 C 10.6697 7.2237 0.0 0
M  V30 23 C 13.3372 5.6836 0.0 0
M  V30 24 C 12.0035 7.9937 0.0 0
M  V30 25 C 13.3372 7.2237 0.0 0
M  V30 26 C 9.3360 3.3736 0.0 0
M  V30 27 C 10.7236 2.7054 0.0 0
M  V30 28 C 7.9484 2.7054 0.0 0
M  V30 29 C 11.0662 1.2040 0.0 0
M  V30 30 C 7.6058 1.2040 0.0 0
M  V30 31 C 10.1060 0.0000 0.0 0
M  V30 32 C 8.5660 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 2 1 26
M  V30 4 1 2 3
M  V30 5 1 2 19
M  V30 6 1 3 4
M  V30 7 1 3 5
M  V30 8 1 3 6
M  V30 9 1 4 7
M  V30 10 1 4 8
M  V30 11 1 4 9
M  V30 12 1 10 11
M  V30 13 1 10 25
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[Cycloheptylidene[4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]phenyl]methyl...
C29H43NO2Si
2173514-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 4.9136 0.0 0
M  V30 2 O 4.0012 7.9937 0.0 0
M  V30 3 Si 2.6675 7.2237 0.0 0
M  V30 4 C 1.3337 6.4537 0.0 0
M  V30 5 C 1.8975 8.5574 0.0 0
M  V30 6 C 3.4375 5.8900 0.0 0
M  V30 7 C 2.1037 5.1200 0.0 0
M  V30 8 C 0.0000 5.6836 0.0 0
M  V30 9 C 0.5637 7.7873 0.0 0
M  V30 10 O 14.6708 7.9937 0.0 0
M  V30 11 C 16.0045 7.2237 0.0 0
M  V30 12 C 17.3382 7.9937 0.0 0
M  V30 13 N 18.6720 7.2237 0.0 0
M  V30 14 C 20.0057 7.9937 0.0 0
M  V30 15 C 8.0023 5.6836 0.0 0
M  V30 16 C 8.0023 7.2237 0.0 0
M  V30 17 C 6.6685 4.9136 0.0 0
M  V30 18 C 6.6685 7.9937 0.0 0
M  V30 19 C 5.3348 5.6836 0.0 0
M  V30 20 C 5.3348 7.2237 0.0 0
M  V30 21 C 10.6697 5.6836 0.0 0
M  V30 22 C 12.0033 4.9136 0.0 0
M  V30 23 C 10.6697 7.2237 0.0 0
M  V30 24 C 13.3372 5.6836 0.0 0
M  V30 25 C 12.0033 7.9937 0.0 0
M  V30 26 C 13.3372 7.2237 0.0 0
M  V30 27 C 9.3360 3.3736 0.0 0
M  V30 28 C 7.9484 2.7054 0.0 0
M  V30 29 C 10.7236 2.7054 0.0 0
M  V30 30 C 7.6058 1.2040 0.0 0
M  V30 31 C 11.0662 1.2040 0.0 0
M  V30 32 C 8.5660 0.0000 0.0 0
M  V30 33 C 10.1060 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 2 1 27
M  V30 4 1 2 3
M  V30 5 1 2 20
M  V30 6 1 3 4
M  V30 7 1 3 5
M  V30 8 1 3 6
M  V30 9 1 4 7
M  V30 10 1 4 8
M  V30 11 1 4 9
M  V30 12 1 10 11
M  V30 13 1 10 26
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173514-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173514-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18469723
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel selective estrogen receptor ligand conjugates incorporating
endoxifen-combretastatin and cyclofenil-combretastatin hybrid scaffolds:
synthesis and biochemical evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelly, Patrick M.; Keely, Niall O.; Bright, Sandra A.; Yassin, Bassem;
Ana, Gloria; Fayne, Darren; Zisterer, Daniela M.; Meegan, Mary J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2017), 22(9), 1440/1-1440/50

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-nitrobenzenesulfonyl chloride
C6H3Cl2NO4S
21792-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.3338 0.0 0 VAL=6
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 O 0.9764 2.1038 0.0 0
M  V30 4 O 3.6436 0.5638 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 6 O 0.0000 5.3349 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 Cl 6.9300 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenesulfonamide
C7H7ClN2O4S
89840-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 5.5411 0.0 0
M  V30 4 O 4.6200 2.4611 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 N 3.0800 1.3338 0.0 0 VAL=5
M  V30 7 O 4.6200 1.3338 0.0 0
M  V30 8 O 2.3100 0.0000 0.0 0
M  V30 9 Cl 0.0000 6.6685 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21792-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89840-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-12870564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for treatment and prevention of disturbances of the central
nervous system associated with an alteration of glutamatergic
neurotransmission by administration of 2-aminobenzenesulfonamide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cannazza, Giuseppe; Parenti, Carlo; Lindner, Wolfgang; Puia, Giulia;
Baraldi, Mario; Braghiroli, Daniela; Tait, Annalisa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002089734 A2 2002-11-14

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)methyl]-2-pyridinecarboxylate
C13H14N4O4
2201104-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2078 4.0287 0.0 0
M  V30 2 C 3.1470 5.3915 0.0 0
M  V30 3 N 0.9052 2.9016 0.0 0 VAL=5
M  V30 4 O 0.0000 1.6557 0.0 0
M  V30 5 O 0.2789 4.3085 0.0 0
M  V30 6 C 2.5805 0.0000 0.0 0
M  V30 7 C 11.5426 4.0287 0.0 0
M  V30 8 O 12.8764 3.2587 0.0 0
M  V30 9 O 11.5426 5.5687 0.0 0
M  V30 10 C 14.2101 4.0287 0.0 0
M  V30 11 N 4.8742 3.2587 0.0 0
M  V30 12 C 3.4674 3.8850 0.0 0
M  V30 13 N 4.7132 1.7271 0.0 0
M  V30 14 C 2.4368 2.7406 0.0 0
M  V30 15 C 3.2068 1.4070 0.0 0
M  V30 16 C 7.5416 3.2587 0.0 0
M  V30 17 C 8.8753 4.0287 0.0 0
M  V30 18 C 7.5416 1.7187 0.0 0
M  V30 19 C 10.2090 3.2587 0.0 0
M  V30 20 C 8.8753 0.9487 0.0 0
M  V30 21 N 10.2090 1.7187 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 16
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3,5-Dimethyl-4-nitro-1H-pyrazol-1-yl)methyl]-N-methyl-2-pyridinecarboxamide
C13H15N5O3
2201104-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2078 4.0287 0.0 0
M  V30 2 C 3.1470 5.3915 0.0 0
M  V30 3 N 0.9052 2.9016 0.0 0 VAL=5
M  V30 4 O 0.2789 4.3085 0.0 0
M  V30 5 O 0.0000 1.6557 0.0 0
M  V30 6 C 2.5805 0.0000 0.0 0
M  V30 7 C 11.5426 4.0287 0.0 0
M  V30 8 N 12.8764 3.2587 0.0 0
M  V30 9 O 11.5426 5.5687 0.0 0
M  V30 10 C 14.2101 4.0287 0.0 0
M  V30 11 N 4.8742 3.2587 0.0 0
M  V30 12 C 3.4674 3.8850 0.0 0
M  V30 13 N 4.7132 1.7271 0.0 0
M  V30 14 C 2.4368 2.7406 0.0 0
M  V30 15 C 3.2068 1.4070 0.0 0
M  V30 16 C 7.5416 3.2587 0.0 0
M  V30 17 C 8.8753 4.0287 0.0 0
M  V30 18 C 7.5416 1.7187 0.0 0
M  V30 19 C 10.2090 3.2587 0.0 0
M  V30 20 C 8.8753 0.9487 0.0 0
M  V30 21 N 10.2090 1.7187 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 16
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2201104-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2201104-30-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20031642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzylpyrazolylbenzamide derivatives for use as antitumor
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Liqiang; Ai, Teng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180071258 A1 2018-03-15

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methyl 3-chloro-5-cyano-2-methoxybenzeneheptanoate
C16H20ClNO3
2205015-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 C 6.6687 5.3901 0.0 0
M  V30 3 C 8.0023 6.1601 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6698 6.1601 0.0 0
M  V30 6 C 12.0035 5.3901 0.0 0
M  V30 7 C 13.3372 6.1601 0.0 0
M  V30 8 O 14.6708 5.3901 0.0 0
M  V30 9 O 13.3372 7.7002 0.0 0
M  V30 10 C 16.0046 6.1601 0.0 0
M  V30 11 O 2.6675 7.7002 0.0 0
M  V30 12 C 1.3338 8.4702 0.0 0
M  V30 13 Cl 0.0000 6.1601 0.0 0
M  V30 14 C 2.6675 1.5400 0.0 0
M  V30 15 N 2.6675 0.0000 0.0 0
M  V30 16 C 4.0012 5.3901 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 C 4.0012 3.8501 0.0 0
M  V30 19 C 1.3338 5.3901 0.0 0
M  V30 20 C 2.6675 3.0801 0.0 0
M  V30 21 C 1.3338 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 1 13 19
M  V30 14 3 14 15
M  V30 15 1 14 20
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-5-cyano-2-hydroxy-N-methylbenzeneheptanamide
C15H19ClN2O2
2205016-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 C 6.6686 5.3901 0.0 0
M  V30 3 C 8.0022 6.1601 0.0 0
M  V30 4 C 9.3359 5.3901 0.0 0
M  V30 5 C 10.6697 6.1601 0.0 0
M  V30 6 C 12.0034 5.3901 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 N 14.6707 5.3901 0.0 0
M  V30 9 O 13.3370 7.7001 0.0 0
M  V30 10 C 16.0045 6.1601 0.0 0
M  V30 11 O 2.6675 7.7001 0.0 0
M  V30 12 Cl 0.0000 6.1601 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 N 2.6675 0.0000 0.0 0
M  V30 15 C 4.0011 5.3901 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 4.0011 3.8500 0.0 0
M  V30 18 C 1.3338 5.3901 0.0 0
M  V30 19 C 2.6675 3.0800 0.0 0
M  V30 20 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 16
M  V30 12 1 12 18
M  V30 13 3 13 14
M  V30 14 1 13 19
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2205015-30-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2205016-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-19184531
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate isolated with 85% yield (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Toward More Drug Like Inhibitors of Trypanosome Alternative Oxidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM West, Ryan A.; Cunningham, Thomas; Pennicott, Lewis E.; Rao, Srinivasa P.
S.; Ward, Simon E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2018), 4(4), 592-604

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methyl 3-chloro-5-cyano-2-methoxybenzenehexanoate
C15H18ClNO3
2205017-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 C 8.0022 6.1601 0.0 0
M  V30 4 C 9.3358 5.3901 0.0 0
M  V30 5 C 10.6697 6.1601 0.0 0
M  V30 6 C 12.0033 5.3901 0.0 0
M  V30 7 O 13.3370 6.1601 0.0 0
M  V30 8 O 12.0033 3.8501 0.0 0
M  V30 9 C 14.6707 5.3901 0.0 0
M  V30 10 O 2.6673 7.7002 0.0 0
M  V30 11 C 1.3337 8.4702 0.0 0
M  V30 12 Cl 0.0000 6.1601 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 N 2.6673 0.0000 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 C 2.6673 6.1601 0.0 0
M  V30 17 C 4.0010 3.8501 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 2.6673 3.0801 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 16
M  V30 12 1 12 18
M  V30 13 3 13 14
M  V30 14 1 13 19
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-5-cyano-2-hydroxy-N-methylbenzenehexanamide
C14H17ClN2O2
2205018-31-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 C 8.0022 6.1601 0.0 0
M  V30 4 C 9.3358 5.3901 0.0 0
M  V30 5 C 10.6697 6.1601 0.0 0
M  V30 6 C 12.0033 5.3901 0.0 0
M  V30 7 N 13.3370 6.1601 0.0 0
M  V30 8 O 12.0033 3.8501 0.0 0
M  V30 9 C 14.6707 5.3901 0.0 0
M  V30 10 O 2.6673 7.7002 0.0 0
M  V30 11 Cl 0.0000 6.1601 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 2.6673 0.0000 0.0 0
M  V30 14 C 4.0010 5.3901 0.0 0
M  V30 15 C 2.6673 6.1601 0.0 0
M  V30 16 C 4.0010 3.8501 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 2.6673 3.0801 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 15
M  V30 11 1 11 17
M  V30 12 3 12 13
M  V30 13 1 12 18
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2205017-46-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2205018-31-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-049-CAS-19184530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate isolated with 85% yield (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Toward More Drug Like Inhibitors of Trypanosome Alternative Oxidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM West, Ryan A.; Cunningham, Thomas; Pennicott, Lewis E.; Rao, Srinivasa P.
S.; Ward, Simon E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2018), 4(4), 592-604

$RFMT $RIREG SCHEME207 STEP1
$RXN



  3  1
$MOL
Bromoacetyl chloride
C2H2BrClO
22118-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-5-methoxy-6-nitro-1H-indole
C9H10N2O3
23772-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3338 1.5400 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 N 1.3338 4.6200 0.0 0 VAL=5
M  V30 4 O 1.3338 6.1600 0.0 0
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 C 5.3347 2.3100 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.7994 1.8341 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 N 6.7994 4.3259 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 7.7047 3.0800 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,3-Dihydro-5-methoxy-6-nitro-1H-indol-1-yl)-2-(methylamino)ethanone
C12H15N3O4
1158528-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0408 3.2907 0.0 0
M  V30 2 C 9.5055 3.7667 0.0 0
M  V30 3 O 7.7206 1.7844 0.0 0
M  V30 4 N 10.6499 2.7361 0.0 0
M  V30 5 C 12.1146 3.2120 0.0 0
M  V30 6 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 7 O 3.0800 0.0000 0.0 0
M  V30 8 O 0.7700 1.3336 0.0 0
M  V30 9 O 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 5.3347 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 N 6.8964 4.3212 0.0 0
M  V30 14 C 4.6200 2.6673 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 5.6506 6.4791 0.0 0
M  V30 17 C 7.0574 5.8528 0.0 0
M  V30 18 C 3.0800 2.6673 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22118-09-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23772-38-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1158528-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5946807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 40-90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R
tyrosine kinase inhibitors towards JNK selectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chamberlain, Stanley D.; Redman, Aniko M.; Wilson, Joseph W.; Deanda,
Felix; Shotwell, J. Brad; Gerding, Roseanne; Lei, Huangshu; Yang, Bin;
Stevens, Kirk L.; Hassell, Anne M.; Shewchuk, Lisa M.; Leesnitzer, M.
Anthony; Smith, Jeffery L.; Sabbatini, Peter; Atkins, Charity; Groy,
Arthur; Rowand, Jason L.; Kumar, Rakesh; Mook, Robert A.; Moorthy,
Ganesh; Patnaik, Samarjit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(2), 360-364

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[[(1Z)-1-[(4Z)-4,5-dihydro-5-oxo-4-(phenylmethylene)-2...
C25H25N3O5
2230166-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9273 5.3347 0.0 0
M  V30 2 C 7.1573 4.0011 0.0 0
M  V30 3 N 9.4673 5.3347 0.0 0
M  V30 4 C 10.2373 6.6684 0.0 0
M  V30 5 C 11.7773 6.6684 0.0 0
M  V30 6 O 9.4673 8.0021 0.0 0
M  V30 7 N 12.5473 8.0021 0.0 0
M  V30 8 C 14.0873 8.0021 0.0 0
M  V30 9 O 14.8573 9.3358 0.0 0
M  V30 10 O 14.8573 6.6684 0.0 0
M  V30 11 C 16.3973 9.3358 0.0 0
M  V30 12 C 16.3973 7.7958 0.0 0
M  V30 13 C 17.9373 9.3358 0.0 0
M  V30 14 C 16.3973 10.8758 0.0 0
M  V30 15 C 3.8987 8.9622 0.0 0
M  V30 16 O 6.8002 10.6372 0.0 0
M  V30 17 C 7.1573 6.6684 0.0 0
M  V30 18 N 5.6258 6.8294 0.0 0
M  V30 19 O 7.7836 8.0753 0.0 0
M  V30 20 C 5.3055 8.3357 0.0 0
M  V30 21 C 6.6392 9.1057 0.0 0
M  V30 22 C 7.9273 2.6674 0.0 0
M  V30 23 C 9.4673 2.6674 0.0 0
M  V30 24 C 7.1573 1.3336 0.0 0
M  V30 25 C 10.2373 1.3336 0.0 0
M  V30 26 C 7.9273 0.0000 0.0 0
M  V30 27 C 9.4673 0.0000 0.0 0
M  V30 28 C 2.6528 8.0570 0.0 0
M  V30 29 C 1.2459 8.6833 0.0 0
M  V30 30 C 2.8137 6.5253 0.0 0
M  V30 31 C 0.0000 7.7781 0.0 0
M  V30 32 C 1.5679 5.6202 0.0 0
M  V30 33 C 0.1609 6.2465 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 20
M  V30 17 1 15 28
M  V30 18 2 16 21
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[[(1Z)-1-[[[(1Z)-1-[(methylamino)carbonyl]-2-phenyleth...
C26H30N4O5
2230166-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 5.3348 0.0 0
M  V30 2 C 6.9302 4.0012 0.0 0
M  V30 3 C 6.9302 6.6685 0.0 0
M  V30 4 N 9.2402 5.3348 0.0 0
M  V30 5 N 5.3901 6.6685 0.0 0
M  V30 6 O 7.7002 8.0022 0.0 0
M  V30 7 C 10.0102 6.6685 0.0 0
M  V30 8 C 4.6201 8.0022 0.0 0
M  V30 9 C 11.5503 6.6685 0.0 0
M  V30 10 O 9.2402 8.0022 0.0 0
M  V30 11 C 3.0801 8.0022 0.0 0
M  V30 12 C 5.3901 9.3360 0.0 0
M  V30 13 N 12.3203 8.0022 0.0 0
M  V30 14 N 4.6201 10.6697 0.0 0
M  V30 15 O 6.9302 9.3360 0.0 0
M  V30 16 C 13.8603 8.0022 0.0 0
M  V30 17 C 5.3901 12.0033 0.0 0
M  V30 18 O 14.6303 9.3360 0.0 0
M  V30 19 O 14.6303 6.6685 0.0 0
M  V30 20 C 16.1704 9.3360 0.0 0
M  V30 21 C 16.1704 10.8760 0.0 0
M  V30 22 C 17.7104 9.3360 0.0 0
M  V30 23 C 16.1704 7.7960 0.0 0
M  V30 24 C 7.7002 2.6673 0.0 0
M  V30 25 C 9.2402 2.6673 0.0 0
M  V30 26 C 6.9302 1.3337 0.0 0
M  V30 27 C 10.0102 1.3337 0.0 0
M  V30 28 C 7.7002 0.0000 0.0 0
M  V30 29 C 9.2402 0.0000 0.0 0
M  V30 30 C 2.3101 6.6685 0.0 0
M  V30 31 C 3.0801 5.3348 0.0 0
M  V30 32 C 0.7700 6.6685 0.0 0
M  V30 33 C 2.3101 4.0012 0.0 0
M  V30 34 C 0.0000 5.3348 0.0 0
M  V30 35 C 0.7700 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 24
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 11 30
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2230166-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230166-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19448100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general method for preparation of N-Boc-protected or N-Fmoc-protected
α,β-didehydropeptide building blocks and their use in the solid-phase
peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolczanski, Grzegorz; Lisowski, Marek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Peptide Science (2018), 24(8-9), n/a

$RFMT $RIREG SCHEME209 STEP1
$RXN



  4  1
$MOL
1,3-Bis(1,1-dimethylethyl) 2-(5-ethynyl-2-thiazolyl)imidodicarbonate
C15H20N2O4S
2230649-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 5.3901 0.0 0
M  V30 2 C 4.0011 3.8501 0.0 0
M  V30 3 C 2.6673 6.1601 0.0 0
M  V30 4 O 2.6673 3.0801 0.0 0
M  V30 5 O 5.3348 3.0801 0.0 0
M  V30 6 O 2.6673 7.7001 0.0 0
M  V30 7 O 1.3337 5.3901 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 1.3337 8.4702 0.0 0
M  V30 10 C 1.1273 1.5400 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 4.2074 1.5400 0.0 0
M  V30 13 C 0.5637 7.1365 0.0 0
M  V30 14 C 0.0000 9.2402 0.0 0
M  V30 15 C 2.1037 9.8038 0.0 0
M  V30 16 C 9.3038 6.5172 0.0 0
M  V30 17 C 10.8353 6.3562 0.0 0
M  V30 18 C 5.3348 6.1601 0.0 0
M  V30 19 S 6.7416 5.5338 0.0 0
M  V30 20 N 5.4957 7.6917 0.0 0
M  V30 21 C 7.7722 6.6782 0.0 0
M  V30 22 C 7.0022 8.0118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 3 16 17
M  V30 17 1 16 21
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-iodo-N-[4-(trifluoromethyl)-2-pyridinyl]benzamide
C13H7F4IN2O
2230649-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.8501 0.0 0
M  V30 2 C 4.0012 4.6201 0.0 0
M  V30 3 O 4.0012 6.1601 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 F 9.8996 2.5164 0.0 0
M  V30 6 F 12.0033 3.0801 0.0 0
M  V30 7 F 11.4397 5.1838 0.0 0
M  V30 8 F 1.3337 6.1601 0.0 0
M  V30 9 I 1.3337 0.0000 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 N 6.6685 6.1601 0.0 0
M  V30 13 C 9.3360 4.6201 0.0 0
M  V30 14 C 8.0022 6.9302 0.0 0
M  V30 15 C 9.3360 6.1601 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 20 C 1.3337 1.5400 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 13
M  V30 9 1 8 17
M  V30 10 1 9 20
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-[2-[2-[[(methylamino)carbonyl]amino]-5-thiazolyl]ethynyl]-N-[4-(tr...
C20H13F4N5O2S
2230649-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 4.5499 0.0 0
M  V30 2 N 6.6685 5.3199 0.0 0
M  V30 3 O 8.0023 3.0098 0.0 0
M  V30 4 F 8.0023 7.6299 0.0 0
M  V30 5 C 13.3372 4.5499 0.0 0
M  V30 6 C 14.6708 3.7799 0.0 0
M  V30 7 C 1.3337 5.3199 0.0 0
M  V30 8 F 2.1037 6.6536 0.0 0
M  V30 9 F 0.0000 6.0899 0.0 0
M  V30 10 F 0.5637 3.9862 0.0 0
M  V30 11 N 19.9735 2.6527 0.0 0
M  V30 12 C 20.8787 1.4068 0.0 0
M  V30 13 N 22.4103 1.5679 0.0 0
M  V30 14 O 20.2524 0.0000 0.0 0
M  V30 15 C 23.3155 0.3219 0.0 0
M  V30 16 C 9.3360 5.3199 0.0 0
M  V30 17 C 10.6697 4.5499 0.0 0
M  V30 18 C 9.3360 6.8599 0.0 0
M  V30 19 C 12.0033 5.3199 0.0 0
M  V30 20 C 10.6697 7.6299 0.0 0
M  V30 21 C 12.0033 6.8599 0.0 0
M  V30 22 C 5.3348 4.5499 0.0 0
M  V30 23 C 4.0012 5.3199 0.0 0
M  V30 24 N 5.3348 3.0098 0.0 0
M  V30 25 C 2.6675 4.5499 0.0 0
M  V30 26 C 4.0012 2.2398 0.0 0
M  V30 27 C 2.6675 3.0098 0.0 0
M  V30 28 C 16.0045 3.0098 0.0 0
M  V30 29 S 17.4115 3.6363 0.0 0
M  V30 30 C 16.1654 1.4783 0.0 0
M  V30 31 C 18.4419 2.4918 0.0 0
M  V30 32 N 17.6719 1.1581 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 4 18
M  V30 6 3 5 6
M  V30 7 1 5 19
M  V30 8 1 6 28
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 25
M  V30 13 1 11 12
M  V30 14 1 11 31
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 2 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2230649-50-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2230649-51-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230649-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30362232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 14221-01-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Sonogashira coupling (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylethynyl aminothiazoles as c-Kit inhibitors for the
treatment of cancer and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bencivenga, Nicholas E.; Dalgarno, David C.; Gozgit, Joseph M.; Huang,
Wei-Sheng; Kohlmann, Anna; Li, Feng; Qi, Jiwei; Shakespeare, William C.;
Thomas, Ranny M.; Wang, Yihan; Zhu, Xiaotian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018112136 A1 2018-06-21

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
4′-[1-Fluoro-1-methyl-2-[[(4-methylphenyl)sulfonyl]amino]ethyl][1,1′-biphenyl...
C23H22FNO4S
2241050-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 8.0023 0.0 0
M  V30 2 C 5.3901 6.6685 0.0 0
M  V30 3 C 4.8265 8.7723 0.0 0
M  V30 4 F 6.9302 9.3360 0.0 0
M  V30 5 N 3.8501 6.6685 0.0 0
M  V30 6 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 7 O 4.4137 4.5648 0.0 0
M  V30 8 O 1.7464 6.1048 0.0 0
M  V30 9 C 15.4961 2.6122 0.0 0
M  V30 10 O 15.4961 1.0722 0.0 0
M  V30 11 O 16.8298 3.3822 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 C 10.1613 5.6923 0.0 0
M  V30 14 C 8.8275 4.9223 0.0 0
M  V30 15 C 10.1613 7.2323 0.0 0
M  V30 16 C 7.4938 5.6923 0.0 0
M  V30 17 C 8.8275 8.0023 0.0 0
M  V30 18 C 7.4938 7.2323 0.0 0
M  V30 19 C 11.4950 4.9223 0.0 0
M  V30 20 C 12.8286 5.6923 0.0 0
M  V30 21 C 11.4950 3.3822 0.0 0
M  V30 22 C 14.1623 4.9223 0.0 0
M  V30 23 C 12.8286 2.6122 0.0 0
M  V30 24 C 14.1625 3.3822 0.0 0
M  V30 25 C 2.3101 4.0012 0.0 0
M  V30 26 C 3.0801 2.6675 0.0 0
M  V30 27 C 0.7700 4.0012 0.0 0
M  V30 28 C 2.3101 1.3337 0.0 0
M  V30 29 C 0.0000 2.6675 0.0 0
M  V30 30 C 0.7700 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 18
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 25
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 12 30
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-[1-Fluoro-1-methyl-2-[[(4-methylphenyl)sulfonyl]amino]ethyl]-N-methyl[1,1′...
C24H25FN2O3S
2241050-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 8.0023 0.0 0
M  V30 2 C 5.3901 6.6685 0.0 0
M  V30 3 C 4.8265 8.7723 0.0 0
M  V30 4 F 6.9302 9.3360 0.0 0
M  V30 5 N 3.8501 6.6685 0.0 0
M  V30 6 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 7 O 1.7464 6.1048 0.0 0
M  V30 8 O 4.4137 4.5648 0.0 0
M  V30 9 C 15.4961 2.6122 0.0 0
M  V30 10 N 16.8298 3.3822 0.0 0
M  V30 11 O 15.4961 1.0722 0.0 0
M  V30 12 C 18.1635 2.6122 0.0 0
M  V30 13 C 0.0000 0.0000 0.0 0
M  V30 14 C 10.1613 5.6923 0.0 0
M  V30 15 C 8.8275 4.9223 0.0 0
M  V30 16 C 10.1613 7.2323 0.0 0
M  V30 17 C 7.4938 5.6923 0.0 0
M  V30 18 C 8.8275 8.0023 0.0 0
M  V30 19 C 7.4938 7.2323 0.0 0
M  V30 20 C 11.4950 4.9223 0.0 0
M  V30 21 C 11.4950 3.3822 0.0 0
M  V30 22 C 12.8286 5.6923 0.0 0
M  V30 23 C 12.8286 2.6122 0.0 0
M  V30 24 C 14.1623 4.9223 0.0 0
M  V30 25 C 14.1623 3.3822 0.0 0
M  V30 26 C 2.3101 4.0012 0.0 0
M  V30 27 C 3.0801 2.6675 0.0 0
M  V30 28 C 0.7700 4.0012 0.0 0
M  V30 29 C 2.3101 1.3337 0.0 0
M  V30 30 C 0.0000 2.6675 0.0 0
M  V30 31 C 0.7700 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 25
M  V30 13 1 10 12
M  V30 14 1 13 31
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2241050-61-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241050-62-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19067980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regiospecific Three-Component Aminofluorination of Olefins via Photoredox
Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mo, Jia-Nan; Yu, Wan-Lei; Chen, Jian-Qiang; Hu, Xiu-Qin; Xu, Peng-Fei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(15), 4471-4474

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,4,5,6-tetrahydro-5-methyl-4,6-dioxo-3-phenylpyrrolo[3,4-c]pyrrole-1-c...
C16H14N2O4
2242709-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.8604 2.4898 0.0 0
M  V30 2 C 7.9700 5.1589 0.0 0
M  V30 3 O 8.5964 6.5659 0.0 0
M  V30 4 O 8.8752 3.9131 0.0 0
M  V30 5 C 10.1280 6.7268 0.0 0
M  V30 6 C 10.7543 8.1338 0.0 0
M  V30 7 O 7.1631 1.3628 0.0 0
M  V30 8 C 4.1023 0.0000 0.0 0
M  V30 9 C 4.1621 3.9845 0.0 0
M  V30 10 C 5.6684 3.6643 0.0 0
M  V30 11 C 4.0010 5.5161 0.0 0
M  V30 12 C 3.3921 2.6509 0.0 0
M  V30 13 C 6.4384 4.9980 0.0 0
M  V30 14 C 5.8293 2.1328 0.0 0
M  V30 15 N 5.4080 6.1426 0.0 0
M  V30 16 N 4.4225 1.5063 0.0 0
M  V30 17 C 2.6673 6.2861 0.0 0
M  V30 18 C 1.3337 5.5161 0.0 0
M  V30 19 C 2.6673 7.8261 0.0 0
M  V30 20 C 0.0000 6.2861 0.0 0
M  V30 21 C 1.3337 8.5961 0.0 0
M  V30 22 C 0.0000 7.8261 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 14
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 17
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N3,N4-Trimethyl-5-phenyl-1H-pyrrole-2,3,4-tricarboxamide
C16H18N4O3
2242709-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 2.6091 0.0 0
M  V30 2 N 4.8087 1.4647 0.0 0
M  V30 3 O 7.3455 2.2889 0.0 0
M  V30 4 C 5.2845 0.0000 0.0 0
M  V30 5 C 2.6528 3.6444 0.0 0
M  V30 6 N 1.2459 4.2707 0.0 0
M  V30 7 O 2.8137 2.1129 0.0 0
M  V30 8 C 0.0000 3.3657 0.0 0
M  V30 9 C 2.6528 6.9949 0.0 0
M  V30 10 N 2.8137 8.5264 0.0 0
M  V30 11 O 1.2459 6.3684 0.0 0
M  V30 12 C 1.5679 9.4316 0.0 0
M  V30 13 C 5.3632 4.0738 0.0 0
M  V30 14 C 3.8987 4.5496 0.0 0
M  V30 15 C 6.2684 5.3196 0.0 0
M  V30 16 C 3.8987 6.0897 0.0 0
M  V30 17 N 5.3632 6.5655 0.0 0
M  V30 18 C 7.8085 5.3196 0.0 0
M  V30 19 C 8.5785 3.9860 0.0 0
M  V30 20 C 8.5785 6.6533 0.0 0
M  V30 21 C 10.1185 3.9860 0.0 0
M  V30 22 C 10.1185 6.6533 0.0 0
M  V30 23 C 10.8885 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242709-22-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242709-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19137697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile access to highly functionalized pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Meng; Zhao, Wenting; Zhao, Hongyi; Lin, Ziyun; Zhang, Dongfeng;
Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14884-890

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Trifluoromethyl)benzoyl chloride
C8H4ClF3O
2251-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 Cl 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(trifluoromethyl)benzamide
C9H8F3NO
41882-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 F 2.1037 4.4137 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 F 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2251-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41882-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7508100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative insights into energy contributions of intermolecular
interactions in fluorine and trifluoromethyl substituted isomeric
N-phenylacetamides and N-methylbenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Panini, Piyush; Chopra, Deepak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM CrystEngComm (2013), 15(18), 3711-3733

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Pyrano[3,4-c]quinolin-4-one
C12H7NO2
2253972-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 3.0800 0.0 0
M  V30 2 C 2.6674 3.0800 0.0 0
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3336 2.3100 0.0 0
M  V30 6 C 5.3347 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 N 4.0011 5.3900 0.0 0
M  V30 9 C 1.3336 5.3900 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 C 5.3347 4.6200 0.0 0
M  V30 12 C 6.6685 2.3100 0.0 0
M  V30 13 C 5.3347 0.0000 0.0 0
M  V30 14 C 0.0000 4.6200 0.0 0
M  V30 15 O 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 2 7 13
M  V30 13 2 8 11
M  V30 14 1 9 14
M  V30 15 2 10 14
M  V30 16 1 12 15
M  V30 17 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylbenzo[c][2,7]naphthyridin-4(3H)-one
C13H10N2O
2234894-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 0.0000 0.0 0
M  V30 2 C 9.2402 2.6673 0.0 0
M  V30 3 C 4.6201 2.6673 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 5.3901 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 6.9302 1.3337 0.0 0
M  V30 11 C 6.9302 4.0010 0.0 0
M  V30 12 N 3.0801 0.0000 0.0 0
M  V30 13 C 0.7700 1.3337 0.0 0
M  V30 14 C 0.7700 4.0010 0.0 0
M  V30 15 N 7.7002 2.6673 0.0 0
M  V30 16 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 2 9 12
M  V30 15 1 10 15
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2253972-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2234894-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22110716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Confirmation of the Revised Structure of Samoquasine A and a Proposed
Structural Revision of Cherimoline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dhoro, Francis; Parkin-Gibbs, Jesse; McIldowie, Matthew; Skelton, Brian
W.; Piggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Natural Products (2018), 81(7), 1658-1665

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C10H8D3IO
2271330-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6673 0.0 0
M  V30 2 C 3.0800 4.2073 0.0 0
M  V30 3 C 1.5400 2.6673 0.0 0
M  V30 4 C 3.0800 1.1273 0.0 0
M  V30 5 O 1.7464 4.9773 0.0 0
M  V30 6 I 4.6200 0.0000 0.0 0
M  V30 7 C 4.6200 2.6673 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 6.9300 1.3336 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6673 0.0 0
M  V30 13 H 0.7700 4.0011 0.0 0 MASS=2
M  V30 14 H 0.0000 2.6673 0.0 0 MASS=2
M  V30 15 H 0.7700 1.3336 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 3 13
M  V30 7 1 3 14
M  V30 8 1 3 15
M  V30 9 1 6 8
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C11H13D3IN
2271330-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.8500 0.0 0
M  V30 2 C 3.0800 2.3100 0.0 0
M  V30 3 C 1.5400 3.8500 0.0 0
M  V30 4 C 3.0800 5.3900 0.0 0
M  V30 5 N 1.7464 1.5400 0.0 0
M  V30 6 C 1.7464 0.0000 0.0 0
M  V30 7 I 4.6200 6.5173 0.0 0
M  V30 8 C 4.6200 3.8500 0.0 0
M  V30 9 C 5.3900 5.1836 0.0 0
M  V30 10 C 5.3900 2.5162 0.0 0
M  V30 11 C 6.9300 5.1836 0.0 0
M  V30 12 C 6.9300 2.5162 0.0 0
M  V30 13 C 7.7000 3.8500 0.0 0
M  V30 14 H 0.7700 5.1836 0.0 0 MASS=2
M  V30 15 H 0.0000 3.8500 0.0 0 MASS=2
M  V30 16 H 0.7700 2.5162 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 3 14
M  V30 7 1 3 15
M  V30 8 1 3 16
M  V30 9 1 5 6
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2271330-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271330-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-19750943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Intermolecular [4+1] Spiroannulation by C(sp3)-H
Activation and Naphthol Dearomatization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Bojun; Bai, Lu; Ding, Pin; Liu, Jingjing; Wang, Yaoyu; Luan, Xinjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(5), 1474-1478

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Neuraminic acid, N-acetyl-, methyl ester
C12H21NO9
22900-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1729 3.5600 0.0 0 CFG=2
M  V30 2 C 2.9055 2.0434 0.0 0 CFG=2
M  V30 3 O 1.9932 4.5499 0.0 0
M  V30 4 C 1.4584 1.5166 0.0 0
M  V30 5 O 4.0852 1.0535 0.0 0
M  V30 6 O 1.1909 0.0000 0.0 0
M  V30 7 N 2.3100 5.4203 0.0 0
M  V30 8 C 1.5400 6.7540 0.0 0
M  V30 9 C 2.3100 8.0878 0.0 0
M  V30 10 O 0.0000 6.7540 0.0 0
M  V30 11 O 3.8500 8.0878 0.0 0
M  V30 12 C 8.1098 4.4304 0.0 0
M  V30 13 O 9.5568 4.9571 0.0 0
M  V30 14 O 7.8423 2.9138 0.0 0
M  V30 15 C 10.7366 3.9673 0.0 0
M  V30 16 O 8.1098 6.4102 0.0 0
M  V30 17 C 4.6200 4.0867 0.0 0 CFG=2
M  V30 18 C 3.8500 5.4203 0.0 0 CFG=2
M  V30 19 O 6.1600 4.0867 0.0 0
M  V30 20 C 4.6200 6.7540 0.0 0 CFG=1
M  V30 21 C 6.9300 5.4203 0.0 0 CFG=2
M  V30 22 C 6.1600 6.7540 0.0 0
M  V30 23 H 4.8875 2.5701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 18 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 11 CFG=1
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 21 12 CFG=1
M  V30 15 1 13 15
M  V30 16 1 21 16 CFG=3
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23 CFG=3
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 2 17 18 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N5-Acetyl-N1-methyl-β-neuraminamide
C12H22N2O8
1021159-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1729 3.5600 0.0 0 CFG=2
M  V30 2 C 2.9055 2.0434 0.0 0 CFG=2
M  V30 3 O 1.9932 4.5499 0.0 0
M  V30 4 C 1.4584 1.5166 0.0 0
M  V30 5 O 4.0852 1.0535 0.0 0
M  V30 6 O 1.1909 0.0000 0.0 0
M  V30 7 N 2.3100 5.4203 0.0 0
M  V30 8 C 1.5400 6.7540 0.0 0
M  V30 9 C 0.0000 6.7540 0.0 0
M  V30 10 O 2.3100 8.0878 0.0 0
M  V30 11 O 3.8500 8.0878 0.0 0
M  V30 12 C 8.1098 4.4304 0.0 0
M  V30 13 N 9.5568 4.9571 0.0 0
M  V30 14 O 7.8423 2.9138 0.0 0
M  V30 15 C 10.7366 3.9673 0.0 0
M  V30 16 O 8.1098 6.4102 0.0 0
M  V30 17 C 4.6200 4.0867 0.0 0 CFG=2
M  V30 18 C 3.8500 5.4203 0.0 0 CFG=2
M  V30 19 O 6.1600 4.0867 0.0 0
M  V30 20 C 4.6200 6.7540 0.0 0 CFG=1
M  V30 21 C 6.9300 5.4203 0.0 0 CFG=2
M  V30 22 C 6.1600 6.7540 0.0 0
M  V30 23 H 4.8875 2.5701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 18 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 11 CFG=1
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 21 12 CFG=1
M  V30 15 1 13 15
M  V30 16 1 21 16 CFG=3
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23 CFG=3
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 2 17 18 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22900-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021159-64-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13445751
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl
5-acetamide-3,5-dideoxy-β-D-glycero-D-galacto-2-nonulopyranosonamide (7).
Compound 5 (198 mg, 0.613 mmol) was dissolved in commercially available
2.0 M MeNH2 (MeOH solution, 3.1 mL) and this solution was stirred for 4
h. To a solution of this mixture was added AG 1X-8 (formate form) in
order to remove NeuAc. After filtration, the eluant was concentrated to
afford monomethyl amide derivative 7 (190 mg, 90%). [α ]25D =-39.6 (c =
1.0, H2O).1H NMR (400 MHz,D2O) δ : 4.08 (ddd, 1H, J = 10.3 Hz, J = 5.09
Hz, J = 13.2 Hz), 4.06 (d, 1H, J = 10.3 Hz), 3.91 (t, 1H, J = 10.3 Hz, J
= 10.3 Hz), 3.84 (dd, 1H, J = 2.54 Hz, J = 11.8 Hz), 3.74 (ddd, 1H J =
2.54 Hz, J = 6.04 Hz, J = 9.22 Hz), 3.63 (dd, 1H, J = 11.8 Hz, J = 6.04
Hz), 3.57 (d, 1H, J = 9.22 Hz), 2.32 (dd, 1H, J = 13.2 Hz, J = 5.09 Hz),
1.68 (t, 1H, J = 13.2 Hz, J = 13.2 Hz);13C NMR (100 MHz, D2O ) δ : 175.2,
173.4, 95.8, 70.7, 70.4, 68.5, 67.1, 63.5, 52.4, 39.8, 26.1, 22.4.
MALDI-HRMS calcd for C12H22N2NaO8 [M+Na]+: 345.1274; found: 345.1297.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of MUC4 sialylglycopeptide through the new
sialylation using 5-acetamido-neuraminamide donors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okamoto, Ryo; Souma, Shingo; Kajihara, Yasuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(9), 3460-3466

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
2-Bromo-5-methoxybenzoic acid
C8H7BrO3
22921-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 Br 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-bromo-5-methoxy-N-methyl-
C9H10BrNO2
171425-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 Br 4.6200 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22921-68-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171425-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31664557
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel nucleocapsid protein-targeting phenanthridine inhibitors of
SARS-CoV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yi-Ting; Long, Xin-Yan; Ding, Xiao; Fan, Shi-Rui; Cai, Jie-Yun;
Yang, Bi-Juan; Zhang, Xin-Fang; Luo, Rong-hua; Yang, Lian; Ruan, Ting;
Ren, Juan; Jing, Chen-Xu; Zheng, Yong-Tang; Hao, Xiao-Jiang; Chen,
Duo-Zhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 227113966

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
rel-(1R,2R,3aS,4R,9bR)-2-Chloro-4-(2,4-dichlorophenyl)-2,3,3a,4,5,9b-hexahydr...
C25H19Cl3N2O4S
2300982-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.5190 6.8703 0.0 0
M  V30 2 Cl 5.8818 9.9310 0.0 0
M  V30 3 C 4.5024 1.5400 0.0 0
M  V30 4 O 4.5024 0.0000 0.0 0
M  V30 5 O 3.1687 2.3100 0.0 0
M  V30 6 Cl 12.5046 4.6200 0.0 0
M  V30 7 N 1.5063 6.2299 0.0 0 VAL=5
M  V30 8 O 2.5367 5.0856 0.0 0
M  V30 9 O 0.0000 5.9098 0.0 0
M  V30 10 Cl 15.1718 9.2400 0.0 0
M  V30 11 C 7.1698 6.1600 0.0 0 CFG=1
M  V30 12 C 8.5035 6.9300 0.0 0 CFG=2
M  V30 13 C 7.1698 4.6200 0.0 0
M  V30 14 C 6.0253 7.1905 0.0 0 CFG=1
M  V30 15 C 9.8371 6.1600 0.0 0 CFG=2
M  V30 16 C 8.1833 8.4365 0.0 0
M  V30 17 C 8.5035 3.8500 0.0 0
M  V30 18 C 5.8362 3.8500 0.0 0
M  V30 19 C 6.6518 8.5974 0.0 0 CFG=2
M  V30 20 N 9.8371 4.6200 0.0 0
M  V30 21 C 8.5035 2.3100 0.0 0
M  V30 22 C 5.8362 2.3100 0.0 0
M  V30 23 C 7.1698 1.5400 0.0 0
M  V30 24 C 11.1709 6.9300 0.0 0
M  V30 25 C 12.5046 6.1600 0.0 0
M  V30 26 C 11.1709 8.4700 0.0 0
M  V30 27 C 13.8382 6.9300 0.0 0
M  V30 28 C 12.5046 9.2400 0.0 0
M  V30 29 C 13.8382 8.4700 0.0 0
M  V30 30 C 3.4886 8.0148 0.0 0
M  V30 31 C 1.9821 7.6946 0.0 0
M  V30 32 C 3.9644 9.4794 0.0 0
M  V30 33 C 0.9517 8.8390 0.0 0
M  V30 34 C 2.9340 10.6239 0.0 0
M  V30 35 C 1.4276 10.3037 0.0 0
M  V30 36 H 5.7629 5.5337 0.0 0
M  V30 37 H 9.7493 7.8353 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=1
M  V30 2 1 1 30
M  V30 3 1 19 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 25
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 31
M  V30 11 1 10 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 36 CFG=1
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 12 37 CFG=1
M  V30 19 1 13 17
M  V30 20 2 13 18
M  V30 21 1 14 19
M  V30 22 1 15 20
M  V30 23 1 15 24 CFG=3
M  V30 24 1 16 19
M  V30 25 1 17 20
M  V30 26 2 17 21
M  V30 27 1 18 22
M  V30 28 1 21 23
M  V30 29 2 22 23
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 11 12 14 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,3aS,4R,9bR)-2-Chloro-4-(2,4-dichlorophenyl)-2,3,3a,4,5,9b-hexahydr...
C26H22Cl3N3O3S
2300979-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.9894 4.5190 0.0 0
M  V30 2 Cl 7.7000 2.5498 0.0 0
M  V30 3 C 2.3100 9.1270 0.0 0
M  V30 4 N 1.5400 10.4606 0.0 0
M  V30 5 O 1.5400 7.7932 0.0 0
M  V30 6 C 0.0000 10.4606 0.0 0
M  V30 7 Cl 10.7800 10.4606 0.0 0
M  V30 8 N 2.0602 3.5673 0.0 0 VAL=5
M  V30 9 O 0.5957 3.0914 0.0 0
M  V30 10 O 2.3804 5.0737 0.0 0
M  V30 11 Cl 15.4000 7.7932 0.0 0
M  V30 12 C 6.9300 6.4595 0.0 0 CFG=1
M  V30 13 C 8.4700 6.4595 0.0 0 CFG=2
M  V30 14 C 6.1600 7.7932 0.0 0
M  V30 15 C 6.4541 4.9950 0.0 0 CFG=1
M  V30 16 C 9.2400 7.7932 0.0 0 CFG=2
M  V30 17 C 8.9459 4.9950 0.0 0
M  V30 18 C 6.9300 9.1270 0.0 0
M  V30 19 C 4.6200 7.7932 0.0 0
M  V30 20 C 7.7000 4.0898 0.0 0 CFG=2
M  V30 21 N 8.4700 9.1270 0.0 0
M  V30 22 C 6.1600 10.4606 0.0 0
M  V30 23 C 3.8500 9.1270 0.0 0
M  V30 24 C 4.6200 10.4606 0.0 0
M  V30 25 C 10.7800 7.7932 0.0 0
M  V30 26 C 11.5500 9.1270 0.0 0
M  V30 27 C 11.5500 6.4595 0.0 0
M  V30 28 C 13.0900 9.1270 0.0 0
M  V30 29 C 13.0900 6.4595 0.0 0
M  V30 30 C 13.8600 7.7932 0.0 0
M  V30 31 C 4.6693 3.0127 0.0 0
M  V30 32 C 3.2047 2.5368 0.0 0
M  V30 33 C 5.8138 1.9823 0.0 0
M  V30 34 C 2.8844 1.0304 0.0 0
M  V30 35 C 5.4935 0.4759 0.0 0
M  V30 36 C 4.0289 0.0000 0.0 0
M  V30 37 H 5.3985 6.2986 0.0 0
M  V30 38 H 10.0015 6.2986 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=3
M  V30 2 1 1 31
M  V30 3 1 20 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 4 6
M  V30 8 1 7 26
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 32
M  V30 12 1 11 30
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 37 CFG=3
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 38 CFG=3
M  V30 20 1 14 18
M  V30 21 2 14 19
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 16 25 CFG=1
M  V30 25 1 17 20
M  V30 26 1 18 21
M  V30 27 2 18 22
M  V30 28 1 19 23
M  V30 29 1 22 24
M  V30 30 2 23 24
M  V30 31 2 25 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 27 29
M  V30 35 2 28 30
M  V30 36 1 29 30
M  V30 37 2 31 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 2 33 35
M  V30 41 2 34 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 12 13 15 16 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2300982-67-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2300979-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20104240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of hexahydrocyclopenta[c]quinoline
derivatives as allosteric inhibitors of CDK2 and EGFR
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlino, Luca; Christodoulou, Michael S.; Restelli, Valentina;
Caporuscio, Fabiana; Foschi, Francesca; Semrau, Marta S.; Costanzi,
Elisa; Tinivella, Annachiara; Pinzi, Luca; Lo Presti, Leonardo;
Battistutta, Roberto; Storici, Paola; Broggini, Massimo; Passarella,
Daniele; Rastelli, Giulio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2018), 13(24), 2627-2634

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1Z)-2-Chloro-2-phenylethenyl]-3-quinolinecarbonitrile
C18H11ClN2
2350238-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 Cl 6.9300 6.6685 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 N 6.1600 0.0000 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 N 4.6200 5.3347 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 6.6685 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 19 C 11.5500 6.6685 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 3 4 5
M  V30 6 1 4 7
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-3-phenylbenzo[b][1,6]naphthyridin-1(2H)-one
C19H14N2O
2350238-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 C 7.7000 6.6685 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 N 4.6200 1.3338 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 N 6.9300 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 17
M  V30 14 2 10 11
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2350238-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2350238-65-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26906882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal-free POCl3 promoted stereoselective hydrochlorination of
ethynylated azaheterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Ritush; Singh, Radhey M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2019), 17(24), 5990-5996

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methoxy-6-[(4-methylphenyl)sulfinyl]-3-pyridinecarboxylate
C15H15NO4S
237390-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3100 0.0 0
M  V30 2 O 1.3337 0.7700 0.0 0
M  V30 3 O 0.0000 3.0800 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 S 6.6684 5.3901 0.0 0 VAL=4
M  V30 8 O 6.6684 6.9301 0.0 0
M  V30 9 C 12.0032 2.3100 0.0 0
M  V30 10 C 2.6673 3.0800 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 N 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 8.0021 4.6201 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 18 C 9.3359 5.3901 0.0 0
M  V30 19 C 9.3359 2.3100 0.0 0
M  V30 20 C 10.6695 4.6201 0.0 0
M  V30 21 C 10.6695 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 15
M  V30 9 1 7 16
M  V30 10 1 9 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methoxy-6-(methylamino)-3-pyridinecarboxylate
C9H12N2O3
187480-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 3.8500 1.3338 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 9.2400 5.3349 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 N 6.1600 2.6674 0.0 0
M  V30 13 C 6.1600 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 237390-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 187480-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12161064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient synthesis of
5-bromo-2-methoxy-6-methylaminopyridine-3-carboxylic acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hirokawa, Yoshimi; Horikawa, Tamaki; Kato, Shiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2000), 48(12), 1847-1853

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[6-[4-(6-chloro-4-pyrimidinyl)-2-(methoxymethoxy)pheny...
C25H30ClN7O4
2377473-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7000 4.0011 0.0 0
M  V30 2 C 6.9300 2.6673 0.0 0
M  V30 3 O 7.7000 1.3336 0.0 0
M  V30 4 C 6.9300 0.0000 0.0 0
M  V30 5 Cl 0.0000 9.3358 0.0 0
M  V30 6 N 17.4759 8.3436 0.0 0
M  V30 7 C 18.8827 7.7173 0.0 0
M  V30 8 C 17.3149 9.8751 0.0 0
M  V30 9 O 20.1287 8.6224 0.0 0
M  V30 10 O 19.0437 6.1856 0.0 0
M  V30 11 C 21.5355 7.9960 0.0 0
M  V30 12 C 22.1618 9.4030 0.0 0
M  V30 13 C 22.9424 7.3697 0.0 0
M  V30 14 C 20.9092 6.5892 0.0 0
M  V30 15 C 7.7000 6.6684 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 6.9300 8.0020 0.0 0
M  V30 18 C 5.3900 5.3347 0.0 0
M  V30 19 C 5.3900 8.0020 0.0 0
M  V30 20 C 4.6200 6.6684 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 10.0101 5.3347 0.0 0
M  V30 23 N 10.0101 8.0020 0.0 0
M  V30 24 N 11.5501 5.3347 0.0 0
M  V30 25 N 11.5501 8.0020 0.0 0
M  V30 26 C 12.3201 6.6684 0.0 0
M  V30 27 C 3.0800 6.6684 0.0 0
M  V30 28 C 2.3100 8.0020 0.0 0
M  V30 29 N 2.3100 5.3347 0.0 0
M  V30 30 C 0.7700 8.0020 0.0 0
M  V30 31 C 0.7700 5.3347 0.0 0
M  V30 32 N 0.0000 6.6684 0.0 0
M  V30 33 N 13.8601 6.6684 0.0 0
M  V30 34 C 14.7653 7.9143 0.0 0
M  V30 35 C 14.7653 5.4225 0.0 0
M  V30 36 C 16.2300 7.4384 0.0 0
M  V30 37 C 16.2300 5.8984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 30
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 36
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 20 27
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 26 33
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[6-[2-(methoxymethoxy)-4-[6-(methylamino)-4-pyrimidiny...
C26H34N8O4
2377473-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 4.0011 0.0 0
M  V30 2 C 8.4700 2.6673 0.0 0
M  V30 3 O 9.2400 1.3336 0.0 0
M  V30 4 C 8.4700 0.0000 0.0 0
M  V30 5 N 1.5400 9.3358 0.0 0
M  V30 6 C 0.0000 9.3358 0.0 0
M  V30 7 N 19.0159 8.3436 0.0 0
M  V30 8 C 20.4227 7.7173 0.0 0
M  V30 9 C 18.8549 9.8751 0.0 0
M  V30 10 O 21.6687 8.6224 0.0 0
M  V30 11 O 20.5837 6.1856 0.0 0
M  V30 12 C 23.0755 7.9960 0.0 0
M  V30 13 C 22.4492 6.5892 0.0 0
M  V30 14 C 24.4824 7.3697 0.0 0
M  V30 15 C 23.7018 9.4030 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 8.0020 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 6.9300 8.0020 0.0 0
M  V30 21 C 6.1600 6.6684 0.0 0
M  V30 22 C 10.7801 6.6684 0.0 0
M  V30 23 C 11.5501 8.0020 0.0 0
M  V30 24 N 11.5501 5.3347 0.0 0
M  V30 25 N 13.0901 8.0020 0.0 0
M  V30 26 N 13.0901 5.3347 0.0 0
M  V30 27 C 13.8601 6.6684 0.0 0
M  V30 28 C 4.6200 6.6684 0.0 0
M  V30 29 C 3.8500 8.0020 0.0 0
M  V30 30 N 3.8500 5.3347 0.0 0
M  V30 31 C 2.3100 8.0020 0.0 0
M  V30 32 C 2.3100 5.3347 0.0 0
M  V30 33 N 1.5400 6.6684 0.0 0
M  V30 34 N 15.4001 6.6684 0.0 0
M  V30 35 C 16.3053 7.9143 0.0 0
M  V30 36 C 16.3053 5.4225 0.0 0
M  V30 37 C 17.7700 7.4384 0.0 0
M  V30 38 C 17.7700 5.8984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 31
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 37
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 21 28
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 1 27 34
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2377473-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377473-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21888507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxyphenyltriazine compounds for treating Huntington's disease and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sydorenko, Nadiya; Alan, Md Rauful; Amedzo, Lukiana; Babu, Suresh;
Baiazitov, Ramil Y.; Barraza, Scott J.; Bhattacharyya, Anuradha; Karp,
Gary Mitchell; Kenton, Nathaniel T.; Mazzotti, Anthony R.; Moon,
Young-Choon; Mszar, Nicholas W.; Narasimhan, Jana; Pal, Sudipta; Patel,
Jigar S.; Turpoff, Anthony; Woll, Mathew G.; Xu, Zhenrong; Zhang, Nanjing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019191229 A1 2019-10-03

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(2-Chloro-9-cyclopentyl-9H-purin-6-yl)amino]methyl]-4,6-dimethyl-2(1H)-py...
C18H21ClN6O
2379756-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1300 4.6201 0.0 0
M  V30 2 C 10.4637 3.8501 0.0 0
M  V30 3 Cl 6.4627 0.0000 0.0 0
M  V30 4 C 10.4637 6.9301 0.0 0
M  V30 5 O 13.1312 2.3100 0.0 0
M  V30 6 C 15.7985 6.9301 0.0 0
M  V30 7 C 6.4627 4.6201 0.0 0
M  V30 8 C 5.1289 3.8501 0.0 0
M  V30 9 C 7.7964 3.8501 0.0 0
M  V30 10 N 6.1424 6.1264 0.0 0
M  V30 11 N 3.9845 4.8805 0.0 0
M  V30 12 N 5.1289 2.3100 0.0 0
M  V30 13 N 7.7964 2.3100 0.0 0
M  V30 14 C 4.6108 6.2874 0.0 0
M  V30 15 C 6.4627 1.5400 0.0 0
M  V30 16 C 2.4780 4.5603 0.0 0
M  V30 17 C 1.8517 3.1535 0.0 0
M  V30 18 C 1.3337 5.5909 0.0 0
M  V30 19 C 0.3202 3.3144 0.0 0
M  V30 20 C 0.0000 4.8209 0.0 0
M  V30 21 C 11.7975 4.6201 0.0 0
M  V30 22 C 11.7975 6.1601 0.0 0
M  V30 23 C 13.1312 3.8501 0.0 0
M  V30 24 C 13.1312 6.9301 0.0 0
M  V30 25 N 14.4648 4.6201 0.0 0
M  V30 26 C 14.4648 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 21
M  V30 4 1 3 15
M  V30 5 1 4 22
M  V30 6 2 5 23
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 11 16
M  V30 17 1 12 15
M  V30 18 2 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[9-Cyclopentyl-2-(methylamino)-9H-purin-6-yl]amino]methyl]-4,6-dimethyl-2...
C19H25N7O
2414607-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1300 5.3900 0.0 0
M  V30 2 C 10.4636 4.6200 0.0 0
M  V30 3 N 6.4627 0.7700 0.0 0
M  V30 4 C 5.1289 0.0000 0.0 0
M  V30 5 C 13.1311 3.0800 0.0 0
M  V30 6 O 10.4636 7.7001 0.0 0
M  V30 7 C 15.7984 7.7001 0.0 0
M  V30 8 C 6.4627 5.3900 0.0 0
M  V30 9 C 5.1289 4.6200 0.0 0
M  V30 10 C 7.7963 4.6200 0.0 0
M  V30 11 N 6.1423 6.8963 0.0 0
M  V30 12 N 3.9845 5.6505 0.0 0
M  V30 13 N 5.1289 3.0800 0.0 0
M  V30 14 N 7.7963 3.0800 0.0 0
M  V30 15 C 4.6108 7.0574 0.0 0
M  V30 16 C 6.4627 2.3100 0.0 0
M  V30 17 C 2.4780 5.3303 0.0 0
M  V30 18 C 1.3336 6.3609 0.0 0
M  V30 19 C 1.8517 3.9235 0.0 0
M  V30 20 C 0.0000 5.5909 0.0 0
M  V30 21 C 0.3202 4.0844 0.0 0
M  V30 22 C 11.7974 5.3900 0.0 0
M  V30 23 C 13.1311 4.6200 0.0 0
M  V30 24 C 11.7974 6.9300 0.0 0
M  V30 25 C 14.4647 5.3900 0.0 0
M  V30 26 N 13.1311 7.7001 0.0 0
M  V30 27 C 14.4647 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 5 23
M  V30 7 2 6 24
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2379756-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414607-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22378336
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of a novel tubulin inhibitor
SKLB0565 targeting the colchicine binding site
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xi; Li, Lu; Zhang, Qiangsheng; Wang, Qianqian; Feng, Zhanzhan; Xu,
Ying; Xia, Yong; Yu, Luoting
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 97103695

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-5-(trifluoromethyl)benzyl bromide
C8H5BrF4
239087-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 2.1037 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5637 3.2864 0.0 0
M  V30 5 C 6.6687 4.6201 0.0 0
M  V30 6 Br 8.0023 3.8501 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methyl-5-(trifluoromethyl)benzenemethanamine
C9H9F4N
690653-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 2.1037 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5637 3.2864 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 F 4.0012 0.0000 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 239087-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 690653-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15518777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM {[3-fluoro-5-(trifluoromethyl)phenyl]methyl}(methyl)amine. Methylamine
33% in MeOH (1.5 mL, 46.5 mmol) was dissolved in MeOH (15 mL). The
mixture was heated at 50°C under stirring and 1-(bromomethyl)-3-fluoro-5-
(trifluoromethyl)benzene (1 g, 3.88 mmol) was added. The reaction mixture
was stirred at this temperature for 3h. The solvent was removed under
vacuo, then NaOH 1M (50 mL) was added and the aqueous layer was extracted
with DCM (100 mL). The organic layer was dried over Na2SO4, filtered and
evaporated under vacuo to give the title compound. Yellow oil, yield
0.5g. 1H NMR (400 MHz, CDCl3) δ ppm 7.50 (s, 1H), 7.30 (m, 2H), 7.25 (m,
1H), 3.88 (s, 2H), 2.54, (s, 3H). UPLC-MS: Rt=0.51; m/z (ES+): 208.1 [M +
H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylmethylphenyloxooctahydropyrrolopiperazinecarboxamide
derivatives for use as neurokinin 1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soerensen, Morten Dahl; Di Fabio, Romani; Pozzan, Alfonso; Catalani,
Maria Pia; Bladh, Haakon; Felding, Jakob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013124286 A1 2013-08-29

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H21ClN2O5
2411622-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2948 2.6528 0.0 0
M  V30 2 C 5.3896 1.4070 0.0 0 CFG=1
M  V30 3 O 7.8265 2.4919 0.0 0
M  V30 4 C 6.0161 0.0000 0.0 0
M  V30 5 Cl 3.8581 1.5679 0.0 0
M  V30 6 N 5.7283 8.0442 0.0 0 VAL=5
M  V30 7 O 7.1928 8.5202 0.0 0
M  V30 8 O 4.5837 9.0747 0.0 0
M  V30 9 C 3.0177 3.3494 0.0 0
M  V30 10 O 1.5530 3.8253 0.0 0
M  V30 11 O 3.3378 1.8431 0.0 0
M  V30 12 C 0.4086 2.7948 0.0 0
M  V30 13 C 6.4385 5.3935 0.0 0 CFG=1
M  V30 14 N 5.6685 4.0597 0.0 0
M  V30 15 C 5.4081 6.5379 0.0 0 CFG=2
M  V30 16 C 4.1621 4.3798 0.0 0 CFG=2
M  V30 17 C 4.0011 5.9115 0.0 0 CFG=1
M  V30 18 C 7.9701 5.5544 0.0 0
M  V30 19 C 8.5966 6.9612 0.0 0
M  V30 20 C 8.8753 4.3085 0.0 0
M  V30 21 C 10.1281 7.1223 0.0 0
M  V30 22 C 10.4069 4.4695 0.0 0
M  V30 23 C 11.0333 5.8763 0.0 0
M  V30 24 C 2.6675 6.6815 0.0 0
M  V30 25 C 2.6675 8.2216 0.0 0
M  V30 26 C 1.3338 5.9115 0.0 0
M  V30 27 C 1.3338 8.9916 0.0 0
M  V30 28 C 0.0000 6.6815 0.0 0
M  V30 29 C 0.0000 8.2216 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 15 6 CFG=1
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 16 9 CFG=3
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18 CFG=3
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 17 24 CFG=3
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 2 13 15 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R,6S,7R,8S,8aS)-Hexahydro-2,3-dimethyl-7-nitro-6,8-diphenylpyrrolo[1,2-a]py...
C21H21N3O4
2411622-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.6398 7.9110 0.0 0 VAL=5
M  V30 2 O 6.9735 8.6810 0.0 0
M  V30 3 O 4.3062 8.6810 0.0 0
M  V30 4 O 2.5598 2.6674 0.0 0
M  V30 5 O 8.7198 2.6674 0.0 0
M  V30 6 C 4.0998 0.0000 0.0 0
M  V30 7 C 7.1798 0.0000 0.0 0
M  V30 8 C 4.3940 5.4658 0.0 0 CFG=2
M  V30 9 C 4.8698 4.0011 0.0 0 CFG=1
M  V30 10 C 5.6398 6.3710 0.0 0 CFG=1
M  V30 11 N 6.4098 4.0011 0.0 0
M  V30 12 C 4.0998 2.6674 0.0 0
M  V30 13 C 6.8857 5.4658 0.0 0 CFG=2
M  V30 14 C 7.1798 2.6674 0.0 0
M  V30 15 N 4.8698 1.3338 0.0 0
M  V30 16 C 6.4098 1.3338 0.0 0 CFG=1
M  V30 17 C 2.9292 5.9417 0.0 0
M  V30 18 C 2.6091 7.4479 0.0 0
M  V30 19 C 1.7849 4.9112 0.0 0
M  V30 20 C 1.1445 7.9240 0.0 0
M  V30 21 C 0.3202 5.3871 0.0 0
M  V30 22 C 0.0000 6.8934 0.0 0
M  V30 23 C 8.3504 5.9417 0.0 0
M  V30 24 C 9.4948 4.9112 0.0 0
M  V30 25 C 8.6706 7.4479 0.0 0
M  V30 26 C 10.9595 5.3871 0.0 0
M  V30 27 C 10.1351 7.9240 0.0 0
M  V30 28 C 11.2796 6.8934 0.0 0
M  V30 29 H 3.3383 4.1620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 2 4 12
M  V30 5 2 5 14
M  V30 6 1 6 15
M  V30 7 1 16 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 17 CFG=3
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 29 CFG=1
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 23 CFG=3
M  V30 19 1 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 10 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2411622-30-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411622-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21957323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitroprolinates as Nucleophiles in Michael-type Additions and Acylations.
Synthesis of Enantiomerically Enriched Fused
Amino-pyrrolidino-[1,2-a]pyrazinones and -diketopiperazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia-Mingueens, Eduardo; Selva, Veronica; Larranaga, Olatz; Najera,
Carmen; Sansano, Jose M.; de Cozar, Abel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2020), 12(7), 2014-2021

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Pentanedione, 5-(o-chlorophenyl)-1-phenyl-
C17H15ClO2
24118-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 O 9.3360 0.0000 0.0 0
M  V30 8 Cl 1.3337 0.0000 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 17 C 12.0033 1.5400 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 19 C 13.3370 2.3101 0.0 0
M  V30 20 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 6 7
M  V30 8 1 6 15
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C18H18ClNO
2173253-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 O 9.3360 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 N 6.6685 0.7700 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 Cl 1.3337 0.7700 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 13.3370 3.0801 0.0 0
M  V30 14 C 12.0033 5.3901 0.0 0
M  V30 15 C 13.3370 4.6201 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 0.0000 3.0801 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 16
M  V30 10 1 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24118-66-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173253-94-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18703505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-Substituted Condensed Tetrahydropyridine-Based Enaminones
via Palladium-Catalyzed Intramolecular C-N Cross-coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dousova, Hana; Ruzickova, Zdenka; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2018), 55(3), 670-684

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
24279-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 Cl 6.0810 1.3627 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620176-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 Cl 6.0810 1.3627 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24279-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8402416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 12 Preparation of
2-methyl-3-(methylaminomethyl)indole c)
2-Chloro-1-methyl-2-(methylaminomethyl)-1H-indole [0793] According to the
procedure of Preparation 12, except substituting
2-chloro-1-methyl-1H-indole-3-carboxaldehyde (3.0 g, 15.5 mmole) for the
1-methylindole-3-carboxaldehyde, the title compound (2.91 g, 90%) was
prepared as an oil. 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J=7.9 Hz, 1H),
7.22 (m, 2H), 7.13 (m, 1H), 3.92 (s, 2H), 3.71 (s, 3H), 2.44 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
24279-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 Cl 6.0810 1.3627 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620176-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 Cl 6.0810 1.3627 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24279-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7223055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
24279-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 O 7.1954 4.2188 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 Cl 6.0810 1.3627 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5864 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 N 3.3405 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 C 4.7473 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620176-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 Cl 6.0810 1.3627 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24279-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620176-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9201958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME226 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-5-phenyl-2-thiophenecarboxaldehyde
C11H7BrOS
72899-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.0494 0.0000 0.0 0
M  V30 2 C 8.2358 4.3856 0.0 0
M  V30 3 O 9.6426 3.7593 0.0 0
M  V30 4 C 4.6200 2.7104 0.0 0
M  V30 5 C 5.5252 1.4645 0.0 0
M  V30 6 S 5.5252 3.9564 0.0 0
M  V30 7 C 6.9898 1.9404 0.0 0
M  V30 8 C 6.9898 3.4804 0.0 0
M  V30 9 C 3.0800 2.7104 0.0 0
M  V30 10 C 2.3100 4.0442 0.0 0
M  V30 11 C 2.3100 1.3768 0.0 0
M  V30 12 C 0.7700 4.0442 0.0 0
M  V30 13 C 0.7700 1.3768 0.0 0
M  V30 14 C 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 3
M  V30 3 1 2 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-bromo-5-phenyl-2-thienyl)methyl]-N-methylcarbamate
C17H20BrNO2S
1708976-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.7384 0.0000 0.0 0
M  V30 2 C 8.3659 4.0287 0.0 0
M  V30 3 N 9.6996 3.2587 0.0 0
M  V30 4 C 11.0333 4.0287 0.0 0
M  V30 5 C 9.6996 1.7187 0.0 0
M  V30 6 O 12.3669 3.2587 0.0 0
M  V30 7 O 11.0333 5.5688 0.0 0
M  V30 8 C 13.7008 4.0287 0.0 0
M  V30 9 C 12.9307 5.3624 0.0 0
M  V30 10 C 15.0344 4.7987 0.0 0
M  V30 11 C 14.4708 2.6951 0.0 0
M  V30 12 C 4.5948 2.7406 0.0 0
M  V30 13 S 5.6253 3.8850 0.0 0
M  V30 14 C 5.3649 1.4070 0.0 0
M  V30 15 C 7.0321 3.2587 0.0 0
M  V30 16 C 6.8712 1.7271 0.0 0
M  V30 17 C 3.0631 2.9016 0.0 0
M  V30 18 C 2.4368 4.3086 0.0 0
M  V30 19 C 2.1580 1.6557 0.0 0
M  V30 20 C 0.9052 4.4695 0.0 0
M  V30 21 C 0.6263 1.8166 0.0 0
M  V30 22 C 0.0000 3.2236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72899-38-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1708976-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8987468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic studies of five-membered heteroaromatic derivatives as
potassium-competitive acid blockers (P-CABs)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arikawa, Yasuyoshi; Hasuoka, Atsushi; Nishida, Haruyuki; Hirase, Keizo;
Inatomi, Nobuhiro; Takagi, Terufumi; Tarui, Naoki; Kawamoto, Makiko;
Imanishi, Akio; Itoh, Fumio; Kajino, Masahiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(10), 2037-2040

$RFMT $RIREG SCHEME227 STEP1
$RXN



  3  1
$MOL
4-Bromo-1-methyl-1H-pyrazole-3-methanol
C5H7BrN2O
915707-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7104 0.0 0
M  V30 2 O 5.9256 4.0442 0.0 0
M  V30 3 Br 3.1864 0.0000 0.0 0
M  V30 4 C 0.0000 4.3856 0.0 0
M  V30 5 C 3.6156 2.7104 0.0 0
M  V30 6 C 2.7104 1.4645 0.0 0
M  V30 7 N 2.7104 3.9564 0.0 0
M  V30 8 C 1.2459 1.9404 0.0 0
M  V30 9 N 1.2459 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-bromo-1-methyl-1H-pyrazol-3-yl)methyl]-N-methylcarbamate
C11H18BrN3O2
1619987-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7106 0.0 0
M  V30 2 N 5.9256 4.0442 0.0 0
M  V30 3 C 7.4656 4.0442 0.0 0
M  V30 4 C 5.1556 5.3780 0.0 0
M  V30 5 O 8.2356 5.3780 0.0 0
M  V30 6 O 8.2356 2.7106 0.0 0
M  V30 7 C 9.7756 5.3780 0.0 0
M  V30 8 C 9.7756 3.8380 0.0 0
M  V30 9 C 11.3156 5.3780 0.0 0
M  V30 10 C 9.7756 6.9180 0.0 0
M  V30 11 Br 3.1864 0.0000 0.0 0
M  V30 12 C 0.0000 4.3858 0.0 0
M  V30 13 C 3.6156 2.7106 0.0 0
M  V30 14 N 2.7104 3.9564 0.0 0
M  V30 15 C 2.7104 1.4647 0.0 0
M  V30 16 N 1.2459 3.4806 0.0 0
M  V30 17 C 1.2459 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 15
M  V30 12 1 12 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 915707-65-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1619987-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42535914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Macrocyclic Inhibitors of DYRK1A/B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Powell, Chelsea E.; Hatcher, John M.; Jiang, Jie; Vatsan, Prasanna S.;
Che, Jianwei; Gray, Nathanael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2022), 13(4), 577-585

$RFMT $RIREG SCHEME227 STEP1
$RXN



  3  1
$MOL
4-Bromo-1-methyl-1H-pyrazole-3-methanol
C5H7BrN2O
915707-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7104 0.0 0
M  V30 2 O 5.9256 4.0442 0.0 0
M  V30 3 Br 3.1864 0.0000 0.0 0
M  V30 4 C 0.0000 4.3856 0.0 0
M  V30 5 C 3.6156 2.7104 0.0 0
M  V30 6 C 2.7104 1.4645 0.0 0
M  V30 7 N 2.7104 3.9564 0.0 0
M  V30 8 C 1.2459 1.9404 0.0 0
M  V30 9 N 1.2459 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-bromo-1-methyl-1H-pyrazol-3-yl)methyl]-N-methylcarbamate
C11H18BrN3O2
1619987-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7106 0.0 0
M  V30 2 N 5.9256 4.0442 0.0 0
M  V30 3 C 7.4656 4.0442 0.0 0
M  V30 4 C 5.1556 5.3780 0.0 0
M  V30 5 O 8.2356 5.3780 0.0 0
M  V30 6 O 8.2356 2.7106 0.0 0
M  V30 7 C 9.7756 5.3780 0.0 0
M  V30 8 C 9.7756 3.8380 0.0 0
M  V30 9 C 11.3156 5.3780 0.0 0
M  V30 10 C 9.7756 6.9180 0.0 0
M  V30 11 Br 3.1864 0.0000 0.0 0
M  V30 12 C 0.0000 4.3858 0.0 0
M  V30 13 C 3.6156 2.7106 0.0 0
M  V30 14 N 2.7104 3.9564 0.0 0
M  V30 15 C 2.7104 1.4647 0.0 0
M  V30 16 N 1.2459 3.4806 0.0 0
M  V30 17 C 1.2459 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 15
M  V30 12 1 12 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 915707-65-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1619987-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22326607
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as inhibitors of ALK, TrkA, TrkB,
TrkC, and ROS1 for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Hatcher, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020069118 A1 2020-04-02

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[4-(2,6-dichlorophenoxy)-3-fluorophenyl]acetamide
C14H9Cl3FNO2
2442526-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 Cl 4.0010 4.6201 0.0 0
M  V30 4 F 6.6685 0.0000 0.0 0
M  V30 5 N 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 2.3101 0.0 0
M  V30 9 Cl 13.3370 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 6.6685 1.5400 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 8.0022 2.3101 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 21 C 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 1 3 12
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(2,6-Dichlorophenoxy)-3-fluorophenyl]-2-(methylamino)acetamide
C15H13Cl2FN2O2
2442526-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 1.5400 0.0 0
M  V30 2 F 6.6685 0.0000 0.0 0
M  V30 3 Cl 4.0010 4.6201 0.0 0
M  V30 4 Cl 1.3337 0.0000 0.0 0
M  V30 5 N 9.3358 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 2.3101 0.0 0
M  V30 9 N 13.3370 3.8501 0.0 0
M  V30 10 C 14.6707 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 8.0022 3.8501 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 12
M  V30 4 1 3 18
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2442526-28-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2442526-50-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22746484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrazole derivatives as caspase inhibitors for the
treatment of inflammatory, infectious and neoplastic diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Doemling, Alexander Stephan Siegfried; Spanu, Pietro; Ulgheri, Fausta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3666769 A1 2020-06-17

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(5-chloro-1,3-diphenyl-1H-pyrazol-4-yl)-2-cyano-2-propenoate
C21H16ClN3O2
254095-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 5.6397 0.0 0
M  V30 2 C 8.5785 6.9735 0.0 0
M  V30 3 C 10.1185 6.9735 0.0 0
M  V30 4 C 7.8085 8.3071 0.0 0
M  V30 5 O 10.8885 8.3071 0.0 0
M  V30 6 O 10.8885 5.6397 0.0 0
M  V30 7 N 7.0385 9.6408 0.0 0
M  V30 8 C 12.4285 8.3071 0.0 0
M  V30 9 C 13.1985 9.6408 0.0 0
M  V30 10 Cl 5.8391 8.3502 0.0 0
M  V30 11 C 5.3632 4.3938 0.0 0
M  V30 12 C 6.2684 5.6397 0.0 0
M  V30 13 N 3.8987 4.8697 0.0 0
M  V30 14 C 5.3632 6.8857 0.0 0
M  V30 15 N 3.8987 6.4097 0.0 0
M  V30 16 C 5.8391 2.9292 0.0 0
M  V30 17 C 7.3455 2.6091 0.0 0
M  V30 18 C 4.8087 1.7847 0.0 0
M  V30 19 C 7.8214 1.1444 0.0 0
M  V30 20 C 5.2845 0.3202 0.0 0
M  V30 21 C 6.7910 0.0000 0.0 0
M  V30 22 C 2.6528 7.3149 0.0 0
M  V30 23 C 1.2459 6.6886 0.0 0
M  V30 24 C 2.8137 8.8466 0.0 0
M  V30 25 C 0.0000 7.5938 0.0 0
M  V30 26 C 1.5679 9.7516 0.0 0
M  V30 27 C 0.1609 9.1253 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 3 4 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 10 14
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 15 22
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dihydro-7-methyl-6-oxo-1,3-diphenyl-1H-pyrazolo[3,4-b]pyridine-5-carbonit...
C20H14N4O
2289608-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2598 9.6648 0.0 0
M  V30 2 C 9.8799 6.9975 0.0 0
M  V30 3 N 11.4200 6.9975 0.0 0
M  V30 4 O 8.3399 9.6648 0.0 0
M  V30 5 C 6.0298 5.6636 0.0 0
M  V30 6 C 5.2598 6.9975 0.0 0
M  V30 7 C 4.9994 4.5192 0.0 0
M  V30 8 C 7.5699 5.6636 0.0 0
M  V30 9 N 3.7535 6.6771 0.0 0
M  V30 10 N 6.0298 8.3311 0.0 0
M  V30 11 N 3.5926 5.1456 0.0 0
M  V30 12 C 8.3399 6.9975 0.0 0
M  V30 13 C 7.5699 8.3311 0.0 0
M  V30 14 C 5.3196 3.0128 0.0 0
M  V30 15 C 4.1752 1.9823 0.0 0
M  V30 16 C 6.7843 2.5369 0.0 0
M  V30 17 C 4.4954 0.4760 0.0 0
M  V30 18 C 7.1045 1.0306 0.0 0
M  V30 19 C 5.9601 0.0000 0.0 0
M  V30 20 C 2.6091 7.7077 0.0 0
M  V30 21 C 1.1444 7.2318 0.0 0
M  V30 22 C 2.9293 9.2140 0.0 0
M  V30 23 C 0.0000 8.2623 0.0 0
M  V30 24 C 1.7847 10.2446 0.0 0
M  V30 25 C 0.3202 9.7686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 3 2 3
M  V30 3 1 2 12
M  V30 4 2 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 14
M  V30 12 2 8 12
M  V30 13 1 9 11
M  V30 14 1 9 20
M  V30 15 1 10 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254095-99-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2289608-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19709086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,8-diazabicyclo[5.4.0]undec-7-ene catalyzed synthesis of some new
7-alkyl-6-oxo-1H-pyrazolo[3,4-b]pyridine-5-carbonitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dorostkar-Ahmadi, Nadieh; Davoodnia, Abolghasem; Tavakoli-Hoseini,
Niloofar; Behmadi, Hossein
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Heterocyclic Chemistry (2018), 28(4), 543-549

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Formic acid, compd. with methanamine (1:1)
CH5N.CH2O2
25596-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.5637 2.3100 0.0 0
M  V30 2 N 2.1037 2.3100 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 0.7700 0.0 0
M  V30 5 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 4
M  V30 3 2 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2,3-dichlorophenyl)-1,3,4,7-tetrahydro-6-hydroxy-3-oxo-5-isobenzofu...
C16H12Cl2O5
840500-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 1.3336 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 C 1.3336 0.0000 0.0 0
M  V30 5 O 6.6519 6.8702 0.0 0
M  V30 6 Cl 6.6684 6.1600 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 Cl 9.3358 4.6200 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 4.0011 6.1600 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 C 5.1454 7.1904 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 1.3336 6.1600 0.0 0
M  V30 16 C 2.9876 8.4363 0.0 0
M  V30 17 O 4.5191 8.5972 0.0 0
M  V30 18 C 5.3347 3.8500 0.0 0
M  V30 19 C 6.6684 4.6200 0.0 0
M  V30 20 C 5.3347 2.3100 0.0 0
M  V30 21 C 8.0021 3.8500 0.0 0
M  V30 22 C 6.6684 1.5400 0.0 0
M  V30 23 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 5 13
M  V30 6 1 6 19
M  V30 7 1 7 14
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2,3-dichlorophenyl)-1,3,4,7-tetrahydro-6-(methylamino)-3-oxo-5-isob...
C17H15Cl2NO4
840500-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 2.3100 0.0 0
M  V30 2 O 8.0022 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 8.0022 0.0000 0.0 0
M  V30 5 O 2.6839 6.8703 0.0 0
M  V30 6 N 9.3359 3.8500 0.0 0
M  V30 7 C 10.6695 4.6201 0.0 0
M  V30 8 Cl 2.6673 6.1601 0.0 0
M  V30 9 Cl 0.0000 4.6201 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 6.6684 6.9301 0.0 0
M  V30 14 C 4.1904 7.1905 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 6.1601 0.0 0
M  V30 17 C 6.3483 8.4364 0.0 0
M  V30 18 O 4.8167 8.5973 0.0 0
M  V30 19 C 4.0011 3.8500 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 1.3337 3.8500 0.0 0
M  V30 23 C 2.6673 1.5400 0.0 0
M  V30 24 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 14
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 20
M  V30 9 1 9 22
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 19
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 25596-28-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 840500-09-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 840500-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-12199919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IKCa-channel blockers. Part 2: Discovery of cyclohexadienes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Urbahns, Klaus; Goldmann, Siegfried; Krueger, Jochen; Horvath, Ervin;
Schuhmacher, Joachim; Grosser, Rolf; Hinz, Volker; Mauler, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(2), 401-404

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Formic acid, compd. with methanamine (1:1)
CH5N.CH2O2
25596-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.5637 2.3100 0.0 0
M  V30 2 N 2.1037 2.3100 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 0.7700 0.0 0
M  V30 5 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 3 4
M  V30 3 2 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[4-chloro-3-(trifluoromethyl)phenyl]-1,3,4,7-tetrahydro-6-hydroxy-3-...
C17H12ClF3O5
840500-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4701 5.1455 0.0 0
M  V30 2 O 10.0101 5.1455 0.0 0
M  V30 3 O 7.7001 6.4791 0.0 0
M  V30 4 C 10.7801 6.4791 0.0 0
M  V30 5 O 2.7392 3.1883 0.0 0
M  V30 6 O 10.0101 2.4780 0.0 0
M  V30 7 C 1.5400 6.4791 0.0 0
M  V30 8 F 1.5400 8.0191 0.0 0
M  V30 9 F 0.0000 6.4791 0.0 0
M  V30 10 F 1.5400 4.9391 0.0 0
M  V30 11 Cl 3.0800 9.1464 0.0 0
M  V30 12 C 6.1600 3.8117 0.0 0
M  V30 13 C 5.3900 2.4780 0.0 0
M  V30 14 C 7.7001 3.8117 0.0 0
M  V30 15 C 6.1600 1.1444 0.0 0
M  V30 16 C 3.8838 2.1579 0.0 0
M  V30 17 C 8.4701 2.4780 0.0 0
M  V30 18 C 7.7001 1.1444 0.0 0
M  V30 19 C 5.1296 0.0000 0.0 0
M  V30 20 O 3.7227 0.6263 0.0 0
M  V30 21 C 5.3900 5.1455 0.0 0
M  V30 22 C 3.8500 5.1455 0.0 0
M  V30 23 C 6.1600 6.4791 0.0 0
M  V30 24 C 3.0800 6.4791 0.0 0
M  V30 25 C 5.3900 7.8128 0.0 0
M  V30 26 C 3.8500 7.8128 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 24
M  V30 11 1 11 26
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,3,4,7-tetrahydro-6-(methylamino)-4-(3-nitrophenyl)-3-oxo-5-isobenzof...
C17H16N2O6
840500-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 7.9857 6.8704 0.0 0
M  V30 6 N 1.3337 3.8501 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 N 10.6697 4.6201 0.0 0 VAL=5
M  V30 9 O 12.0033 3.8501 0.0 0
M  V30 10 O 10.6697 6.1601 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 4.0012 6.9302 0.0 0
M  V30 15 C 6.4792 7.1906 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 6.1601 0.0 0
M  V30 18 C 4.3213 8.4365 0.0 0
M  V30 19 O 5.8529 8.5974 0.0 0
M  V30 20 C 6.6685 3.8501 0.0 0
M  V30 21 C 8.0022 4.6201 0.0 0
M  V30 22 C 6.6685 2.3101 0.0 0
M  V30 23 C 9.3360 3.8501 0.0 0
M  V30 24 C 8.0022 1.5400 0.0 0
M  V30 25 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 5 15
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 25596-28-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 840500-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 840500-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-113-CAS-934829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IKCa-channel blockers. Part 2: Discovery of cyclohexadienes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Urbahns, Klaus; Goldmann, Siegfried; Krueger, Jochen; Horvath, Ervin;
Schuhmacher, Joachim; Grosser, Rolf; Hinz, Volker; Mauler, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(2), 401-404

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl 3-[[(5-bromo-2,3-dihydro-7-benzofuranyl)sulfonyl]amino]-5-(1-cyanocycl...
C26H21BrN2O6S
2596364-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6865 1.5400 0.0 0
M  V30 2 N 12.2265 1.5400 0.0 0
M  V30 3 N 6.4791 6.1600 0.0 0
M  V30 4 S 5.1454 5.3900 0.0 0 VAL=6
M  V30 5 O 5.9154 4.0564 0.0 0
M  V30 6 O 4.3754 6.7236 0.0 0
M  V30 7 C 11.8138 6.1600 0.0 0
M  V30 8 O 13.1474 5.3900 0.0 0
M  V30 9 O 11.8138 7.7000 0.0 0
M  V30 10 O 9.1465 7.7000 0.0 0
M  V30 11 Br 2.4780 0.7700 0.0 0
M  V30 12 C 9.1465 1.5400 0.0 0
M  V30 13 C 9.1465 0.0000 0.0 0
M  V30 14 C 7.6065 1.5400 0.0 0
M  V30 15 C 7.6065 0.0000 0.0 0
M  V30 16 C 9.1465 3.0800 0.0 0
M  V30 17 C 7.8127 3.8500 0.0 0
M  V30 18 C 10.4802 3.8500 0.0 0
M  V30 19 C 7.8127 5.3900 0.0 0
M  V30 20 C 10.4802 5.3900 0.0 0
M  V30 21 C 9.1465 6.1600 0.0 0
M  V30 22 C 3.8118 4.6200 0.0 0
M  V30 23 C 2.4780 5.3900 0.0 0
M  V30 24 C 3.8118 3.0800 0.0 0
M  V30 25 C 1.1444 4.6200 0.0 0
M  V30 26 O 2.1578 6.8963 0.0 0
M  V30 27 C 2.4780 2.3100 0.0 0
M  V30 28 C 1.1444 3.0800 0.0 0
M  V30 29 C 0.0000 5.6504 0.0 0
M  V30 30 C 0.6263 7.0574 0.0 0
M  V30 31 C 14.4812 6.1600 0.0 0
M  V30 32 C 14.4812 7.7000 0.0 0
M  V30 33 C 15.8149 5.3900 0.0 0
M  V30 34 C 15.8149 8.4700 0.0 0
M  V30 35 C 17.1485 6.1600 0.0 0
M  V30 36 C 17.1485 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 8 31
M  V30 12 1 10 21
M  V30 13 1 11 27
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 2 24 27
M  V30 30 2 25 28
M  V30 31 1 25 29
M  V30 32 1 26 30
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(5-Bromo-2,3-dihydro-7-benzofuranyl)sulfonyl]amino]-5-(1-cyanocyclobutyl)...
C21H20BrN3O5S
2596362-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6865 1.5400 0.0 0
M  V30 2 N 12.2265 1.5400 0.0 0
M  V30 3 N 6.4791 6.1600 0.0 0
M  V30 4 S 5.1454 5.3900 0.0 0 VAL=6
M  V30 5 O 4.3754 6.7236 0.0 0
M  V30 6 O 5.9154 4.0564 0.0 0
M  V30 7 C 11.8138 6.1600 0.0 0
M  V30 8 N 13.1476 5.3900 0.0 0
M  V30 9 O 11.8138 7.7000 0.0 0
M  V30 10 C 14.4812 6.1600 0.0 0
M  V30 11 O 9.1465 7.7000 0.0 0
M  V30 12 Br 2.4782 0.7700 0.0 0
M  V30 13 C 9.1465 1.5400 0.0 0
M  V30 14 C 7.6065 1.5400 0.0 0
M  V30 15 C 9.1465 0.0000 0.0 0
M  V30 16 C 7.6065 0.0000 0.0 0
M  V30 17 C 9.1465 3.0800 0.0 0
M  V30 18 C 7.8129 3.8500 0.0 0
M  V30 19 C 10.4802 3.8500 0.0 0
M  V30 20 C 7.8129 5.3900 0.0 0
M  V30 21 C 10.4802 5.3900 0.0 0
M  V30 22 C 9.1465 6.1600 0.0 0
M  V30 23 C 3.8118 4.6200 0.0 0
M  V30 24 C 2.4782 5.3900 0.0 0
M  V30 25 C 3.8118 3.0800 0.0 0
M  V30 26 C 1.1444 4.6200 0.0 0
M  V30 27 O 2.1580 6.8963 0.0 0
M  V30 28 C 2.4782 2.3100 0.0 0
M  V30 29 C 1.1444 3.0800 0.0 0
M  V30 30 C 0.0000 5.6504 0.0 0
M  V30 31 C 0.6263 7.0574 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 23
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 8 10
M  V30 12 1 11 22
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 2 25 28
M  V30 30 2 26 29
M  V30 31 1 26 30
M  V30 32 1 27 31
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2596364-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2596362-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23488217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted N-phenyl sulfonamides as WDR5-MYC inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tansey, William P.; Fesik, Stephen W.; Stauffer, Shaun R.; Waterson, Alex
G.; Han, Changho; Alvarado, Joseph R.; Macdonald, Jonathan D.; Chacon
Simon, Selena; Nikhar, Sameer S.; Kuznetsov, Alexey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021021951 A1 2021-02-04

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Imidazole, 2-methoxy-4,4-dimethyl-5-phenyl-, 3-oxide
C12H14N2O2
259672-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6221 1.7271 0.0 0
M  V30 2 C 4.0012 0.1954 0.0 0
M  V30 3 O 7.9701 2.9016 0.0 0
M  V30 4 C 8.5965 4.3086 0.0 0
M  V30 5 O 6.2949 0.0000 0.0 0
M  V30 6 C 4.0012 3.2587 0.0 0
M  V30 7 N 5.4080 3.8850 0.0 0
M  V30 8 C 4.1621 1.7271 0.0 0
M  V30 9 C 6.4384 2.7406 0.0 0
M  V30 10 N 5.6684 1.4070 0.0 0 VAL=5
M  V30 11 C 2.6673 4.0287 0.0 0
M  V30 12 C 1.3337 3.2587 0.0 0
M  V30 13 C 2.6673 5.5688 0.0 0
M  V30 14 C 0.0000 4.0287 0.0 0
M  V30 15 C 1.3337 6.3388 0.0 0
M  V30 16 C 0.0000 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 2 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Imidazol-2-amine, N,4,4-trimethyl-5-phenyl-, 3-oxide
C12H15N3O
343247-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6221 1.7271 0.0 0
M  V30 2 C 4.0012 0.1954 0.0 0
M  V30 3 N 7.9701 2.9016 0.0 0
M  V30 4 C 8.5965 4.3086 0.0 0
M  V30 5 O 6.2949 0.0000 0.0 0
M  V30 6 C 4.0012 3.2587 0.0 0
M  V30 7 N 5.4080 3.8850 0.0 0
M  V30 8 C 4.1621 1.7271 0.0 0
M  V30 9 C 6.4384 2.7406 0.0 0
M  V30 10 N 5.6684 1.4070 0.0 0 VAL=5
M  V30 11 C 2.6673 4.0287 0.0 0
M  V30 12 C 2.6673 5.5688 0.0 0
M  V30 13 C 1.3337 3.2587 0.0 0
M  V30 14 C 1.3337 6.3388 0.0 0
M  V30 15 C 0.0000 4.0287 0.0 0
M  V30 16 C 0.0000 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 2 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 259672-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 343247-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10559040
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of amino nitrones 5a,b-7a,b. A
saturated solution of amine in MeOH (10 mL) was added to a solution of
α-methoxy nitrones 1-3 (2 mmol) in MeOH (2 mL). After the starting
compound was consumed (TLC control), the solvent was evaporated in vacuo.
2-Methylamino-4,4-dimethyl-5-phenyl-4H-imidazole 3-oxide (6a) was
isolated by chromatography on SiO2 with the use of the 10 : 1 CHCl3-MeOH
mixture as the eluent and recrystallized from hexane. M.p.: 175-179°C,
Molecular formula: C12H15N3O•0.5 H2O, IR spectrum (in KBr), v/cm-1: 1670
(N-C=N), UV spectrum (ETOH), λmax/nm (log ε): 245 (3.82); 273 (3.92); 409
(3.34). 1H NMR, CDCl3, δ (J/Hz): 1.64 (s, 6 H, gem-Me); 3.19 (c, 3 H,
NH-Me); 7.48, 7.97 (both m, 3 H and 2 H, N=C-Ph), 13C NMR, CDCl3, δ
(J/Hz): 21.91 (gem-Me); 25.79 (N-Me); 75.07 (CMe2); 150.81 (N-C=N);
182.08 (Ph-C=N); Ph: 129.98 (C i ); 127.68 (C o ); 128.86 (C m ); 132.24
(C p ).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of cyclic α-methoxy nitrones with nucleophilic reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grigor'ev, I. A.; Bakunova, S. M.; Kirilyuk, I. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya
Khimicheskaya) (2000), 49(12), 2031-2036

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Methoxy-3,5-dinitrophenyl)-6,8-dinitro[1,2,4]triazolo[1,5-a]pyridine
C13H7N7O9
2599854-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6336 7.0811 0.0 0 VAL=5
M  V30 2 O 11.9672 7.8511 0.0 0
M  V30 3 O 9.3000 7.8511 0.0 0
M  V30 4 N 13.3009 2.4611 0.0 0 VAL=5
M  V30 5 O 13.3009 0.9211 0.0 0
M  V30 6 O 14.6347 3.2311 0.0 0
M  V30 7 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 8 O 0.7700 1.3336 0.0 0
M  V30 9 O 3.0800 0.0000 0.0 0
M  V30 10 N 2.3100 6.6685 0.0 0 VAL=5
M  V30 11 O 3.0800 8.0022 0.0 0
M  V30 12 O 0.7700 6.6685 0.0 0
M  V30 13 O 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 15 C 9.3000 4.7711 0.0 0
M  V30 16 N 9.3000 3.2311 0.0 0
M  V30 17 C 10.6336 5.5411 0.0 0
M  V30 18 N 7.8353 5.2470 0.0 0
M  V30 19 N 7.8353 2.7552 0.0 0
M  V30 20 C 10.6336 2.4611 0.0 0
M  V30 21 C 11.9672 4.7711 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 C 11.9672 3.2311 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 4.6200 2.6674 0.0 0
M  V30 26 C 4.6200 5.3347 0.0 0
M  V30 27 C 3.0800 2.6674 0.0 0
M  V30 28 C 3.0800 5.3347 0.0 0
M  V30 29 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 27
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 28
M  V30 13 1 13 14
M  V30 14 1 13 29
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 19 22
M  V30 23 2 20 23
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(6,8-Dinitro[1,2,4]triazolo[1,5-a]pyridin-2-yl)-N-methyl-2,6-dinitrobenzena...
C13H8N8O8
2599854-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6336 7.0811 0.0 0 VAL=5
M  V30 2 O 11.9672 7.8511 0.0 0
M  V30 3 O 9.3000 7.8511 0.0 0
M  V30 4 N 13.3009 2.4611 0.0 0 VAL=5
M  V30 5 O 14.6347 3.2311 0.0 0
M  V30 6 O 13.3009 0.9211 0.0 0
M  V30 7 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 8 O 0.7700 1.3336 0.0 0
M  V30 9 O 3.0800 0.0000 0.0 0
M  V30 10 N 2.3100 6.6685 0.0 0 VAL=5
M  V30 11 O 3.0800 8.0022 0.0 0
M  V30 12 O 0.7700 6.6685 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 15 C 9.3000 4.7711 0.0 0
M  V30 16 N 9.3000 3.2311 0.0 0
M  V30 17 C 10.6336 5.5411 0.0 0
M  V30 18 N 7.8353 5.2470 0.0 0
M  V30 19 N 7.8353 2.7552 0.0 0
M  V30 20 C 10.6336 2.4611 0.0 0
M  V30 21 C 11.9672 4.7711 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 C 11.9672 3.2311 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 4.6200 2.6674 0.0 0
M  V30 26 C 4.6200 5.3347 0.0 0
M  V30 27 C 3.0800 2.6674 0.0 0
M  V30 28 C 3.0800 5.3347 0.0 0
M  V30 29 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 23
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 27
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 28
M  V30 13 1 13 14
M  V30 14 1 13 29
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 19 22
M  V30 23 2 20 23
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2599854-09-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2599854-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23143886
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new 2-substituted 6,8-dinitro[1,2,4]triazolo[1,5-a]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bastrakov, Maxim A.; Starosotnikov, Alexey M.; Fedyanin, Ivan V.;
Dalinger, Igor L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2021),
57(1), 95-98

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-nitro-N′-[(tetrahydro-3-furanyl)methyl]carbamimidate
C7H13N3O4
262609-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 N 5.1048 3.0801 0.0 0
M  V30 3 C 6.4384 2.3101 0.0 0
M  V30 4 N 7.7722 3.0801 0.0 0
M  V30 5 O 6.4384 0.7700 0.0 0
M  V30 6 N 9.1059 2.3101 0.0 0 VAL=5
M  V30 7 C 5.1048 0.0000 0.0 0
M  V30 8 O 9.1059 0.7700 0.0 0
M  V30 9 O 10.4396 3.0801 0.0 0
M  V30 10 C 2.4374 3.0801 0.0 0
M  V30 11 C 1.0304 2.4536 0.0 0
M  V30 12 C 2.2763 4.6116 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 14 O 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dinotefuran
C7H14N4O3
165252-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 N 5.1048 3.0801 0.0 0
M  V30 3 C 6.4384 2.3101 0.0 0
M  V30 4 N 7.7722 3.0801 0.0 0
M  V30 5 N 6.4384 0.7700 0.0 0
M  V30 6 N 9.1059 2.3101 0.0 0 VAL=5
M  V30 7 C 5.1048 0.0000 0.0 0
M  V30 8 O 9.1059 0.7700 0.0 0
M  V30 9 O 10.4396 3.0801 0.0 0
M  V30 10 C 2.4374 3.0801 0.0 0
M  V30 11 C 2.2763 4.6116 0.0 0
M  V30 12 C 1.0304 2.4536 0.0 0
M  V30 13 C 0.7700 4.9318 0.0 0
M  V30 14 O 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 262609-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 165252-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18412330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel and practical method for the synthesis of dinotefuran through
Michael addition of nitromethane to diethyl maleate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Haifeng; Wang, Lailai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2018), 74(2), 336-340

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5,6,7,9-tetrahydro-7-iodo-8H-pyrido[2,3-b]azepin-8-one
C9H8BrIN2O
2651965-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.2480 0.0000 0.0 0
M  V30 2 Br 8.9149 4.1316 0.0 0
M  V30 3 I 0.0000 2.5916 0.0 0
M  V30 4 C 4.9138 1.8215 0.0 0
M  V30 5 C 4.9138 3.3616 0.0 0
M  V30 6 N 3.7098 0.8613 0.0 0
M  V30 7 N 6.2474 1.0515 0.0 0
M  V30 8 C 6.2474 4.1316 0.0 0
M  V30 9 C 3.7098 4.3216 0.0 0
M  V30 10 C 2.2082 1.2040 0.0 0
M  V30 11 C 7.5811 1.8215 0.0 0
M  V30 12 C 7.5811 3.3616 0.0 0
M  V30 13 C 2.2082 3.9790 0.0 0
M  V30 14 C 1.5400 2.5916 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 12
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5,6,7,9-tetrahydro-7-(methylamino)-8H-pyrido[2,3-b]azepin-8-one
C10H12BrN3O
2887449-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.0181 0.0000 0.0 0
M  V30 2 Br 9.6849 4.1316 0.0 0
M  V30 3 N 0.7700 2.5916 0.0 0
M  V30 4 C 0.0000 3.9252 0.0 0
M  V30 5 C 5.6838 1.8215 0.0 0
M  V30 6 C 5.6838 3.3616 0.0 0
M  V30 7 N 4.4798 0.8613 0.0 0
M  V30 8 N 7.0174 1.0515 0.0 0
M  V30 9 C 7.0174 4.1316 0.0 0
M  V30 10 C 4.4798 4.3216 0.0 0
M  V30 11 C 2.9783 1.2040 0.0 0
M  V30 12 C 8.3511 1.8215 0.0 0
M  V30 13 C 8.3511 3.3616 0.0 0
M  V30 14 C 2.9783 3.9790 0.0 0
M  V30 15 C 2.3100 2.5916 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2651965-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2887449-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35399048
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 8-Oxo-5,6,7,9-tetrahydropyrido[2,3-b]azepine-propenamide derivatives as
antibacterial agents and their preparation, pharmaceutical compositions
and use in the treatment of bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gerusz, Vincent; Finn, Terry; Pauls, Heinz; Berman, Judd; Bravo, Juan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022268890 A1 2022-12-29

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
(1R,2S)-2-(Benzoylamino)cyclohexanecarboxylic acid
C14H17NO3
26693-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 C 3.0800 1.3338 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 8 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 8 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-2-[(Methylamino)carbonyl]cyclohexyl]benzamide
C15H20N2O2
1352917-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 4.0011 0.0 0
M  V30 2 N 9.2401 4.0011 0.0 0
M  V30 3 O 6.9301 5.3348 0.0 0
M  V30 4 C 10.0101 5.3348 0.0 0
M  V30 5 N 4.6201 4.0011 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 O 2.3100 2.6675 0.0 0
M  V30 8 C 6.9301 2.6675 0.0 0 CFG=2
M  V30 9 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 10 C 7.7001 1.3337 0.0 0
M  V30 11 C 4.6201 1.3337 0.0 0
M  V30 12 C 6.9301 0.0000 0.0 0
M  V30 13 C 5.3901 0.0000 0.0 0
M  V30 14 C 2.3100 5.3348 0.0 0
M  V30 15 C 3.0800 6.6686 0.0 0
M  V30 16 C 0.7700 5.3348 0.0 0
M  V30 17 C 2.3100 8.0022 0.0 0
M  V30 18 C 0.0000 6.6686 0.0 0
M  V30 19 C 0.7700 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 9 5 CFG=3
M  V30 7 2 6 7
M  V30 8 1 6 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 26693-55-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352917-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10847763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chiral 1,3-diamines derived from
cis-2-benzamidocyclohexanecarboxylic acid and their application in the
Cu-catalyzed enantioselective Henry reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kodama, Koichi; Sugawara, Kazuyuki; Hirose, Takuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2011), 17(48), 13584-13592,
S13584/1-S13584/28

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-[3-methoxy-4-(5-oxazolyl)phenyl]-6-phenyl-1,3,5-triazin-2-amine
C19H14ClN5O2
267646-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.3336 0.0 0
M  V30 2 C 4.6798 0.0000 0.0 0
M  V30 3 N 8.5298 4.0011 0.0 0
M  V30 4 Cl 8.5298 9.3358 0.0 0
M  V30 5 C 3.9098 4.0011 0.0 0
M  V30 6 C 4.6798 2.6674 0.0 0
M  V30 7 C 4.6798 5.3347 0.0 0
M  V30 8 C 6.2198 2.6674 0.0 0
M  V30 9 C 6.2198 5.3347 0.0 0
M  V30 10 C 6.9898 4.0011 0.0 0
M  V30 11 C 2.3698 4.0011 0.0 0
M  V30 12 C 1.4645 2.7552 0.0 0
M  V30 13 O 1.4645 5.2469 0.0 0
M  V30 14 N 0.0000 3.2311 0.0 0
M  V30 15 C 0.0000 4.7711 0.0 0
M  V30 16 C 9.2998 5.3347 0.0 0
M  V30 17 N 10.8398 5.3347 0.0 0
M  V30 18 N 8.5298 6.6684 0.0 0
M  V30 19 C 11.6098 6.6684 0.0 0
M  V30 20 C 9.2998 8.0022 0.0 0
M  V30 21 N 10.8398 8.0022 0.0 0
M  V30 22 C 13.1498 6.6684 0.0 0
M  V30 23 C 13.9198 5.3347 0.0 0
M  V30 24 C 13.9198 8.0022 0.0 0
M  V30 25 C 15.4598 5.3347 0.0 0
M  V30 26 C 15.4598 8.0022 0.0 0
M  V30 27 C 16.2298 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 10
M  V30 4 1 3 16
M  V30 5 1 4 20
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[3-Methoxy-4-(5-oxazolyl)phenyl]-N4-methyl-6-phenyl-1,3,5-triazine-2,4-dia...
C20H18N6O2
267646-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5298 6.6684 0.0 0
M  V30 2 N 8.5298 1.3336 0.0 0
M  V30 3 C 9.2998 0.0000 0.0 0
M  V30 4 O 3.9098 9.3358 0.0 0
M  V30 5 C 4.6798 10.6694 0.0 0
M  V30 6 C 11.6098 4.0011 0.0 0
M  V30 7 N 10.8398 5.3347 0.0 0
M  V30 8 N 10.8398 2.6673 0.0 0
M  V30 9 C 9.2998 5.3347 0.0 0
M  V30 10 C 9.2998 2.6673 0.0 0
M  V30 11 N 8.5298 4.0011 0.0 0
M  V30 12 C 13.1498 4.0011 0.0 0
M  V30 13 C 13.9198 5.3347 0.0 0
M  V30 14 C 13.9198 2.6673 0.0 0
M  V30 15 C 15.4598 5.3347 0.0 0
M  V30 16 C 15.4598 2.6673 0.0 0
M  V30 17 C 16.2298 4.0011 0.0 0
M  V30 18 C 6.9898 6.6684 0.0 0
M  V30 19 C 6.2198 8.0021 0.0 0
M  V30 20 C 6.2198 5.3347 0.0 0
M  V30 21 C 4.6798 8.0021 0.0 0
M  V30 22 C 4.6798 5.3347 0.0 0
M  V30 23 C 3.9098 6.6684 0.0 0
M  V30 24 C 2.3698 6.6684 0.0 0
M  V30 25 C 1.4645 5.4225 0.0 0
M  V30 26 O 1.4645 7.9142 0.0 0
M  V30 27 N 0.0000 5.8984 0.0 0
M  V30 28 C 0.0000 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 267646-06-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 267646-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13181530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid synthesis of triazine inhibitors of inosine monophosphate
dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pitts, William J.; Guo, Junqing; Dhar, T. G. Murali; Shen, Zhongqi; Gu,
Henry H.; Watterson, Scott H.; Bednarz, Mark S.; Chen, Bang-Chi; Barrish,
Joel C.; Bassolino, Donna; Cheney, Daniel; Fleener, Catherine A.;
Rouleau, Katherine A.; Hollenbaugh, Diane L.; Iwanowicz, Edwin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(16), 2137-2140

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-[3-methoxy-4-(5-oxazolyl)phenyl]-N4-methyl-1,3,5-triazine-2,4-dia...
C14H13ClN6O2
267648-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4374 1.5400 0.0 0
M  V30 2 C 2.4374 0.0000 0.0 0
M  V30 3 N 7.7722 1.5400 0.0 0
M  V30 4 N 13.1070 1.5400 0.0 0
M  V30 5 C 14.4408 2.3100 0.0 0
M  V30 6 Cl 10.4397 6.1601 0.0 0
M  V30 7 C 3.7711 3.8501 0.0 0
M  V30 8 C 3.7711 2.3100 0.0 0
M  V30 9 C 5.1049 4.6201 0.0 0
M  V30 10 C 5.1049 1.5400 0.0 0
M  V30 11 C 6.4385 3.8501 0.0 0
M  V30 12 C 6.4385 2.3100 0.0 0
M  V30 13 C 2.4374 4.6201 0.0 0
M  V30 14 C 1.0306 3.9936 0.0 0
M  V30 15 O 2.2765 6.1516 0.0 0
M  V30 16 N 0.0000 5.1381 0.0 0
M  V30 17 C 0.7700 6.4718 0.0 0
M  V30 18 C 9.1060 2.3100 0.0 0
M  V30 19 N 10.4397 1.5400 0.0 0
M  V30 20 N 9.1060 3.8501 0.0 0
M  V30 21 C 11.7733 2.3100 0.0 0
M  V30 22 C 10.4397 4.6201 0.0 0
M  V30 23 N 11.7733 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 12
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 22
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 13
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[3-Methoxy-4-(5-oxazolyl)phenyl]-N4,N6-dimethyl-1,3,5-triazine-2,4,6-triamine
C15H17N7O2
478946-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4374 1.5400 0.0 0
M  V30 2 C 2.4374 0.0000 0.0 0
M  V30 3 N 7.7722 1.5400 0.0 0
M  V30 4 N 13.1071 1.5400 0.0 0
M  V30 5 C 14.4409 2.3101 0.0 0
M  V30 6 N 10.4397 6.1601 0.0 0
M  V30 7 C 11.7734 6.9302 0.0 0
M  V30 8 C 3.7711 3.8501 0.0 0
M  V30 9 C 3.7711 2.3101 0.0 0
M  V30 10 C 5.1049 4.6201 0.0 0
M  V30 11 C 5.1049 1.5400 0.0 0
M  V30 12 C 6.4386 3.8501 0.0 0
M  V30 13 C 6.4386 2.3101 0.0 0
M  V30 14 C 2.4374 4.6201 0.0 0
M  V30 15 C 1.0306 3.9938 0.0 0
M  V30 16 O 2.2765 6.1517 0.0 0
M  V30 17 N 0.0000 5.1382 0.0 0
M  V30 18 C 0.7700 6.4718 0.0 0
M  V30 19 C 9.1061 2.3101 0.0 0
M  V30 20 N 10.4397 1.5400 0.0 0
M  V30 21 N 9.1061 3.8501 0.0 0
M  V30 22 C 11.7734 2.3101 0.0 0
M  V30 23 C 10.4397 4.6201 0.0 0
M  V30 24 N 11.7734 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 13
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 14
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 267648-09-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478946-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15461970
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid synthesis of triazine inhibitors of inosine monophosphate
dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pitts, William J.; Guo, Junqing; Dhar, T. G. Murali; Shen, Zhongqi; Gu,
Henry H.; Watterson, Scott H.; Bednarz, Mark S.; Chen, Bang-Chi; Barrish,
Joel C.; Bassolino, Donna; Cheney, Daniel; Fleener, Catherine A.;
Rouleau, Katherine A.; Hollenbaugh, Diane L.; Iwanowicz, Edwin J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(16), 2137-2140

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(3-Furanylmethyl)-N-methyl-N-phenyl-2-propylpyrazolo[1,5-a]-1,3,5-triazin-4...
C20H21N5O
2712477-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 8.0022 0.0 0
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 10.3508 4.6245 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 N 6.9300 6.6684 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 C 5.3900 6.6684 0.0 0
M  V30 10 N 7.9604 7.8129 0.0 0
M  V30 11 C 9.2064 5.6549 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 N 4.6200 5.3347 0.0 0
M  V30 14 C 9.3674 7.1864 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 3.0800 8.0022 0.0 0
M  V30 17 C 2.3100 6.6684 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 0.7700 6.6684 0.0 0
M  V30 20 C 0.7700 9.3358 0.0 0
M  V30 21 C 0.0000 8.0022 0.0 0
M  V30 22 C 11.8155 5.1003 0.0 0
M  V30 23 C 12.2914 6.5650 0.0 0
M  V30 24 C 13.0614 4.1951 0.0 0
M  V30 25 C 13.8314 6.5650 0.0 0
M  V30 26 O 14.3072 5.1003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 16
M  V30 4 1 3 11
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 1 4 15
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 13 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(3-Furanylmethyl)-N-methyl-2-propylpyrazolo[1,5-a]-1,3,5-triazin-4-amine
C14H17N5O
1209347-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9846 6.5606 0.0 0
M  V30 2 N 7.2589 0.7700 0.0 0
M  V30 3 C 8.5925 0.0000 0.0 0
M  V30 4 C 9.9262 5.3901 0.0 0
M  V30 5 C 11.2598 4.6200 0.0 0
M  V30 6 C 12.5936 5.3901 0.0 0
M  V30 7 C 5.9251 4.6200 0.0 0
M  V30 8 N 5.9251 3.0800 0.0 0
M  V30 9 C 4.4605 5.0961 0.0 0
M  V30 10 N 7.2589 5.3901 0.0 0
M  V30 11 C 7.2589 2.3100 0.0 0
M  V30 12 N 4.4605 2.6042 0.0 0
M  V30 13 C 3.5553 3.8500 0.0 0
M  V30 14 C 8.5925 4.6200 0.0 0
M  V30 15 N 8.5925 3.0800 0.0 0
M  V30 16 C 2.4782 6.8808 0.0 0
M  V30 17 C 1.8519 8.2877 0.0 0
M  V30 18 C 1.3338 5.8504 0.0 0
M  V30 19 C 0.3203 8.1267 0.0 0
M  V30 20 O 0.0000 6.6204 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2712477-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1209347-76-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24429807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel substituted pyrazolo[1,5-a]-1,3,5-triazine derivatives and their
analogs, pharmaceutical compositions containing same, use thereof as
medicine and methods for preparing same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernard, Philippe; Raboisson, Pierre; Joseph, Benoit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090105261 A1 2009-04-23

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(3-Furanylmethyl)-N-methyl-N-phenyl-2-propylpyrazolo[1,5-a]-1,3,5-triazin-4...
C20H21N5O
2712477-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 8.0022 0.0 0
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 10.3508 4.6245 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 N 6.9300 6.6684 0.0 0
M  V30 8 C 7.7000 5.3347 0.0 0
M  V30 9 C 5.3900 6.6684 0.0 0
M  V30 10 N 7.9604 7.8129 0.0 0
M  V30 11 C 9.2064 5.6549 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 N 4.6200 5.3347 0.0 0
M  V30 14 C 9.3674 7.1864 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 3.0800 8.0022 0.0 0
M  V30 17 C 2.3100 6.6684 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 C 0.7700 6.6684 0.0 0
M  V30 20 C 0.7700 9.3358 0.0 0
M  V30 21 C 0.0000 8.0022 0.0 0
M  V30 22 C 11.8155 5.1003 0.0 0
M  V30 23 C 12.2914 6.5650 0.0 0
M  V30 24 C 13.0614 4.1951 0.0 0
M  V30 25 C 13.8314 6.5650 0.0 0
M  V30 26 O 14.3072 5.1003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 16
M  V30 4 1 3 11
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 1 4 15
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 13 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(3-Furanylmethyl)-N-methyl-2-propylpyrazolo[1,5-a]-1,3,5-triazin-4-amine
C14H17N5O
1209347-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9846 6.5606 0.0 0
M  V30 2 N 7.2589 0.7700 0.0 0
M  V30 3 C 8.5925 0.0000 0.0 0
M  V30 4 C 9.9262 5.3901 0.0 0
M  V30 5 C 11.2598 4.6200 0.0 0
M  V30 6 C 12.5936 5.3901 0.0 0
M  V30 7 C 5.9251 4.6200 0.0 0
M  V30 8 N 5.9251 3.0800 0.0 0
M  V30 9 C 4.4605 5.0961 0.0 0
M  V30 10 N 7.2589 5.3901 0.0 0
M  V30 11 C 7.2589 2.3100 0.0 0
M  V30 12 N 4.4605 2.6042 0.0 0
M  V30 13 C 3.5553 3.8500 0.0 0
M  V30 14 C 8.5925 4.6200 0.0 0
M  V30 15 N 8.5925 3.0800 0.0 0
M  V30 16 C 2.4782 6.8808 0.0 0
M  V30 17 C 1.8519 8.2877 0.0 0
M  V30 18 C 1.3338 5.8504 0.0 0
M  V30 19 C 0.3203 8.1267 0.0 0
M  V30 20 O 0.0000 6.6204 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2712477-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1209347-76-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24592368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolo[1,5-a]-1,3,5-triazine derivatives and
their analogues, as selective PDE2 and PDE4 inhibitors and therapeutic
uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernard, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060106019 A1 2006-05-18

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-[3-(1-Methyl-1H-indol-5-yl)-4-pyridinyl]-2-propenoic acid
C17H14N2O2
2725882-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0574 5.3182 0.0 0
M  V30 2 C 8.5974 5.3182 0.0 0
M  V30 3 C 9.3674 3.9845 0.0 0
M  V30 4 O 8.5974 2.6509 0.0 0
M  V30 5 O 10.9074 3.9845 0.0 0
M  V30 6 C 1.7270 0.0000 0.0 0
M  V30 7 C 4.7473 6.6520 0.0 0
M  V30 8 C 6.2873 6.6520 0.0 0
M  V30 9 C 3.9773 7.9857 0.0 0
M  V30 10 C 7.0574 7.9857 0.0 0
M  V30 11 N 4.7473 9.3194 0.0 0
M  V30 12 C 6.2873 9.3194 0.0 0
M  V30 13 C 3.9773 5.3182 0.0 0
M  V30 14 C 2.4373 5.3182 0.0 0
M  V30 15 C 4.7473 3.9845 0.0 0
M  V30 16 C 1.6672 3.9845 0.0 0
M  V30 17 C 3.9773 2.6509 0.0 0
M  V30 18 C 2.4373 2.6509 0.0 0
M  V30 19 C 0.1609 3.6644 0.0 0
M  V30 20 N 1.4068 1.5063 0.0 0
M  V30 21 C 0.0000 2.1328 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-3-[3-(1-methyl-1H-indol-5-yl)-4-pyridinyl]-2-propenamide
C18H17N3O
2725882-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0574 5.3182 0.0 0
M  V30 2 C 8.5974 5.3182 0.0 0
M  V30 3 C 9.3674 3.9845 0.0 0
M  V30 4 N 10.9074 3.9845 0.0 0
M  V30 5 O 8.5974 2.6509 0.0 0
M  V30 6 C 11.6775 2.6509 0.0 0
M  V30 7 C 1.7270 0.0000 0.0 0
M  V30 8 C 4.7473 6.6520 0.0 0
M  V30 9 C 6.2873 6.6520 0.0 0
M  V30 10 C 3.9773 7.9857 0.0 0
M  V30 11 C 7.0574 7.9857 0.0 0
M  V30 12 N 4.7473 9.3194 0.0 0
M  V30 13 C 6.2873 9.3194 0.0 0
M  V30 14 C 3.9773 5.3182 0.0 0
M  V30 15 C 2.4373 5.3182 0.0 0
M  V30 16 C 4.7473 3.9845 0.0 0
M  V30 17 C 1.6672 3.9845 0.0 0
M  V30 18 C 3.9773 2.6509 0.0 0
M  V30 19 C 2.4373 2.6509 0.0 0
M  V30 20 C 0.1609 3.6644 0.0 0
M  V30 21 N 1.4068 1.5063 0.0 0
M  V30 22 C 0.0000 2.1328 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 21
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 18 19
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2725882-85-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2725882-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31702566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of 3, 4-disubstituted pyridine derivatives as novel CDK8
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Haochao; Jing, Liandong; Liu, Man; Goto, Masuo; Lai, Fangfang;
Liu, Xiao; Sheng, Li; Yang, Yajun; Yang, Ying; Li, Yan; Chen, Xiaoguang;
Lee, Kuo-Hsiung; Xiao, Zhiyan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 223113634

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[3-cyclopropyl-5-[(1S)-1-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]...
C18H24N6O4
2739681-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2182 6.3593 0.0 0 CFG=2
M  V30 2 N 4.7119 6.0391 0.0 0
M  V30 3 C 6.6941 7.8240 0.0 0
M  V30 4 C 3.6813 7.1836 0.0 0
M  V30 5 O 2.1750 6.8635 0.0 0
M  V30 6 O 4.1573 8.6482 0.0 0
M  V30 7 C 1.1446 8.0079 0.0 0
M  V30 8 C 0.0000 6.9774 0.0 0
M  V30 9 C 0.1140 9.1524 0.0 0
M  V30 10 C 2.2890 9.0383 0.0 0
M  V30 11 C 13.4004 8.0433 0.0 0
M  V30 12 O 14.1705 9.3770 0.0 0
M  V30 13 O 14.1705 6.7096 0.0 0
M  V30 14 C 15.7105 9.3770 0.0 0
M  V30 15 N 8.7803 5.3758 0.0 0
M  V30 16 C 7.2488 5.2149 0.0 0
M  V30 17 N 9.4067 3.9690 0.0 0
M  V30 18 N 6.9285 3.7086 0.0 0
M  V30 19 C 8.2623 2.9385 0.0 0
M  V30 20 C 9.5504 6.7096 0.0 0
M  V30 21 C 11.0904 6.7096 0.0 0
M  V30 22 N 8.7803 8.0433 0.0 0
M  V30 23 C 11.8604 8.0433 0.0 0
M  V30 24 C 9.5504 9.3770 0.0 0
M  V30 25 N 11.0904 9.3770 0.0 0
M  V30 26 C 8.4232 1.4068 0.0 0
M  V30 27 C 9.3284 0.1609 0.0 0
M  V30 28 C 7.7969 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 23
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 19 26
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C18H25N7O3
2739681-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2182 6.3593 0.0 0 CFG=2
M  V30 2 N 4.7119 6.0391 0.0 0
M  V30 3 C 6.6941 7.8240 0.0 0
M  V30 4 C 3.6813 7.1836 0.0 0
M  V30 5 O 2.1750 6.8635 0.0 0
M  V30 6 O 4.1573 8.6482 0.0 0
M  V30 7 C 1.1446 8.0079 0.0 0
M  V30 8 C 0.0000 6.9774 0.0 0
M  V30 9 C 0.1140 9.1524 0.0 0
M  V30 10 C 2.2890 9.0383 0.0 0
M  V30 11 C 13.4004 8.0433 0.0 0
M  V30 12 N 14.1705 9.3770 0.0 0
M  V30 13 O 14.1705 6.7096 0.0 0
M  V30 14 C 15.7105 9.3770 0.0 0
M  V30 15 N 8.7803 5.3758 0.0 0
M  V30 16 C 7.2488 5.2149 0.0 0
M  V30 17 N 9.4067 3.9690 0.0 0
M  V30 18 N 6.9285 3.7086 0.0 0
M  V30 19 C 8.2623 2.9385 0.0 0
M  V30 20 C 9.5504 6.7096 0.0 0
M  V30 21 C 11.0904 6.7096 0.0 0
M  V30 22 N 8.7803 8.0433 0.0 0
M  V30 23 C 11.8604 8.0433 0.0 0
M  V30 24 C 9.5504 9.3770 0.0 0
M  V30 25 N 11.0904 9.3770 0.0 0
M  V30 26 C 8.4232 1.4068 0.0 0
M  V30 27 C 9.3284 0.1609 0.0 0
M  V30 28 C 7.7969 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 23
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 19 26
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2739681-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2739681-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25051475
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel heteroaryl-triazole compounds as pesticides and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeschke, Peter; Fuesslein, Martin; Schwarz, Hans-Georg; Telser, Joachim;
Cancho Grande, Yolanda; Arlt, Alexander; Mueller, Steffen;
Ebbinghaus-Kintscher, Ulrich; Loesel, Peter; Linka, Marc; Damijonaitis,
Arunas Jonas; Heisler, Iring; Turberg, Andreas; Mandzhulo, Oleksandr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021224323 A1 2021-11-11

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Himic anhydride
C9H8O3
2746-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6460 2.7105 0.0 0
M  V30 2 O 1.9512 0.0000 0.0 0
M  V30 3 C 3.9952 3.4208 0.0 0 CFG=2
M  V30 4 C 2.6614 2.6508 0.0 0 CFG=1
M  V30 5 C 3.9998 4.9527 0.0 0 CFG=1
M  V30 6 C 5.1395 2.3904 0.0 0
M  V30 7 C 1.3324 3.4128 0.0 0 CFG=2
M  V30 8 C 2.9817 1.1445 0.0 0
M  V30 9 C 2.4301 4.5916 0.0 0
M  V30 10 C 2.6657 5.7235 0.0 0
M  V30 11 O 4.5132 0.9834 0.0 0
M  V30 12 C 1.3319 4.9535 0.0 0
M  V30 13 H 5.4029 4.0451 0.0 0
M  V30 14 H 1.4169 1.7437 0.0 0
M  V30 15 H 5.3347 5.7206 0.0 0
M  V30 16 H 0.0000 2.6406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 14 CFG=3
M  V30 10 1 5 9 CFG=1
M  V30 11 1 5 10
M  V30 12 1 5 15
M  V30 13 1 6 11
M  V30 14 1 7 9 CFG=1
M  V30 15 1 7 12
M  V30 16 1 7 16
M  V30 17 1 8 11
M  V30 18 2 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 5 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4R,7S,7aS)-3a,4,7,7a-Tetrahydro-2-methyl-4,7-methano-1H-isoindole-1,...
C10H11NO2
56420-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0608 0.0 0
M  V30 2 O 4.6949 0.3502 0.0 0
M  V30 3 C 1.3628 0.0000 0.0 0
M  V30 4 C 2.6508 3.7710 0.0 0 CFG=2
M  V30 5 C 3.9846 3.0010 0.0 0 CFG=1
M  V30 6 C 2.6462 5.3031 0.0 0 CFG=1
M  V30 7 C 1.5064 2.7406 0.0 0
M  V30 8 C 5.3137 3.7630 0.0 0 CFG=2
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 C 4.2160 4.9419 0.0 0
M  V30 11 C 3.9803 6.0738 0.0 0
M  V30 12 N 2.1328 1.3337 0.0 0
M  V30 13 C 5.3141 5.3038 0.0 0
M  V30 14 H 1.2431 4.3954 0.0 0
M  V30 15 H 5.2291 2.0940 0.0 0
M  V30 16 H 1.3113 6.0709 0.0 0
M  V30 17 H 6.6461 2.9909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 15 CFG=1
M  V30 11 1 6 10 CFG=3
M  V30 12 1 6 11
M  V30 13 1 6 16
M  V30 14 1 7 12
M  V30 15 1 8 10 CFG=3
M  V30 16 1 8 13
M  V30 17 1 8 17
M  V30 18 1 9 12
M  V30 19 2 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2746-19-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56420-87-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31792650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Native Chemical Ligation: Ultrafast Synthesis of Block Copolymers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pal, Subhajit; Mandal, Ankita; Hong, Linda; Ortuso, Roberto D.;
Petri-Fink, Alke; Salentinig, Stefan; Kilbinger, Andreas F. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Macromolecules (Washington, DC, United States) (2022), 55(7), 2854-2860

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Himic anhydride
C9H8O3
2746-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6460 2.7105 0.0 0
M  V30 2 O 1.9512 0.0000 0.0 0
M  V30 3 C 3.9952 3.4208 0.0 0 CFG=2
M  V30 4 C 2.6614 2.6508 0.0 0 CFG=1
M  V30 5 C 3.9998 4.9527 0.0 0 CFG=1
M  V30 6 C 5.1395 2.3904 0.0 0
M  V30 7 C 1.3324 3.4128 0.0 0 CFG=2
M  V30 8 C 2.9817 1.1445 0.0 0
M  V30 9 C 2.4301 4.5916 0.0 0
M  V30 10 C 2.6657 5.7235 0.0 0
M  V30 11 O 4.5132 0.9834 0.0 0
M  V30 12 C 1.3319 4.9535 0.0 0
M  V30 13 H 5.4029 4.0451 0.0 0
M  V30 14 H 1.4169 1.7437 0.0 0
M  V30 15 H 5.3347 5.7206 0.0 0
M  V30 16 H 0.0000 2.6406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 14 CFG=3
M  V30 10 1 5 9 CFG=1
M  V30 11 1 5 10
M  V30 12 1 5 15
M  V30 13 1 6 11
M  V30 14 1 7 9 CFG=1
M  V30 15 1 7 12
M  V30 16 1 7 16
M  V30 17 1 8 11
M  V30 18 2 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 5 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4R,7S,7aS)-3a,4,7,7a-Tetrahydro-2-methyl-4,7-methano-1H-isoindole-1,...
C10H11NO2
56420-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0608 0.0 0
M  V30 2 O 4.6949 0.3502 0.0 0
M  V30 3 C 1.3628 0.0000 0.0 0
M  V30 4 C 2.6508 3.7710 0.0 0 CFG=2
M  V30 5 C 3.9846 3.0010 0.0 0 CFG=1
M  V30 6 C 2.6462 5.3031 0.0 0 CFG=1
M  V30 7 C 1.5064 2.7406 0.0 0
M  V30 8 C 5.3137 3.7630 0.0 0 CFG=2
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 C 4.2160 4.9419 0.0 0
M  V30 11 C 3.9803 6.0738 0.0 0
M  V30 12 N 2.1328 1.3337 0.0 0
M  V30 13 C 5.3141 5.3038 0.0 0
M  V30 14 H 1.2431 4.3954 0.0 0
M  V30 15 H 5.2291 2.0940 0.0 0
M  V30 16 H 1.3113 6.0709 0.0 0
M  V30 17 H 6.6461 2.9909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 15 CFG=1
M  V30 11 1 6 10 CFG=3
M  V30 12 1 6 11
M  V30 13 1 6 16
M  V30 14 1 7 12
M  V30 15 1 8 10 CFG=3
M  V30 16 1 8 13
M  V30 17 1 8 17
M  V30 18 1 9 12
M  V30 19 2 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2746-19-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56420-87-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-20659932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Living Ring Opening Metathesis Polymerisation: The Importance
of Ring Strain in Chain Transfer Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Peng; Yasir, Mohammad; Kilbinger, Andreas F. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(43), 15278-15282

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxylic acid
C12H10N4O2
2757487-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 4.2506 0.0 0
M  V30 2 O 2.5367 5.3950 0.0 0
M  V30 3 O 0.0000 4.5708 0.0 0
M  V30 4 C 11.4169 3.4372 0.0 0
M  V30 5 N 3.4469 2.3101 0.0 0
M  V30 6 C 3.4469 0.7700 0.0 0
M  V30 7 C 1.9822 2.7859 0.0 0
M  V30 8 C 4.7806 3.0801 0.0 0
M  V30 9 C 4.7806 0.0000 0.0 0
M  V30 10 N 1.9822 0.2941 0.0 0
M  V30 11 C 1.0769 1.5400 0.0 0
M  V30 12 C 6.1142 2.3101 0.0 0
M  V30 13 C 6.1142 0.7700 0.0 0
M  V30 14 C 7.4479 3.0801 0.0 0
M  V30 15 C 7.6090 4.6116 0.0 0
M  V30 16 C 8.8549 2.4537 0.0 0
M  V30 17 N 9.1153 4.9318 0.0 0
M  V30 18 N 9.8853 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide
C13H13N5O
2757487-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9823 1.7847 0.0 0
M  V30 2 N 0.4760 1.4646 0.0 0
M  V30 3 O 3.0127 0.6403 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 11.8930 2.5982 0.0 0
M  V30 6 N 3.9229 3.7253 0.0 0
M  V30 7 C 3.9229 5.2653 0.0 0
M  V30 8 C 2.4582 3.2495 0.0 0
M  V30 9 C 5.2566 2.9553 0.0 0
M  V30 10 N 2.4582 5.7412 0.0 0
M  V30 11 C 5.2566 6.0354 0.0 0
M  V30 12 C 1.5530 4.4953 0.0 0
M  V30 13 C 6.5902 3.7253 0.0 0
M  V30 14 C 6.5902 5.2653 0.0 0
M  V30 15 C 7.9240 2.9553 0.0 0
M  V30 16 C 8.0850 1.4238 0.0 0
M  V30 17 C 9.3309 3.5818 0.0 0
M  V30 18 N 9.5913 1.1036 0.0 0
M  V30 19 N 10.3613 2.4372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 2 11 14
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2757487-09-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2757487-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31354467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 3,6-disubstituted-imidazo[1,2-a]pyridine derivatives as a
new class of CLK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yun; Xia, Anjie; Zhang, Shiyu; Lin, Guifeng; Liu, Jingming; Chen,
Pei; Mu, Bo; Jiao, Yan; Xu, Wenwen; Chen, Mingxin; Li, Linli
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 41127881

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
rel-1-(1,1-Dimethylethyl) (2R,5S)-2-(5-carboxy-2-thienyl)-5-methyl-1-piperidi...
C16H23NO4S
2760487-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 5.3348 0.0 0
M  V30 2 O 2.1037 5.3348 0.0 0
M  V30 3 O 4.4137 6.6685 0.0 0
M  V30 4 C 1.3337 6.6685 0.0 0
M  V30 5 C 2.6673 7.4385 0.0 0
M  V30 6 C 0.5637 8.0022 0.0 0
M  V30 7 C 0.0000 5.8985 0.0 0
M  V30 8 C 9.9825 7.6286 0.0 0
M  V30 9 O 11.2284 6.7233 0.0 0
M  V30 10 O 10.1434 9.1601 0.0 0
M  V30 11 C 3.6437 0.0000 0.0 0
M  V30 12 C 5.9538 4.0012 0.0 0 CFG=1
M  V30 13 N 4.4137 4.0012 0.0 0
M  V30 14 C 6.7238 2.6673 0.0 0
M  V30 15 C 3.6437 2.6673 0.0 0
M  V30 16 C 5.9538 1.3337 0.0 0
M  V30 17 C 4.4137 1.3337 0.0 0 CFG=1
M  V30 18 C 6.7238 5.3348 0.0 0
M  V30 19 S 8.2554 5.4958 0.0 0
M  V30 20 C 6.0975 6.7417 0.0 0
M  V30 21 C 8.5755 7.0022 0.0 0
M  V30 22 C 7.2419 7.7722 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 21
M  V30 11 1 17 11 CFG=3
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18 CFG=1
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (2R,5S)-5-methyl-2-[5-[(methylamino)carbonyl]-2-thienyl...
C17H26N2O3S
2760487-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 O 3.8501 2.6673 0.0 0
M  V30 3 O 6.1601 4.0012 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 3.2864 0.5637 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 C 5.9538 2.1037 0.0 0
M  V30 8 C 9.7758 8.3437 0.0 0
M  V30 9 N 11.1828 7.7174 0.0 0
M  V30 10 O 9.6149 9.8753 0.0 0
M  V30 11 C 12.4287 8.6225 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 4.6201 6.6685 0.0 0 CFG=1
M  V30 14 N 3.8501 5.3348 0.0 0
M  V30 15 C 3.8501 8.0022 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 2.3101 8.0022 0.0 0
M  V30 18 C 1.5400 6.6685 0.0 0 CFG=1
M  V30 19 C 6.1601 6.6685 0.0 0
M  V30 20 S 7.0654 7.9144 0.0 0
M  V30 21 C 7.0654 5.4226 0.0 0
M  V30 22 C 8.5299 7.4385 0.0 0
M  V30 23 C 8.5299 5.8985 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 1 9 11
M  V30 12 1 18 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19 CFG=3
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2760487-93-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2760487-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31745962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the
treatment of MTAP-deficient and/or MT-A accumulating cancers and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cottrell, Kevin M.; Maxwell, John P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022026892 A1 2022-02-03

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-3-methyl-2-[[[(E)-[1-[6-(trifluoromethyl)-4-pyri...
C19H19F3N4O4
2761370-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 16.0045 5.3901 0.0 0
M  V30 16 F 16.7745 4.0564 0.0 0
M  V30 17 F 17.3383 6.1601 0.0 0
M  V30 18 F 15.2345 6.7238 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 C 13.3372 5.3901 0.0 0
M  V30 27 N 12.0035 3.0801 0.0 0
M  V30 28 C 14.6708 4.6201 0.0 0
M  V30 29 C 13.3372 2.3101 0.0 0
M  V30 30 N 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methoxyimino)-N,3-dimethyl-2-[[[(E)-[1-[6-(trifluoromethyl)-4-pyrimid...
C19H20F3N5O3
2761370-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 16.0045 5.3901 0.0 0
M  V30 16 F 16.7745 4.0564 0.0 0
M  V30 17 F 17.3383 6.1601 0.0 0
M  V30 18 F 15.2345 6.7238 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 C 13.3372 5.3901 0.0 0
M  V30 27 N 12.0035 3.0801 0.0 0
M  V30 28 C 14.6708 4.6201 0.0 0
M  V30 29 C 13.3372 2.3101 0.0 0
M  V30 30 N 14.6708 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761370-67-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761370-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31600359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
containing an amino acid substitution F129L in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors VIII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Andreas; Fehr, Marcus; Tegge, Vanessa; Dey, Chandan; Poonoth,
Manojkumar; Kulkarni, Sarang; Le Vezouet, Ronan; Winter, Christian
Harald; Rudolf, Georg Christoph; Rath, Rakesh; Khanna, Smriti; Craig, Ian
Robert; Grammenos, Wassilios; Grote, Thomas; Stammler, Gerd; Mentzel,
Tobias; Haden, Egon; Rheinheimer, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022033906 A1 2022-02-17

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-α-(methoxyimino)-3-methyl-2-[[[(E)-[1-[5-(trifluoromethyl)-2-thia...
C18H18F3N3O4S
2761370-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 O 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 15.9725 4.2630 0.0 0
M  V30 16 F 15.8114 5.7945 0.0 0
M  V30 17 F 17.5040 4.4239 0.0 0
M  V30 18 F 16.1334 2.7314 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 S 13.4103 5.2464 0.0 0
M  V30 27 N 12.1644 3.0885 0.0 0
M  V30 28 C 14.4407 4.1020 0.0 0
M  V30 29 C 13.6707 2.7684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-α-(Methoxyimino)-N,3-dimethyl-2-[[[(E)-[1-[5-(trifluoromethyl)-2-thiazol...
C18H19F3N4O3S
2761370-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 O 1.3338 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 6.6687 4.6201 0.0 0
M  V30 10 O 8.0023 5.3901 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 5.3901 0.0 0
M  V30 13 C 10.6697 6.9302 0.0 0
M  V30 14 C 6.6687 7.7002 0.0 0
M  V30 15 C 15.9725 4.2630 0.0 0
M  V30 16 F 16.1334 2.7314 0.0 0
M  V30 17 F 17.5040 4.4239 0.0 0
M  V30 18 F 15.8114 5.7945 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 5.3348 5.3901 0.0 0
M  V30 21 C 2.6675 5.3901 0.0 0
M  V30 22 C 5.3348 6.9302 0.0 0
M  V30 23 C 2.6675 6.9302 0.0 0
M  V30 24 C 4.0012 7.7002 0.0 0
M  V30 25 C 12.0035 4.6201 0.0 0
M  V30 26 S 13.4103 5.2464 0.0 0
M  V30 27 N 12.1644 3.0885 0.0 0
M  V30 28 C 14.4407 4.1020 0.0 0
M  V30 29 C 13.6707 2.7684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 22
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 2 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761370-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761370-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31600327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of strobilurin type compounds for combating phytopathogenic fungi
containing an amino acid substitution F129L in the mitochondrial
cytochrome b protein conferring resistance to Qo inhibitors VIII
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koch, Andreas; Fehr, Marcus; Tegge, Vanessa; Dey, Chandan; Poonoth,
Manojkumar; Kulkarni, Sarang; Le Vezouet, Ronan; Winter, Christian
Harald; Rudolf, Georg Christoph; Rath, Rakesh; Khanna, Smriti; Craig, Ian
Robert; Grammenos, Wassilios; Grote, Thomas; Stammler, Gerd; Mentzel,
Tobias; Haden, Egon; Rheinheimer, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022033906 A1 2022-02-17

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
[(R)-(2-Bromophenyl)hydroxymethyl]ferrocene
C17H15BrFeO
276855-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0014 8.2817 0.0 0
M  V30 2 O 5.0014 9.1579 0.0 0
M  V30 3 Br 6.5800 9.1941 0.0 0
M  V30 4 Fe 2.1266 4.5790 0.0 0 CHG=2 VAL=10
M  V30 5 C 4.2434 7.8448 0.0 0 CHG=-1 VAL=4
M  V30 6 C 2.9134 7.0748 0.0 0 VAL=5
M  V30 7 C 2.1266 9.1941 0.0 0 VAL=5
M  V30 8 C 0.0483 7.8448 0.0 0 VAL=5
M  V30 9 C 1.3734 7.0748 0.0 0 VAL=5
M  V30 10 C 0.0000 1.3541 0.0 0 CHG=-1 VAL=4
M  V30 11 C 4.1976 1.3541 0.0 0 VAL=5
M  V30 12 C 2.8652 2.1241 0.0 0 VAL=5
M  V30 13 C 1.3252 2.1241 0.0 0 VAL=5
M  V30 14 C 2.0783 0.0000 0.0 0 VAL=5
M  V30 15 C 5.7593 7.8448 0.0 0
M  V30 16 C 6.5800 8.3203 0.0 0
M  V30 17 C 5.7593 6.8938 0.0 0
M  V30 18 C 7.4055 7.8448 0.0 0
M  V30 19 C 6.5800 6.4183 0.0 0
M  V30 20 C 7.4055 6.8938 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 15
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 4 10
M  V30 11 1 4 11
M  V30 12 1 4 12
M  V30 13 1 4 13
M  V30 14 1 4 14
M  V30 15 1 5 6
M  V30 16 1 5 7
M  V30 17 2 6 9
M  V30 18 2 7 8
M  V30 19 1 8 9
M  V30 20 1 10 13
M  V30 21 1 10 14
M  V30 22 1 11 12
M  V30 23 2 11 14
M  V30 24 2 12 13
M  V30 25 2 15 16
M  V30 26 1 15 17
M  V30 27 1 16 18
M  V30 28 2 17 19
M  V30 29 2 18 20
M  V30 30 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, [(R)-(2-bromophenyl)(methylamino)methyl]-
C18H18BrFeN
2866502-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0014 8.2817 0.0 0 CFG=2
M  V30 2 N 5.0014 9.1579 0.0 0
M  V30 3 C 3.9779 9.7469 0.0 0
M  V30 4 Br 6.5800 9.1941 0.0 0
M  V30 5 Fe 2.1266 4.5790 0.0 0 CHG=2 VAL=10
M  V30 6 C 4.2434 7.8448 0.0 0 CHG=-1 VAL=4
M  V30 7 C 2.9134 7.0748 0.0 0 VAL=5
M  V30 8 C 2.1266 9.1941 0.0 0 VAL=5
M  V30 9 C 0.0483 7.8448 0.0 0 VAL=5
M  V30 10 C 1.3734 7.0748 0.0 0 VAL=5
M  V30 11 C 0.0000 1.3541 0.0 0 CHG=-1 VAL=4
M  V30 12 C 4.1976 1.3541 0.0 0 VAL=5
M  V30 13 C 2.8652 2.1241 0.0 0 VAL=5
M  V30 14 C 1.3252 2.1241 0.0 0 VAL=5
M  V30 15 C 2.0783 0.0000 0.0 0 VAL=5
M  V30 16 C 5.7593 7.8448 0.0 0
M  V30 17 C 6.5800 8.3203 0.0 0
M  V30 18 C 5.7593 6.8938 0.0 0
M  V30 19 C 7.4055 7.8448 0.0 0
M  V30 20 C 6.5800 6.4183 0.0 0
M  V30 21 C 7.4055 6.8938 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 6
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 5 11
M  V30 12 1 5 12
M  V30 13 1 5 13
M  V30 14 1 5 14
M  V30 15 1 5 15
M  V30 16 1 6 7
M  V30 17 1 6 8
M  V30 18 2 7 10
M  V30 19 2 8 9
M  V30 20 1 9 10
M  V30 21 1 11 14
M  V30 22 1 11 15
M  V30 23 1 12 13
M  V30 24 2 12 15
M  V30 25 2 13 14
M  V30 26 2 16 17
M  V30 27 1 16 18
M  V30 28 1 17 19
M  V30 29 2 18 20
M  V30 30 2 19 21
M  V30 31 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 276855-17-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2866502-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39132139
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, pyridine also acts as solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recyclable Silica-Support Taniaphos/Copper(I) complex for asymmetric
allylic alkylation reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Chao; Wang, Yan; Jia, Xuelei; Huang, Junrong; You, Hengzhi; Chen,
Fen-Er
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2023), 42550-56

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[6-(3-Methyl-4-isoxazolyl)-1-oxo-2(1H)-isoquinolinyl]methyl]benzoic acid
C21H16N2O4
2800892-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7722 6.4718 0.0 0
M  V30 2 C 10.4397 4.9318 0.0 0
M  V30 3 C 0.7103 3.9845 0.0 0
M  V30 4 C 15.7746 4.9318 0.0 0
M  V30 5 O 17.1082 4.1618 0.0 0
M  V30 6 O 15.7746 6.4718 0.0 0
M  V30 7 C 6.4386 2.6218 0.0 0
M  V30 8 C 6.4386 4.1618 0.0 0
M  V30 9 C 5.1047 1.8517 0.0 0
M  V30 10 C 7.7722 1.8517 0.0 0
M  V30 11 C 7.7722 4.9318 0.0 0
M  V30 12 C 5.1047 4.9318 0.0 0
M  V30 13 C 3.7711 2.6218 0.0 0
M  V30 14 C 9.1059 2.6218 0.0 0
M  V30 15 N 9.1059 4.1618 0.0 0
M  V30 16 C 3.7711 4.1618 0.0 0
M  V30 17 C 2.4374 1.8517 0.0 0
M  V30 18 C 1.0306 2.4782 0.0 0
M  V30 19 C 2.2765 0.3202 0.0 0
M  V30 20 N 0.0000 1.3337 0.0 0
M  V30 21 O 0.7700 0.0000 0.0 0
M  V30 22 C 11.7734 4.1618 0.0 0
M  V30 23 C 13.1071 4.9318 0.0 0
M  V30 24 C 11.7734 2.6218 0.0 0
M  V30 25 C 14.4407 4.1618 0.0 0
M  V30 26 C 13.1071 1.8517 0.0 0
M  V30 27 C 14.4407 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 15
M  V30 3 1 2 22
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 25
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 1 14 15
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[[6-(3-methyl-4-isoxazolyl)-1-oxo-2(1H)-isoquinolinyl]methyl]benza...
C22H19N3O3
2800889-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7722 6.4718 0.0 0
M  V30 2 C 10.4396 4.9318 0.0 0
M  V30 3 C 0.7103 3.9845 0.0 0
M  V30 4 C 15.7744 4.9318 0.0 0
M  V30 5 N 17.1082 4.1618 0.0 0
M  V30 6 O 15.7744 6.4718 0.0 0
M  V30 7 C 18.4419 4.9318 0.0 0
M  V30 8 C 6.4386 2.6218 0.0 0
M  V30 9 C 6.4386 4.1618 0.0 0
M  V30 10 C 5.1047 1.8517 0.0 0
M  V30 11 C 7.7722 1.8517 0.0 0
M  V30 12 C 7.7722 4.9318 0.0 0
M  V30 13 C 5.1047 4.9318 0.0 0
M  V30 14 C 3.7711 2.6218 0.0 0
M  V30 15 C 9.1059 2.6218 0.0 0
M  V30 16 N 9.1059 4.1618 0.0 0
M  V30 17 C 3.7711 4.1618 0.0 0
M  V30 18 C 2.4374 1.8517 0.0 0
M  V30 19 C 1.0304 2.4782 0.0 0
M  V30 20 C 2.2765 0.3202 0.0 0
M  V30 21 N 0.0000 1.3337 0.0 0
M  V30 22 O 0.7700 0.0000 0.0 0
M  V30 23 C 11.7734 4.1618 0.0 0
M  V30 24 C 13.1071 4.9318 0.0 0
M  V30 25 C 11.7734 2.6218 0.0 0
M  V30 26 C 14.4407 4.1618 0.0 0
M  V30 27 C 13.1071 1.8517 0.0 0
M  V30 28 C 14.4407 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 16
M  V30 3 1 2 23
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 26
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2800892-94-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2800889-76-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33622457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel substituted bicyclic derivatives as selective
inhibitors of ROCK1 and ROCK2 protein kinases and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Wongil; Devine, William G.; Diebold, R. Bruce; Hwang, So Young;
Choi, Yunggeun; Liu, Yan; Seung, Sang-Ae; Yong, Miyong; Kim, Sewon; Lee,
Jaekyoo; Koh, Jong Sung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022150381 A1 2022-07-14

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(3-amino-6-fluoro-2-methylphenyl)imidazo[1,5-a]pyridine-1-carboxylate
C16H14FN3O2
2803475-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 3.3777 0.0 0
M  V30 2 O 11.8156 2.9019 0.0 0
M  V30 3 O 10.0307 4.8842 0.0 0
M  V30 4 C 12.9600 3.9323 0.0 0
M  V30 5 C 3.0801 5.3350 0.0 0
M  V30 6 F 3.0801 0.0000 0.0 0
M  V30 7 N 0.0000 5.3350 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 N 6.9301 1.3338 0.0 0
M  V30 10 C 9.2064 2.3473 0.0 0
M  V30 11 C 6.9301 4.0011 0.0 0
M  V30 12 C 5.3901 1.3338 0.0 0
M  V30 13 C 7.9606 0.1893 0.0 0
M  V30 14 N 9.3674 0.8158 0.0 0
M  V30 15 C 5.3901 4.0011 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 3.0801 2.6675 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 2.3100 1.3338 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.7700 1.3338 0.0 0
M  V30 22 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 18
M  V30 6 1 6 19
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3-Amino-6-fluoro-2-methylphenyl)-N-methylimidazo[1,5-a]pyridine-1-carboxamide
C16H15FN4O
2803475-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 3.3777 0.0 0
M  V30 2 N 11.8156 2.9019 0.0 0
M  V30 3 O 10.0307 4.8842 0.0 0
M  V30 4 C 12.9600 3.9323 0.0 0
M  V30 5 C 3.0801 5.3350 0.0 0
M  V30 6 F 3.0801 0.0000 0.0 0
M  V30 7 N 0.0000 5.3350 0.0 0
M  V30 8 C 7.7001 2.6675 0.0 0
M  V30 9 N 6.9301 1.3338 0.0 0
M  V30 10 C 9.2064 2.3473 0.0 0
M  V30 11 C 6.9301 4.0011 0.0 0
M  V30 12 C 5.3901 1.3338 0.0 0
M  V30 13 C 7.9606 0.1893 0.0 0
M  V30 14 N 9.3674 0.8158 0.0 0
M  V30 15 C 5.3901 4.0011 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 3.0801 2.6675 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 2.3100 1.3338 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.7700 1.3338 0.0 0
M  V30 22 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 18
M  V30 6 1 6 19
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2803475-26-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2803475-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33739156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-Heteroarylphenyl sulfonamides as GCN2 modulators and
uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramurthy, Savithri; Mulvihill, Mark J.; Sherborne, Bradley; Rahemtulla,
Benjamin; Talbot, Eric P. A.; Thomson, Christopher G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022159746 A1 2022-07-28

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3-Oxadiazolium, 5-hydroxy-3-[2-(2,2,2-trichloroacetyl)phenyl]-, inner salt
C10H5Cl3N2O3
286960-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 O 3.8500 5.3347 0.0 0
M  V30 4 Cl 1.5400 2.4611 0.0 0
M  V30 5 Cl 0.0000 4.0011 0.0 0
M  V30 6 Cl 1.5400 5.5411 0.0 0
M  V30 7 O 9.4186 6.2947 0.0 0 CHG=-1
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 C 3.0800 1.3336 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 N 6.1600 4.0011 0.0 0 CHG=1 VAL=4
M  V30 15 N 5.5337 5.4079 0.0 0
M  V30 16 C 7.6915 4.1620 0.0 0
M  V30 17 O 6.6781 6.4384 0.0 0
M  V30 18 C 8.0117 5.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 18
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3-Oxadiazolium, 5-hydroxy-3-[2-[(methylamino)carbonyl]phenyl]-, inner salt
C10H9N3O3
108005-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 N 0.7700 4.0012 0.0 0
M  V30 3 O 3.0801 5.3348 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 O 8.6488 6.2949 0.0 0 CHG=-1
M  V30 6 C 4.6201 2.6675 0.0 0
M  V30 7 C 3.0801 2.6675 0.0 0
M  V30 8 C 5.3901 1.3337 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 3.0801 0.0000 0.0 0
M  V30 12 N 5.3901 4.0012 0.0 0 CHG=1 VAL=4
M  V30 13 N 4.7638 5.4080 0.0 0
M  V30 14 C 6.9217 4.1621 0.0 0
M  V30 15 O 5.9082 6.4386 0.0 0
M  V30 16 C 7.2419 5.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 286960-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108005-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2590530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Activated carbonyl species for the preparation of ortho-acylarylsydnones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Turnbull, Kenneth; Beladakere, Ravindra N.; McCall, Neal D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2000), 37(2), 383-388

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H20N2O2
2871810-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9694 5.9723 0.0 0
M  V30 2 C 0.4631 6.2925 0.0 0
M  V30 3 C 2.9998 7.1167 0.0 0
M  V30 4 O 0.0000 3.2617 0.0 0
M  V30 5 O 7.9110 4.8017 0.0 0
M  V30 6 C 3.9099 2.4917 0.0 0 CFG=1
M  V30 7 C 3.9099 4.0317 0.0 0 CFG=1
M  V30 8 N 2.4452 2.0159 0.0 0
M  V30 9 C 4.8151 1.2459 0.0 0
M  V30 10 C 5.2436 1.7217 0.0 0
M  V30 11 N 2.4452 4.5076 0.0 0
M  V30 12 C 5.2436 4.8017 0.0 0
M  V30 13 C 1.5400 3.2617 0.0 0
M  V30 14 C 2.4452 0.4759 0.0 0
M  V30 15 C 3.9099 0.0000 0.0 0
M  V30 16 C 6.5772 2.4917 0.0 0
M  V30 17 C 6.5772 4.0317 0.0 0
M  V30 18 H 3.7490 5.5633 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 4 13
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9 CFG=1
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 18 CFG=1
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 11 13
M  V30 18 1 12 17
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H,5H-Pyrrolo[1,2-c]benzimidazol-5-one, octahydro-8-(methylamino)-6-(1-methyl...
C14H25N3O
2871810-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9694 5.9723 0.0 0
M  V30 2 C 2.9998 7.1167 0.0 0
M  V30 3 C 0.4629 6.2925 0.0 0
M  V30 4 O 0.0000 3.2617 0.0 0
M  V30 5 N 7.9109 4.8017 0.0 0
M  V30 6 C 9.2447 4.0317 0.0 0
M  V30 7 C 3.9099 2.4917 0.0 0 CFG=2
M  V30 8 C 3.9099 4.0317 0.0 0 CFG=1
M  V30 9 N 2.4452 2.0159 0.0 0
M  V30 10 C 5.2436 1.7217 0.0 0
M  V30 11 C 4.8151 1.2459 0.0 0
M  V30 12 N 2.4452 4.5076 0.0 0
M  V30 13 C 5.2436 4.8017 0.0 0
M  V30 14 C 1.5400 3.2617 0.0 0
M  V30 15 C 2.4452 0.4759 0.0 0
M  V30 16 C 6.5772 2.4917 0.0 0
M  V30 17 C 3.9099 0.0000 0.0 0
M  V30 18 C 6.5772 4.0317 0.0 0 CFG=2
M  V30 19 H 3.7488 5.5633 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11 CFG=1
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 19 CFG=1
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 14
M  V30 19 1 13 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 7 8 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2871810-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2871810-74-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36148911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (dr = 88:12)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scaffold Remodelling of Diazaspirotricycles Enables Synthesis of Diverse
sp3-Rich Compounds With Distinct Phenotypic Effects
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okolo, Ephraim A.; Pahl, Axel; Sievers, Sonja; Pask, Christopher M.;
Nelson, Adam; Marsden, Stephen P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2023), 29(26), e202203992

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dihydro-4,5-dioxo-2-phenyl-4H-pyrano[3,4-c]quinoline-9-carbonitrile
C19H10N2O3
2882178-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3336 10.0100 0.0 0
M  V30 2 O 0.0000 7.7000 0.0 0
M  V30 3 C 9.3358 6.9300 0.0 0
M  V30 4 N 10.6694 6.1600 0.0 0
M  V30 5 C 4.0011 6.9300 0.0 0
M  V30 6 C 5.3347 7.7000 0.0 0
M  V30 7 C 2.6673 7.7000 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0
M  V30 9 C 5.3347 9.2400 0.0 0
M  V30 10 C 6.6684 6.9300 0.0 0
M  V30 11 C 2.6673 9.2400 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 2.6673 4.6200 0.0 0
M  V30 14 N 4.0011 10.0100 0.0 0
M  V30 15 C 6.6684 10.0100 0.0 0
M  V30 16 C 8.0021 7.7000 0.0 0
M  V30 17 O 1.3336 5.3900 0.0 0
M  V30 18 C 8.0020 9.2400 0.0 0
M  V30 19 C 2.6673 3.0800 0.0 0
M  V30 20 C 4.0011 2.3100 0.0 0
M  V30 21 C 1.3336 2.3100 0.0 0
M  V30 22 C 4.0011 0.7700 0.0 0
M  V30 23 C 1.3336 0.7700 0.0 0
M  V30 24 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 3 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 1 10 16
M  V30 16 1 11 14
M  V30 17 1 12 17
M  V30 18 1 13 17
M  V30 19 1 13 19
M  V30 20 1 15 18
M  V30 21 2 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5,6-Tetrahydro-3-methyl-4,5-dioxo-2-phenylbenzo[c][2,7]naphthyridine-9-ca...
C20H13N3O2
2882178-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 7.7000 0.0 0
M  V30 2 O 1.3336 10.0100 0.0 0
M  V30 3 C 0.0000 4.6200 0.0 0
M  V30 4 C 9.3358 6.9300 0.0 0
M  V30 5 N 10.6694 6.1600 0.0 0
M  V30 6 C 4.0011 6.9300 0.0 0
M  V30 7 C 2.6673 7.7000 0.0 0
M  V30 8 C 5.3347 7.7000 0.0 0
M  V30 9 C 4.0011 5.3900 0.0 0
M  V30 10 C 1.3336 6.9300 0.0 0
M  V30 11 C 2.6673 9.2400 0.0 0
M  V30 12 C 5.3347 9.2400 0.0 0
M  V30 13 C 6.6684 6.9300 0.0 0
M  V30 14 C 2.6673 4.6200 0.0 0
M  V30 15 N 1.3336 5.3900 0.0 0
M  V30 16 N 4.0011 10.0100 0.0 0
M  V30 17 C 6.6684 10.0100 0.0 0
M  V30 18 C 8.0021 7.7000 0.0 0
M  V30 19 C 8.0021 9.2400 0.0 0
M  V30 20 C 2.6673 3.0800 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 1.3336 2.3100 0.0 0
M  V30 23 C 4.0011 0.7700 0.0 0
M  V30 24 C 1.3336 0.7700 0.0 0
M  V30 25 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 11
M  V30 3 1 3 15
M  V30 4 3 4 5
M  V30 5 1 4 18
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 14 15
M  V30 20 1 14 20
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2882178-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2882178-51-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35111775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent Sequential Reactions of β-(2-Aminophenyl)-α,β-ynones with
Malonyl Chloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marsicano, Vincenzo; Marraffa, Gianpaolo; Chiarini, Marco; Palombi,
Laura; Arcadi, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2022), 2022(45), e202201187

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[3-chloro-6-(3-formylphenyl)-2-quinolinyl]-, 1...
C25H26ClN3O3
2892827-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 11.5500 6.6685 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 O 0.0000 0.0002 0.0 0
M  V30 4 C 17.7100 4.0011 0.0 0
M  V30 5 O 18.4800 5.3349 0.0 0
M  V30 6 O 18.4800 2.6674 0.0 0
M  V30 7 C 20.0200 5.3349 0.0 0
M  V30 8 C 20.0200 6.8749 0.0 0
M  V30 9 C 21.5600 5.3347 0.0 0
M  V30 10 C 20.0200 3.7947 0.0 0
M  V30 11 C 8.4700 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 N 10.7800 2.6674 0.0 0
M  V30 16 C 8.4700 1.3338 0.0 0
M  V30 17 C 6.1600 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 6.9300 1.3338 0.0 0
M  V30 21 C 4.6200 2.6674 0.0 0
M  V30 22 C 3.8500 1.3338 0.0 0
M  V30 23 C 3.8500 4.0011 0.0 0
M  V30 24 C 2.3100 1.3338 0.0 0
M  V30 25 C 2.3100 4.0011 0.0 0
M  V30 26 C 1.5400 2.6674 0.0 0
M  V30 27 N 13.0900 4.0011 0.0 0
M  V30 28 C 13.8600 5.3349 0.0 0
M  V30 29 C 13.8600 2.6674 0.0 0
M  V30 30 C 15.4000 5.3349 0.0 0
M  V30 31 C 15.4000 2.6674 0.0 0
M  V30 32 N 16.1700 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 2 2 3
M  V30 3 1 2 24
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 32
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 19 27
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperazinecarboxylic acid, 4-[3-chloro-6-[3-[(methylamino)methyl]phenyl]-2-...
C26H31ClN4O2
2892827-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.0022 6.9302 0.0 0
M  V30 2 C 20.0057 6.1601 0.0 0
M  V30 3 N 21.3393 6.9302 0.0 0
M  V30 4 C 22.6730 6.1601 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 4.0012 0.0000 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 0.5637 2.8737 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 2.1037 0.2064 0.0 0
M  V30 12 C 12.0033 4.6201 0.0 0
M  V30 13 C 12.0033 6.1601 0.0 0
M  V30 14 N 10.6697 3.8501 0.0 0
M  V30 15 C 13.3370 3.8501 0.0 0
M  V30 16 C 13.3370 6.9302 0.0 0
M  V30 17 C 10.6697 6.9302 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 14.6708 4.6201 0.0 0
M  V30 20 C 14.6708 6.1601 0.0 0
M  V30 21 C 9.3360 6.1601 0.0 0
M  V30 22 N 8.0022 3.8501 0.0 0
M  V30 23 C 6.6685 4.6201 0.0 0
M  V30 24 C 8.0022 2.3101 0.0 0
M  V30 25 C 5.3348 3.8501 0.0 0
M  V30 26 C 6.6685 1.5400 0.0 0
M  V30 27 N 5.3348 2.3101 0.0 0
M  V30 28 C 16.0045 6.9302 0.0 0
M  V30 29 C 17.3382 6.1601 0.0 0
M  V30 30 C 16.0045 8.4702 0.0 0
M  V30 31 C 18.6718 6.9302 0.0 0
M  V30 32 C 17.3382 9.2402 0.0 0
M  V30 33 C 18.6718 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 31
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 27
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 20 28
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2892827-04-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2892827-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35707409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyridinylpiperazines, quinolinylpiperazines
and quinoxalinylpiperazines as Gram-negative bacteria efflux pump
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vieira da Cruz, Anaies; Ple, Coline; Flipo, Marion; Compagne, Nina;
Willand, Nicolas; Heng-Keat, Tam; Jimenez Castellanos, Juan Carlos; Pos,
Klass Martinus; Hartkoorn, Ruben Christiaan; Mueller, Reinke Tobias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023002011 A1 2023-01-26

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Diazabicyclo[3.1.1]heptane-6-carboxylic acid, 3-[6-(methoxycarbonyl)-3-py...
C17H23N3O4
2897691-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8292 2.9088 0.0 0
M  V30 2 O 3.0797 1.5634 0.0 0
M  V30 3 O 3.0389 4.2304 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5163 3.0797 0.0 0
M  V30 6 C 0.0000 1.5163 0.0 0
M  V30 7 C 1.5634 0.0000 0.0 0
M  V30 8 C 14.9386 4.3597 0.0 0
M  V30 9 O 15.7086 5.6934 0.0 0
M  V30 10 O 15.7086 3.0261 0.0 0
M  V30 11 C 17.2486 5.6934 0.0 0
M  V30 12 N 5.3691 2.9323 0.0 0
M  V30 13 C 6.5624 3.4131 0.0 0
M  V30 14 C 6.7669 2.4183 0.0 0
M  V30 15 C 7.7859 1.6629 0.0 0
M  V30 16 C 7.3751 4.8801 0.0 0
M  V30 17 C 7.6426 3.9384 0.0 0
M  V30 18 N 8.7786 4.3597 0.0 0
M  V30 19 C 10.3186 4.3597 0.0 0
M  V30 20 C 11.0886 3.0261 0.0 0
M  V30 21 C 11.0886 5.6934 0.0 0
M  V30 22 C 12.6286 3.0261 0.0 0
M  V30 23 N 12.6286 5.6934 0.0 0
M  V30 24 C 13.3986 4.3597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 15
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Diazabicyclo[3.1.1]heptane-6-carboxylic acid, 3-[6-[(methylamino)carbonyl...
C17H24N4O3
2897691-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8292 2.9088 0.0 0
M  V30 2 O 3.0797 1.5634 0.0 0
M  V30 3 O 3.0389 4.2304 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5163 3.0797 0.0 0
M  V30 6 C 0.0000 1.5163 0.0 0
M  V30 7 C 1.5634 0.0000 0.0 0
M  V30 8 C 14.9386 4.3597 0.0 0
M  V30 9 N 15.7086 5.6934 0.0 0
M  V30 10 O 15.7086 3.0261 0.0 0
M  V30 11 C 17.2486 5.6934 0.0 0
M  V30 12 N 5.3691 2.9323 0.0 0
M  V30 13 C 6.5624 3.4131 0.0 0
M  V30 14 C 6.7669 2.4183 0.0 0
M  V30 15 C 7.7859 1.6629 0.0 0
M  V30 16 C 7.3751 4.8801 0.0 0
M  V30 17 C 7.6426 3.9384 0.0 0
M  V30 18 N 8.7786 4.3597 0.0 0
M  V30 19 C 10.3186 4.3597 0.0 0
M  V30 20 C 11.0886 3.0261 0.0 0
M  V30 21 C 11.0886 5.6934 0.0 0
M  V30 22 C 12.6286 3.0261 0.0 0
M  V30 23 N 12.6286 5.6934 0.0 0
M  V30 24 C 13.3986 4.3597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 24
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 15
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2897691-59-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2897691-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41162527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Conte, Aurelia; Chen, Jiyun;
Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20240132522 A1 2024-04-25

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Fmoc-Gly-OH
C17H15NO4
29022-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 O 13.7554 5.2310 0.0 0
M  V30 9 O 12.4218 2.9209 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[2-(methylamino)-2-oxoethyl]carbamate
C18H18N2O3
1360114-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7531 5.2309 0.0 0
M  V30 2 O 7.0869 4.4609 0.0 0
M  V30 3 C 8.4206 5.2309 0.0 0
M  V30 4 N 9.7542 4.4609 0.0 0
M  V30 5 O 8.4206 6.7709 0.0 0
M  V30 6 C 11.0878 5.2309 0.0 0
M  V30 7 C 12.4216 4.4609 0.0 0
M  V30 8 N 13.7553 5.2309 0.0 0
M  V30 9 O 12.4216 2.9209 0.0 0
M  V30 10 C 15.0889 4.4609 0.0 0
M  V30 11 C 4.4195 4.4609 0.0 0
M  V30 12 C 4.2586 2.9292 0.0 0
M  V30 13 C 3.0127 5.0872 0.0 0
M  V30 14 C 2.7521 2.6091 0.0 0
M  V30 15 C 5.2890 1.7849 0.0 0
M  V30 16 C 1.9821 3.9429 0.0 0
M  V30 17 C 2.5368 6.5519 0.0 0
M  V30 18 C 2.2763 1.1445 0.0 0
M  V30 19 C 4.8131 0.3202 0.0 0
M  V30 20 C 0.4759 4.2630 0.0 0
M  V30 21 C 1.0304 6.8721 0.0 0
M  V30 22 C 3.3068 0.0000 0.0 0
M  V30 23 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 29022-11-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360114-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-634117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel access to 1,4-benzodiazepin-2-ones via the Buchwald reaction and
application to the synthesis of novel heterocyclics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Salome, Christophe; Schmitt, Martine; Bourguignon, Jean-Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(9), 1033-1035

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H21O3.ClO4
2904546-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3370 9.2401 0.0 0
M  V30 2 C 14.6707 8.4701 0.0 0
M  V30 3 O 0.0000 6.1600 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 C 8.0022 9.2401 0.0 0
M  V30 6 C 9.3358 8.4701 0.0 0
M  V30 7 C 8.0022 10.7801 0.0 0
M  V30 8 O 6.6685 8.4701 0.0 0 CHG=1 VAL=3
M  V30 9 C 10.6697 9.2401 0.0 0
M  V30 10 C 9.3358 6.9301 0.0 0
M  V30 11 C 6.6685 11.5502 0.0 0
M  V30 12 C 9.3358 11.5502 0.0 0
M  V30 13 C 5.3348 9.2401 0.0 0
M  V30 14 C 12.0033 8.4701 0.0 0
M  V30 15 C 10.6697 10.7801 0.0 0
M  V30 16 C 10.6697 6.1600 0.0 0
M  V30 17 C 5.3348 10.7801 0.0 0
M  V30 18 C 4.0010 8.4701 0.0 0
M  V30 19 C 12.0033 6.9301 0.0 0
M  V30 20 C 4.0010 11.5502 0.0 0
M  V30 21 C 2.6673 9.2401 0.0 0
M  V30 22 C 4.0010 6.9301 0.0 0
M  V30 23 C 2.6673 10.7801 0.0 0
M  V30 24 C 1.3337 8.4701 0.0 0
M  V30 25 C 2.6673 6.1600 0.0 0
M  V30 26 C 1.3337 6.9301 0.0 0
M  V30 27 Cl 7.3353 1.5400 0.0 0 VAL=7
M  V30 28 O 5.7953 1.5400 0.0 0
M  V30 29 O 8.8753 1.5400 0.0 0
M  V30 30 O 7.3353 0.0000 0.0 0
M  V30 31 O 7.3353 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 26
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 15
M  V30 18 2 13 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 18 22
M  V30 25 1 20 23
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 2 27 29
M  V30 33 2 27 30
M  V30 34 1 27 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-3,10-dimethoxy-14-methyl-, perchlor...
C24H24NO2.ClO4
2904546-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.9301 0.0 0
M  V30 2 O 13.3370 9.2401 0.0 0
M  V30 3 C 14.6707 8.4701 0.0 0
M  V30 4 O 0.0000 6.1600 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 C 8.0022 9.2401 0.0 0
M  V30 7 C 9.3358 8.4701 0.0 0
M  V30 8 C 8.0022 10.7801 0.0 0
M  V30 9 N 6.6685 8.4701 0.0 0 CHG=1 VAL=4
M  V30 10 C 10.6697 9.2401 0.0 0
M  V30 11 C 9.3358 6.9301 0.0 0
M  V30 12 C 6.6685 11.5502 0.0 0
M  V30 13 C 9.3358 11.5502 0.0 0
M  V30 14 C 5.3348 9.2401 0.0 0
M  V30 15 C 12.0033 8.4701 0.0 0
M  V30 16 C 10.6697 10.7801 0.0 0
M  V30 17 C 10.6697 6.1600 0.0 0
M  V30 18 C 5.3348 10.7801 0.0 0
M  V30 19 C 4.0010 8.4701 0.0 0
M  V30 20 C 12.0033 6.9301 0.0 0
M  V30 21 C 4.0010 11.5502 0.0 0
M  V30 22 C 2.6673 9.2401 0.0 0
M  V30 23 C 4.0010 6.9301 0.0 0
M  V30 24 C 2.6673 10.7801 0.0 0
M  V30 25 C 1.3337 8.4701 0.0 0
M  V30 26 C 2.6673 6.1600 0.0 0
M  V30 27 C 1.3337 6.9301 0.0 0
M  V30 28 Cl 7.3353 1.5400 0.0 0 VAL=7
M  V30 29 O 5.7953 1.5400 0.0 0
M  V30 30 O 8.8753 1.5400 0.0 0
M  V30 31 O 7.3353 0.0000 0.0 0
M  V30 32 O 7.3353 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 10 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 2 14 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 2 28 30
M  V30 34 2 28 31
M  V30 35 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2904546-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, α-[(2-bromo-5-methoxyphenyl)methylene]-4-methoxy-, (αE)-
C17H15BrO4
2906233-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.9300 0.0 0
M  V30 2 C 2.6673 6.1600 0.0 0
M  V30 3 C 4.0011 8.4700 0.0 0
M  V30 4 O 5.3347 9.2400 0.0 0
M  V30 5 O 2.6673 9.2400 0.0 0
M  V30 6 O 9.3358 3.8500 0.0 0
M  V30 7 C 10.6694 4.6200 0.0 0
M  V30 8 Br 0.0000 4.6200 0.0 0
M  V30 9 O 5.3347 1.5400 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 C 5.3347 6.1600 0.0 0
M  V30 12 C 6.6684 6.9300 0.0 0
M  V30 13 C 5.3347 4.6200 0.0 0
M  V30 14 C 8.0020 6.1600 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 8.0020 4.6200 0.0 0
M  V30 17 C 2.6673 4.6200 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 1.3336 3.8500 0.0 0
M  V30 20 C 4.0011 2.3100 0.0 0
M  V30 21 C 1.3336 2.3100 0.0 0
M  V30 22 C 2.6673 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, α-[(2-bromo-5-methoxyphenyl)methylene]-4-methoxy-N-methyl-,...
C18H18BrNO3
2906233-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 C 6.1600 8.0021 0.0 0
M  V30 3 C 8.4700 6.6684 0.0 0
M  V30 4 N 9.2400 8.0021 0.0 0
M  V30 5 O 9.2400 5.3347 0.0 0
M  V30 6 C 10.7800 8.0021 0.0 0
M  V30 7 Br 4.6200 10.6694 0.0 0
M  V30 8 O 3.8500 1.3336 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 O 1.5400 5.3347 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 16 C 3.8500 4.0011 0.0 0
M  V30 17 C 4.6200 2.6673 0.0 0
M  V30 18 C 4.6200 8.0021 0.0 0
M  V30 19 C 3.8500 6.6684 0.0 0
M  V30 20 C 3.8500 9.3358 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 2.3100 9.3358 0.0 0
M  V30 23 C 1.5400 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 17
M  V30 11 1 10 11
M  V30 12 1 10 21
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906233-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906233-37-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35547598
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed C(sp2)-N Coupling of
(E)-3-(2-Bromophenyl)-2-arylacrylamides for the Synthesis of
3-Arylquinolin-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Yi; Gu, Jiayi; Nie, Wenxing; Lu, Guoqing; Xin, Meixiu; Zhu,
Zefeng; Jiang, Jiayao; Meng, Yingfen; Miao, Hui; Zou, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2022), 7(47), e202204339

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-carboxaldehyde, 5-(2,4-dichlorophenyl)-2-methyl-1-phenyl-
C18H13Cl2NO
2906967-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6286 1.8403 0.0 0
M  V30 2 C 9.3038 4.7419 0.0 0
M  V30 3 O 9.9301 6.1487 0.0 0
M  V30 4 Cl 5.3348 8.1791 0.0 0
M  V30 5 Cl 0.0000 8.1791 0.0 0
M  V30 6 N 5.4958 3.5673 0.0 0
M  V30 7 C 5.3348 5.0991 0.0 0
M  V30 8 C 7.0022 3.2472 0.0 0
M  V30 9 C 6.7417 5.7254 0.0 0
M  V30 10 C 7.7722 4.5810 0.0 0
M  V30 11 C 4.3514 2.5369 0.0 0
M  V30 12 C 4.6715 1.0306 0.0 0
M  V30 13 C 2.8866 3.0128 0.0 0
M  V30 14 C 3.5270 0.0000 0.0 0
M  V30 15 C 1.7422 1.9823 0.0 0
M  V30 16 C 2.0624 0.4760 0.0 0
M  V30 17 C 4.0012 5.8691 0.0 0
M  V30 18 C 4.0012 7.4091 0.0 0
M  V30 19 C 2.6673 5.0991 0.0 0
M  V30 20 C 2.6673 8.1791 0.0 0
M  V30 21 C 1.3337 5.8691 0.0 0
M  V30 22 C 1.3337 7.4091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 18
M  V30 5 1 5 22
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-methanamine, 5-(2,4-dichlorophenyl)-N,2-dimethyl-1-phenyl-
C19H18Cl2N2
2906967-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6285 1.8403 0.0 0
M  V30 2 C 9.3037 4.7419 0.0 0
M  V30 3 N 9.9302 6.1487 0.0 0
M  V30 4 C 11.4618 6.3098 0.0 0
M  V30 5 Cl 5.3348 8.1791 0.0 0
M  V30 6 Cl 0.0000 8.1791 0.0 0
M  V30 7 N 5.4959 3.5673 0.0 0
M  V30 8 C 5.3348 5.0990 0.0 0
M  V30 9 C 7.0022 3.2471 0.0 0
M  V30 10 C 6.7418 5.7253 0.0 0
M  V30 11 C 7.7722 4.5810 0.0 0
M  V30 12 C 4.3513 2.5369 0.0 0
M  V30 13 C 4.6715 1.0306 0.0 0
M  V30 14 C 2.8868 3.0127 0.0 0
M  V30 15 C 3.5271 0.0000 0.0 0
M  V30 16 C 1.7422 1.9823 0.0 0
M  V30 17 C 2.0624 0.4760 0.0 0
M  V30 18 C 4.0011 5.8690 0.0 0
M  V30 19 C 4.0011 7.4091 0.0 0
M  V30 20 C 2.6675 5.0990 0.0 0
M  V30 21 C 2.6675 8.1791 0.0 0
M  V30 22 C 1.3337 5.8690 0.0 0
M  V30 23 C 1.3337 7.4091 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 19
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 8 18
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906967-03-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906967-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35560098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 1-(1,5-bis(4-substituted
phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors
with potential antidepressant action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wunnava, Anjani Uma Rani; Kurati, Sony Priya; Eswar Kumar, Kilari;
Muthyala, Murali Krishna Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Medicinal Chemistry (2023), 14(2), 393-402

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-carboxaldehyde, 5-(4-chlorophenyl)-2-methyl-1-phenyl-
C18H14ClNO
2906967-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6286 1.8403 0.0 0
M  V30 2 C 9.3038 4.7419 0.0 0
M  V30 3 O 9.9301 6.1487 0.0 0
M  V30 4 Cl 0.0000 8.1791 0.0 0
M  V30 5 C 5.3348 5.0991 0.0 0
M  V30 6 N 5.4958 3.5673 0.0 0
M  V30 7 C 6.7417 5.7254 0.0 0
M  V30 8 C 7.0022 3.2472 0.0 0
M  V30 9 C 7.7722 4.5810 0.0 0
M  V30 10 C 4.0012 5.8691 0.0 0
M  V30 11 C 2.6673 5.0991 0.0 0
M  V30 12 C 4.0012 7.4091 0.0 0
M  V30 13 C 1.3337 5.8691 0.0 0
M  V30 14 C 2.6673 8.1791 0.0 0
M  V30 15 C 1.3337 7.4091 0.0 0
M  V30 16 C 4.3514 2.5369 0.0 0
M  V30 17 C 2.8866 3.0128 0.0 0
M  V30 18 C 4.6715 1.0306 0.0 0
M  V30 19 C 1.7422 1.9823 0.0 0
M  V30 20 C 3.5270 0.0000 0.0 0
M  V30 21 C 2.0624 0.4760 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 9
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-methanamine, 5-(4-chlorophenyl)-N,2-dimethyl-1-phenyl-
C19H19ClN2
2906967-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6285 1.8403 0.0 0
M  V30 2 C 9.3037 4.7419 0.0 0
M  V30 3 N 9.9302 6.1487 0.0 0
M  V30 4 C 11.4618 6.3098 0.0 0
M  V30 5 Cl 0.0000 8.1791 0.0 0
M  V30 6 C 5.3348 5.0990 0.0 0
M  V30 7 N 5.4959 3.5673 0.0 0
M  V30 8 C 6.7418 5.7253 0.0 0
M  V30 9 C 7.0022 3.2471 0.0 0
M  V30 10 C 7.7722 4.5810 0.0 0
M  V30 11 C 4.0011 5.8690 0.0 0
M  V30 12 C 4.0011 7.4091 0.0 0
M  V30 13 C 2.6675 5.0990 0.0 0
M  V30 14 C 2.6675 8.1791 0.0 0
M  V30 15 C 1.3337 5.8690 0.0 0
M  V30 16 C 1.3337 7.4091 0.0 0
M  V30 17 C 4.3513 2.5369 0.0 0
M  V30 18 C 4.6715 1.0306 0.0 0
M  V30 19 C 2.8866 3.0127 0.0 0
M  V30 20 C 3.5271 0.0000 0.0 0
M  V30 21 C 1.7422 1.9823 0.0 0
M  V30 22 C 2.0624 0.4760 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906967-06-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906967-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35560117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 1-(1,5-bis(4-substituted
phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors
with potential antidepressant action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wunnava, Anjani Uma Rani; Kurati, Sony Priya; Eswar Kumar, Kilari;
Muthyala, Murali Krishna Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Medicinal Chemistry (2023), 14(2), 393-402

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-carboxaldehyde, 5-(4-chlorophenyl)-2-methyl-1-(4-methylphenyl)-
C19H16ClNO
2906967-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5932 9.8150 0.0 0
M  V30 2 C 1.4068 8.7797 0.0 0
M  V30 3 O 0.0000 8.1532 0.0 0
M  V30 4 C 11.1826 7.1045 0.0 0
M  V30 5 Cl 6.0209 0.0000 0.0 0
M  V30 6 N 5.0226 7.1045 0.0 0
M  V30 7 C 4.1173 5.8586 0.0 0
M  V30 8 C 4.1173 8.3503 0.0 0
M  V30 9 C 2.6528 6.3345 0.0 0
M  V30 10 C 2.6528 7.8745 0.0 0
M  V30 11 C 6.5626 7.1045 0.0 0
M  V30 12 C 7.3326 5.7708 0.0 0
M  V30 13 C 7.3326 8.4381 0.0 0
M  V30 14 C 8.8726 5.7708 0.0 0
M  V30 15 C 8.8726 8.4381 0.0 0
M  V30 16 C 9.6426 7.1045 0.0 0
M  V30 17 C 4.5932 4.3939 0.0 0
M  V30 18 C 6.0996 4.0738 0.0 0
M  V30 19 C 3.5628 3.2496 0.0 0
M  V30 20 C 6.5755 2.6091 0.0 0
M  V30 21 C 4.0387 1.7849 0.0 0
M  V30 22 C 5.5451 1.4647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 16
M  V30 5 1 5 22
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-methanamine, 5-(4-chlorophenyl)-N,2-dimethyl-1-(4-methylphenyl)-
C20H21ClN2
2906967-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5894 9.8150 0.0 0
M  V30 2 C 9.7756 8.7797 0.0 0
M  V30 3 N 11.1826 8.1532 0.0 0
M  V30 4 C 12.4284 9.0584 0.0 0
M  V30 5 C 0.0000 7.1045 0.0 0
M  V30 6 Cl 5.1616 0.0000 0.0 0
M  V30 7 N 6.1600 7.1045 0.0 0
M  V30 8 C 7.0652 5.8586 0.0 0
M  V30 9 C 7.0652 8.3503 0.0 0
M  V30 10 C 8.5298 6.3345 0.0 0
M  V30 11 C 8.5298 7.8745 0.0 0
M  V30 12 C 4.6200 7.1045 0.0 0
M  V30 13 C 3.8500 8.4381 0.0 0
M  V30 14 C 3.8500 5.7708 0.0 0
M  V30 15 C 2.3100 8.4381 0.0 0
M  V30 16 C 2.3100 5.7708 0.0 0
M  V30 17 C 1.5400 7.1045 0.0 0
M  V30 18 C 6.5894 4.3939 0.0 0
M  V30 19 C 7.6198 3.2496 0.0 0
M  V30 20 C 5.0829 4.0738 0.0 0
M  V30 21 C 7.1439 1.7849 0.0 0
M  V30 22 C 4.6071 2.6091 0.0 0
M  V30 23 C 5.6375 1.4647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 17
M  V30 6 1 6 23
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 8 18
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906967-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906967-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35560115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 1-(1,5-bis(4-substituted
phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors
with potential antidepressant action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wunnava, Anjani Uma Rani; Kurati, Sony Priya; Eswar Kumar, Kilari;
Muthyala, Murali Krishna Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Medicinal Chemistry (2023), 14(2), 393-402

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-carboxaldehyde, 5-(2-chlorophenyl)-2-methyl-1-phenyl-
C18H14ClNO
2906967-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5027 7.9699 0.0 0
M  V30 2 Cl 6.6855 1.3337 0.0 0
M  V30 3 C 8.4042 6.2948 0.0 0
M  V30 4 O 9.6501 5.3896 0.0 0
M  V30 5 C 5.1455 4.0010 0.0 0
M  V30 6 N 4.5192 5.4079 0.0 0
M  V30 7 C 6.6771 4.1621 0.0 0
M  V30 8 C 5.6636 6.4384 0.0 0
M  V30 9 C 6.9972 5.6684 0.0 0
M  V30 10 C 4.3755 2.6673 0.0 0
M  V30 11 C 5.1455 1.3337 0.0 0
M  V30 12 C 2.8355 2.6673 0.0 0
M  V30 13 C 4.3755 0.0000 0.0 0
M  V30 14 C 2.0655 1.3337 0.0 0
M  V30 15 C 2.8355 0.0000 0.0 0
M  V30 16 C 3.0127 5.7281 0.0 0
M  V30 17 C 2.5369 7.1928 0.0 0
M  V30 18 C 1.9823 4.5837 0.0 0
M  V30 19 C 1.0304 7.5130 0.0 0
M  V30 20 C 0.4759 4.9039 0.0 0
M  V30 21 C 0.0000 6.3685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-methanamine, 5-(2-chlorophenyl)-N,2-dimethyl-1-phenyl-
C19H19ClN2
2906967-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5027 7.9700 0.0 0
M  V30 2 Cl 6.6856 1.3337 0.0 0
M  V30 3 C 8.4042 6.2949 0.0 0
M  V30 4 N 9.6501 5.3896 0.0 0
M  V30 5 C 11.0571 6.0160 0.0 0
M  V30 6 C 5.1455 4.0010 0.0 0
M  V30 7 N 4.5192 5.4080 0.0 0
M  V30 8 C 6.6771 4.1621 0.0 0
M  V30 9 C 5.6636 6.4384 0.0 0
M  V30 10 C 6.9974 5.6684 0.0 0
M  V30 11 C 4.3755 2.6673 0.0 0
M  V30 12 C 5.1455 1.3337 0.0 0
M  V30 13 C 2.8355 2.6673 0.0 0
M  V30 14 C 4.3755 0.0000 0.0 0
M  V30 15 C 2.0655 1.3337 0.0 0
M  V30 16 C 2.8355 0.0000 0.0 0
M  V30 17 C 3.0128 5.7281 0.0 0
M  V30 18 C 2.5369 7.1929 0.0 0
M  V30 19 C 1.9823 4.5837 0.0 0
M  V30 20 C 1.0306 7.5130 0.0 0
M  V30 21 C 0.4760 4.9039 0.0 0
M  V30 22 C 0.0000 6.3685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906967-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906967-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35560120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 1-(1,5-bis(4-substituted
phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors
with potential antidepressant action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wunnava, Anjani Uma Rani; Kurati, Sony Priya; Eswar Kumar, Kilari;
Muthyala, Murali Krishna Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Medicinal Chemistry (2023), 14(2), 393-402

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-carboxaldehyde, 5-(2-chlorophenyl)-1-(4-chlorophenyl)-2-methyl-
C18H13Cl2NO
2906967-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0089 7.9699 0.0 0
M  V30 2 C 9.9105 6.2948 0.0 0
M  V30 3 O 11.1565 5.3896 0.0 0
M  V30 4 Cl 8.1920 1.3337 0.0 0
M  V30 5 Cl 0.0000 6.6886 0.0 0
M  V30 6 N 6.0255 5.4079 0.0 0
M  V30 7 C 6.6520 4.0010 0.0 0
M  V30 8 C 7.1700 6.4384 0.0 0
M  V30 9 C 8.1835 4.1621 0.0 0
M  V30 10 C 8.5037 5.6684 0.0 0
M  V30 11 C 4.5192 5.7281 0.0 0
M  V30 12 C 4.0433 7.1928 0.0 0
M  V30 13 C 3.4888 4.5837 0.0 0
M  V30 14 C 2.5369 7.5130 0.0 0
M  V30 15 C 1.9823 4.9039 0.0 0
M  V30 16 C 1.5064 6.3685 0.0 0
M  V30 17 C 5.8820 2.6673 0.0 0
M  V30 18 C 6.6520 1.3337 0.0 0
M  V30 19 C 4.3419 2.6673 0.0 0
M  V30 20 C 5.8820 0.0000 0.0 0
M  V30 21 C 3.5719 1.3337 0.0 0
M  V30 22 C 4.3419 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 18
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-methanamine, 5-(2-chlorophenyl)-1-(4-chlorophenyl)-N,2-dimethyl-
C19H18Cl2N2
2906967-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0090 7.9700 0.0 0
M  V30 2 C 9.9106 6.2949 0.0 0
M  V30 3 N 11.1565 5.3897 0.0 0
M  V30 4 C 12.5633 6.0160 0.0 0
M  V30 5 Cl 8.1919 1.3337 0.0 0
M  V30 6 Cl 0.0000 6.6887 0.0 0
M  V30 7 N 6.0255 5.4080 0.0 0
M  V30 8 C 6.6519 4.0010 0.0 0
M  V30 9 C 7.1699 6.4384 0.0 0
M  V30 10 C 8.1834 4.1621 0.0 0
M  V30 11 C 8.5036 5.6684 0.0 0
M  V30 12 C 4.5191 5.7282 0.0 0
M  V30 13 C 3.4886 4.5838 0.0 0
M  V30 14 C 4.0432 7.1929 0.0 0
M  V30 15 C 1.9822 4.9039 0.0 0
M  V30 16 C 2.5367 7.5131 0.0 0
M  V30 17 C 1.5063 6.3685 0.0 0
M  V30 18 C 5.8819 2.6673 0.0 0
M  V30 19 C 6.6519 1.3337 0.0 0
M  V30 20 C 4.3418 2.6673 0.0 0
M  V30 21 C 5.8819 0.0000 0.0 0
M  V30 22 C 3.5718 1.3337 0.0 0
M  V30 23 C 4.3418 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 5 19
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 8 18
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906967-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906967-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35560116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 1-(1,5-bis(4-substituted
phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors
with potential antidepressant action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wunnava, Anjani Uma Rani; Kurati, Sony Priya; Eswar Kumar, Kilari;
Muthyala, Murali Krishna Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Medicinal Chemistry (2023), 14(2), 393-402

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-2-methyl-1-phenyl-
C18H14FNO
2906967-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5027 7.9699 0.0 0
M  V30 2 F 6.6855 1.3337 0.0 0
M  V30 3 C 8.4042 6.2948 0.0 0
M  V30 4 O 9.6501 5.3896 0.0 0
M  V30 5 C 5.1455 4.0010 0.0 0
M  V30 6 N 4.5192 5.4079 0.0 0
M  V30 7 C 6.6771 4.1621 0.0 0
M  V30 8 C 5.6636 6.4384 0.0 0
M  V30 9 C 6.9972 5.6684 0.0 0
M  V30 10 C 4.3755 2.6673 0.0 0
M  V30 11 C 5.1455 1.3337 0.0 0
M  V30 12 C 2.8355 2.6673 0.0 0
M  V30 13 C 4.3755 0.0000 0.0 0
M  V30 14 C 2.0655 1.3337 0.0 0
M  V30 15 C 2.8355 0.0000 0.0 0
M  V30 16 C 3.0127 5.7281 0.0 0
M  V30 17 C 2.5369 7.1928 0.0 0
M  V30 18 C 1.9823 4.5837 0.0 0
M  V30 19 C 1.0304 7.5130 0.0 0
M  V30 20 C 0.4759 4.9039 0.0 0
M  V30 21 C 0.0000 6.3685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N,2-dimethyl-1-phenyl-
C19H19FN2
2906967-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5027 7.9700 0.0 0
M  V30 2 F 6.6856 1.3337 0.0 0
M  V30 3 C 8.4042 6.2949 0.0 0
M  V30 4 N 9.6501 5.3896 0.0 0
M  V30 5 C 11.0571 6.0160 0.0 0
M  V30 6 C 5.1455 4.0010 0.0 0
M  V30 7 N 4.5192 5.4080 0.0 0
M  V30 8 C 6.6771 4.1621 0.0 0
M  V30 9 C 5.6636 6.4384 0.0 0
M  V30 10 C 6.9974 5.6684 0.0 0
M  V30 11 C 4.3755 2.6673 0.0 0
M  V30 12 C 5.1455 1.3337 0.0 0
M  V30 13 C 2.8355 2.6673 0.0 0
M  V30 14 C 4.3755 0.0000 0.0 0
M  V30 15 C 2.0655 1.3337 0.0 0
M  V30 16 C 2.8355 0.0000 0.0 0
M  V30 17 C 3.0128 5.7281 0.0 0
M  V30 18 C 2.5369 7.1929 0.0 0
M  V30 19 C 1.9823 4.5837 0.0 0
M  V30 20 C 1.0306 7.5130 0.0 0
M  V30 21 C 0.4760 4.9039 0.0 0
M  V30 22 C 0.0000 6.3685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2906967-11-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2906967-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35560122
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 1-(1,5-bis(4-substituted
phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors
with potential antidepressant action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wunnava, Anjani Uma Rani; Kurati, Sony Priya; Eswar Kumar, Kilari;
Muthyala, Murali Krishna Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Medicinal Chemistry (2023), 14(2), 393-402

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrylium, 4-(4-methoxyphenyl)-2,6-diphenyl-, tetrafluoroborate(1-) (1:1)
C24H19O2.BF4
2907-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0031 14.6300 0.0 0
M  V30 2 C 13.3367 13.8600 0.0 0
M  V30 3 C 6.6684 11.5500 0.0 0
M  V30 4 C 6.6684 10.0100 0.0 0
M  V30 5 C 5.3347 12.3200 0.0 0
M  V30 6 C 5.3347 9.2400 0.0 0
M  V30 7 C 4.0009 11.5500 0.0 0
M  V30 8 O 4.0009 10.0100 0.0 0 CHG=1 VAL=3
M  V30 9 C 8.0020 12.3200 0.0 0
M  V30 10 C 9.3358 11.5500 0.0 0
M  V30 11 C 8.0020 13.8600 0.0 0
M  V30 12 C 10.6694 12.3200 0.0 0
M  V30 13 C 9.3358 14.6300 0.0 0
M  V30 14 C 10.6694 13.8600 0.0 0
M  V30 15 C 5.3347 7.7000 0.0 0
M  V30 16 C 4.0009 6.9300 0.0 0
M  V30 17 C 6.6684 6.9300 0.0 0
M  V30 18 C 4.0009 5.3900 0.0 0
M  V30 19 C 6.6684 5.3900 0.0 0
M  V30 20 C 5.3347 4.6200 0.0 0
M  V30 21 C 2.6673 12.3200 0.0 0
M  V30 22 C 2.6673 13.8600 0.0 0
M  V30 23 C 1.3336 11.5500 0.0 0
M  V30 24 C 1.3336 14.6300 0.0 0
M  V30 25 C 0.0000 12.3200 0.0 0
M  V30 26 C 0.0000 13.8600 0.0 0
M  V30 27 B 6.6684 1.5400 0.0 0 CHG=3 VAL=4
M  V30 28 F 5.1284 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 29 F 8.2084 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 30 F 6.6684 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 31 F 6.6684 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 1 7 21
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 4-(4-methoxyphenyl)-1-methyl-2,6-diphenyl-, tetrafluoroborate(1-)...
C25H22NO.BF4
476682-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 9.2401 0.0 0
M  V30 2 O 12.0032 14.6301 0.0 0
M  V30 3 C 13.3369 13.8601 0.0 0
M  V30 4 C 4.0010 11.5501 0.0 0
M  V30 5 N 4.0010 10.0101 0.0 0 CHG=1 VAL=4
M  V30 6 C 5.3348 12.3201 0.0 0
M  V30 7 C 5.3348 9.2401 0.0 0
M  V30 8 C 6.6684 11.5501 0.0 0
M  V30 9 C 6.6684 10.0101 0.0 0
M  V30 10 C 2.6673 12.3201 0.0 0
M  V30 11 C 2.6673 13.8601 0.0 0
M  V30 12 C 1.3337 11.5501 0.0 0
M  V30 13 C 1.3337 14.6301 0.0 0
M  V30 14 C 0.0000 12.3201 0.0 0
M  V30 15 C 0.0000 13.8601 0.0 0
M  V30 16 C 5.3348 7.7000 0.0 0
M  V30 17 C 4.0010 6.9300 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 4.0010 5.3900 0.0 0
M  V30 20 C 6.6684 5.3900 0.0 0
M  V30 21 C 5.3348 4.6200 0.0 0
M  V30 22 C 8.0021 12.3201 0.0 0
M  V30 23 C 9.3359 11.5501 0.0 0
M  V30 24 C 8.0021 13.8601 0.0 0
M  V30 25 C 10.6695 12.3201 0.0 0
M  V30 26 C 9.3359 14.6301 0.0 0
M  V30 27 C 10.6695 13.8601 0.0 0
M  V30 28 B 6.6684 1.5400 0.0 0 CHG=3 VAL=4
M  V30 29 F 5.1284 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 30 F 8.2084 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 31 F 6.6684 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 32 F 6.6684 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 1 2 27
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 1 8 22
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2907-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476682-49-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9574271
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of 2,6-diphenyl-4-arylpyrylium tetrafluoroborate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Shrong Shi; Li, Cheng Yong; Wang, Xuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2002), 13(7), 605-606

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dioxan-4-one, 6-(4-acetylphenyl)-, (6S)-
C12H12O4
2909531-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 C 9.3358 1.5400 0.0 0
M  V30 3 C 9.3358 0.0000 0.0 0
M  V30 4 O 10.6694 2.3100 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 8.0021 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 12 C 2.6673 3.8500 0.0 0
M  V30 13 O 4.0011 6.1600 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6673 6.9300 0.0 0
M  V30 16 O 1.3336 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 11 5 CFG=3
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, 4-acetyl-β-hydroxy-N-methyl-, (βS)-
C12H15NO3
2909531-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0 CFG=1
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 10.6695 3.8500 0.0 0
M  V30 6 O 9.3359 6.1601 0.0 0
M  V30 7 C 12.0032 4.6201 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2909531-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2909531-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35676963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective C(sp3)-H Functionalization of Oxacycles via
Photo-HAT/Nickel Dual Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Sheng; Ping, Yuanyuan; Li, Wei; Guo, Haoyun; Su, Yinyan; Li, Ziyang;
Wang, Minyan; Kong, Wangqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2023), 145(9), 5231-5241

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Mannopyranose, 2-deoxy-2-isothiocyanato-, 1,3,4,6-tetraacetate
C15H19NO9S
294639-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 8.4700 0.0 0
M  V30 2 C 4.0011 9.2400 0.0 0
M  V30 3 C 2.6673 8.4700 0.0 0
M  V30 4 O 4.0011 10.7800 0.0 0
M  V30 5 O 2.6673 6.9300 0.0 0
M  V30 6 C 1.3336 6.1600 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 O 0.0000 6.9300 0.0 0
M  V30 9 C 8.0020 6.9300 0.0 0
M  V30 10 O 9.3358 6.1600 0.0 0
M  V30 11 C 10.6694 6.9300 0.0 0
M  V30 12 C 12.0031 6.1600 0.0 0
M  V30 13 O 10.6694 8.4700 0.0 0
M  V30 14 N 2.6673 3.8500 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 S 2.6673 0.7700 0.0 0
M  V30 17 O 5.3347 2.3100 0.0 0
M  V30 18 C 6.6684 1.5400 0.0 0
M  V30 19 C 6.6684 0.0000 0.0 0
M  V30 20 O 8.0020 2.3100 0.0 0
M  V30 21 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 22 C 4.0011 6.1600 0.0 0 CFG=2
M  V30 23 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 24 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 25 O 6.6684 4.6200 0.0 0
M  V30 26 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 14 15
M  V30 15 1 24 14 CFG=1
M  V30 16 2 15 16
M  V30 17 1 17 18
M  V30 18 1 26 17 CFG=3
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 21 22 23 24 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
α-D-Mannopyranose, 2-deoxy-2-[[(methylamino)thioxomethyl]amino]-, 1,3,4,6-tet...
C16H24N2O9S
1817619-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 5.3347 0.0 0
M  V30 2 C 2.3100 6.6684 0.0 0
M  V30 3 N 0.7700 6.6684 0.0 0
M  V30 4 S 3.0800 8.0021 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 O 4.6200 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 O 2.3100 4.0011 0.0 0
M  V30 10 O 4.6200 8.0021 0.0 0
M  V30 11 C 5.3900 9.3358 0.0 0
M  V30 12 C 4.6200 10.6694 0.0 0
M  V30 13 O 6.9300 9.3358 0.0 0
M  V30 14 O 7.7000 2.6673 0.0 0
M  V30 15 C 6.9300 1.3336 0.0 0
M  V30 16 C 5.3900 1.3336 0.0 0
M  V30 17 O 7.7000 0.0000 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 O 10.0100 6.6684 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 12.3200 8.0021 0.0 0
M  V30 22 O 12.3200 5.3347 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 24 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 25 C 5.3900 6.6684 0.0 0 CFG=1
M  V30 26 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 27 O 6.9300 6.6684 0.0 0
M  V30 28 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 25 10 CFG=1
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 26 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 28 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 294639-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1817619-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-15810298
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of NAM-thiazoline derivatives as novel O-GlcNAcase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kong, Hanchu; Chen, Wei; Liu, Tian; Lu, Huizhe; Yang, Qing; Dong,
Yanhong; Liang, Xiaomei; Jin, Shuhui; Zhang, Jianjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2016), 42954-61

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Diazabicyclo[3.2.1]octane-8-carboxylic acid, 3-[5-(methoxycarbonyl)-2-pyr...
C17H24N4O4
2958660-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8292 2.9086 0.0 0
M  V30 2 O 3.0797 1.5634 0.0 0
M  V30 3 O 3.0390 4.2304 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5164 3.0797 0.0 0
M  V30 6 C 0.0000 1.5164 0.0 0
M  V30 7 C 1.5634 0.0000 0.0 0
M  V30 8 C 15.1031 4.4283 0.0 0
M  V30 9 O 15.8731 5.7621 0.0 0
M  V30 10 O 15.8731 3.0946 0.0 0
M  V30 11 C 17.4131 5.7621 0.0 0
M  V30 12 C 6.6202 3.4360 0.0 0
M  V30 13 N 5.3691 2.9322 0.0 0
M  V30 14 C 7.4721 4.9739 0.0 0
M  V30 15 C 7.4793 2.2412 0.0 0
M  V30 16 C 6.8345 2.3933 0.0 0
M  V30 17 N 8.9431 4.4283 0.0 0
M  V30 18 C 7.5115 0.8678 0.0 0
M  V30 19 C 7.7522 3.9868 0.0 0
M  V30 20 C 10.4831 4.4283 0.0 0
M  V30 21 N 11.2531 5.7621 0.0 0
M  V30 22 N 11.2531 3.0946 0.0 0
M  V30 23 C 12.7931 5.7621 0.0 0
M  V30 24 C 12.7931 3.0946 0.0 0
M  V30 25 C 13.5631 4.4283 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Diazabicyclo[3.2.1]octane-8-carboxylic acid, 3-[5-[(methylamino)carbonyl]...
C17H25N5O3
2958660-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8292 2.9086 0.0 0
M  V30 2 O 3.0797 1.5634 0.0 0
M  V30 3 O 3.0390 4.2304 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5164 3.0797 0.0 0
M  V30 6 C 0.0000 1.5164 0.0 0
M  V30 7 C 1.5634 0.0000 0.0 0
M  V30 8 C 15.1031 4.4283 0.0 0
M  V30 9 N 15.8731 5.7621 0.0 0
M  V30 10 O 15.8731 3.0946 0.0 0
M  V30 11 C 17.4131 5.7621 0.0 0
M  V30 12 C 6.6202 3.4360 0.0 0
M  V30 13 N 5.3691 2.9322 0.0 0
M  V30 14 C 7.4721 4.9739 0.0 0
M  V30 15 C 7.4793 2.2412 0.0 0
M  V30 16 C 6.8345 2.3933 0.0 0
M  V30 17 N 8.9431 4.4283 0.0 0
M  V30 18 C 7.5115 0.8678 0.0 0
M  V30 19 C 7.7522 3.9868 0.0 0
M  V30 20 C 10.4831 4.4283 0.0 0
M  V30 21 N 11.2531 5.7621 0.0 0
M  V30 22 N 11.2531 3.0946 0.0 0
M  V30 23 C 12.7931 5.7621 0.0 0
M  V30 24 C 12.7931 3.0946 0.0 0
M  V30 25 C 13.5631 4.4283 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2958660-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2958660-82-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37576685
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (4-piperazin-1-yl)-4-alkyl-phthalazin-1(2H)-one compounds
and analogs as poly(adp-ribose) polymerase 7 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vakkalanka, Swaroop Kumar Venkata Satya; Bhuniya, Debnath; Eleswarapu,
Venkata Satyanarayana; Babu, Govindarajulu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023139536 A1 2023-07-27

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-5-sulfonyl chloride, 1-(2,6-dichlorophenyl)-2,3-dihydro-2-oxo-
C14H8Cl3NO3S
2958723-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.2587 5.8689 0.0 0
M  V30 2 Cl 0.8242 4.5191 0.0 0
M  V30 3 Cl 4.3938 0.5546 0.0 0
M  V30 4 S 9.8797 3.2471 0.0 0 VAL=6
M  V30 5 Cl 11.4197 3.2471 0.0 0
M  V30 6 O 9.8797 4.7871 0.0 0
M  V30 7 O 9.8797 1.7071 0.0 0
M  V30 8 C 5.2597 3.2471 0.0 0
M  V30 9 N 3.7534 3.5673 0.0 0
M  V30 10 C 6.0297 4.5809 0.0 0
M  V30 11 C 6.0297 1.9135 0.0 0
M  V30 12 C 3.5925 5.0989 0.0 0
M  V30 13 C 4.9993 5.7253 0.0 0
M  V30 14 C 7.5697 4.5809 0.0 0
M  V30 15 C 7.5697 1.9135 0.0 0
M  V30 16 C 8.3397 3.2471 0.0 0
M  V30 17 C 2.6091 2.5368 0.0 0
M  V30 18 C 1.1444 3.0127 0.0 0
M  V30 19 C 2.9292 1.0306 0.0 0
M  V30 20 C 0.0000 1.9823 0.0 0
M  V30 21 C 1.7847 0.0000 0.0 0
M  V30 22 C 0.3202 0.4760 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 18
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 4 7
M  V30 7 1 4 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 17
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-5-sulfonamide, 1-(2,6-dichlorophenyl)-2,3-dihydro-N-methyl-2-oxo-
C15H12Cl2N2O3S
2958723-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.2587 5.8689 0.0 0
M  V30 2 Cl 4.3938 0.5546 0.0 0
M  V30 3 Cl 0.8242 4.5191 0.0 0
M  V30 4 S 9.8797 3.2471 0.0 0 VAL=6
M  V30 5 N 11.4197 3.2471 0.0 0
M  V30 6 O 9.8797 1.7071 0.0 0
M  V30 7 O 9.8797 4.7871 0.0 0
M  V30 8 C 12.1897 1.9135 0.0 0
M  V30 9 N 3.7534 3.5673 0.0 0
M  V30 10 C 5.2597 3.2471 0.0 0
M  V30 11 C 3.5925 5.0989 0.0 0
M  V30 12 C 6.0297 4.5809 0.0 0
M  V30 13 C 6.0297 1.9135 0.0 0
M  V30 14 C 4.9993 5.7253 0.0 0
M  V30 15 C 7.5697 4.5809 0.0 0
M  V30 16 C 7.5697 1.9135 0.0 0
M  V30 17 C 8.3397 3.2471 0.0 0
M  V30 18 C 2.6091 2.5368 0.0 0
M  V30 19 C 2.9292 1.0306 0.0 0
M  V30 20 C 1.1444 3.0127 0.0 0
M  V30 21 C 1.7847 0.0000 0.0 0
M  V30 22 C 0.0000 1.9823 0.0 0
M  V30 23 C 0.3202 0.4760 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 19
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 4 7
M  V30 7 1 4 17
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2958723-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2958723-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37229174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel sulfonamide-functionalized arylidene indolones as potent
α-glucosidase inhibitors: Synthesis, characterization and in vitro and in
silico studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nguyen, Giang V.; Dang, Hoang T.; Nguyen, Luyen D.; Nguyen, Hai V.; Le,
Huong T.; Nguyen, Huy H. N.; Nguyen, An V.; Nguyen, Yen H.; Nguyen,
Van-Ha; Do, Huy-Hoang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Mendeleev Communications (2023), 33(4), 543-545

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
3-(3-Methylphenyl)-2-propynoic acid
C10H8O2
29835-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 8.0022 0.0000 0.0 0
M  V30 5 O 9.3359 2.3100 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 5.3901 0.0 0
M  V30 10 C 1.3337 3.8500 0.0 0
M  V30 11 C 2.6675 6.1601 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(3-methylphenyl)-2-propynamide
C11H11NO
2093275-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 N 9.3360 2.3101 0.0 0
M  V30 5 O 8.0023 0.0000 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 29835-27-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2093275-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16999826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of amine/THF stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substrate-Assisted, Transition-Metal-Free Diboration of Alkynamides with
Mixed Diboron: Regio- and Stereoselective Access to
trans-1,2-Vinyldiboronates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verma, Astha; Snead, Russell F.; Dai, Yumin; Slebodnick, Carla; Yang,
Yinuo; Yu, Haizhu; Yao, Fu; Santos, Webster L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(18), 5111-5115

$RFMT $RIREG SCHEME271 STEP1
$RXN



  5  1
$MOL
Quinoline
C9H7N
91-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Isothiocyanatomethyl)-4-methylbenzene
C9H9NS
3694-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 6.9300 2.6673 0.0 0
M  V30 3 C 8.4700 2.6673 0.0 0
M  V30 4 S 10.0100 2.6673 0.0 0
M  V30 5 C 0.0000 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 2 3 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-5-carboxaldehyde, 6-amino-2-(1-methylethenyl)-
C12H12N2O
2991873-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 5.2891 0.0 0
M  V30 2 C 8.3912 6.8291 0.0 0
M  V30 3 C 9.7250 4.5191 0.0 0
M  V30 4 C 0.7700 2.6673 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 N 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 5.6507 5.1455 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 N 6.8966 2.9875 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 7.0575 4.5191 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 4 5
M  V30 5 1 4 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
15cH-Indolizino[3,2-f]quino[1,2-c]quinazoline-13,14-dicarboxylic acid, 11-met...
C37H33N5O4
2991873-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5128 7.4720 0.0 0
M  V30 2 O 5.2719 8.9930 0.0 0
M  V30 3 O 6.9505 6.9200 0.0 0
M  V30 4 C 3.8342 9.5448 0.0 0
M  V30 5 C 10.4080 2.3100 0.0 0
M  V30 6 N 10.4080 0.7700 0.0 0
M  V30 7 C 11.7416 0.0000 0.0 0
M  V30 8 C 1.6004 2.7651 0.0 0
M  V30 9 C 2.1580 8.0706 0.0 0
M  V30 10 O 0.6265 8.2316 0.0 0
M  V30 11 O 3.0632 9.3166 0.0 0
M  V30 12 C 0.0000 9.6384 0.0 0
M  V30 13 N 11.7416 7.7000 0.0 0
M  V30 14 C 13.0754 6.9300 0.0 0
M  V30 15 C 18.4102 10.0101 0.0 0
M  V30 16 C 6.4069 4.6200 0.0 0
M  V30 17 C 7.7407 5.3900 0.0 0
M  V30 18 N 4.9423 5.0959 0.0 0
M  V30 19 C 6.4069 3.0800 0.0 0
M  V30 20 C 7.7407 6.9300 0.0 0
M  V30 21 C 9.0743 4.6200 0.0 0
M  V30 22 C 4.0371 3.8500 0.0 0
M  V30 23 C 4.3159 6.5028 0.0 0
M  V30 24 C 4.9423 2.6042 0.0 0
M  V30 25 C 7.7407 2.3100 0.0 0
M  V30 26 N 9.0743 7.7000 0.0 0
M  V30 27 C 6.4069 7.7000 0.0 0
M  V30 28 C 9.0743 3.0800 0.0 0
M  V30 29 N 10.4080 5.3900 0.0 0
M  V30 30 C 2.5056 4.0110 0.0 0
M  V30 31 C 2.7843 6.6638 0.0 0
M  V30 32 C 10.4080 6.9300 0.0 0
M  V30 33 C 9.0743 9.2400 0.0 0
M  V30 34 C 6.4069 9.2400 0.0 0
M  V30 35 C 1.8791 5.4179 0.0 0
M  V30 36 C 7.7407 10.0101 0.0 0
M  V30 37 C 10.4080 10.0101 0.0 0
M  V30 38 C 7.7407 11.5501 0.0 0
M  V30 39 C 10.4080 11.5501 0.0 0
M  V30 40 C 9.0743 12.3201 0.0 0
M  V30 41 C 14.4091 7.7000 0.0 0
M  V30 42 C 14.4091 9.2400 0.0 0
M  V30 43 C 15.7427 6.9300 0.0 0
M  V30 44 C 15.7427 10.0101 0.0 0
M  V30 45 C 17.0764 7.7000 0.0 0
M  V30 46 C 17.0764 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 8 30
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 31
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 32
M  V30 15 1 14 41
M  V30 16 1 15 46
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 19 25
M  V30 26 1 20 26
M  V30 27 1 20 27
M  V30 28 1 21 28
M  V30 29 1 21 29
M  V30 30 2 22 24
M  V30 31 1 22 30
M  V30 32 2 23 31
M  V30 33 2 25 28
M  V30 34 1 26 32
M  V30 35 1 26 33
M  V30 36 2 27 34
M  V30 37 2 29 32
M  V30 38 2 30 35
M  V30 39 1 31 35
M  V30 40 1 33 36
M  V30 41 2 33 37
M  V30 42 1 34 36
M  V30 43 2 36 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 2 39 40
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-22-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3694-46-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2991873-09-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2991873-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37936693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable and reusable catalyst used, catalyst prepared
and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of new quinolinoquinazoline derivatives via one-pot
multicomponent reactions using ZnO/TiO2@MWCNTs as a new nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasani, Leila; Ezzatzadeh, Elham; Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2023), 60(12), 2023-2035

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C50H66N4O5
3030341-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  59 64 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.5593 10.4621 0.0 0
M  V30 2 O 13.3551 11.7805 0.0 0
M  V30 3 O 13.3031 9.1136 0.0 0
M  V30 4 C 14.8948 11.7504 0.0 0
M  V30 5 C 13.2510 7.9126 0.0 0
M  V30 6 C 14.5848 7.1426 0.0 0
M  V30 7 C 15.9185 7.9126 0.0 0
M  V30 8 O 17.2521 7.1426 0.0 0
M  V30 9 O 15.9185 9.4526 0.0 0
M  V30 10 C 18.5858 7.9126 0.0 0
M  V30 11 C 19.9196 7.1426 0.0 0
M  V30 12 C 21.2532 7.9126 0.0 0
M  V30 13 C 22.5869 7.1426 0.0 0
M  V30 14 C 23.9207 7.9126 0.0 0
M  V30 15 C 25.2543 7.1426 0.0 0
M  V30 16 C 26.5880 7.9126 0.0 0
M  V30 17 C 27.9216 7.1426 0.0 0
M  V30 18 C 29.2554 7.9126 0.0 0
M  V30 19 C 30.5891 7.1426 0.0 0
M  V30 20 C 31.9227 7.9126 0.0 0
M  V30 21 C 33.2564 7.1426 0.0 0
M  V30 22 C 34.5902 7.9126 0.0 0
M  V30 23 C 35.9238 7.1426 0.0 0
M  V30 24 C 37.2575 7.9126 0.0 0
M  V30 25 O 10.6111 13.2195 0.0 0
M  V30 26 C 6.5349 13.1067 0.0 0
M  V30 27 C 12.8948 4.5658 0.0 0
M  V30 28 C 1.4522 9.3739 0.0 0
M  V30 29 C 0.0000 8.8612 0.0 0
M  V30 30 C 8.0293 0.9152 0.0 0
M  V30 31 C 1.1934 6.0139 0.0 0
M  V30 32 C 4.7086 1.4949 0.0 0
M  V30 33 C 5.0786 0.0000 0.0 0
M  V30 34 C 10.0586 9.2452 0.0 0
M  V30 35 C 8.6678 9.7401 0.0 0
M  V30 36 C 10.5007 7.7715 0.0 0
M  V30 37 C 11.0196 10.4921 0.0 0 CFG=1
M  V30 38 C 8.6250 11.2949 0.0 0
M  V30 39 N 7.2987 9.1680 0.0 0
M  V30 40 C 11.9174 7.1426 0.0 0 CFG=1
M  V30 41 N 9.4620 6.6204 0.0 0
M  V30 42 C 10.1186 11.7603 0.0 0
M  V30 43 C 7.1084 11.6774 0.0 0
M  V30 44 C 6.2817 10.3604 0.0 0
M  V30 45 C 11.7537 5.5998 0.0 0 CFG=2
M  V30 46 C 10.2349 5.2852 0.0 0
M  V30 47 C 4.7742 10.1096 0.0 0
M  V30 48 C 9.5585 3.9236 0.0 0
M  V30 49 C 4.1311 8.7297 0.0 0
M  V30 50 C 8.0655 3.6709 0.0 0
M  V30 51 C 2.6222 8.3726 0.0 0
M  V30 52 N 4.9416 7.4115 0.0 0
M  V30 53 N 6.9906 4.7810 0.0 0
M  V30 54 C 7.3477 2.2962 0.0 0
M  V30 55 C 2.5025 6.8249 0.0 0
M  V30 56 C 3.9409 6.2429 0.0 0
M  V30 57 C 5.6103 4.1004 0.0 0
M  V30 58 C 5.8182 2.5629 0.0 0
M  V30 59 C 4.2782 4.7830 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 37 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 40 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 2 25 42
M  V30 26 1 26 43
M  V30 27 1 45 27 CFG=3
M  V30 28 1 28 29
M  V30 29 1 28 51
M  V30 30 1 30 54
M  V30 31 1 31 55
M  V30 32 2 32 33
M  V30 33 1 32 58
M  V30 34 1 34 35
M  V30 35 2 34 36
M  V30 36 1 34 37
M  V30 37 2 35 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 1 36 41
M  V30 41 1 37 42
M  V30 42 1 38 42
M  V30 43 1 38 43
M  V30 44 1 39 44
M  V30 45 1 40 45
M  V30 46 2 41 46
M  V30 47 2 43 44
M  V30 48 1 44 47
M  V30 49 1 45 46
M  V30 50 1 46 48
M  V30 51 2 47 49
M  V30 52 2 48 50
M  V30 53 1 49 51
M  V30 54 1 49 52
M  V30 55 1 50 53
M  V30 56 1 50 54
M  V30 57 2 51 55
M  V30 58 2 52 56
M  V30 59 1 53 57
M  V30 60 2 54 58
M  V30 61 1 55 56
M  V30 62 1 56 59
M  V30 63 1 57 58
M  V30 64 2 57 59
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 37 40 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C51H71N5O5
3030341-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2217 12.2046 0.0 0
M  V30 2 C 10.6778 12.7060 0.0 0
M  V30 3 O 10.9717 14.2177 0.0 0
M  V30 4 O 11.8401 11.6956 0.0 0
M  V30 5 C 12.4278 14.7192 0.0 0
M  V30 6 C 12.7281 10.2599 0.0 0
M  V30 7 C 14.0617 9.4898 0.0 0
M  V30 8 C 15.3954 10.2599 0.0 0
M  V30 9 O 16.7292 9.4898 0.0 0
M  V30 10 O 15.3954 11.7999 0.0 0
M  V30 11 C 18.0629 10.2599 0.0 0
M  V30 12 C 19.3966 9.4898 0.0 0
M  V30 13 C 20.7302 10.2599 0.0 0
M  V30 14 C 22.0641 9.4898 0.0 0
M  V30 15 C 23.3977 10.2599 0.0 0
M  V30 16 C 24.7314 9.4898 0.0 0
M  V30 17 C 26.0651 10.2599 0.0 0
M  V30 18 C 27.3989 9.4898 0.0 0
M  V30 19 C 28.7326 10.2599 0.0 0
M  V30 20 C 30.0662 9.4897 0.0 0
M  V30 21 C 31.3999 10.2599 0.0 0
M  V30 22 C 32.7337 9.4897 0.0 0
M  V30 23 C 34.0674 10.2597 0.0 0
M  V30 24 C 35.4011 9.4897 0.0 0
M  V30 25 C 36.7347 10.2597 0.0 0
M  V30 26 C 6.9115 13.3686 0.0 0
M  V30 27 N 5.8612 14.4948 0.0 0
M  V30 28 O 8.4120 13.7149 0.0 0
M  V30 29 C 6.3114 15.9677 0.0 0
M  V30 30 C 13.3684 7.5834 0.0 0
M  V30 31 C 3.7435 12.2778 0.0 0
M  V30 32 C 10.7511 2.2172 0.0 0
M  V30 33 C 1.1262 6.9115 0.0 0
M  V30 34 C 0.0000 5.8612 0.0 0
M  V30 35 C 7.5833 1.1264 0.0 0
M  V30 36 C 8.6336 0.0000 0.0 0
M  V30 37 C 2.2170 3.7437 0.0 0
M  V30 38 C 8.9277 10.6929 0.0 0
M  V30 39 C 9.8547 9.4629 0.0 0
M  V30 40 C 7.3880 10.6660 0.0 0
M  V30 41 C 11.3944 9.4898 0.0 0 CFG=1
M  V30 42 N 9.4044 7.9902 0.0 0
M  V30 43 C 6.4612 11.8958 0.0 0
M  V30 44 N 6.5046 9.4044 0.0 0
M  V30 45 C 11.8957 8.0336 0.0 0 CFG=2
M  V30 46 C 10.6658 7.1069 0.0 0
M  V30 47 C 5.0051 11.3944 0.0 0
M  V30 48 C 5.0319 9.8547 0.0 0
M  V30 49 C 10.6928 5.5671 0.0 0
M  V30 50 C 3.8019 8.9279 0.0 0
M  V30 51 C 9.4627 4.6403 0.0 0
M  V30 52 C 3.8288 7.3880 0.0 0
M  V30 53 N 7.9900 5.0904 0.0 0
M  V30 54 C 9.4897 3.1005 0.0 0
M  V30 55 C 2.5990 6.4614 0.0 0
M  V30 56 N 5.0904 6.5048 0.0 0
M  V30 57 C 7.1068 3.8290 0.0 0
M  V30 58 C 8.0336 2.5991 0.0 0
M  V30 59 C 3.1004 5.0051 0.0 0
M  V30 60 C 4.6401 5.0321 0.0 0
M  V30 61 C 5.5669 3.8020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 38
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 41 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 26 27
M  V30 27 2 26 28
M  V30 28 1 26 43
M  V30 29 1 27 29
M  V30 30 1 45 30 CFG=3
M  V30 31 1 31 47
M  V30 32 1 32 54
M  V30 33 1 33 34
M  V30 34 1 33 55
M  V30 35 2 35 36
M  V30 36 1 35 58
M  V30 37 1 37 59
M  V30 38 2 38 39
M  V30 39 1 38 40
M  V30 40 1 39 41
M  V30 41 1 39 42
M  V30 42 2 40 43
M  V30 43 1 40 44
M  V30 44 1 41 45
M  V30 45 2 42 46
M  V30 46 1 43 47
M  V30 47 1 44 48
M  V30 48 1 45 46
M  V30 49 1 46 49
M  V30 50 2 47 48
M  V30 51 1 48 50
M  V30 52 2 49 51
M  V30 53 2 50 52
M  V30 54 1 51 53
M  V30 55 1 51 54
M  V30 56 1 52 55
M  V30 57 1 52 56
M  V30 58 1 53 57
M  V30 59 2 54 58
M  V30 60 2 55 59
M  V30 61 2 56 60
M  V30 62 1 57 58
M  V30 63 2 57 61
M  V30 64 1 59 60
M  V30 65 1 60 61
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 41 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3030341-27-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3030341-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39444394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, product further converted into their nickel complex
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral induction of helical mesophase by amphiphilic chlorin e6
derivatives and their metal complexes: Effect of chiral and achiral
aliphatic chains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burmistrov, Vladimir; Novikov, Igor; Aleksandriiskii, Viktor; Batrakova,
Alena; Belykh, Dmitry; Startseva, Olga; Koifman, Oskar I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Liquids (2024), 396123957

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-d]pyrimidine, 4-chloro-6-nitro-2-[3-(trifluoromethyl)phenyl]-
C13H5ClF3N3O2S
3032519-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.0022 0.0000 0.0 0
M  V30 2 N 13.2458 3.0801 0.0 0 VAL=5
M  V30 3 O 14.0158 4.4137 0.0 0
M  V30 4 O 14.0158 1.7464 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 F 0.5637 5.1838 0.0 0
M  V30 7 F 0.0000 3.0801 0.0 0
M  V30 8 F 2.1037 2.5164 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 9.3360 3.8501 0.0 0
M  V30 11 C 10.8006 1.8342 0.0 0
M  V30 12 C 8.0022 1.5400 0.0 0
M  V30 13 N 8.0022 4.6201 0.0 0
M  V30 14 S 10.8006 4.3260 0.0 0
M  V30 15 C 11.7058 3.0801 0.0 0
M  V30 16 N 6.6685 2.3101 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 4.0012 3.8501 0.0 0
M  V30 20 C 5.3348 6.1601 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 4.0012 6.9302 0.0 0
M  V30 23 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 21
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-d]pyrimidin-4-amine, N-methyl-6-nitro-2-[3-(trifluoromethyl)phenyl]-
C14H9F3N4O2S
3032520-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.0336 1.3338 0.0 0
M  V30 2 C 8.2636 0.0000 0.0 0
M  V30 3 N 12.0348 6.6229 0.0 0 VAL=5
M  V30 4 O 12.0348 8.1629 0.0 0
M  V30 5 O 13.3684 5.8529 0.0 0
M  V30 6 C 1.3338 6.6685 0.0 0
M  V30 7 F 0.0000 5.8985 0.0 0
M  V30 8 F 0.5636 8.0021 0.0 0
M  V30 9 F 2.6674 7.4385 0.0 0
M  V30 10 C 9.0336 4.0011 0.0 0
M  V30 11 C 8.2636 5.3347 0.0 0
M  V30 12 C 8.2636 2.6674 0.0 0
M  V30 13 C 10.5401 4.3212 0.0 0
M  V30 14 N 6.7236 5.3347 0.0 0
M  V30 15 S 9.2942 6.4792 0.0 0
M  V30 16 N 6.7236 2.6674 0.0 0
M  V30 17 C 10.7010 5.8529 0.0 0
M  V30 18 C 5.9536 4.0011 0.0 0
M  V30 19 C 4.4136 4.0011 0.0 0
M  V30 20 C 3.6436 5.3347 0.0 0
M  V30 21 C 3.6436 2.6674 0.0 0
M  V30 22 C 2.1036 5.3347 0.0 0
M  V30 23 C 2.1036 2.6674 0.0 0
M  V30 24 C 1.3336 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 22
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3032519-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032520-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34552088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thieno[2,3-d]pyrimidine-Core Compounds Show Activity against Clinically
Relevant Gram-Positive Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riabova, Olga; Egorova, Anna; Lepioshkin, Alexander; Li, Yan; Voigt,
Kerstin; Kloss, Florian; Makarov, Vadim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2022), 17(17), e202200207

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(5H)-Oxazolone, 2-amino-5-[1-(6-bromo-1H-indol-3-yl)ethyl]-
C13H12BrN3O2
3033532-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3858 1.9694 0.0 0
M  V30 2 C 4.7059 0.4629 0.0 0
M  V30 3 Br 11.6566 2.6796 0.0 0
M  V30 4 O 1.6752 0.0000 0.0 0
M  V30 5 N 0.0000 5.1558 0.0 0
M  V30 6 C 7.0366 2.6796 0.0 0
M  V30 7 C 5.5301 2.9998 0.0 0
M  V30 8 C 7.8066 4.0132 0.0 0
M  V30 9 C 7.8066 1.3460 0.0 0
M  V30 10 C 5.3692 4.5313 0.0 0
M  V30 11 N 6.7760 5.1578 0.0 0
M  V30 12 C 9.3466 4.0132 0.0 0
M  V30 13 C 9.3466 1.3460 0.0 0
M  V30 14 C 10.1166 2.6796 0.0 0
M  V30 15 C 2.9211 2.4452 0.0 0
M  V30 16 O 2.4452 3.9099 0.0 0
M  V30 17 C 1.6752 1.5400 0.0 0
M  V30 18 C 0.9052 3.9099 0.0 0
M  V30 19 N 0.4294 2.4452 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 1 3 14
M  V30 5 2 4 17
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(5H)-Oxazolone, 5-[1-(6-bromo-1H-indol-3-yl)ethyl]-2-(methylamino)-
C14H14BrN3O2
3033532-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9172 1.9694 0.0 0
M  V30 2 C 6.2375 0.4629 0.0 0
M  V30 3 Br 13.1880 2.6796 0.0 0
M  V30 4 O 3.2068 0.0000 0.0 0
M  V30 5 N 1.5315 5.1558 0.0 0
M  V30 6 C 0.0000 4.9949 0.0 0
M  V30 7 C 8.5680 2.6796 0.0 0
M  V30 8 C 7.0617 2.9998 0.0 0
M  V30 9 C 9.3380 4.0133 0.0 0
M  V30 10 C 9.3380 1.3460 0.0 0
M  V30 11 C 6.9008 4.5313 0.0 0
M  V30 12 N 8.3076 5.1578 0.0 0
M  V30 13 C 10.8780 4.0133 0.0 0
M  V30 14 C 10.8780 1.3460 0.0 0
M  V30 15 C 11.6480 2.6796 0.0 0
M  V30 16 C 4.4526 2.4452 0.0 0
M  V30 17 O 3.9768 3.9099 0.0 0
M  V30 18 C 3.2068 1.5400 0.0 0
M  V30 19 C 2.4368 3.9099 0.0 0
M  V30 20 N 1.9609 2.4452 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 16
M  V30 4 1 3 15
M  V30 5 2 4 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033532-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033532-68-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33810343
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and antibacterial activity of derivatives of
Tryptophanyl-tRNA synthetase inhibitor indolmycin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Lianqi; Zhang, Shuo; Kou, Shibo; Yi, Hong; Cui, Along; Li, Zhuorong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 241114647

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(5H)-Oxazolone, 2-amino-5-[1-(6-methyl-1H-indol-3-yl)ethyl]-
C14H15N3O2
3033532-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3858 1.9694 0.0 0
M  V30 2 C 4.7059 0.4629 0.0 0
M  V30 3 C 11.6566 2.6796 0.0 0
M  V30 4 O 1.6752 0.0000 0.0 0
M  V30 5 N 0.0000 5.1558 0.0 0
M  V30 6 C 7.0366 2.6796 0.0 0
M  V30 7 C 5.5301 2.9998 0.0 0
M  V30 8 C 7.8066 4.0132 0.0 0
M  V30 9 C 7.8066 1.3460 0.0 0
M  V30 10 C 5.3692 4.5313 0.0 0
M  V30 11 N 6.7760 5.1578 0.0 0
M  V30 12 C 9.3466 4.0132 0.0 0
M  V30 13 C 9.3466 1.3460 0.0 0
M  V30 14 C 10.1166 2.6796 0.0 0
M  V30 15 C 2.9211 2.4452 0.0 0
M  V30 16 O 2.4452 3.9099 0.0 0
M  V30 17 C 1.6752 1.5400 0.0 0
M  V30 18 C 0.9052 3.9099 0.0 0
M  V30 19 N 0.4294 2.4452 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 1 3 14
M  V30 5 2 4 17
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4(5H)-Oxazolone, 2-(methylamino)-5-[1-(6-methyl-1H-indol-3-yl)ethyl]-
C15H17N3O2
3033532-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9172 1.9694 0.0 0
M  V30 2 C 6.2375 0.4629 0.0 0
M  V30 3 C 13.1880 2.6796 0.0 0
M  V30 4 O 3.2068 0.0000 0.0 0
M  V30 5 N 1.5315 5.1558 0.0 0
M  V30 6 C 0.0000 4.9949 0.0 0
M  V30 7 C 8.5680 2.6796 0.0 0
M  V30 8 C 7.0617 2.9998 0.0 0
M  V30 9 C 9.3380 4.0133 0.0 0
M  V30 10 C 9.3380 1.3460 0.0 0
M  V30 11 C 6.9008 4.5313 0.0 0
M  V30 12 N 8.3076 5.1578 0.0 0
M  V30 13 C 10.8780 4.0133 0.0 0
M  V30 14 C 10.8780 1.3460 0.0 0
M  V30 15 C 11.6480 2.6796 0.0 0
M  V30 16 C 4.4526 2.4452 0.0 0
M  V30 17 O 3.9768 3.9099 0.0 0
M  V30 18 C 3.2068 1.5400 0.0 0
M  V30 19 C 2.4368 3.9099 0.0 0
M  V30 20 N 1.9609 2.4452 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 16
M  V30 4 1 3 15
M  V30 5 2 4 18
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3033532-26-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3033532-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33810354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and antibacterial activity of derivatives of
Tryptophanyl-tRNA synthetase inhibitor indolmycin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Lianqi; Zhang, Shuo; Kou, Shibo; Yi, Hong; Cui, Along; Li, Zhuorong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 241114647

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purine, 2,6-dichloro-9-[[2-(difluoromethyl)phenyl]methyl]-
C13H8Cl2F2N4
3038727-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.2891 0.0 0
M  V30 2 Cl 11.1388 3.9646 0.0 0
M  V30 3 Cl 7.5693 0.0000 0.0 0
M  V30 4 C 1.5400 5.2891 0.0 0
M  V30 5 F 2.3100 3.9555 0.0 0
M  V30 6 F 0.0000 5.2891 0.0 0
M  V30 7 C 7.0652 4.0433 0.0 0
M  V30 8 C 8.5298 4.5191 0.0 0
M  V30 9 N 6.1600 5.2891 0.0 0
M  V30 10 N 6.7450 2.5368 0.0 0
M  V30 11 C 9.6743 3.4887 0.0 0
M  V30 12 N 8.5298 6.0591 0.0 0
M  V30 13 C 7.0652 6.5350 0.0 0
M  V30 14 C 7.8894 1.5064 0.0 0
M  V30 15 N 9.3541 1.9823 0.0 0
M  V30 16 C 3.8500 6.6228 0.0 0
M  V30 17 C 2.3100 6.6228 0.0 0
M  V30 18 C 4.6200 7.9564 0.0 0
M  V30 19 C 1.5400 7.9564 0.0 0
M  V30 20 C 3.8500 9.2902 0.0 0
M  V30 21 C 2.3100 9.2902 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 11
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purin-6-amine, 2-chloro-9-[[2-(difluoromethyl)phenyl]methyl]-N-methyl-
C14H12ClF2N5
3038726-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.2891 0.0 0
M  V30 2 N 11.1388 3.9646 0.0 0
M  V30 3 C 12.2833 2.9340 0.0 0
M  V30 4 Cl 7.5693 0.0000 0.0 0
M  V30 5 C 1.5400 5.2891 0.0 0
M  V30 6 F 2.3100 3.9555 0.0 0
M  V30 7 F 0.0000 5.2891 0.0 0
M  V30 8 C 7.0652 4.0433 0.0 0
M  V30 9 C 8.5298 4.5191 0.0 0
M  V30 10 N 6.1600 5.2891 0.0 0
M  V30 11 N 6.7450 2.5368 0.0 0
M  V30 12 C 9.6743 3.4887 0.0 0
M  V30 13 N 8.5298 6.0591 0.0 0
M  V30 14 C 7.0652 6.5350 0.0 0
M  V30 15 C 7.8894 1.5064 0.0 0
M  V30 16 N 9.3541 1.9823 0.0 0
M  V30 17 C 3.8500 6.6228 0.0 0
M  V30 18 C 2.3100 6.6228 0.0 0
M  V30 19 C 4.6200 7.9564 0.0 0
M  V30 20 C 1.5400 7.9564 0.0 0
M  V30 21 C 3.8500 9.2902 0.0 0
M  V30 22 C 2.3100 9.2902 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 18
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3038727-00-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038726-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40947847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Design of a Potent and Selective YTHDC1 Ligand
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zalesak, Frantisek; Nai, Francesco; Herok, Marcin; Bochenkova, Elena;
Bedi, Rajiv K.; Li, Yaozong; Errani, Francesco; Caflisch, Amedeo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(11), 9516-9535

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylbenzo[b]thiophene-3-carboxaldehyde
C10H8OS
30446-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.3320 0.0 0
M  V30 2 O 7.1957 2.8561 0.0 0
M  V30 3 C 6.0811 0.0000 0.0 0
M  V30 4 C 3.0801 2.6218 0.0 0
M  V30 5 C 4.5865 2.3016 0.0 0
M  V30 6 C 2.3101 1.2881 0.0 0
M  V30 7 C 2.3101 3.9554 0.0 0
M  V30 8 C 4.7475 0.7700 0.0 0
M  V30 9 S 3.3406 0.1435 0.0 0
M  V30 10 C 0.7700 1.2881 0.0 0
M  V30 11 C 0.7700 3.9554 0.0 0
M  V30 12 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethylbenzo[b]thiophene-3-methanamine
C11H13NS
335033-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3320 0.0 0
M  V30 2 N 7.1955 2.8561 0.0 0
M  V30 3 C 8.3399 3.8866 0.0 0
M  V30 4 C 6.0811 0.0000 0.0 0
M  V30 5 C 3.0801 2.6218 0.0 0
M  V30 6 C 4.5864 2.3016 0.0 0
M  V30 7 C 2.3101 1.2881 0.0 0
M  V30 8 C 2.3101 3.9554 0.0 0
M  V30 9 C 4.7473 0.7700 0.0 0
M  V30 10 S 3.3405 0.1435 0.0 0
M  V30 11 C 0.7700 1.2881 0.0 0
M  V30 12 C 0.7700 3.9554 0.0 0
M  V30 13 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30446-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12652771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 11 Preparation of
1-methyl-3-(methylaminomethyl)-1H-indole (Method B) b)
2-Methyl-3-(methylaminomethyl)benzo[b]thiophene [0689] According to the
procedures of Preparation 1, except substituting
2-methylbenzo[b]thiophene-3-carboxaldehyde (5.0 g, 28.4 mmole) for
1-methylindole-3-carboxaldehyde, the title compound (4.89 g, 90%) was
prepared as an oil which solidified in the freezer. 1H NMR (400 MHz,
CDCl3) δ 7.78 (d, J=7.9 Hz, 1H), 7.75 (d, J=7.9 Hz, 1H), 7.37 (t, 1H),
7.29 (t, 1H), 3.95 (s, 2H), 2.60 (s, 3H), 2.50 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylbenzo[b]thiophene-3-carboxaldehyde
C10H8OS
30446-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.3320 0.0 0
M  V30 2 O 7.1957 2.8561 0.0 0
M  V30 3 C 6.0811 0.0000 0.0 0
M  V30 4 C 3.0801 2.6218 0.0 0
M  V30 5 C 4.5865 2.3016 0.0 0
M  V30 6 C 2.3101 1.2881 0.0 0
M  V30 7 C 2.3101 3.9554 0.0 0
M  V30 8 C 4.7475 0.7700 0.0 0
M  V30 9 S 3.3406 0.1435 0.0 0
M  V30 10 C 0.7700 1.2881 0.0 0
M  V30 11 C 0.7700 3.9554 0.0 0
M  V30 12 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethylbenzo[b]thiophene-3-methanamine
C11H13NS
335033-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3320 0.0 0
M  V30 2 N 7.1955 2.8561 0.0 0
M  V30 3 C 8.3399 3.8866 0.0 0
M  V30 4 C 6.0811 0.0000 0.0 0
M  V30 5 C 3.0801 2.6218 0.0 0
M  V30 6 C 4.5864 2.3016 0.0 0
M  V30 7 C 2.3101 1.2881 0.0 0
M  V30 8 C 2.3101 3.9554 0.0 0
M  V30 9 C 4.7473 0.7700 0.0 0
M  V30 10 S 3.3405 0.1435 0.0 0
M  V30 11 C 0.7700 1.2881 0.0 0
M  V30 12 C 0.7700 3.9554 0.0 0
M  V30 13 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30446-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11525710
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylbenzo[b]thiophene-3-carboxaldehyde
C10H8OS
30446-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.3320 0.0 0
M  V30 2 O 7.1957 2.8561 0.0 0
M  V30 3 C 6.0811 0.0000 0.0 0
M  V30 4 C 3.0801 2.6218 0.0 0
M  V30 5 C 4.5865 2.3016 0.0 0
M  V30 6 C 2.3101 1.2881 0.0 0
M  V30 7 C 2.3101 3.9554 0.0 0
M  V30 8 C 4.7475 0.7700 0.0 0
M  V30 9 S 3.3406 0.1435 0.0 0
M  V30 10 C 0.7700 1.2881 0.0 0
M  V30 11 C 0.7700 3.9554 0.0 0
M  V30 12 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethylbenzo[b]thiophene-3-methanamine
C11H13NS
335033-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3320 0.0 0
M  V30 2 N 7.1955 2.8561 0.0 0
M  V30 3 C 8.3399 3.8866 0.0 0
M  V30 4 C 6.0811 0.0000 0.0 0
M  V30 5 C 3.0801 2.6218 0.0 0
M  V30 6 C 4.5864 2.3016 0.0 0
M  V30 7 C 2.3101 1.2881 0.0 0
M  V30 8 C 2.3101 3.9554 0.0 0
M  V30 9 C 4.7473 0.7700 0.0 0
M  V30 10 S 3.3405 0.1435 0.0 0
M  V30 11 C 0.7700 1.2881 0.0 0
M  V30 12 C 0.7700 3.9554 0.0 0
M  V30 13 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30446-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9078899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylbenzo[b]thiophene-3-carboxaldehyde
C10H8OS
30446-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.3320 0.0 0
M  V30 2 O 7.1957 2.8561 0.0 0
M  V30 3 C 6.0811 0.0000 0.0 0
M  V30 4 C 3.0801 2.6218 0.0 0
M  V30 5 C 4.5865 2.3016 0.0 0
M  V30 6 C 2.3101 1.2881 0.0 0
M  V30 7 C 2.3101 3.9554 0.0 0
M  V30 8 C 4.7475 0.7700 0.0 0
M  V30 9 S 3.3406 0.1435 0.0 0
M  V30 10 C 0.7700 1.2881 0.0 0
M  V30 11 C 0.7700 3.9554 0.0 0
M  V30 12 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethylbenzo[b]thiophene-3-methanamine
C11H13NS
335033-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3320 0.0 0
M  V30 2 N 7.1955 2.8561 0.0 0
M  V30 3 C 8.3399 3.8866 0.0 0
M  V30 4 C 6.0811 0.0000 0.0 0
M  V30 5 C 3.0801 2.6218 0.0 0
M  V30 6 C 4.5864 2.3016 0.0 0
M  V30 7 C 2.3101 1.2881 0.0 0
M  V30 8 C 2.3101 3.9554 0.0 0
M  V30 9 C 4.7473 0.7700 0.0 0
M  V30 10 S 3.3405 0.1435 0.0 0
M  V30 11 C 0.7700 1.2881 0.0 0
M  V30 12 C 0.7700 3.9554 0.0 0
M  V30 13 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30446-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335033-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5851305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To 1,2-dimethylindole-3-carboxaldehyde (11.50
g, 66.4 mmole) was added a solution of 2 M methylamine in methanol (100
mL, 200 mmole). The reaction was stirred for 4 h at RT then was
concentrated to dryness to afford the crude title compound.
1,2-Dimethyl-3-(methyliminomethyl)-1H-indole was taken up in ethanol (200
mL) and NaBH4 (2.6 g, 68.7 mmole) was added portionwise with stirring at
RT (vigorous gas evolution). After 16 h the reaction was concentrated
under vacuum, and the residue was basified with aqueous 1.0 N NaOH (200
mL). The mixture was extracted with Et2O (250 mL), and the combined Et2O
extracts were washed with brine, dried (Na2SO4) and concentrated.
Purification by flash chromatography on silica gel (5-10% (5%
NH4OH/MeOH)/CHCl3) gave the title compound, which solidified in the
freezer. 2-Methyl-3-(methylaminomethyl)benzo[b]thiophene. According to
the procedures of Preparation 53 (b) and (c), except substituting
2-methylbenzo[b]thiophene-3-carboxaldehyde (5.0 g, 28.4 mmole) for
1,2-dimethylindole-3-carboxaldehyde, the title compound (4.89 g, 90%) was
prepared as an oil which solidified in the freezer. 1H NMR (400 MHz,
CDCl3) δ 7.78 (d, J = 7.9 Hz, 1 H), 7.75 (d, J = 7.9 Hz, 1 H), 7.37 (t, 1
H), 7.29 (t, 1 H), 3.95 (s, 2 H), 2.60 (s, 3 H), 2.50 (s, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME278 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 1-methyl-2,6-bis(4-nitrophenyl)-4-oxo-3,5-piperidinedicarboxylate
C22H21N3O9
306994-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 O 5.3348 0.7700 0.0 0
M  V30 3 O 4.0011 3.0800 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 8.0022 6.9301 0.0 0
M  V30 6 O 8.0022 0.7700 0.0 0
M  V30 7 C 10.6697 2.3100 0.0 0
M  V30 8 O 10.6697 0.7700 0.0 0
M  V30 9 O 12.0034 3.0800 0.0 0
M  V30 10 C 12.0034 0.0000 0.0 0
M  V30 11 N 1.3338 7.7001 0.0 0 VAL=5
M  V30 12 O 1.3338 9.2401 0.0 0
M  V30 13 O 0.0000 6.9301 0.0 0
M  V30 14 N 14.6707 7.7001 0.0 0 VAL=5
M  V30 15 O 16.0045 6.9301 0.0 0
M  V30 16 O 14.6707 9.2401 0.0 0
M  V30 17 C 6.6686 4.6201 0.0 0
M  V30 18 C 6.6686 3.0800 0.0 0
M  V30 19 N 8.0022 5.3901 0.0 0
M  V30 20 C 8.0022 2.3100 0.0 0
M  V30 21 C 9.3359 4.6201 0.0 0
M  V30 22 C 9.3359 3.0800 0.0 0
M  V30 23 C 5.3348 5.3901 0.0 0
M  V30 24 C 4.0011 4.6201 0.0 0
M  V30 25 C 5.3348 6.9301 0.0 0
M  V30 26 C 2.6675 5.3901 0.0 0
M  V30 27 C 4.0011 7.7001 0.0 0
M  V30 28 C 2.6675 6.9301 0.0 0
M  V30 29 C 10.6697 5.3901 0.0 0
M  V30 30 C 12.0034 4.6201 0.0 0
M  V30 31 C 10.6697 6.9301 0.0 0
M  V30 32 C 13.3370 5.3901 0.0 0
M  V30 33 C 12.0034 7.7001 0.0 0
M  V30 34 C 13.3370 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 2 6 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 28
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 34
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 21 29
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,5-Dimethyl (1S,2S,4R,5R)-3,7-dimethyl-2,4-bis(4-nitrophenyl)-9-oxo-3,7-...
C25H26N4O9
250339-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5757 7.4987 0.0 0
M  V30 2 O 1.4881 8.5890 0.0 0
M  V30 3 O 2.1751 6.0117 0.0 0
M  V30 4 C 0.0000 8.1923 0.0 0
M  V30 5 O 6.2067 7.6724 0.0 0
M  V30 6 C 6.9268 4.9850 0.0 0
M  V30 7 C 9.4382 9.3376 0.0 0
M  V30 8 O 9.8349 10.8256 0.0 0
M  V30 9 O 10.5285 8.2499 0.0 0
M  V30 10 C 11.3218 11.2261 0.0 0
M  V30 11 C 5.0880 11.8475 0.0 0
M  V30 12 N 1.9182 1.3336 0.0 0 VAL=5
M  V30 13 O 2.6882 0.0000 0.0 0
M  V30 14 O 0.3782 1.3336 0.0 0
M  V30 15 N 13.0900 4.3271 0.0 0 VAL=5
M  V30 16 O 13.0900 2.7871 0.0 0
M  V30 17 O 14.4236 5.0971 0.0 0
M  V30 18 C 4.0636 7.8954 0.0 0 CFG=1
M  V30 19 C 4.9982 6.6684 0.0 0 CFG=1
M  V30 20 C 5.8081 9.1601 0.0 0
M  V30 21 C 4.2623 9.4154 0.0 0
M  V30 22 N 6.5282 6.4725 0.0 0
M  V30 23 C 7.9512 8.9371 0.0 0 CFG=1
M  V30 24 N 5.4866 10.3600 0.0 0
M  V30 25 C 7.7553 7.4071 0.0 0 CFG=1
M  V30 26 C 7.0192 10.1541 0.0 0
M  V30 27 C 4.2282 5.3347 0.0 0
M  V30 28 C 2.6882 5.3347 0.0 0
M  V30 29 C 4.9982 4.0011 0.0 0
M  V30 30 C 1.9182 4.0011 0.0 0
M  V30 31 C 4.2282 2.6674 0.0 0
M  V30 32 C 2.6882 2.6674 0.0 0
M  V30 33 C 9.0889 6.6371 0.0 0
M  V30 34 C 9.0889 5.0971 0.0 0
M  V30 35 C 10.4226 7.4071 0.0 0
M  V30 36 C 10.4226 4.3271 0.0 0
M  V30 37 C 11.7562 6.6371 0.0 0
M  V30 38 C 11.7562 5.0971 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 5 20
M  V30 6 1 6 22
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 23
M  V30 10 1 8 10
M  V30 11 1 11 24
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 32
M  V30 15 2 15 16
M  V30 16 2 15 17
M  V30 17 1 15 38
M  V30 18 1 18 19
M  V30 19 1 18 20 CFG=1
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 27 CFG=3
M  V30 23 1 23 20 CFG=1
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 24 26
M  V30 29 1 25 33 CFG=3
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 23 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 306994-53-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 250339-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-14682199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Synthesis of
2,4-Diaryl-Substituted
1,5-Dialkyl-3,7-dimethyl-3,7-diaza-9-oxobicyclo-[3.3.1]nonane-1,5-dicarboxylates
11-19 (modified after procedures in ref 19). Exactly 0.0025 mol of the
piperidin-4-one was dissolved in 20 mL of methanol by refluxing. To this
solution, was added 0.6 mL of a 35% aqueous solution of HCHO, followed by
0.4 mL of a 40% aqueous solution of methylamine. The mixture was refluxed
for 7-8 min, and afterward it was allowed to stand for 3 h at ambient
temperature. Three different workup procedures were possible. First, the
obtained precipitate was filtered and washed with a mixture of
ethanol/diethyl ether. When no precipitate appeared within 24 h, the
solvent was removed in vacuo at 40-50 °C, and the remaining oil was
dissolved in a small amount of ethanol and diethyl ether. Crystals
usually appeared within 2 days. When no crystals were obtained during
this time, the solvent was removed again, and the remaining oil was
treated with diethyl ether. The raw product can be recrystallized from
ethanol. The perchlorates and oxalates of HZ2 were formed according to
known procedures.20 Entry: 11a Entry: 15a 1.20g; Yield: 90% molecular
formula: C25H26N4O9, 526.6 mp: 180°C (trans); 215°C (cis) elemental
analyses calc: 57.02%C, 4.98%H, 10.65%N found: 56.60%C, 5.14%H, 10.37%N
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Opioid Receptor Affinity of a Series of
2,4-Diaryl-Substituted 3,7-Diazabicyclononanones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siener, Tom; Cambareri, Antonella; Kuhl, Ulrich; Englberger, Werner;
Haurand, Michael; Koegel, Babette; Holzgrabe, Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(20), 3746-3751

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(5,6-Dihydro-1,3-dithiolo[4,5-b][1,4]dioxin-2-ylidene)-1,3-dithiole-4-carbo...
C9H5ClO3S4
308797-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.1928 1.5317 0.0 0
M  V30 2 Cl 11.5996 2.1580 0.0 0
M  V30 3 O 10.0319 0.0000 0.0 0
M  V30 4 C 5.0370 3.2069 0.0 0
M  V30 5 S 4.1320 1.9609 0.0 0
M  V30 6 S 4.1320 4.4528 0.0 0
M  V30 7 C 2.6673 2.4369 0.0 0
M  V30 8 C 2.6673 3.9769 0.0 0
M  V30 9 O 1.3336 1.6669 0.0 0
M  V30 10 O 1.3336 4.7469 0.0 0
M  V30 11 C 0.0000 2.4369 0.0 0
M  V30 12 C 0.0000 3.9769 0.0 0
M  V30 13 C 6.5770 3.2069 0.0 0
M  V30 14 S 7.4822 1.9609 0.0 0
M  V30 15 S 7.4822 4.4528 0.0 0
M  V30 16 C 8.9469 2.4369 0.0 0
M  V30 17 C 8.9469 3.9769 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(5,6-Dihydro-1,3-dithiolo[4,5-b][1,4]dioxin-2-ylidene)-N-methyl-1,3-dithiol...
C10H9NO3S4
308797-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.1929 1.5317 0.0 0
M  V30 2 N 11.5996 2.1580 0.0 0
M  V30 3 O 10.0319 0.0000 0.0 0
M  V30 4 C 12.8456 1.2528 0.0 0
M  V30 5 C 5.0371 3.2069 0.0 0
M  V30 6 S 4.1321 1.9609 0.0 0
M  V30 7 S 4.1321 4.4527 0.0 0
M  V30 8 C 2.6674 2.4369 0.0 0
M  V30 9 C 2.6674 3.9769 0.0 0
M  V30 10 O 1.3338 1.6669 0.0 0
M  V30 11 O 1.3338 4.7469 0.0 0
M  V30 12 C 0.0000 2.4369 0.0 0
M  V30 13 C 0.0000 3.9769 0.0 0
M  V30 14 C 6.5771 3.2069 0.0 0
M  V30 15 S 7.4823 1.9609 0.0 0
M  V30 16 S 7.4823 4.4527 0.0 0
M  V30 17 C 8.9470 2.4369 0.0 0
M  V30 18 C 8.9470 3.9769 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 308797-11-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 308797-13-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14965987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of ethylenedioxotetrathiafulvalene (EDO-TTF) and
analysis of the role of S...S Van der Waals interactions in the crystal
chemistry of neutral TTF derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meziere, Cecile; Fourmigue, Marc; Fabre, Jean-Marc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Comptes Rendus de l'Academie des Sciences, Serie IIc: Chimie (2000),
3(5), 387-395

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis(chloromethyl)pyridine
C7H7Cl2N
3099-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 Cl 8.0023 2.3101 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N6-Dimethyl-2,6-pyridinedimethanamine
C9H15N3
134956-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0801 0.0 0
M  V30 2 N 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 C 2.6673 3.0801 0.0 0
M  V30 5 N 1.3337 2.3101 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 N 5.3348 3.0801 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 6.6685 0.7700 0.0 0
M  V30 11 C 4.0012 0.7700 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3099-28-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 134956-67-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18455146
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A CuI/CuIII prototypical organometallic mechanism for the deactivation of
an active pincer-like CuI catalyst in Ullmann-type couplings
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rovira, Mireia; Jasikova, Lucie; Andris, Erik; Acuna-Pares, Ferran;
Soler, Marta; Guell, Imma; Wang, Ming-Zheng; Gomez, Laura; Luis, Josep
M.; Roithova, Jana; Ribas, Xavi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2017), 53(62),
8786-8789

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclo[(2S)-2-amino-7-carboxyheptanoyl-1-methoxy-L-tryptophyl-L-isoleucyl-(2R)...
C32H45N5O7
312956-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9682 5.2308 0.0 0
M  V30 2 O 1.6657 4.1037 0.0 0
M  V30 3 C 0.7605 2.8578 0.0 0
M  V30 4 O 4.3008 6.7708 0.0 0
M  V30 5 O 9.6355 5.2308 0.0 0
M  V30 6 C 2.6268 8.2708 0.0 0 CFG=1
M  V30 7 C 1.4471 9.2605 0.0 0
M  V30 8 C 2.3594 6.7542 0.0 0
M  V30 9 C 0.0000 8.7338 0.0 0
M  V30 10 C 12.3030 6.7708 0.0 0
M  V30 11 C 13.6366 7.5408 0.0 0
M  V30 12 C 14.9703 6.7708 0.0 0
M  V30 13 C 16.3041 7.5408 0.0 0
M  V30 14 C 17.6377 6.7708 0.0 0
M  V30 15 C 18.9714 7.5408 0.0 0
M  V30 16 O 20.3050 6.7708 0.0 0
M  V30 17 O 18.9714 9.0808 0.0 0
M  V30 18 O 5.6346 12.1608 0.0 0
M  V30 19 O 8.3019 9.0808 0.0 0
M  V30 20 C 5.4735 2.9292 0.0 0
M  V30 21 C 5.6346 4.4608 0.0 0
M  V30 22 C 3.9672 2.6091 0.0 0
M  V30 23 C 6.5041 1.7849 0.0 0
M  V30 24 C 4.2276 5.0873 0.0 0
M  V30 25 N 3.1972 3.9427 0.0 0
M  V30 26 C 3.4914 1.1444 0.0 0
M  V30 27 C 6.0281 0.3202 0.0 0
M  V30 28 C 4.5218 0.0000 0.0 0
M  V30 29 C 6.9682 6.7708 0.0 0 CFG=2
M  V30 30 C 5.6346 7.5408 0.0 0
M  V30 31 N 8.3019 7.5408 0.0 0
M  V30 32 N 5.6346 9.0808 0.0 0
M  V30 33 C 9.6355 6.7708 0.0 0
M  V30 34 C 6.9682 9.8508 0.0 0 CFG=1
M  V30 35 C 10.9693 7.5408 0.0 0 CFG=2
M  V30 36 C 6.9682 11.3908 0.0 0
M  V30 37 N 10.9693 9.0808 0.0 0
M  V30 38 N 8.3019 12.1608 0.0 0
M  V30 39 C 9.6355 9.8508 0.0 0
M  V30 40 C 9.6355 11.3908 0.0 0 CFG=2
M  V30 41 C 8.3019 13.7008 0.0 0
M  V30 42 C 10.9693 12.1608 0.0 0
M  V30 43 C 9.6355 14.4708 0.0 0
M  V30 44 C 10.9693 13.7008 0.0 0
M  V30 45 H 8.4848 10.1183 0.0 0
M  V30 46 H 10.9693 10.6208 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 29 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 25
M  V30 5 2 4 30
M  V30 6 2 5 33
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 6 34
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 35 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 18 36
M  V30 20 2 19 39
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 25
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 34 32 CFG=1
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 34 45
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 38 41
M  V30 44 1 39 40
M  V30 45 1 40 42
M  V30 46 1 40 46 CFG=1
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 29 34 35 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclo[(2S)-2-amino-8-(methylamino)-8-oxooctanoyl-1-methoxy-L-tryptophyl-L-iso...
C33H48N6O6
312956-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9683 5.2309 0.0 0
M  V30 2 O 1.6655 4.1037 0.0 0
M  V30 3 C 0.7605 2.8578 0.0 0
M  V30 4 O 4.3008 6.7709 0.0 0
M  V30 5 O 9.6357 5.2309 0.0 0
M  V30 6 C 2.6268 8.2709 0.0 0 CFG=1
M  V30 7 C 1.4470 9.2607 0.0 0
M  V30 8 C 2.3593 6.7543 0.0 0
M  V30 9 C 0.0000 8.7340 0.0 0
M  V30 10 C 12.3031 6.7709 0.0 0
M  V30 11 C 13.6368 7.5409 0.0 0
M  V30 12 C 14.9705 6.7709 0.0 0
M  V30 13 C 16.3041 7.5409 0.0 0
M  V30 14 C 17.6380 6.7709 0.0 0
M  V30 15 C 18.9716 7.5409 0.0 0
M  V30 16 N 20.3053 6.7709 0.0 0
M  V30 17 O 18.9716 9.0809 0.0 0
M  V30 18 C 21.6389 7.5409 0.0 0
M  V30 19 O 5.6345 12.1610 0.0 0
M  V30 20 O 8.3020 9.0809 0.0 0
M  V30 21 C 5.6345 4.4608 0.0 0
M  V30 22 C 5.4736 2.9293 0.0 0
M  V30 23 C 4.2277 5.0873 0.0 0
M  V30 24 C 3.9673 2.6091 0.0 0
M  V30 25 C 6.5040 1.7849 0.0 0
M  V30 26 N 3.1973 3.9428 0.0 0
M  V30 27 C 3.4912 1.1444 0.0 0
M  V30 28 C 6.0281 0.3202 0.0 0
M  V30 29 C 4.5218 0.0000 0.0 0
M  V30 30 C 6.9683 6.7709 0.0 0 CFG=2
M  V30 31 C 5.6345 7.5409 0.0 0
M  V30 32 N 8.3020 7.5409 0.0 0
M  V30 33 N 5.6345 9.0809 0.0 0
M  V30 34 C 9.6357 6.7709 0.0 0
M  V30 35 C 6.9683 9.8509 0.0 0 CFG=1
M  V30 36 C 10.9693 7.5409 0.0 0 CFG=2
M  V30 37 C 6.9683 11.3910 0.0 0
M  V30 38 N 10.9693 9.0809 0.0 0
M  V30 39 N 8.3020 12.1610 0.0 0
M  V30 40 C 9.6357 9.8509 0.0 0
M  V30 41 C 9.6357 11.3910 0.0 0 CFG=2
M  V30 42 C 8.3020 13.7010 0.0 0
M  V30 43 C 10.9693 12.1610 0.0 0
M  V30 44 C 9.6357 14.4710 0.0 0
M  V30 45 C 10.9693 13.7010 0.0 0
M  V30 46 H 8.4849 10.1185 0.0 0
M  V30 47 H 10.9693 10.6210 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 30 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 26
M  V30 5 2 4 31
M  V30 6 2 5 34
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 6 35
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 36 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 19 37
M  V30 21 2 20 40
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 35 33 CFG=1
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 35 46
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 39 42
M  V30 45 1 40 41
M  V30 46 1 41 43
M  V30 47 1 41 47 CFG=1
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 30 35 36 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 312956-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 312956-85-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-155016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of side chain modified apicidin derivatives: potent
mechanism-based histone deacetylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meinke, Peter T.; Colletti, Steven L.; Ayer, Michelle B.; Darkin-Rattray,
Sandra J.; Myers, Robert W.; Schmatz, Dennis M.; Wyvratt, Matthew J.;
Fisher, Michael H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2000), 41(41), 7831-7835

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Triethyl phosphonoacetate
C8H17O5P
867-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 O 7.7000 5.1836 0.0 0
M  V30 10 O 5.3900 6.5173 0.0 0
M  V30 11 C 0.0000 5.1836 0.0 0
M  V30 12 C 2.5164 0.0000 0.0 0
M  V30 13 C 8.4700 6.5173 0.0 0
M  V30 14 C 10.0100 6.5173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Acetyl-1,3-benzodioxole
C9H8O3
3162-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 O 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 O 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,β-Dimethyl-1,3-benzodioxole-5-propanamide
C12H15NO3
1188543-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 N 10.3720 2.3100 0.0 0
M  V30 6 O 9.0383 0.0000 0.0 0
M  V30 7 C 11.7056 1.5400 0.0 0
M  V30 8 C 2.3698 2.3100 0.0 0
M  V30 9 C 2.3698 3.8500 0.0 0
M  V30 10 C 3.7036 1.5400 0.0 0
M  V30 11 O 0.9052 1.8341 0.0 0
M  V30 12 C 3.7036 4.6200 0.0 0
M  V30 13 O 0.9052 4.3259 0.0 0
M  V30 14 C 5.0372 2.3100 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 867-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3162-29-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1188543-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23808987
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 8
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of β-phenylalkanamide derivatives useful for treatment of
central nervous system diseases and disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pesyan, Amir; Balandrin, Manuel F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20210130285 A1 2021-05-06

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Triethyl phosphonoacetate
C8H17O5P
867-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 O 7.7000 5.1836 0.0 0
M  V30 10 O 5.3900 6.5173 0.0 0
M  V30 11 C 0.0000 5.1836 0.0 0
M  V30 12 C 2.5164 0.0000 0.0 0
M  V30 13 C 8.4700 6.5173 0.0 0
M  V30 14 C 10.0100 6.5173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Acetyl-1,3-benzodioxole
C9H8O3
3162-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 O 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 O 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,β-Dimethyl-1,3-benzodioxole-5-propanamide
C12H15NO3
1188543-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 N 10.3720 2.3100 0.0 0
M  V30 6 O 9.0383 0.0000 0.0 0
M  V30 7 C 11.7056 1.5400 0.0 0
M  V30 8 C 2.3698 2.3100 0.0 0
M  V30 9 C 2.3698 3.8500 0.0 0
M  V30 10 C 3.7036 1.5400 0.0 0
M  V30 11 O 0.9052 1.8341 0.0 0
M  V30 12 C 3.7036 4.6200 0.0 0
M  V30 13 O 0.9052 4.3259 0.0 0
M  V30 14 C 5.0372 2.3100 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 867-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3162-29-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1188543-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21518485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 8
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel β-phenylalkanamide compounds advantageous in the
treatment of central nervous system diseases and disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pesyan, Amir; Balandrin, Manuel F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017066103 A1 2017-04-20

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Triethyl phosphonoacetate
C8H17O5P
867-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 O 7.7000 5.1836 0.0 0
M  V30 10 O 5.3900 6.5173 0.0 0
M  V30 11 C 0.0000 5.1836 0.0 0
M  V30 12 C 2.5164 0.0000 0.0 0
M  V30 13 C 8.4700 6.5173 0.0 0
M  V30 14 C 10.0100 6.5173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Acetyl-1,3-benzodioxole
C9H8O3
3162-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 O 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 O 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,β-Dimethyl-1,3-benzodioxole-5-propanamide
C12H15NO3
1188543-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 N 10.3720 2.3100 0.0 0
M  V30 6 O 9.0383 0.0000 0.0 0
M  V30 7 C 11.7056 1.5400 0.0 0
M  V30 8 C 2.3698 2.3100 0.0 0
M  V30 9 C 2.3698 3.8500 0.0 0
M  V30 10 C 3.7036 1.5400 0.0 0
M  V30 11 O 0.9052 1.8341 0.0 0
M  V30 12 C 3.7036 4.6200 0.0 0
M  V30 13 O 0.9052 4.3259 0.0 0
M  V30 14 C 5.0372 2.3100 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 867-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3162-29-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1188543-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15801169
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 8
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel β-phenylalkanamide compounds advantageous in the
treatment of central nervous system diseases and disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pesyan, Amir; Balandrin, Manuel F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160137592 A1 2016-05-19

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Triethyl phosphonoacetate
C8H17O5P
867-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 O 7.7000 5.1836 0.0 0
M  V30 10 O 5.3900 6.5173 0.0 0
M  V30 11 C 0.0000 5.1836 0.0 0
M  V30 12 C 2.5164 0.0000 0.0 0
M  V30 13 C 8.4700 6.5173 0.0 0
M  V30 14 C 10.0100 6.5173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Acetyl-1,3-benzodioxole
C9H8O3
3162-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 O 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 O 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,β-Dimethyl-1,3-benzodioxole-5-propanamide
C12H15NO3
1188543-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 N 10.3720 2.3100 0.0 0
M  V30 6 O 9.0383 0.0000 0.0 0
M  V30 7 C 11.7056 1.5400 0.0 0
M  V30 8 C 2.3698 2.3100 0.0 0
M  V30 9 C 2.3698 3.8500 0.0 0
M  V30 10 C 3.7036 1.5400 0.0 0
M  V30 11 O 0.9052 1.8341 0.0 0
M  V30 12 C 3.7036 4.6200 0.0 0
M  V30 13 O 0.9052 4.3259 0.0 0
M  V30 14 C 5.0372 2.3100 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 867-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3162-29-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1188543-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2669400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 8
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide compounds for treatment of central nervous system
diseases and disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pesyan, Amir; Balandrin, Manuel F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011034849 A1 2011-03-24

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
Triethyl phosphonoacetate
C8H17O5P
867-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 5.3900 3.8500 0.0 0
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 6.1600 5.1836 0.0 0
M  V30 7 C 1.5400 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 O 7.7000 5.1836 0.0 0
M  V30 10 O 5.3900 6.5173 0.0 0
M  V30 11 C 0.0000 5.1836 0.0 0
M  V30 12 C 2.5164 0.0000 0.0 0
M  V30 13 C 8.4700 6.5173 0.0 0
M  V30 14 C 10.0100 6.5173 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Acetyl-1,3-benzodioxole
C9H8O3
3162-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 O 6.3709 0.0000 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7036 1.5400 0.0 0
M  V30 7 O 0.9052 1.8341 0.0 0
M  V30 8 C 3.7036 4.6200 0.0 0
M  V30 9 O 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,β-Dimethyl-1,3-benzodioxole-5-propanamide
C12H15NO3
1188543-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 C 9.0383 1.5400 0.0 0
M  V30 5 N 10.3720 2.3100 0.0 0
M  V30 6 O 9.0383 0.0000 0.0 0
M  V30 7 C 11.7056 1.5400 0.0 0
M  V30 8 C 2.3698 2.3100 0.0 0
M  V30 9 C 2.3698 3.8500 0.0 0
M  V30 10 C 3.7036 1.5400 0.0 0
M  V30 11 O 0.9052 1.8341 0.0 0
M  V30 12 C 3.7036 4.6200 0.0 0
M  V30 13 O 0.9052 4.3259 0.0 0
M  V30 14 C 5.0372 2.3100 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 867-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3162-29-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1188543-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5682907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 4. Preparation of Compound D
[3-(3-Fluorophenyl)butyramide]. In a 3-necked, 500-mL round-bottomed
flask, a suspension of sodium hydride (60% in oil, 1.1 eq. 80 mmol, 3.20
g) in N,N-dimethylformamide (DMF, 100 mL) under nitrogen was treated
drop-wise with a solution of triethyl phosphonoacetate (1.2 eq. 87 mmol,
19.50 g) in DMF (50 mL). After the addition, the reaction mixture was
heated in a water bath (100°C) until all visible signs of the sodium
hydride were gone (30 minutes). The mixture was cooled to ambient
temperature and then treated with a solution of 3'-fluoroacetophenone
(1.0 eq. 10 g, 72.4 mmol) in DMF (50 mL). The reaction mixture was
stirred for 2 hours at ambient temperature and a 1-mL aliquot was removed
and quenched in water (~ 2 mL). Diethyl ether (~2 mL) was added to this
and the mixture was equilibrated. Analysis of the organic layer by GC/MS
showed complete consumption of the starting benzophenone. As a result,
the reaction mixture was quenched by the addition of water. The mixture
was transferred to a large round-bottomed flask and the majority of the
solvents were removed using a rotary evaporator. The mixture was cooled
and transferred to a separatory funnel using [a] diethyl ether (500 mL)
and water (250 mL). The mixture was equilibrated and the aqueous layer
was removed. The organic layer was washed an additional 3 times with
water (3 x 250 mL). GC/MS analysis of this solution showed only product
(with no remaining phosphonoacetate). The organic solution was dried over
anhydrous MgSO4, filtered, and concentrated to afford 18.09 g of crude
material (containing oil from the sodium hydride). A solution of crude of
[3-(3-fluorophenyl)-but-2-enoic acid ethyl ester] (9 g, 0.015 mmol) in
methanol (75 mL) was treated with Pd/C (10%, 450 mg). The reaction
mixture was subjected to hydrogenation at 45 psi for 1 hour. The reaction
mixture was passed through a Celite plug to remove palladium on carbon.
The filtrate was concentrated under reduced pressure. This afforded 10.1
g of a colorless oil [3-(3-fluorophenyl)butyric acid ethyl ester]. The
material was determined to be 94% pure by GC/MS analysis. This product
was used without purification (to remove mineral oil). A crude solution
of 3-(3-fluorophenyl)butyric acid ethyl ester, 10.1 g, 48 mmol] in
ethanol (50 mL) was treated with 10 M NaOH solution (50 mL, 857 mmol).
The reaction mixture was refluxed overnight. The reaction mixture was
dried under reduced pressure in order to get rid of the ethyl alcohol.
The resulting residue was redissolved in 150 mL of water. The mixture was
transferred to a separatory funnel using water (50 mL) and diethyl ether
(200 mL). The mixture was equilibrated and the ether layer was removed.
The aqueous layer was acidified by HCl solution (pH~2) and extracted with
diethyl ether (300 mL). The organic layer was dried over magnesium
sulfate, filtered, and concentrated under reduced pressure. This afforded
8.1 g of an orange viscous oil, 3-(3-fluorophenyl)butyric acid (92.6%
yield). This material was determined to be 100% pure by GC/MS analysis. A
solution of 3-(3-fluorophenyl)butyric acid (8.1 g, 44.46 mmol) in CH2Cl2
(100 mL) and DMF (0.7 mL) was treated with oxalyl chloride (5.43 mL, 7.9
mmol) at 0°C under static nitrogen. The reaction solution was stirred at
room temperature overnight under nitrogen. The excess dichloromethane was
removed under reduced pressure. The resulting residue was azeotroped by
toluene (70 mL). Ammonia (gas) was bubbled through the solution of the
acid chloride [3-(3-fluoro-phenyl)butyryl chloride] in anhydrous THF (100
mL) at 5 degrees Celsius for 15 minutes. The reaction mixture was stirred
overnight at room temperature under static nitrogen. The white
precipitate (ammonium chloride) was filtered and washed with THF (200
mL). The filtrate and wash-solution were combined and evaporated under
reduced pressure. The resulting white solid was re-dissolved in ethyl
acetate (350 mL). The ethyl acetate layer was washed with H2O, 1.0 M HCl,
a saturated solution of sodium bicarbonate, and brine solution. The ethyl
acetate solution was then dried over magnesium sulfate, filtered, and
evaporated under reduced pressure. The resulting white solid was
triturated with a chilled solution of diethyl ether and hexane (50:50).
This afforded 6.8 g of off-white powder of 3-(3-fluorophenyl)butyramide
(84% yield). This material was determined to be 100% pure by GC/MS
analysis (a mixture of R and S enantiomers). 1H-NMR spectroscopy gave
signals consistent with the product's structure and indicated greater
than 98% purity. Examples 5-14. Preparation of Compounds E-N. Compounds
E-N were prepared using the corresponding acetophenones (shown in Table 1
below) with the method used for the preparation of Compound D in Example
4, above. In addition, Compound M (Example 13) and Compound N (Example
14) were prepared using the corresponding amines, i.e., methylamine and
dimethylamine, respectively. All of the final products were determined to
be 100% pure by GC/MS analysis. 1H-NMR spectroscopy of each final product
gave signals consistent with its structure and indicated greater than 98%
purity. N-methyl-3-(3,4-methylenedioxyphenyl)butyramide, yield 90%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzene derivatives for treatment of central nervous
system diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pesyan, Amir; Balandrin, Manuel M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009117515 A2 2009-09-24

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-1,3-Dihydro-α-(2-methylpropyl)-1,3-dioxo-2H-isoindole-2-acetyl chloride
C14H14ClNO3
3183-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0 CFG=2
M  V30 2 C 7.4148 3.1854 0.0 0
M  V30 3 C 6.0811 5.4955 0.0 0
M  V30 4 C 8.7486 3.9554 0.0 0
M  V30 5 Cl 4.7475 6.2655 0.0 0
M  V30 6 O 7.4148 6.2655 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 8.7486 5.4955 0.0 0
M  V30 9 O 3.0203 5.3182 0.0 0
M  V30 10 O 5.7309 0.6234 0.0 0
M  V30 11 N 4.7475 3.1854 0.0 0
M  V30 12 C 3.3405 3.8119 0.0 0
M  V30 13 C 4.5865 1.6538 0.0 0
M  V30 14 C 2.3101 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 0.0000 1.3337 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 2 9 12
M  V30 10 2 10 13
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-1,3-Dihydro-N-methyl-α-(2-methylpropyl)-1,3-dioxo-2H-isoindole-2-acetamide
C15H18N2O3
512827-75-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.8501 0.0 0 CFG=1
M  V30 2 C 7.4148 4.6201 0.0 0
M  V30 3 C 6.0811 2.3101 0.0 0
M  V30 4 N 8.7486 3.8501 0.0 0
M  V30 5 O 7.4148 6.1601 0.0 0
M  V30 6 C 7.4148 1.5400 0.0 0
M  V30 7 C 10.0823 4.6201 0.0 0
M  V30 8 C 8.7486 2.3101 0.0 0
M  V30 9 C 7.4148 0.0000 0.0 0
M  V30 10 O 5.7309 7.1821 0.0 0
M  V30 11 O 3.0203 2.4873 0.0 0
M  V30 12 N 4.7475 4.6201 0.0 0
M  V30 13 C 4.5865 6.1517 0.0 0
M  V30 14 C 3.3405 3.9936 0.0 0
M  V30 15 C 3.0801 6.4718 0.0 0
M  V30 16 C 2.3101 5.1382 0.0 0
M  V30 17 C 2.3101 7.8055 0.0 0
M  V30 18 C 0.7700 5.1382 0.0 0
M  V30 19 C 0.7700 7.8055 0.0 0
M  V30 20 C 0.0000 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 13
M  V30 11 2 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3183-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 512827-75-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-5851907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phthalimide as a chromophoric tag in the circular dichroism determination
of absolute configuration of α-amino acid amides and dipeptides. A case
of a dipeptide isostructurality
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skowronek, P.; Katrusiak, A.; Gawronski, J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(52), 10463-10468

$RFMT $RIREG SCHEME284 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Chloro-2-butyn-1-yl)oxy]-4-methylbenzene
C11H11ClO
36763-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6673 0.0 0
M  V30 2 C 6.9300 1.3336 0.0 0
M  V30 3 C 8.4700 1.3336 0.0 0
M  V30 4 C 10.0100 1.3336 0.0 0
M  V30 5 C 11.5500 1.3336 0.0 0
M  V30 6 Cl 12.3200 0.0000 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 4.0009 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-4-[[(4-methylphenyl)sulfonyl]oxy]-2H-pyran-2-one
C13H12O5S
31913-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 6.1600 0.0 0 VAL=6
M  V30 2 O 5.3349 4.6200 0.0 0
M  V30 3 O 5.3349 7.7000 0.0 0
M  V30 4 O 3.7949 6.1600 0.0 0
M  V30 5 C 11.4949 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 O 2.6674 0.0000 0.0 0
M  V30 8 C 6.8749 6.1600 0.0 0
M  V30 9 C 7.6449 4.8264 0.0 0
M  V30 10 C 7.6449 7.4936 0.0 0
M  V30 11 C 9.1849 4.8264 0.0 0
M  V30 12 C 9.1849 7.4936 0.0 0
M  V30 13 C 9.9549 6.1600 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 C 2.6674 4.6200 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 2.6674 1.5400 0.0 0
M  V30 19 O 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 14
M  V30 6 1 5 13
M  V30 7 1 6 17
M  V30 8 2 7 18
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-4-[methyl[4-(4-methylphenoxy)-2-butyn-1-yl]amino]-2H-pyran-2-one
C18H19NO3
336102-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6687 3.8501 0.0 0
M  V30 3 C 5.3348 6.1601 0.0 0
M  V30 4 C 8.0023 4.6201 0.0 0
M  V30 5 C 9.3360 5.3901 0.0 0
M  V30 6 C 10.6697 6.1601 0.0 0
M  V30 7 O 12.0035 5.3901 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 17.3383 8.4702 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 1.3338 3.8501 0.0 0
M  V30 15 C 2.6675 1.5400 0.0 0
M  V30 16 O 1.3338 2.3101 0.0 0
M  V30 17 C 13.3372 6.1601 0.0 0
M  V30 18 C 13.3372 7.7002 0.0 0
M  V30 19 C 14.6708 5.3901 0.0 0
M  V30 20 C 14.6708 8.4702 0.0 0
M  V30 21 C 16.0045 6.1601 0.0 0
M  V30 22 C 16.0045 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 3 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 17
M  V30 9 1 8 14
M  V30 10 2 9 15
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36763-49-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 31913-41-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 336102-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13921889
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies in sigmatropic rearrangement: synthesis of
4-aryloxy-methylene-1,7-dimethyl-1,2,3-trihydropyridino-[3,2-c]pyran-5-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Majumdar, K. C.; Ghosh, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2001), 57(8), 1589-1592

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
1-Benzyl-4-methylpiperidin-3-one
C13H17NO
32018-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 O 0.0000 3.0800 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 N 4.0011 2.3100 0.0 0
M  V30 5 C 2.6675 3.0800 0.0 0
M  V30 6 C 4.0011 0.7700 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 8.0022 3.0800 0.0 0
M  V30 12 C 6.6684 0.7700 0.0 0
M  V30 13 C 9.3359 2.3100 0.0 0
M  V30 14 C 8.0022 0.0000 0.0 0
M  V30 15 C 9.3359 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine
C14H22N2
384338-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 9.2400 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 7.7000 2.6674 0.0 0
M  V30 9 C 5.3900 1.3338 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 0.7700 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 8
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32018-96-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 384338-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12592182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for the preparation of
(3R,4R)-N-(1-benzyl-4-methylpiperidin-3-yl)methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sathe, Dhananjay. G.; Das, Arijit; Patil, Yogesh Subhash; Bonde, Nilesh
L.; Kekan, Ankush Sampat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015087201 A1 2015-06-18

$RFMT $RIREG SCHEME286 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-indole-5-carboxaldehyde
C10H9NO
90923-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.1885 0.0 0
M  V30 2 C 7.2708 2.4782 0.0 0
M  V30 3 O 8.0408 3.8119 0.0 0
M  V30 4 C 2.6507 2.4782 0.0 0
M  V30 5 C 3.4207 1.1444 0.0 0
M  V30 6 N 1.1444 2.1580 0.0 0
M  V30 7 C 3.4207 3.8119 0.0 0
M  V30 8 C 4.9608 1.1444 0.0 0
M  V30 9 C 2.3903 0.0000 0.0 0
M  V30 10 C 0.9835 0.6263 0.0 0
M  V30 11 C 4.9608 3.8119 0.0 0
M  V30 12 C 5.7308 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[Isocyano[(4-methylphenyl)sulfonyl]methyl]-1,2,3-trimethoxybenzene
C18H19NO5S
324519-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 S 8.0022 3.8501 0.0 0 VAL=6
M  V30 3 N 6.6685 1.5400 0.0 0 CHG=1 VAL=4
M  V30 4 O 8.7722 2.5164 0.0 0
M  V30 5 O 7.2322 5.1838 0.0 0
M  V30 6 C 6.6685 0.0000 0.0 0 CHG=-1
M  V30 7 O 1.3337 3.0801 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 O 4.0010 7.7002 0.0 0
M  V30 10 C 2.6673 8.4702 0.0 0
M  V30 11 O 1.3337 6.1601 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 13.3370 6.9302 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0010 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.0010 6.1601 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 9.3360 4.6201 0.0 0
M  V30 21 C 10.6697 3.8501 0.0 0
M  V30 22 C 9.3360 6.1601 0.0 0
M  V30 23 C 12.0033 4.6201 0.0 0
M  V30 24 C 10.6697 6.9302 0.0 0
M  V30 25 C 12.0033 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 20
M  V30 7 3 3 6
M  V30 8 1 7 8
M  V30 9 1 7 17
M  V30 10 1 9 10
M  V30 11 1 9 18
M  V30 12 1 11 12
M  V30 13 1 11 19
M  V30 14 1 13 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-[1-methyl-4-(3,4,5-trimethoxyphenyl)-1H-imidazol-5-yl]-1H-indole
C22H23N3O3
424834-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8562 0.1437 0.0 0
M  V30 2 O 11.7348 5.1046 0.0 0
M  V30 3 C 12.5048 3.7710 0.0 0
M  V30 4 O 7.1148 7.7721 0.0 0
M  V30 5 C 7.8848 9.1057 0.0 0
M  V30 6 O 10.1948 7.7721 0.0 0
M  V30 7 C 11.7348 7.7721 0.0 0
M  V30 8 C 1.2459 8.1549 0.0 0
M  V30 9 C 7.1148 2.4374 0.0 0
M  V30 10 C 5.5833 2.2763 0.0 0
M  V30 11 N 7.7411 1.0304 0.0 0
M  V30 12 N 5.2629 0.7700 0.0 0
M  V30 13 C 6.5967 0.0000 0.0 0
M  V30 14 C 7.8848 3.7710 0.0 0
M  V30 15 C 9.4248 3.7710 0.0 0
M  V30 16 C 7.1148 5.1046 0.0 0
M  V30 17 C 10.1948 5.1046 0.0 0
M  V30 18 C 7.8848 6.4384 0.0 0
M  V30 19 C 9.4248 6.4384 0.0 0
M  V30 20 C 4.5527 3.4208 0.0 0
M  V30 21 C 3.0464 3.1006 0.0 0
M  V30 22 C 5.0286 4.8853 0.0 0
M  V30 23 C 2.0159 4.2450 0.0 0
M  V30 24 C 3.9981 6.0299 0.0 0
M  V30 25 C 2.4919 5.7097 0.0 0
M  V30 26 C 0.4759 4.2450 0.0 0
M  V30 27 N 1.2459 6.6149 0.0 0
M  V30 28 C 0.0000 5.7097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 4 5
M  V30 5 1 4 18
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 10 20
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90923-75-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 324519-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 424834-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-13217704
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Formation of N-Methyl-4,5-disubstituted
Imidazoles. The representative procedure for the formation of
N-methyl-4,5-disubstituted imidazoles is asfollows. A mixture of
N-methyl-5-indolecarboxaldehyde (0.16g, 1 mmol) and 2.0 M methylamine in
methanol (2.5 mL, 5mmol) in 15 mL of ethanol was treated with 0.3 mL of
aceticacid. Then, the solution was heated under reflux for 2 h. Afterit
was cooled to room temperature, the solution was treatedwith 5 mL of DME,
21a (0.49 g, 1.5 mmol), and potassiumcarbonate (0.552 g, 4 mmol). The
solution was heated at reflux for 6 h. After it was cooled to room
temperature, the reactionmixture was concentrated in vacuo, diluted with
EtOAc,washed with water and brine, dried (MgSO4), filtered,
andconcentrated in vacuo. The residue was purified by flashcolumn
chromatography on silica gel eluting with EtOAc.
1-methyl-4-(3,4,5-trimethoxyphenyl)-5-(N-methyl-indol-5-yl)imidazole
(24h) as a white solid, yield 0.341 g, 90%. 1HNMR (CDCl3): δ 7.63 (s,
1H), 7.60 (s, 1H), 7.43 (d, J =8.5 Hz,1H), 7.20 (dd, J =7.8, 1.3 Hz, 1H),
7.12 (d, J =3.1 Hz, 1H),6.81 (s, 2H), 6.51 (d, J =3.1 Hz, 1H), 3.85 (s,
3H), 3.78 (s,3H), 3.53 (s, 6H), 3.48 (s, 3H). ESI (+)/MS: 378 (M +
H)+.Anal. Calcd for C22H23N3O3•HCl: C, 63.84; H, 5.84; N, 10.15.Found: C,
63.61; H, 5.96; N, 10.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues:
Synthesis, Structure-Activity Relationship, Pharmacokinetics, and In Vivo
Antitumor Activity Evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Le; Woods, Keith W.; Li, Qun; Barr, Kenneth J.; McCroskey, Richard
W.; Hannick, Steven M.; Gherke, Laura; Credo, R. Bruce; Hui, Yu-Hua;
Marsh, Kennan; Warner, Robert; Lee, Jang Y.; Zielinski-Mozng, Nicolette;
Frost, David; Rosenberg, Saul H.; Sham, Hing L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(8), 1697-1711

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]glycyl-N6-[(phenylmethoxy)carbonyl]-L-lysine ...
C22H33N3O7
32689-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 4.0009 0.0 0 CFG=2
M  V30 2 N 13.8600 4.0009 0.0 0
M  V30 3 C 11.5500 5.3347 0.0 0
M  V30 4 C 11.5500 2.6673 0.0 0
M  V30 5 C 14.6300 5.3347 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 O 12.3200 1.3336 0.0 0
M  V30 8 O 10.0100 2.6673 0.0 0
M  V30 9 C 16.1700 5.3347 0.0 0
M  V30 10 O 13.8600 6.6684 0.0 0
M  V30 11 C 9.2400 6.6684 0.0 0
M  V30 12 C 11.5500 0.0000 0.0 0
M  V30 13 N 16.9400 6.6684 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 18.4800 6.6684 0.0 0
M  V30 16 N 6.9300 8.0020 0.0 0
M  V30 17 O 19.2500 8.0020 0.0 0
M  V30 18 O 19.2500 5.3347 0.0 0
M  V30 19 C 5.3900 8.0020 0.0 0
M  V30 20 C 20.7900 8.0020 0.0 0
M  V30 21 O 4.6200 9.3358 0.0 0
M  V30 22 O 4.6200 6.6684 0.0 0
M  V30 23 C 20.7900 9.5420 0.0 0
M  V30 24 C 22.3300 8.0020 0.0 0
M  V30 25 C 20.7900 6.4620 0.0 0
M  V30 26 C 3.0800 9.3358 0.0 0
M  V30 27 C 2.3100 10.6694 0.0 0
M  V30 28 C 0.7700 10.6694 0.0 0
M  V30 29 C 3.0800 12.0031 0.0 0
M  V30 30 C 0.0000 12.0031 0.0 0
M  V30 31 C 2.3100 13.3367 0.0 0
M  V30 32 C 0.7700 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 26 27
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 2 29 31
M  V30 31 2 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]glycyl-N-methyl-N6-[(phenylmethoxy)carbonyl]-...
C22H34N4O6
156310-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 4.0009 0.0 0 CFG=2
M  V30 2 N 13.8600 4.0009 0.0 0
M  V30 3 C 11.5500 5.3347 0.0 0
M  V30 4 C 11.5500 2.6673 0.0 0
M  V30 5 C 14.6300 5.3347 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 N 12.3200 1.3336 0.0 0
M  V30 8 O 10.0100 2.6673 0.0 0
M  V30 9 C 16.1700 5.3347 0.0 0
M  V30 10 O 13.8600 6.6684 0.0 0
M  V30 11 C 9.2400 6.6684 0.0 0
M  V30 12 C 11.5500 0.0000 0.0 0
M  V30 13 N 16.9400 6.6684 0.0 0
M  V30 14 C 7.7000 6.6684 0.0 0
M  V30 15 C 18.4800 6.6684 0.0 0
M  V30 16 N 6.9300 8.0020 0.0 0
M  V30 17 O 19.2500 8.0020 0.0 0
M  V30 18 O 19.2500 5.3347 0.0 0
M  V30 19 C 5.3900 8.0020 0.0 0
M  V30 20 C 20.7900 8.0020 0.0 0
M  V30 21 O 4.6200 9.3358 0.0 0
M  V30 22 O 4.6200 6.6684 0.0 0
M  V30 23 C 20.7900 6.4620 0.0 0
M  V30 24 C 22.3300 8.0020 0.0 0
M  V30 25 C 20.7900 9.5420 0.0 0
M  V30 26 C 3.0800 9.3358 0.0 0
M  V30 27 C 2.3100 10.6694 0.0 0
M  V30 28 C 3.0800 12.0031 0.0 0
M  V30 29 C 0.7700 10.6694 0.0 0
M  V30 30 C 2.3100 13.3367 0.0 0
M  V30 31 C 0.0000 12.0031 0.0 0
M  V30 32 C 0.7700 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 26 27
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 2 29 31
M  V30 31 2 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32689-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 156310-89-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10148179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail, reactant (methylamine) assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N and N+1 cap effects of Gly, Ala, Leu, Val, Pro and Aib in
Boc-(D)Glu1-Xxx2-Yyy3-Lys4-NHMe, a 310 type protohelix endlocked by
Boc-(D)Glu
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bobade, V. D.; Gaikwad, N. D.; Mhaske, P. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2009), 48B(3), 386-396

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-ethoxy(2-methoxy-4,5-dimethylphenyl)methylene]...
C20H16Cr2O10
332847-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0857 0.7689 0.0 0
M  V30 2 O 6.8546 0.7689 0.0 0 VAL=3
M  V30 3 C 3.4177 0.7689 0.0 0
M  V30 4 O 2.6467 0.7689 0.0 0 VAL=3
M  V30 5 C 4.7517 0.0000 0.0 0
M  V30 6 O 5.5206 0.0000 0.0 0 VAL=3
M  V30 7 C 7.0521 11.4576 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.3861 12.2287 0.0 0 CHG=1 VAL=7
M  V30 9 O 6.3852 11.8442 0.0 0
M  V30 10 C 9.9261 12.2287 0.0 0
M  V30 11 C 6.8461 12.2287 0.0 0
M  V30 12 C 8.3861 13.7687 0.0 0
M  V30 13 C 9.7201 12.9997 0.0 0
M  V30 14 C 8.3861 10.6887 0.0 0
M  V30 15 C 5.7097 11.4703 0.0 0
M  V30 16 O 10.6972 12.2287 0.0 0 VAL=3
M  V30 17 O 6.1473 12.5537 0.0 0 VAL=3
M  V30 18 O 9.1572 13.7687 0.0 0 VAL=3
M  V30 19 O 10.4911 12.9997 0.0 0 VAL=3
M  V30 20 O 9.1572 10.6887 0.0 0 VAL=3
M  V30 21 C 5.0427 11.8548 0.0 0
M  V30 22 O 9.2103 7.7701 0.0 0
M  V30 23 C 9.8772 7.3856 0.0 0
M  V30 24 C 0.0000 7.5577 0.0 0
M  V30 25 C 3.0120 9.5650 0.0 0
M  V30 26 Cr 4.7517 1.5400 0.0 0 CHG=1 VAL=9
M  V30 27 C 6.0814 5.9476 0.0 0 VAL=5
M  V30 28 C 8.5433 7.3856 0.0 0 VAL=5
M  V30 29 C 3.2117 5.9476 0.0 0 VAL=5
M  V30 30 C 6.0814 8.8215 0.0 0 VAL=5
M  V30 31 C 0.7519 7.3856 0.0 0 VAL=5
M  V30 32 C 3.2117 8.8215 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 26
M  V30 3 3 3 4
M  V30 4 1 3 26
M  V30 5 3 5 6
M  V30 6 1 5 26
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 27
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 15 21
M  V30 22 1 22 23
M  V30 23 1 22 28
M  V30 24 1 24 31
M  V30 25 1 25 32
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 29 1 26 30
M  V30 30 1 26 31
M  V30 31 1 26 32
M  V30 32 1 27 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-(2-methoxy-4,5-dimethylphenyl)(methylamino)met...
C19H15Cr2NO9
332847-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0835 0.7711 0.0 0
M  V30 2 O 6.8546 0.7711 0.0 0 VAL=3
M  V30 3 C 3.4156 0.7711 0.0 0
M  V30 4 O 2.6446 0.7711 0.0 0 VAL=3
M  V30 5 C 4.7496 0.0000 0.0 0
M  V30 6 O 5.5206 0.0000 0.0 0 VAL=3
M  V30 7 C 7.5131 11.2898 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.8470 12.0609 0.0 0 CHG=1 VAL=7
M  V30 9 N 5.1553 12.6514 0.0 0
M  V30 10 C 10.3870 12.0609 0.0 0
M  V30 11 C 7.3049 12.0609 0.0 0
M  V30 12 C 8.8470 13.6009 0.0 0
M  V30 13 C 10.1810 12.8319 0.0 0
M  V30 14 C 8.8470 10.5209 0.0 0
M  V30 15 C 4.3800 12.2223 0.0 0
M  V30 16 O 11.1581 12.0609 0.0 0 VAL=3
M  V30 17 O 6.6061 12.3858 0.0 0 VAL=3
M  V30 18 O 9.6160 13.6009 0.0 0 VAL=3
M  V30 19 O 10.9499 12.8319 0.0 0 VAL=3
M  V30 20 O 9.6160 10.5209 0.0 0 VAL=3
M  V30 21 O 9.2103 7.7701 0.0 0
M  V30 22 C 9.8772 7.3856 0.0 0
M  V30 23 C 0.0000 7.5577 0.0 0
M  V30 24 C 3.0099 9.5650 0.0 0
M  V30 25 Cr 4.7496 1.5400 0.0 0 CHG=1 VAL=9
M  V30 26 C 6.0814 5.9497 0.0 0 VAL=5
M  V30 27 C 8.5433 7.3856 0.0 0 VAL=5
M  V30 28 C 3.2096 5.9497 0.0 0 VAL=5
M  V30 29 C 6.0814 8.8215 0.0 0 VAL=5
M  V30 30 C 0.7498 7.3856 0.0 0 VAL=5
M  V30 31 C 3.2096 8.8215 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 25
M  V30 3 3 3 4
M  V30 4 1 3 25
M  V30 5 3 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 26
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 21 22
M  V30 22 1 21 27
M  V30 23 1 23 30
M  V30 24 1 24 31
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 29 1 25 30
M  V30 30 1 25 31
M  V30 31 1 26 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 332847-68-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-3644270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dibromo-α-[[4-(2-oxiranylmethyl)-1-piperazinyl]methyl]-9H-carbazole-9-eth...
C22H25Br2N3O2
335166-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2597 6.6956 0.0 0
M  V30 2 C 8.5934 5.9256 0.0 0
M  V30 3 C 9.9272 6.6956 0.0 0
M  V30 4 O 8.5934 4.3856 0.0 0
M  V30 5 Br 4.3374 0.0000 0.0 0
M  V30 6 Br 0.0000 7.5126 0.0 0
M  V30 7 C 15.2620 3.6155 0.0 0
M  V30 8 N 5.9261 5.9256 0.0 0
M  V30 9 C 5.7651 4.3940 0.0 0
M  V30 10 C 4.5191 6.5519 0.0 0
M  V30 11 C 4.2587 4.0739 0.0 0
M  V30 12 C 6.7956 3.2495 0.0 0
M  V30 13 C 3.4886 5.4075 0.0 0
M  V30 14 C 4.0432 8.0166 0.0 0
M  V30 15 C 3.7828 2.6091 0.0 0
M  V30 16 C 6.3197 1.7849 0.0 0
M  V30 17 C 1.9823 5.7277 0.0 0
M  V30 18 C 2.5369 8.3368 0.0 0
M  V30 19 C 4.8132 1.4647 0.0 0
M  V30 20 C 1.5065 7.1924 0.0 0
M  V30 21 N 11.2609 5.9256 0.0 0
M  V30 22 C 12.5946 6.6956 0.0 0
M  V30 23 C 11.2609 4.3856 0.0 0
M  V30 24 C 13.9282 5.9256 0.0 0
M  V30 25 C 12.5946 3.6155 0.0 0
M  V30 26 N 13.9282 4.3856 0.0 0
M  V30 27 C 16.5957 4.3856 0.0 0
M  V30 28 C 18.1357 4.3856 0.0 0
M  V30 29 O 17.3657 5.7192 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 21
M  V30 6 1 5 19
M  V30 7 1 6 20
M  V30 8 1 7 26
M  V30 9 1 7 27
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 13
M  V30 17 2 11 15
M  V30 18 1 12 16
M  V30 19 2 13 17
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 2 18 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α1-[(3,6-Dibromo-9H-carbazol-9-yl)methyl]-α4-[(methylamino)methyl]-1,4-pipera...
C23H30Br2N4O2
335166-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2597 6.6956 0.0 0
M  V30 2 C 8.5934 5.9256 0.0 0
M  V30 3 C 9.9271 6.6956 0.0 0
M  V30 4 O 8.5934 4.3856 0.0 0
M  V30 5 Br 4.3374 0.0000 0.0 0
M  V30 6 Br 0.0000 7.5126 0.0 0
M  V30 7 C 15.2619 3.6155 0.0 0
M  V30 8 C 16.5957 4.3856 0.0 0
M  V30 9 C 17.9294 3.6155 0.0 0
M  V30 10 O 16.5957 5.9256 0.0 0
M  V30 11 N 19.2630 4.3856 0.0 0
M  V30 12 C 20.5967 3.6155 0.0 0
M  V30 13 C 5.7650 4.3940 0.0 0
M  V30 14 C 4.2587 4.0739 0.0 0
M  V30 15 N 5.9260 5.9256 0.0 0
M  V30 16 C 6.7956 3.2495 0.0 0
M  V30 17 C 3.4886 5.4075 0.0 0
M  V30 18 C 3.7828 2.6091 0.0 0
M  V30 19 C 4.5191 6.5519 0.0 0
M  V30 20 C 6.3195 1.7849 0.0 0
M  V30 21 C 1.9822 5.7277 0.0 0
M  V30 22 C 4.8132 1.4647 0.0 0
M  V30 23 C 4.0432 8.0166 0.0 0
M  V30 24 C 1.5063 7.1924 0.0 0
M  V30 25 C 2.5367 8.3368 0.0 0
M  V30 26 N 11.2609 5.9256 0.0 0
M  V30 27 C 11.2609 4.3856 0.0 0
M  V30 28 C 12.5945 6.6956 0.0 0
M  V30 29 C 12.5945 3.6155 0.0 0
M  V30 30 C 13.9282 5.9256 0.0 0
M  V30 31 N 13.9282 4.3856 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 26
M  V30 6 1 5 22
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 2 20 22
M  V30 26 1 21 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 335166-16-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335166-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-3013980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 43.
(±)-1-(3.6-Dibromo-carbazol-9-yl)-3-[4-(2-hydroxy-3-methylamino-propyl)-piperazin-1-yl]-propan-2-ol.
To
(±)-1-(3,6-dibromo-carbazol-9-yl)-3-(4-oxiranylmethyl-piperazin-1-yl)-propan-2-ol
(0.110 g, 0.21 mmol) was added methyl amine (3 mL, 2M in MeOH). The
resulting mixture was stirred for 16 hr at rt. Concentration in vacuo,
flash chromatography on a 2 × 14 cm2 column of SiO2 using (ACN:(aqueous
NH4OH-25%)) (5:1) as eluting solvent. Slow addition of HCl (1 mL, 1M in
Et2O) into a solution of the above compound in DCM (2 mL). Title compound
as a white foam in a 90% yield, the hydrochloride salt of the title
compound (0.39 g) as a white solid in a 35% yield. M.p.: 65-75 °C M.p. >
200 °C.1H NMR (DMSO-d6, 300 MHz) δ 8.78 (br s, 2H), 8.41 (d, 2H, J= 1.8
Hz), 7.66 (d, 2H, J= 8.8 Hz), 7.54 (dd, 2H, J= 8.8, 1.8 Hz), 4.36-2.83
(m, 18H), 2.43 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, product further converted into HCl salt with 35% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 9-(piperazinylalkyl)carbazoles as Bax-modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halazy, Serge; Church, Dennis; Antonsson, Bruno; Bombrun, Agnes; Gerber,
Patrick; Martinou, Jean-Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1094063 A1 2001-04-25

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(5aR,9aR)-1-Formyl-6,7-dihydro-4-methoxy-N,N-dimethyl-9a(5aH)-dibenzofura...
C18H21NO4
340158-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 3.4159 0.0 0
M  V30 2 C 1.9823 3.0957 0.0 0
M  V30 3 N 1.5064 1.6312 0.0 0
M  V30 4 O 0.9517 4.2403 0.0 0
M  V30 5 C 0.0000 1.3109 0.0 0
M  V30 6 C 2.5369 0.4866 0.0 0
M  V30 7 C 3.7753 1.5400 0.0 0
M  V30 8 O 3.7753 0.0000 0.0 0
M  V30 9 O 9.1101 4.6200 0.0 0
M  V30 10 C 10.4438 3.8500 0.0 0
M  V30 11 C 3.9645 4.8806 0.0 0 CFG=1
M  V30 12 C 5.1090 3.8500 0.0 0
M  V30 13 C 4.5909 6.2874 0.0 0 CFG=2
M  V30 14 C 2.4329 4.7197 0.0 0
M  V30 15 C 6.4427 4.6200 0.0 0
M  V30 16 C 5.1090 2.3100 0.0 0
M  V30 17 O 6.1225 6.1265 0.0 0
M  V30 18 C 3.6857 7.5333 0.0 0
M  V30 19 C 1.5277 5.9656 0.0 0
M  V30 20 C 7.7763 3.8500 0.0 0
M  V30 21 C 6.4427 1.5400 0.0 0
M  V30 22 C 2.1542 7.3724 0.0 0
M  V30 23 C 7.7763 2.3100 0.0 0
M  V30 24 H 5.3610 7.6212 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 1 7 16
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 24 CFG=1
M  V30 19 2 14 19
M  V30 20 1 15 17
M  V30 21 2 15 20
M  V30 22 1 16 21
M  V30 23 1 18 22
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(5aR,9aR)-6,7-Dihydro-4-methoxy-N,N-dimethyl-1-[(methylamino)methyl]-9a(5...
C19H26N2O3
340158-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 4.1859 0.0 0
M  V30 2 C 1.9823 3.8658 0.0 0
M  V30 3 N 1.5065 2.4012 0.0 0
M  V30 4 O 0.9517 5.0103 0.0 0
M  V30 5 C 2.5369 1.2567 0.0 0
M  V30 6 C 0.0000 2.0809 0.0 0
M  V30 7 C 3.7754 2.3100 0.0 0
M  V30 8 N 3.7754 0.7700 0.0 0
M  V30 9 C 5.1090 0.0000 0.0 0
M  V30 10 O 9.1102 5.3901 0.0 0
M  V30 11 C 10.4438 4.6201 0.0 0
M  V30 12 C 3.9645 5.6507 0.0 0 CFG=1
M  V30 13 C 5.1090 4.6201 0.0 0
M  V30 14 C 4.5910 7.0575 0.0 0 CFG=2
M  V30 15 C 2.4329 5.4897 0.0 0
M  V30 16 C 6.4427 5.3901 0.0 0
M  V30 17 C 5.1090 3.0800 0.0 0
M  V30 18 O 6.1225 6.8965 0.0 0
M  V30 19 C 3.6857 8.3033 0.0 0
M  V30 20 C 1.5277 6.7356 0.0 0
M  V30 21 C 7.7764 4.6201 0.0 0
M  V30 22 C 6.4427 2.3100 0.0 0
M  V30 23 C 2.1542 8.1424 0.0 0
M  V30 24 C 7.7764 3.0800 0.0 0
M  V30 25 H 5.3610 8.3913 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 21
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 25 CFG=1
M  V30 20 2 15 20
M  V30 21 1 16 18
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 19 23
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 340158-09-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 340158-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6708550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general approach to the galanthamine ring system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Parsons, P. J.; Charles, M. D.; Harvey, D. M.; Sumoreeah, L. R.; Shell,
A.; Spoors, G.; Gill, A. L.; Smith, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2001), 42(11), 2209-2211

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-fluorobenzenesulfonamide
C6H5ClFNO2S
351003-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 N 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 F 1.3338 4.4137 0.0 0
M  V30 6 Cl 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-(methylamino)benzenesulfonamide
C7H9ClN2O2S
53486-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.3338 0.0 0 VAL=6
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 O 0.9764 2.1038 0.0 0
M  V30 4 O 3.6436 0.5638 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 Cl 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351003-57-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53486-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-480239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, key intermediate, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted
7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with
X-ray Structure Analysis to Understand the Unexpected Structure-Activity
Relationship at AMPA Receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Larsen, Anja Probst; Francotte, Pierre; Frydenvang, Karla; Tapken,
Daniel; Goffin, Eric; Fraikin, Pierre; Caignard, Daniel-Henri; Lestage,
Pierre; Danober, Laurence; Pirotte, Bernard; Kastrup, Jette Sandholm
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Neuroscience (2016), 7(3), 378-390

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-5-nitrobenzofuroxan
C6HCl2N3O4
353507-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3101 5.3350 0.0 0
M  V30 2 O 8.0408 1.9572 0.0 0
M  V30 3 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 4 O 0.0000 1.3338 0.0 0
M  V30 5 O 0.0000 4.0012 0.0 0
M  V30 6 Cl 2.3101 0.0000 0.0 0
M  V30 7 C 4.6201 4.0012 0.0 0
M  V30 8 C 5.3901 2.6675 0.0 0
M  V30 9 C 3.0801 4.0012 0.0 0
M  V30 10 N 5.6505 5.1457 0.0 0
M  V30 11 C 4.6201 1.3338 0.0 0
M  V30 12 N 6.8964 2.9877 0.0 0 VAL=5
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 O 7.0574 4.5192 0.0 0
M  V30 15 C 3.0801 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzoxadiazol-4-amine, 6-chloro-N-methyl-5-nitro-, 1-oxide
C7H5ClN4O4
1237661-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 8.0408 4.7114 0.0 0
M  V30 4 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 O 0.0000 5.3348 0.0 0
M  V30 7 Cl 2.3101 6.6687 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 5.3901 4.0012 0.0 0
M  V30 10 C 3.0801 2.6675 0.0 0
M  V30 11 N 5.6505 1.5229 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 N 6.8964 3.6810 0.0 0 VAL=5
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 O 7.0574 2.1494 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 353507-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1237661-74-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5349559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4,6-Bis(methylamino)-5,7-dinitrobenzofuroxane
(III). A solution of 0.15 g of furoxane I in 5 ml of benzene was mixed
with a solution of 0.03 g of methylamine in 10 ml of benzene. The
reaction mixture was kept for 30 min, the precipitate formed was filtered
off and washed successively with concentrated hydrochloric acid, with
benzene, and dried to the constant weight in an oil-pump vacuum (40°C,
0.06 mm). 6-Chloro-4-methylamino-5-nitrobenzofuroxane (V). Furoxane II,
0.125 g, was reacted with 0.03 g of methylamine according to the
above-described procedure to give 0.11 g (90%) of compound V. mp 220°C.
IR spectrum, ν, cm-1 : 1331 (NO2, symm), 1530 (NO2, asymm), 1291, 1624
(furoxane ring), 3310 (NH). 1H NMR spectrum (DMSO-d 6), δ, ppm: 3.27 s
(3H, CH3N), 6.89 s (1Harom), 8.60 s (1H, NH). Found, %: C 33.95, H 2.51,
Cl 14.30, N 22.91. C7H5ClN4O4. Calculated, %: C 34.37; H 2.06, Cl 14.49.
Crystal data: Color, appearance: Red prismatic,Crystal system: Triclinic;
Space group: P-1;Unit cell parameters : a 7.220(1), α 118.041(2), b
8.526(1), β 101.432(2), c 8.802(1) Å, γ 94.172(2)°.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reaction of dichloronitrobenzofuroxanes with amines and their derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chugunova, E. A.; Kasymova, E. M.; Burilov, A. R.; Krivolapov, D. B.;
Yusupova, L. M.; Pudovik, M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of General Chemistry (2009), 79(10), 2207-2211

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2-Benzopyrano[6′,5′,4′:10,5,6]anthra[2,1,9-def]isoquinoline-1,3,8,10(9H)-t...
C34H31NO7Si
361335-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3370 6.1601 0.0 0
M  V30 2 O 10.6697 10.7802 0.0 0
M  V30 3 C 13.3370 9.2402 0.0 0
M  V30 4 C 14.6708 8.4702 0.0 0
M  V30 5 O 16.0045 9.2402 0.0 0
M  V30 6 C 17.3382 8.4702 0.0 0
M  V30 7 C 18.6718 9.2402 0.0 0
M  V30 8 O 20.0057 8.4702 0.0 0
M  V30 9 Si 21.3393 9.2402 0.0 0
M  V30 10 C 22.6730 10.0102 0.0 0
M  V30 11 C 22.1093 7.9065 0.0 0
M  V30 12 C 20.5693 10.5739 0.0 0
M  V30 13 C 21.9030 11.3439 0.0 0
M  V30 14 C 24.0067 10.7802 0.0 0
M  V30 15 C 23.4430 8.6765 0.0 0
M  V30 16 O 2.6673 0.0000 0.0 0
M  V30 17 O 0.0000 4.6201 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3358 6.9302 0.0 0
M  V30 20 C 6.6685 6.9302 0.0 0
M  V30 21 C 8.0022 4.6201 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 23 C 9.3358 8.4702 0.0 0
M  V30 24 C 5.3348 6.1601 0.0 0
M  V30 25 C 6.6685 8.4702 0.0 0
M  V30 26 C 6.6685 3.8501 0.0 0
M  V30 27 C 9.3360 3.8501 0.0 0
M  V30 28 C 12.0033 6.9302 0.0 0
M  V30 29 C 10.6697 4.6201 0.0 0
M  V30 30 C 10.6697 9.2402 0.0 0
M  V30 31 C 8.0022 9.2402 0.0 0
M  V30 32 C 5.3348 4.6201 0.0 0
M  V30 33 C 4.0010 6.9302 0.0 0
M  V30 34 C 6.6685 2.3101 0.0 0
M  V30 35 N 12.0033 8.4702 0.0 0
M  V30 36 C 4.0012 3.8501 0.0 0
M  V30 37 C 2.6673 6.1601 0.0 0
M  V30 38 C 5.3348 1.5400 0.0 0
M  V30 39 C 4.0012 2.3101 0.0 0
M  V30 40 C 2.6673 4.6201 0.0 0
M  V30 41 C 2.6673 1.5400 0.0 0
M  V30 42 C 1.3337 3.8501 0.0 0
M  V30 43 O 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 28
M  V30 2 2 2 30
M  V30 3 1 3 4
M  V30 4 1 3 35
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 2 16 41
M  V30 17 2 17 42
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 20 25
M  V30 25 1 21 26
M  V30 26 2 21 27
M  V30 27 1 22 28
M  V30 28 2 22 29
M  V30 29 1 23 30
M  V30 30 2 23 31
M  V30 31 1 24 32
M  V30 32 2 24 33
M  V30 33 1 25 31
M  V30 34 1 26 32
M  V30 35 2 26 34
M  V30 36 1 27 29
M  V30 37 1 28 35
M  V30 38 1 30 35
M  V30 39 2 32 36
M  V30 40 1 33 37
M  V30 41 1 34 38
M  V30 42 1 36 39
M  V30 43 1 36 40
M  V30 44 2 37 40
M  V30 45 2 38 39
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Anthra[2,1,9-def:6,5,10-d'e'f′]diisoquinoline-1,3,8,10(2H,9H)-tetrone, 2-[2-[...
C35H34N2O6Si
361335-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.8600 2.8738 0.0 0
M  V30 2 O 13.8600 8.2085 0.0 0
M  V30 3 C 15.4000 5.5411 0.0 0
M  V30 4 C 16.1700 4.2074 0.0 0
M  V30 5 O 17.7100 4.2074 0.0 0
M  V30 6 C 18.4800 2.8738 0.0 0
M  V30 7 C 20.0200 2.8738 0.0 0
M  V30 8 O 20.7900 1.5400 0.0 0
M  V30 9 Si 22.3300 1.5400 0.0 0
M  V30 10 C 23.8700 1.5400 0.0 0
M  V30 11 C 22.3300 3.0800 0.0 0
M  V30 12 C 22.3300 0.0000 0.0 0
M  V30 13 C 23.8700 0.0000 0.0 0
M  V30 14 C 25.4100 1.5400 0.0 0
M  V30 15 C 23.8700 3.0800 0.0 0
M  V30 16 O 1.5400 2.8738 0.0 0
M  V30 17 O 1.5400 8.2085 0.0 0
M  V30 18 C 0.0000 5.5411 0.0 0
M  V30 19 C 9.2400 5.5411 0.0 0
M  V30 20 C 10.7800 5.5411 0.0 0
M  V30 21 C 8.4700 6.8747 0.0 0
M  V30 22 C 8.4700 4.2074 0.0 0
M  V30 23 C 11.5500 4.2074 0.0 0
M  V30 24 C 11.5500 6.8747 0.0 0
M  V30 25 C 6.9300 6.8747 0.0 0
M  V30 26 C 9.2400 8.2085 0.0 0
M  V30 27 C 6.9300 4.2074 0.0 0
M  V30 28 C 9.2400 2.8738 0.0 0
M  V30 29 C 13.0900 4.2074 0.0 0
M  V30 30 C 10.7800 2.8738 0.0 0
M  V30 31 C 13.0900 6.8747 0.0 0
M  V30 32 C 10.7800 8.2085 0.0 0
M  V30 33 C 6.1600 5.5411 0.0 0
M  V30 34 C 6.1600 8.2085 0.0 0
M  V30 35 C 6.1600 2.8738 0.0 0
M  V30 36 N 13.8600 5.5411 0.0 0
M  V30 37 C 4.6200 5.5411 0.0 0
M  V30 38 C 4.6200 8.2085 0.0 0
M  V30 39 C 4.6200 2.8738 0.0 0
M  V30 40 C 3.8500 4.2074 0.0 0
M  V30 41 C 3.8500 6.8747 0.0 0
M  V30 42 C 2.3100 4.2074 0.0 0
M  V30 43 C 2.3100 6.8747 0.0 0
M  V30 44 N 1.5400 5.5411 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 29
M  V30 2 2 2 31
M  V30 3 1 3 4
M  V30 4 1 3 36
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 2 16 42
M  V30 17 2 17 43
M  V30 18 1 18 44
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 21 26
M  V30 26 1 22 27
M  V30 27 2 22 28
M  V30 28 1 23 29
M  V30 29 2 23 30
M  V30 30 1 24 31
M  V30 31 2 24 32
M  V30 32 1 25 33
M  V30 33 2 25 34
M  V30 34 1 26 32
M  V30 35 1 27 33
M  V30 36 2 27 35
M  V30 37 1 28 30
M  V30 38 1 29 36
M  V30 39 1 31 36
M  V30 40 2 33 37
M  V30 41 1 34 38
M  V30 42 1 35 39
M  V30 43 1 37 40
M  V30 44 1 37 41
M  V30 45 2 38 41
M  V30 46 2 39 40
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 361335-63-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 361335-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-17127324
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 5970-45-6
$DTYPE RXN:VAR(1):NOTES
$DATUM quinoline may also be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biomarkers for the labeling, visual detection and quantification of
biomolecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bevers, Susan Ann; Andrade, Rodrigo Bohn; Alexandrov, Kiril Stefan;
Zdraveski, Zoran Zare
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001069254 A2 2001-09-20

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2-Benzopyrano[6′,5′,4′:10,5,6]anthra[2,1,9-def]isoquinoline-1,3,8,10(9H)-t...
C34H29Br2NO7Si
361335-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.3348 9.2402 0.0 0
M  V30 2 O 10.6697 10.7802 0.0 0
M  V30 3 O 13.3370 6.1601 0.0 0
M  V30 4 Br 8.0022 1.5400 0.0 0
M  V30 5 C 13.3370 9.2402 0.0 0
M  V30 6 C 14.6707 8.4702 0.0 0
M  V30 7 O 16.0045 9.2402 0.0 0
M  V30 8 C 17.3382 8.4702 0.0 0
M  V30 9 C 18.6718 9.2402 0.0 0
M  V30 10 O 20.0057 8.4702 0.0 0
M  V30 11 Si 21.3393 9.2402 0.0 0
M  V30 12 C 22.6730 10.0102 0.0 0
M  V30 13 C 22.1093 7.9065 0.0 0
M  V30 14 C 20.5693 10.5739 0.0 0
M  V30 15 C 21.9030 11.3439 0.0 0
M  V30 16 C 24.0067 10.7802 0.0 0
M  V30 17 C 23.4430 8.6765 0.0 0
M  V30 18 O 2.6673 0.0000 0.0 0
M  V30 19 O 0.0000 4.6201 0.0 0
M  V30 20 C 8.0022 6.1601 0.0 0
M  V30 21 C 9.3358 6.9302 0.0 0
M  V30 22 C 8.0022 4.6201 0.0 0
M  V30 23 C 6.6685 6.9302 0.0 0
M  V30 24 C 9.3358 8.4702 0.0 0
M  V30 25 C 10.6697 6.1601 0.0 0
M  V30 26 C 6.6685 3.8501 0.0 0
M  V30 27 C 9.3360 3.8501 0.0 0
M  V30 28 C 5.3348 6.1601 0.0 0
M  V30 29 C 6.6685 8.4702 0.0 0
M  V30 30 C 10.6697 9.2402 0.0 0
M  V30 31 C 8.0022 9.2402 0.0 0
M  V30 32 C 12.0033 6.9302 0.0 0
M  V30 33 C 10.6697 4.6201 0.0 0
M  V30 34 C 5.3348 4.6201 0.0 0
M  V30 35 C 6.6685 2.3101 0.0 0
M  V30 36 C 4.0010 6.9302 0.0 0
M  V30 37 N 12.0033 8.4702 0.0 0
M  V30 38 C 4.0012 3.8501 0.0 0
M  V30 39 C 5.3348 1.5400 0.0 0
M  V30 40 C 2.6673 6.1601 0.0 0
M  V30 41 C 4.0012 2.3101 0.0 0
M  V30 42 C 2.6673 4.6201 0.0 0
M  V30 43 C 2.6673 1.5400 0.0 0
M  V30 44 C 1.3337 3.8501 0.0 0
M  V30 45 O 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 2 2 30
M  V30 3 2 3 32
M  V30 4 1 4 35
M  V30 5 1 5 6
M  V30 6 1 5 37
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 2 18 43
M  V30 19 2 19 44
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 2 22 27
M  V30 27 1 23 28
M  V30 28 2 23 29
M  V30 29 1 24 30
M  V30 30 2 24 31
M  V30 31 1 25 32
M  V30 32 2 25 33
M  V30 33 1 26 34
M  V30 34 2 26 35
M  V30 35 1 27 33
M  V30 36 1 28 34
M  V30 37 2 28 36
M  V30 38 1 29 31
M  V30 39 1 30 37
M  V30 40 1 32 37
M  V30 41 2 34 38
M  V30 42 1 35 39
M  V30 43 1 36 40
M  V30 44 1 38 41
M  V30 45 1 38 42
M  V30 46 2 39 41
M  V30 47 2 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Anthra[2,1,9-def:6,5,10-d'e'f′]diisoquinoline-1,3,8,10(2H,9H)-tetrone, 5,12-d...
C35H32Br2N2O6Si
361335-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 8.4700 0.0000 0.0 0
M  V30 2 O 13.8600 1.3338 0.0 0
M  V30 3 O 13.8600 6.6685 0.0 0
M  V30 4 Br 6.9300 8.0021 0.0 0
M  V30 5 C 15.4000 4.0011 0.0 0
M  V30 6 C 16.1700 5.3347 0.0 0
M  V30 7 O 17.7100 5.3347 0.0 0
M  V30 8 C 18.4800 6.6684 0.0 0
M  V30 9 C 20.0200 6.6684 0.0 0
M  V30 10 O 20.7900 8.0021 0.0 0
M  V30 11 Si 22.3300 8.0021 0.0 0
M  V30 12 C 23.8700 8.0021 0.0 0
M  V30 13 C 22.3300 9.5421 0.0 0
M  V30 14 C 22.3300 6.4621 0.0 0
M  V30 15 C 23.8700 6.4621 0.0 0
M  V30 16 C 25.4100 8.0021 0.0 0
M  V30 17 C 23.8700 9.5421 0.0 0
M  V30 18 O 1.5400 6.6685 0.0 0
M  V30 19 O 1.5400 1.3338 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 23 C 8.4700 5.3347 0.0 0
M  V30 24 C 8.4700 2.6674 0.0 0
M  V30 25 C 11.5500 2.6674 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 6.9300 5.3347 0.0 0
M  V30 28 C 9.2400 6.6685 0.0 0
M  V30 29 C 6.9300 2.6674 0.0 0
M  V30 30 C 9.2400 1.3338 0.0 0
M  V30 31 C 13.0900 2.6674 0.0 0
M  V30 32 C 10.7800 1.3338 0.0 0
M  V30 33 C 13.0900 5.3347 0.0 0
M  V30 34 C 10.7800 6.6685 0.0 0
M  V30 35 C 6.1600 4.0011 0.0 0
M  V30 36 C 6.1600 6.6685 0.0 0
M  V30 37 C 6.1600 1.3338 0.0 0
M  V30 38 N 13.8600 4.0011 0.0 0
M  V30 39 C 4.6200 4.0011 0.0 0
M  V30 40 C 4.6200 6.6685 0.0 0
M  V30 41 C 4.6200 1.3338 0.0 0
M  V30 42 C 3.8500 5.3347 0.0 0
M  V30 43 C 3.8500 2.6674 0.0 0
M  V30 44 C 2.3100 5.3347 0.0 0
M  V30 45 C 2.3100 2.6674 0.0 0
M  V30 46 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 30
M  V30 2 2 2 31
M  V30 3 2 3 33
M  V30 4 1 4 36
M  V30 5 1 5 6
M  V30 6 1 5 38
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 2 18 44
M  V30 19 2 19 45
M  V30 20 1 20 46
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 2 23 28
M  V30 28 1 24 29
M  V30 29 2 24 30
M  V30 30 1 25 31
M  V30 31 2 25 32
M  V30 32 1 26 33
M  V30 33 2 26 34
M  V30 34 1 27 35
M  V30 35 2 27 36
M  V30 36 1 28 34
M  V30 37 1 29 35
M  V30 38 2 29 37
M  V30 39 1 30 32
M  V30 40 1 31 38
M  V30 41 1 33 38
M  V30 42 2 35 39
M  V30 43 1 36 40
M  V30 44 1 37 41
M  V30 45 1 39 42
M  V30 46 1 39 43
M  V30 47 2 40 42
M  V30 48 2 41 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 361335-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 361335-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-17127328
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 5970-45-6
$DTYPE RXN:VAR(1):NOTES
$DATUM quinoline may also be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biomarkers for the labeling, visual detection and quantification of
biomolecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bevers, Susan Ann; Andrade, Rodrigo Bohn; Alexandrov, Kiril Stefan;
Zdraveski, Zoran Zare
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001069254 A2 2001-09-20

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloronicotinaldehyde
C6H4ClNO
36404-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 N 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-3-pyridinemethanamine
C7H9ClN2
120739-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 N 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36404-88-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120739-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2853077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular N-arylation in heterocyclization: synthesis of new
pyrido-fused pyrrolo[1,2-a][1,4]diazepinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Legeren, Loreto; Dominguez, Domingo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2010), 51(31), 4053-4057

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR)-α-[2-[(R)-(4-Methylphenyl)sulfinyl]-2-propen-1-yl]-3-pyridinemethanol
C16H17NO2S
371764-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.7000 1.3338 0.0 0 CFG=2 VAL=4
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 7.7000 4.0011 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 7 O 5.3900 5.3349 0.0 0
M  V30 8 C 13.8600 1.3338 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 C 10.0100 0.0000 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 11.5500 0.0000 0.0 0
M  V30 13 C 11.5500 2.6674 0.0 0
M  V30 14 C 12.3200 1.3338 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 5.3349 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 0.7700 5.3349 0.0 0
M  V30 19 N 0.7700 2.6674 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9 CFG=3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 15
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[3-(Methylamino)-2-[(R)-(4-methylphenyl)sulfinyl]propyl]-3-pyridinemet...
C17H22N2O2S
371764-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6684 0.0 0 CFG=3
M  V30 2 S 4.6200 8.0021 0.0 0 CFG=2 VAL=4
M  V30 3 C 4.6200 5.3347 0.0 0
M  V30 4 C 2.3100 6.6684 0.0 0
M  V30 5 O 3.8500 9.3358 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0 CFG=2
M  V30 7 N 1.5400 8.0021 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 C 10.7800 8.0021 0.0 0
M  V30 11 C 6.1600 8.0021 0.0 0
M  V30 12 C 6.9300 9.3358 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 8.4700 9.3358 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 9.2400 8.0021 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 C 6.9300 1.3336 0.0 0
M  V30 21 N 4.6200 0.0000 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 11
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 6 17
M  V30 10 1 7 9
M  V30 11 1 10 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371764-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 371764-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-5555906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, other isomer detected, Michael addn.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies on the diastereoselective allylation of aldehydes with
enantiopure 2-sulfinylallyl building blocks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marquez, F.; Llebaria, A.; Delgado, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2001), 12(11), 1625-1634

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fenclorim
C10H6Cl2N2
3740-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.0021 4.6200 0.0 0
M  V30 2 Cl 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 N 5.3347 4.6200 0.0 0
M  V30 5 N 4.0011 2.3100 0.0 0
M  V30 6 C 6.6685 3.8500 0.0 0
M  V30 7 C 5.3347 1.5400 0.0 0
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyrimidinamine, 6-chloro-N-methyl-2-phenyl-
C11H10ClN3
1017782-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 4.6201 0.0 0
M  V30 2 C 9.3359 3.8500 0.0 0
M  V30 3 Cl 5.3348 0.0000 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 N 5.3348 4.6201 0.0 0
M  V30 6 N 4.0011 2.3100 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 6.6684 2.3100 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 3.8500 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3740-92-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1017782-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17185623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chlorobenzene-substituted azaaryl compounds as anticancer agents and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yen, Yun; Liou, Jing-Ping; Chen, Chun-Han
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017015400 A1 2017-01-26

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αE)-2-[[[(E)-[1-[(1R,2R)-2-(2,6-difluorophenyl)cyclopropyl]ethyli...
C22H22F2N2O4
374925-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 5.3901 0.0 0
M  V30 2 N 8.2086 4.6201 0.0 0
M  V30 3 C 6.8748 6.9301 0.0 0
M  V30 4 O 9.5423 5.3901 0.0 0
M  V30 5 C 10.8759 4.6201 0.0 0
M  V30 6 F 4.0011 7.7001 0.0 0
M  V30 7 F 1.3338 3.0800 0.0 0
M  V30 8 C 13.5434 3.0800 0.0 0
M  V30 9 C 12.2097 2.3100 0.0 0
M  V30 10 N 14.8770 2.3100 0.0 0
M  V30 11 O 12.2097 0.7700 0.0 0
M  V30 12 O 10.8759 3.0800 0.0 0
M  V30 13 O 16.2107 3.0800 0.0 0
M  V30 14 C 10.8759 0.0000 0.0 0
M  V30 15 C 17.5445 2.3100 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 17 C 5.5411 4.6201 0.0 0 CFG=1
M  V30 18 C 4.7711 3.2864 0.0 0
M  V30 19 C 2.6675 5.3901 0.0 0
M  V30 20 C 2.6675 6.9301 0.0 0
M  V30 21 C 1.3338 4.6201 0.0 0
M  V30 22 C 1.3338 7.7001 0.0 0
M  V30 23 C 0.0000 5.3901 0.0 0
M  V30 24 C 0.0000 6.9301 0.0 0
M  V30 25 C 12.2097 5.3901 0.0 0
M  V30 26 C 13.5434 4.6201 0.0 0
M  V30 27 C 12.2097 6.9301 0.0 0
M  V30 28 C 14.8770 5.3901 0.0 0
M  V30 29 C 13.5434 7.7001 0.0 0
M  V30 30 C 14.8770 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 20
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(αE)-2-[[[(E)-[1-[(1R,2R)-2-(2,6-Difluorophenyl)cyclopropyl]ethylidene]am...
C22H23F2N3O3
374925-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 5.3901 0.0 0
M  V30 2 N 8.2086 4.6201 0.0 0
M  V30 3 C 6.8748 6.9301 0.0 0
M  V30 4 O 9.5423 5.3901 0.0 0
M  V30 5 C 10.8759 4.6201 0.0 0
M  V30 6 F 1.3338 3.0800 0.0 0
M  V30 7 F 4.0011 7.7001 0.0 0
M  V30 8 C 13.5434 3.0800 0.0 0
M  V30 9 C 12.2097 2.3100 0.0 0
M  V30 10 N 14.8770 2.3100 0.0 0
M  V30 11 N 12.2097 0.7700 0.0 0
M  V30 12 O 10.8759 3.0800 0.0 0
M  V30 13 O 16.2107 3.0800 0.0 0
M  V30 14 C 10.8759 0.0000 0.0 0
M  V30 15 C 17.5445 2.3100 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0 CFG=1
M  V30 17 C 5.5411 4.6201 0.0 0 CFG=1
M  V30 18 C 4.7711 3.2864 0.0 0
M  V30 19 C 2.6675 5.3901 0.0 0
M  V30 20 C 1.3338 4.6201 0.0 0
M  V30 21 C 2.6675 6.9301 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 23 C 1.3338 7.7001 0.0 0
M  V30 24 C 0.0000 6.9301 0.0 0
M  V30 25 C 12.2097 5.3901 0.0 0
M  V30 26 C 13.5434 4.6201 0.0 0
M  V30 27 C 12.2097 6.9301 0.0 0
M  V30 28 C 14.8770 5.3901 0.0 0
M  V30 29 C 13.5434 7.7001 0.0 0
M  V30 30 C 14.8770 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 6 20
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19 CFG=3
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 374925-52-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 374925-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19708477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (hetero)arylcyclopropyl oxime ethers as agrochemical
fungicides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ross, Ronald, Jr.; Nguyen, Duyan Vuong; Szapacs, Edward Michael; Smith,
Frisby David; Shaber, Steven Howard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001087826 A1 2001-11-22

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, 2-(3-formylphenoxy)-, methyl ester
C10H10O4
37748-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 4.6201 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetamide, 2-(3-formylphenoxy)-N-methyl-
C10H11NO3
1016701-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 4.6201 0.0 0
M  V30 6 C 12.0033 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37748-10-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1016701-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16454466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Phenyl-3H-imidazo[4,5-b]pyridine derivatives as inhibitors or mammalian
tyrosine kinase ROR1 activity and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mellstedt, Haakan; Bystroem, Styrbjoern; Vaagberg, Jan; Olsson, Elisabeth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016124553 A1 2016-08-11

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-[3-[4-[[3-chloro-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinaz...
C30H22ClN5O3
383434-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 9.3360 0.0 0
M  V30 2 C 14.6303 8.0022 0.0 0
M  V30 3 C 15.4003 6.6685 0.0 0
M  V30 4 C 16.1704 5.3348 0.0 0
M  V30 5 N 17.7104 5.3348 0.0 0
M  V30 6 C 18.4804 4.0010 0.0 0
M  V30 7 O 20.0204 4.0010 0.0 0
M  V30 8 O 17.7104 2.6673 0.0 0
M  V30 9 Cl 4.6201 12.0033 0.0 0
M  V30 10 O 3.0801 9.3360 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 11.5503 10.6697 0.0 0
M  V30 13 C 10.0102 10.6697 0.0 0
M  V30 14 C 12.3203 12.0033 0.0 0
M  V30 15 C 12.3203 9.3360 0.0 0
M  V30 16 N 9.2402 12.0033 0.0 0
M  V30 17 C 13.8603 12.0033 0.0 0
M  V30 18 N 11.5503 13.3370 0.0 0
M  V30 19 C 13.8603 9.3360 0.0 0
M  V30 20 C 10.0102 13.3370 0.0 0
M  V30 21 C 14.6303 10.6697 0.0 0
M  V30 22 C 7.7002 9.3360 0.0 0
M  V30 23 C 6.9302 10.6697 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 5.3901 10.6697 0.0 0
M  V30 26 C 5.3901 8.0022 0.0 0
M  V30 27 C 4.6201 9.3360 0.0 0
M  V30 28 C 2.3101 8.0022 0.0 0
M  V30 29 C 3.0801 6.6685 0.0 0
M  V30 30 C 0.7700 8.0022 0.0 0
M  V30 31 C 2.3101 5.3348 0.0 0
M  V30 32 N 0.0000 6.6685 0.0 0
M  V30 33 C 0.7700 5.3348 0.0 0
M  V30 34 C 20.7905 2.6673 0.0 0
M  V30 35 C 20.0204 1.3337 0.0 0
M  V30 36 C 22.3305 2.6673 0.0 0
M  V30 37 C 20.7905 0.0000 0.0 0
M  V30 38 C 23.1005 1.3337 0.0 0
M  V30 39 C 22.3305 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 3 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 34
M  V30 11 1 9 25
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 1 11 33
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 14 18
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 2 17 21
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-[[3-Chloro-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]...
C25H21ClN6O2
383430-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 6.6684 0.0 0
M  V30 2 C 14.6300 5.3347 0.0 0
M  V30 3 C 15.4000 4.0011 0.0 0
M  V30 4 C 16.1700 2.6673 0.0 0
M  V30 5 N 17.7100 2.6673 0.0 0
M  V30 6 C 18.4800 1.3336 0.0 0
M  V30 7 N 20.0200 1.3336 0.0 0
M  V30 8 O 17.7100 0.0000 0.0 0
M  V30 9 C 20.7900 0.0000 0.0 0
M  V30 10 Cl 4.6200 9.3358 0.0 0
M  V30 11 O 3.0800 6.6684 0.0 0
M  V30 12 C 0.0000 1.3336 0.0 0
M  V30 13 C 11.5500 8.0021 0.0 0
M  V30 14 C 10.0100 8.0021 0.0 0
M  V30 15 C 12.3200 9.3358 0.0 0
M  V30 16 C 12.3200 6.6684 0.0 0
M  V30 17 N 9.2400 9.3358 0.0 0
M  V30 18 C 13.8600 9.3358 0.0 0
M  V30 19 N 11.5500 10.6694 0.0 0
M  V30 20 C 13.8600 6.6684 0.0 0
M  V30 21 C 10.0100 10.6694 0.0 0
M  V30 22 C 14.6300 8.0021 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 C 5.3900 8.0021 0.0 0
M  V30 27 C 5.3900 5.3347 0.0 0
M  V30 28 C 4.6200 6.6684 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 3.0800 4.0011 0.0 0
M  V30 32 C 0.0000 4.0011 0.0 0
M  V30 33 N 2.3100 2.6673 0.0 0
M  V30 34 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 3 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 26
M  V30 12 1 11 28
M  V30 13 1 11 29
M  V30 14 1 12 34
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 383434-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 383430-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2773010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method D: Synthesis of
1-(3-{4-[3-Chloro-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-3-methyl-urea
(4)
1-(3-{4-[3-Chloro-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-3-methyl-urea:
A mixture of
(3-{4-[3-Chloro-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-carbamic
acid phenyl ester (0.1 g, 0.18 mmol) prepared by Method B, methyl amine
(2.0M methanol solution, 1 mL, 2 mmol) and DMSO (0.5 mL) was stirred at
80° C. overnight. The solvents were removed under vacuum (GeneVac HT-8)
and the residue was re-dissolved in MeOH (~1 mL). HCl gas was bubbled
through the solution and EtOAc resulting in precipitation of the desired
product. The title compound (80 mg, 90% yield) was obtained by filtration
as a yellow solid. 1H NMR (400 MHz, CD3OD) δ 2.72 (3H, s), 2.76 (3H, s),
4.19 (2H, s), 7.49 (1H, d, J=9 Hz), 7.84 (1H, d, J=2 Hz), 7.86 (1H, d,
J=2 Hz), 7.92 (1H, d, J=9 Hz), 8.12 (2H, m, J=2 Hz), 8.16 (1H, d, J=2.4
Hz), 8.60 (1H, d, J=3.2 Hz), 8.74 (1H, d, J=1.2 Hz), 8.87 (1H, s). LRMS
(M+): 473.0, 475.0, 476.0.
$DTYPE RXN:VAR(1):NOTES
$DATUM HCl gas used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective erbb2 inhibitor/anti-erbb antibody combinations in the
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Connell, Richard D.; Denis, Louis J.; Jani, Jitesh P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050101618 A1 2005-05-12

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-[3-[4-[[3-chloro-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinaz...
C30H22ClN5O3
383434-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 9.3360 0.0 0
M  V30 2 C 14.6303 8.0022 0.0 0
M  V30 3 C 15.4003 6.6685 0.0 0
M  V30 4 C 16.1704 5.3348 0.0 0
M  V30 5 N 17.7104 5.3348 0.0 0
M  V30 6 C 18.4804 4.0010 0.0 0
M  V30 7 O 20.0204 4.0010 0.0 0
M  V30 8 O 17.7104 2.6673 0.0 0
M  V30 9 Cl 4.6201 12.0033 0.0 0
M  V30 10 O 3.0801 9.3360 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 11.5503 10.6697 0.0 0
M  V30 13 C 10.0102 10.6697 0.0 0
M  V30 14 C 12.3203 12.0033 0.0 0
M  V30 15 C 12.3203 9.3360 0.0 0
M  V30 16 N 9.2402 12.0033 0.0 0
M  V30 17 C 13.8603 12.0033 0.0 0
M  V30 18 N 11.5503 13.3370 0.0 0
M  V30 19 C 13.8603 9.3360 0.0 0
M  V30 20 C 10.0102 13.3370 0.0 0
M  V30 21 C 14.6303 10.6697 0.0 0
M  V30 22 C 7.7002 9.3360 0.0 0
M  V30 23 C 6.9302 10.6697 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 5.3901 10.6697 0.0 0
M  V30 26 C 5.3901 8.0022 0.0 0
M  V30 27 C 4.6201 9.3360 0.0 0
M  V30 28 C 2.3101 8.0022 0.0 0
M  V30 29 C 3.0801 6.6685 0.0 0
M  V30 30 C 0.7700 8.0022 0.0 0
M  V30 31 C 2.3101 5.3348 0.0 0
M  V30 32 N 0.0000 6.6685 0.0 0
M  V30 33 C 0.7700 5.3348 0.0 0
M  V30 34 C 20.7905 2.6673 0.0 0
M  V30 35 C 20.0204 1.3337 0.0 0
M  V30 36 C 22.3305 2.6673 0.0 0
M  V30 37 C 20.7905 0.0000 0.0 0
M  V30 38 C 23.1005 1.3337 0.0 0
M  V30 39 C 22.3305 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 3 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 34
M  V30 11 1 9 25
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 1 11 33
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 14 18
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 2 17 21
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-[[3-Chloro-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]...
C25H21ClN6O2
383430-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 6.6684 0.0 0
M  V30 2 C 14.6300 5.3347 0.0 0
M  V30 3 C 15.4000 4.0011 0.0 0
M  V30 4 C 16.1700 2.6673 0.0 0
M  V30 5 N 17.7100 2.6673 0.0 0
M  V30 6 C 18.4800 1.3336 0.0 0
M  V30 7 N 20.0200 1.3336 0.0 0
M  V30 8 O 17.7100 0.0000 0.0 0
M  V30 9 C 20.7900 0.0000 0.0 0
M  V30 10 Cl 4.6200 9.3358 0.0 0
M  V30 11 O 3.0800 6.6684 0.0 0
M  V30 12 C 0.0000 1.3336 0.0 0
M  V30 13 C 11.5500 8.0021 0.0 0
M  V30 14 C 10.0100 8.0021 0.0 0
M  V30 15 C 12.3200 9.3358 0.0 0
M  V30 16 C 12.3200 6.6684 0.0 0
M  V30 17 N 9.2400 9.3358 0.0 0
M  V30 18 C 13.8600 9.3358 0.0 0
M  V30 19 N 11.5500 10.6694 0.0 0
M  V30 20 C 13.8600 6.6684 0.0 0
M  V30 21 C 10.0100 10.6694 0.0 0
M  V30 22 C 14.6300 8.0021 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 C 5.3900 8.0021 0.0 0
M  V30 27 C 5.3900 5.3347 0.0 0
M  V30 28 C 4.6200 6.6684 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 3.0800 4.0011 0.0 0
M  V30 32 C 0.0000 4.0011 0.0 0
M  V30 33 N 2.3100 2.6673 0.0 0
M  V30 34 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 3 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 26
M  V30 12 1 11 28
M  V30 13 1 11 29
M  V30 14 1 12 34
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 383434-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 383430-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3078537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives for the treatment of abnormal cell
growth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kath, John Charles; Moyer, James Dale; Connell, Richard Damian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003049740 A1 2003-06-19

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl N-[3-[4-[[3-chloro-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinaz...
C30H22ClN5O3
383434-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 9.3360 0.0 0
M  V30 2 C 14.6303 8.0022 0.0 0
M  V30 3 C 15.4003 6.6685 0.0 0
M  V30 4 C 16.1704 5.3348 0.0 0
M  V30 5 N 17.7104 5.3348 0.0 0
M  V30 6 C 18.4804 4.0010 0.0 0
M  V30 7 O 20.0204 4.0010 0.0 0
M  V30 8 O 17.7104 2.6673 0.0 0
M  V30 9 Cl 4.6201 12.0033 0.0 0
M  V30 10 O 3.0801 9.3360 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 11.5503 10.6697 0.0 0
M  V30 13 C 10.0102 10.6697 0.0 0
M  V30 14 C 12.3203 12.0033 0.0 0
M  V30 15 C 12.3203 9.3360 0.0 0
M  V30 16 N 9.2402 12.0033 0.0 0
M  V30 17 C 13.8603 12.0033 0.0 0
M  V30 18 N 11.5503 13.3370 0.0 0
M  V30 19 C 13.8603 9.3360 0.0 0
M  V30 20 C 10.0102 13.3370 0.0 0
M  V30 21 C 14.6303 10.6697 0.0 0
M  V30 22 C 7.7002 9.3360 0.0 0
M  V30 23 C 6.9302 10.6697 0.0 0
M  V30 24 C 6.9302 8.0022 0.0 0
M  V30 25 C 5.3901 10.6697 0.0 0
M  V30 26 C 5.3901 8.0022 0.0 0
M  V30 27 C 4.6201 9.3360 0.0 0
M  V30 28 C 2.3101 8.0022 0.0 0
M  V30 29 C 3.0801 6.6685 0.0 0
M  V30 30 C 0.7700 8.0022 0.0 0
M  V30 31 C 2.3101 5.3348 0.0 0
M  V30 32 N 0.0000 6.6685 0.0 0
M  V30 33 C 0.7700 5.3348 0.0 0
M  V30 34 C 20.7905 2.6673 0.0 0
M  V30 35 C 20.0204 1.3337 0.0 0
M  V30 36 C 22.3305 2.6673 0.0 0
M  V30 37 C 20.7905 0.0000 0.0 0
M  V30 38 C 23.1005 1.3337 0.0 0
M  V30 39 C 22.3305 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 22
M  V30 3 3 2 3
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 34
M  V30 11 1 9 25
M  V30 12 1 10 27
M  V30 13 1 10 28
M  V30 14 1 11 33
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 14 18
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 2 17 21
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[4-[[3-Chloro-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]...
C25H21ClN6O2
383430-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 6.6684 0.0 0
M  V30 2 C 14.6300 5.3347 0.0 0
M  V30 3 C 15.4000 4.0011 0.0 0
M  V30 4 C 16.1700 2.6673 0.0 0
M  V30 5 N 17.7100 2.6673 0.0 0
M  V30 6 C 18.4800 1.3336 0.0 0
M  V30 7 N 20.0200 1.3336 0.0 0
M  V30 8 O 17.7100 0.0000 0.0 0
M  V30 9 C 20.7900 0.0000 0.0 0
M  V30 10 Cl 4.6200 9.3358 0.0 0
M  V30 11 O 3.0800 6.6684 0.0 0
M  V30 12 C 0.0000 1.3336 0.0 0
M  V30 13 C 11.5500 8.0021 0.0 0
M  V30 14 C 10.0100 8.0021 0.0 0
M  V30 15 C 12.3200 9.3358 0.0 0
M  V30 16 C 12.3200 6.6684 0.0 0
M  V30 17 N 9.2400 9.3358 0.0 0
M  V30 18 C 13.8600 9.3358 0.0 0
M  V30 19 N 11.5500 10.6694 0.0 0
M  V30 20 C 13.8600 6.6684 0.0 0
M  V30 21 C 10.0100 10.6694 0.0 0
M  V30 22 C 14.6300 8.0021 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 6.9300 8.0021 0.0 0
M  V30 25 C 6.9300 5.3347 0.0 0
M  V30 26 C 5.3900 8.0021 0.0 0
M  V30 27 C 5.3900 5.3347 0.0 0
M  V30 28 C 4.6200 6.6684 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 3.0800 4.0011 0.0 0
M  V30 32 C 0.0000 4.0011 0.0 0
M  V30 33 N 2.3100 2.6673 0.0 0
M  V30 34 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 3 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 26
M  V30 12 1 11 28
M  V30 13 1 11 29
M  V30 14 1 12 34
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 383434-57-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 383430-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9581144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method D: Synthesis of
1-(3-{4-[3-Chloro-4-(6-methypyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-3-methyurea(4):
1-(3-{4-[3-Chloro-4-(6-methypyridin-3-yloxy)-phenylamino]-quina2olin-6-yl}-prop-2-ynyl)-3-methyurea:
A mixture of
(3-{4-[3-Chloro-4-(6-methypyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-prop-2-ynyl)-carbamic
acid phenyl ester (0.1 g, 0.18 mmol) prepared by Method B, methyl amine
(2.0M methanol solution, 1 mL, 2 mmol) and DMSO (0.5 mL) was stirred at
80°C overnight. The solvents were removed under vacuum (Gene Vac HT- 8)
and the residue was re-dissolved in MeOH (~1 mL). HCl gas was bubbled
through the solution and EtOAc resulting in precipitation of the desired
product. The title compound was obtained by filtration. Yellow solid,
yield 80 mg, 90%. 1H NMR (400MHz, CD3OD) δ 2.72 (3H,s), 2.76 (3H, s),
4.19 (2H, s), 7.49 (1H, d, J=9Hz), 7.84 (1H, d, J=2Hz), 7.86 (1H, d,
J=2Hz), 7.92 (1H, d, J=9Hz), 8.12 (2H, m, J=2Hz), 8.16 (1H, d, J=2.4Hz),
8.60 (1H, d, J=3.2Hz), 8.74 (1H, d, J=1.2Hz), 8.87 (1H, s ). LRMS (M+):
473.0, 475.0, 476.0. HPLC RT: 5.37.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 4-quinazolinamines for the treatment of
abnormal cell growth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kath, John Charles; Bhattacharya, Samit Kumar; Morris, Joel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001098277 A2 2001-12-27

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Trifluoromethyl)-3-pyridinecarboxaldehyde
C7H4F3NO
386704-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 N 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-(trifluoromethyl)-3-pyridinemethanamine
C8H9F3N2
886364-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 N 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 386704-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 886364-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME302 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroisatoic anhydride
C8H4ClNO3
40928-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Cl 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6685 3.8500 0.0 0
M  V30 12 O 1.3336 2.3100 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-fluorobenzaldehyde
C7H4ClFO
387-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 Cl 3.0800 5.3349 0.0 0
M  V30 4 F 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6675 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-2-(2-chloro-6-fluorophenyl)-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C15H11Cl2FN2O
1542270-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 Cl 4.0011 6.9300 0.0 0
M  V30 3 F 1.3336 2.3100 0.0 0
M  V30 4 O 5.3347 0.0000 0.0 0
M  V30 5 Cl 10.6694 4.6200 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 5.3347 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 6.6684 3.8500 0.0 0
M  V30 10 C 5.3347 1.5400 0.0 0
M  V30 11 C 6.6684 2.3100 0.0 0
M  V30 12 C 8.0021 4.6200 0.0 0
M  V30 13 C 8.0021 1.5400 0.0 0
M  V30 14 C 9.3358 3.8500 0.0 0
M  V30 15 C 9.3358 2.3100 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 C 2.6673 6.1600 0.0 0
M  V30 18 C 1.3336 3.8500 0.0 0
M  V30 19 C 1.3336 6.9300 0.0 0
M  V30 20 C 0.0000 4.6200 0.0 0
M  V30 21 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 17
M  V30 3 1 3 18
M  V30 4 2 4 10
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40928-13-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 387-45-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1542270-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21054732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7585-39-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM sulfonic acid functionalized
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7790-94-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, green chemistry-solvent,
alternative preparation shown, recyclable catalyst upto 3 cycles,
catalyst prepared and used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2,3-dihydroquinazolin-4(1H)-one derivatives in aqueous
media with β-cyclodextrin-SO3H as a recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Jian; Du, Xianli; Ma, Juan; Zhang, Yuping; Shi, Qingcai; Luo, Lijun;
Song, Baoan; Yang, Song; Hu, Deyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2014), 16(6), 3210-3217

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
3,5-Bis(trifluoromethyl)benzenesulfonyl chloride
C8H3ClF6O2S
39234-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4938 0.0 0
M  V30 3 F 0.0000 6.9302 0.0 0
M  V30 4 F 0.5637 4.8265 0.0 0
M  V30 5 C 6.6687 6.1601 0.0 0
M  V30 6 F 7.4387 4.8265 0.0 0
M  V30 7 F 8.0023 6.9302 0.0 0
M  V30 8 F 5.8986 7.4938 0.0 0
M  V30 9 S 4.0012 1.5400 0.0 0 VAL=6
M  V30 10 Cl 4.0012 0.0000 0.0 0
M  V30 11 O 5.5412 1.5400 0.0 0
M  V30 12 O 2.4611 1.5400 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 4.0012 6.1601 0.0 0
M  V30 15 C 2.6675 3.8501 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 4.0012 3.0801 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 9 12
M  V30 12 1 9 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, N-methyl-3,5-bis(trifluoromethyl)-
C9H7F6NO2S
1208534-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 6.1601 0.0 0 VAL=6
M  V30 2 N 8.0023 6.9302 0.0 0
M  V30 3 O 5.8985 7.4938 0.0 0
M  V30 4 O 7.4385 4.8265 0.0 0
M  V30 5 C 9.3360 6.1601 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 F 2.1037 7.4938 0.0 0
M  V30 8 F 0.0000 6.9302 0.0 0
M  V30 9 F 0.5637 4.8265 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 F 5.5412 1.5400 0.0 0
M  V30 12 F 4.0012 0.0000 0.0 0
M  V30 13 F 2.4611 1.5400 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 4.0012 6.1601 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 2.6675 5.3901 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 39234-86-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208534-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23234125
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalization of α-C(sp3)-H Bonds in Amides Using Radical
Translocating Arylating Groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Radhoff, Niklas; Studer, Armido
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2021), 60(7), 3561-3565

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pentenoyl chloride
C5H7ClO
39716-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-pentenamide
C6H11NO
52565-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39716-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52565-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-4733194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: N-Methylpent-4-enamide A solution of DIPEA (14.7 mL, 84.7 mmol)
in methylenechloride (400 mL) was cooled using an ice bath then saturated
with methylamine gas. A solution of 4-pentenoyl chloride (10.0 g, 84.7
mmol) in methylenechloride (100 mL) was added to the reaction flask
dropwise via an addition funnel. Contents of the reaction flask were
stirred with cooling 2 h then washed with 5% potassium bisulfate. The
organic layer was dried with sodium sulfate (anh.), filtered and
evaporated. Flash column chromatography eluting with ethyl acetate/hexane
60/40 gave after evaporation N-methylpent-4-enamide as a colorless oil,
8.65 g (90% yield). N-Methylpent-4-enamide, Yield (8.65 g 90%)
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine gas used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as HCV NS3 protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Holloway, M. Katharine; Liverton, Nigel J.; Ludmerer, Steven W.;
Mccauley, John A.; Olsen, David B.; Rudd, Michael T.; Vacca, Joseph P.;
Mcintyre, Charles J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070027071 A1 2007-02-01

$RFMT $RIREG SCHEME305 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 3-oxoazetidine-1-carboxylate
C8H13NO3
398489-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 O 9.1079 2.8737 0.0 0
M  V30 9 N 5.3900 2.8737 0.0 0
M  V30 10 C 6.4790 3.9626 0.0 0
M  V30 11 C 6.4790 1.7847 0.0 0
M  V30 12 C 7.5679 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-cyano-3-(methylamino)-1-azetidinecarboxylate
C10H17N3O2
1514167-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2986 3.4375 0.0 0
M  V30 2 N 9.6323 4.2075 0.0 0
M  V30 3 N 7.7350 1.3337 0.0 0
M  V30 4 C 6.9650 0.0000 0.0 0
M  V30 5 C 3.3736 3.6297 0.0 0
M  V30 6 O 2.9750 5.1172 0.0 0
M  V30 7 O 2.2846 2.5407 0.0 0
M  V30 8 C 1.4875 5.5159 0.0 0
M  V30 9 C 1.0890 4.0283 0.0 0
M  V30 10 C 0.0000 5.9145 0.0 0
M  V30 11 C 1.8861 7.0035 0.0 0
M  V30 12 C 6.9650 2.6675 0.0 0
M  V30 13 C 6.1949 4.0012 0.0 0
M  V30 14 C 5.6313 1.8975 0.0 0
M  V30 15 N 4.8613 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 398489-26-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1514167-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-19161829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and process development of a novel TACE inhibitor for the
topical treatment of psoriasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boiteau, Jean-Guy; Ouvry, Gilles; Arlabosse, Jean-Marie; Astri,
Stephanie; Beillard, Audrey; Bhurruth-Alcor, Yushma; Bonnary, Laetitia;
Bouix-Peter, Claire; Bouquet, Karine; Bourotte, Marilyne; Cardinaud,
Isabelle; Comino, Catherine; Deprez, Benoit; Duvert, Denis; Feret,
Angelique; Hacini-Rachinel, Feriel; Harris, Craig S.; Luzy, Anne-Pascale;
Mathieu, Arnaud; Millois, Corinne; Orsini, Nicolas; Pascau, Jonathan;
Pinto, Artur; Piwnica, David; Polge, Gaelle; Reitz, Arnaud; Reverse,
Kevin; Rodeville, Nicolas; Rossio, Patricia; Spiesse, Delphine; Tabet,
Samuel; Taquet, Nathalie; Tomas, Loic; Vial, Emmanuel; Hennequin, Laurent
F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2018), 26(4), 945-956

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Bis(trifluoromethyl)benzaldehyde
C9H4F6O
401-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4937 0.0 0
M  V30 3 F 0.0000 6.9301 0.0 0
M  V30 4 F 0.5636 4.8264 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 F 2.4611 1.5400 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 F 5.5411 1.5400 0.0 0
M  V30 9 C 6.6686 6.1601 0.0 0
M  V30 10 O 8.0022 5.3901 0.0 0
M  V30 11 C 2.6675 5.3901 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 6.1601 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 2 9 10
M  V30 10 1 9 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,5-bis(trifluoromethyl)benzenemethanamine
C10H9F6N
159820-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 6.1601 0.0 0
M  V30 2 F 2.1037 7.4938 0.0 0
M  V30 3 F 0.0000 6.9302 0.0 0
M  V30 4 F 0.5637 4.8265 0.0 0
M  V30 5 C 4.0012 1.5400 0.0 0
M  V30 6 F 5.5412 1.5400 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 F 2.4611 1.5400 0.0 0
M  V30 9 C 6.6685 6.1601 0.0 0
M  V30 10 N 8.0023 5.3901 0.0 0
M  V30 11 C 9.3360 6.1601 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 6.1601 0.0 0
M  V30 15 C 4.0012 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 401-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 159820-24-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6120282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 13762-51-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3,5-(Bistrifluoromethylbenzyl)methylamine Hydrochloride (7a). To a
stirred solution of 3,5-bis(trifluoromethyl)benzaldehyde (15 g, 58.6
mmol) in dry methanol (90 mL) a 8Msolution ofMeNH2 in methanol (8.5mL,
68mmol) was added.After 50 minKBH4 (3.3 g, 61.2 mmol) was added. The
reaction mixture was stirred for 1 h at room temperature, then
concentrated in vacuo to remove methanol, and diluted with ethyl ether
(80 mL). Finally, a 1 M solution of HCl in diethyl ether (93 mL) was
added. The solid obtained was filtered and washed with diethyl ether
(40mL) to give title compound 6a (16.34 g, 89.8%) as a white powder.
1HNMR (400MHz,DMSO-d6) δ ppm 9.30 (2H, bs), 8.32 (2H, s), 8.18 (1H, s),
4.31 (2H, s), 2.55 (3H, s).
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk technique used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Biological Characterization of
(2R,4S)-1'-Acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide
as a New Potent and Selective Neurokinin 1 (NK1) Receptor Antagonist
Clinical Candidate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Di Fabio, Romano; Alvaro, Giuseppe; Griffante, Cristiana; Pizzi, Domenica
A.; Donati, Daniele; Mattioli, Mario; Cimarosti, Zadeo; Guercio,
Giuseppe; Marchioro, Carla; Provera, Stefano; Zonzini, Laura; Montanari,
Dino; Melotto, Sergio; Gerrard, Philip A.; Trist, David G.; Ratti,
Emiliangelo; Corsi, Mauro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(4), 1071-1079

$RFMT $RIREG SCHEME307 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Thiazolecarboxylic acid, 2-(hydroxymethyl)-, ethyl ester
C7H9NO3S
40235-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.5400 0.0 0
M  V30 2 O 7.5415 2.3101 0.0 0
M  V30 3 O 6.2079 0.0000 0.0 0
M  V30 4 C 8.8752 1.5400 0.0 0
M  V30 5 C 10.2089 2.3101 0.0 0
M  V30 6 C 0.9051 2.6672 0.0 0
M  V30 7 O 0.0000 3.9131 0.0 0
M  V30 8 C 4.8741 2.3101 0.0 0
M  V30 9 N 3.4672 1.6836 0.0 0
M  V30 10 C 4.7131 3.8416 0.0 0
M  V30 11 C 2.4368 2.8281 0.0 0
M  V30 12 S 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[[(methylamino)carbonyl]oxy]methyl]-4-thiazolecarboxylate
C9H12N2O4S
43121-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3420 2.6672 0.0 0
M  V30 2 O 2.4368 3.9131 0.0 0
M  V30 3 O 2.7155 1.2602 0.0 0
M  V30 4 C 0.9052 3.7521 0.0 0
M  V30 5 C 0.0000 4.9980 0.0 0
M  V30 6 C 8.6447 1.5400 0.0 0
M  V30 7 O 9.9783 2.3101 0.0 0
M  V30 8 C 11.3122 1.5400 0.0 0
M  V30 9 N 12.6458 2.3101 0.0 0
M  V30 10 O 11.3122 0.0000 0.0 0
M  V30 11 C 13.9795 1.5400 0.0 0
M  V30 12 C 4.8736 2.8281 0.0 0
M  V30 13 N 5.9040 1.6837 0.0 0
M  V30 14 C 5.6436 4.1618 0.0 0
M  V30 15 C 7.3110 2.3101 0.0 0
M  V30 16 S 7.1501 3.8416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40235-65-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 43121-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-8805019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Carbamate 34. Thiazole 33 (0.50 g, 2.67 mmol) was combined in CH2Cl2 (20
mL) with 0.52 g (3.20 mmol, 1.2 equiv.) of carbonyldiimidazole. The
solution was stirred at rt for 1 h. The reaction was then cooled down to
0 °C and methylamine (5.40 mmol, 2.0 equiv., 2M in THF) was added. The
reaction mixture was warmed up to rt and stirred for further 3 h. Then
the solution was washed with 0.01M HCl until neutrality. The organic
layer was separated, dried with MgSO4 and filtered. The solvent was
removed in vacuum. The obtained crude product was purified by flash
chromatography on silica gel (EtOAc). The title compound 34 was isolated
as white solid crystals (0.59 g, 2.40 mmol, 90%): m.p. 186 °C; 1H NMR
(300 MHz, CDCl3) δ = 1.38 (t, J = 7.1 Hz, 3H), 2.82 (d, J = 5.1 Hz, 3H),
4.40 (q, J = 7.0 Hz, 2H), 4.90 (bs, 1H), 5.38 (s, 2H), 8.16 (s, 1H); 13C
NMR (100 MHz, CDCl3) δ = 14.4, 27.7, 61.6, 63.0, 128.4, 147.1, 156.0,
161.2, 166.8; HRMS calculated for C9H12N2O4S1: 244.0518, found: 244.0522.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Total Synthesis of Archazolid A and B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Menche, Dirk; Hassfeld, Jorma; Li, Jun; Mayer, Kerstin; Rudolph, Sven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(19), 7220-7229

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-(2-Deoxy-β-D-erythro-pentofuranosyl)-2-methyl-6-(4H-1,2,4-triazol-4-yl)-9H-...
C13H15N7O3
402750-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0305 0.0000 0.0 0
M  V30 2 C 0.1609 5.4473 0.0 0
M  V30 3 O 0.0000 6.9788 0.0 0
M  V30 4 O 0.8575 2.1701 0.0 0
M  V30 5 C 6.6968 3.8501 0.0 0
M  V30 6 C 8.0305 4.6201 0.0 0
M  V30 7 N 5.5523 4.8805 0.0 0
M  V30 8 N 6.6968 2.3101 0.0 0
M  V30 9 C 9.3642 3.8501 0.0 0
M  V30 10 N 7.7103 6.1264 0.0 0
M  V30 11 C 6.1788 6.2875 0.0 0
M  V30 12 C 8.0305 1.5400 0.0 0
M  V30 13 N 9.3642 2.3101 0.0 0
M  V30 14 C 4.0460 4.5603 0.0 0 CFG=1
M  V30 15 O 2.9016 5.5908 0.0 0
M  V30 16 C 3.4196 3.1535 0.0 0
M  V30 17 C 1.5678 4.8208 0.0 0 CFG=2
M  V30 18 C 1.8879 3.3145 0.0 0 CFG=2
M  V30 19 N 10.6980 4.6201 0.0 0
M  V30 20 C 10.8589 6.1517 0.0 0
M  V30 21 C 12.1048 3.9938 0.0 0
M  V30 22 N 12.3652 6.4718 0.0 0
M  V30 23 N 13.1353 5.1382 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=1
M  V30 4 1 18 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 14 7 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 19
M  V30 15 2 10 11
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 2′-deoxy-N,2-dimethyl-
C12H17N5O3
402750-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.6980 4.6201 0.0 0
M  V30 2 C 12.0317 3.8501 0.0 0
M  V30 3 C 8.0305 0.0000 0.0 0
M  V30 4 C 0.1609 5.4473 0.0 0
M  V30 5 O 0.0000 6.9788 0.0 0
M  V30 6 O 0.8575 2.1701 0.0 0
M  V30 7 N 5.5524 4.8805 0.0 0
M  V30 8 C 6.6968 3.8501 0.0 0
M  V30 9 C 6.1788 6.2875 0.0 0
M  V30 10 C 8.0305 4.6201 0.0 0
M  V30 11 N 6.6968 2.3101 0.0 0
M  V30 12 N 7.7103 6.1264 0.0 0
M  V30 13 C 9.3643 3.8501 0.0 0
M  V30 14 C 8.0305 1.5400 0.0 0
M  V30 15 N 9.3643 2.3101 0.0 0
M  V30 16 C 4.0460 4.5603 0.0 0 CFG=1
M  V30 17 O 2.9016 5.5908 0.0 0
M  V30 18 C 3.4196 3.1535 0.0 0
M  V30 19 C 1.5679 4.8208 0.0 0 CFG=2
M  V30 20 C 1.8881 3.3145 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=1
M  V30 6 1 20 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 16 7 CFG=1
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402750-82-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402750-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28384061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of 8 (150 mg, 0.472 mmol) and methylamine (1.0 M in THF, 3 mL)
in absolute ethanol (3 mL) was heated at 100°C in a sealed tube for 12 h.
After the solvent was evaporated, the residue was chromatographed on
silica (AcOEt/ CH2Cl2/EtOH, 4:5:1) and then recrystallized from ethanol
to give 9 (118 mg, 90%) as a white solid;
2,N6-Dimethyl-2'-deoxyadenosine, Yield 118 mg, 90% mp 150°C. 1H NMR (200
MHz, CDCl3): δ 2.26-2.36 (m, 1H, 2'-Ha), 2.61 (s, 3H, CH3), 3.10-3.25 (m,
1H, 2'-Hb), 3.24 (m, 3H, CH3), 3.78-4.09 (m, 2H, 5'-H), 4.28-4.31 (m, 1H,
4'-H), 4.82-4.89 (m, 1H, 3'- H), 5.98 (s, 1H, NH), 6.29-6.37 (m, 1H,
1'-H), 7.74 (s, 1H, 3'- OH), 8.25 (s, 2H, 8-H, 5'-OH); m/z 280 (M + H)+.
Anal. (C12H17N5O3•0.5 H2O) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Antagonists Acting at the P2Y1 Purinergic Receptor: Synthesis and
Conformational Analysis Using Potentiometric and Nuclear Magnetic
Resonance Titration Techniques
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raboisson, Pierre; Baurand, Anthony; Cazenave, Jean-Pierre; Gachet,
Christian; Retat, Myriam; Spiess, Bernard; Bourguignon, Jean-Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(4), 962-972

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
3′,5′-Bis-O-[(1,1-dimethylethyl)dimethylsilyl]thymidine
C22H42N2O5Si2
40733-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0763 0.0 0
M  V30 2 C 9.3037 6.6392 0.0 0
M  V30 3 O 9.9300 8.0461 0.0 0
M  V30 4 Si 11.4617 8.2070 0.0 0
M  V30 5 C 12.9933 8.3680 0.0 0
M  V30 6 C 11.6226 6.6755 0.0 0
M  V30 7 C 11.3006 9.7386 0.0 0
M  V30 8 C 12.8322 9.8997 0.0 0
M  V30 9 C 14.5248 8.5291 0.0 0
M  V30 10 C 13.1542 6.8364 0.0 0
M  V30 11 O 7.6285 3.7376 0.0 0
M  V30 12 Si 6.7232 2.4917 0.0 0
M  V30 13 C 5.8180 1.2459 0.0 0
M  V30 14 C 5.4774 3.3970 0.0 0
M  V30 15 C 7.9691 1.5865 0.0 0
M  V30 16 C 4.5721 2.1511 0.0 0
M  V30 17 C 4.9130 0.0000 0.0 0
M  V30 18 C 7.0640 0.3407 0.0 0
M  V30 19 C 0.0000 6.9963 0.0 0
M  V30 20 O 0.0000 10.0763 0.0 0
M  V30 21 C 5.3348 6.9963 0.0 0 CFG=1
M  V30 22 O 6.7416 7.6228 0.0 0
M  V30 23 C 5.4957 5.4647 0.0 0
M  V30 24 C 7.7721 6.4782 0.0 0 CFG=2
M  V30 25 C 7.0021 5.1446 0.0 0 CFG=2
M  V30 26 N 4.0011 7.7663 0.0 0
M  V30 27 C 4.0011 9.3063 0.0 0
M  V30 28 C 2.6673 6.9963 0.0 0
M  V30 29 N 2.6673 10.0763 0.0 0
M  V30 30 C 1.3337 7.7663 0.0 0
M  V30 31 C 1.3337 9.3063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 27
M  V30 2 1 2 3
M  V30 3 1 24 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 1 25 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 19 30
M  V30 20 2 20 31
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 26 CFG=3
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 21 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H45N3O4Si2
2062540-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 10.0763 0.0 0
M  V30 2 O 7.6284 3.7376 0.0 0
M  V30 3 Si 6.7232 2.4917 0.0 0
M  V30 4 C 5.8180 1.2459 0.0 0
M  V30 5 C 5.4773 3.3969 0.0 0
M  V30 6 C 7.9691 1.5865 0.0 0
M  V30 7 C 7.0640 0.3407 0.0 0
M  V30 8 C 4.9129 0.0000 0.0 0
M  V30 9 C 4.5721 2.1511 0.0 0
M  V30 10 C 9.3036 6.6391 0.0 0
M  V30 11 O 9.9300 8.0461 0.0 0
M  V30 12 Si 11.4617 8.2070 0.0 0
M  V30 13 C 12.9932 8.3679 0.0 0
M  V30 14 C 11.3006 9.7385 0.0 0
M  V30 15 C 11.6226 6.6755 0.0 0
M  V30 16 C 13.1541 6.8364 0.0 0
M  V30 17 C 14.5247 8.5290 0.0 0
M  V30 18 C 12.8323 9.8996 0.0 0
M  V30 19 C 0.0000 6.9963 0.0 0
M  V30 20 N 0.0000 10.0763 0.0 0
M  V30 21 C 0.0000 11.6163 0.0 0
M  V30 22 C 5.3347 6.9963 0.0 0 CFG=2
M  V30 23 C 5.4957 5.4647 0.0 0
M  V30 24 O 6.7415 7.6227 0.0 0
M  V30 25 C 7.0021 5.1446 0.0 0 CFG=2
M  V30 26 C 7.7721 6.4782 0.0 0 CFG=2
M  V30 27 N 4.0011 7.7663 0.0 0
M  V30 28 C 4.0011 9.3063 0.0 0
M  V30 29 C 2.6673 6.9963 0.0 0
M  V30 30 N 2.6673 10.0763 0.0 0
M  V30 31 C 1.3336 7.7663 0.0 0
M  V30 32 C 1.3336 9.3063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 28
M  V30 2 1 2 3
M  V30 3 1 25 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 11
M  V30 11 1 26 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 19 31
M  V30 20 1 20 21
M  V30 21 1 20 32
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 27 CFG=3
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 22 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 40733-26-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2062540-26-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21376859
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reactant also recovered, alternate two step method gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile functionalization at the C4 position of pyrimidine nucleosides via
amide group activation with
(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate
(BOP) and biological evaluations of the products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akula, Hari K.; Kokatla, Hariprasad; Andrei, Graciela; Snoeck, Robert;
Schols, Dominique; Balzarini, Jan; Yang, Lijia; Lakshman, Mahesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(5), 1130-1139

$RFMT $RIREG SCHEME310 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroisatoic anhydride
C8H4ClNO3
40928-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Cl 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6685 3.8500 0.0 0
M  V30 12 O 1.3336 2.3100 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromophthalide
C8H5BrO2
6940-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 O 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6,6a-dihydro-6-methylisoindolo[2,1-a]quinazoline-5,11-dione
C16H11ClN2O2
1486571-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.6253 7.2708 0.0 0
M  V30 2 C 2.2475 1.5400 0.0 0
M  V30 3 O 4.9150 0.0000 0.0 0
M  V30 4 Cl 10.2498 4.6201 0.0 0
M  V30 5 N 4.9150 4.6201 0.0 0
M  V30 6 C 3.5813 3.8501 0.0 0
M  V30 7 C 6.2487 3.8501 0.0 0
M  V30 8 C 4.5948 6.1264 0.0 0
M  V30 9 C 2.4368 4.8805 0.0 0
M  V30 10 N 3.5813 2.3100 0.0 0
M  V30 11 C 6.2487 2.3100 0.0 0
M  V30 12 C 7.5823 4.6201 0.0 0
M  V30 13 C 3.0633 6.2873 0.0 0
M  V30 14 C 0.9052 4.7196 0.0 0
M  V30 15 C 4.9150 1.5400 0.0 0
M  V30 16 C 7.5823 1.5400 0.0 0
M  V30 17 C 8.9162 3.8501 0.0 0
M  V30 18 C 2.1580 7.5332 0.0 0
M  V30 19 C 0.0000 5.9655 0.0 0
M  V30 20 C 8.9162 2.3100 0.0 0
M  V30 21 C 0.6263 7.3723 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 10
M  V30 3 2 3 15
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40928-13-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 6940-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1486571-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26159682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 25322-68-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal-Catalyst-Free Green and efficient synthesis of five and six
membered fused N-heterocyclic quinazoline derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Madhubabu, M. V.; Shankar, R.; Reddy, G. Rajeshwar; Rao, T. Srinivasa;
Basaveswara Rao, Mandava V.; Akula, Raghunadh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(46), 5033-5037

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Phenyl 1,4-dihydro-4-oxo-7-(phenylmethoxy)-6-quinolinecarboxylate
C23H17NO4
417724-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 8.0023 0.0 0
M  V30 2 C 7.7002 9.3360 0.0 0
M  V30 3 C 5.3901 5.3348 0.0 0
M  V30 4 O 4.6201 4.0012 0.0 0
M  V30 5 O 6.9302 5.3348 0.0 0
M  V30 6 O 0.0000 6.6685 0.0 0
M  V30 7 C 5.3901 8.0023 0.0 0
M  V30 8 C 4.6201 6.6685 0.0 0
M  V30 9 C 4.6201 9.3360 0.0 0
M  V30 10 C 3.0801 6.6685 0.0 0
M  V30 11 C 3.0801 9.3360 0.0 0
M  V30 12 C 2.3101 8.0023 0.0 0
M  V30 13 N 2.3101 10.6697 0.0 0
M  V30 14 C 0.7700 8.0023 0.0 0
M  V30 15 C 0.7700 10.6697 0.0 0
M  V30 16 C 0.0000 9.3360 0.0 0
M  V30 17 C 9.2402 9.3360 0.0 0
M  V30 18 C 10.0102 10.6697 0.0 0
M  V30 19 C 10.0102 8.0023 0.0 0
M  V30 20 C 11.5503 10.6697 0.0 0
M  V30 21 C 11.5503 8.0023 0.0 0
M  V30 22 C 12.3203 9.3360 0.0 0
M  V30 23 C 5.3901 2.6673 0.0 0
M  V30 24 C 4.6201 1.3337 0.0 0
M  V30 25 C 6.9302 2.6673 0.0 0
M  V30 26 C 5.3901 0.0000 0.0 0
M  V30 27 C 7.7002 1.3337 0.0 0
M  V30 28 C 6.9302 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 4 23
M  V30 8 2 6 14
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methyl-7-(phenylmethoxy)-6-quinolinecarboxamide
C18H15ClN2O2
417724-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0011 0.0 0
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 N 4.6200 1.3336 0.0 0
M  V30 4 O 6.9300 2.6674 0.0 0
M  V30 5 C 5.3900 0.0000 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 4.6200 6.6685 0.0 0
M  V30 13 N 2.3100 8.0021 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 0.0000 6.6685 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 9.2400 6.6685 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 11.5500 8.0021 0.0 0
M  V30 22 C 11.5500 5.3347 0.0 0
M  V30 23 C 12.3200 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 18
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 417724-43-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 417724-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-472071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Production Example 645-3.
N6-Methyl-7-(benzyloxy)-4-chloro-6-quinolinecarboxamide. After adding
thionyl chloride (12 ml) and a catalytic amount of dimethylformamide to
phenyl 7-(benzyloxy)-4-oxo-1,4-dihydro-6-quinolinecarboxylate (1.20 g,
3.23 mmol), the mixture was heated to reflux for 2 hours while stirring.
The reaction solution was concentrated under reduced pressure and
azeotropically distilled twice with toluene, the residue was suspended in
dimethylformamide (20 ml), a 40% methylamine-methanol solution (5 ml) was
gradually added while cooling in an ice water bath, and the mixture was
stirred for 1 hour. The reaction solution was distributed between ethyl
acetate-tetrahydrofuran (1:1) and water, and the organic layer was washed
with saturated aqueous ammonium chloride solution, water and saturated
brine and then dried over anhydrous sodium sulfate. The solvent was
distilled off, diethyl ether and then hexane were added for
crystallization, and the crystals were filtered out and blow-dried to
obtain the title compound (947mg, 2.90 mmol, 89.7%) as light yellow
crystals. 1H-NMR Spectrum (CDCl3) δ (ppm): 2.97 (3H, d, J = 4.8 Hz), 5.35
(2H, s), 7.40-7.52 (6H, m), 7.64 (1H, s), 7.91 (1H, m), 8.75 (1H, q, J =
4.8 Hz), 9.16 (1H, s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of urea derivatives containing nitrogenous aromatic ring
compounds as inhibitors of angiogenesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Funahashi, Yasuhiro; Tsuruoka, Akihiko; Matsukura, Masayuki; Haneda,
Toru; Fukuda, Yoshio; Kamata, Junichi; Takahashi, Keiko; Matsushima,
Tomohiro; Miyazaki, Kazuki; Nomoto, Ken-Ichi; Watanabe, Tatsuo; Obaishi,
Hiroshi; Yamaguchi, Atsumi; Suzuki, Sachi; Nakamura, Katsuji; Mimura,
Fusayo; Yamamoto, Yuji; Matsui, Junji; Matsui, Kenji; Yoshiba, Takako;
Suzuki, Yasuyuki; Arimoto, Itaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7253286 B2 2007-08-07

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine
C5H2Cl2N4
42754-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 C 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 N 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C6H6ClN5
7251-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 C 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 N 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42754-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7251-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16401494
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM LRRK2 inhibitors and methods of making and using the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Hatcher, John; Choi, Hwan Geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016130920 A2 2016-08-18

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine
C5H2Cl2N4
42754-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 C 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 N 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C6H6ClN5
7251-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 C 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 N 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42754-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7251-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10815921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective,
and Brain Penetrant LRRK2 Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatcher, John M.; Zhang, Jinwei; Choi, Hwan Geun; Ito, Genta; Alessi,
Dario R.; Gray, Nathanael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2015), 6(5), 584-589

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, 5′-O-[(4-methoxyphenyl)diphenylmethyl]-1-methyl-
C31H31N5O5
434329-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.9300 0.0 0
M  V30 2 O 6.1600 6.9300 0.0 0
M  V30 3 C 6.9300 8.2636 0.0 0
M  V30 4 O 4.6200 0.7700 0.0 0
M  V30 5 C 3.2862 0.0000 0.0 0
M  V30 6 O 8.8992 10.9742 0.0 0
M  V30 7 O 12.0856 9.9389 0.0 0
M  V30 8 N 16.8923 4.7337 0.0 0
M  V30 9 C 18.1449 7.5472 0.0 0
M  V30 10 C 4.6200 5.3900 0.0 0
M  V30 11 C 3.2862 4.6200 0.0 0
M  V30 12 C 5.9536 4.6200 0.0 0
M  V30 13 C 3.2862 3.0800 0.0 0
M  V30 14 C 5.9536 3.0800 0.0 0
M  V30 15 C 4.6200 2.3100 0.0 0
M  V30 16 C 3.0800 6.9300 0.0 0
M  V30 17 C 2.3100 8.2636 0.0 0
M  V30 18 C 2.3100 5.5964 0.0 0
M  V30 19 C 0.7700 8.2636 0.0 0
M  V30 20 C 0.7700 5.5964 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 22 C 4.6200 8.4700 0.0 0
M  V30 23 C 3.2862 9.2400 0.0 0
M  V30 24 C 5.9536 9.2400 0.0 0
M  V30 25 C 3.2862 10.7800 0.0 0
M  V30 26 C 5.9536 10.7800 0.0 0
M  V30 27 C 4.6200 11.5500 0.0 0
M  V30 28 C 8.4700 8.2636 0.0 0 CFG=2
M  V30 29 O 9.3751 7.0178 0.0 0
M  V30 30 C 9.3751 9.5095 0.0 0 CFG=1
M  V30 31 C 10.8398 7.4936 0.0 0 CFG=1
M  V30 32 C 10.8398 9.0336 0.0 0 CFG=1
M  V30 33 N 12.0856 6.5884 0.0 0
M  V30 34 C 13.5503 7.0644 0.0 0
M  V30 35 C 12.0856 5.0484 0.0 0
M  V30 36 C 14.4555 5.8184 0.0 0
M  V30 37 N 14.1766 8.4712 0.0 0
M  V30 38 N 13.5503 4.5726 0.0 0
M  V30 39 C 15.9870 5.9795 0.0 0
M  V30 40 C 15.7082 8.6322 0.0 0
M  V30 41 N 16.6134 7.3863 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 1 22
M  V30 5 1 2 3
M  V30 6 1 28 3 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 15
M  V30 9 1 30 6 CFG=1
M  V30 10 1 32 7 CFG=1
M  V30 11 2 8 39
M  V30 12 1 9 41
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 31 33 CFG=3
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 1 34 37
M  V30 41 2 35 38
M  V30 42 1 36 38
M  V30 43 1 36 39
M  V30 44 2 37 40
M  V30 45 1 39 41
M  V30 46 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 28 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 5′-O-[(4-methoxyphenyl)diphenylmethyl]-N-methyl-
C31H31N5O5
434329-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.9300 0.0 0
M  V30 2 O 6.1600 6.9300 0.0 0
M  V30 3 C 6.9300 8.2636 0.0 0
M  V30 4 O 4.6200 0.7700 0.0 0
M  V30 5 C 3.2864 0.0000 0.0 0
M  V30 6 O 8.8994 10.9742 0.0 0
M  V30 7 O 12.0858 9.9389 0.0 0
M  V30 8 N 16.8923 4.7337 0.0 0
M  V30 9 C 18.4239 4.8946 0.0 0
M  V30 10 C 4.6200 5.3900 0.0 0
M  V30 11 C 3.2864 4.6200 0.0 0
M  V30 12 C 5.9538 4.6200 0.0 0
M  V30 13 C 3.2864 3.0800 0.0 0
M  V30 14 C 5.9538 3.0800 0.0 0
M  V30 15 C 4.6200 2.3100 0.0 0
M  V30 16 C 3.0800 6.9300 0.0 0
M  V30 17 C 2.3100 5.5964 0.0 0
M  V30 18 C 2.3100 8.2636 0.0 0
M  V30 19 C 0.7700 5.5964 0.0 0
M  V30 20 C 0.7700 8.2636 0.0 0
M  V30 21 C 0.0000 6.9300 0.0 0
M  V30 22 C 4.6200 8.4700 0.0 0
M  V30 23 C 5.9538 9.2400 0.0 0
M  V30 24 C 3.2864 9.2400 0.0 0
M  V30 25 C 5.9538 10.7800 0.0 0
M  V30 26 C 3.2864 10.7800 0.0 0
M  V30 27 C 4.6200 11.5500 0.0 0
M  V30 28 C 8.4700 8.2636 0.0 0 CFG=2
M  V30 29 O 9.3752 7.0178 0.0 0
M  V30 30 C 9.3752 9.5095 0.0 0 CFG=1
M  V30 31 C 10.8399 7.4936 0.0 0 CFG=1
M  V30 32 C 10.8399 9.0336 0.0 0 CFG=1
M  V30 33 N 12.0858 6.5884 0.0 0
M  V30 34 C 13.5505 7.0644 0.0 0
M  V30 35 C 12.0858 5.0484 0.0 0
M  V30 36 C 14.4555 5.8184 0.0 0
M  V30 37 N 14.1768 8.4712 0.0 0
M  V30 38 N 13.5505 4.5726 0.0 0
M  V30 39 C 15.9872 5.9795 0.0 0
M  V30 40 C 15.7083 8.6322 0.0 0
M  V30 41 N 16.6135 7.3863 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 1 22
M  V30 5 1 2 3
M  V30 6 1 28 3 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 15
M  V30 9 1 30 6 CFG=1
M  V30 10 1 32 7 CFG=1
M  V30 11 1 8 9
M  V30 12 1 8 39
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 31 33 CFG=3
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 34 37
M  V30 41 2 35 38
M  V30 42 1 36 38
M  V30 43 2 36 39
M  V30 44 1 37 40
M  V30 45 1 39 41
M  V30 46 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 28 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434329-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 434329-13-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26626973
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemical incorporation of 1-methyladenosine into oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mikhailov, Sergey N.; Rozenski, Jef; Efimtseva, Ekaterina V.; Busson,
Roger; Van Aerschot, Arthur; Herdewijn, Piet
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Research (2002), 30(5), 1124-1131

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Benzyloxy)benzaldehyde
C14H12O2
4397-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 O 12.3203 4.0010 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 10.0102 2.6673 0.0 0
M  V30 11 C 3.0801 1.3337 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(phenylmethoxy)benzenemethanamine
C15H17NO
169943-94-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 N 12.3203 4.0010 0.0 0
M  V30 5 C 13.8603 4.0010 0.0 0
M  V30 6 C 6.9302 2.6673 0.0 0
M  V30 7 C 7.7002 1.3337 0.0 0
M  V30 8 C 7.7002 4.0010 0.0 0
M  V30 9 C 9.2402 1.3337 0.0 0
M  V30 10 C 9.2402 4.0010 0.0 0
M  V30 11 C 10.0102 2.6673 0.0 0
M  V30 12 C 3.0801 1.3337 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 15 C 0.7700 2.6673 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4397-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 169943-94-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12875335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (4-Benzyloxy-benzyl)-methyl-amine A suspension of 4-benzyloxybenzaldehyde
(3.0g, 14.2mmol) in 100mL methanol was 5 treated with a 2M solution of
methylamine in THF (14mL, 28mmol). Molecular sieves 3A and sodium
borohydride (1.61 g, 0.042mmol) were added to the solution, which was
stirred at RT for 16h. The mixture was filtered and evaporated, and the
resulting residue partitioned between ethyl acetate and water. The
organic layer was separated, washed with brine, dried (Na2SO4) and
evaporated. The resulting oil was dissolved in methanol and purified on
SCX-2 cartridge eluting with methanol then with 2N NH3 in methanol, to
afford the title compound as an amber oil, which crystallised on
standing. Yield: 2.91 g (90%) LC-MS (Method 4): Rt 0.57 mins, m/z 197
[M-MeNH]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieve used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxazole and thiazole derivatives as M3 muscarinic receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ray, Nicholas Charles; Bull, Richard James; Finch, Harry; Van den Heuvel,
Marco; Bravo, Jose Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008096093 A1 2008-08-14

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1R,2S,3S)-2-(1-Methylethyl)-3-[2-oxo-2-[(phenylmethoxy)amino]ethyl]cyclop...
C25H32N2O4
443149-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.9300 0.0 0
M  V30 2 C 4.0011 5.3900 0.0 0 CFG=2
M  V30 3 C 5.3347 4.6200 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 O 1.3338 5.3900 0.0 0
M  V30 6 O 2.6674 3.0800 0.0 0
M  V30 7 C 0.0000 4.6200 0.0 0
M  V30 8 C 8.2085 6.9300 0.0 0
M  V30 9 C 9.5421 7.7000 0.0 0
M  V30 10 N 10.8758 6.9300 0.0 0
M  V30 11 O 9.5421 9.2400 0.0 0
M  V30 12 O 12.2094 7.7000 0.0 0
M  V30 13 C 13.5432 6.9300 0.0 0
M  V30 14 C 6.1047 10.5736 0.0 0
M  V30 15 C 4.7711 11.3436 0.0 0
M  V30 16 C 7.4385 11.3436 0.0 0
M  V30 17 C 5.3347 7.7000 0.0 0 CFG=1
M  V30 18 C 6.8747 7.7000 0.0 0 CFG=1
M  V30 19 C 6.1047 9.0336 0.0 0 CFG=1
M  V30 20 C 5.3347 3.0800 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 6.6685 2.3100 0.0 0
M  V30 23 C 4.0011 0.7700 0.0 0
M  V30 24 C 6.6685 0.7700 0.0 0
M  V30 25 C 5.3347 0.0000 0.0 0
M  V30 26 C 14.8769 7.7000 0.0 0
M  V30 27 C 16.2105 6.9300 0.0 0
M  V30 28 C 14.8769 9.2400 0.0 0
M  V30 29 C 17.5443 7.7000 0.0 0
M  V30 30 C 16.2105 10.0100 0.0 0
M  V30 31 C 17.5443 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 20
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 18 8 CFG=3
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 13 26
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 19 14 CFG=1
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-N-Methyl-α-[[(1R,2S,3S)-2-(1-methylethyl)-3-[2-oxo-2-[(phenylmethoxy)ami...
C25H33N3O3
443149-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 6.9300 0.0 0
M  V30 2 C 4.0011 5.3900 0.0 0 CFG=2
M  V30 3 C 5.3347 4.6200 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 N 1.3338 5.3900 0.0 0
M  V30 6 O 2.6674 3.0800 0.0 0
M  V30 7 C 0.0000 4.6200 0.0 0
M  V30 8 C 8.2085 6.9300 0.0 0
M  V30 9 C 9.5421 7.7000 0.0 0
M  V30 10 N 10.8758 6.9300 0.0 0
M  V30 11 O 9.5421 9.2400 0.0 0
M  V30 12 O 12.2096 7.7000 0.0 0
M  V30 13 C 13.5432 6.9300 0.0 0
M  V30 14 C 6.1047 10.5736 0.0 0
M  V30 15 C 7.4385 11.3436 0.0 0
M  V30 16 C 4.7711 11.3436 0.0 0
M  V30 17 C 5.3347 7.7000 0.0 0 CFG=1
M  V30 18 C 6.8747 7.7000 0.0 0 CFG=1
M  V30 19 C 6.1047 9.0336 0.0 0 CFG=1
M  V30 20 C 5.3347 3.0800 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 6.6685 2.3100 0.0 0
M  V30 23 C 4.0011 0.7700 0.0 0
M  V30 24 C 6.6685 0.7700 0.0 0
M  V30 25 C 5.3347 0.0000 0.0 0
M  V30 26 C 14.8769 7.7000 0.0 0
M  V30 27 C 16.2105 6.9300 0.0 0
M  V30 28 C 14.8769 9.2400 0.0 0
M  V30 29 C 17.5443 7.7000 0.0 0
M  V30 30 C 16.2105 10.0100 0.0 0
M  V30 31 C 17.5443 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 20
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 1 18 8 CFG=3
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 13 26
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 19 14 CFG=1
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 443149-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 443149-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6574426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-{[1R-(1α, 2α, 3β)] -3-Benzoxycarbamoylmethyl-2-isopropylcyclopropyl
}-L-phenylalanine N'-Methyl Amide. A solution of 21 (25 mg, 0.059 mmol)
in 33% ethanolic MeNH2 (2 mL) containing NaCN (0.5 mg, 0.010 mmol) was
heated in a closed vial at 55 °C for 17 h. The solvent was removed under
reduced pressure, and the resulting crude product was purified by flash
chromatography eluting with CHCl3/MeOH (100:1) to give 23 mg (90%) of a
white solid: N-{[1R-(1α, 2α, 3β)]
-3-Benzoxycarbamoylmethyl-2-isopropylcyclopropyl }-L-phenylalanine
N'-Methyl Amide. yield 23 mg (90%) mp 126-130 °C; 1H NMR (CD3OD) δ
7.42-7.33 (comp, 5 H), 7.26-7.14 (comp, 5 H), 4.84 (d, J = 10.9 Hz, 1 H),
4.80 (d, J = 10.9 Hz, 1 H), 3.34-3.29 (m, 1 H), 2.86 (dd, J = 7.1, 13.4
Hz, 1 H), 2.74 (dd, J = 7.4, 13.4 Hz, 1 H), 2.63 (s, 3 H), 2.00-1.86
(comp, 2 H), 1.80 (dd, J = 7.9, 14.4 Hz, 1 H), 1.38-1.21 (m, 1 H), 0.92
(d, J = 6.7 Hz, 3 H), 0.91 (d, J = 6.7 Hz, 3 H), 0.52-0.43 (m, 1 H), 0.34
(ddd, J = 5.6, 7.5, 10.0 Hz, 1 H); 13C NMR (CD3OD) δ 177.4, 172.2, 139.4,
136.9, 130.4, 130.3, 129.7, 129.5, 129.3, 127.5, 79.1, 65.4, 41.2, 40.6,
36.8, 35.6, 28.0, 26.0, 23.1, 22.8; IR ν 3226, 2957, 1652, 1461, 1406,
1124 cm-1; MS m/z 424.2590 [C25H33N3O3 + H requires 424.2600], 333, 318,
273, 259, 179 (base), 164, 140, 120.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Matrix Metalloprotease Inhibitors
Bearing Cyclopropane-Derived Peptidomimetics as P1' and P2' Replacements
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reichelt, Andreas; Gaul, Christoph; Frey, Robin R.; Kennedy, April;
Martin, Stephen F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2002), 67(12), 4062-4075

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Triphenylpyrylium tetrafluoroborate
C23H17O.BF4
448-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 11.5502 0.0 0
M  V30 2 C 5.3348 12.3202 0.0 0
M  V30 3 C 4.0012 10.0101 0.0 0
M  V30 4 C 6.6685 11.5502 0.0 0
M  V30 5 C 5.3348 9.2401 0.0 0
M  V30 6 O 6.6685 10.0101 0.0 0 CHG=1 VAL=3
M  V30 7 C 2.6673 12.3202 0.0 0
M  V30 8 C 1.3337 11.5502 0.0 0
M  V30 9 C 2.6673 13.8602 0.0 0
M  V30 10 C 0.0000 12.3202 0.0 0
M  V30 11 C 1.3337 14.6302 0.0 0
M  V30 12 C 0.0000 13.8602 0.0 0
M  V30 13 C 8.0023 12.3202 0.0 0
M  V30 14 C 8.0023 13.8602 0.0 0
M  V30 15 C 9.3360 11.5502 0.0 0
M  V30 16 C 9.3360 14.6302 0.0 0
M  V30 17 C 10.6697 12.3202 0.0 0
M  V30 18 C 10.6697 13.8602 0.0 0
M  V30 19 C 5.3348 7.7001 0.0 0
M  V30 20 C 6.6685 6.9301 0.0 0
M  V30 21 C 4.0012 6.9301 0.0 0
M  V30 22 C 6.6685 5.3900 0.0 0
M  V30 23 C 4.0012 5.3900 0.0 0
M  V30 24 C 5.3348 4.6200 0.0 0
M  V30 25 B 5.3348 1.5400 0.0 0 CHG=3 VAL=4
M  V30 26 F 3.7948 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 27 F 6.8748 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 28 F 5.3348 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 29 F 5.3348 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 13
M  V30 8 2 5 6
M  V30 9 1 5 19
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 1 25 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 1-methyl-2,4,6-triphenyl-, tetrafluoroborate(1-) (1:1)
C24H20N.BF4
2355-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 13.8602 0.0 0
M  V30 2 C 4.0012 11.5502 0.0 0
M  V30 3 N 5.3348 12.3202 0.0 0 CHG=1 VAL=4
M  V30 4 C 4.0012 10.0101 0.0 0
M  V30 5 C 6.6685 11.5502 0.0 0
M  V30 6 C 5.3348 9.2401 0.0 0
M  V30 7 C 6.6685 10.0101 0.0 0
M  V30 8 C 2.6673 12.3202 0.0 0
M  V30 9 C 1.3337 11.5502 0.0 0
M  V30 10 C 2.6673 13.8602 0.0 0
M  V30 11 C 0.0000 12.3202 0.0 0
M  V30 12 C 1.3337 14.6302 0.0 0
M  V30 13 C 0.0000 13.8602 0.0 0
M  V30 14 C 8.0023 12.3202 0.0 0
M  V30 15 C 8.0023 13.8602 0.0 0
M  V30 16 C 9.3360 11.5502 0.0 0
M  V30 17 C 9.3360 14.6302 0.0 0
M  V30 18 C 10.6697 12.3202 0.0 0
M  V30 19 C 10.6697 13.8602 0.0 0
M  V30 20 C 5.3348 7.7001 0.0 0
M  V30 21 C 6.6685 6.9301 0.0 0
M  V30 22 C 4.0012 6.9301 0.0 0
M  V30 23 C 6.6685 5.3900 0.0 0
M  V30 24 C 4.0012 5.3900 0.0 0
M  V30 25 C 5.3348 4.6200 0.0 0
M  V30 26 B 5.3348 1.5400 0.0 0 CHG=3 VAL=4
M  V30 27 F 3.7948 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 28 F 6.8748 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 29 F 5.3348 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 30 F 5.3348 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 14
M  V30 9 2 6 7
M  V30 10 1 6 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 448-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2355-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13037561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1N-methyl-2,4,6-triphenylpyridinium tetrafluoroborate, [Rf](BF4): The
pyrylium salt [TPyrH3](BF4) (1.25 g, 3.15 mmol) and anhydrous NaOAc (1.0
g) were suspended in absolute EtOH (24 mL), and a solution of methylamine
in EtOH (8.03 M, d = 0.759; 0.259 g or 0.34 mL, 2.74 mmol) was then
added. The solution mixture was heated under reflux whilst stirring and
under argon for 24 hours. The reaction medium was then stored overnight
at 4 °C and the precipitate was filtered off and washed with Et2O. The
product was extracted from the solid with CH2Cl2, evaporated to dryness
under reduced pressure and recrystallized from a mixture of EtOAc and
CH2Cl2. The recrystallized product was washed with Et2O and dried in
oven, yielding the pure product as a white microcrystalline solid (m =
1.01 g, 90 %): mp 210 °C; 1H NMR (500 MHz, CD3CN, 25 °C, ppm): δ 8.21 (s,
2H; HA3); 8.01 (d, 2H, J = 7.5 Hz; HD2); 7.73-7.67 (m, 10H; HC2, C3, C4);
7.65 (d, 1H, J = 7.0 Hz; HD4); 7.62 (d, 2H, J = 8.0, 7.0 Hz; HD3); 3.75
(s, 3H; HMe(A1)). 13C NMR (126 MHz, CD3CN, 25 °C, ppm): δ 158.0; 156.2;
134.8; 134.0; 133.3; 132.3; 130.7; 130.3; 130.1; 129.3; 126.8; 46.1.
FTMS: m/z: calcd for C24H20N: 322.1590 [M-BF4]+; found: 322.1581
[M-BF4]+. Anal. Calcd for C24H20NBF4: C, 70.44; H, 4.93; N, 3.42. Found:
C, 70.25; H, 4.99; N, 3.43.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing Multifunctional Expanded Pyridiniums: Properties of Branched
and Fused Head-to-Tail Bipyridiniums
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fortage, Jerome; Peltier, Cyril; Nastasi, Francesco; Puntoriero, Fausto;
Tuyeras, Fabien; Griveau, Sophie; Bedioui, Fethi; Adamo, Carlo; Ciofini,
Ilaria; Campagna, Sebastiano; Laine, Philippe P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2010), 132(46), 16700-16713

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
3-Fluoro-4-hydroxybenzeneacetic acid
C8H7FO3
458-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 6.1600 5.3349 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 O 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-hydroxy-N-methylbenzeneacetamide
C9H10FNO2
847603-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 8.0023 3.0801 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 F 0.0000 3.0801 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 458-09-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847603-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6782997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (B) Example of Method A To a suspension or solution of acid, for example
{3-fluoro-4-[2-(1-methyl-1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-phenyl}-acetic
acid (126 mg, 0.329 mmol) in CH2Cl2 (5 mL) was added 2 M oxalyl chloride
in CH2Cl2 (0.49 mL, 0.987 mmol, 3 eq), followed by 3 drops of DMF. The
mixture was stirred at ambient temperature for one hour, concentrated and
dried under vacuum. The crude phenylacetylchloride was re-dissolved in
CH2Cl2 (5 mL), and the corresponding amine, for example
2-amino-4,6-dimethylpyridine (60 mg, 0.492 mmol, 1.5 eq) was added,
followed by DMAP (catalytic amount) and triethylamine (1-1.5 eq). The
mixture was stirred at ambient temperature overnight, concentrated and
purified by reversed phase HPLC eluted with 30%-70% acetonitrile in
water, or by normal phase silica gel column eluting with 1%-10% MeOH in
CHCl3 or gradient of EtOAc in hexanes (depending on the polarity of the
product) to give the desired amide in 20-90% yield Intermediate 2a:
2-(3-Fluoro-4-hydroxy-phenyl)-N-methyl-acetamide was prepared from
3-fluoro-4-hydroxyphenylactic acid and methyl amine following Method A.
1H NMR (300 MHz, CD3OD) δ 7.89 (s, 1H), 6.90 (d, 1H, J= 13.37 Hz),
6.82-6.71 (m, 1H), 3.29 (s, 2H), 2.62 (s, 3H). LCMS (ESI+) [M+H]/z Calc'd
184, found 184.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (thienopyridinyloxy)phenylacetamides as new
anti-angiogenic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Mingying; Kania, Robert Steven; Lou, Jihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005021554 A1 2005-03-10

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichloroisatoic anhydride
C8H3Cl2NO3
4693-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 Cl 3.8500 0.0000 0.0 0
M  V30 3 Cl 8.4700 2.6674 0.0 0
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 O 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 6.1600 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3,5-dichloro-N-methylbenzamide
C8H8Cl2N2O
1006619-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4693-00-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1006619-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34866027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Route Design and Development of Tetrachlorantraniliprole:
Copper-Catalyzed Cyclization and One-Pot Preparation of Pyrazole Acid
Chloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Haibo; Yang, Huibin; Chen, Lin; Wang, Gang; Zhao, Guimin; Wang,
Xueling; Wu, Hongfei; Shi, Xuegeng; Dong, Yan; Li, Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2022), 26(12), 3216-3225

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
(αS)-α-[(Di-2-propen-1-ylamino)methyl]benzenemethanol
C14H19NO
469874-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 N 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 5.3347 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 7.7000 6.6685 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-N1-Methyl-1-phenyl-N2,N2-di-2-propen-1-yl-1,2-ethanediamine
C15H22N2
469874-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 N 4.6200 6.6685 0.0 0
M  V30 4 N 3.0800 4.0011 0.0 0
M  V30 5 C 5.3900 8.0021 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 0.7700 5.3347 0.0 0
M  V30 9 C 3.0800 1.3336 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 469874-44-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 469874-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-4243026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chiral non-racemic 1,2-diamines from O-acetyl mandelic acid:
application in enantioselective deprotonation of epoxides and diethylzinc
addition to aldehydes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saravanan, P.; Bisai, Alakesh; Baktharaman, S.; Chandrasekhar, M.; Singh,
Vinod K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(23), 4693-4706

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Dimethylamino)methylene]-3-oxo-N-phenylbutanamide
C13H16N2O2
474369-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, 2-[(methylamino)methylene]-3-oxo-N-phenyl-
C12H14N2O2
2197964-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 11
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 474369-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine
C9H17NO2
166398-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4386 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.4374 3.3918 0.0 0
M  V30 5 C 3.7711 1.0817 0.0 0
M  V30 6 O 2.2765 0.3202 0.0 0
M  V30 7 O 1.0304 2.4782 0.0 0
M  V30 8 C 3.7711 4.1618 0.0 0
M  V30 9 C 5.1048 1.8517 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166398-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-902334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-heteroaryl-N'-heterocyclylureas as neuropeptide Y Y5 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stamford, Andrew; Dong, Youhao; McCombie, Stuart W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040006086 A1 2004-01-08

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine
C9H17NO2
166398-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4386 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.4374 3.3918 0.0 0
M  V30 5 C 3.7711 1.0817 0.0 0
M  V30 6 O 2.2765 0.3202 0.0 0
M  V30 7 O 1.0304 2.4782 0.0 0
M  V30 8 C 3.7711 4.1618 0.0 0
M  V30 9 C 5.1048 1.8517 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166398-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4063566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred mixture of 1,4-cyclohexanedione monoethylene ketal (4.68 g,
30 mmol) and 40% w/w aq. methylamine (6.0 mL) in 1,2-dichloroethane (75
mL), was added Na(OAc)3BH (9.6 g, 45 mmol) in portions. The reaction
mixture was vigorously stirred for 16 h, then 1 N NaOH (75 mL) was added.
The organic layer was washed with sat'd NaCl, dried (MgSO4), filtered,
and evaporated to give the product as an oil, yield 4.60 g, 90%. 1H NMR
(CDCl3, 400 MHz) δ 3.97 (4H, s), 2.47 (1H, m), 2.46 (3H, s), 1.91 (2H,
m), 1.80 (2H, m), 1.59 (2H, m), 1.45 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted ureas as neuropeptide Y5 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, William J.; Huang, Ying; Kelly, Joseph M.; McCombie, Stuart W.;
Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030114517 A1 2003-06-19

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine
C9H17NO2
166398-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4386 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.4374 3.3918 0.0 0
M  V30 5 C 3.7711 1.0817 0.0 0
M  V30 6 O 2.2765 0.3202 0.0 0
M  V30 7 O 1.0304 2.4782 0.0 0
M  V30 8 C 3.7711 4.1618 0.0 0
M  V30 9 C 5.1048 1.8517 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166398-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7992522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 13 To a stirred mixture of 1,4-cyclohexanedione monoethylene
ketal (4.68 g, 30 mmol) and 40% aq. methylamine (6.0 ml) in
1,2-dichloroethane (75 ml), was added NaBH(OAc)3 (9.6 g, 45 mmol) in
portions. The reaction mixture was vigorously stirred for 16 hr, then 1N
NaOH (75 ml) was added. The organic layer was washed with sat'd NaCl,
dried (MgSO4), filtered, and evaporated. An oil (4.60 g, 90%) that was
used without further purification. 1H NMR (CDCl3, 400 MHz) δ 3.97 (4H,
s), 2.47 (1H, m), 2.46 (3H, s), 1.91 (2H, m), 1.80 (2H, m), 1.59 (2H, m),
1.45 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-heteroaryl-N'-heterocyclylureas as neuropeptide Y Y5 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stamford, Andrew W.; Dong, Youhao; McCombie, Stuart W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002049648 A1 2002-06-27

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine
C9H17NO2
166398-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4386 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.4374 3.3918 0.0 0
M  V30 5 C 3.7711 1.0817 0.0 0
M  V30 6 O 2.2765 0.3202 0.0 0
M  V30 7 O 1.0304 2.4782 0.0 0
M  V30 8 C 3.7711 4.1618 0.0 0
M  V30 9 C 5.1048 1.8517 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166398-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17628598
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Substituted ureas as neuropeptide Y5 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenlee, William J.; Huang, Ying; Kelly, Joseph M.; McCombie, Stuart W.;
Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002022592 A2 2002-03-21

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]decan-8-one
C8H12O3
4746-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9898 1.3337 0.0 0
M  V30 2 C 2.3698 1.3337 0.0 0
M  V30 3 C 3.1398 2.6673 0.0 0
M  V30 4 C 3.1398 0.0000 0.0 0
M  V30 5 O 1.4646 0.0878 0.0 0
M  V30 6 O 1.4646 2.5795 0.0 0
M  V30 7 C 4.6798 2.6673 0.0 0
M  V30 8 C 4.6798 0.0000 0.0 0
M  V30 9 C 0.0000 0.5636 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 5.4498 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,4-dioxaspiro[4.5]decan-8-amine
C9H17NO2
166398-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4386 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.4374 3.3918 0.0 0
M  V30 5 C 3.7711 1.0817 0.0 0
M  V30 6 O 2.2765 0.3202 0.0 0
M  V30 7 O 1.0304 2.4782 0.0 0
M  V30 8 C 3.7711 4.1618 0.0 0
M  V30 9 C 5.1048 1.8517 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4746-97-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166398-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9915959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred mixture of 1,4-cyclohexanedione monoethylene ketal (4.68 g,
30 mmol) and 40% w/w aq. CH3NH2 (6.0 ml) in 1,2-dichloroethane (75 ml),
was added Na(OAC)3BH (9.6 g, 45 mmol) in portions. The reaction mixture
was vigorously stirred for 16 h, then 1N NaOH (75 ml) was added. The
organic layer was washed with sat'd NaCl, dried (MgSO4), filtered and
evaporated to give, that was used without further purification. Oil,
yield 4.60 g, 90%. 1H NMR (CDCl3, 400 MHz) δ 3.97 (4H, s), 2.47 (1H, m),
2.46 (3H, s), 1.91 (2H, m), 1.80 (2H, m), 1.59 (2H, m), 1.45 (2H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl amides and ureas as neuropeptide Y5 receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dugar, Sundeep; Neustadt, Bernard R.; Stamford, Andrew W.; Wu, Yusheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6329395 B1 2001-12-11

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4,5-dicarboxylic acid, 1-β-D-glucopyranosyl-, dimethyl ester
C12H17N3O9
475568-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5894 2.6091 0.0 0
M  V30 2 O 7.6198 1.4647 0.0 0
M  V30 3 O 5.0829 2.2889 0.0 0
M  V30 4 C 7.1439 0.0000 0.0 0
M  V30 5 C 9.7757 3.6444 0.0 0
M  V30 6 O 11.1826 4.2709 0.0 0
M  V30 7 O 9.6147 2.1129 0.0 0
M  V30 8 C 12.4285 3.3657 0.0 0
M  V30 9 O 4.6200 7.9871 0.0 0
M  V30 10 C 1.5400 2.6524 0.0 0
M  V30 11 O 0.0000 2.6524 0.0 0
M  V30 12 O 1.5400 7.9871 0.0 0
M  V30 13 O 0.0000 5.3196 0.0 0
M  V30 14 N 6.1600 5.3196 0.0 0
M  V30 15 C 7.0652 4.0738 0.0 0
M  V30 16 N 7.0652 6.5655 0.0 0
M  V30 17 C 8.5298 4.5496 0.0 0
M  V30 18 N 8.5298 6.0897 0.0 0
M  V30 19 C 4.6200 5.3196 0.0 0 CFG=1
M  V30 20 O 3.8500 3.9860 0.0 0
M  V30 21 C 3.8500 6.6533 0.0 0 CFG=2
M  V30 22 C 2.3100 3.9860 0.0 0 CFG=2
M  V30 23 C 2.3100 6.6533 0.0 0 CFG=1
M  V30 24 C 1.5400 5.3196 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 21 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 22 10 CFG=3
M  V30 12 1 23 12 CFG=3
M  V30 13 1 24 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 19 14 CFG=3
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 19 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4,5-dicarboxamide, 1-β-D-glucopyranosyl-N,N′-dimethyl-
C12H19N5O7
475568-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5894 2.6091 0.0 0
M  V30 2 N 7.6198 1.4647 0.0 0
M  V30 3 O 5.0829 2.2889 0.0 0
M  V30 4 C 7.1439 0.0000 0.0 0
M  V30 5 C 9.7757 3.6444 0.0 0
M  V30 6 N 11.1826 4.2709 0.0 0
M  V30 7 O 9.6147 2.1129 0.0 0
M  V30 8 C 12.4285 3.3657 0.0 0
M  V30 9 O 4.6200 7.9871 0.0 0
M  V30 10 C 1.5400 2.6524 0.0 0
M  V30 11 O 0.0000 2.6524 0.0 0
M  V30 12 O 1.5400 7.9871 0.0 0
M  V30 13 O 0.0000 5.3196 0.0 0
M  V30 14 N 6.1600 5.3196 0.0 0
M  V30 15 C 7.0652 4.0738 0.0 0
M  V30 16 N 7.0652 6.5655 0.0 0
M  V30 17 C 8.5298 4.5496 0.0 0
M  V30 18 N 8.5298 6.0897 0.0 0
M  V30 19 C 4.6200 5.3196 0.0 0 CFG=1
M  V30 20 O 3.8500 3.9860 0.0 0
M  V30 21 C 3.8500 6.6533 0.0 0 CFG=2
M  V30 22 C 2.3100 3.9860 0.0 0 CFG=2
M  V30 23 C 2.3100 6.6533 0.0 0 CFG=1
M  V30 24 C 1.5400 5.3196 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 21 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 22 10 CFG=3
M  V30 12 1 23 12 CFG=3
M  V30 13 1 24 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 19 14 CFG=3
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 19 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 475568-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 475568-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15165754
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
1-β-D-glucopyranosyl-1,2,3-triazole-4,5-N-dicarboxamide and
N-dialkyldicarboxamide N-nucleosides. A solution of 6 (0.50 g, 0.97 mmol)
in the appropriate amine was stirred at room temperature for 18 h, then
the reaction mixture was evaporated to dryness. The residue was
partitioned between water (30 mL) and ether (3 x 20 mL) and the aqueous
layer was evaporated to dryness. The residue was co-evaporated with EtOH
(4 x 10 mL), then recrystallized from EtOH to give the desired
nucleoside.
1-(β-D-Glucopyranosyl)-1,2,3-triazole-4,5-N-dimethyldicarboxamide (9).
From methyl-amine (0.5mL). Yield: 0.30g, 90%. m.p. 169-171°C decomp.; Rf
(CH2Cl2-MeOH 7:3 v/v) 0.55. δΗ (DMSO-d6): 10.74 (d, 1H, J = 4.7 Hz, NH);
9.18 (d, 1H, J = 4.7Hz, NH); 6.47 (d, 1H, J1',2' = 9.3Hz, H-1'); 5.39 (d,
1H, J2',OH = 5.8Hz, C2-OH); 5.1 (d, 1H, J3',OH = 5.1Hz, C3'-OH); 5.13 (d,
1H, J4'-OH = 5.4Hz, C4'-OH); 4.61 (t, 1H, J6'a,6'b -OH = 5.8 Hz, C6'-OH);
4.01 (m, 1H, H-2'); 3.67 (dd, 1H, J5',6'a-= 5.4 Hz, J6'a,6'b = 11.7Hz,
H-6'a); 3.44 (m, 1H, H-6'b); 3.34-3.17 (m, 3H, H-3', H-4'; H-5'); 2.83,
2.81 (2s, 6H, 2 x NMe). δC (DMSO-d6): 161.2, 156.9 (C=O); 138.5 (C-4);
133.0 (C-5); 86.4 (C-1'); 80.4 (C-5'); 77.4 (C-3'); 71.8 (C-2'); 69.6
(C-4'); 61.5 (C-6'); 26.2, 25.8 (2 x NMe). Anal. calc, for C12H19N5O7
(345.3): C, 41.74; H, 5.55, N, 20.28. Found: C, 41.58; H, 5.48; N, 20.12.
MS: m/z (FAB) 346 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New glycosyl-(carboxamide)-1,2,3-triazole-N-nucleosides: synthesis and
antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Masoudi, Najim A.; Al-Soud, Yaseen A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2002), 21(4 & 5), 361-375

$RFMT $RIREG SCHEME323 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl oxalyl chloride
C4H5ClO3
4755-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 Cl 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethyl 4-ethoxy-2,5-dihydro-1-methyl-5-oxo-1H-pyrrole-2,3-dicarboxylate
C11H15NO6
484001-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3196 2.3100 0.0 0
M  V30 2 O 6.6533 1.5400 0.0 0
M  V30 3 O 3.9860 1.5400 0.0 0
M  V30 4 C 6.6533 0.0000 0.0 0
M  V30 5 C 2.6091 4.2792 0.0 0
M  V30 6 O 1.4647 5.3098 0.0 0
M  V30 7 O 2.2889 2.7729 0.0 0
M  V30 8 C 0.0000 4.8339 0.0 0
M  V30 9 O 8.0302 4.2792 0.0 0
M  V30 10 C 9.1746 5.3098 0.0 0
M  V30 11 C 10.6393 4.8339 0.0 0
M  V30 12 C 3.6444 7.4656 0.0 0
M  V30 13 O 6.9949 7.4656 0.0 0
M  V30 14 C 5.3196 3.8500 0.0 0
M  V30 15 C 4.0738 4.7552 0.0 0
M  V30 16 C 6.5655 4.7552 0.0 0
M  V30 17 N 4.5496 6.2198 0.0 0
M  V30 18 C 6.0896 6.2198 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 2 13 18
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 4755-77-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 484001-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9111444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM intramolecular Wittig reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A one-pot synthesis of functionalised 3-pyrrolin-2-ones by a
four-component reaction between triphenylphosphine, primary amines,
dimethyl acetylenedicarboxylate and ethyl chlorooxoacetate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anary-Abbasinejad, Mohammad; Anaraki-Ardakani, Hossein; Dehghan,
Alimohammad; Hassanabadi, Alireza; Seyedmir, Mohammad Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2007), (10), 574-576

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[4-[[4-(Methylthio)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-1H-1,2,3-tria...
C13H17N7O3S
476372-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3775 0.0 0
M  V30 2 S 1.5400 0.0000 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 12.6918 3.3775 0.0 0
M  V30 5 O 13.8364 2.3471 0.0 0
M  V30 6 C 15.3009 2.8230 0.0 0
M  V30 7 C 16.4454 1.7926 0.0 0
M  V30 8 C 17.9100 2.2684 0.0 0
M  V30 9 O 16.1253 0.2861 0.0 0
M  V30 10 O 19.0545 1.2380 0.0 0
M  V30 11 C 4.6200 2.6673 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 N 6.1265 2.3471 0.0 0
M  V30 14 N 3.8500 4.0009 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 4.8804 0.1891 0.0 0
M  V30 17 N 6.2874 0.8156 0.0 0
M  V30 18 C 2.3100 4.0009 0.0 0
M  V30 19 N 1.5400 2.6673 0.0 0
M  V30 20 C 8.7355 2.9017 0.0 0
M  V30 21 C 9.9814 3.8069 0.0 0
M  V30 22 N 9.2114 1.4371 0.0 0
M  V30 23 N 11.2273 2.9017 0.0 0
M  V30 24 N 10.7514 1.4371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[4-[[4-(Methylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-1H-1,2,3-tri...
C13H18N8O3
476372-31-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3775 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 12.6918 3.3775 0.0 0
M  V30 5 O 13.8364 2.3471 0.0 0
M  V30 6 C 15.3009 2.8230 0.0 0
M  V30 7 C 16.4454 1.7926 0.0 0
M  V30 8 C 17.9100 2.2684 0.0 0
M  V30 9 O 16.1253 0.2861 0.0 0
M  V30 10 O 19.0545 1.2380 0.0 0
M  V30 11 C 4.6200 2.6673 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 N 6.1265 2.3471 0.0 0
M  V30 14 N 3.8500 4.0009 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 4.8804 0.1891 0.0 0
M  V30 17 N 6.2874 0.8156 0.0 0
M  V30 18 C 2.3100 4.0009 0.0 0
M  V30 19 N 1.5400 2.6673 0.0 0
M  V30 20 C 8.7355 2.9017 0.0 0
M  V30 21 C 9.9814 3.8069 0.0 0
M  V30 22 N 9.2114 1.4371 0.0 0
M  V30 23 N 11.2273 2.9017 0.0 0
M  V30 24 N 10.7514 1.4371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476372-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476372-31-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11300307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological activity of some 4-substituted
1-[1-(2,3-dihydroxy-1-propoxy)methyl-1,2,3-triazol-(4 &
5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moukha-Chafiq, Omar; Taha, Mohamed Labd; Lazrek, Hassan Bihi; Vasseur,
Jean-Jacques; Pannecouque, Christophe; Witvrouw, Myriam; De Clercq, Erik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Farmaco (2002), 57(1), 27-32

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-leucyl-L-phenylalanine methyl ester
C24H30N2O5
4818-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 2 C 4.0011 6.1600 0.0 0
M  V30 3 N 6.6685 6.1600 0.0 0
M  V30 4 C 5.3347 8.4700 0.0 0
M  V30 5 C 6.6685 4.6200 0.0 0
M  V30 6 O 6.6685 9.2400 0.0 0
M  V30 7 O 4.0011 9.2400 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 9 O 5.3347 3.8500 0.0 0
M  V30 10 C 6.6685 10.7800 0.0 0
M  V30 11 N 9.3358 4.6200 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 10.6694 3.8500 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 O 12.0032 4.6200 0.0 0
M  V30 16 O 10.6694 2.3100 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 5.3347 2.3100 0.0 0
M  V30 19 C 13.3369 3.8500 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 2.6674 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 1.3338 9.2400 0.0 0
M  V30 25 C 0.0000 8.4700 0.0 0
M  V30 26 C 14.6705 4.6200 0.0 0
M  V30 27 C 14.6705 6.1600 0.0 0
M  V30 28 C 16.0041 3.8500 0.0 0
M  V30 29 C 16.0041 6.9300 0.0 0
M  V30 30 C 17.3379 4.6200 0.0 0
M  V30 31 C 17.3379 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 19 26
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(Phenylmethoxy)carbonyl]-L-leucyl-N-methyl-L-phenylalaninamide
C24H31N3O4
60079-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 2 C 4.0011 6.1600 0.0 0
M  V30 3 N 6.6685 6.1600 0.0 0
M  V30 4 C 5.3347 8.4700 0.0 0
M  V30 5 C 6.6685 4.6200 0.0 0
M  V30 6 N 6.6685 9.2400 0.0 0
M  V30 7 O 4.0011 9.2400 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0 CFG=2
M  V30 9 O 5.3347 3.8500 0.0 0
M  V30 10 C 6.6685 10.7800 0.0 0
M  V30 11 N 9.3358 4.6200 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 10.6694 3.8500 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 O 12.0032 4.6200 0.0 0
M  V30 16 O 10.6694 2.3100 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 5.3347 2.3100 0.0 0
M  V30 19 C 13.3369 3.8500 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 1.3338 6.1600 0.0 0
M  V30 22 C 2.6674 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 1.3338 9.2400 0.0 0
M  V30 25 C 0.0000 8.4700 0.0 0
M  V30 26 C 14.6705 4.6200 0.0 0
M  V30 27 C 14.6705 6.1600 0.0 0
M  V30 28 C 16.0041 3.8500 0.0 0
M  V30 29 C 16.0041 6.9300 0.0 0
M  V30 30 C 17.3379 4.6200 0.0 0
M  V30 31 C 17.3379 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 19 26
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4818-00-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60079-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9323096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of
succinylhydroxamate MMP inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Campestre, Cristina; Tortorella, Paolo; Agamennone, Mariangela; Preziuso,
Serena; Biasone, Alessandro; Nuti, Elisa; Rossello, Armando; Gallina,
Carlo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2008), 43(5), 1008-1014

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloropyrazine
C4H2Cl2N2
4858-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 2.6673 0.0 0
M  V30 2 Cl 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 2.3101 4.0010 0.0 0
M  V30 6 N 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N3-Dimethyl-2,3-pyrazinediamine
C6H10N4
446287-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 N 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 N 1.5400 1.3337 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4858-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 446287-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19145215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tunable Multicolor Phosphorescence of Crystalline Polymeric Complex Salts
with Metallophilic Backbones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Qi; Xie, Mo; Chang, Xiaoyong; Cao, Shuang; Zou, Chao; Fu, Wen-Fu;
Che, Chi-Ming; Chen, Yong; Lu, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2018), 57(21), 6279-6283

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenyl-1,3-cyclohexanedione
C12H12O2
493-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 4.6200 0.0 0
M  V30 2 O 5.3347 0.0000 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 C 5.3347 4.6200 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 6.6685 3.8500 0.0 0
M  V30 7 C 5.3347 1.5400 0.0 0
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 1.3336 6.9300 0.0 0
M  V30 13 C 0.0000 4.6200 0.0 0
M  V30 14 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-5-phenyl-2-cyclohexen-1-one
C13H15NO
143768-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 4.6201 0.0 0
M  V30 2 C 9.3359 3.8500 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 6.6684 3.8500 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 6.6684 2.3100 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 3.8500 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 493-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 143768-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11590880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3-Aminocyclohex-2-enones 7; General Procedure.
Method A: A soln containing equimolar quantities of a primary amine and a
cyclohexane-1,3-dione 6 in benzene was refluxed at a Dean-Stark trap
until the separation of H2O had finished (ca. 3 h). The solvent was
removed in vacuo and the residual solid or viscous oil was triturated
(EtOAc) to give 7 as a crystalline solid. Compound 7D1, crystalline
solid, yield 40-90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Partially saturated indeno[1,2-b]indole derivatives via deoxygenation of
heterocyclic α-hydroxy-N,O-hemiaminals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hemmerling, Hans-Joerg; Reiss, Guido
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2009), (6), 985-999

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
3-Bromo-1-methyl-1H-indole-2-carboxylic acid
C10H8BrNO2
499983-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.0205 0.1773 0.0 0
M  V30 2 C 5.7309 4.8721 0.0 0
M  V30 3 C 6.0811 1.5400 0.0 0
M  V30 4 O 7.4150 2.3101 0.0 0
M  V30 5 O 6.0811 0.0000 0.0 0
M  V30 6 C 2.3101 2.8281 0.0 0
M  V30 7 C 3.0801 4.1618 0.0 0
M  V30 8 C 3.3406 1.6836 0.0 0
M  V30 9 C 0.7700 2.8281 0.0 0
M  V30 10 N 4.5865 3.8416 0.0 0
M  V30 11 C 2.3101 5.4955 0.0 0
M  V30 12 C 4.7475 2.3101 0.0 0
M  V30 13 C 0.0000 4.1618 0.0 0
M  V30 14 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N,1-dimethyl-1H-indole-2-carboxamide
C11H11BrN2O
876620-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5771 2.7106 0.0 0
M  V30 2 N 7.3471 4.0442 0.0 0
M  V30 3 O 7.3471 1.3769 0.0 0
M  V30 4 C 8.8871 4.0442 0.0 0
M  V30 5 Br 4.6079 0.0000 0.0 0
M  V30 6 C 4.6079 5.4212 0.0 0
M  V30 7 C 5.0371 2.7106 0.0 0
M  V30 8 C 4.1320 1.4647 0.0 0
M  V30 9 N 4.1320 3.9565 0.0 0
M  V30 10 C 2.6673 1.9406 0.0 0
M  V30 11 C 2.6673 3.4806 0.0 0
M  V30 12 C 1.3337 1.1706 0.0 0
M  V30 13 C 1.3337 4.2506 0.0 0
M  V30 14 C 0.0000 1.9406 0.0 0
M  V30 15 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 499983-77-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876620-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15445394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 2. A suspension of the crude bromo-acid (2.52 mmol), a
catalytic amount of anhydrous DMF (mmol, 30 μL) and thionyl chloride
(oxalyl chloride for 2d) (7.56 mmol) in dry CH2Cl2 (50 mL) was heated at
reflux under stirring for 3h (for 2d the mixture was stirred at room
temperature for 1h, then at reflux for 1h). The solution was cooled to
room temperature and concentrated in vacuo. The residue was dissolved in
anhydrous CH2Cl2 (20 mL) and added dropwise to a solution of the amine
(5.54 mmol) (for 3c: 2.52 mmol of the amine and 2.6 of anhydrous TEA) in
CH2Cl2 (20 mL) cooled to 0°C under stirring. The reaction mixture was
allowed to warm to room temperature and stirring was continued for 2 h.
After treatment with saturated aq. NaHCO3 (2 x 50 mL) and separation of
the organic phase, the aqueous layer was extracted with AcOEt (2 x 50
mL). The combined organic extracts were dried over Na2SO4 and evaporated
under reduced pressure. The crude residue was purified by chromatography
on silica gel (PE/AcOEt). 3-Bromo-1-metil-1H-indole-2-carboxylic acid
methylamide (2d). Yield: 90%. M.p.: 140-141 °C (AcOEt/PE, 9/1). 1H NMR
(CDCl3/D2O): δ 3.06 (s, 3H), 4.05 (s, 3H), 7.22-7.29 (m, 1H), 7.38-7.41
(m, 2H), 7.62 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3): δ 26.4, 32.4, 91.6,
110.2, 120.5, 121.1, 125.1, 126.0, 129.4, 137.4, 161.6. IR (nujol): 3380,
1646, 1547 cm- 1. MS (EI, 70 eV): m/z (%) 268 (100), 266 (100), 238 (41),
236 (48), 210 (18), 209 (19), 208 (21), 169 (36), 167 (35), 158 (36), 129
(36), 128 (35), 114 (22), 89 (24), 88 (18). Anal calcd for C11H11BrN2O:
C, 49.46; H, 4.15; N, 10.49. Found: C, 49.23; H, 4.02; N, 10.54.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Simple Catalytic Synthesis of Condensed Pyridones from
o-Bromoarylcarboxamides Involving ipso Substitution via Palladacycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ferraccioli, Raffaella; Carenzi, Davide; Motti, Elena; Catellani, Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(3), 722-723

$RFMT $RIREG SCHEME329 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Aniline
C6H7N
62-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H14N2O3
3053160-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0176 1.9424 0.0 0
M  V30 2 C 7.9700 4.1474 0.0 0
M  V30 3 O 8.5963 5.5543 0.0 0
M  V30 4 O 8.8752 2.9015 0.0 0
M  V30 5 C 10.1280 5.7152 0.0 0
M  V30 6 N 6.2948 1.2459 0.0 0
M  V30 7 C 5.3895 0.0000 0.0 0
M  V30 8 N 4.0011 4.5045 0.0 0
M  V30 9 C 5.4080 5.1308 0.0 0
M  V30 10 C 4.1620 2.9730 0.0 0
M  V30 11 C 6.4384 3.9864 0.0 0
M  V30 12 C 5.6684 2.6528 0.0 0
M  V30 13 C 2.6674 5.2745 0.0 0
M  V30 14 C 2.6674 6.8145 0.0 0
M  V30 15 C 1.3338 4.5045 0.0 0
M  V30 16 C 1.3338 7.5845 0.0 0
M  V30 17 C 0.0000 5.2745 0.0 0
M  V30 18 C 0.0000 6.8145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 62-53-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053160-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41265453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 97-05-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, product formed via Michael addition and Mannich type
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the versatility of 5-sulfosalicylic acid dihydrate as catalyst
in 3-pyrrolin-2-one Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gadge, Dhananjay D.; Kulkarni, Pramod S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2024), 50(8), 3785-3801

$RFMT $RIREG SCHEME330 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-6,6-difluoro-2,2-dimethyl-5-(phenylamino)-4-hexen-3-one
C14H16ClF2NO
906673-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 2.6675 0.0 0
M  V30 2 C 3.6437 4.0012 0.0 0
M  V30 3 N 5.9538 2.6675 0.0 0
M  V30 4 C 3.6437 1.3338 0.0 0
M  V30 5 C 2.1037 4.0012 0.0 0
M  V30 6 Cl 2.3101 2.1038 0.0 0
M  V30 7 F 2.8737 0.0000 0.0 0
M  V30 8 F 4.9774 0.5638 0.0 0
M  V30 9 C 1.3337 5.3348 0.0 0
M  V30 10 O 1.3337 2.6675 0.0 0
M  V30 11 C 2.6673 6.1048 0.0 0
M  V30 12 C 0.5637 6.6687 0.0 0
M  V30 13 C 0.0000 4.5648 0.0 0
M  V30 14 C 6.7238 4.0012 0.0 0
M  V30 15 C 8.2638 4.0012 0.0 0
M  V30 16 C 5.9538 5.3348 0.0 0
M  V30 17 C 9.0338 5.3348 0.0 0
M  V30 18 C 6.7238 6.6687 0.0 0
M  V30 19 C 8.2638 6.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Chlorodifluoromethyl)-1,2,3,6-tetrahydro-1-methyl-3-phenyl-5-pyrimidiny...
C17H21ClF2N2O
906673-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 5.3349 0.0 0
M  V30 2 Cl 4.8264 6.1049 0.0 0
M  V30 3 F 6.9301 6.6686 0.0 0
M  V30 4 F 7.4937 4.5649 0.0 0
M  V30 5 C 3.0800 5.3349 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 O 3.8500 6.6686 0.0 0
M  V30 8 C 1.5400 6.8749 0.0 0
M  V30 9 C 0.0000 5.3349 0.0 0
M  V30 10 C 1.5400 3.7949 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 N 6.1601 2.6675 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 C 5.3901 1.3338 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 N 3.8500 1.3338 0.0 0
M  V30 17 C 3.0800 2.6675 0.0 0
M  V30 18 C 7.7001 2.6675 0.0 0
M  V30 19 C 8.4701 4.0011 0.0 0
M  V30 20 C 8.4701 1.3338 0.0 0
M  V30 21 C 10.0101 4.0011 0.0 0
M  V30 22 C 10.0101 1.3338 0.0 0
M  V30 23 C 10.7801 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 11 16
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 906673-60-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 906673-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-11776532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient three-component reaction for the construction of
multifunctional 6-fluoroalkyl-1,2,3,4-tetrahydropyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Yun; Liu, Jin-Tao; Zhao, Fu-Lu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2005), 126(11-12), 1539-1542

$RFMT $RIREG SCHEME331 STEP1
$RXN



  3  1
$MOL
Chloroacetone
C3H5ClO
78-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Cyclohexanedione
C6H8O2
504-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7-Tetrahydro-1,2-dimethyl-4H-indol-4-one
C10H13NO
111141-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.0607 0.0 0
M  V30 2 O 6.6519 3.0012 0.0 0
M  V30 3 C 1.3627 0.0000 0.0 0
M  V30 4 C 2.6508 3.7712 0.0 0
M  V30 5 C 3.9844 3.0012 0.0 0
M  V30 6 N 1.5064 2.7406 0.0 0
M  V30 7 C 2.6508 5.3112 0.0 0
M  V30 8 C 5.3182 3.7712 0.0 0
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 C 2.1327 1.3338 0.0 0
M  V30 11 C 3.9844 6.0812 0.0 0
M  V30 12 C 5.3182 5.3112 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-95-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 504-02-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 111141-07-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13056718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolo[2,3-h]quinolinones: synthesis and photochemotherapic activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barraja, Paola; Diana, Patrizia; Lauria, Antonino; Montalbano,
Alessandra; Almerico, Anna Maria; Dattolo, Gaetano; Cirrincione,
Girolamo; Viola, Giampietro; Dall'Acqua, Francesco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(16), 2809-2811

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S,4S,21R)-9-acetyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetrameth...
C36H38N4O6
507231-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.5587 10.4617 0.0 0
M  V30 2 O 13.3545 11.7801 0.0 0
M  V30 3 O 13.3026 9.1133 0.0 0
M  V30 4 C 14.8942 11.7501 0.0 0
M  V30 5 C 13.2506 7.9123 0.0 0
M  V30 6 C 14.5842 7.1423 0.0 0
M  V30 7 C 15.9180 7.9123 0.0 0
M  V30 8 O 17.2516 7.1423 0.0 0
M  V30 9 O 15.9180 9.4523 0.0 0
M  V30 10 C 18.5852 7.9123 0.0 0
M  V30 11 O 10.6108 13.2190 0.0 0
M  V30 12 C 6.5347 13.1063 0.0 0
M  V30 13 C 12.8944 4.5657 0.0 0
M  V30 14 C 1.4520 9.3736 0.0 0
M  V30 15 C 0.0000 8.8609 0.0 0
M  V30 16 C 8.0290 0.9152 0.0 0
M  V30 17 C 1.1932 6.0137 0.0 0
M  V30 18 C 4.7084 1.4948 0.0 0
M  V30 19 C 3.2288 1.9219 0.0 0
M  V30 20 O 5.0785 0.0000 0.0 0
M  V30 21 C 10.0583 9.2448 0.0 0
M  V30 22 C 8.6674 9.7398 0.0 0
M  V30 23 C 10.5004 7.7713 0.0 0
M  V30 24 C 11.0190 10.4917 0.0 0 CFG=1
M  V30 25 C 8.6247 11.2945 0.0 0
M  V30 26 N 7.2985 9.1677 0.0 0
M  V30 27 C 11.9170 7.1423 0.0 0 CFG=1
M  V30 28 N 9.4615 6.6201 0.0 0
M  V30 29 C 10.1183 11.7599 0.0 0
M  V30 30 C 7.1081 11.6771 0.0 0
M  V30 31 C 6.2815 10.3601 0.0 0
M  V30 32 C 11.7531 5.5996 0.0 0 CFG=2
M  V30 33 C 10.2346 5.2850 0.0 0
M  V30 34 C 4.7739 10.1092 0.0 0
M  V30 35 C 9.5581 3.9235 0.0 0
M  V30 36 C 4.1309 8.7294 0.0 0
M  V30 37 C 8.0652 3.6708 0.0 0
M  V30 38 C 2.6221 8.3723 0.0 0
M  V30 39 N 4.9414 7.4112 0.0 0
M  V30 40 N 6.9903 4.7808 0.0 0
M  V30 41 C 7.3475 2.2961 0.0 0
M  V30 42 C 2.5024 6.8246 0.0 0
M  V30 43 C 3.9408 6.2427 0.0 0
M  V30 44 C 5.6101 4.1003 0.0 0
M  V30 45 C 5.8180 2.5628 0.0 0
M  V30 46 C 4.2779 4.7828 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 27 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 29
M  V30 12 1 12 30
M  V30 13 1 32 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 38
M  V30 16 1 16 41
M  V30 17 1 17 42
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 45
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 21 24
M  V30 24 2 22 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 23 28
M  V30 28 1 24 29
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 1 26 31
M  V30 32 1 27 32
M  V30 33 2 28 33
M  V30 34 2 30 31
M  V30 35 1 31 34
M  V30 36 1 32 33
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 38
M  V30 41 1 36 39
M  V30 42 1 37 40
M  V30 43 1 37 41
M  V30 44 2 38 42
M  V30 45 2 39 43
M  V30 46 1 40 44
M  V30 47 2 41 45
M  V30 48 1 42 43
M  V30 49 1 43 46
M  V30 50 1 44 45
M  V30 51 2 44 46
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 27 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
21H,23H-Porphine-7-propanoic acid, 13-acetyl-18-ethyl-7,8-dihydro-5-(2-methox...
C37H43N5O6
507230-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.4123 11.7595 0.0 0
M  V30 2 C 11.9438 11.9204 0.0 0
M  V30 3 O 12.5703 13.3273 0.0 0
M  V30 4 O 12.8491 10.6746 0.0 0
M  V30 5 C 14.1019 13.4883 0.0 0
M  V30 6 C 8.4232 13.4132 0.0 0
M  V30 7 N 7.6532 14.7470 0.0 0
M  V30 8 O 9.9632 13.4132 0.0 0
M  V30 9 C 8.4232 16.0807 0.0 0
M  V30 10 C 5.0910 13.0630 0.0 0
M  V30 11 C 13.3913 9.0757 0.0 0
M  V30 12 C 14.5175 8.0254 0.0 0
M  V30 13 C 15.9903 8.4757 0.0 0
M  V30 14 O 17.1167 7.4254 0.0 0
M  V30 15 O 16.3368 9.9762 0.0 0
M  V30 16 C 18.5894 7.8756 0.0 0
M  V30 17 C 13.4132 6.3238 0.0 0
M  V30 18 C 1.3337 8.4232 0.0 0
M  V30 19 C 0.0000 7.6532 0.0 0
M  V30 20 C 1.6839 5.0910 0.0 0
M  V30 21 C 9.6560 1.6839 0.0 0
M  V30 22 C 6.3238 1.3337 0.0 0
M  V30 23 C 7.0938 0.0000 0.0 0
M  V30 24 O 4.7838 1.3337 0.0 0
M  V30 25 C 8.2795 10.6727 0.0 0
M  V30 26 C 9.7860 10.3525 0.0 0
M  V30 27 C 7.6532 12.0795 0.0 0
M  V30 28 N 7.1350 9.6423 0.0 0
M  V30 29 C 10.4123 8.9456 0.0 0
M  V30 30 C 6.1215 11.9186 0.0 0
M  V30 31 C 5.8013 10.4123 0.0 0
M  V30 32 C 11.9186 8.6254 0.0 0 CFG=1
M  V30 33 N 9.6423 7.6119 0.0 0
M  V30 34 C 4.3943 9.7860 0.0 0
M  V30 35 C 12.0795 7.0938 0.0 0 CFG=2
M  V30 36 C 10.6727 6.4675 0.0 0
M  V30 37 C 4.0743 8.2795 0.0 0
M  V30 38 C 10.3525 4.9610 0.0 0
M  V30 39 C 2.6675 7.6532 0.0 0
M  V30 40 N 5.1047 7.1351 0.0 0
M  V30 41 C 8.9456 4.3347 0.0 0
M  V30 42 C 2.8284 6.1215 0.0 0
M  V30 43 C 4.3347 5.8013 0.0 0
M  V30 44 N 7.6119 5.1047 0.0 0
M  V30 45 C 8.6254 2.8284 0.0 0
M  V30 46 C 4.9610 4.3943 0.0 0
M  V30 47 C 6.4675 4.0743 0.0 0
M  V30 48 C 7.0938 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 27
M  V30 9 1 7 9
M  V30 10 1 10 30
M  V30 11 1 11 12
M  V30 12 1 32 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 35 17 CFG=3
M  V30 18 1 18 19
M  V30 19 1 18 39
M  V30 20 1 20 42
M  V30 21 1 21 45
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 1 22 48
M  V30 25 1 25 26
M  V30 26 2 25 27
M  V30 27 1 25 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 29 33
M  V30 33 2 30 31
M  V30 34 1 31 34
M  V30 35 1 32 35
M  V30 36 2 33 36
M  V30 37 2 34 37
M  V30 38 1 35 36
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 1 37 40
M  V30 42 2 38 41
M  V30 43 2 39 42
M  V30 44 2 40 43
M  V30 45 1 41 44
M  V30 46 1 41 45
M  V30 47 1 42 43
M  V30 48 1 43 46
M  V30 49 1 44 47
M  V30 50 2 45 48
M  V30 51 2 46 47
M  V30 52 1 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 32 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 507231-23-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 507230-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-160-CAS-2456849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of chlorin photosensitizing agents for use in photodynamic
therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Robinson, Byron C.; Phadke, Avinash; Small, Ward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003028629 A2 2003-04-10

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-nitrobenzoic acid
C8H7NO5
5081-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1601 0.0 0
M  V30 2 C 2.6675 6.9301 0.0 0
M  V30 3 N 6.6686 4.6201 0.0 0 VAL=5
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 O 6.6686 6.1601 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-4-nitrobenzoic acid
C8H8N2O4
214778-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6685 6.1600 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5081-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214778-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17900395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bis-benzimidazoles as tryptase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mittendorf, Joachim; Henning, Rolf; Raddatz, Siegfried; Schlemmer,
Karl-heinz; Hiraoka, Makiko; Kadono, Hiroshi; Mogi, Muneto; Moriwaki,
Toshiya; Murata, Toshiki; Sakakibara, Sachiko; Shimada, Mitsuyuki;
Yoshida, Nagahiro; Yoshino, Takashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000020401 A1 2000-04-13

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-1-[(1S)-1-(Dimethylamino)ethyl]-2-(phenylthio)ferrocene
C20H23FeNS
508240-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8209 1.4214 0.0 0 CFG=2
M  V30 2 N 3.8209 0.5448 0.0 0
M  V30 3 C 4.5813 1.8620 0.0 0
M  V30 4 C 4.5813 0.1041 0.0 0
M  V30 5 C 2.9541 0.0436 0.0 0
M  V30 6 S 5.0607 2.0364 0.0 0
M  V30 7 Fe 2.1308 5.4626 0.0 0 CHG=2 VAL=10
M  V30 8 C 2.8693 3.0049 0.0 0 CFG=1 VAL=5
M  V30 9 C 4.2059 2.2349 0.0 0 CHG=-1 CFG=2 VAL=4
M  V30 10 C 1.3293 3.0049 0.0 0 CFG=2 VAL=5
M  V30 11 C 2.0848 0.8790 0.0 0 CFG=1 VAL=5
M  V30 12 C 0.0000 2.2349 0.0 0 CFG=2 VAL=5
M  V30 13 C 1.3778 7.9639 0.0 0 CHG=-1 VAL=4
M  V30 14 C 2.1308 10.0899 0.0 0 VAL=5
M  V30 15 C 4.2519 8.7364 0.0 0 VAL=5
M  V30 16 C 2.9178 7.9639 0.0 0 VAL=5
M  V30 17 C 0.0484 8.7364 0.0 0 VAL=5
M  V30 18 C 5.8210 2.4747 0.0 0
M  V30 19 C 5.8210 3.4287 0.0 0
M  V30 20 C 6.6491 2.0001 0.0 0
M  V30 21 C 6.6491 3.9057 0.0 0
M  V30 22 C 7.4724 2.4747 0.0 0
M  V30 23 C 7.4724 3.4287 0.0 0
M  V30 24 H 1.5569 2.1575 0.0 0
M  V30 25 H 2.0848 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 9
M  V30 7 1 6 18
M  V30 8 1 8 7 CFG=3
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 7 CFG=1
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 7 15
M  V30 16 1 7 16
M  V30 17 1 7 17
M  V30 18 1 8 9
M  V30 19 2 8 10
M  V30 20 1 9 11
M  V30 21 1 10 12
M  V30 22 1 10 24 CFG=3
M  V30 23 2 11 12
M  V30 24 1 11 25
M  V30 25 1 13 16
M  V30 26 1 13 17
M  V30 27 1 14 15
M  V30 28 2 14 17
M  V30 29 2 15 16
M  V30 30 2 18 19
M  V30 31 1 18 20
M  V30 32 1 19 21
M  V30 33 2 20 22
M  V30 34 2 21 23
M  V30 35 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 1 8 9 10 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1S)-1-(methylamino)ethyl]-2-(phenylthio)-, (2S)-
C19H21FeNS
888954-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.4061 3.7530 0.0 0
M  V30 2 C 1.1511 1.3590 0.0 0
M  V30 3 N 1.1511 0.4836 0.0 0
M  V30 4 C 0.3917 1.7991 0.0 0
M  V30 5 C 0.3168 0.0000 0.0 0
M  V30 6 Fe 4.0360 5.0226 0.0 0 CHG=2 VAL=10
M  V30 7 C 3.2380 2.5681 0.0 0 VAL=5
M  V30 8 C 1.9104 1.7991 0.0 0 CHG=-1 VAL=4
M  V30 9 C 3.9900 0.4449 0.0 0 VAL=5
M  V30 10 C 4.7759 2.5681 0.0 0 VAL=5
M  V30 11 C 6.1108 1.7991 0.0 0 VAL=5
M  V30 12 C 6.1567 8.2920 0.0 0 CHG=-1 VAL=4
M  V30 13 C 1.9587 8.2920 0.0 0 VAL=5
M  V30 14 C 3.2839 7.5206 0.0 0 VAL=5
M  V30 15 C 4.8243 7.5206 0.0 0 VAL=5
M  V30 16 C 4.0360 9.6437 0.0 0 VAL=5
M  V30 17 C 1.6468 3.3153 0.0 0
M  V30 18 C 0.8246 3.7893 0.0 0
M  V30 19 C 1.6468 2.3626 0.0 0
M  V30 20 C 0.0000 3.3129 0.0 0
M  V30 21 C 0.8222 1.8862 0.0 0
M  V30 22 C 0.0000 2.3626 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 8
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 6 13
M  V30 14 1 6 14
M  V30 15 1 6 15
M  V30 16 1 6 16
M  V30 17 1 7 8
M  V30 18 2 7 10
M  V30 19 1 8 9
M  V30 20 2 9 11
M  V30 21 1 10 11
M  V30 22 1 12 15
M  V30 23 1 12 16
M  V30 24 1 13 14
M  V30 25 2 13 16
M  V30 26 2 14 15
M  V30 27 2 17 18
M  V30 28 1 17 19
M  V30 29 1 18 20
M  V30 30 2 19 21
M  V30 31 2 20 22
M  V30 32 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 508240-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888954-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-14344205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Easily accessible ferrocenyl N-P/S type ligands and their applications in
asymmetric allylic substitutions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lam, Fuk Loi; Au-Yeung, Terry T. L.; Cheung, Hong Yee; Kok, Stanton H.
L.; Lam, Wing Sze; Wong, Kwok Yin; Chan, Albert S. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2006), 17(4), 497-499

$RFMT $RIREG SCHEME335 STEP1
$RXN



  3  1
$MOL
1-Chloro-4-[(1E)-2-nitroethenyl]benzene
C8H6ClNO2
5153-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0 VAL=5
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-4-Chloro-N-methyl-β-(nitromethyl)-α-phenylbenzenepropanamide
C17H17ClN2O3
1457935-43-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0 CFG=2
M  V30 3 C 4.6201 6.6685 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 5.3901 8.0023 0.0 0 VAL=5
M  V30 6 N 4.6201 1.3337 0.0 0
M  V30 7 O 6.9302 2.6675 0.0 0
M  V30 8 O 4.6201 9.3360 0.0 0
M  V30 9 O 6.9302 8.0023 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 Cl 11.5503 5.3348 0.0 0
M  V30 12 C 6.9302 5.3348 0.0 0
M  V30 13 C 7.7002 4.0012 0.0 0
M  V30 14 C 7.7002 6.6685 0.0 0
M  V30 15 C 9.2402 4.0012 0.0 0
M  V30 16 C 9.2402 6.6685 0.0 0
M  V30 17 C 10.0102 5.3348 0.0 0
M  V30 18 C 3.0801 4.0012 0.0 0
M  V30 19 C 2.3101 5.3348 0.0 0
M  V30 20 C 2.3101 2.6675 0.0 0
M  V30 21 C 0.7700 5.3348 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 17
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-70-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-43-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-11124471
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 73% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME336 STEP1
$RXN



  3  1
$MOL
Oxalyl chloride
C2Cl2O2
79-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Cl 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromoindole
C8H6BrN
52415-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 3.7036 0.0000 0.0 0
M  V30 5 C 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 N 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-α-oxo-1H-indole-3-acetamide
C11H9BrN2O2
209169-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2596 2.6219 0.0 0
M  V30 2 C 8.5932 1.8518 0.0 0
M  V30 3 O 7.2596 4.1619 0.0 0
M  V30 4 N 9.9268 2.6219 0.0 0
M  V30 5 O 8.5932 0.3118 0.0 0
M  V30 6 C 11.2605 1.8518 0.0 0
M  V30 7 Br 0.0000 3.4387 0.0 0
M  V30 8 C 4.5190 2.4782 0.0 0
M  V30 9 C 5.9258 1.8518 0.0 0
M  V30 10 C 3.4886 1.3338 0.0 0
M  V30 11 C 4.0431 3.9429 0.0 0
M  V30 12 C 5.7648 0.3202 0.0 0
M  V30 13 N 4.2586 0.0000 0.0 0
M  V30 14 C 1.9821 1.6540 0.0 0
M  V30 15 C 2.5367 4.2630 0.0 0
M  V30 16 C 1.5063 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52415-29-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 209169-03-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-091-CAS-23542512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concerning the preparation of 6-bromotryptamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scott Wiens, P.; Johnson, Jerry L.; Gribble, Gordon W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2021), 85132055

$RFMT $RIREG SCHEME337 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4-(4-methoxyphenyl)-1-methyl-1H-naphth[2,3-d]imidazol-2-amine
C21H21N3O3
700813-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 9.9313 0.0 0
M  V30 2 C 2.6673 10.7013 0.0 0
M  V30 3 C 4.6245 0.3504 0.0 0
M  V30 4 N 7.9565 0.0000 0.0 0
M  V30 5 O 1.3337 8.3912 0.0 0
M  V30 6 C 0.0000 7.6212 0.0 0
M  V30 7 O 12.0032 8.3912 0.0 0
M  V30 8 C 13.3369 7.6212 0.0 0
M  V30 9 C 6.6684 5.3112 0.0 0
M  V30 10 C 5.3348 6.0812 0.0 0
M  V30 11 C 6.6684 3.7712 0.0 0
M  V30 12 C 4.0010 5.3112 0.0 0
M  V30 13 C 5.3348 7.6212 0.0 0
M  V30 14 C 5.3348 3.0012 0.0 0
M  V30 15 N 7.8128 2.7406 0.0 0
M  V30 16 C 4.0010 3.7712 0.0 0
M  V30 17 C 2.6673 6.0812 0.0 0
M  V30 18 C 4.0010 8.3912 0.0 0
M  V30 19 N 5.6549 1.4947 0.0 0
M  V30 20 C 7.1865 1.3338 0.0 0
M  V30 21 C 2.6673 7.6212 0.0 0
M  V30 22 C 8.0021 6.0812 0.0 0
M  V30 23 C 8.0021 7.6212 0.0 0
M  V30 24 C 9.3359 5.3112 0.0 0
M  V30 25 C 9.3359 8.3911 0.0 0
M  V30 26 C 10.6695 6.0812 0.0 0
M  V30 27 C 10.6695 7.6212 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 19
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 22
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 2 14 16
M  V30 20 1 14 19
M  V30 21 2 15 20
M  V30 22 1 17 21
M  V30 23 2 18 21
M  V30 24 1 19 20
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl N-[6,7-dimethoxy-4-(4-methoxyphenyl)-1-methyl-1H-naphth[2,3-d]imidazol...
C23H23N3O5
2234276-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9425 11.1806 0.0 0
M  V30 2 N 11.9119 8.4700 0.0 0
M  V30 3 C 12.6819 7.1364 0.0 0
M  V30 4 O 14.2219 7.1364 0.0 0
M  V30 5 O 11.9119 5.8026 0.0 0
M  V30 6 C 14.9919 5.8027 0.0 0
M  V30 7 O 1.3336 6.9300 0.0 0
M  V30 8 C 0.0000 7.7000 0.0 0
M  V30 9 O 1.3336 10.0100 0.0 0
M  V30 10 C 1.3336 11.5500 0.0 0
M  V30 11 O 6.6684 0.7700 0.0 0
M  V30 12 C 5.3347 0.0000 0.0 0
M  V30 13 C 6.6684 6.9300 0.0 0
M  V30 14 C 8.0021 7.7000 0.0 0
M  V30 15 C 5.3347 7.7000 0.0 0
M  V30 16 C 8.0021 9.2400 0.0 0
M  V30 17 N 9.4667 7.2241 0.0 0
M  V30 18 C 5.3347 9.2400 0.0 0
M  V30 19 C 4.0011 6.9300 0.0 0
M  V30 20 C 6.6684 10.0100 0.0 0
M  V30 21 N 9.4667 9.7159 0.0 0
M  V30 22 C 10.3719 8.4700 0.0 0
M  V30 23 C 4.0011 10.0100 0.0 0
M  V30 24 C 2.6674 7.7000 0.0 0
M  V30 25 C 2.6674 9.2400 0.0 0
M  V30 26 C 6.6684 5.3900 0.0 0
M  V30 27 C 8.0021 4.6200 0.0 0
M  V30 28 C 5.3347 4.6200 0.0 0
M  V30 29 C 8.0021 3.0800 0.0 0
M  V30 30 C 5.3347 3.0800 0.0 0
M  V30 31 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 1 11 12
M  V30 12 1 11 31
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 26
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 16 21
M  V30 22 2 17 22
M  V30 23 1 18 20
M  V30 24 2 18 23
M  V30 25 1 19 24
M  V30 26 1 21 22
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 700813-16-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2234276-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26275526
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Marine Natural Products for Drug Discovery: First Discovery of
Kealiinines A-C and Their Derivatives as Novel Antiviral and
Antiphytopathogenic Fungus Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Gang; Guo, Jincheng; Wang, Ziwen; Liu, Yuxiu; Song, Haibin; Wang,
Qingmin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2018), 66(28), 7310-7318

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-(2-bromoethyl)phosphonate
C6H14BrO3P
5324-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 2 C 2.3100 3.8500 0.0 0
M  V30 3 O 5.3900 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 1.5400 5.1836 0.0 0
M  V30 7 C 6.1600 5.1836 0.0 0
M  V30 8 C 2.5164 1.5400 0.0 0
M  V30 9 Br 0.0000 5.1836 0.0 0
M  V30 10 C 7.7000 5.1836 0.0 0
M  V30 11 C 2.5164 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[2-(methylamino)ethyl]phosphonate
C7H18NO3P
67264-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 2 C 4.7710 5.3348 0.0 0
M  V30 3 O 3.2310 2.6675 0.0 0
M  V30 4 O 2.6673 4.7712 0.0 0
M  V30 5 O 5.3348 3.2311 0.0 0
M  V30 6 C 6.3111 5.3348 0.0 0
M  V30 7 C 4.0010 1.3338 0.0 0
M  V30 8 C 1.3337 4.0012 0.0 0
M  V30 9 N 7.0811 6.6687 0.0 0
M  V30 10 C 3.2310 0.0000 0.0 0
M  V30 11 C 0.0000 4.7712 0.0 0
M  V30 12 C 8.6211 6.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5324-30-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67264-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6177413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, photopolymerization and adhesive properties of new
hydrolytically stable phosphonic acids for dental applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Degrange, Michel; Le Pluart, Loic; Madec, Pierre-Jean;
Pham, Thi-Nhan; Picton, Luc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Polymer Science, Part A: Polymer Chemistry (2008), 46(21),
7074-7090

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
4-(Trifluoromethyl)hydrocinnamic acid
C10H9F3O2
53473-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 O 10.7800 0.0000 0.0 0
M  V30 9 O 10.7800 2.6673 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenepropanamine
C11H14F3N
459872-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 10.0100 1.3336 0.0 0
M  V30 8 N 10.7800 0.0000 0.0 0
M  V30 9 C 12.3200 0.0000 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 5.3900 1.3336 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 53473-36-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459872-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-224497
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 4:
N-[3-(4-chlorophenyl)propyl]-N-methylamine. A stirred solution of 3.0 g
(16.2 mmol) of 4-chlorophenylpropionic acid in 20 mL of DCM was reacted
with 3.1 g (19.4 mmol, 1.2 equiv.) of 1.1'-carbonyldiimidazole by
addition of 500 mg portions over a 15 min period, during which time
significant evolution of CO was observed. The resulting solution was
stirred 90 min at RT, then cooled to 0 °C and treated with 8 mL of a cold
(0 °C) 40% aqueous solution of methylamine. The resulting mixture was
allowed to warm to RT and stirred vigorously for 14 h. The reaction
mixture was then acidified to a pH of 1 by careful addition of conc. HCl,
diluted with 70 mL of chloroform and extracted with H2O (1 x 100 mL). The
organic layer was separated, dried (MgSO4), and concentrated in vacuo to
afford 3.1 g of a white solid. This material was immediately dissolved in
80 mL of THF, and 19.4 mL of a 1.0 M solution of LiA4 in THF was added
dropwise over 10 min. After the addition was complete, the resulting
solution was stirred 10 min at RT and then was heated to 60 °C for 6 h.
The reaction mixture was then cooled to 0 °C and the reaction was
quenched by careful addition of 0.76 mL of H2O, followed by 0.76 mL of
15% NaOH and then 2.7 mL of H2O. The resulting slurry was stirred
vigorously for 10 min. and then filtered through a pad of Celite to
remove the salts. The salts were isolated, triturated with EtOAc, and
refiltered through a pad of Celite. The filtrates were combined, dried
(MgSO4), and concentrated in vacuo to afford of the title compound, which
was used without further purification: Intermediate 7:
N-[3-(4-trifluoromethylphenylpropyl]-N-methylamine. The title compound
was prepared in 90% yield via the procedure outlined for Intermediate 4
using 3-(4-trifluoromethylphenyl)propionic acid to give a colorless oil.
1H NMR (CDCl3, 400 MHz) δ 7.53 (d, 2 H, J = 8.0), 7.29 (d, 2 H, J = 8.0),
2.71 (m, 2 H), 2.61 (m, 2 H), 2.44 (s, 3 H), 1.83 (m, 2 H), 1.55 (s, br,
1 H); GCMS (DB-5, 30m x 0.25mm x 0.25nm; 100 °C-300 °C, initial hold 1
min; ramp rate 25 °C/min for 8min, final hold 1 min; total 10 min) t =
3.74 min, 94.7o/o purity; MS m/e 217(M+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyltriazines as estrogen receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hale, Ronnie Lee; Henke, Brad Richard; Lambert, Millard Hurst, III; Lu,
Amy Tsai; Spearing, Paul Kenneth; Turnbull, Philip Stewart
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002072561 A1 2002-09-19

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylsulfonyl)benzaldehyde
C8H8O3S
5398-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[[4-(Methylsulfonyl)phenyl]methylene]methanamine
C9H11NO2S
2070885-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5398-77-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2070885-52-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16557431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three-component carboarylation of unactivated imines with arynes and
carbon nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Jing-Kun; Li, Sheng-Jun; Wang, Hai-Yang; Xu, Wen-Cong; Tian, Shi-Kai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2017), 53(10),
1708-1711

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-(2-oxopropyl)-2(3H)-benzoxazolone
C10H8ClNO3
54080-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5368 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 C 0.0000 2.6091 0.0 0
M  V30 4 O 0.5546 0.0000 0.0 0
M  V30 5 O 0.5675 4.4953 0.0 0
M  V30 6 Cl 8.4783 2.9553 0.0 0
M  V30 7 C 4.4773 3.7253 0.0 0
M  V30 8 C 4.4773 5.2653 0.0 0
M  V30 9 N 3.0127 3.2494 0.0 0
M  V30 10 C 5.8111 2.9553 0.0 0
M  V30 11 O 3.0127 5.7411 0.0 0
M  V30 12 C 5.8111 6.0353 0.0 0
M  V30 13 C 2.1075 4.4953 0.0 0
M  V30 14 C 7.1447 3.7253 0.0 0
M  V30 15 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Chloro-2-hydroxyphenyl)-1,3-dihydro-3,4-dimethyl-2H-imidazol-2-one
C11H11ClN2O2
67980-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9526 0.6966 0.0 0
M  V30 2 O 3.9690 6.3388 0.0 0
M  V30 3 C 1.6752 0.0000 0.0 0
M  V30 4 C 0.0000 2.9016 0.0 0
M  V30 5 Cl 9.3040 3.2587 0.0 0
M  V30 6 N 3.9690 3.2587 0.0 0
M  V30 7 C 3.8080 1.7271 0.0 0
M  V30 8 C 2.5622 3.8850 0.0 0
M  V30 9 N 2.3017 1.4070 0.0 0
M  V30 10 C 1.5317 2.7406 0.0 0
M  V30 11 C 5.3028 4.0287 0.0 0
M  V30 12 C 5.3028 5.5688 0.0 0
M  V30 13 C 6.6365 3.2587 0.0 0
M  V30 14 C 6.6365 6.3388 0.0 0
M  V30 15 C 7.9701 4.0287 0.0 0
M  V30 16 C 7.9701 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 12
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54080-56-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67980-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16928222
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-23-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of a new polycyclic heterocyclic ring system. Part III.
Benzo[b]imidazo[1,5-d][1,4]oxazepine-1,4(2H,5H)-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stanisheva, Desislava V.; Gerova, Mariana S.; Petrov, Ognyan I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocyclic Communications (2017), 23(1), 23-27

$RFMT $RIREG SCHEME342 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Oxopentanedioic acid
C5H6O5
542-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 O 6.6685 0.0000 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanedial
C4H6O2
638-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 C 1.3338 0.0000 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 O 6.6687 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tropinone
C8H13NO
532-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.8094 0.0 0
M  V30 2 O 6.8249 2.8094 0.0 0
M  V30 3 C 2.8380 2.7022 0.0 0
M  V30 4 N 1.5063 2.4895 0.0 0
M  V30 5 C 4.0110 4.0116 0.0 0
M  V30 6 C 3.4097 1.3459 0.0 0
M  V30 7 C 2.8149 1.6379 0.0 0
M  V30 8 C 5.3236 3.1523 0.0 0
M  V30 9 C 3.1354 0.0000 0.0 0
M  V30 10 C 4.0645 2.9869 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 542-05-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 638-37-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 532-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-17355989
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Robinson-Schopf cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Succindialdehyde
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Husson, Henri-Philippe; Royer, Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2001), 1-2

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N,N-diphenylacetamide
C14H12ClNO
5428-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 C 6.6686 4.6201 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0
M  V30 5 Cl 8.0022 5.3901 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 6.9301 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7001 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N,N-diphenylacetamide
C15H16N2O
860217-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 N 8.0023 5.3901 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 5.3901 0.0 0
M  V30 8 C 2.6675 6.9302 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 1.3337 7.7002 0.0 0
M  V30 11 C 0.0000 5.3901 0.0 0
M  V30 12 C 0.0000 6.9302 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 18 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5428-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860217-40-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1186187
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel Diphenyl Oxalamide and Diphenyl Acetamide
Derivatives as Anticonvulsants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikalje, Anna Pratima G.; Ghodke, Mangesh; Girbane, Amol
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2012), 345(1), 57-64

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Pyridinedicarboxaldehyde
C7H5NO2
5431-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N,N′-(2,6-pyridinediyldimethylidyne)bis-
C9H11N3
98997-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 N 9.3360 2.3101 0.0 0
M  V30 6 C 10.6697 3.0801 0.0 0
M  V30 7 N 5.3348 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5431-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98997-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18733366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vessel,molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Distinct Mechanical and Self-Healing Properties in Two
Polydimethylsiloxane Coordination Polymers with Fine-Tuned Bond Strength
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Da-Peng; Lai, Jian-Cheng; Lai, Hui-Ying; Mo, Sheng-Ran; Zeng,
Ke-Yu; Li, Cheng-Hui; Zuo, Jing-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2018), 57(6), 3232-3242

$RFMT $RIREG SCHEME345 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trichloroacetonitrile
C2Cl3N
545-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 Cl 1.5400 3.0800 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 Cl 1.5400 0.0000 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aR)-3a,8a-Dihydro-3a,8a-dihydroxy-3-methyl-2-(trichloromethyl)inden...
C12H9Cl3N2O3
1566600-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.5278 5.0206 0.0 0
M  V30 2 O 4.5278 0.4006 0.0 0
M  V30 3 C 6.4683 5.4211 0.0 0
M  V30 4 O 2.5874 0.0000 0.0 0
M  V30 5 C 8.4377 2.7106 0.0 0
M  V30 6 Cl 8.4377 4.2506 0.0 0
M  V30 7 Cl 9.9777 2.7106 0.0 0
M  V30 8 Cl 8.4377 1.1706 0.0 0
M  V30 9 C 4.5278 3.4806 0.0 0 CFG=1
M  V30 10 C 4.5278 1.9406 0.0 0 CFG=2
M  V30 11 C 3.0632 3.9564 0.0 0
M  V30 12 N 5.9924 3.9564 0.0 0
M  V30 13 C 3.0632 1.4647 0.0 0
M  V30 14 N 5.9924 1.4647 0.0 0
M  V30 15 C 2.1580 2.7106 0.0 0
M  V30 16 C 2.4367 5.3634 0.0 0
M  V30 17 C 6.8977 2.7106 0.0 0
M  V30 18 C 0.6265 2.8715 0.0 0
M  V30 19 C 0.9052 5.5243 0.0 0
M  V30 20 C 0.0000 4.2784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 10 2 CFG=3
M  V30 3 1 3 12
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 15
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 545-06-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1566600-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-9440630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile and Efficient Synthesis of New Class of Imidazole Derivatives via
One-Pot Multicomponent Reactions in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossaini, Zinatossadat; Seyfi, Samereh; Rostami-Charati, Faramarz;
Ghambarian, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2013), 16(10),
788-790

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde
C8H10O
5453-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.8642 3.8380 0.0 0
M  V30 2 O 6.2783 3.0216 0.0 0
M  V30 3 C 1.9157 2.6720 0.0 0
M  V30 4 C 3.4502 3.0216 0.0 0
M  V30 5 C 1.1247 0.0000 0.0 0
M  V30 6 C 0.7914 3.6412 0.0 0
M  V30 7 C 2.5202 2.0183 0.0 0
M  V30 8 C 1.1976 1.5044 0.0 0
M  V30 9 C 0.0000 2.6691 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylbicyclo[2.2.1]hept-5-ene-2-methanamine
C9H15N
15907-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7597 3.7556 0.0 0
M  V30 2 N 6.1435 2.9567 0.0 0
M  V30 3 C 7.5271 3.7556 0.0 0
M  V30 4 C 3.3761 2.9567 0.0 0
M  V30 5 C 1.8746 2.6147 0.0 0
M  V30 6 C 2.4661 1.9749 0.0 0
M  V30 7 C 1.1003 0.0000 0.0 0
M  V30 8 C 0.7744 3.5631 0.0 0
M  V30 9 C 1.1719 1.4721 0.0 0
M  V30 10 C 0.0000 2.6118 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5453-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15907-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1910623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile and purification free synthesis of peptides utilizing ROMPgel- and
ROMPsphere-supported coupling reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrett, Anthony G. M.; Bibal, Brigitte; Hopkins, Brian T.; Koebberling,
Johannes; Love, Andrew C.; Tedeschi, Livio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2005), 61(51), 12033-12041

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
5,6-Bis(4-methylphenyl)-2-pyrazinecarboxylic acid
C19H16N2O2
548760-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 6.6685 0.0 0
M  V30 2 O 0.0000 8.0021 0.0 0
M  V30 3 O 0.0000 5.3347 0.0 0
M  V30 4 C 7.7000 0.0000 0.0 0
M  V30 5 C 11.5500 6.6685 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 5.3900 6.6685 0.0 0
M  V30 8 N 3.0800 5.3347 0.0 0
M  V30 9 N 4.6200 8.0021 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 C 3.0800 8.0021 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 5.3900 1.3336 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 6.9300 6.6685 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 10.0100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 17
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 7 18
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5,6-bis(4-methylphenyl)-2-pyrazinecarboxamide
C20H19N3O
945756-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 6.6685 0.0 0
M  V30 2 N 11.5500 8.0021 0.0 0
M  V30 3 O 11.5500 5.3347 0.0 0
M  V30 4 C 13.0900 8.0021 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 6.1600 6.6685 0.0 0
M  V30 9 N 8.4700 5.3347 0.0 0
M  V30 10 N 6.9300 8.0021 0.0 0
M  V30 11 C 9.2400 6.6685 0.0 0
M  V30 12 C 8.4700 8.0021 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 6.1600 1.3336 0.0 0
M  V30 17 C 3.8500 2.6674 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 4.6200 6.6685 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 C 3.8500 8.0021 0.0 0
M  V30 22 C 2.3100 5.3347 0.0 0
M  V30 23 C 2.3100 8.0021 0.0 0
M  V30 24 C 1.5400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 18
M  V30 6 1 6 24
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 8 19
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 548760-12-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945756-93-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12779095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-solid supported reagent, PS-DIEA used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a
hydroxyl group improves the pharmaceutical properties and in vivo
efficacy of the series
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ellsworth, Bruce A.; Wang, Ying; Zhu, Yeheng; Pendri, Annapurna; Gerritz,
Samuel W.; Sun, Chongqing; Carlson, Kenneth E.; Kang, Liya; Baska, Rose
A.; Yang, Yifan; Huang, Qi; Burford, Neil T.; Cullen, Mary Jane;
Johnghar, Susan; Behnia, Kamelia; Pelleymounter, Mary Ann; Washburn,
William N.; Ewing, William R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(14), 3978-3982

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (6S,8R)-1,3-dichloro-4,6,7,8-tetrahydro-8-[3-(2-naphthalenyl)propyl]-4-...
C23H22Cl2N2O3
550375-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.2597 7.9273 0.0 0
M  V30 2 C 8.5933 7.1573 0.0 0
M  V30 3 C 9.9271 7.9273 0.0 0
M  V30 4 Cl 5.0738 10.3927 0.0 0
M  V30 5 C 3.6323 3.8986 0.0 0
M  V30 6 O 4.5375 2.6527 0.0 0
M  V30 7 O 2.1007 3.7376 0.0 0
M  V30 8 C 3.9110 1.2459 0.0 0
M  V30 9 C 4.8163 0.0000 0.0 0
M  V30 10 O 0.9517 5.8150 0.0 0
M  V30 11 Cl 0.0000 8.7443 0.0 0
M  V30 12 C 4.5190 7.7836 0.0 0
M  V30 13 N 3.4886 6.6392 0.0 0
M  V30 14 C 5.9260 7.1573 0.0 0 CFG=2
M  V30 15 C 4.0432 9.2483 0.0 0
M  V30 16 C 4.2586 5.3055 0.0 0 CFG=2
M  V30 17 C 1.9823 6.9594 0.0 0
M  V30 18 C 5.7651 5.6257 0.0 0
M  V30 19 N 2.5369 9.5685 0.0 0
M  V30 20 C 1.5065 8.4241 0.0 0
M  V30 21 C 11.2608 7.1573 0.0 0
M  V30 22 C 12.5945 7.9273 0.0 0
M  V30 23 C 11.2608 5.6172 0.0 0
M  V30 24 C 13.9281 7.1573 0.0 0
M  V30 25 C 12.5945 4.8472 0.0 0
M  V30 26 C 13.9281 5.6172 0.0 0
M  V30 27 C 15.2619 7.9273 0.0 0
M  V30 28 C 15.2619 4.8472 0.0 0
M  V30 29 C 16.5956 7.1573 0.0 0
M  V30 30 C 16.5956 5.6172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 21
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 16 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 10 17
M  V30 12 1 11 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 24 27
M  V30 29 1 25 26
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl (6S,8R)-1-chloro-4,6,7,8-tetrahydro-3-(methylamino)-8-[3-(2-naphthaleny...
C24H26ClN3O3
550375-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7128 2.7842 0.0 0
M  V30 2 O 8.1198 2.1579 0.0 0
M  V30 3 O 5.4669 1.8791 0.0 0
M  V30 4 C 8.2807 0.6263 0.0 0
M  V30 5 C 9.6877 0.0000 0.0 0
M  V30 6 O 3.4333 3.1036 0.0 0
M  V30 7 C 7.8400 8.0870 0.0 0
M  V30 8 C 9.3800 8.0870 0.0 0
M  V30 9 C 10.1500 9.4207 0.0 0
M  V30 10 Cl 4.7142 9.1291 0.0 0
M  V30 11 N 1.1444 5.1646 0.0 0
M  V30 12 C 0.0000 6.1951 0.0 0
M  V30 13 N 5.2182 5.0859 0.0 0
M  V30 14 C 5.5384 6.5922 0.0 0
M  V30 15 C 6.5519 4.3159 0.0 0 CFG=2
M  V30 16 C 3.7535 4.6101 0.0 0
M  V30 17 C 7.0700 6.7532 0.0 0 CFG=2
M  V30 18 C 4.3940 7.6227 0.0 0
M  V30 19 C 7.6964 5.3464 0.0 0
M  V30 20 C 2.6091 5.6405 0.0 0
M  V30 21 N 2.9293 7.1468 0.0 0
M  V30 22 C 11.6901 9.4207 0.0 0
M  V30 23 C 12.4601 10.7543 0.0 0
M  V30 24 C 12.4601 8.0870 0.0 0
M  V30 25 C 14.0001 10.7543 0.0 0
M  V30 26 C 14.0001 8.0870 0.0 0
M  V30 27 C 14.7701 9.4207 0.0 0
M  V30 28 C 14.7701 12.0880 0.0 0
M  V30 29 C 16.3101 9.4207 0.0 0
M  V30 30 C 16.3101 12.0880 0.0 0
M  V30 31 C 17.0802 10.7543 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 1 17 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 9 22
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 1 11 20
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 25 28
M  V30 30 1 26 27
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 550375-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 550375-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11034209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Potent, Non-peptide Inhibitors of HCV NS3
Protease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Schmitt, Aaron C.; Jiang, Wen; Wasserman, Zelda; Decicco,
Carl P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(6), 1157-1160

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2,3,5-tri-O-benzoyl-3-C-ethynyl-β-D-ribofuranosyl)-9H-purine
C33H23ClN4O7
565450-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.5015 9.8709 0.0 0
M  V30 2 C 6.5015 11.4110 0.0 0
M  V30 3 O 7.8353 12.1810 0.0 0
M  V30 4 C 8.4617 10.5079 0.0 0
M  V30 5 C 9.0880 11.9147 0.0 0
M  V30 6 O 5.3901 7.8550 0.0 0
M  V30 7 C 4.6201 6.5214 0.0 0
M  V30 8 O 5.3901 5.1877 0.0 0
M  V30 9 C 10.5458 9.5303 0.0 0
M  V30 10 O 11.9527 8.9040 0.0 0
M  V30 11 C 13.1986 9.8092 0.0 0
M  V30 12 O 13.0377 11.3407 0.0 0
M  V30 13 Cl 7.0806 0.0000 0.0 0
M  V30 14 C 7.8353 9.1009 0.0 0 CFG=2
M  V30 15 C 6.9301 7.8550 0.0 0 CFG=1
M  V30 16 C 9.2999 8.6251 0.0 0 CFG=1
M  V30 17 C 7.8353 6.6092 0.0 0 CFG=2
M  V30 18 O 9.2999 7.0850 0.0 0
M  V30 19 N 7.3593 5.1446 0.0 0
M  V30 20 C 8.2645 3.8986 0.0 0
M  V30 21 C 5.8947 4.6686 0.0 0
M  V30 22 C 7.3593 2.6527 0.0 0
M  V30 23 N 9.7961 3.7376 0.0 0
M  V30 24 N 5.8947 3.1286 0.0 0
M  V30 25 C 7.9858 1.2459 0.0 0
M  V30 26 C 10.4226 2.3308 0.0 0
M  V30 27 N 9.5173 1.0848 0.0 0
M  V30 28 C 5.1679 12.1810 0.0 0
M  V30 29 C 5.1679 13.7210 0.0 0
M  V30 30 C 3.8342 11.4110 0.0 0
M  V30 31 C 3.8342 14.4910 0.0 0
M  V30 32 C 2.5005 12.1810 0.0 0
M  V30 33 C 2.5005 13.7210 0.0 0
M  V30 34 C 3.0800 6.5214 0.0 0
M  V30 35 C 2.3100 7.8550 0.0 0
M  V30 36 C 2.3100 5.1877 0.0 0
M  V30 37 C 0.7700 7.8550 0.0 0
M  V30 38 C 0.7700 5.1877 0.0 0
M  V30 39 C 0.0000 6.5214 0.0 0
M  V30 40 C 14.6054 9.1827 0.0 0
M  V30 41 C 15.8515 10.0879 0.0 0
M  V30 42 C 14.7665 7.6511 0.0 0
M  V30 43 C 17.2583 9.4616 0.0 0
M  V30 44 C 16.1733 7.0248 0.0 0
M  V30 45 C 17.4192 7.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 28
M  V30 5 3 4 5
M  V30 6 1 14 4 CFG=1
M  V30 7 1 6 7
M  V30 8 1 15 6 CFG=3
M  V30 9 2 7 8
M  V30 10 1 7 34
M  V30 11 1 9 10
M  V30 12 1 16 9 CFG=1
M  V30 13 1 10 11
M  V30 14 2 11 12
M  V30 15 1 11 40
M  V30 16 1 13 25
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 17 19 CFG=1
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 2 21 24
M  V30 28 1 22 24
M  V30 29 2 22 25
M  V30 30 1 23 26
M  V30 31 1 25 27
M  V30 32 2 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 3′-C-ethynyl-N-methyl-
C13H15N5O4
565450-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6354 6.4219 0.0 0
M  V30 2 C 1.2459 4.5865 0.0 0
M  V30 3 C 0.0000 5.4917 0.0 0
M  V30 4 O 1.4613 2.5369 0.0 0
M  V30 5 C 3.2020 1.0304 0.0 0
M  V30 6 O 4.3465 0.0000 0.0 0
M  V30 7 N 10.4989 8.0724 0.0 0
M  V30 8 C 12.0389 8.0724 0.0 0
M  V30 9 N 5.9126 5.7253 0.0 0
M  V30 10 C 7.4189 5.4051 0.0 0
M  V30 11 C 5.7516 7.2569 0.0 0
M  V30 12 C 8.1889 6.7388 0.0 0
M  V30 13 N 8.1889 4.0713 0.0 0
M  V30 14 N 7.1585 7.8832 0.0 0
M  V30 15 C 9.7289 6.7388 0.0 0
M  V30 16 C 9.7289 4.0713 0.0 0
M  V30 17 N 10.4989 5.4051 0.0 0
M  V30 18 C 4.7680 4.6947 0.0 0 CFG=2
M  V30 19 C 3.2618 5.0149 0.0 0 CFG=2
M  V30 20 O 4.9291 3.1632 0.0 0
M  V30 21 C 2.4917 3.6813 0.0 0 CFG=1
M  V30 22 C 3.5222 2.5369 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 3 2 3
M  V30 3 1 21 2 CFG=3
M  V30 4 1 21 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=3
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 565450-79-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 565450-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5500805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Dowex H+ resin used for neutralization (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sugar modified nucleosides as antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hong, Zhi; An, Haoyun; Ding, Yili; Girardet, Jean-luc; Zhong, Weidong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003062255 A2 2003-07-31

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
N-BOC-Piperazine
C9H18N2O2
57260-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.8736 0.0 0
M  V30 2 O 5.3900 1.5400 0.0 0
M  V30 3 O 5.3900 4.2073 0.0 0
M  V30 4 C 6.9300 1.5400 0.0 0
M  V30 5 C 6.9300 0.0000 0.0 0
M  V30 6 C 8.4700 1.5400 0.0 0
M  V30 7 C 6.9300 3.0800 0.0 0
M  V30 8 N 3.0800 2.8736 0.0 0
M  V30 9 C 2.3100 4.2073 0.0 0
M  V30 10 C 2.3100 1.5400 0.0 0
M  V30 11 C 0.7700 4.2073 0.0 0
M  V30 12 C 0.7700 1.5400 0.0 0
M  V30 13 N 0.0000 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-piperazinecarboxamide
C6H13N3O
163361-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 N 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 57260-71-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 163361-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5073749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7693-46-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM PREPARATION 8: Preparation of piperazine-1-carboxylic acid methylamide 11
g (59 mmol) of N-butyloxycarbonylpiperazine was dissolved in 250 ml of
anhydrous tetrahydrofuran, and then 20.6 ml (118 mmol) of
N,N-diisopropylethylamine and 13.1 g (64.9 mmol) of
4-nitrophenylchloroformate were added thereto, followed by stirring under
reflux for 1 hour. 177 ml of methylamine (2 M tetrahydrofuran solution)
was added to the reaction, followed by stirring under reflux for 30
minutes. After completion of the reaction, the reaction solution was
concentrated, after addition of 100 ml of water, and then extracted twice
with 100 ml of dichloromethane. 30 ml of 4 N hydrochloric
acid/1,4-dioxane solution was added thereto, followed by stirring for 5
hours at room temperature. A solid, which was produced from completion of
the reaction, was filtered off and dried to obtain 9.53 g (53 mmol, yield
of 90%) of the title compound as hydrochloride salt. 1H NMR (DMSO-d6,
ppm); δ 9.28 (1H, bs), 7.94 (1H, bs), 3.52 (4H, m), 3.01 (4H, m), 2.57
(3H, s) FAB MS(m/e) = 144 [M+1]
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of [1,3]thiazolo[5,4-b]pyridine-2-amine derivatives as VEGF
receptor 2 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoon, Seung-Hyun; Joo, Hyun Woo; Song, Jeong Uk; Kim, Young Kwan; Koo,
Sun-Young; Yang, So Yeun; Kim, Kyoung-Hee; Hwang, Jin-a; Cho, Heung Soo;
Choi, Hwan Geun; Lim, Dongchul; Song, Ji Soo; Yoon, Hae-Seong; Hong,
Sang-Yong; Kim, Min-Jeong; Choi, Seihyun; Jo, Kiwon; Kim, Min-Hyeung;
Kim, Jieun; Kim, Jung In; Park, Tae Kyo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007058482 A1 2007-05-24

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(1-Naphthalenylmethylene)-2-phenyl-5(4H)-oxazolone
C20H13NO2
57427-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.7106 0.0 0
M  V30 2 O 7.3594 0.0000 0.0 0
M  V30 3 C 3.0800 4.0442 0.0 0
M  V30 4 C 4.6200 4.0442 0.0 0
M  V30 5 C 2.3100 5.3779 0.0 0
M  V30 6 C 2.3100 2.7106 0.0 0
M  V30 7 C 5.3900 5.3779 0.0 0
M  V30 8 C 3.0800 6.7117 0.0 0
M  V30 9 C 0.7700 5.3779 0.0 0
M  V30 10 C 0.7700 2.7106 0.0 0
M  V30 11 C 4.6200 6.7117 0.0 0
M  V30 12 C 0.0000 4.0442 0.0 0
M  V30 13 C 6.9300 2.7106 0.0 0
M  V30 14 N 7.8353 3.9564 0.0 0
M  V30 15 C 7.8353 1.4647 0.0 0
M  V30 16 C 9.2998 3.4806 0.0 0
M  V30 17 O 9.2998 1.9406 0.0 0
M  V30 18 C 10.5457 4.3858 0.0 0
M  V30 19 C 10.3847 5.9173 0.0 0
M  V30 20 C 11.9526 3.7593 0.0 0
M  V30 21 C 11.6306 6.8225 0.0 0
M  V30 22 C 13.1985 4.6645 0.0 0
M  V30 23 C 13.0376 6.1961 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 1 13
M  V30 3 2 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 11
M  V30 13 2 9 12
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-[(Methylamino)carbonyl]-2-(1-naphthalenyl)ethenyl]benzamide
C21H18N2O2
564441-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 N 5.3900 1.3336 0.0 0
M  V30 7 O 3.0800 2.6674 0.0 0
M  V30 8 O 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 10.0100 6.6684 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0
M  V30 15 C 9.2400 8.0021 0.0 0
M  V30 16 C 11.5500 6.6684 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 0.7700 6.6684 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 0.0000 8.0021 0.0 0
M  V30 25 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 20
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 2 16 19
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57427-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 564441-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4844814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternative prepn. shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM meta-Substituent effects on the photocyclization of aryl-substituted
N-acyl-α-dehydroalanine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maekawa, Kei; Kajiwara, Hiroo; Iseya, Yoshiyuki; Igarashi, Tetsutaro;
Sakurai, Tadamitsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2003), 60(3), 637-654

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1,3-diphenyl-2,4(1H,3H)-pyrimidinedione
C16H11ClN2O2
5759-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 4.6201 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 O 8.0023 0.0000 0.0 0
M  V30 4 N 4.0012 2.3101 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 N 6.6685 2.3101 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 C 6.6685 0.7700 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 8.0023 3.0801 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 9.3360 5.3901 0.0 0
M  V30 20 C 10.6697 3.0801 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylamino)-1,3-diphenyl-2,4(1H,3H)-pyrimidinedione
C17H15N3O2
66400-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 1.5400 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 O 8.0022 1.5400 0.0 0
M  V30 5 N 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 N 6.6684 3.8500 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 3.8500 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 9.3359 6.9301 0.0 0
M  V30 21 C 10.6695 4.6201 0.0 0
M  V30 22 C 10.6695 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 9 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5759-74-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66400-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4747028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3 Synthesis of 6-methylamino-1,3-diphenyl-1H-pyrimidine-2,4-dione.
In the same manner as in Step 4 of Example 1-1 and using
6-chloro-1,3-diphenyl-1H-pyrimidine-2,4-dione 20 (5.0 g) obtained in step
2, ethanol (25 ml), a 40% solution (21.7 ml) of methylamine in methanol,
6-methylamino-1,3-diphenyl-1H-pyrimidine-2,4-dione 21 (4.42 g, yield 90%)
was obtained as colorless crystals.
$DTYPE RXN:VAR(1):NOTES
$DATUM analog prepared similarly
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidines and
related compounds as MEK inhibitors and p15 and p27 protein inducers for
the treatment of cancer and rheumatic diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sakai, Toshiyuki; Kawasaki, Hisashi; Abe, Hiroyuki; Hayakawa, Kazuhide;
Iida, Tetsuya; Kikuchi, Shinichi; Yamaguchi, Takayuki; Nanayama,
Toyomichi; Kurachi, Hironori; Tamaru, Masahiro; Hori, Yoshikazu;
Takahashi, Mitsuru; Yoshida, Takayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005121142 A1 2005-12-22

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzenemethanesulfonyl chloride
C7H6ClNO4S
58032-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 S 1.3337 2.3101 0.0 0 VAL=6
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 O 2.1037 3.6437 0.0 0
M  V30 5 O 0.5637 0.9764 0.0 0
M  V30 6 N 8.0023 1.5400 0.0 0 VAL=5
M  V30 7 O 8.0023 0.0000 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenemethanesulfonamide
C8H10N2O4S
344885-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 S 8.0023 2.3101 0.0 0 VAL=6
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.7723 0.9764 0.0 0
M  V30 5 O 7.2323 3.6437 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58032-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 344885-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-10007339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a. Synthesis of (3-nitrophenyl)-N-methylmethanesulfonamide. 40% aqueous
methylamine (10 mL, 0.1 mol) was added to a vigorously stirred solution
of (3-Nitrophenyl)methanesulfonyl chloride (2.36 g, 10 mmol) in benzene
(30 mL) and allowed to stir for 2 h at room temperature. To this end, the
benzene layer was separated, and the aqueous layer extracted with CH2Cl2
(2x25 mL). The combined organic layers were washed with saturated aqueous
NaHCO3 (30 mL), water (30 mL), filtered over anhydrous Na2SO4, filtered
and the solvent removed under reduced pressure 2.07 g (90%) of
(3-nitrophenyl)-N-methylmethanesulfonamide as crystals.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminopyrimidines as inhibitors of cyclin-dependent
kinases.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wabnitz, Philipp; Schauerte, Heike; Allgeier, Hans; Augustin, Martin;
Zeitlmann, Lutz; Pleiss, Michael A.; Stumm, Gabriele; Mueller, Anke;
Choidas, Axel; Klebl, Bert; Mueller, Gerhard; Schwab, Wilfried; Le,
Jolle; Macritchie, Jackie; Simpson, Don
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008129080 A1 2008-10-30

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzenemethanesulfonyl chloride
C7H6ClNO4S
58032-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 S 1.3337 2.3101 0.0 0 VAL=6
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 O 2.1037 3.6437 0.0 0
M  V30 5 O 0.5637 0.9764 0.0 0
M  V30 6 N 8.0023 1.5400 0.0 0 VAL=5
M  V30 7 O 8.0023 0.0000 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenemethanesulfonamide
C8H10N2O4S
344885-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 S 8.0023 2.3101 0.0 0 VAL=6
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.7723 0.9764 0.0 0
M  V30 5 O 7.2323 3.6437 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58032-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 344885-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15368958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 4: Synthesis of
C-{3-[6-(2-ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-methyl-methanesulfonamide
(Reference compound 4) a. Synthesis of
(3-nitrophenyl)-N-methylmethanesulfonamide 40% aqueous methylamine (10
mL, 0.1 mol) was added to a vigorously stirred solution of
(3-nitrophenyl)methanesulfonyl chloride (2.36 g, 10 mmol) in benzene (30
mL) and allowed to stir for 2 h at room temperature. The benzene layer
was separated, and the aqueous layer extracted with CH2Cl2 (2×25 mL). The
combined organic layers were washed with saturated aqueous NaHCO3 (30
mL), water (30 mL), filtered over anhydrous Na2SO4, filtered and the
solvent removed under reduced pressure to give 2.07 g (90%) of
(3-nitrophenyl)-N-methylmethanesulfonamide as crystals.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as inhibitors of cyclin-dependent
kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schauerte, Heike; Allgeier, Hans; Pleiss, Michael A.; Augustin, Martin;
Peraus, Gisela; Stumm, Gabriele; Wabnitz, Philipp
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008129069 A1 2008-10-30

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[4-[(butylamino)sulfonyl]phenyl]-1,4,5,6-tetrahydrobenzo[1,2-c:3,4-c′...
C21H25N5O4S
586353-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4068 3.9683 0.0 0
M  V30 2 O 1.5679 2.4367 0.0 0
M  V30 3 O 0.0000 4.5946 0.0 0
M  V30 4 C 0.3220 1.5315 0.0 0
M  V30 5 C 0.4829 0.0000 0.0 0
M  V30 6 S 11.1826 5.6435 0.0 0 VAL=6
M  V30 7 N 12.7226 5.6435 0.0 0
M  V30 8 O 11.1826 4.1035 0.0 0
M  V30 9 O 11.1826 7.1835 0.0 0
M  V30 10 C 13.4926 4.3099 0.0 0
M  V30 11 C 15.0326 4.3099 0.0 0
M  V30 12 C 15.8026 2.9761 0.0 0
M  V30 13 C 17.3426 2.9761 0.0 0
M  V30 14 C 4.1174 6.8894 0.0 0
M  V30 15 N 5.0226 5.6435 0.0 0
M  V30 16 C 2.6528 6.4135 0.0 0
M  V30 17 C 4.4375 8.3958 0.0 0
M  V30 18 N 4.1174 4.3976 0.0 0
M  V30 19 C 2.6528 4.8735 0.0 0
M  V30 20 C 1.5083 7.4439 0.0 0
M  V30 21 C 3.2931 9.4262 0.0 0
M  V30 22 C 5.7713 9.1658 0.0 0
M  V30 23 C 1.8284 8.9503 0.0 0
M  V30 24 N 3.9195 10.8330 0.0 0
M  V30 25 N 5.4510 10.6721 0.0 0
M  V30 26 C 6.5626 5.6435 0.0 0
M  V30 27 C 7.3326 4.3099 0.0 0
M  V30 28 C 7.3326 6.9771 0.0 0
M  V30 29 C 8.8726 4.3099 0.0 0
M  V30 30 C 8.8726 6.9771 0.0 0
M  V30 31 C 9.6426 5.6435 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 31
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 26
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 17 22
M  V30 23 2 18 19
M  V30 24 1 20 23
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-[(Butylamino)sulfonyl]phenyl]-1,4,5,6-tetrahydro-N-methylbenzo[1,2-c:3,4...
C20H24N6O3S
586354-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4068 6.8649 0.0 0
M  V30 2 N 1.5679 8.3964 0.0 0
M  V30 3 O 0.0000 6.2384 0.0 0
M  V30 4 C 0.3220 9.3016 0.0 0
M  V30 5 S 11.1826 5.1896 0.0 0 VAL=6
M  V30 6 N 12.7226 5.1896 0.0 0
M  V30 7 O 11.1826 3.6496 0.0 0
M  V30 8 O 11.1826 6.7296 0.0 0
M  V30 9 C 13.4926 6.5233 0.0 0
M  V30 10 C 15.0326 6.5233 0.0 0
M  V30 11 C 15.8026 7.8569 0.0 0
M  V30 12 C 17.3426 7.8569 0.0 0
M  V30 13 C 4.1173 3.9438 0.0 0
M  V30 14 N 5.0226 5.1896 0.0 0
M  V30 15 C 2.6528 4.4196 0.0 0
M  V30 16 C 4.4375 2.4374 0.0 0
M  V30 17 N 4.1173 6.4355 0.0 0
M  V30 18 C 2.6528 5.9596 0.0 0
M  V30 19 C 1.5083 3.3891 0.0 0
M  V30 20 C 3.2931 1.4069 0.0 0
M  V30 21 C 5.7713 1.6674 0.0 0
M  V30 22 C 1.8284 1.8828 0.0 0
M  V30 23 N 3.9195 0.0000 0.0 0
M  V30 24 N 5.4510 0.1611 0.0 0
M  V30 25 C 6.5626 5.1896 0.0 0
M  V30 26 C 7.3326 6.5233 0.0 0
M  V30 27 C 7.3326 3.8559 0.0 0
M  V30 28 C 8.8726 6.5233 0.0 0
M  V30 29 C 8.8726 3.8559 0.0 0
M  V30 30 C 9.6426 5.1896 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 30
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 25
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 16 21
M  V30 22 2 17 18
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586353-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586354-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15158020
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzodipyrazoles: a new class of potent CDK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM D'Alessio, Roberto; Bargiotti, Alberto; Metz, Suzanne; Brasca, M.
Gabriella; Cameron, Alexander; Ermoli, Antonella; Marsiglio, Aurelio;
Polucci, Paolo; Roletto, Fulvia; Tibolla, Marcellino; Vazquez, Michael
L.; Vulpetti, Anna; Pevarello, Paolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(5), 1315-1319

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-2-...
C21H16BrF2NO4
586377-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 0.0000 0.0 0
M  V30 2 C 6.1601 5.3348 0.0 0
M  V30 3 C 4.6201 5.3348 0.0 0
M  V30 4 Br 9.2402 0.0000 0.0 0
M  V30 5 C 1.5400 5.3348 0.0 0
M  V30 6 O 0.0000 5.3348 0.0 0
M  V30 7 O 2.3101 6.6687 0.0 0
M  V30 8 O 10.7802 2.6675 0.0 0
M  V30 9 C 11.5503 4.0012 0.0 0
M  V30 10 F 13.0903 6.6687 0.0 0
M  V30 11 F 17.7104 4.0012 0.0 0
M  V30 12 N 6.1601 2.6675 0.0 0
M  V30 13 C 6.9302 1.3338 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 8.4702 1.3338 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 2.6675 0.0 0
M  V30 18 C 4.6201 2.6675 0.0 0
M  V30 19 C 3.8501 4.0012 0.0 0
M  V30 20 C 3.8501 1.3338 0.0 0
M  V30 21 C 2.3101 4.0012 0.0 0
M  V30 22 C 2.3101 1.3338 0.0 0
M  V30 23 C 1.5400 2.6675 0.0 0
M  V30 24 C 13.0903 4.0012 0.0 0
M  V30 25 C 13.8603 5.3348 0.0 0
M  V30 26 C 13.8603 2.6675 0.0 0
M  V30 27 C 15.4003 5.3348 0.0 0
M  V30 28 C 15.4003 2.6675 0.0 0
M  V30 29 C 16.1704 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 19
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 24
M  V30 11 1 10 25
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,...
C22H19BrF2N2O3
586377-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9301 0.0000 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 C 5.3901 5.3348 0.0 0
M  V30 4 Br 10.0101 0.0000 0.0 0
M  V30 5 C 2.3100 5.3348 0.0 0
M  V30 6 N 0.7700 5.3348 0.0 0
M  V30 7 O 3.0800 6.6686 0.0 0
M  V30 8 C 0.0000 6.6686 0.0 0
M  V30 9 O 11.5501 2.6675 0.0 0
M  V30 10 C 12.3201 4.0011 0.0 0
M  V30 11 F 13.8602 6.6686 0.0 0
M  V30 12 F 18.4802 4.0011 0.0 0
M  V30 13 N 6.9301 2.6675 0.0 0
M  V30 14 C 7.7001 1.3338 0.0 0
M  V30 15 C 7.7001 4.0011 0.0 0
M  V30 16 C 9.2401 1.3338 0.0 0
M  V30 17 C 9.2401 4.0011 0.0 0
M  V30 18 C 10.0101 2.6675 0.0 0
M  V30 19 C 5.3901 2.6675 0.0 0
M  V30 20 C 4.6201 4.0011 0.0 0
M  V30 21 C 4.6201 1.3338 0.0 0
M  V30 22 C 3.0800 4.0011 0.0 0
M  V30 23 C 3.0800 1.3338 0.0 0
M  V30 24 C 2.3100 2.6675 0.0 0
M  V30 25 C 13.8602 4.0011 0.0 0
M  V30 26 C 14.6302 5.3348 0.0 0
M  V30 27 C 14.6302 2.6675 0.0 0
M  V30 28 C 16.1702 5.3348 0.0 0
M  V30 29 C 16.1702 2.6675 0.0 0
M  V30 30 C 16.9402 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 20
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 25
M  V30 12 1 11 26
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586377-11-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586377-18-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13963938
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 60-90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of PH-797804, a highly selective and potent inhibitor of p38
MAP kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selness, Shaun R.; Devraj, Rajesh V.; Devadas, Balekudru; Walker, John
K.; Boehm, Terri L.; Durley, Richard C.; Shieh, Huey; Xing, Li; Rucker,
Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen,
Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo,
Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal,
Radhika; Messing, Dean; Yang, Jerry; Mao, Michael K.; Yalamanchili, Gopi;
Vonder Embse, Richard; Hirsch, Jeffrey; Saabye, Matthew; Bonar, Sheri;
Webb, Elizabeth; Anderson, Gary; Monahan, Joseph B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(13), 4066-4071

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-3-...
C21H16BrF2NO4
586379-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 6.6687 0.0 0
M  V30 2 C 6.9302 1.3338 0.0 0
M  V30 3 C 5.3901 1.3338 0.0 0
M  V30 4 Br 10.0102 6.6687 0.0 0
M  V30 5 O 11.5503 4.0012 0.0 0
M  V30 6 C 12.3203 2.6675 0.0 0
M  V30 7 C 0.7700 4.0012 0.0 0
M  V30 8 O 0.0000 2.6675 0.0 0
M  V30 9 O 0.0000 5.3348 0.0 0
M  V30 10 F 13.8603 0.0000 0.0 0
M  V30 11 F 18.4804 2.6675 0.0 0
M  V30 12 N 6.9302 4.0012 0.0 0
M  V30 13 C 7.7002 5.3348 0.0 0
M  V30 14 C 7.7002 2.6675 0.0 0
M  V30 15 C 9.2402 5.3348 0.0 0
M  V30 16 C 9.2402 2.6675 0.0 0
M  V30 17 C 10.0102 4.0012 0.0 0
M  V30 18 C 5.3901 4.0012 0.0 0
M  V30 19 C 4.6201 2.6675 0.0 0
M  V30 20 C 4.6201 5.3348 0.0 0
M  V30 21 C 3.0801 2.6675 0.0 0
M  V30 22 C 3.0801 5.3348 0.0 0
M  V30 23 C 2.3101 4.0012 0.0 0
M  V30 24 C 13.8603 2.6675 0.0 0
M  V30 25 C 14.6303 1.3338 0.0 0
M  V30 26 C 14.6303 4.0012 0.0 0
M  V30 27 C 16.1704 1.3338 0.0 0
M  V30 28 C 16.1704 4.0012 0.0 0
M  V30 29 C 16.9404 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 19
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 10 25
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,...
C22H19BrF2N2O3
586379-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 6.6687 0.0 0
M  V30 2 C 8.4702 1.3338 0.0 0
M  V30 3 C 6.9302 1.3338 0.0 0
M  V30 4 Br 11.5503 6.6687 0.0 0
M  V30 5 O 13.0903 4.0012 0.0 0
M  V30 6 C 13.8603 2.6675 0.0 0
M  V30 7 C 2.3101 4.0012 0.0 0
M  V30 8 N 1.5400 5.3348 0.0 0
M  V30 9 O 1.5400 2.6675 0.0 0
M  V30 10 C 0.0000 5.3348 0.0 0
M  V30 11 F 15.4003 0.0000 0.0 0
M  V30 12 F 20.0204 2.6675 0.0 0
M  V30 13 N 8.4702 4.0012 0.0 0
M  V30 14 C 9.2402 5.3348 0.0 0
M  V30 15 C 9.2402 2.6675 0.0 0
M  V30 16 C 10.7802 5.3348 0.0 0
M  V30 17 C 10.7802 2.6675 0.0 0
M  V30 18 C 11.5503 4.0012 0.0 0
M  V30 19 C 6.9302 4.0012 0.0 0
M  V30 20 C 6.1601 2.6675 0.0 0
M  V30 21 C 6.1601 5.3348 0.0 0
M  V30 22 C 4.6201 2.6675 0.0 0
M  V30 23 C 4.6201 5.3348 0.0 0
M  V30 24 C 3.8501 4.0012 0.0 0
M  V30 25 C 15.4003 2.6675 0.0 0
M  V30 26 C 16.1704 1.3338 0.0 0
M  V30 27 C 16.1704 4.0012 0.0 0
M  V30 28 C 17.7104 1.3338 0.0 0
M  V30 29 C 17.7104 4.0012 0.0 0
M  V30 30 C 18.4804 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 20
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 25
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 24
M  V30 11 1 8 10
M  V30 12 1 11 26
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586379-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586379-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11842313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 60-90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of PH-797804, a highly selective and potent inhibitor of p38
MAP kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selness, Shaun R.; Devraj, Rajesh V.; Devadas, Balekudru; Walker, John
K.; Boehm, Terri L.; Durley, Richard C.; Shieh, Huey; Xing, Li; Rucker,
Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen,
Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo,
Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal,
Radhika; Messing, Dean; Yang, Jerry; Mao, Michael K.; Yalamanchili, Gopi;
Vonder Embse, Richard; Hirsch, Jeffrey; Saabye, Matthew; Bonar, Sheri;
Webb, Elizabeth; Anderson, Gary; Monahan, Joseph B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(13), 4066-4071

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-4-...
C21H16BrF2NO4
586379-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 1.3336 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 Br 9.2400 1.3336 0.0 0
M  V30 5 C 1.5400 1.3336 0.0 0
M  V30 6 O 0.0000 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 10.7800 4.0011 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 F 13.0900 8.0021 0.0 0
M  V30 11 F 17.7100 5.3347 0.0 0
M  V30 12 N 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 2.3100 5.3347 0.0 0
M  V30 23 C 1.5400 4.0011 0.0 0
M  V30 24 C 13.0900 5.3347 0.0 0
M  V30 25 C 13.8600 6.6685 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 C 15.4000 6.6685 0.0 0
M  V30 28 C 15.4000 4.0011 0.0 0
M  V30 29 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 20
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 24
M  V30 11 1 10 25
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
PH 797804
C22H19BrF2N2O3
586379-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0032 5.3900 0.0 0
M  V30 2 C 9.3358 0.7700 0.0 0
M  V30 3 C 10.6694 0.0000 0.0 0
M  V30 4 Br 9.3358 6.9300 0.0 0
M  V30 5 C 16.0041 3.0800 0.0 0
M  V30 6 N 17.3379 2.3100 0.0 0
M  V30 7 O 16.0041 4.6200 0.0 0
M  V30 8 C 18.6716 3.0800 0.0 0
M  V30 9 O 6.6684 5.3900 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 F 2.6674 3.0800 0.0 0
M  V30 12 F 0.0000 7.7000 0.0 0
M  V30 13 N 10.6694 3.0800 0.0 0
M  V30 14 C 10.6694 4.6200 0.0 0
M  V30 15 C 9.3358 2.3100 0.0 0
M  V30 16 C 9.3358 5.3900 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 12.0032 2.3100 0.0 0
M  V30 20 C 13.3369 3.0800 0.0 0
M  V30 21 C 12.0032 0.7700 0.0 0
M  V30 22 C 14.6705 2.3100 0.0 0
M  V30 23 C 13.3369 0.0000 0.0 0
M  V30 24 C 14.6705 0.7700 0.0 0
M  V30 25 C 4.0011 5.3900 0.0 0
M  V30 26 C 2.6674 4.6200 0.0 0
M  V30 27 C 4.0011 6.9300 0.0 0
M  V30 28 C 1.3336 5.3900 0.0 0
M  V30 29 C 2.6674 7.7000 0.0 0
M  V30 30 C 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 25
M  V30 12 1 11 26
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586379-64-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586379-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13695732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 60-90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of PH-797804, a highly selective and potent inhibitor of p38
MAP kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selness, Shaun R.; Devraj, Rajesh V.; Devadas, Balekudru; Walker, John
K.; Boehm, Terri L.; Durley, Richard C.; Shieh, Huey; Xing, Li; Rucker,
Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen,
Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo,
Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal,
Radhika; Messing, Dean; Yang, Jerry; Mao, Michael K.; Yalamanchili, Gopi;
Vonder Embse, Richard; Hirsch, Jeffrey; Saabye, Matthew; Bonar, Sheri;
Webb, Elizabeth; Anderson, Gary; Monahan, Joseph B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(13), 4066-4071

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-4-...
C21H16BrF2NO4
586379-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 1.3336 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 Br 9.2400 1.3336 0.0 0
M  V30 5 C 1.5400 1.3336 0.0 0
M  V30 6 O 0.0000 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 10.7800 4.0011 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 F 13.0900 8.0021 0.0 0
M  V30 11 F 17.7100 5.3347 0.0 0
M  V30 12 N 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 2.3100 5.3347 0.0 0
M  V30 23 C 1.5400 4.0011 0.0 0
M  V30 24 C 13.0900 5.3347 0.0 0
M  V30 25 C 13.8600 6.6685 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 C 15.4000 6.6685 0.0 0
M  V30 28 C 15.4000 4.0011 0.0 0
M  V30 29 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 20
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 24
M  V30 11 1 10 25
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
PH 797804
C22H19BrF2N2O3
586379-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0032 5.3900 0.0 0
M  V30 2 C 9.3358 0.7700 0.0 0
M  V30 3 C 10.6694 0.0000 0.0 0
M  V30 4 Br 9.3358 6.9300 0.0 0
M  V30 5 C 16.0041 3.0800 0.0 0
M  V30 6 N 17.3379 2.3100 0.0 0
M  V30 7 O 16.0041 4.6200 0.0 0
M  V30 8 C 18.6716 3.0800 0.0 0
M  V30 9 O 6.6684 5.3900 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 F 2.6674 3.0800 0.0 0
M  V30 12 F 0.0000 7.7000 0.0 0
M  V30 13 N 10.6694 3.0800 0.0 0
M  V30 14 C 10.6694 4.6200 0.0 0
M  V30 15 C 9.3358 2.3100 0.0 0
M  V30 16 C 9.3358 5.3900 0.0 0
M  V30 17 C 8.0021 3.0800 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 12.0032 2.3100 0.0 0
M  V30 20 C 13.3369 3.0800 0.0 0
M  V30 21 C 12.0032 0.7700 0.0 0
M  V30 22 C 14.6705 2.3100 0.0 0
M  V30 23 C 13.3369 0.0000 0.0 0
M  V30 24 C 14.6705 0.7700 0.0 0
M  V30 25 C 4.0011 5.3900 0.0 0
M  V30 26 C 2.6674 4.6200 0.0 0
M  V30 27 C 4.0011 6.9300 0.0 0
M  V30 28 C 1.3336 5.3900 0.0 0
M  V30 29 C 2.6674 7.7000 0.0 0
M  V30 30 C 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 25
M  V30 12 1 11 26
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586379-64-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586379-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5178096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
(-)3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide
(1)
3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoic
acid (2)(1.4 kg, 3.0 moles) was suspended in 7 L tetrahydrofuran with 28
ml N,N-dimethylformamide and chilled to 5°C. Oxalyl chloride (368 ml,
4.22 moles) was added to the reactor at a rate such that the temperature
was maintained below 10°C. and the gas evolution was under control. After
the oxalyl chloride had been added the reaction mixture was allowed to
warm to room temperature. The reaction was completed when the mixture
became homogeneous. The reaction mixture was drained into separate
container and set aside. 40% methylamine (4.4 L, 50.3 moles) and 2.6 L
water were added to the reactor and chilled to below 5°C. The reaction
mixture was then added to the chilled methylamine solution at a rate such
that the temperature was maintained below 15°C. Once the addition was
completed the mixture was allowed to warm to room temperature and stirred
an additional 30 minutes. 12.6 L water was added to the mixture and the
stirring was continued for another hour. The product was filtered and
washed with 10 L water to give 1.25 kg (90%). 1H NMR (300 MHz, DMSO-d6) δ
7.95 (bs, 1H), 7.88 (dd, J=1.2, 5.7 Hz, 1H), 7.68 (q, J=5.1 Hz, 1H), 7.64
(d, J=1.2 Hz, 1H), 7.46 (d, J=6.0 Hz, 1H), 7.36 (bs, 1H), 7.29 (dt,
J=1.8, 7.8 Hz, 1H), 7.16 (dt, J=1.8, 76.0 Hz, 1H), 6.70 (s, 1H), 6.18 (s,
1H), 5.33 (s, 2H), 3.32 (s, 3H), 1.97 (s, 3H), 1.88 (s, 3H). Anal. Cald.
for C21H17BrF2N2O3+0.66 EtOH+0.1H2O: C, 54.11; H, 4.30; N, 5.65. Found:
C, 54.03; H, 4.59; N, 5.79.
$DTYPE RXN:VAR(1):NOTES
$DATUM product mixture from stage two added to amine from stage three in stage
four
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Processes for the preparation of
3-[4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide
and related compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dukeshereer, Daniel; Mao, Michael; Vonder Embse, Richard; Yalamanchili,
Gopichand; Vaidyanathan, Rajappa; Chekal, Brian; Klemm, George;
Vanderroest, Ronald; Geurink, Randy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008072079 A2 2008-06-19

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloronicotinoyl chloride
C6H3Cl2NO
58757-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methylnicotinamide
C7H7ClN2O
54189-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58757-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54189-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14781102
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 6-chloro-N-methylnicotinamide A solution of
6-chloronicotinyl chloride (5.22 g, 30 mmol) in methylene chloride at
room temperature was treated with methylamine (2.0 M in THF, 22 mL, 45
mmol), stirred at room temperature for 4 h and filtered. After
concentration, the filtrate was filtered. The filtercake was washed with
ethyl ether and dried under vacumm to provide the title compound as a
white solid, 4.6 g (90%). MS (ES) m/z 169.0 [M−H]−.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoquinolinyl and isoindolinyl derivatives as histamine-3
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Dahui; Gross, Jonathan Laird; Robichaud, Albert Jean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090069300 A1 2009-03-12

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-3-[3,5-difluoro-4-[1-(methoxycarbonyl)-3-methyl-3-azetidinyl]phen...
C17H18F2N2O6
590421-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2055 1.1706 0.0 0
M  V30 2 F 6.7455 0.0433 0.0 0
M  V30 3 F 6.7455 5.3780 0.0 0
M  V30 4 C 2.5766 5.3395 0.0 0
M  V30 5 O 1.0889 4.9409 0.0 0
M  V30 6 O 2.9751 6.8271 0.0 0
M  V30 7 C 0.0000 6.0299 0.0 0
M  V30 8 O 11.7947 0.0000 0.0 0
M  V30 9 C 14.9811 4.3858 0.0 0
M  V30 10 O 16.3881 3.7594 0.0 0
M  V30 11 O 14.8202 5.9173 0.0 0
M  V30 12 C 17.6339 4.6647 0.0 0
M  V30 13 C 5.2055 2.7106 0.0 0
M  V30 14 C 5.2055 4.2506 0.0 0
M  V30 15 C 3.6655 2.7106 0.0 0
M  V30 16 N 3.6655 4.2506 0.0 0
M  V30 17 C 6.7455 2.7106 0.0 0
M  V30 18 C 7.5155 1.3769 0.0 0
M  V30 19 C 7.5155 4.0442 0.0 0
M  V30 20 C 9.0555 1.3769 0.0 0
M  V30 21 C 9.0555 4.0442 0.0 0
M  V30 22 C 9.8255 2.7106 0.0 0
M  V30 23 N 11.3655 2.7106 0.0 0
M  V30 24 C 12.2706 3.9564 0.0 0
M  V30 25 C 12.2706 1.4647 0.0 0
M  V30 26 C 13.7353 3.4806 0.0 0 CFG=2
M  V30 27 O 13.7353 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 18
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 2 8 25
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 26 9 CFG=3
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 17
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-(-)-N-Methyl-3-[3,5-difluoro-4-[1-(methoxycarbonyl)-3-methylazetidin-3-y...
C17H19F2N3O5
590421-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2055 1.1706 0.0 0
M  V30 2 F 6.7455 5.3780 0.0 0
M  V30 3 F 6.7455 0.0433 0.0 0
M  V30 4 C 2.5766 5.3395 0.0 0
M  V30 5 O 1.0889 4.9409 0.0 0
M  V30 6 O 2.9751 6.8271 0.0 0
M  V30 7 C 0.0000 6.0299 0.0 0
M  V30 8 O 11.7947 0.0000 0.0 0
M  V30 9 C 14.9811 4.3858 0.0 0
M  V30 10 N 16.3881 3.7594 0.0 0
M  V30 11 O 14.8202 5.9173 0.0 0
M  V30 12 C 17.6339 4.6647 0.0 0
M  V30 13 C 5.2055 2.7106 0.0 0
M  V30 14 C 5.2055 4.2506 0.0 0
M  V30 15 C 3.6655 2.7106 0.0 0
M  V30 16 N 3.6655 4.2506 0.0 0
M  V30 17 C 6.7455 2.7106 0.0 0
M  V30 18 C 7.5155 4.0442 0.0 0
M  V30 19 C 7.5155 1.3769 0.0 0
M  V30 20 C 9.0555 4.0442 0.0 0
M  V30 21 C 9.0555 1.3769 0.0 0
M  V30 22 C 9.8255 2.7106 0.0 0
M  V30 23 N 11.3655 2.7106 0.0 0
M  V30 24 C 12.2706 3.9564 0.0 0
M  V30 25 C 12.2706 1.4647 0.0 0
M  V30 26 C 13.7353 3.4806 0.0 0 CFG=2
M  V30 27 O 13.7353 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 18
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 2 8 25
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 26 9 CFG=3
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 17
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 590421-38-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 590421-40-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11084815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-aryl-2-oxo-5-oxazolidinecarboxamides and analogs as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomas, Richard Charles; Poel, Toni-jo; Barbachyn, Michael Robert;
Gordeev, Mikhail Fedor; Luehr, Gary W.; Renslo, Adam; Singh, Upinder;
Josyula, Vara Prasad Venkata Nagendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040147760 A1 2004-07-29

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-3-[3,5-difluoro-4-[1-(methoxycarbonyl)-3-methyl-3-azetidinyl]phen...
C17H18F2N2O6
590421-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2055 1.1706 0.0 0
M  V30 2 F 6.7455 0.0433 0.0 0
M  V30 3 F 6.7455 5.3780 0.0 0
M  V30 4 C 2.5766 5.3395 0.0 0
M  V30 5 O 1.0889 4.9409 0.0 0
M  V30 6 O 2.9751 6.8271 0.0 0
M  V30 7 C 0.0000 6.0299 0.0 0
M  V30 8 O 11.7947 0.0000 0.0 0
M  V30 9 C 14.9811 4.3858 0.0 0
M  V30 10 O 16.3881 3.7594 0.0 0
M  V30 11 O 14.8202 5.9173 0.0 0
M  V30 12 C 17.6339 4.6647 0.0 0
M  V30 13 C 5.2055 2.7106 0.0 0
M  V30 14 C 5.2055 4.2506 0.0 0
M  V30 15 C 3.6655 2.7106 0.0 0
M  V30 16 N 3.6655 4.2506 0.0 0
M  V30 17 C 6.7455 2.7106 0.0 0
M  V30 18 C 7.5155 1.3769 0.0 0
M  V30 19 C 7.5155 4.0442 0.0 0
M  V30 20 C 9.0555 1.3769 0.0 0
M  V30 21 C 9.0555 4.0442 0.0 0
M  V30 22 C 9.8255 2.7106 0.0 0
M  V30 23 N 11.3655 2.7106 0.0 0
M  V30 24 C 12.2706 3.9564 0.0 0
M  V30 25 C 12.2706 1.4647 0.0 0
M  V30 26 C 13.7353 3.4806 0.0 0 CFG=2
M  V30 27 O 13.7353 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 18
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 2 8 25
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 26 9 CFG=3
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 17
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-(-)-N-Methyl-3-[3,5-difluoro-4-[1-(methoxycarbonyl)-3-methylazetidin-3-y...
C17H19F2N3O5
590421-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2055 1.1706 0.0 0
M  V30 2 F 6.7455 5.3780 0.0 0
M  V30 3 F 6.7455 0.0433 0.0 0
M  V30 4 C 2.5766 5.3395 0.0 0
M  V30 5 O 1.0889 4.9409 0.0 0
M  V30 6 O 2.9751 6.8271 0.0 0
M  V30 7 C 0.0000 6.0299 0.0 0
M  V30 8 O 11.7947 0.0000 0.0 0
M  V30 9 C 14.9811 4.3858 0.0 0
M  V30 10 N 16.3881 3.7594 0.0 0
M  V30 11 O 14.8202 5.9173 0.0 0
M  V30 12 C 17.6339 4.6647 0.0 0
M  V30 13 C 5.2055 2.7106 0.0 0
M  V30 14 C 5.2055 4.2506 0.0 0
M  V30 15 C 3.6655 2.7106 0.0 0
M  V30 16 N 3.6655 4.2506 0.0 0
M  V30 17 C 6.7455 2.7106 0.0 0
M  V30 18 C 7.5155 4.0442 0.0 0
M  V30 19 C 7.5155 1.3769 0.0 0
M  V30 20 C 9.0555 4.0442 0.0 0
M  V30 21 C 9.0555 1.3769 0.0 0
M  V30 22 C 9.8255 2.7106 0.0 0
M  V30 23 N 11.3655 2.7106 0.0 0
M  V30 24 C 12.2706 3.9564 0.0 0
M  V30 25 C 12.2706 1.4647 0.0 0
M  V30 26 C 13.7353 3.4806 0.0 0 CFG=2
M  V30 27 O 13.7353 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 18
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 2 8 25
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 26 9 CFG=3
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 17
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 590421-38-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 590421-40-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5235615
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-aryl-2-oxo-5-oxazolidinecarboxamides and analogs as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomas, Richard C.; Poel, Toni-Jo; Barbachyn, Michael R.; Gordeev,
Mikhail F.; Luehr, Gary W.; Renslo, Adam; Singh, Upinder
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003072553 A1 2003-09-04

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2,5-furandione
C4HBrO3
5926-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.3320 0.0 0
M  V30 2 O 0.3502 0.0000 0.0 0
M  V30 3 O 5.3026 2.2049 0.0 0
M  V30 4 C 1.3337 2.5620 0.0 0
M  V30 5 C 1.4946 1.0304 0.0 0
M  V30 6 C 2.7406 3.1885 0.0 0
M  V30 7 O 3.0011 0.7103 0.0 0
M  V30 8 C 3.7711 2.0439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-1-methyl-1H-pyrrole-2,5-dione
C5H4BrNO2
65060-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3628 0.0 0
M  V30 2 C 3.0608 0.0000 0.0 0
M  V30 3 Br 0.3502 4.6949 0.0 0
M  V30 4 O 5.3026 2.4899 0.0 0
M  V30 5 C 1.3337 2.1328 0.0 0
M  V30 6 N 2.7406 1.5065 0.0 0
M  V30 7 C 1.4946 3.6644 0.0 0
M  V30 8 C 3.7711 2.6509 0.0 0
M  V30 9 C 3.0011 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5926-51-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65060-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-14507435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Preparation of Compounds 2, Exemplified for
Compound 2c 3-Bromomaleic anhydride (1.0 equiv, 5.65 mmol, 1.0 g) was
dissolved in AcOH (20 mL). Methylamine hydrochloride (1.0 equiv, 5.65
mmol, 0.37 g) was then added, and the reaction was heated at 80 °C for 3
h. Solvent was removed in vacuo, and the crude mixture was purified by
column chromatography over silica gel (EtOAc-hexane 0-30%) using an
ISCOTM purification system. 0.97 g of a white solid (90% yield). 1H NMR
(400 MHz, CDCl3): δ = 6.89 (s,1 H), 3.08 (s, 3 H). 13C NMR (100 MHz,
CDCl3): δ = 168.5, 165.3, 131.9, 131.3, 24.6. MS: m/z = 191 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A tandem [3 + 2] cycloaddition-elimination cascade reaction to generate
pyrrolo[3,4-c]pyrrole-1,3-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez-Ariza, Guillermo; Dietrich, Justin; De Moliner, Fabio; Hulme,
Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(14), 1801-1804

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Imidazole-5-carbonitrile, 4,4-dimethyl-2-(2-pyridinyl)-, 3-oxide
C11H10N4O
593286-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0177 5.6421 0.0 0
M  V30 2 C 7.9701 3.4370 0.0 0
M  V30 3 N 9.5017 3.2761 0.0 0
M  V30 4 C 5.1925 6.3964 0.0 0
M  V30 5 C 7.0754 5.5581 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 N 5.4080 2.4536 0.0 0
M  V30 8 N 4.1621 4.6116 0.0 0 VAL=5
M  V30 9 C 6.4386 3.5981 0.0 0
M  V30 10 C 5.6686 4.9318 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 N 1.3337 3.0801 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 3 2 3
M  V30 3 1 2 9
M  V30 4 1 4 10
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Imidazol-5-amine, N,4,4-trimethyl-2-(2-pyridinyl)-, 3-oxide
C11H14N4O
593286-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0177 0.7543 0.0 0
M  V30 2 N 7.9701 2.9593 0.0 0
M  V30 3 C 8.5965 4.3662 0.0 0
M  V30 4 C 5.1925 0.0000 0.0 0
M  V30 5 C 7.0754 0.8382 0.0 0
M  V30 6 C 4.0012 3.3163 0.0 0
M  V30 7 N 5.4080 3.9428 0.0 0
M  V30 8 N 4.1621 1.7847 0.0 0 VAL=5
M  V30 9 C 6.4384 2.7982 0.0 0
M  V30 10 C 5.6684 1.4646 0.0 0
M  V30 11 C 2.6673 4.0863 0.0 0
M  V30 12 C 2.6673 5.6264 0.0 0
M  V30 13 N 1.3337 3.3163 0.0 0
M  V30 14 C 1.3337 6.3964 0.0 0
M  V30 15 C 0.0000 4.0863 0.0 0
M  V30 16 C 0.0000 5.6264 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 10
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 593286-15-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 593286-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26426214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Ethyl-4,4-dimethyl-5-pyrrolidin-1-yl-4H-imidazole 3-Oxide (6e) The
4H-imidazole 3-oxide 6e was extracted from the reaction mixture with H2O
(5 × 15 mL). The H2O solution was saturated with KCl and Na2CO3 and
extracted with CHCl3 (5 × 15 mL). The extract was dried (K2CO3) and CHCl3
was removed under vacuum. White-orange crystals, yield 90%. mp 119-121 °C
(t-BuOMe). IR (KBr): 1613, 1567, 1459, 1417, 1317, 1173, 1080, 939 cm-1.
1H NMR (CDCl3): δ = 1.55 (s, 6 H, CH3-4), 1.20 (t, 3 H, J = 7.9, CH3),
2.63 (q, 2 H, J = 7.9, CH2CH3), 1.97 (br m, 4 H, Pyr), 3.59 (br m, 4 H,
Pyr). 13C NMR (CDCl3): δ = 18.91 (CH3-4), 71.86 (C4), 154.93 (C2), 172.63
(C5), 8.72 (Et), 18.50 (Et), 22.45 (br, Pyr), 25.38 (br, Pyr), 45.86 (br,
Pyr), 47.70 (br, Pyr). UV (EtOH): λmax (log ε) = 331 nm (3.87). Anal.
Calcd for C11H19N3O•H2O: C, 53.86; H, 9.45; N, 17.13. Found: C, 53.67; H,
9.34; N, 17.06.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Grignard reagent addition to 5-alkylamino-4H-imidazole 3-oxides:
Synthesis of new pH-sensitive spin probes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kirilyuk, Igor A.; Shevelev, Tikhon G.; Morozov, Denis A.; Khromovskih,
Ekaterina L.; Skuridin, Nikita G.; Khramtsov, Valery V.; Grigor'ev, Igor
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2003), (6), 871-878

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Diethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate
C11H18O6
59779-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 5.0169 0.0 0
M  V30 2 O 2.3100 5.0169 0.0 0
M  V30 3 O 4.6200 6.3507 0.0 0
M  V30 4 C 1.5400 6.3507 0.0 0
M  V30 5 C 0.0000 6.3507 0.0 0
M  V30 6 C 7.1819 4.6667 0.0 0
M  V30 7 O 8.6884 4.3465 0.0 0
M  V30 8 O 6.7061 6.1314 0.0 0
M  V30 9 C 9.7188 5.4910 0.0 0
M  V30 10 C 11.2251 5.1709 0.0 0
M  V30 11 C 3.9935 0.2154 0.0 0
M  V30 12 C 6.0433 0.0000 0.0 0
M  V30 13 C 4.6200 3.6832 0.0 0 CFG=2
M  V30 14 C 6.1515 3.5223 0.0 0 CFG=2
M  V30 15 O 3.9935 2.2764 0.0 0
M  V30 16 O 6.4717 2.0159 0.0 0
M  V30 17 C 5.1381 1.2459 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 14 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 1 12 17
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R,5R)-N4,N5,2,2-Tetramethyl-1,3-dioxolane-4,5-dicarboxamide
C9H16N2O4
475643-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.0168 0.0 0
M  V30 2 N 0.7700 5.0168 0.0 0
M  V30 3 O 3.0800 6.3506 0.0 0
M  V30 4 C 0.0000 6.3506 0.0 0
M  V30 5 C 5.6420 4.6666 0.0 0
M  V30 6 N 7.1483 4.3464 0.0 0
M  V30 7 O 5.1662 6.1313 0.0 0
M  V30 8 C 8.1788 5.4910 0.0 0
M  V30 9 C 2.4536 0.2154 0.0 0
M  V30 10 C 4.5032 0.0000 0.0 0
M  V30 11 C 3.0800 3.6832 0.0 0 CFG=2
M  V30 12 C 4.6116 3.5222 0.0 0 CFG=2
M  V30 13 O 2.4536 2.2764 0.0 0
M  V30 14 O 4.9318 2.0158 0.0 0
M  V30 15 C 3.5980 1.2458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 12 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 59779-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 475643-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-703483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-dicarboxamide (III). Diethyl
2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate, 10 g (0.046 mol), was
placed in an ampule, and the latter was connected to an ampule containing
3 g (0.097 mol) of cooled methylamine. The system was frozen and
evacuated, and the ampule containing methylamine was allowed to slowly
warm up to room temperature in order to recondense it into the first
ampule. The resulting colorless crystalline material was dried under
reduced pressure and recrystallized from ethanol. Yield 8.6 g (90%). Mp
132-134°C, [α]D = -7.81° (c = 1.9, EtOH). 1H (CDCl3), δ, ppm: 1.48 s (6H,
Me2C), 2.86 s (3H, NMe), 2.88 s (3H, NMe), 4.51 s (2H, CH), 7.10 br.s
(2H, NH). 13C NMR spectmm (CDCl3), δC, ppm: 25.81 (CCH3), 25.93 (NCH3),
77.23 (CH), 112.00 (C2), 170.05 (C=O). Found, %: C 49.67; H 7.80; N
12.95. C9H16N2O4. Calculated, %: C 49.99; H 7.46; N 12.95.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Chiral Diamines of the Dioxolane Series:
(+)-(4S,5S)-2,2-Dimethyl-4,5-bis(diphenylaminomethyl)- 1,3-dioxolane and
(+)-(4S,5S)-2,2-Dimethyl-4,5-bis(methyl- aminomethyl)-1,3-dioxolane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shainyan, B. A.; Nindakova, L. O.; Ustinov, M. V.; Chipanina, N. N.;
Sherstyannikova, L. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (Translation of Zhurnal
Organicheskoi Khimii) (2002), 38(12), 1802-1805

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromopropionic acid
C3H5BrO2
598-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Br 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-DL-alanine
C4H9NO2
600-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 N 4.0011 1.5400 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 598-72-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 600-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7663431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic enantioselective synthesis of N,Cα,Cα-trisubstituted α-amino
acid derivatives using 1H-imidazol-4(5H)-ones as key templates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Etxabe, Julen; Izquierdo, Joseba; Landa, Aitor; Oiarbide, Mikel; Palomo,
Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(23), 6883-6886

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
5-(4-Chlorophenyl)-6-(2,4-dichlorophenyl)-2-(phenylmethoxy)-3-pyridinecarboxy...
C25H16Cl3NO3
611219-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 9.3358 0.0 0
M  V30 2 O 10.7800 9.3358 0.0 0
M  V30 3 O 8.4700 10.6694 0.0 0
M  V30 4 Cl 8.4700 2.6673 0.0 0
M  V30 5 O 10.7800 6.6684 0.0 0
M  V30 6 C 11.5500 5.3347 0.0 0
M  V30 7 Cl 0.0000 6.6684 0.0 0
M  V30 8 Cl 3.8500 0.0000 0.0 0
M  V30 9 C 6.1600 6.6684 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 6.9300 8.0021 0.0 0
M  V30 12 N 8.4700 5.3347 0.0 0
M  V30 13 C 8.4700 8.0021 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 C 3.8500 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 1.5400 6.6684 0.0 0
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 4.6200 4.0011 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 3.8500 2.6673 0.0 0
M  V30 26 C 4.6200 1.3336 0.0 0
M  V30 27 C 13.0900 5.3347 0.0 0
M  V30 28 C 13.8600 6.6684 0.0 0
M  V30 29 C 13.8600 4.0011 0.0 0
M  V30 30 C 15.4000 6.6684 0.0 0
M  V30 31 C 15.4000 4.0011 0.0 0
M  V30 32 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 27
M  V30 8 1 7 20
M  V30 9 1 8 26
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 1 10 21
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(benzyloxy)-6-(2,4-dichlorophenyl)-5-(4-chlorophenyl)pyridine-3-ca...
C26H19Cl3N2O2
611219-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 2.6673 0.0 0
M  V30 2 N 8.4702 1.3337 0.0 0
M  V30 3 O 10.7802 2.6673 0.0 0
M  V30 4 C 9.2402 0.0000 0.0 0
M  V30 5 Cl 8.4702 9.3360 0.0 0
M  V30 6 O 10.7802 5.3348 0.0 0
M  V30 7 C 11.5503 6.6685 0.0 0
M  V30 8 Cl 0.0000 5.3348 0.0 0
M  V30 9 Cl 3.8501 12.0033 0.0 0
M  V30 10 C 6.1601 5.3348 0.0 0
M  V30 11 C 6.9302 6.6685 0.0 0
M  V30 12 C 6.9302 4.0012 0.0 0
M  V30 13 N 8.4702 6.6685 0.0 0
M  V30 14 C 8.4702 4.0012 0.0 0
M  V30 15 C 9.2402 5.3348 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 3.8501 6.6685 0.0 0
M  V30 18 C 3.8501 4.0012 0.0 0
M  V30 19 C 2.3101 6.6685 0.0 0
M  V30 20 C 2.3101 4.0012 0.0 0
M  V30 21 C 1.5400 5.3348 0.0 0
M  V30 22 C 6.1601 8.0022 0.0 0
M  V30 23 C 6.9302 9.3360 0.0 0
M  V30 24 C 4.6201 8.0022 0.0 0
M  V30 25 C 6.1601 10.6697 0.0 0
M  V30 26 C 3.8501 9.3360 0.0 0
M  V30 27 C 4.6201 10.6697 0.0 0
M  V30 28 C 13.0903 6.6685 0.0 0
M  V30 29 C 13.8603 8.0022 0.0 0
M  V30 30 C 13.8603 5.3348 0.0 0
M  V30 31 C 15.4003 8.0022 0.0 0
M  V30 32 C 15.4003 5.3348 0.0 0
M  V30 33 C 16.1704 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 28
M  V30 9 1 8 21
M  V30 10 1 9 27
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 1 11 22
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 611219-08-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 611219-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-266522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate preparation also described
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meurer, Laura C.; Finke, Paul E.; Mills, Sander G.; Walsh, Thomas F.;
Toupence, Richard B.; Goulet, Mark T.; Wang, Junying; Tong, Xinchun;
Fong, Tung M.; Lao, Julie; Schaeffer, Marie-Therese; Chen, Jing; Shen,
Chun-Pyn; Sloan Stribling, D.; Shearman, Lauren P.; Strack, Alison M.;
Van der Ploeg, Lex H. T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(3), 645-651

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
exo-5,6-Dehydronorcantharidin
C8H6O4
6118-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6460 2.7105 0.0 0
M  V30 2 O 1.9512 0.0000 0.0 0
M  V30 3 C 3.9952 3.4208 0.0 0 CFG=2
M  V30 4 C 2.6614 2.6508 0.0 0 CFG=1
M  V30 5 C 3.9998 4.9527 0.0 0 CFG=1
M  V30 6 C 5.1395 2.3904 0.0 0
M  V30 7 C 1.3324 3.4128 0.0 0 CFG=2
M  V30 8 C 2.9817 1.1445 0.0 0
M  V30 9 O 2.4301 4.5916 0.0 0
M  V30 10 C 2.6657 5.7235 0.0 0
M  V30 11 O 4.5132 0.9834 0.0 0
M  V30 12 C 1.3319 4.9535 0.0 0
M  V30 13 H 5.4029 4.0451 0.0 0
M  V30 14 H 1.4169 1.7437 0.0 0
M  V30 15 H 5.3347 5.7206 0.0 0
M  V30 16 H 0.0000 2.6406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 14 CFG=3
M  V30 10 1 5 9 CFG=1
M  V30 11 1 5 10
M  V30 12 1 5 15
M  V30 13 1 6 11
M  V30 14 1 7 9 CFG=1
M  V30 15 1 7 12
M  V30 16 1 7 16
M  V30 17 1 8 11
M  V30 18 2 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 5 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,7R,7aS)-3a,4,7,7a-Tetrahydro-2-methyl-4,7-epoxy-1H-isoindole-1,3(...
C9H9NO3
58617-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0608 0.0 0
M  V30 2 O 4.6949 0.3502 0.0 0
M  V30 3 C 1.3628 0.0000 0.0 0
M  V30 4 C 2.6508 3.7710 0.0 0 CFG=2
M  V30 5 C 3.9846 3.0010 0.0 0 CFG=1
M  V30 6 C 2.6462 5.3031 0.0 0 CFG=1
M  V30 7 C 1.5064 2.7406 0.0 0
M  V30 8 C 5.3137 3.7630 0.0 0 CFG=2
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 O 4.2160 4.9419 0.0 0
M  V30 11 C 3.9803 6.0738 0.0 0
M  V30 12 N 2.1328 1.3337 0.0 0
M  V30 13 C 5.3141 5.3038 0.0 0
M  V30 14 H 1.2431 4.3954 0.0 0
M  V30 15 H 5.2291 2.0940 0.0 0
M  V30 16 H 1.3113 6.0709 0.0 0
M  V30 17 H 6.6461 2.9909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 15 CFG=1
M  V30 11 1 6 10 CFG=3
M  V30 12 1 6 11
M  V30 13 1 6 16
M  V30 14 1 7 12
M  V30 15 1 8 10 CFG=3
M  V30 16 1 8 13
M  V30 17 1 8 17
M  V30 18 1 9 12
M  V30 19 2 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6118-51-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58617-31-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41129873
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of hCA I, hCA II, AChE and BChE Inhibitory Properties of
Some Norcantharimide Derivatives; Molecular Docking, SAR and in silico
ADME Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Polat Kose, Leyla; Kose, Aytekin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2024), 9(16), e202400684

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8-ethynyl-6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
C22H17N3O2
612526-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5540 5.7813 0.0 0
M  V30 2 O 12.8133 6.6677 0.0 0
M  V30 3 O 11.6921 4.2475 0.0 0
M  V30 4 C 14.2107 6.0203 0.0 0
M  V30 5 C 15.4699 6.9069 0.0 0
M  V30 6 C 1.5400 6.4966 0.0 0
M  V30 7 C 0.0000 6.4966 0.0 0
M  V30 8 N 7.6828 6.7261 0.0 0
M  V30 9 C 6.1600 6.4966 0.0 0
M  V30 10 C 8.8117 5.6787 0.0 0
M  V30 11 C 8.3302 8.1235 0.0 0
M  V30 12 C 5.3900 5.1630 0.0 0
M  V30 13 C 5.3900 7.8303 0.0 0
M  V30 14 C 10.1568 6.4286 0.0 0
M  V30 15 C 8.6965 4.1431 0.0 0
M  V30 16 N 9.8591 7.9396 0.0 0
M  V30 17 C 5.9526 3.7294 0.0 0
M  V30 18 C 3.8500 5.1630 0.0 0
M  V30 19 C 3.8500 7.8303 0.0 0
M  V30 20 N 7.4242 3.2754 0.0 0
M  V30 21 C 3.0800 6.4966 0.0 0
M  V30 22 C 4.9051 2.6004 0.0 0
M  V30 23 C 5.3590 1.1290 0.0 0
M  V30 24 C 3.4037 2.9432 0.0 0
M  V30 25 C 4.3115 0.0000 0.0 0
M  V30 26 C 2.3562 1.8143 0.0 0
M  V30 27 C 2.8102 0.3427 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 3 6 7
M  V30 7 1 6 21
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 10 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 16
M  V30 20 1 15 20
M  V30 21 2 17 20
M  V30 22 1 17 22
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Ethynyl-N-methyl-6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide
C21H16N4O
1413432-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5542 5.7813 0.0 0
M  V30 2 N 12.8134 6.6677 0.0 0
M  V30 3 O 11.6921 4.2475 0.0 0
M  V30 4 C 14.2108 6.0205 0.0 0
M  V30 5 C 1.5400 6.4966 0.0 0
M  V30 6 C 0.0000 6.4966 0.0 0
M  V30 7 C 6.1600 6.4966 0.0 0
M  V30 8 N 7.6829 6.7261 0.0 0
M  V30 9 C 5.3900 5.1630 0.0 0
M  V30 10 C 5.3900 7.8303 0.0 0
M  V30 11 C 8.8117 5.6787 0.0 0
M  V30 12 C 8.3302 8.1235 0.0 0
M  V30 13 C 5.9527 3.7294 0.0 0
M  V30 14 C 3.8500 5.1630 0.0 0
M  V30 15 C 3.8500 7.8303 0.0 0
M  V30 16 C 10.1568 6.4286 0.0 0
M  V30 17 C 8.6967 4.1431 0.0 0
M  V30 18 N 9.8592 7.9396 0.0 0
M  V30 19 N 7.4243 3.2754 0.0 0
M  V30 20 C 3.0800 6.4966 0.0 0
M  V30 21 C 4.9052 2.6004 0.0 0
M  V30 22 C 3.4039 2.9432 0.0 0
M  V30 23 C 5.3592 1.1290 0.0 0
M  V30 24 C 2.3564 1.8143 0.0 0
M  V30 25 C 4.3117 0.0000 0.0 0
M  V30 26 C 2.8103 0.3427 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 2 11 16
M  V30 16 1 11 17
M  V30 17 2 12 18
M  V30 18 2 13 19
M  V30 19 1 13 21
M  V30 20 1 14 20
M  V30 21 2 15 20
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 612526-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1413432-97-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11755624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Synthesis of Amide Derivatives 15-17 Compound 1
(1 mmol) and methylamine (33% wt solution in ethanol, 2 mL) were
dissolved in CH2Cl2 (2 mL). The resulting suspension was stirred at
45-50° C. for 24 h during which time it became a clear solution. After
removing the solvent and methylamine under reduced pressure, the residue
was purified by a wash column (silica gel, plain CH2Cl2-0.5% MeOH in
CH2Cl2), Compounds 15-17 as white powders.
8-Ethynyl-N-methyl-6-phenyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxamide
(15). Compound 15 (YT-III-31) was prepared in 90% yield from 1 using the
procedure described above. 15: mp: 237-238° C.; 1H NMR (CDCl3) δ
2.97-2.99 (d, 3H, J=5.04 Hz), 3.17 (s, 1H), 4.05-4.09 (d, 1H, J=12.09
Hz), 6.26-6.29 (d, 1H, J=10.71 Hz), 7.08-7.09 (t, 1H), 7.36-7.59 (m, 7H),
7.75-7.78 (dd, 1H, J=1.83 Hz and 1.62 Hz), 7.85 (s, 1H); MS (m/z) 340
(100). HRMS (TOF) Calcd for C21H16N4ONa (M+Na)+363.1222, found: 363.1202.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM GABAergic receptor subtype selective ligands and their uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cook, James M.; Clayton, Terry S.; Jain, Hiteshkumar D.; Rallipalli,
Sundari K.; Johnson, Yun Teng; Yang, Jie; Poe, Michael Ming-Jin;
Namjoshi, Ojas A.; Wang, Zhi-Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120295892 A1 2012-11-22

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-[[(4-methylphenyl)sulfonyl]oxy]-2-[[[(4-methylphe...
C24H31NO8S2
61478-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 8.8083 0.0 0
M  V30 2 O 3.0127 10.2729 0.0 0
M  V30 3 O 2.4582 7.6638 0.0 0
M  V30 4 C 1.5065 10.5931 0.0 0
M  V30 5 C 1.8266 12.0995 0.0 0
M  V30 6 C 0.0000 10.9132 0.0 0
M  V30 7 C 1.1861 9.0868 0.0 0
M  V30 8 C 4.8514 5.7475 0.0 0
M  V30 9 O 5.6214 4.4139 0.0 0
M  V30 10 S 4.8514 3.0800 0.0 0 VAL=6
M  V30 11 O 4.0814 1.7464 0.0 0
M  V30 12 O 3.5177 3.8501 0.0 0
M  V30 13 O 8.8801 9.3749 0.0 0
M  V30 14 S 9.0410 10.9065 0.0 0 VAL=6
M  V30 15 O 9.2020 12.4382 0.0 0
M  V30 16 O 7.5095 11.0675 0.0 0
M  V30 17 C 10.1862 0.0000 0.0 0
M  V30 18 C 15.1674 10.2626 0.0 0
M  V30 19 N 4.9951 8.4882 0.0 0
M  V30 20 C 5.6214 7.0812 0.0 0 CFG=2
M  V30 21 C 6.1395 9.5186 0.0 0
M  V30 22 C 7.1530 7.2421 0.0 0
M  V30 23 C 7.4731 8.7486 0.0 0 CFG=2
M  V30 24 C 6.1850 2.3100 0.0 0
M  V30 25 C 6.1850 0.7700 0.0 0
M  V30 26 C 7.5189 3.0800 0.0 0
M  V30 27 C 7.5189 0.0000 0.0 0
M  V30 28 C 8.8525 2.3100 0.0 0
M  V30 29 C 8.8525 0.7700 0.0 0
M  V30 30 C 10.5726 10.7455 0.0 0
M  V30 31 C 11.4778 11.9914 0.0 0
M  V30 32 C 11.1991 9.3387 0.0 0
M  V30 33 C 13.0094 11.8305 0.0 0
M  V30 34 C 12.7306 9.1776 0.0 0
M  V30 35 C 13.6358 10.4237 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 20 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 2 14 15
M  V30 17 2 14 16
M  V30 18 1 14 30
M  V30 19 1 17 29
M  V30 20 1 18 35
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
C11H20N2O2
244768-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1255 3.6200 0.0 0
M  V30 2 O 7.4592 2.8500 0.0 0
M  V30 3 O 6.1255 5.1600 0.0 0
M  V30 4 C 8.7928 3.6200 0.0 0
M  V30 5 C 9.5628 2.2862 0.0 0
M  V30 6 C 10.1266 4.3900 0.0 0
M  V30 7 C 8.0228 4.9537 0.0 0
M  V30 8 C 0.0000 2.4282 0.0 0
M  V30 9 N 4.7918 2.8500 0.0 0
M  V30 10 C 3.3443 2.5203 0.0 0 CFG=2
M  V30 11 C 3.9145 1.9036 0.0 0
M  V30 12 C 2.5982 0.0000 0.0 0
M  V30 13 C 2.2840 3.4344 0.0 0
M  V30 14 C 2.6670 1.4190 0.0 0 CFG=1
M  V30 15 N 1.5376 2.5175 0.0 0
M  V30 16 H 3.7161 4.0147 0.0 0
M  V30 17 H 1.2343 0.8544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 16 CFG=3
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 14 17 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61478-27-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 244768-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5030615
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-tert-Butoxycarbonyl-5-methyl-2,5-diazabicyclo[2.2.1]heptane (2b). A
solution of pyrrolidine 1a (7.9 g, 15.0 mmol) in toluene (100 ml) and
methylamine (2 g, 65 mmol) in methanol (15 ml) was stirred. The reaction
mixture was maintained at 40°C for 30 days and cooled. Methylamine
tosylate was filtered off. The filtrate was evaporated to dryness and
dissolved in ether (10 ml). A small amount of residue insoluble in ether
was filtered off. Ether was evaporated to give 2b. Oil, yield 2.9 g, 13.7
mmol, 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of substituted 2,5-diazabicyclo[2.2.1]heptanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yakovlev, M. E.; Lobanov, P. S.; Potekhin, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York)(Translation of Khimiya
Geterotsiklicheskikh Soedinenii) (2000), 36(4), 429-431

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrylium, 4-(4-nitrophenyl)-2,6-diphenyl-, tetrafluoroborate(1-) (1:1)
C23H16NO3.BF4
61636-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0031 14.6300 0.0 0 VAL=5
M  V30 2 O 13.3367 13.8600 0.0 0
M  V30 3 O 12.0031 16.1700 0.0 0
M  V30 4 C 6.6684 11.5500 0.0 0
M  V30 5 C 6.6684 10.0100 0.0 0
M  V30 6 C 5.3347 12.3200 0.0 0
M  V30 7 C 5.3347 9.2400 0.0 0
M  V30 8 C 4.0009 11.5500 0.0 0
M  V30 9 O 4.0009 10.0100 0.0 0 CHG=1 VAL=3
M  V30 10 C 8.0020 12.3200 0.0 0
M  V30 11 C 8.0020 13.8600 0.0 0
M  V30 12 C 9.3358 11.5500 0.0 0
M  V30 13 C 9.3358 14.6300 0.0 0
M  V30 14 C 10.6694 12.3200 0.0 0
M  V30 15 C 10.6694 13.8600 0.0 0
M  V30 16 C 5.3347 7.7000 0.0 0
M  V30 17 C 6.6684 6.9300 0.0 0
M  V30 18 C 4.0009 6.9300 0.0 0
M  V30 19 C 6.6684 5.3900 0.0 0
M  V30 20 C 4.0009 5.3900 0.0 0
M  V30 21 C 5.3347 4.6200 0.0 0
M  V30 22 C 2.6673 12.3200 0.0 0
M  V30 23 C 1.3336 11.5500 0.0 0
M  V30 24 C 2.6673 13.8600 0.0 0
M  V30 25 C 0.0000 12.3200 0.0 0
M  V30 26 C 1.3336 14.6300 0.0 0
M  V30 27 C 0.0000 13.8600 0.0 0
M  V30 28 B 6.6684 1.5400 0.0 0 CHG=3 VAL=4
M  V30 29 F 5.1284 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 30 F 8.2084 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 31 F 6.6684 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 32 F 6.6684 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 2 8 9
M  V30 12 1 8 22
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 1-methyl-4-(4-nitrophenyl)-2,6-diphenyl-, tetrafluoroborate(1-) (...
C24H19N2O2.BF4
476682-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 9.2400 0.0 0
M  V30 2 N 12.0031 14.6300 0.0 0 VAL=5
M  V30 3 O 12.0031 16.1700 0.0 0
M  V30 4 O 13.3367 13.8600 0.0 0
M  V30 5 C 4.0009 11.5500 0.0 0
M  V30 6 N 4.0009 10.0100 0.0 0 CHG=1 VAL=4
M  V30 7 C 5.3347 12.3200 0.0 0
M  V30 8 C 5.3347 9.2400 0.0 0
M  V30 9 C 6.6684 11.5500 0.0 0
M  V30 10 C 6.6684 10.0100 0.0 0
M  V30 11 C 2.6673 12.3200 0.0 0
M  V30 12 C 1.3336 11.5500 0.0 0
M  V30 13 C 2.6673 13.8600 0.0 0
M  V30 14 C 0.0000 12.3200 0.0 0
M  V30 15 C 1.3336 14.6300 0.0 0
M  V30 16 C 0.0000 13.8600 0.0 0
M  V30 17 C 5.3347 7.7000 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 4.0009 6.9300 0.0 0
M  V30 20 C 6.6684 5.3900 0.0 0
M  V30 21 C 4.0009 5.3900 0.0 0
M  V30 22 C 5.3347 4.6200 0.0 0
M  V30 23 C 8.0020 12.3200 0.0 0
M  V30 24 C 9.3358 11.5500 0.0 0
M  V30 25 C 8.0020 13.8600 0.0 0
M  V30 26 C 10.6694 12.3200 0.0 0
M  V30 27 C 9.3358 14.6300 0.0 0
M  V30 28 C 10.6694 13.8600 0.0 0
M  V30 29 B 6.6684 1.5400 0.0 0 CHG=3 VAL=4
M  V30 30 F 5.1284 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 31 F 8.2084 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 32 F 6.6684 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 33 F 6.6684 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 28
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 17
M  V30 12 2 9 10
M  V30 13 1 9 23
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 1 29 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61636-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476682-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11394999
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of 2,6-diphenyl-4-arylpyrylium tetrafluoroborate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Shrong Shi; Li, Cheng Yong; Wang, Xuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2002), 13(7), 605-606

$RFMT $RIREG SCHEME369 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phthalaldehyde
C8H6O2
643-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylphenacyl bromide
C9H9BrO
619-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,6-Trimethyl 4a-methoxy-1-(4-methylphenyl)-4aH,13bH-benzo[a]pyrano[4,3-h]q...
C30H27NO8
2624254-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.1261 4.0012 0.0 0
M  V30 2 C 9.6662 4.0012 0.0 0
M  V30 3 C 7.3561 2.6673 0.0 0
M  V30 4 O 6.5861 1.3337 0.0 0
M  V30 5 O 8.8962 2.6673 0.0 0
M  V30 6 C 7.3561 0.0000 0.0 0
M  V30 7 C 4.2761 2.6673 0.0 0
M  V30 8 O 2.7360 2.6673 0.0 0
M  V30 9 O 5.0461 1.3337 0.0 0
M  V30 10 C 1.9660 1.3337 0.0 0
M  V30 11 C 11.2062 6.6685 0.0 0
M  V30 12 O 11.9762 8.0022 0.0 0
M  V30 13 O 11.9762 5.3348 0.0 0
M  V30 14 C 13.5163 8.0022 0.0 0
M  V30 15 C 0.0000 10.2018 0.0 0
M  V30 16 C 7.3561 5.3348 0.0 0
M  V30 17 C 6.5861 6.6685 0.0 0
M  V30 18 C 6.5861 4.0012 0.0 0
M  V30 19 C 8.8962 5.3348 0.0 0
M  V30 20 C 7.3561 8.0022 0.0 0
M  V30 21 C 5.0461 6.6685 0.0 0
M  V30 22 C 5.0461 4.0012 0.0 0
M  V30 23 C 9.6662 6.6685 0.0 0
M  V30 24 N 8.8962 8.0022 0.0 0
M  V30 25 C 6.5861 9.3360 0.0 0
M  V30 26 O 4.2761 5.3348 0.0 0
M  V30 27 C 9.6662 9.3360 0.0 0
M  V30 28 C 7.3561 10.6697 0.0 0
M  V30 29 C 5.0461 9.3360 0.0 0
M  V30 30 C 8.8962 10.6697 0.0 0
M  V30 31 C 6.5861 12.0033 0.0 0
M  V30 32 C 4.2761 10.6697 0.0 0
M  V30 33 C 5.0461 12.0033 0.0 0
M  V30 34 C 3.7846 7.5519 0.0 0
M  V30 35 C 2.3887 6.9010 0.0 0
M  V30 36 C 3.9188 9.0860 0.0 0
M  V30 37 C 1.1273 7.7843 0.0 0
M  V30 38 C 2.6573 9.9694 0.0 0
M  V30 39 C 1.2614 9.3184 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 23
M  V30 14 1 12 14
M  V30 15 1 15 39
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 21 34
M  V30 27 1 22 26
M  V30 28 1 23 24
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 2 25 29
M  V30 32 2 27 30
M  V30 33 1 28 30
M  V30 34 2 28 31
M  V30 35 1 29 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 643-79-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 619-41-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2624254-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28008879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, phosphonium salt prepared in stage 3 was
added in stage 4 to isoquinolinium intermediate prepared in stages 1-2,
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-promoted Green Synthesis of Pyrido[2,1-a]isoquinoline
Derivatives and Studies on their Antioxidant Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharafian, Shirin; Hossaini, Zinatossadat; Rostami-Charati, Faramarz;
Khalilzadeh, Mohammad A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(1),
119-128

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzoic acid
C7H5NO4
62-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzamide
C8H8N2O3
2585-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 62-23-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2585-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1541379
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave, silica gel as dry media
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A rapid and convenient synthesis of amides from aromatic acids and
aliphatic amines in dry media under microwave irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hajipour, Abdol Reza; Ghasemi, Majid
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2001), 40B(6), 504-507

$RFMT $RIREG SCHEME371 STEP1
$RXN



  3  1
$MOL
Ethyl propiolate
C5H6O2
623-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 3 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dimethyl 3-ethoxy-5-(methylamino)-4-oxo-2,5-cyclopentadiene-1,2-dicarboxy...
C12H15NO6
1606129-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3196 2.3100 0.0 0
M  V30 2 O 6.6533 1.5400 0.0 0
M  V30 3 O 3.9860 1.5400 0.0 0
M  V30 4 C 6.6533 0.0000 0.0 0
M  V30 5 C 2.6091 4.2794 0.0 0
M  V30 6 O 1.4647 5.3098 0.0 0
M  V30 7 O 2.2889 2.7729 0.0 0
M  V30 8 C 0.0000 4.8339 0.0 0
M  V30 9 O 8.0302 4.2794 0.0 0
M  V30 10 C 9.1745 5.3098 0.0 0
M  V30 11 C 10.6392 4.8339 0.0 0
M  V30 12 N 3.6444 7.4658 0.0 0
M  V30 13 C 4.2709 8.8726 0.0 0
M  V30 14 O 6.9948 7.4658 0.0 0
M  V30 15 C 5.3196 3.8500 0.0 0
M  V30 16 C 4.0738 4.7552 0.0 0
M  V30 17 C 6.5655 4.7552 0.0 0
M  V30 18 C 4.5496 6.2198 0.0 0
M  V30 19 C 6.0896 6.2198 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 18
M  V30 14 2 14 19
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 623-47-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1606129-21-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25305949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, equimolar ratio of reactants, one-pot
three-component reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 4-oxo-2,5-cyclopentadiene using multi-component reactions of
primary amines and electron deficient acetylenic compounds with
triphenylphosphine in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seyfi, Samereh; Rostami-Charati, Faramarz; Hossaini, Zinatossadat;
Zardoost, Mohammad R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Organic Chemistry (2014), 11(6), 409-412

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloropyridine
C5H4ClN
626-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)pyridine
C6H8N2
18364-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18364-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10305711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1148148-01-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE TWENTY-SIX: Synthesis of N-Methylpyridin-3-amine (Figure 11,
Table 7, entry 3) Following general procedure B, a mixture of
3-chloropyridine (95 μl, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol), NaO
t-Bu (120 mg, 1.2 mmol), BrettPhos precatalyst 10 (8 mg, 0.01 mmol), and
E-BuOH (4 mL) was stirred at room temperature for 2 h. The crude product
was purified via column chromatography (20:1 CH2Cl2/MeOH) to provide the
title compound as a pale yellow liquid (97 mg, 90%). The isolated product
was a 35:1 mixture of mono:diarylation methylamine.
N-Methylpyridin-3-amine, yield (97 mg, 90%) 1H NMR (400 MHz, CDCl3) δ:
8.02 (d, J = 2.9, 1H), 7.95 (dd, J = 4.7, 1.3, 1H), 7.09 (dd, J = 8.3,
4.7, 1H), 6.86 (ddd, J = 8.2, 2.9, 1.3, 1H), 3.79 (bs, 1H), 2.85 (d,
.7=5.1, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ: 145.3, 138.9, 136.0, 123.9,
118.2, 30.5 ppm. Watanabe, T.; Tanaka, Y.; Sekiya, K.; Akita, Y.; Ohta,
A. Synthesis 1980, 39.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligands for transition-metal-catalyzed cross-couplings, and methods of
use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchwald, Stephen L.; Fors, Brett P.; Surry, David S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009076622 A2 2009-06-18

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloropyridine
C5H4ClN
626-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)pyridine
C6H8N2
18364-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18364-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1516634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1070663-78-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1070663-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure A: An oven-dried test tube,
which was equipped with a magnetic stir bar and fitted with a teflon
septum, was charged with 5 (1 mol%) 1 (1 mol%) and K2CO3 (97 mg, 0.7
mmol). The vessel was evacuated and backfilled with argon (this process
was repeated a total of 3 times) and then the aryl mesylate (0.5 mmol),
amine (0.6 mmol), and tert-butanol (6 mL) were added via syringe (aryl
chlorides or amines that were solids at room temperature were added with
the catalyst and base). The solution was heated to 110 °C until the
starting material was completely consumed as monitored by GC. The
reaction mixture was then cooled to room temperature, diluted with ethyl
acetate, washed with water, concentrated in vacuo, and purified via the
Biotage SP4 (silica-packed 25+M cartridge). Procedure C: General
procedure A was used with the following modification: 2M methylamine
solution in THF (1 mL, 2.0 mmol), and t-BuOH (4 mL) were premixed and
added to the reaction vessel. N-Methylpyridin-3-amine. (RT, 1% Pd):
Following general procedure C, a mixture of 3-chloropyridine (95 μL, 1.0
mmol), 2M methylamine (1 mL, 2.0 mmol), NaOt-Bu (120 mg, 1.2 mmol),
BrettPhos precatalyst (8 mg, 0.01 mmol), and t-BuOH (4 mL) was stirred at
room temperature for 2 h. The crude product was purified via column
chromatography (10:1 CH2Cl2/MeOH) to provide the title compound as a pale
yellow liquid (97 mg, 90%). The isolated product was a 35:1 mixture of
mono:diarylation methylamine. 1H NMR (400 MHz, CDCl3) δ: 8.02 (d, J =
2.9, 1H), 7.95 (dd, J = 4.7, 1.3, 1H), 7.09 (dd, J = 8.3, 4.7, 1H), 6.86
(ddd, J = 8.2, 2.9, 1.3, 1H), 3.79 (bs, 1H), 2.85 (d, J = 5.1, 3H) ppm.
13C NMR (75 MHz, CDCl3) δ: 145.3, 138.9, 136.0, 123.9, 118.2, 30.5 ppm.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Active Catalyst for Pd-Catalyzed Amination Reactions:
Cross-Coupling Reactions Using Aryl Mesylates and the Highly Selective
Monoarylation of Primary Amines Using Aryl Chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fors, Brett P.; Watson, Donald A.; Biscoe, Mark R.; Buchwald, Stephen L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(41), 13552-13554

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
2-Bromo-4,5-dimethoxybenzoic acid
C9H9BrO4
6286-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9301 0.0 0
M  V30 4 Br 4.0011 6.9301 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 8 C 8.0022 3.0800 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0011 5.3901 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4,5-dimethoxy-N-methylbenzamide
C10H12BrNO3
82463-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 Br 4.0012 6.9302 0.0 0
M  V30 6 O 4.0012 0.7700 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6286-46-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82463-72-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31664560
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel nucleocapsid protein-targeting phenanthridine inhibitors of
SARS-CoV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yi-Ting; Long, Xin-Yan; Ding, Xiao; Fan, Shi-Rui; Cai, Jie-Yun;
Yang, Bi-Juan; Zhang, Xin-Fang; Luo, Rong-hua; Yang, Lian; Ruan, Ting;
Ren, Juan; Jing, Chen-Xu; Zheng, Yong-Tang; Hao, Xiao-Jiang; Chen,
Duo-Zhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 227113966

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-7-methyl-1H-indole-4-carbo...
C18H27NO3Si
630399-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3080 3.9302 0.0 0
M  V30 2 C 7.6418 4.7002 0.0 0
M  V30 3 O 8.9755 3.9302 0.0 0
M  V30 4 Si 10.3091 4.7002 0.0 0
M  V30 5 C 11.6428 5.4702 0.0 0
M  V30 6 C 9.5391 6.0339 0.0 0
M  V30 7 C 11.0792 3.3665 0.0 0
M  V30 8 C 10.8728 6.8039 0.0 0
M  V30 9 C 12.9766 6.2402 0.0 0
M  V30 10 C 12.4128 4.1365 0.0 0
M  V30 11 C 4.1221 1.4646 0.0 0
M  V30 12 O 3.6462 0.0000 0.0 0
M  V30 13 O 5.6284 1.7849 0.0 0
M  V30 14 C 0.0000 6.0425 0.0 0
M  V30 15 C 3.5675 4.0737 0.0 0
M  V30 16 C 2.5369 5.2183 0.0 0
M  V30 17 C 4.9743 4.7002 0.0 0
M  V30 18 C 3.0915 2.6091 0.0 0
M  V30 19 N 3.3069 6.5519 0.0 0
M  V30 20 C 1.0306 4.8981 0.0 0
M  V30 21 C 4.8134 6.2317 0.0 0
M  V30 22 C 1.5852 2.2890 0.0 0
M  V30 23 C 0.5547 3.4334 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 18
M  V30 14 1 14 20
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 21
M  V30 23 1 20 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-N,7-dimethyl-1H-indole-4-c...
C19H30N2O2Si
630399-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3080 5.0747 0.0 0
M  V30 2 C 7.6418 5.8447 0.0 0
M  V30 3 O 8.9755 5.0747 0.0 0
M  V30 4 Si 10.3091 5.8447 0.0 0
M  V30 5 C 11.6428 6.6148 0.0 0
M  V30 6 C 11.0792 4.5109 0.0 0
M  V30 7 C 9.5391 7.1784 0.0 0
M  V30 8 C 10.8728 7.9484 0.0 0
M  V30 9 C 12.9766 7.3848 0.0 0
M  V30 10 C 12.4128 5.2809 0.0 0
M  V30 11 C 4.1221 2.6091 0.0 0
M  V30 12 N 3.6462 1.1446 0.0 0
M  V30 13 O 5.6284 2.9293 0.0 0
M  V30 14 C 4.6766 0.0000 0.0 0
M  V30 15 C 0.0000 7.1870 0.0 0
M  V30 16 C 3.5675 5.2183 0.0 0
M  V30 17 C 2.5369 6.3628 0.0 0
M  V30 18 C 4.9743 5.8447 0.0 0
M  V30 19 C 3.0915 3.7537 0.0 0
M  V30 20 N 3.3069 7.6965 0.0 0
M  V30 21 C 1.0306 6.0426 0.0 0
M  V30 22 C 4.8134 7.3763 0.0 0
M  V30 23 C 1.5852 3.4335 0.0 0
M  V30 24 C 0.5547 4.5779 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 1 15 21
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 22
M  V30 24 1 21 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 630399-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 630399-72-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12088354
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyranoindole derivatives to treat infection with hepatitis
C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gopalsamy, Ariamala; Collette, Marc S.; Ellingboe, John W.; Laporte,
Matthew G.; Mansour, Tarek S.; Burns, Christopher J.; Park, Kaapjoo;
Condon, Stephen M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003099275 A1 2003-12-04

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
6-Methoxy-2-pyridinemethanol
C7H9NO2
63071-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanamine, 6-methoxy-N-[(6-methoxy-2-pyridinyl)methyl]-N-methyl-
C15H19N3O2
3014416-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 O 14.6708 3.0801 0.0 0
M  V30 6 C 16.0046 2.3101 0.0 0
M  V30 7 O 1.3338 3.0801 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 10.6698 2.3101 0.0 0
M  V30 10 N 12.0035 3.0801 0.0 0
M  V30 11 C 10.6698 0.7700 0.0 0
M  V30 12 C 13.3372 2.3101 0.0 0
M  V30 13 C 12.0035 0.0000 0.0 0
M  V30 14 C 13.3372 0.7700 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 N 4.0012 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 4.0012 0.0000 0.0 0
M  V30 20 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63071-12-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3014416-02-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37225654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Bifunctional Ruthenium Catalyst for Effective Renewable Hydrogen
Production from Biomass-Derived Sorbitol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sahoo, Satabdee Tanaya; Mohanty, Aisa; Sharma, Raju; Rout, Smruti Rekha;
Dandela, Rambabu; Daw, Prosenjit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2023), 42(9), 745-751

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile
C15H10FNO
64169-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2608 3.4387 0.0 0
M  V30 2 N 12.7671 3.7589 0.0 0
M  V30 3 F 0.0000 4.9318 0.0 0
M  V30 4 C 5.3348 1.8517 0.0 0
M  V30 5 C 6.7416 2.4782 0.0 0
M  V30 6 O 5.4957 0.3202 0.0 0
M  V30 7 C 7.7722 1.3337 0.0 0
M  V30 8 C 7.2175 3.9428 0.0 0
M  V30 9 C 7.0022 0.0000 0.0 0
M  V30 10 C 9.2785 1.6538 0.0 0
M  V30 11 C 8.7240 4.2630 0.0 0
M  V30 12 C 9.7544 3.1186 0.0 0
M  V30 13 C 4.0011 2.6217 0.0 0
M  V30 14 C 4.0011 4.1618 0.0 0
M  V30 15 C 2.6673 1.8517 0.0 0
M  V30 16 C 2.6673 4.9318 0.0 0
M  V30 17 C 1.3337 2.6217 0.0 0
M  V30 18 C 1.3337 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Fluorophenyl)-1,3-dihydro-N-methyl-5-isobenzofuranmethanamine
C16H16FNO
2797295-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7042 3.8016 0.0 0
M  V30 2 N 11.4742 2.4680 0.0 0
M  V30 3 C 13.0142 2.4680 0.0 0
M  V30 4 F 0.0000 0.0000 0.0 0
M  V30 5 C 4.5778 4.1218 0.0 0
M  V30 6 C 6.0842 3.8016 0.0 0
M  V30 7 O 4.4169 5.6535 0.0 0
M  V30 8 C 6.8542 5.1353 0.0 0
M  V30 9 C 6.8542 2.4680 0.0 0
M  V30 10 C 5.8237 6.2798 0.0 0
M  V30 11 C 8.3942 5.1353 0.0 0
M  V30 12 C 8.3942 2.4680 0.0 0
M  V30 13 C 9.1642 3.8016 0.0 0
M  V30 14 C 3.4334 3.0914 0.0 0
M  V30 15 C 3.7536 1.5851 0.0 0
M  V30 16 C 1.9687 3.5673 0.0 0
M  V30 17 C 2.6091 0.5546 0.0 0
M  V30 18 C 0.8244 2.5368 0.0 0
M  V30 19 C 1.1445 1.0304 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 64169-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2797295-74-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32794901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 22031-12-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 60871-84-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-catalyzed hydrogenative coupling of nitriles and amines for
general amine synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chandrashekhar, Vishwas G.; Baumann, Wolfgang; Beller, Matthias;
Jagadeesh, Rajenahally V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Science (Washington, DC, United States) (2022), 376(6600), 1433-1441

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [1-(2-amino-2-oxoethyl)-5-(1,3-benzodioxol-5-yl)-2,3-dihydro-2...
C26H22N4O6
645059-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5808 5.7804 0.0 0
M  V30 2 C 8.3508 7.1142 0.0 0
M  V30 3 O 9.8909 7.1142 0.0 0
M  V30 4 O 7.5808 8.4479 0.0 0
M  V30 5 C 10.6609 8.4479 0.0 0
M  V30 6 C 3.5286 2.5489 0.0 0
M  V30 7 C 4.6576 1.5015 0.0 0
M  V30 8 N 6.1291 1.9553 0.0 0
M  V30 9 O 4.3148 0.0000 0.0 0
M  V30 10 O 6.3330 3.1889 0.0 0
M  V30 11 C 3.8713 7.5106 0.0 0
M  V30 12 C 2.6673 6.5504 0.0 0
M  V30 13 N 5.3728 7.1680 0.0 0
M  V30 14 C 2.6673 5.0104 0.0 0
M  V30 15 C 1.3336 7.3204 0.0 0
M  V30 16 C 6.0408 5.7804 0.0 0
M  V30 17 N 3.8713 4.0504 0.0 0
M  V30 18 C 1.3336 4.2404 0.0 0
M  V30 19 C 0.0000 6.5504 0.0 0
M  V30 20 C 5.3728 4.3930 0.0 0
M  V30 21 C 0.0000 5.0104 0.0 0
M  V30 22 C 3.5286 9.0121 0.0 0
M  V30 23 C 2.0570 9.4660 0.0 0
M  V30 24 C 4.6576 10.0595 0.0 0
M  V30 25 C 1.7143 10.9673 0.0 0
M  V30 26 C 4.3148 11.5610 0.0 0
M  V30 27 C 2.8433 12.0148 0.0 0
M  V30 28 O 0.3693 11.7173 0.0 0
M  V30 29 O 2.1959 13.4122 0.0 0
M  V30 30 C 0.6670 13.2284 0.0 0
M  V30 31 C 12.2009 8.4479 0.0 0
M  V30 32 C 12.9709 7.1142 0.0 0
M  V30 33 C 12.9709 9.7815 0.0 0
M  V30 34 C 14.5109 7.1142 0.0 0
M  V30 35 C 14.5109 9.7815 0.0 0
M  V30 36 C 15.2809 8.4479 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 31
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 10 20
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 22
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [5-(1,3-benzodioxol-5-yl)-2,3-dihydro-1-[2-(methylamino)-2-oxo...
C27H24N4O6
645059-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5809 6.8280 0.0 0
M  V30 2 C 8.3509 8.1618 0.0 0
M  V30 3 O 9.8909 8.1618 0.0 0
M  V30 4 O 7.5809 9.4954 0.0 0
M  V30 5 C 10.6609 9.4954 0.0 0
M  V30 6 C 3.5286 3.5964 0.0 0
M  V30 7 C 4.6576 2.5489 0.0 0
M  V30 8 N 4.3148 1.0475 0.0 0
M  V30 9 O 6.1291 3.0029 0.0 0
M  V30 10 C 5.4438 0.0000 0.0 0
M  V30 11 O 6.3330 4.2364 0.0 0
M  V30 12 C 3.8713 8.5582 0.0 0
M  V30 13 C 2.6673 7.5980 0.0 0
M  V30 14 N 5.3728 8.2155 0.0 0
M  V30 15 C 2.6673 6.0580 0.0 0
M  V30 16 C 1.3337 8.3680 0.0 0
M  V30 17 C 6.0409 6.8280 0.0 0
M  V30 18 N 3.8713 5.0978 0.0 0
M  V30 19 C 1.3337 5.2879 0.0 0
M  V30 20 C 0.0000 7.5980 0.0 0
M  V30 21 C 5.3728 5.4406 0.0 0
M  V30 22 C 0.0000 6.0580 0.0 0
M  V30 23 C 3.5286 10.0595 0.0 0
M  V30 24 C 2.0570 10.5135 0.0 0
M  V30 25 C 4.6576 11.1070 0.0 0
M  V30 26 C 1.7143 12.0149 0.0 0
M  V30 27 C 4.3148 12.6084 0.0 0
M  V30 28 C 2.8433 13.0624 0.0 0
M  V30 29 O 0.3693 12.7649 0.0 0
M  V30 30 O 2.1959 14.4598 0.0 0
M  V30 31 C 0.6670 14.2759 0.0 0
M  V30 32 C 12.2009 9.4954 0.0 0
M  V30 33 C 12.9709 8.1618 0.0 0
M  V30 34 C 12.9709 10.8291 0.0 0
M  V30 35 C 14.5109 8.1618 0.0 0
M  V30 36 C 14.5109 10.8291 0.0 0
M  V30 37 C 15.2809 9.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 32
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 21
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 23
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 2 27 28
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 645059-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 645059-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-14300302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM High affinity, bioavailable 3-Amino-1,4-benzodiazepine-Based γ-Secretase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Owens, Andrew P.; Nadin, Alan; Talbot, Adam C.; Clarke, Earl E.;
Harrison, Timothy; Lewis, Huw D.; Reilly, Michael; Wrigley, Jonathan D.
J.; Castro, Jose L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(22), 4143-4145

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tricarbonyl[(5a,6,7,8,9,9a-η)-methyl 7-chloro-2,3-dihydro-2-oxo-1H-1,4-benzod...
C14H9ClCrN2O6
652156-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1969 0.4218 0.0 0
M  V30 2 O 5.6187 0.4218 0.0 0 VAL=3
M  V30 3 C 3.7373 0.4218 0.0 0
M  V30 4 O 3.3154 0.4218 0.0 0 VAL=3
M  V30 5 C 4.4671 0.0000 0.0 0
M  V30 6 O 4.8889 0.0000 0.0 0 VAL=3
M  V30 7 Cl 6.9714 4.1487 0.0 0
M  V30 8 C 4.2137 6.6251 0.0 0
M  V30 9 O 4.5786 6.4147 0.0 0
M  V30 10 O 4.2137 7.0469 0.0 0
M  V30 11 C 4.9435 6.6251 0.0 0
M  V30 12 O 0.0000 6.2067 0.0 0
M  V30 13 Cr 4.4671 0.8425 0.0 0 VAL=9
M  V30 14 C 3.6246 4.8389 0.0 0 VAL=5
M  V30 15 C 2.2730 4.0510 0.0 0 VAL=5
M  V30 16 C 5.1992 4.8389 0.0 0 VAL=5
M  V30 17 C 3.6246 3.2631 0.0 0 VAL=5
M  V30 18 C 6.5495 4.0510 0.0 0 VAL=5
M  V30 19 C 5.1992 3.2631 0.0 0 VAL=5
M  V30 20 C 3.8477 6.4147 0.0 0
M  V30 21 N 0.8100 4.6693 0.0 0
M  V30 22 N 2.7786 7.4269 0.0 0
M  V30 23 C 0.4149 6.1335 0.0 0
M  V30 24 C 1.3155 7.4269 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 13
M  V30 3 3 3 4
M  V30 4 1 3 13
M  V30 5 3 5 6
M  V30 6 1 5 13
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 20
M  V30 11 1 9 11
M  V30 12 2 12 23
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 14 15
M  V30 20 2 14 16
M  V30 21 1 14 20
M  V30 22 2 15 17
M  V30 23 1 15 21
M  V30 24 1 16 18
M  V30 25 1 17 19
M  V30 26 2 18 19
M  V30 27 2 20 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,3-dihydro-7-(methylamino)-2-oxo-1H-1,4-benzodiazepine-5-carboxylate
C12H13N3O3
652156-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1352 2.6005 0.0 0
M  V30 2 O 4.5891 1.1290 0.0 0
M  V30 3 O 2.6339 2.9431 0.0 0
M  V30 4 C 3.5417 0.0000 0.0 0
M  V30 5 N 0.7700 6.4967 0.0 0
M  V30 6 C 0.0000 7.8303 0.0 0
M  V30 7 O 9.4754 6.2413 0.0 0
M  V30 8 C 4.6200 5.1629 0.0 0
M  V30 9 C 5.1827 3.7294 0.0 0
M  V30 10 C 5.3900 6.4967 0.0 0
M  V30 11 C 3.0800 5.1629 0.0 0
M  V30 12 N 6.6542 3.2754 0.0 0
M  V30 13 N 6.9129 6.7261 0.0 0
M  V30 14 C 4.6200 7.8303 0.0 0
M  V30 15 C 2.3100 6.4967 0.0 0
M  V30 16 C 7.9267 4.1429 0.0 0
M  V30 17 C 8.0418 5.6786 0.0 0
M  V30 18 C 3.0800 7.8303 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 652156-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 652156-40-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-478-CAS-15172706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 10139-51-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 91-17-8
$DTYPE RXN:VAR(1):NOTES
$DATUM under Ar
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM η6-Arenetricarbonylchromium(0) Complexes in the Synthesis of
1,4-Benzodiazepines and Its Nucleophilic Substituted Products
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Santra, P. K.; Kishore, D.; Jain, Pratima
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(21), 3695-3706

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Thiabicyclo[3.3.1]nonane, 2,6-dichloro-
C8H12Cl2S
6522-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.4390 0.0 0
M  V30 2 Cl 7.0417 1.5475 0.0 0
M  V30 3 C 1.9282 0.7700 0.0 0
M  V30 4 S 3.0477 2.6069 0.0 0
M  V30 5 C 1.5254 2.2465 0.0 0
M  V30 6 C 3.2619 0.0000 0.0 0
M  V30 7 C 5.1074 3.2275 0.0 0
M  V30 8 C 2.2891 3.5883 0.0 0
M  V30 9 C 4.7466 0.4091 0.0 0
M  V30 10 C 5.5166 1.7428 0.0 0
M  V30 11 C 3.7801 3.9893 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,5R,6R)-N2,N6-Dimethyl-9-thiabicyclo[3.3.1]nonane-2,6-diamine
C10H20N2S
350595-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3327 1.6491 0.0 0
M  V30 2 C 0.0000 2.4184 0.0 0
M  V30 3 N 7.4858 5.1983 0.0 0
M  V30 4 C 8.8169 4.4266 0.0 0
M  V30 5 C 3.8796 1.4850 0.0 0 CFG=1
M  V30 6 C 2.6652 2.4184 0.0 0 CFG=2
M  V30 7 S 3.6606 3.6268 0.0 0
M  V30 8 C 5.4086 1.6780 0.0 0
M  V30 9 C 2.4623 3.9501 0.0 0
M  V30 10 C 4.9273 5.3674 0.0 0 CFG=1
M  V30 11 C 6.3447 2.9024 0.0 0
M  V30 12 C 3.4083 5.1718 0.0 0
M  V30 13 C 6.1517 4.4314 0.0 0 CFG=2
M  V30 14 H 3.4768 0.0000 0.0 0
M  V30 15 H 5.3265 6.8535 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=3
M  V30 3 1 3 4
M  V30 4 1 13 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 1 10 7 CFG=1
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 5 6 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6522-21-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 350595-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8893097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2,6-Dimethylamino-9-thiabicyclo[3.3.1]nonane (2b). A suspension of
sulfide 1 (200 mg, 0.95 mmol) in 4 mL of aqueous methylamine (40% w/w)
was stirred for 16 h at rt. The organic aqueous suspension was extracted
4x with CH2Cl2. Evaporation of the organic layer gave 171 mg (0.86 mmol,
90% yield) of 2b as a colorless liquid.
2,6-Dimethylamino-9-thiabicyclo[3.3.1]nonane (2b), yield 171 mg, 0.86
mmol, 90% 1H NMR (400 MHz, CDCl3) δ 1.48 (bs, 2H), 1.50 (m, 2H), 1.88 (m,
2H), 2.06 (m, 2H), 2.28 (m, 2H), 2.41 (s, 6H), 2.75 (bs, 2H), 3.08 (m,
2H); 13C NMR (100 MHz, CDCl3): δ 26.3, 29.5, 33.4, 34.0, 61.1; HRMS
(MALDI) caled for C10H19N2S [(M-H)+}: 199.1263, found: 199.1264.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: A Privileged, Bivalent Scaffold
for the Display of Nucleophilic Components
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Converso, Antonella; Burow, Kristina; Marzinzik, Andreas; Sharpless, K.
Barry; Finn, M. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(12), 4386-4392

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(1-Methyl-4-phenyl-1H-imidazol-5-yl)-4-(methylsulfonyl)thieno[2,3-d]pyrimidine
C17H14N4O2S2
655253-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2317 0.7103 0.0 0
M  V30 2 S 10.3881 5.4385 0.0 0 VAL=6
M  V30 3 C 11.7218 4.6685 0.0 0
M  V30 4 O 11.1582 6.7721 0.0 0
M  V30 5 O 9.6181 4.1048 0.0 0
M  V30 6 C 5.0989 2.4374 0.0 0
M  V30 7 C 3.5673 2.2765 0.0 0
M  V30 8 N 5.7252 1.0304 0.0 0
M  V30 9 N 3.2472 0.7700 0.0 0
M  V30 10 C 4.5808 0.0000 0.0 0
M  V30 11 C 5.8689 3.7711 0.0 0
M  V30 12 C 7.4005 3.9320 0.0 0
M  V30 13 S 5.2426 5.1781 0.0 0
M  V30 14 C 7.7207 5.4385 0.0 0
M  V30 15 C 6.3870 6.2085 0.0 0
M  V30 16 C 9.0545 6.2085 0.0 0
M  V30 17 N 6.3870 7.7485 0.0 0
M  V30 18 N 9.0545 7.7485 0.0 0
M  V30 19 C 7.7207 8.5185 0.0 0
M  V30 20 C 2.5369 3.4209 0.0 0
M  V30 21 C 3.0128 4.8856 0.0 0
M  V30 22 C 1.0304 3.1007 0.0 0
M  V30 23 C 1.9822 6.0300 0.0 0
M  V30 24 C 0.0000 4.2451 0.0 0
M  V30 25 C 0.4759 5.7098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 2 5
M  V30 5 1 2 16
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 20
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-d]pyrimidin-4-amine, N-methyl-6-(1-methyl-4-phenyl-1H-imidazol-5-yl)-
C17H15N5S
655253-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2316 0.7103 0.0 0
M  V30 2 N 10.3880 5.4384 0.0 0
M  V30 3 C 11.7217 6.2084 0.0 0
M  V30 4 C 5.8688 3.7710 0.0 0
M  V30 5 C 7.4004 3.9320 0.0 0
M  V30 6 S 5.2425 5.1780 0.0 0
M  V30 7 C 7.7206 5.4384 0.0 0
M  V30 8 C 6.3869 6.2084 0.0 0
M  V30 9 C 9.0544 6.2084 0.0 0
M  V30 10 N 6.3869 7.7484 0.0 0
M  V30 11 N 9.0544 7.7484 0.0 0
M  V30 12 C 7.7206 8.5184 0.0 0
M  V30 13 C 5.0988 2.4374 0.0 0
M  V30 14 C 3.5673 2.2765 0.0 0
M  V30 15 N 5.7252 1.0304 0.0 0
M  V30 16 N 3.2471 0.7700 0.0 0
M  V30 17 C 4.5808 0.0000 0.0 0
M  V30 18 C 2.5369 3.4208 0.0 0
M  V30 19 C 1.0304 3.1007 0.0 0
M  V30 20 C 3.0127 4.8855 0.0 0
M  V30 21 C 0.0000 4.2451 0.0 0
M  V30 22 C 1.9822 6.0299 0.0 0
M  V30 23 C 0.4759 5.7098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 655253-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 655253-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1591655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of condensed pyridines and pyrimidines as Tie2 receptor
tyrosine kinase inhibitors and their anti-angiogenic effect
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luke, Richard William Arthur; Jones, Clifford David; McCoull, William;
Hayter, Barry Raymond
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004013141 A1 2004-02-12

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
β-D-Glucopyranosyl isocyanide, 2,3,4,6-tetraacetate
C15H19NO9
66118-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8500 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 O 4.0011 0.0000 0.0 0
M  V30 9 O 2.6673 6.9300 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 C 4.0011 9.2400 0.0 0
M  V30 12 O 1.3336 9.2400 0.0 0
M  V30 13 C 8.0020 3.8500 0.0 0
M  V30 14 O 9.3358 4.6200 0.0 0
M  V30 15 C 10.6694 3.8500 0.0 0
M  V30 16 C 10.6694 2.3100 0.0 0
M  V30 17 O 12.0031 4.6200 0.0 0
M  V30 18 N 5.3347 8.4700 0.0 0 CHG=1 VAL=4
M  V30 19 C 5.3347 10.0100 0.0 0 CHG=-1
M  V30 20 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 21 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 22 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 23 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 24 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 25 O 6.6684 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 20 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 22 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 23 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 3 18 19
M  V30 19 1 24 18 CFG=3
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)urea
C16H24N2O10
37793-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 7.7002 0.0 0
M  V30 2 C 2.6673 9.2402 0.0 0
M  V30 3 C 4.0012 10.0102 0.0 0
M  V30 4 O 1.3337 10.0102 0.0 0
M  V30 5 O 5.3348 9.2402 0.0 0
M  V30 6 C 6.6685 10.0102 0.0 0
M  V30 7 C 6.6685 11.5503 0.0 0
M  V30 8 O 8.0022 9.2402 0.0 0
M  V30 9 O 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 N 8.0022 7.7002 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 N 10.6697 7.7002 0.0 0
M  V30 16 O 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 O 6.6685 2.3101 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 8.0022 0.0000 0.0 0
M  V30 22 O 5.3348 0.0000 0.0 0
M  V30 23 C 4.0012 6.9302 0.0 0 CFG=1
M  V30 24 C 5.3348 7.7002 0.0 0 CFG=1
M  V30 25 C 4.0012 5.3901 0.0 0 CFG=2
M  V30 26 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 27 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 28 O 6.6685 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 24 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 25 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 26 13 CFG=3
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 27 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66118-22-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 37793-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26674517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-59-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, molecular sieves used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protecting group free synthesis of urea-linked glycoconjugates: efficient
synthesis of β-urea glycosides in aqueous solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ichikawa, Yoshiyasu; Minami, Takahiro; Kusaba, Shohei; Saeki, Nobuyoshi;
Tonegawa, Yuta; Tomita, Yumiko; Nakano, Keiji; Kotsuki, Hiyoshizo;
Masuda, Toshiya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(23), 3924-3931

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
α-D-Glucopyranosyl isocyanide, 2,3,4,6-tetraacetate
C15H19NO9
66118-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8500 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 4.0011 0.0000 0.0 0
M  V30 8 O 2.6673 2.3100 0.0 0
M  V30 9 O 2.6673 6.9300 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 C 4.0011 9.2400 0.0 0
M  V30 12 O 1.3336 9.2400 0.0 0
M  V30 13 C 8.0020 3.8500 0.0 0
M  V30 14 O 9.3358 4.6200 0.0 0
M  V30 15 C 10.6694 3.8500 0.0 0
M  V30 16 C 10.6694 2.3100 0.0 0
M  V30 17 O 12.0031 4.6200 0.0 0
M  V30 18 N 5.3347 8.4700 0.0 0 CHG=1 VAL=4
M  V30 19 C 5.3347 10.0100 0.0 0 CHG=-1
M  V30 20 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 21 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 22 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 23 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 24 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 25 O 6.6684 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 20 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 22 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 23 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 3 18 19
M  V30 19 1 24 18 CFG=1
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 20 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-(2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl)urea
C16H24N2O10
1327280-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 7.7002 0.0 0
M  V30 2 C 2.6673 9.2402 0.0 0
M  V30 3 C 4.0012 10.0102 0.0 0
M  V30 4 O 1.3337 10.0102 0.0 0
M  V30 5 O 5.3348 9.2402 0.0 0
M  V30 6 C 6.6685 10.0102 0.0 0
M  V30 7 C 6.6685 11.5503 0.0 0
M  V30 8 O 8.0022 9.2402 0.0 0
M  V30 9 O 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 N 8.0022 7.7002 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 N 10.6697 7.7002 0.0 0
M  V30 16 O 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 O 6.6685 2.3101 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 8.0022 0.0000 0.0 0
M  V30 22 O 5.3348 0.0000 0.0 0
M  V30 23 C 4.0012 6.9302 0.0 0 CFG=1
M  V30 24 C 5.3348 7.7002 0.0 0 CFG=1
M  V30 25 C 4.0012 5.3901 0.0 0 CFG=2
M  V30 26 C 6.6685 6.9302 0.0 0 CFG=1
M  V30 27 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 28 O 6.6685 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 24 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 25 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 26 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 27 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66118-23-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1327280-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25741800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 694-59-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protecting group free synthesis of urea-linked glycoconjugates: efficient
synthesis of β-urea glycosides in aqueous solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ichikawa, Yoshiyasu; Minami, Takahiro; Kusaba, Shohei; Saeki, Nobuyoshi;
Tonegawa, Yuta; Tomita, Yumiko; Nakano, Keiji; Kotsuki, Hiyoshizo;
Masuda, Toshiya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(23), 3924-3931

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitro-1,8-naphthalic anhydride
C12H5NO5
6642-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 4.6201 0.0 0 VAL=5
M  V30 2 O 9.3359 3.8500 0.0 0
M  V30 3 O 8.0022 6.1601 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 6.6684 3.8500 0.0 0
M  V30 11 C 5.3348 6.1601 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 15 C 2.6675 6.1601 0.0 0
M  V30 16 C 6.6684 2.3100 0.0 0
M  V30 17 C 4.0011 6.9301 0.0 0
M  V30 18 O 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 13
M  V30 5 2 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 2 9 15
M  V30 15 2 10 16
M  V30 16 2 11 17
M  V30 17 1 12 16
M  V30 18 1 13 18
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-6-nitro-1H-benz[de]isoquinoline-1,3(2H)-dione
C13H8N2O4
39061-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 4.6201 0.0 0 VAL=5
M  V30 2 O 8.0023 6.1601 0.0 0
M  V30 3 O 9.3360 3.8501 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 4.0012 6.9302 0.0 0
M  V30 19 N 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 13
M  V30 5 2 5 15
M  V30 6 1 6 19
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 17
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6642-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 39061-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-13340675
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 2.1. General procedure for the preparation of
naphthalimide derivatives. Ultrasound irradiation: A mixture of 0.03 mol
4-nitro-1,8-naphthalimide and 0.03 mol amine in 10 mL water was sonicated
at 35 KHz in a sonic bath maintained at 25 °C. Thin-layer chromatography
(TLC) was performed at the end of the reaction, and then the contents
were filtered, and recrystallized in ethanol.
4-Nitro-N-methyl-1,8-naphthalimides (2a), Yield: 90%, Time: 35 minutes.
Mp 210-211 °C, Lit. 211.02 °C, FTIR (KBr) νmax (cm-1): C-H str. Ar.
3079.24, C═O str. 1671.6, 1707, C═C str. 1583.86, NO2 str. 1351.55,
1524.99, 1H NMR (CDCl3) δ: 3.58 (3H, NCH3), 7.98 (1H, 6-H), 8.40 (1H,
5-H), 8.69 (1H, 7-H), 8.73 (1H, 2-H), 8.83 (1H, 3-H), 13 CNMR (CDCl3) δ:
219.16, 218.71 (C═O ketone), 139.83, 1339.30, 134.23, 130.92, 128.38,
119.29, 119.09, 109.29 (Ar), 26.66 (Aliphatic), Anal. Calcd. (%): C =
60.94, H = 3.13, N = 10.93, Found (%): C = 61, H = 3.3, N = 10.8.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound (35 kHz), alternative reaction conditions
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 4-nitro-N-substituted-1,8-naphthalimide derivatives
using ultrasound in aqueous media
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rouhani, Shohre; Gharanjig, Kamaladin; Nezhad, Mozhgan Hossein
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry Letters and Reviews (2014), 7(2), 174-178, 6 pp.

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-6-methyl-2-pyrone
C6H6O3
675-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6200 0.0 0
M  V30 2 C 5.3349 4.6200 0.0 0
M  V30 3 O 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 1.3338 2.3100 0.0 0
M  V30 8 O 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-1,6-dimethyl-2(1H)-pyridinone
C7H9NO2
6052-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 5.3349 0.0 0
M  V30 4 O 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 2 3 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 675-10-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6052-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33625699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaromatic compounds as inhibitors of Mycobacterium tuberculosis
lipoamide dehydrogenase and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ginn, John; Sun, Shan; Michino, Mayako; Liverton, Nigel; Liang, Rui;
Meinke, Peter T.; Huggins, David; Bryk, Ruslana; Nathan, Carl F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022150574 A1 2022-07-14

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-2,3-dihydro-1,4-dioxino[2,3-g]quinoline-8-methanol
C12H10ClNO3
681441-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 2.6674 0.0 0
M  V30 2 O 10.0100 4.0011 0.0 0
M  V30 3 Cl 7.7000 0.0000 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 N 5.3900 1.3338 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 6.9300 1.3338 0.0 0
M  V30 14 O 2.3100 6.6685 0.0 0
M  V30 15 O 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-7-(methylamino)-1,4-dioxino[2,3-g]quinoline-8-methanol
C13H14N2O3
681441-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 1.3336 0.0 0
M  V30 2 O 6.9300 0.0000 0.0 0
M  V30 3 N 9.2400 4.0011 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 4.6200 6.6685 0.0 0
M  V30 10 N 6.9300 5.3347 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 O 0.7700 5.3347 0.0 0
M  V30 16 O 2.3100 8.0021 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 681441-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 681441-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12516133
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vazquez, M. T.; Romero, M.; Pujol, M. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(5), 949-956

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3R)-1-(2,3-dihydro-5-benzofuranyl)-2,3,4,9-tetrahydro-2-(1-oxo-2-p...
C24H22N2O4
691871-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 C 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=2
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 C 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=3
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3R)-1-(2,3-dihydro-5-benzofuranyl)-2,3,4,9-tetrahydro-2-[3-(methyl...
C25H27N3O4
691871-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.5288 6.2873 0.0 0
M  V30 2 C 9.8627 7.0573 0.0 0
M  V30 3 O 8.5288 4.7473 0.0 0
M  V30 4 C 11.1963 6.2873 0.0 0
M  V30 5 N 12.5300 7.0573 0.0 0
M  V30 6 C 13.8636 6.2873 0.0 0
M  V30 7 C 8.5288 9.3674 0.0 0
M  V30 8 O 8.5288 10.9074 0.0 0
M  V30 9 O 9.8627 8.5974 0.0 0
M  V30 10 C 9.8627 11.6774 0.0 0
M  V30 11 C 5.8615 6.2873 0.0 0 CFG=2
M  V30 12 C 4.5278 7.0573 0.0 0
M  V30 13 N 7.1952 7.0573 0.0 0
M  V30 14 C 4.5278 8.5974 0.0 0
M  V30 15 N 3.0631 6.5815 0.0 0
M  V30 16 C 7.1952 8.5974 0.0 0 CFG=1
M  V30 17 C 3.0631 9.0734 0.0 0
M  V30 18 C 5.8615 9.3674 0.0 0
M  V30 19 C 2.1579 7.8274 0.0 0
M  V30 20 C 2.4368 10.4802 0.0 0
M  V30 21 C 0.6263 7.9884 0.0 0
M  V30 22 C 0.9051 10.6411 0.0 0
M  V30 23 C 0.0000 9.3953 0.0 0
M  V30 24 C 5.8615 4.7473 0.0 0
M  V30 25 C 4.5278 3.9773 0.0 0
M  V30 26 C 7.1952 3.9773 0.0 0
M  V30 27 C 4.5278 2.4372 0.0 0
M  V30 28 C 7.1952 2.4372 0.0 0
M  V30 29 C 5.8615 1.6672 0.0 0
M  V30 30 C 3.3833 1.4068 0.0 0
M  V30 31 O 5.5413 0.1609 0.0 0
M  V30 32 C 4.0098 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 24 CFG=1
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 2 28 29
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 691871-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 691871-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10941293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Weiqin; Alford, Vernon C.; Qiu, Yuhong; Bhattacharjee, Sheela;
John, T. Matthew; Haynes-Johnson, Donna; Kraft, Patricia J.; Lundeen,
Scott G.; Sui, Zhihua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(6), 1505-1515

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-chlorobenzene
C6H4BrCl
694-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 2.6673 0.0 0
M  V30 2 Cl 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylbenzenamine
C7H8ClN
932-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 694-80-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 932-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4222976
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, alternative preparation shown, oxime
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-6-bromopyrazine-2-carboxylate
C6H6BrN3O2
6966-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-bromo-N-methyl-2-pyrazinecarboxamide
C6H7BrN4O
146940-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6966-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146940-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6531957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 2 :
5-(4-(ethylsulfonyl)piperazin-1-yl)-3-(1-methyl-1H-benzordlimidazol-2-yl)pyrazin-2-amine
(Compound 1-15) METHOD B: Step 1 :
3-amino-6-bromo-N-methylpyrazine-2-carboxamide [00261] Methyl
3-amino-6-bromo-pyrazine-2-carboxylate (7.5 g, 32.32 mmol) was suspended
in 40% aqueous methylamine and the resulting mixture stirred vigorously
at RT for 4 hours. The resultant precipitate was collected, washed with
water and dried to give the desired product (6.73g, 90% Yield). 1H NMR
(400.0MHz, DMSO) d 2.76 (s, 3H), 7.75 (br s, 2H), 8.34 (s, 1H), 8.58 (b
rs, 1H) ppm; MS (ES+) 232.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazine compounds as inhibitors of ATR kinase for use in
treating disease and as biological tools
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charrier, Jean-Damien; Durrant, Steven; Kay, David; O'Donnell, Michael;
Knegtel, Ronald; Maccormick, Somhairle; Pinder, Joanne; Virani, Anisa;
Young, Stephen; Binch, Hayley; Cleveland, Thomas; Fanning, Lev T. D.;
Hurley, Dennis; Joshi, Pramod; Sheth, Urvi; Silina, Alina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010054398 A1 2010-05-14

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-6-bromopyrazine-2-carboxylate
C6H6BrN3O2
6966-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-bromo-N-methyl-2-pyrazinecarboxamide
C6H7BrN4O
146940-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6966-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146940-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8247451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First synthesis of piperazine-derived [1,2,4]triazolo[1,5-a]pyrazine as
an adenosine A2A receptor antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peng, Hairuo; Sha, Li; Chang, He Xi; Vessels, Jeffery T.; Haque, Serajul;
Conlon, Patrick R.; Dowling, James E.; Wang, Joy; Engber, Thomas M.;
Kumaravel, Gnanasambandam; Scott, Daniel M.; Petter, Russell C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2005), 65(10), 2321-2327

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-amino-6-bromopyrazine-2-carboxylate
C6H6BrN3O2
6966-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-6-bromo-N-methyl-2-pyrazinecarboxamide
C6H7BrN4O
146940-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 N 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 N 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6966-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146940-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8317412
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (b) 3-Amino-6-bromo-pyrazine-2-carboxylicacid methylamide Methyl
3-amino-6-bromo-2-pyrazine-carboxylate (14.3 g, 61.6 mmol; see Example 16
(a) above) was suspended in 40 % aqueous methylamine (3 50 mL) and the
resulting mixture was stirred vigorously for 7 hours at room temperature.
The precipitate was collected, washed with water, and dried to afford
3-amino-6-bromopyrazine- 2- carboxylic acid methylamide as a yellow solid
(12.7 g, 90 %). 3-Amino-6-bromo-pyrazine-2-carboxylicacid methylamide,
Yield (12.7 g, 90 %). 1H NMR (300 MHz, DMSO-d6) δ 2.77 (d, J= 3 Hz, 3 H),
7.70 (br s, 2 H), 8.33 (s, 1 H), 8.56 (q, J= 3 Hz, 1 H); 13C NMR (100
MHz, DMSO-d6) δ 27.84, 123.49, 127.69, 150.43, 156.04, 167.18.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolopyrazines as A2a adenosine receptor antagonists
for the treatment of Parkinson's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dowling, James; Yao, Gang; Chang, Hexi; Peng, Hairuo; Vessels, Jeffrey;
Petter, Russell C.; Kumaravel, Gnanasambandam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004092177 A1 2004-10-28

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-3-methylbenzo[b]thiophene-2-carboxaldehyde
C10H7FOS
698367-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5604 0.0000 0.0 0
M  V30 2 C 7.6210 1.3627 0.0 0
M  V30 3 O 8.9548 2.1327 0.0 0
M  V30 4 F 0.0000 3.9844 0.0 0
M  V30 5 C 3.8500 2.6508 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 4.8806 1.5064 0.0 0
M  V30 8 C 2.3100 2.6508 0.0 0
M  V30 9 S 6.1264 3.6643 0.0 0
M  V30 10 C 3.8500 5.3182 0.0 0
M  V30 11 C 6.2874 2.1327 0.0 0
M  V30 12 C 1.5400 3.9844 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(5-Fluoro-3-methylbenzo[b]thiophen-2-yl)methyl]methylamine
C11H12FNS
709649-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5602 0.0000 0.0 0
M  V30 2 C 7.6210 1.3627 0.0 0
M  V30 3 N 8.9548 2.1327 0.0 0
M  V30 4 C 10.2884 1.3627 0.0 0
M  V30 5 F 0.0000 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 4.6200 3.9844 0.0 0
M  V30 8 C 4.8806 1.5064 0.0 0
M  V30 9 C 2.3100 2.6508 0.0 0
M  V30 10 S 6.1264 3.6643 0.0 0
M  V30 11 C 3.8500 5.3182 0.0 0
M  V30 12 C 6.2874 2.1327 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 14 C 2.3100 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 698367-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14418806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) (5-Fluoro-3-methyl-benzo[b]thiophen-2-ylmethyl)methylamine [0824] To
5-fluoro-3-methyl-benzo[b]thiophene-2-carbaldehyde (5.43 g, 28.0 mmol)
was added a solution of 2 M methylamine in methanol (94 mL) and the
resulting mixture was stirred overnight at room temperature. The mixture
was concentrated under reduced pressure and the residue taken up in
ethanol (90 mL). The solution was cooled to 0° C. and then NaBH4 (1.06 g,
28.0 mmol) was added in one portion. The mixture was stirred 4 hr, after
which time NaBH4 (0.54 g, 14.0 mmol) was added and the mixture was
stirred overnight. The mixture was concentrated under reduced pressure
and the residue combined with 1 M NaOH (200 mL). The mixture was
extracted with diethyl ether (3×150 mL) and the combined organics were
washed with brine (100 mL), dried over Na2SO4, filtered and concentrated
under reduced pressure to the title compound (5.26 g, 90%) as a pale
yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.71 (dd, J=9.0, 4.8 Hz, 1H), 7.27
(dd, J=9.3, 2.6 Hz, 1H), 7.09-7.04 (m, 1H), 4.00 (s, 2H), 2.51 (s, 3H),
2.31 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of reagent in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-3-methylbenzo[b]thiophene-2-carboxaldehyde
C10H7FOS
698367-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5604 0.0000 0.0 0
M  V30 2 C 7.6210 1.3627 0.0 0
M  V30 3 O 8.9548 2.1327 0.0 0
M  V30 4 F 0.0000 3.9844 0.0 0
M  V30 5 C 3.8500 2.6508 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 4.8806 1.5064 0.0 0
M  V30 8 C 2.3100 2.6508 0.0 0
M  V30 9 S 6.1264 3.6643 0.0 0
M  V30 10 C 3.8500 5.3182 0.0 0
M  V30 11 C 6.2874 2.1327 0.0 0
M  V30 12 C 1.5400 3.9844 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(5-Fluoro-3-methylbenzo[b]thiophen-2-yl)methyl]methylamine
C11H12FNS
709649-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5602 0.0000 0.0 0
M  V30 2 C 7.6210 1.3627 0.0 0
M  V30 3 N 8.9548 2.1327 0.0 0
M  V30 4 C 10.2884 1.3627 0.0 0
M  V30 5 F 0.0000 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 4.6200 3.9844 0.0 0
M  V30 8 C 4.8806 1.5064 0.0 0
M  V30 9 C 2.3100 2.6508 0.0 0
M  V30 10 S 6.1264 3.6643 0.0 0
M  V30 11 C 3.8500 5.3182 0.0 0
M  V30 12 C 6.2874 2.1327 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 14 C 2.3100 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 698367-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13280573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of reagent in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-3-methylbenzo[b]thiophene-2-carboxaldehyde
C10H7FOS
698367-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5604 0.0000 0.0 0
M  V30 2 C 7.6210 1.3627 0.0 0
M  V30 3 O 8.9548 2.1327 0.0 0
M  V30 4 F 0.0000 3.9844 0.0 0
M  V30 5 C 3.8500 2.6508 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 4.8806 1.5064 0.0 0
M  V30 8 C 2.3100 2.6508 0.0 0
M  V30 9 S 6.1264 3.6643 0.0 0
M  V30 10 C 3.8500 5.3182 0.0 0
M  V30 11 C 6.2874 2.1327 0.0 0
M  V30 12 C 1.5400 3.9844 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(5-Fluoro-3-methylbenzo[b]thiophen-2-yl)methyl]methylamine
C11H12FNS
709649-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5602 0.0000 0.0 0
M  V30 2 C 7.6210 1.3627 0.0 0
M  V30 3 N 8.9548 2.1327 0.0 0
M  V30 4 C 10.2884 1.3627 0.0 0
M  V30 5 F 0.0000 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 4.6200 3.9844 0.0 0
M  V30 8 C 4.8806 1.5064 0.0 0
M  V30 9 C 2.3100 2.6508 0.0 0
M  V30 10 S 6.1264 3.6643 0.0 0
M  V30 11 C 3.8500 5.3182 0.0 0
M  V30 12 C 6.2874 2.1327 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 14 C 2.3100 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 698367-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3596002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) (5-Fluoro-3-methyl-benzo[b]thiophen-2-ylmethyl)methylamine To
5-fluoro-3-methyl-benzo[b]thiophene-2-carbaldehyde (5.43 g, 28.0 mmol)
was added a solution of 2 M methylamine in methanol (94 mL) and the
resulting mixture was stirred overnight at room temperature. The mixture
was concentrated under reduced pressure and the residue taken up in
ethanol (90 mL). The solution was cooled to 0 °C and then NaBH4 (1.06 g,
28.0 mmol) was added in one portion. The mixture was stirred 4 hr, after
which time NaBH4 (0.54 g, 14.0 mmol) was added and the mixture was
stirred overnight. The mixture was concentrated under reduced pressure
and the residue combined with 1 M NaOH (200 mL). The mixture was
extracted with diethyl ether (3 x 150 mL) and the combined organics were
washed with brine (100 mL), dried over Na2SO4, filtered and concentrated
under reduced pressure to the title compound as a pale yellow oil.
(5-Fluoro-3-methyl-benzo[b]thiophen-2-ylmethyl)methylamine, yield 5.26 g,
90%. 1H NMR (300 MHz, CDCl3) δ 7.71 (dd, J = 9.0,4.8 Hz, 1H), 7.27 (dd, J
= 9.3, 2.6 Hz, 1H), 7.09-7.04 (m, 1H), 4.00 (s, 2H), 2.51 (s, 3H), 2.31
(s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of NaBH4 in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME390 STEP1
$RXN



  3  1
$MOL
Phenacyl bromide
C8H7BrO
70-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethyl 1-methyl-5-phenyl-1H-pyrrole-2,3-dicarboxylate
C15H15NO4
1234371-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 5.5543 0.0 0
M  V30 2 O 8.5963 6.9611 0.0 0
M  V30 3 O 8.8752 4.3085 0.0 0
M  V30 4 C 10.1280 7.1222 0.0 0
M  V30 5 C 6.2947 2.6528 0.0 0
M  V30 6 O 5.3895 1.4069 0.0 0
M  V30 7 O 7.8263 2.4919 0.0 0
M  V30 8 C 6.0160 0.0000 0.0 0
M  V30 9 C 5.7282 8.0442 0.0 0
M  V30 10 C 6.4384 5.3934 0.0 0
M  V30 11 C 5.6684 4.0596 0.0 0
M  V30 12 N 5.4080 6.5378 0.0 0
M  V30 13 C 4.1620 4.3798 0.0 0
M  V30 14 C 4.0011 5.9114 0.0 0
M  V30 15 C 2.6674 6.6814 0.0 0
M  V30 16 C 1.3338 5.9114 0.0 0
M  V30 17 C 2.6674 8.2214 0.0 0
M  V30 18 C 0.0000 6.6814 0.0 0
M  V30 19 C 1.3338 8.9914 0.0 0
M  V30 20 C 0.0000 8.2214 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 9 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 70-11-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1234371-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9729027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 174501-65-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ionic liquid used as both catalyst and solvent, reusable
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic liquid-promoted multicomponent reaction. A good strategy for the
eco-compatible synthesis of functionalized pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siddiqui, I. R.; Kumar, Devesh; Shamim, Shayna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2013), 50(S1), E111-E115

$RFMT $RIREG SCHEME391 STEP1
$RXN



  3  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-L-alanyl-L-serine methyl ester
C12H22N2O6
71017-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3101 0.0 0 CFG=1
M  V30 2 N 9.3358 3.0801 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 C 10.6697 0.7700 0.0 0
M  V30 5 C 8.0022 2.3101 0.0 0
M  V30 6 O 13.3370 2.3101 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 O 12.0033 0.0000 0.0 0
M  V30 9 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 10 O 8.0022 0.7700 0.0 0
M  V30 11 C 14.6707 3.0801 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 4.0010 3.0801 0.0 0
M  V30 15 O 2.6673 2.3101 0.0 0
M  V30 16 O 4.0010 4.6201 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.1037 4.4137 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 20 C 0.5637 1.7464 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 9 12
M  V30 12 1 9 13 CFG=1
M  V30 13 1 12 14
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenyl chloroformate
C7H4ClNO4
7693-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 Cl 8.0023 2.3101 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (4S)-3-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxopropyl]-1-me...
C14H23N3O6
2306235-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8691 5.3026 0.0 0
M  V30 2 C 7.4091 5.3026 0.0 0 CFG=2
M  V30 3 O 5.0991 6.6363 0.0 0
M  V30 4 N 8.1791 6.6363 0.0 0
M  V30 5 C 8.1791 3.9690 0.0 0
M  V30 6 C 9.7192 6.6363 0.0 0
M  V30 7 O 10.4892 7.9700 0.0 0
M  V30 8 O 10.4892 5.3026 0.0 0
M  V30 9 C 12.0292 7.9700 0.0 0
M  V30 10 C 12.0292 9.5100 0.0 0
M  V30 11 C 13.5692 7.9700 0.0 0
M  V30 12 C 12.0292 6.4299 0.0 0
M  V30 13 C 2.5369 4.9524 0.0 0
M  V30 14 O 1.0306 4.6323 0.0 0
M  V30 15 O 3.0128 6.4170 0.0 0
M  V30 16 C 0.0000 5.7767 0.0 0
M  V30 17 O 7.2317 2.2418 0.0 0
M  V30 18 C 4.7419 0.0000 0.0 0
M  V30 19 N 5.0991 3.9690 0.0 0
M  V30 20 C 3.5673 3.8079 0.0 0 CFG=2
M  V30 21 C 5.7254 2.5620 0.0 0
M  V30 22 C 3.2472 2.3016 0.0 0
M  V30 23 N 4.5810 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 20 13 CFG=1
M  V30 16 1 14 16
M  V30 17 2 17 21
M  V30 18 1 18 23
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 71017-97-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7693-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2306235-83-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-20024588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 288-32-4
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM In-peptide synthesis of imidazolidin-2-one scaffolds, equippable with
proteinogenic or taggable/linkable side chains, general promoters of
unusual secondary structures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Marco, Rossella; Zhao, Junwei; Greco, Arianna; Ioannone, Simone;
Gentilucci, Luca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2019), 84(9), 4992-5004

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-(Hydroxymethyl)-9-anthracenecarboxaldehyde
C16H12O2
71774-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 5.3900 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 C 6.6685 2.3100 0.0 0
M  V30 4 O 8.0021 3.0800 0.0 0
M  V30 5 C 4.0011 5.3900 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 6.9300 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 6.6685 5.3900 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 5.3347 7.7000 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6685 6.9300 0.0 0
M  V30 15 C 1.3336 2.3100 0.0 0
M  V30 16 C 4.0011 0.7700 0.0 0
M  V30 17 C 1.3336 0.7700 0.0 0
M  V30 18 C 2.6674 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-[(Methylamino)methyl]-9-anthracenemethanol
C17H17NO
191417-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 O 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 5.3901 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 4.0012 6.9302 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 2.6675 7.7002 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 4.0012 0.7700 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 2 11 14
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71774-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 191417-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11944660
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The First Fluorescent Diboronic Acid Sensor Specific for Hepatocellular
Carcinoma Cells Expressing Sialyl Lewis X
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Wenqian; Fan, Haiying; Gao, Xingming; Gao, Shouhai; Karnati, Vishnu
Vardhan Reddy; Ni, Weijuan; Hooks, W. Borden; Carson, John; Weston,
Brent; Wang, Binghe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biology (2004), 11(4), 439-448

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-(Hydroxymethyl)-9-anthracenecarboxaldehyde
C16H12O2
71774-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 5.3900 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 C 6.6685 2.3100 0.0 0
M  V30 4 O 8.0021 3.0800 0.0 0
M  V30 5 C 4.0011 5.3900 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 6.9300 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 6.6685 5.3900 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 5.3347 7.7000 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 6.6685 6.9300 0.0 0
M  V30 15 C 1.3336 2.3100 0.0 0
M  V30 16 C 4.0011 0.7700 0.0 0
M  V30 17 C 1.3336 0.7700 0.0 0
M  V30 18 C 2.6674 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-[(Methylamino)methyl]-9-anthracenemethanol
C17H17NO
191417-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 N 8.0023 4.6201 0.0 0
M  V30 3 C 9.3360 5.3901 0.0 0
M  V30 4 C 1.3337 2.3101 0.0 0
M  V30 5 O 0.0000 3.0801 0.0 0
M  V30 6 C 4.0012 5.3901 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 4.0012 6.9302 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 2.6675 7.7002 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 4.0012 0.7700 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 2 11 14
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71774-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 191417-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9308220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorescent sensor compounds for detecting saccharides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Binghe; Weston, Brent; Yang, Wenqian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003094926 A1 2003-11-20

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azidoethyl acetate
C4H7N3O2
71879-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0 CHG=1 VAL=4
M  V30 9 N 9.3360 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-N-methylacetamide
C3H6N4O
98025-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0 CHG=1 VAL=4
M  V30 8 N 8.0023 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 71879-65-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98025-59-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29978326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azidoacetic Acid Amides in the Synthesis of Substituted
Arylidene-1-H-imidazol-5-(4H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zaitseva, Snizhana O.; Golodukhina, Svetlana V.; Baleeva, Nadezhda S.;
Levina, Evgenia A.; Smirnov, Alexander Yu.; Zagudaylova, Marina B.;
Baranov, Mikhail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2018), 3(30), 8593-8596

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
3-Azido-1-propanol
C3H7N3O
72320-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 N 2.6675 1.5400 0.0 0
M  V30 4 C 6.6687 0.7700 0.0 0
M  V30 5 N 1.3337 0.7700 0.0 0 CHG=1 VAL=4
M  V30 6 O 8.0023 1.5400 0.0 0
M  V30 7 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Azido-N-methyl-1-propanamine
C4H10N4
252353-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 N 8.0023 0.7700 0.0 0 CHG=1 VAL=4
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 N 9.3360 0.0000 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 72320-38-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 252353-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-7337534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polar Red-Emitting Rhodamine Dyes with Reactive Groups: Synthesis,
Photophysical Properties, and Two-Color STED Nanoscopy Applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kolmakov, Kirill; Wurm, Christian A.; Meineke, Dirk N. H.; Goettfert,
Fabian; Boyarskiy, Vadim P.; Belov, Vladimir N.; Hell, Stefan W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2014), 20(1), 146-157

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
3-[4-(Phenylmethoxy)phenyl]-2-propynoic acid
C16H12O3
73583-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 C 13.0903 2.6673 0.0 0
M  V30 5 C 14.6303 2.6673 0.0 0
M  V30 6 O 15.4003 1.3337 0.0 0
M  V30 7 O 15.4003 4.0010 0.0 0
M  V30 8 C 6.9302 2.6673 0.0 0
M  V30 9 C 7.7002 4.0010 0.0 0
M  V30 10 C 7.7002 1.3337 0.0 0
M  V30 11 C 9.2402 4.0010 0.0 0
M  V30 12 C 9.2402 1.3337 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 3.0801 1.3337 0.0 0
M  V30 15 C 2.3101 2.6673 0.0 0
M  V30 16 C 2.3101 0.0000 0.0 0
M  V30 17 C 0.7700 2.6673 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 19 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 3 3 4
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[4-(phenylmethoxy)phenyl]-2-propynamide
C17H15NO2
2093275-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 2.6673 0.0 0
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 C 13.0903 2.6673 0.0 0
M  V30 5 C 14.6303 2.6673 0.0 0
M  V30 6 N 15.4003 4.0010 0.0 0
M  V30 7 O 15.4003 1.3337 0.0 0
M  V30 8 C 16.9404 4.0010 0.0 0
M  V30 9 C 6.9302 2.6673 0.0 0
M  V30 10 C 7.7002 4.0010 0.0 0
M  V30 11 C 7.7002 1.3337 0.0 0
M  V30 12 C 9.2402 4.0010 0.0 0
M  V30 13 C 9.2402 1.3337 0.0 0
M  V30 14 C 10.0102 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 16 C 2.3101 2.6673 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 0.7700 2.6673 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 20 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 3 3 4
M  V30 5 1 3 14
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 73583-44-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2093275-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16999840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of amine/THF stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substrate-Assisted, Transition-Metal-Free Diboration of Alkynamides with
Mixed Diboron: Regio- and Stereoselective Access to
trans-1,2-Vinyldiboronates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verma, Astha; Snead, Russell F.; Dai, Yumin; Slebodnick, Carla; Yang,
Yinuo; Yu, Haizhu; Yao, Fu; Santos, Webster L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(18), 5111-5115

$RFMT $RIREG SCHEME396 STEP1
$RXN



  3  1
$MOL
5-Pyrimidinecarboxylic acid, 2-(methylthio)-, ethyl ester
C8H10N2O2S
73781-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 S 1.3337 4.6201 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 N 4.0012 4.6201 0.0 0
M  V30 12 N 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethylamine
C2H7N
75-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 N 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Ethylamino)-N-methyl-5-pyrimidinecarboxamide
C8H12N4O
1862914-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 9.2402 2.6673 0.0 0
M  V30 7 C 10.7802 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 N 6.1601 0.0000 0.0 0
M  V30 12 N 6.1601 2.6673 0.0 0
M  V30 13 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 73781-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-04-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1862914-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23212336
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic Diazepinones as Dual Ligands of the α2δ-1 Subunit of
Voltage-Gated Calcium Channels and the Norepinephrine Transporter
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Diaz, Jose Luis; Cuevas, Felix; Pazos, Gonzalo; Alvarez-Bercedo, Paula;
Oliva, Ana I.; Sarmentero, M. Angeles; Font, Daniel; Jimenez-Aquino,
Agustin; Moron, Maria; Port, Adriana; Pascual, Rosalia; Dordal, Albert;
Portillo-Salido, Enrique; Reinoso, Raquel F.; Vela, Jose Miguel; Almansa,
Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(4), 2167-2185

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-1-[(1R)-1-(Acetyloxy)ethyl]-2-(diphenylphosphino)ferrocene
C26H25FeO2P
74311-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 8.1784 12.8489 0.0 0
M  V30 2 C 3.4063 16.1304 0.0 0 CFG=1
M  V30 3 O 4.6315 16.8366 0.0 0
M  V30 4 C 2.1812 16.8366 0.0 0
M  V30 5 C 5.8567 16.1304 0.0 0
M  V30 6 C 7.0819 16.8366 0.0 0
M  V30 7 O 5.8567 14.7140 0.0 0
M  V30 8 Fe 3.4063 7.3277 0.0 0 CHG=2 VAL=10
M  V30 9 C 6.7932 12.5563 0.0 0 CHG=-1 CFG=1 VAL=4
M  V30 10 C 3.4063 14.7140 0.0 0 CFG=2 VAL=5
M  V30 11 C 4.6628 11.3233 0.0 0 CFG=2 VAL=5
M  V30 12 C 0.0780 12.5563 0.0 0 CFG=1 VAL=5
M  V30 13 C 2.2007 11.3233 0.0 0 CFG=2 VAL=5
M  V30 14 C 0.0000 2.1655 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.7190 2.1655 0.0 0 VAL=5
M  V30 16 C 4.5886 3.4024 0.0 0 VAL=5
M  V30 17 C 2.1226 3.4024 0.0 0 VAL=5
M  V30 18 C 3.3322 0.0000 0.0 0 VAL=5
M  V30 19 C 9.4035 13.5552 0.0 0
M  V30 20 C 9.4035 15.0925 0.0 0
M  V30 21 C 10.7341 12.7865 0.0 0
M  V30 22 C 10.7341 15.8612 0.0 0
M  V30 23 C 12.0646 13.5552 0.0 0
M  V30 24 C 12.0646 15.0925 0.0 0
M  V30 25 C 8.1784 11.4325 0.0 0
M  V30 26 C 6.8439 10.6639 0.0 0
M  V30 27 C 9.5050 10.6639 0.0 0
M  V30 28 C 6.8439 9.1304 0.0 0
M  V30 29 C 9.5050 9.1304 0.0 0
M  V30 30 C 8.1784 8.3617 0.0 0
M  V30 31 H 4.2960 12.6889 0.0 0
M  V30 32 H 2.5674 12.6889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 3 CFG=1
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 1 9 11
M  V30 22 2 10 12
M  V30 23 2 11 13
M  V30 24 1 11 31 CFG=1
M  V30 25 1 12 13
M  V30 26 1 13 32 CFG=1
M  V30 27 1 14 17
M  V30 28 1 14 18
M  V30 29 1 15 16
M  V30 30 2 15 18
M  V30 31 2 16 17
M  V30 32 2 19 20
M  V30 33 1 19 21
M  V30 34 1 20 22
M  V30 35 2 21 23
M  V30 36 2 22 24
M  V30 37 1 23 24
M  V30 38 2 25 26
M  V30 39 1 25 27
M  V30 40 1 26 28
M  V30 41 2 27 29
M  V30 42 2 28 30
M  V30 43 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 9 10 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R)-1-(Diphenylphosphino)-2-[(1R)-1-(methylamino)ethyl]ferrocene
C25H26FeNP
406681-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 8.1045 12.7328 0.0 0
M  V30 2 C 3.3756 15.9847 0.0 0 CFG=1
M  V30 3 N 4.5897 16.6845 0.0 0
M  V30 4 C 2.1615 16.6845 0.0 0
M  V30 5 C 5.9237 15.9151 0.0 0
M  V30 6 Fe 3.3756 7.2615 0.0 0 CHG=2 VAL=10
M  V30 7 C 6.7318 12.4428 0.0 0 CHG=-1 CFG=1 VAL=4
M  V30 8 C 3.3756 14.5811 0.0 0 CFG=2 VAL=5
M  V30 9 C 4.6206 11.2210 0.0 0 CFG=2 VAL=5
M  V30 10 C 0.0773 12.4428 0.0 0 CFG=1 VAL=5
M  V30 11 C 2.1808 11.2210 0.0 0 CFG=2 VAL=5
M  V30 12 C 0.0000 2.1460 0.0 0 CHG=-1 VAL=4
M  V30 13 C 6.6584 2.1460 0.0 0 VAL=5
M  V30 14 C 4.5472 3.3717 0.0 0 VAL=5
M  V30 15 C 2.1035 3.3717 0.0 0 VAL=5
M  V30 16 C 3.3021 0.0000 0.0 0 VAL=5
M  V30 17 C 9.3186 13.4327 0.0 0
M  V30 18 C 9.3186 14.9562 0.0 0
M  V30 19 C 10.6371 12.6710 0.0 0
M  V30 20 C 10.6371 15.7179 0.0 0
M  V30 21 C 11.9556 13.4327 0.0 0
M  V30 22 C 11.9556 14.9562 0.0 0
M  V30 23 C 8.1045 11.3292 0.0 0
M  V30 24 C 6.7821 10.5675 0.0 0
M  V30 25 C 9.4191 10.5675 0.0 0
M  V30 26 C 6.7821 9.0479 0.0 0
M  V30 27 C 9.4191 9.0479 0.0 0
M  V30 28 C 8.1045 8.2862 0.0 0
M  V30 29 H 4.2572 12.5743 0.0 0
M  V30 30 H 2.5442 12.5743 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 2 3 CFG=1
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 1 7 9
M  V30 20 2 8 10
M  V30 21 2 9 11
M  V30 22 1 9 29 CFG=1
M  V30 23 1 10 11
M  V30 24 1 11 30 CFG=1
M  V30 25 1 12 15
M  V30 26 1 12 16
M  V30 27 1 13 14
M  V30 28 2 13 16
M  V30 29 2 14 15
M  V30 30 2 17 18
M  V30 31 1 17 19
M  V30 32 1 18 20
M  V30 33 2 19 21
M  V30 34 2 20 22
M  V30 35 1 21 22
M  V30 36 2 23 24
M  V30 37 1 23 25
M  V30 38 1 24 26
M  V30 39 2 25 27
M  V30 40 2 26 28
M  V30 41 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 7 8 9 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74311-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 406681-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17354222
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ferrocene-based chiral phosphine-triazines: a new family of highly
efficient P,N ligands for asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xiang-Ping; Chen, Hui-Lin; Zheng, Zhuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2005), 347(4), 541-548

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(4-nitrophenyl)propiolate
C10H7NO4
7515-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 1.3337 0.0 0
M  V30 2 C 8.4702 1.3337 0.0 0
M  V30 3 C 10.0102 1.3337 0.0 0
M  V30 4 O 10.7802 2.6673 0.0 0
M  V30 5 O 10.7802 0.0000 0.0 0
M  V30 6 C 12.3203 2.6673 0.0 0
M  V30 7 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 8 O 0.0000 2.6673 0.0 0
M  V30 9 O 0.0000 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 4.6201 2.6673 0.0 0
M  V30 13 C 3.0801 0.0000 0.0 0
M  V30 14 C 3.0801 2.6673 0.0 0
M  V30 15 C 2.3101 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitro-β-oxobenzenepropanamide
C10H10N2O4
2102513-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 10.6695 3.8500 0.0 0
M  V30 6 O 9.3359 6.1601 0.0 0
M  V30 7 C 12.0032 4.6201 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7515-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2102513-99-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-235-CAS-17222937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Regioselective Synthesis of 6-Alkyl- and 6-Aryluracils by Cs2CO3- or
K3PO4-Promoted Dimerization of 3-Alkyl- and 3-Aryl-2-Propynamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajapaksha, Suranga M.; Mlsna, Todd E.; Pittman, Charles U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(11), 5678-5688

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-2-methoxy-3-methyl-5-nitroso-4(3H)-pyrimidinone
C6H8N4O3
75482-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 5.3900 0.0000 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 N 2.3100 5.3349 0.0 0
M  V30 6 N 0.7700 2.6674 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 2 4 11
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-3-methyl-2-(methylamino)-5-nitroso-4(3H)-pyrimidinone
C6H9N5O2
440354-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 5.3900 0.0000 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 N 2.3100 5.3349 0.0 0
M  V30 6 N 0.7700 2.6674 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 2 4 11
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75482-16-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 440354-70-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-881615
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aminolysis of methoxy groups in pyrimidine derivatives. Activation by
5-nitroso group
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Melguizo, M.; Marchal, A.; Nogueras, M.; Sanchez, A.; Low, J. N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2002), 39(1), 97-103

$RFMT $RIREG SCHEME400 STEP1
$RXN



  3  1
$MOL
Chloroacetyl chloride
C2H2Cl2O
79-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Cl 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S,4R,5S)-4-Nitro-3,5-diphenyl-L-proline methyl ester
C18H18N2O4
872088-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3050 8.0441 0.0 0 VAL=5
M  V30 2 O 6.4496 9.0746 0.0 0
M  V30 3 O 3.8405 8.5201 0.0 0
M  V30 4 C 4.7385 2.6528 0.0 0
M  V30 5 O 5.6437 1.4070 0.0 0
M  V30 6 O 3.2068 2.4919 0.0 0
M  V30 7 C 5.0172 0.0000 0.0 0
M  V30 8 C 4.5948 5.3934 0.0 0 CFG=1
M  V30 9 C 5.6252 6.5378 0.0 0 CFG=1
M  V30 10 C 5.3648 4.0596 0.0 0 CFG=1
M  V30 11 C 7.0321 5.9115 0.0 0 CFG=2
M  V30 12 N 6.8712 4.3798 0.0 0
M  V30 13 C 3.0632 5.5543 0.0 0
M  V30 14 C 2.1580 4.3085 0.0 0
M  V30 15 C 2.4368 6.9611 0.0 0
M  V30 16 C 0.6265 4.4694 0.0 0
M  V30 17 C 0.9052 7.1222 0.0 0
M  V30 18 C 0.0000 5.8762 0.0 0
M  V30 19 C 8.3658 6.6815 0.0 0
M  V30 20 C 9.6994 5.9115 0.0 0
M  V30 21 C 8.3658 8.2215 0.0 0
M  V30 22 C 11.0332 6.6815 0.0 0
M  V30 23 C 9.6994 8.9915 0.0 0
M  V30 24 C 11.0332 8.2215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 10 4 CFG=3
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13 CFG=3
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 11 19 CFG=3
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(6R,7S,8R,8aR)-Hexahydro-2-methyl-7-nitro-6,8-diphenylpyrrolo[1,2-a]pyraz...
C20H19N3O4
2411622-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.6398 7.9110 0.0 0 VAL=5
M  V30 2 O 4.3062 8.6810 0.0 0
M  V30 3 O 6.9735 8.6810 0.0 0
M  V30 4 O 2.5598 2.6674 0.0 0
M  V30 5 O 8.7198 2.6674 0.0 0
M  V30 6 C 4.0998 0.0000 0.0 0
M  V30 7 C 4.3940 5.4658 0.0 0 CFG=2
M  V30 8 C 4.8698 4.0011 0.0 0 CFG=1
M  V30 9 C 5.6398 6.3710 0.0 0 CFG=1
M  V30 10 N 6.4098 4.0011 0.0 0
M  V30 11 C 4.0998 2.6674 0.0 0
M  V30 12 C 6.8857 5.4658 0.0 0 CFG=2
M  V30 13 C 7.1798 2.6674 0.0 0
M  V30 14 N 4.8698 1.3338 0.0 0
M  V30 15 C 6.4098 1.3338 0.0 0
M  V30 16 C 2.9292 5.9417 0.0 0
M  V30 17 C 2.6091 7.4479 0.0 0
M  V30 18 C 1.7849 4.9112 0.0 0
M  V30 19 C 1.1445 7.9240 0.0 0
M  V30 20 C 0.3202 5.3871 0.0 0
M  V30 21 C 0.0000 6.8934 0.0 0
M  V30 22 C 8.3504 5.9417 0.0 0
M  V30 23 C 9.4948 4.9112 0.0 0
M  V30 24 C 8.6706 7.4479 0.0 0
M  V30 25 C 10.9595 5.3871 0.0 0
M  V30 26 C 10.1351 7.9240 0.0 0
M  V30 27 C 11.2796 6.8934 0.0 0
M  V30 28 H 3.3383 4.1620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 2 4 11
M  V30 5 2 5 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16 CFG=3
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 28 CFG=1
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 1 12 22 CFG=3
M  V30 18 1 13 15
M  V30 19 1 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 7 8 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-04-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 872088-39-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411622-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21957321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitroprolinates as Nucleophiles in Michael-type Additions and Acylations.
Synthesis of Enantiomerically Enriched Fused
Amino-pyrrolidino-[1,2-a]pyrazinones and -diketopiperazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia-Mingueens, Eduardo; Selva, Veronica; Larranaga, Olatz; Najera,
Carmen; Sansano, Jose M.; de Cozar, Abel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2020), 12(7), 2014-2021

$RFMT $RIREG SCHEME401 STEP1
$RXN



  3  1
$MOL
Ethynylcyclohexane
C8H12
931-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl chloroformate
C2H3ClO2
79-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyclohexyl-N-methyl-2-propynamide
C10H15NO
2370974-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 7.7001 1.3337 0.0 0
M  V30 4 N 8.4701 2.6673 0.0 0
M  V30 5 O 8.4701 0.0000 0.0 0
M  V30 6 C 10.0101 2.6673 0.0 0
M  V30 7 C 3.0800 1.3337 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 931-48-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79-22-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2370974-99-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29287581
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM trans-Hydroboration of Propiolamides: Access to Primary and Secondary
(E)-β-Borylacrylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grams, R. Justin; Fritzemeier, Russell G.; Slebodnick, Carla; Santos,
Webster L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(17), 6795-6799

$RFMT $RIREG SCHEME402 STEP1
$RXN



  3  1
$MOL
5,6-Dimethoxy[1,1′-biphenyl]-2-carboxylic acid
C15H14O4
93899-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 C 6.6684 6.9301 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 1.3337 2.3100 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 1.3337 3.8500 0.0 0
M  V30 16 C 2.6675 6.1601 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 1.3337 6.9301 0.0 0
M  V30 19 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Oxalyl chloride
C2Cl2O2
79-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Cl 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Dimethoxy-N-methyl[1,1′-biphenyl]-2-acetamide
C17H19NO3
736143-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0
M  V30 2 C 8.0021 5.3900 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0
M  V30 4 O 8.0021 6.9300 0.0 0
M  V30 5 C 10.6694 5.3900 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 0.0000 5.3900 0.0 0
M  V30 8 O 1.3336 7.7000 0.0 0
M  V30 9 C 1.3336 9.2400 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 5.3347 5.3900 0.0 0
M  V30 12 C 2.6673 5.3900 0.0 0
M  V30 13 C 5.3347 6.9300 0.0 0
M  V30 14 C 2.6673 6.9300 0.0 0
M  V30 15 C 4.0011 7.7000 0.0 0
M  V30 16 C 4.0011 3.0800 0.0 0
M  V30 17 C 5.3347 2.3100 0.0 0
M  V30 18 C 2.6673 2.3100 0.0 0
M  V30 19 C 5.3347 0.7700 0.0 0
M  V30 20 C 2.6673 0.7700 0.0 0
M  V30 21 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93899-25-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 736143-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-1142434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16853-85-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The palladium(0) Suzuki cross-coupling reaction as the key step in the
synthesis of aporphinoids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suau, R.; Rico, R.; Najera, F.; Ortiz-Lopez, F. J.; Lopez-Romero, J. M.;
Moreno-Manas, M.; Roglans, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(27), 5725-5735

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 2-[4,5-dihydro-5-oxo-4-(phenylmethylene)-2-oxaz...
C19H22N2O4
79778-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7536 3.1885 0.0 0
M  V30 2 O 2.2889 2.7126 0.0 0
M  V30 3 O 4.0738 4.6948 0.0 0
M  V30 4 C 1.1445 3.7430 0.0 0
M  V30 5 C 0.1140 2.5985 0.0 0
M  V30 6 C 0.0000 4.7735 0.0 0
M  V30 7 C 2.1750 4.8874 0.0 0
M  V30 8 C 10.0319 6.5067 0.0 0
M  V30 9 O 6.9711 7.8695 0.0 0
M  V30 10 C 6.4045 2.4782 0.0 0 CFG=2
M  V30 11 N 4.8980 2.1579 0.0 0
M  V30 12 C 7.1745 1.1444 0.0 0
M  V30 13 C 4.7371 0.6263 0.0 0
M  V30 14 C 6.1439 0.0000 0.0 0
M  V30 15 C 7.0308 3.8850 0.0 0
M  V30 16 N 8.5371 4.2052 0.0 0
M  V30 17 O 6.2608 5.2187 0.0 0
M  V30 18 C 8.6982 5.7367 0.0 0
M  V30 19 C 7.2912 6.3632 0.0 0
M  V30 20 C 11.3655 5.7367 0.0 0
M  V30 21 C 11.3655 4.1967 0.0 0
M  V30 22 C 12.6993 6.5067 0.0 0
M  V30 23 C 12.6993 3.4267 0.0 0
M  V30 24 C 14.0330 5.7367 0.0 0
M  V30 25 C 14.0330 4.1967 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 18
M  V30 9 1 8 20
M  V30 10 2 9 19
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15 CFG=3
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylalaninamide, 1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl-α,β-didehydro-N-...
C20H27N3O4
111258-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3348 0.0 0
M  V30 2 N 5.3900 5.3348 0.0 0
M  V30 3 O 7.7001 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 5.3900 2.6673 0.0 0
M  V30 7 N 4.6200 1.3336 0.0 0
M  V30 8 O 6.9300 2.6673 0.0 0
M  V30 9 C 5.3900 0.0000 0.0 0
M  V30 10 C 10.2620 5.6850 0.0 0
M  V30 11 O 11.7685 6.0051 0.0 0
M  V30 12 O 9.7862 4.2204 0.0 0
M  V30 13 C 12.7989 4.8607 0.0 0
M  V30 14 C 11.6543 3.8302 0.0 0
M  V30 15 C 13.8293 3.7162 0.0 0
M  V30 16 C 13.9433 5.8912 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0 CFG=2
M  V30 18 N 9.2316 6.8295 0.0 0
M  V30 19 C 7.0736 8.0754 0.0 0
M  V30 20 C 9.5518 8.3358 0.0 0
M  V30 21 C 8.2181 9.1058 0.0 0
M  V30 22 C 2.3100 5.3348 0.0 0
M  V30 23 C 3.0800 6.6684 0.0 0
M  V30 24 C 0.7700 5.3348 0.0 0
M  V30 25 C 2.3100 8.0022 0.0 0
M  V30 26 C 0.0000 6.6684 0.0 0
M  V30 27 C 0.7700 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 22
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 18
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79778-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 111258-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19448096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general method for preparation of N-Boc-protected or N-Fmoc-protected
α,β-didehydropeptide building blocks and their use in the solid-phase
peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wolczanski, Grzegorz; Lisowski, Marek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Peptide Science (2018), 24(8-9), n/a

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dioxaspiro[4.5]dec-7-ene-8-ethanol, 8-methanesulfonate
C11H18O5S
811819-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4384 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 O 9.1059 4.1618 0.0 0
M  V30 4 S 10.4396 3.3918 0.0 0 VAL=6
M  V30 5 C 11.2096 4.7254 0.0 0
M  V30 6 O 11.7733 2.6218 0.0 0
M  V30 7 O 9.6696 2.0581 0.0 0
M  V30 8 C 2.4373 1.8517 0.0 0
M  V30 9 C 3.7711 1.0817 0.0 0
M  V30 10 C 2.4373 3.3918 0.0 0
M  V30 11 O 1.0304 2.4781 0.0 0
M  V30 12 O 2.2763 0.3202 0.0 0
M  V30 13 C 5.1048 1.8517 0.0 0
M  V30 14 C 3.7711 4.1618 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,4-dioxaspiro[4.5]dec-7-ene-8-ethanamine
C11H19NO2
811819-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4384 4.1618 0.0 0
M  V30 2 C 7.7722 3.3918 0.0 0
M  V30 3 N 9.1059 4.1618 0.0 0
M  V30 4 C 10.4396 3.3918 0.0 0
M  V30 5 C 2.4374 1.8517 0.0 0
M  V30 6 C 3.7711 1.0817 0.0 0
M  V30 7 C 2.4374 3.3918 0.0 0
M  V30 8 O 2.2763 0.3202 0.0 0
M  V30 9 O 1.0304 2.4782 0.0 0
M  V30 10 C 5.1048 1.8517 0.0 0
M  V30 11 C 3.7711 4.1618 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 14 C 5.1048 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 811819-77-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 811819-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15412208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Heck cyclization to the galanthamine-type alkaloids: total
synthesis of (±)-lycoramine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liang, Pi-Hui; Liu, Jing-Ping; Hsin, Ling-Wei; Cheng, Chen-Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(50), 11655-11660

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,2-Oxazaphospholidine, 3-[(4-nitrophenyl)sulfonyl]-2-phenyl-, 2-sulfide
C14H13N2O5PS2
847198-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6392 4.6201 0.0 0 VAL=6
M  V30 2 O 5.8692 3.2864 0.0 0
M  V30 3 O 7.4093 5.9538 0.0 0
M  V30 4 S 4.6686 3.4300 0.0 0
M  V30 5 N 11.9741 1.5400 0.0 0 VAL=5
M  V30 6 O 13.3077 2.3101 0.0 0
M  V30 7 O 11.9741 0.0000 0.0 0
M  V30 8 N 5.3056 5.3901 0.0 0
M  V30 9 P 3.8986 4.7636 0.0 0 VAL=5
M  V30 10 C 5.1446 6.9217 0.0 0
M  V30 11 O 2.8682 5.9082 0.0 0
M  V30 12 C 3.6382 7.2419 0.0 0
M  V30 13 C 2.6527 3.8586 0.0 0
M  V30 14 C 2.8138 2.3268 0.0 0
M  V30 15 C 1.2459 4.4849 0.0 0
M  V30 16 C 1.5678 1.4218 0.0 0
M  V30 17 C 0.0000 3.5797 0.0 0
M  V30 18 C 0.1609 2.0481 0.0 0
M  V30 19 C 7.9729 3.8501 0.0 0
M  V30 20 C 7.9729 2.3101 0.0 0
M  V30 21 C 9.3067 4.6201 0.0 0
M  V30 22 C 9.3067 1.5400 0.0 0
M  V30 23 C 10.6404 3.8501 0.0 0
M  V30 24 C 10.6404 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 19
M  V30 5 2 4 9
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-[2-[[(4-Nitrophenyl)sulfonyl]amino]ethyl] N-methyl-P-phenylphosphonamidothi...
C15H18N3O5PS2
847198-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.6200 2.3100 0.0 0 VAL=5
M  V30 2 O 6.1600 2.3100 0.0 0
M  V30 3 N 4.6200 0.7700 0.0 0
M  V30 4 S 4.6200 3.8500 0.0 0
M  V30 5 C 6.9300 3.6436 0.0 0
M  V30 6 C 5.9536 0.0000 0.0 0
M  V30 7 C 8.4700 3.6436 0.0 0
M  V30 8 N 9.2400 4.9773 0.0 0
M  V30 9 S 10.7800 4.9773 0.0 0 VAL=6
M  V30 10 O 10.7800 3.4373 0.0 0
M  V30 11 O 10.7800 6.5173 0.0 0
M  V30 12 N 16.9400 4.9773 0.0 0 VAL=5
M  V30 13 O 17.7100 6.3111 0.0 0
M  V30 14 O 17.7100 3.6436 0.0 0
M  V30 15 C 3.0800 2.3100 0.0 0
M  V30 16 C 2.3100 0.9762 0.0 0
M  V30 17 C 2.3100 3.6436 0.0 0
M  V30 18 C 0.7700 0.9762 0.0 0
M  V30 19 C 0.7700 3.6436 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 C 12.3200 4.9773 0.0 0
M  V30 22 C 13.0900 3.6436 0.0 0
M  V30 23 C 13.0900 6.3111 0.0 0
M  V30 24 C 14.6300 3.6436 0.0 0
M  V30 25 C 14.6300 6.3111 0.0 0
M  V30 26 C 15.4000 4.9773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 21
M  V30 13 2 12 13
M  V30 14 2 12 14
M  V30 15 1 12 26
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847198-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847198-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-567-CAS-12860957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phospholidines incorporating a β N-sulfonylaminoalcohol moiety: first
observed selectivity of phosphorus heterocycle aminolysis in the presence
of water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dujols, Frederic; Marty, Laurence; Mulliez, Michel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2005), 3(2), 227-232

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(4-chlorophenyl)-6-cyclohexyl-3-formyl-4H-thieno[3,2-b]pyrrole-2-car...
C21H20ClNO3S
848243-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.4703 8.3503 0.0 0
M  V30 2 O 9.4397 9.4947 0.0 0
M  V30 3 C 12.4395 5.6398 0.0 0
M  V30 4 O 13.2095 4.3061 0.0 0
M  V30 5 O 13.2095 6.9734 0.0 0
M  V30 6 C 14.7495 4.3061 0.0 0
M  V30 7 Cl 0.0000 5.6398 0.0 0
M  V30 8 C 7.0651 4.3939 0.0 0
M  V30 9 C 8.5298 4.8698 0.0 0
M  V30 10 C 6.1600 5.6398 0.0 0
M  V30 11 C 8.5298 6.4098 0.0 0
M  V30 12 S 9.9944 4.3939 0.0 0
M  V30 13 N 7.0651 6.8856 0.0 0
M  V30 14 C 9.9944 6.8856 0.0 0
M  V30 15 C 10.8995 5.6398 0.0 0
M  V30 16 C 6.5892 2.9292 0.0 0
M  V30 17 C 5.0829 2.6091 0.0 0
M  V30 18 C 7.6198 1.7849 0.0 0
M  V30 19 C 4.6071 1.1444 0.0 0
M  V30 20 C 7.1438 0.3202 0.0 0
M  V30 21 C 5.6375 0.0000 0.0 0
M  V30 22 C 4.6200 5.6398 0.0 0
M  V30 23 C 3.8500 6.9734 0.0 0
M  V30 24 C 3.8500 4.3061 0.0 0
M  V30 25 C 2.3100 6.9734 0.0 0
M  V30 26 C 2.3100 4.3061 0.0 0
M  V30 27 C 1.5400 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 7 27
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 22
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 2 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(4-chlorophenyl)-6-cyclohexyl-3-[(methylamino)methyl]-4H-thieno[3,2-...
C22H25ClN2O2S
1201013-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2792 2.6091 0.0 0
M  V30 2 N 5.3098 1.4645 0.0 0
M  V30 3 C 4.8338 0.0000 0.0 0
M  V30 4 C 2.3100 5.3195 0.0 0
M  V30 5 O 1.5400 6.6533 0.0 0
M  V30 6 O 1.5400 3.9858 0.0 0
M  V30 7 C 0.0000 6.6533 0.0 0
M  V30 8 Cl 14.7495 5.3195 0.0 0
M  V30 9 C 6.2198 6.0895 0.0 0
M  V30 10 C 7.6844 6.5655 0.0 0
M  V30 11 C 6.2198 4.5495 0.0 0
M  V30 12 S 4.7551 6.5655 0.0 0
M  V30 13 C 8.5895 5.3195 0.0 0
M  V30 14 C 4.7551 4.0736 0.0 0
M  V30 15 N 7.6844 4.0736 0.0 0
M  V30 16 C 3.8500 5.3195 0.0 0
M  V30 17 C 8.1603 8.0300 0.0 0
M  V30 18 C 9.6666 8.3502 0.0 0
M  V30 19 C 7.1297 9.1745 0.0 0
M  V30 20 C 10.1424 9.8149 0.0 0
M  V30 21 C 7.6058 10.6391 0.0 0
M  V30 22 C 9.1120 10.9593 0.0 0
M  V30 23 C 10.1295 5.3195 0.0 0
M  V30 24 C 10.8995 6.6533 0.0 0
M  V30 25 C 10.8995 3.9858 0.0 0
M  V30 26 C 12.4395 6.6533 0.0 0
M  V30 27 C 12.4395 3.9858 0.0 0
M  V30 28 C 13.2095 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 8 28
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 17
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 13 23
M  V30 19 2 14 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848243-77-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1201013-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10018069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-85-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimization of Thienopyrrole-Based Finger-Loop Inhibitors of the
Hepatitis C Virus NS5B Polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martin Hernando, Jose Ignacio; Ontoria, Jesus Maria; Malancona, Savina;
Attenni, Barbara; Fiore, Fabrizio; Bonelli, Fabio; Koch, Uwe; Di Marco,
Stefania; Colarusso, Stefania; Ponzi, Simona; Gennari, Nadia; Vignetti,
Sue Ellen; Ferreira, Maria del Rosario Rico; Habermann, Joerg; Rowley,
Michael; Narjes, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2009), 4(10), 1695-1713

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-[2-(4-hydroxyphenyl)-2-oxoethyl]-1H-pyrrole-2-carboxylate
C14H13NO4
852068-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7849 1.9822 0.0 0
M  V30 2 O 0.3202 1.5063 0.0 0
M  V30 3 O 2.9293 0.9517 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 4.8457 3.3450 0.0 0
M  V30 6 C 6.1794 4.1150 0.0 0
M  V30 7 O 6.1794 5.6550 0.0 0
M  V30 8 O 11.5142 1.0349 0.0 0
M  V30 9 C 2.1051 3.4886 0.0 0
M  V30 10 N 3.5119 4.1150 0.0 0
M  V30 11 C 1.0746 4.6330 0.0 0
M  V30 12 C 3.3510 5.6465 0.0 0
M  V30 13 C 1.8447 5.9667 0.0 0
M  V30 14 C 7.5131 3.3450 0.0 0
M  V30 15 C 8.8467 4.1150 0.0 0
M  V30 16 C 7.5131 1.8049 0.0 0
M  V30 17 C 10.1805 3.3450 0.0 0
M  V30 18 C 8.8467 1.0349 0.0 0
M  V30 19 C 10.1805 1.8049 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 1 6 14
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Hydroxyphenyl)-2-methylpyrrolo[1,2-a]pyrazin-1(2H)-one
C14H12N2O2
852068-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7473 0.0000 0.0 0
M  V30 2 O 1.6672 0.0000 0.0 0
M  V30 3 O 10.9073 2.6673 0.0 0
M  V30 4 C 4.7473 2.6673 0.0 0
M  V30 5 C 3.9772 4.0011 0.0 0
M  V30 6 N 3.9772 1.3337 0.0 0
M  V30 7 N 2.4372 4.0011 0.0 0
M  V30 8 C 2.4372 1.3337 0.0 0
M  V30 9 C 1.6672 2.6673 0.0 0
M  V30 10 C 1.4068 5.1455 0.0 0
M  V30 11 C 0.1609 2.9876 0.0 0
M  V30 12 C 0.0000 4.5192 0.0 0
M  V30 13 C 6.2873 2.6673 0.0 0
M  V30 14 C 7.0573 4.0011 0.0 0
M  V30 15 C 7.0573 1.3337 0.0 0
M  V30 16 C 8.5973 4.0011 0.0 0
M  V30 17 C 8.5973 1.3337 0.0 0
M  V30 18 C 9.3673 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 18
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 852068-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852068-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3129930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel synthesis of arylpyrrolo[1,2-a]pyrazinone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Fei; Wang, Jiawei; Zhang, Shoufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2004), 9(7), 574-582

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
3-Nitrosalicylic acid
C7H5NO5
85-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 O 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-2-hydroxy-N-methylbenzamide
C8H10N2O2
194413-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 2.6674 4.6200 0.0 0
M  V30 6 N 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 85-38-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194413-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9677170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3,4-diaminocyclobutene-1,2-diones as CXC chemokine
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taveras, Arthur G.; Aki, Cynthia J.; Bond, Richard W.; Chao, Jianping;
Dwyer, Michael; Ferreira, Johan A.; Pachter, Jonathan A.; Baldwin, John
J.; Kaiser, Bernd; Li, Ge; Merritt, J. Robert; Nelson, Kingsley H.;
Rokosz, Laura L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030204085 A1 2003-10-30

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
3-Nitrosalicylic acid
C7H5NO5
85-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 4.6200 0.0 0
M  V30 4 O 4.0011 4.6200 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-2-hydroxy-N-methylbenzamide
C8H10N2O2
194413-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 O 2.6674 4.6200 0.0 0
M  V30 6 N 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 85-38-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 194413-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5904370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: 3-Nitrosalicylic
acid (1.0g, 5.5mmol) was dissolved in ethyl acetate (20mL).
1,3-Dicyclohexylcarbodiimide (0.568g, 2.8mmol) was added and the mixture
was stirred for approximately 10 minutes and cooled to 0°C. During this
time a precipitate formed. Azetidine (0.39mL, 5.8mmol) was added and the
reaction was stirred overnight and allowed to warm to room temperature.
After this time the reaction was cooled to 0°C and filtered. The
collected solid was washed with chilled ethyl acetate. The filtrate was
concentrated and purified by column chromatography (80% EtOAc/Hex) to
give the product. The nitro compound (0.48g, 2.1 mmol) from Preparative
Example 32 Step A was dissolved in methanol (25ml) and stirred with 10%
Pd/C under a hydrogen gas atmosphere overnight. The reaction mixture was
filtered through celite, the filtrate concentrated in vacuo to give the
product. Following the two-step procedure set forth in Preparative
Example 32 but using the carboxylic acid and amine listed in the Table
III below, the Products were obtained. PREPARATIVE EXAMPLE 41, yield 90%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3,4-diaminocyclobutene-1,2-diones as CXC chemokine
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taveras, Arthur G.; Aki, Cynthia J.; Bond, Richard W.; Chao, Jianping;
Dwyer, Michael; Ferreira, Johan A.; Pachter, Jonathan; Baldwin, John J.;
Kaiser, Bernd; Li, Ge; Merritt, J. Robert; Nelson, Kingsley H., Jr.;
Rokosz, Laura L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002076926 A1 2002-10-03

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(5-Butyl-4-propyl-1H-pyrrol-2-yl)-2-cyano-3-(ethylthio)-2-propenamide
C17H25N3OS
854275-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.6816 0.0 0
M  V30 2 C 2.6673 5.9116 0.0 0
M  V30 3 S 4.0010 8.2216 0.0 0
M  V30 4 C 2.6673 4.3715 0.0 0
M  V30 5 C 1.3337 6.6816 0.0 0
M  V30 6 C 2.6673 8.9916 0.0 0
M  V30 7 N 4.0010 3.6015 0.0 0
M  V30 8 O 1.3337 3.6015 0.0 0
M  V30 9 N 0.0000 7.4516 0.0 0
M  V30 10 C 2.6673 10.5316 0.0 0
M  V30 11 C 9.3038 5.5544 0.0 0
M  V30 12 C 9.9301 6.9612 0.0 0
M  V30 13 C 11.4617 7.1223 0.0 0
M  V30 14 C 12.0880 8.5291 0.0 0
M  V30 15 C 7.6285 2.6529 0.0 0
M  V30 16 C 6.7233 1.4070 0.0 0
M  V30 17 C 7.3496 0.0000 0.0 0
M  V30 18 C 5.3348 5.9116 0.0 0
M  V30 19 N 6.7416 6.5379 0.0 0
M  V30 20 C 5.4957 4.3798 0.0 0
M  V30 21 C 7.7721 5.3935 0.0 0
M  V30 22 C 7.0020 4.0597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 3 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 16 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Butyl-3-imino-1-(methylamino)-6-propyl-3H-pyrrolizine-2-carboxamide
C16H24N4O
943825-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6261 5.8689 0.0 0
M  V30 2 C 8.9598 5.0989 0.0 0
M  V30 3 C 10.2936 5.8689 0.0 0
M  V30 4 C 11.6273 5.0989 0.0 0
M  V30 5 N 4.7419 8.4659 0.0 0
M  V30 6 N 1.1144 4.4371 0.0 0
M  V30 7 C 1.1144 2.8971 0.0 0
M  V30 8 C 7.2759 2.5367 0.0 0
M  V30 9 C 6.9557 1.0304 0.0 0
M  V30 10 C 8.1001 0.0000 0.0 0
M  V30 11 C 1.4647 7.7693 0.0 0
M  V30 12 N 0.0000 7.2934 0.0 0
M  V30 13 O 1.7849 9.2756 0.0 0
M  V30 14 N 4.8856 5.7252 0.0 0
M  V30 15 C 3.8550 4.5808 0.0 0
M  V30 16 C 6.2924 5.0989 0.0 0
M  V30 17 C 4.1156 7.0591 0.0 0
M  V30 18 C 2.4482 5.2072 0.0 0
M  V30 19 C 4.6250 3.2472 0.0 0
M  V30 20 C 6.1315 3.5673 0.0 0
M  V30 21 C 2.6091 6.7389 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 17
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 21
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 2 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 854275-21-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943825-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1349931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile coupling of 2-(1-ethylthioethenyl)pyrroles with amines: a route to
2-(1-aminoethenyl)pyrroles and 1-amino-3-iminopyrrolizines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trofimov, Boris A.; Sobenina, Lyubov' N.; Mikhaleva, Al'bina I.; Petrova,
Ol'ga V.; Drichkov, Vladislav N.; Ushakov, Igor A.; Tarasova, Ol'ga A.;
Toryashinova, Darya-Suren D.; Rusakov, Yuriy Yu.; Krivdin, Leonid B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(3), 505-513

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(R)-2-naphthalenylphenylphosphino]-...
C30H27FeO2P
860268-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 6.4975 7.9793 0.0 0
M  V30 2 C 6.7535 3.5183 0.0 0
M  V30 3 O 6.7535 2.1141 0.0 0
M  V30 4 C 5.5355 4.2243 0.0 0
M  V30 5 C 5.5355 1.4081 0.0 0
M  V30 6 C 4.3174 2.1141 0.0 0
M  V30 7 O 5.5355 0.0000 0.0 0
M  V30 8 Fe 11.3813 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 10.0973 5.4579 0.0 0 VAL=5
M  V30 10 C 7.9715 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 12.5683 5.4579 0.0 0 VAL=5
M  V30 12 C 11.3076 2.0520 0.0 0 VAL=5
M  V30 13 C 14.7056 4.2243 0.0 0 VAL=5
M  V30 14 C 14.7832 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 8.0491 14.6397 0.0 0 VAL=5
M  V30 16 C 10.1749 13.4023 0.0 0 VAL=5
M  V30 17 C 12.6458 13.4023 0.0 0 VAL=5
M  V30 18 C 11.3813 16.8081 0.0 0 VAL=5
M  V30 19 C 5.2794 7.2772 0.0 0
M  V30 20 C 3.9606 8.0452 0.0 0
M  V30 21 C 5.2794 5.7372 0.0 0
M  V30 22 C 2.6378 7.2772 0.0 0
M  V30 23 C 3.9606 4.9691 0.0 0
M  V30 24 C 2.6378 5.7372 0.0 0
M  V30 25 C 1.3189 8.0452 0.0 0
M  V30 26 C 1.3189 4.9691 0.0 0
M  V30 27 C 0.0000 7.2772 0.0 0
M  V30 28 C 0.0000 5.7372 0.0 0
M  V30 29 C 6.4975 9.3874 0.0 0
M  V30 30 C 7.8164 10.1477 0.0 0
M  V30 31 C 5.1747 10.1516 0.0 0
M  V30 32 C 7.8203 11.6799 0.0 0
M  V30 33 C 5.1747 11.6761 0.0 0
M  V30 34 C 6.4975 12.4403 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 2 19 20
M  V30 31 1 19 21
M  V30 32 1 20 22
M  V30 33 2 21 23
M  V30 34 2 22 24
M  V30 35 1 22 25
M  V30 36 1 23 24
M  V30 37 1 24 26
M  V30 38 2 25 27
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(R)-2-naphthalenylphenylphosphino...
C29H28FeNP
860268-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 6.4759 6.6190 0.0 0
M  V30 2 C 6.7311 2.1728 0.0 0
M  V30 3 N 6.7311 0.7732 0.0 0
M  V30 4 C 5.5171 2.8765 0.0 0
M  V30 5 C 5.3934 0.0000 0.0 0
M  V30 6 Fe 11.3435 8.0301 0.0 0 CHG=2 VAL=10
M  V30 7 C 10.0638 4.1059 0.0 0 VAL=5
M  V30 8 C 7.9451 2.8765 0.0 0 CHG=-1 VAL=4
M  V30 9 C 12.5265 4.1059 0.0 0 VAL=5
M  V30 10 C 11.2700 0.7114 0.0 0 VAL=5
M  V30 11 C 14.6568 2.8765 0.0 0 VAL=5
M  V30 12 C 14.7341 13.2573 0.0 0 CHG=-1 VAL=4
M  V30 13 C 8.0224 13.2573 0.0 0 VAL=5
M  V30 14 C 10.1411 12.0239 0.0 0 VAL=5
M  V30 15 C 12.6039 12.0239 0.0 0 VAL=5
M  V30 16 C 11.3435 15.4185 0.0 0 VAL=5
M  V30 17 C 5.2619 5.9192 0.0 0
M  V30 18 C 3.9474 6.6847 0.0 0
M  V30 19 C 5.2619 4.3843 0.0 0
M  V30 20 C 2.6290 5.9192 0.0 0
M  V30 21 C 3.9474 3.6188 0.0 0
M  V30 22 C 2.6290 4.3843 0.0 0
M  V30 23 C 1.3145 6.6847 0.0 0
M  V30 24 C 1.3145 3.6188 0.0 0
M  V30 25 C 0.0000 5.9192 0.0 0
M  V30 26 C 0.0000 4.3843 0.0 0
M  V30 27 C 6.4759 8.0224 0.0 0
M  V30 28 C 7.7904 8.7802 0.0 0
M  V30 29 C 5.1575 8.7840 0.0 0
M  V30 30 C 7.7943 10.3073 0.0 0
M  V30 31 C 5.1575 10.3035 0.0 0
M  V30 32 C 6.4759 11.0651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 2 17 18
M  V30 29 1 17 19
M  V30 30 1 18 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 22
M  V30 35 1 22 24
M  V30 36 2 23 25
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 860268-11-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860268-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1401676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc, SFe,RP)-2-[(1-N-Methylamino)ethyl]-1-[ (2- naphthyl)
phenylphosphino] ferrocene [(Rc,SFe,RP)-21]. A solution of (Rc,SFe,RP)-15
(633 mg, 1.25 mmol) and 40% methylamine aqueous solution (3.0 mL) in THF
(10 mL) and MeOH (2.5 mL) was stirred for 3 days at room temperature, and
concentrated. The residue was dissolved in Et2O(20 mL), washed with brine
(10 mL), dried (Na2SO4), and evaporated under reduced pressure. The crude
product was purified by chromatography (SiO2, hexane-EtOAc-Et3N = 85: 10:
5) to give the title compound as orange crystals, yield 537 mg, 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metallocene-based chiral phosphine or arsine ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068477 A1 2005-07-28

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(R)-2-naphthalenylphenylphosphino]-...
C30H27FeO2P
860268-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 6.4975 7.9793 0.0 0
M  V30 2 C 6.7535 3.5183 0.0 0
M  V30 3 O 6.7535 2.1141 0.0 0
M  V30 4 C 5.5355 4.2243 0.0 0
M  V30 5 C 5.5355 1.4081 0.0 0
M  V30 6 C 4.3174 2.1141 0.0 0
M  V30 7 O 5.5355 0.0000 0.0 0
M  V30 8 Fe 11.3813 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 10.0973 5.4579 0.0 0 VAL=5
M  V30 10 C 7.9715 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 12.5683 5.4579 0.0 0 VAL=5
M  V30 12 C 11.3076 2.0520 0.0 0 VAL=5
M  V30 13 C 14.7056 4.2243 0.0 0 VAL=5
M  V30 14 C 14.7832 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 8.0491 14.6397 0.0 0 VAL=5
M  V30 16 C 10.1749 13.4023 0.0 0 VAL=5
M  V30 17 C 12.6458 13.4023 0.0 0 VAL=5
M  V30 18 C 11.3813 16.8081 0.0 0 VAL=5
M  V30 19 C 5.2794 7.2772 0.0 0
M  V30 20 C 3.9606 8.0452 0.0 0
M  V30 21 C 5.2794 5.7372 0.0 0
M  V30 22 C 2.6378 7.2772 0.0 0
M  V30 23 C 3.9606 4.9691 0.0 0
M  V30 24 C 2.6378 5.7372 0.0 0
M  V30 25 C 1.3189 8.0452 0.0 0
M  V30 26 C 1.3189 4.9691 0.0 0
M  V30 27 C 0.0000 7.2772 0.0 0
M  V30 28 C 0.0000 5.7372 0.0 0
M  V30 29 C 6.4975 9.3874 0.0 0
M  V30 30 C 7.8164 10.1477 0.0 0
M  V30 31 C 5.1747 10.1516 0.0 0
M  V30 32 C 7.8203 11.6799 0.0 0
M  V30 33 C 5.1747 11.6761 0.0 0
M  V30 34 C 6.4975 12.4403 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 2 19 20
M  V30 31 1 19 21
M  V30 32 1 20 22
M  V30 33 2 21 23
M  V30 34 2 22 24
M  V30 35 1 22 25
M  V30 36 1 23 24
M  V30 37 1 24 26
M  V30 38 2 25 27
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(R)-2-naphthalenylphenylphosphino...
C29H28FeNP
860268-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 6.4759 6.6190 0.0 0
M  V30 2 C 6.7311 2.1728 0.0 0
M  V30 3 N 6.7311 0.7732 0.0 0
M  V30 4 C 5.5171 2.8765 0.0 0
M  V30 5 C 5.3934 0.0000 0.0 0
M  V30 6 Fe 11.3435 8.0301 0.0 0 CHG=2 VAL=10
M  V30 7 C 10.0638 4.1059 0.0 0 VAL=5
M  V30 8 C 7.9451 2.8765 0.0 0 CHG=-1 VAL=4
M  V30 9 C 12.5265 4.1059 0.0 0 VAL=5
M  V30 10 C 11.2700 0.7114 0.0 0 VAL=5
M  V30 11 C 14.6568 2.8765 0.0 0 VAL=5
M  V30 12 C 14.7341 13.2573 0.0 0 CHG=-1 VAL=4
M  V30 13 C 8.0224 13.2573 0.0 0 VAL=5
M  V30 14 C 10.1411 12.0239 0.0 0 VAL=5
M  V30 15 C 12.6039 12.0239 0.0 0 VAL=5
M  V30 16 C 11.3435 15.4185 0.0 0 VAL=5
M  V30 17 C 5.2619 5.9192 0.0 0
M  V30 18 C 3.9474 6.6847 0.0 0
M  V30 19 C 5.2619 4.3843 0.0 0
M  V30 20 C 2.6290 5.9192 0.0 0
M  V30 21 C 3.9474 3.6188 0.0 0
M  V30 22 C 2.6290 4.3843 0.0 0
M  V30 23 C 1.3145 6.6847 0.0 0
M  V30 24 C 1.3145 3.6188 0.0 0
M  V30 25 C 0.0000 5.9192 0.0 0
M  V30 26 C 0.0000 4.3843 0.0 0
M  V30 27 C 6.4759 8.0224 0.0 0
M  V30 28 C 7.7904 8.7802 0.0 0
M  V30 29 C 5.1575 8.7840 0.0 0
M  V30 30 C 7.7943 10.3073 0.0 0
M  V30 31 C 5.1575 10.3035 0.0 0
M  V30 32 C 6.4759 11.0651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 2 17 18
M  V30 29 1 17 19
M  V30 30 1 18 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 22
M  V30 35 1 22 24
M  V30 36 2 23 25
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 860268-11-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860268-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2724385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Re,SFe,Rp)-2-[(1-N-Methylamino)ethyl]-1-[(2-naphthyl)phenylphosphino]ferrocene
[(Rc,SFe, Rp)-21]: A solution of (Rc, SFe, Rp)-15 (633 mg, 1.25 mmol) and
40% methylamine aqueous solution (3.0 mL) in THF (10 mL) and MeOH (2.5
mL) was stirred for 3 days at room temperature, and concentrated. The
residue was dissolved in Et2O (20 mL), washed with brine (10 mL), dried
(Na2SO4), and evaporated under reduced pressure. The crude product was
purified by chromatography (SiO2, hexane-EtOAc-Et3N = 85:10:5) to give
the title compound (537 mg, 90%) as orange crystals
(Re,SFe,Rp)-2-[(1-N-Methylamino)ethyl]-1-[(2-
naphthyl)phenylphosphino]ferrocene [(Rc,SFe, Rp)-21]: yield (537 mg, 90%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of ferrocene-based chiral phosphines or arsines
as transformation catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068478 A1 2005-07-28

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(R)-1-naphthalenylphenylphosphino]-...
C30H27FeO2P
860294-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3515 5.8419 0.0 0
M  V30 2 C 4.4028 3.5183 0.0 0
M  V30 3 O 4.4028 2.1141 0.0 0
M  V30 4 C 3.1847 4.2243 0.0 0
M  V30 5 C 3.1847 1.4081 0.0 0
M  V30 6 C 1.9667 2.1141 0.0 0
M  V30 7 O 3.1847 0.0000 0.0 0
M  V30 8 Fe 9.0344 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 7.7504 5.4579 0.0 0 VAL=5
M  V30 10 C 5.6208 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 10.2175 5.4579 0.0 0 VAL=5
M  V30 12 C 8.9607 2.0520 0.0 0 VAL=5
M  V30 13 C 12.3588 4.2243 0.0 0 VAL=5
M  V30 14 C 12.4325 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.6984 14.6397 0.0 0 VAL=5
M  V30 16 C 7.8241 13.4023 0.0 0 VAL=5
M  V30 17 C 10.2951 13.4023 0.0 0 VAL=5
M  V30 18 C 9.0344 16.8081 0.0 0 VAL=5
M  V30 19 C 2.6455 7.0599 0.0 0
M  V30 20 C 3.9644 7.8280 0.0 0
M  V30 21 C 1.3266 7.8280 0.0 0
M  V30 22 C 3.9644 9.3680 0.0 0
M  V30 23 C 5.2833 7.0599 0.0 0
M  V30 24 C 1.3266 9.3680 0.0 0
M  V30 25 C 2.6455 10.1361 0.0 0
M  V30 26 C 5.2833 10.1361 0.0 0
M  V30 27 C 6.6022 7.8280 0.0 0
M  V30 28 C 6.6022 9.3680 0.0 0
M  V30 29 C 2.6455 4.6239 0.0 0
M  V30 30 C 2.6455 3.0955 0.0 0
M  V30 31 C 1.3228 5.3881 0.0 0
M  V30 32 C 1.3228 2.3352 0.0 0
M  V30 33 C 0.0000 4.6239 0.0 0
M  V30 34 C 0.0000 3.0955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 1 19 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 24
M  V30 35 1 22 25
M  V30 36 1 22 26
M  V30 37 2 23 27
M  V30 38 2 24 25
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(R)-1-naphthalenylphenylphosphino...
C29H28FeNP
860268-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3440 4.4936 0.0 0
M  V30 2 C 4.3929 2.1752 0.0 0
M  V30 3 N 4.3929 0.7741 0.0 0
M  V30 4 C 3.1776 2.8796 0.0 0
M  V30 5 C 3.0576 0.0000 0.0 0
M  V30 6 Fe 9.0142 8.0389 0.0 0 CHG=2 VAL=10
M  V30 7 C 7.7331 4.1104 0.0 0 VAL=5
M  V30 8 C 5.6082 2.8796 0.0 0 CHG=-1 VAL=4
M  V30 9 C 10.1947 4.1104 0.0 0 VAL=5
M  V30 10 C 8.9407 0.7122 0.0 0 VAL=5
M  V30 11 C 12.3312 2.8796 0.0 0 VAL=5
M  V30 12 C 12.4047 13.2717 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.6856 13.2717 0.0 0 VAL=5
M  V30 14 C 7.8066 12.0370 0.0 0 VAL=5
M  V30 15 C 10.2721 12.0370 0.0 0 VAL=5
M  V30 16 C 9.0142 15.4352 0.0 0 VAL=5
M  V30 17 C 2.6396 5.7089 0.0 0
M  V30 18 C 3.9556 6.4752 0.0 0
M  V30 19 C 1.3237 6.4752 0.0 0
M  V30 20 C 3.9556 8.0118 0.0 0
M  V30 21 C 5.2715 5.7089 0.0 0
M  V30 22 C 1.3237 8.0118 0.0 0
M  V30 23 C 2.6396 8.7781 0.0 0
M  V30 24 C 5.2715 8.7781 0.0 0
M  V30 25 C 6.5875 6.4752 0.0 0
M  V30 26 C 6.5875 8.0118 0.0 0
M  V30 27 C 2.6396 3.2782 0.0 0
M  V30 28 C 2.6396 1.7533 0.0 0
M  V30 29 C 1.3198 4.0407 0.0 0
M  V30 30 C 1.3198 0.9947 0.0 0
M  V30 31 C 0.0000 3.2782 0.0 0
M  V30 32 C 0.0000 1.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 1 17 18
M  V30 29 2 17 19
M  V30 30 2 18 20
M  V30 31 1 18 21
M  V30 32 1 19 22
M  V30 33 1 20 23
M  V30 34 1 20 24
M  V30 35 2 21 25
M  V30 36 2 22 23
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 860294-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860268-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4731029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc, SFc,
RP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene
[(Rc, SFc, RP)-8c]: A solution of (Rc, SFc, RP)-7c (633 mg, 1.25 mmol)
and 40% methylamine aqueous solution (3.0 mL) in THF (10 mL) and MeOH
(2.5 mL) was stirred for 3 days at 40 °C, and concentrated. The residue
was dissolved in Et2O (20 mL), washed with brine (10 mL), dried (Na2SO4),
and evaporated under reduced pressure. The crude product was purified by
chromatography (SiO2, hexane-EtOAc-Et3N = 85:10:5) to give the title
compound as orange crystals. (Rc, SFc,
RP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene,
yield 537 mg, 90%. 1H NMR (CDCl3, 400.13 MHz): δ 1.45 (d, 3H, J = 6.5
Hz); 1.83 (s, 3H); 3.82 (m, 1H); 3.97 (m, 1H); 4.07 (s, 5H); 3 4.35 (t,
1H, J = 2.5 Hz); 4.53 (m, 1H); 7.20 (m, 1H); 7.30 ~ 7.36 (m, 5H); 7.40
(m, 1H); 7.56 ~ 7.61 (m, 2H); 7.78 (t, 2H, J = 8.2 Hz), 8.38 (m, 1H). 31P
NMR (CDCl3, 162 MHz): δ -32.25.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Very Simple, Highly Stereoselective and Modular Synthesis of
Ferrocene-Based P-Chiral Phosphine Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Weiping; Mbafor, William; Roberts, Stanley M.; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(12), 3922-3923

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(R)-1-naphthalenylphenylphosphino]-...
C30H27FeO2P
860294-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3515 5.8419 0.0 0
M  V30 2 C 4.4028 3.5183 0.0 0
M  V30 3 O 4.4028 2.1141 0.0 0
M  V30 4 C 3.1847 4.2243 0.0 0
M  V30 5 C 3.1847 1.4081 0.0 0
M  V30 6 C 1.9667 2.1141 0.0 0
M  V30 7 O 3.1847 0.0000 0.0 0
M  V30 8 Fe 9.0344 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 7.7504 5.4579 0.0 0 VAL=5
M  V30 10 C 5.6208 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 10.2175 5.4579 0.0 0 VAL=5
M  V30 12 C 8.9607 2.0520 0.0 0 VAL=5
M  V30 13 C 12.3588 4.2243 0.0 0 VAL=5
M  V30 14 C 12.4325 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.6984 14.6397 0.0 0 VAL=5
M  V30 16 C 7.8241 13.4023 0.0 0 VAL=5
M  V30 17 C 10.2951 13.4023 0.0 0 VAL=5
M  V30 18 C 9.0344 16.8081 0.0 0 VAL=5
M  V30 19 C 2.6455 7.0599 0.0 0
M  V30 20 C 3.9644 7.8280 0.0 0
M  V30 21 C 1.3266 7.8280 0.0 0
M  V30 22 C 3.9644 9.3680 0.0 0
M  V30 23 C 5.2833 7.0599 0.0 0
M  V30 24 C 1.3266 9.3680 0.0 0
M  V30 25 C 2.6455 10.1361 0.0 0
M  V30 26 C 5.2833 10.1361 0.0 0
M  V30 27 C 6.6022 7.8280 0.0 0
M  V30 28 C 6.6022 9.3680 0.0 0
M  V30 29 C 2.6455 4.6239 0.0 0
M  V30 30 C 2.6455 3.0955 0.0 0
M  V30 31 C 1.3228 5.3881 0.0 0
M  V30 32 C 1.3228 2.3352 0.0 0
M  V30 33 C 0.0000 4.6239 0.0 0
M  V30 34 C 0.0000 3.0955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 1 19 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 24
M  V30 35 1 22 25
M  V30 36 1 22 26
M  V30 37 2 23 27
M  V30 38 2 24 25
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(R)-1-naphthalenylphenylphosphino...
C29H28FeNP
860268-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3440 4.4936 0.0 0
M  V30 2 C 4.3929 2.1752 0.0 0
M  V30 3 N 4.3929 0.7741 0.0 0
M  V30 4 C 3.1776 2.8796 0.0 0
M  V30 5 C 3.0576 0.0000 0.0 0
M  V30 6 Fe 9.0142 8.0389 0.0 0 CHG=2 VAL=10
M  V30 7 C 7.7331 4.1104 0.0 0 VAL=5
M  V30 8 C 5.6082 2.8796 0.0 0 CHG=-1 VAL=4
M  V30 9 C 10.1947 4.1104 0.0 0 VAL=5
M  V30 10 C 8.9407 0.7122 0.0 0 VAL=5
M  V30 11 C 12.3312 2.8796 0.0 0 VAL=5
M  V30 12 C 12.4047 13.2717 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.6856 13.2717 0.0 0 VAL=5
M  V30 14 C 7.8066 12.0370 0.0 0 VAL=5
M  V30 15 C 10.2721 12.0370 0.0 0 VAL=5
M  V30 16 C 9.0142 15.4352 0.0 0 VAL=5
M  V30 17 C 2.6396 5.7089 0.0 0
M  V30 18 C 3.9556 6.4752 0.0 0
M  V30 19 C 1.3237 6.4752 0.0 0
M  V30 20 C 3.9556 8.0118 0.0 0
M  V30 21 C 5.2715 5.7089 0.0 0
M  V30 22 C 1.3237 8.0118 0.0 0
M  V30 23 C 2.6396 8.7781 0.0 0
M  V30 24 C 5.2715 8.7781 0.0 0
M  V30 25 C 6.5875 6.4752 0.0 0
M  V30 26 C 6.5875 8.0118 0.0 0
M  V30 27 C 2.6396 3.2782 0.0 0
M  V30 28 C 2.6396 1.7533 0.0 0
M  V30 29 C 1.3198 4.0407 0.0 0
M  V30 30 C 1.3198 0.9947 0.0 0
M  V30 31 C 0.0000 3.2782 0.0 0
M  V30 32 C 0.0000 1.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 1 17 18
M  V30 29 2 17 19
M  V30 30 2 18 20
M  V30 31 1 18 21
M  V30 32 1 19 22
M  V30 33 1 20 23
M  V30 34 1 20 24
M  V30 35 2 21 25
M  V30 36 2 22 23
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 860294-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860268-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12713483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc,SFe,RP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)
phenylphosphino]ferrocene [(Rc,SFe,RP)-19] : A solution of (Rc,SFe,RP)-7
(633 mg, 1.25 mmol) and 40% methylamine aqueous solution (3.0 mL) in THF
(10 mL) and MeOH (2.5 mL) was stirred for 3 days at 40 °C, and
concentrated. The residue was dissolved in Et2O(20 mL), washed with brine
(10 mL), dried (Na2SO4), and evaporated under reduced pressure. The crude
product was purified by chromatography (SiO2, hexane- EtOAc-Et3N = 85:
10: 5) to give the title compoundas orange crystals, yield 537 mg, 90%.
1H NMR(CDCl3, 400.13 MHz):δ1.45 (d, 3H, J = 6. 5 Hz); 1.83 (s, 3H); 3.82
(m, 1 H); 3.97 (m, 1 H); 4. 07 (s, 5H); 3 4.35 (t, 1 H, J = 2. 5 Hz);
4.53 (m, 1H) ; 7.20 (m, 1H) ; 7. 30-7. 36 (m, 5H); 7.40 (m, 1H) ; 7.
56-7. 61 (m, 2H); 7.78 (t, 2H, J = 8. 2 Hz), 8.38 (m, 1H). 31P NMR
(CDCl3, 162 MHz) δ-32. 25.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metallocene-based chiral phosphine or arsine ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068477 A1 2005-07-28

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(R)-1-naphthalenylphenylphosphino]-...
C30H27FeO2P
860294-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3515 5.8419 0.0 0
M  V30 2 C 4.4028 3.5183 0.0 0
M  V30 3 O 4.4028 2.1141 0.0 0
M  V30 4 C 3.1847 4.2243 0.0 0
M  V30 5 C 3.1847 1.4081 0.0 0
M  V30 6 C 1.9667 2.1141 0.0 0
M  V30 7 O 3.1847 0.0000 0.0 0
M  V30 8 Fe 9.0344 9.3952 0.0 0 CHG=2 VAL=10
M  V30 9 C 7.7504 5.4579 0.0 0 VAL=5
M  V30 10 C 5.6208 4.2243 0.0 0 CHG=-1 VAL=4
M  V30 11 C 10.2175 5.4579 0.0 0 VAL=5
M  V30 12 C 8.9607 2.0520 0.0 0 VAL=5
M  V30 13 C 12.3588 4.2243 0.0 0 VAL=5
M  V30 14 C 12.4325 14.6397 0.0 0 CHG=-1 VAL=4
M  V30 15 C 5.6984 14.6397 0.0 0 VAL=5
M  V30 16 C 7.8241 13.4023 0.0 0 VAL=5
M  V30 17 C 10.2951 13.4023 0.0 0 VAL=5
M  V30 18 C 9.0344 16.8081 0.0 0 VAL=5
M  V30 19 C 2.6455 7.0599 0.0 0
M  V30 20 C 3.9644 7.8280 0.0 0
M  V30 21 C 1.3266 7.8280 0.0 0
M  V30 22 C 3.9644 9.3680 0.0 0
M  V30 23 C 5.2833 7.0599 0.0 0
M  V30 24 C 1.3266 9.3680 0.0 0
M  V30 25 C 2.6455 10.1361 0.0 0
M  V30 26 C 5.2833 10.1361 0.0 0
M  V30 27 C 6.6022 7.8280 0.0 0
M  V30 28 C 6.6022 9.3680 0.0 0
M  V30 29 C 2.6455 4.6239 0.0 0
M  V30 30 C 2.6455 3.0955 0.0 0
M  V30 31 C 1.3228 5.3881 0.0 0
M  V30 32 C 1.3228 2.3352 0.0 0
M  V30 33 C 0.0000 4.6239 0.0 0
M  V30 34 C 0.0000 3.0955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 29
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 2 9 11
M  V30 22 1 10 12
M  V30 23 1 11 13
M  V30 24 2 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 1 19 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 20 23
M  V30 34 1 21 24
M  V30 35 1 22 25
M  V30 36 1 22 26
M  V30 37 2 23 27
M  V30 38 2 24 25
M  V30 39 2 26 28
M  V30 40 1 27 28
M  V30 41 2 29 30
M  V30 42 1 29 31
M  V30 43 1 30 32
M  V30 44 2 31 33
M  V30 45 2 32 34
M  V30 46 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(methylamino)ethyl]-2-[(R)-1-naphthalenylphenylphosphino...
C29H28FeNP
860268-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3440 4.4936 0.0 0
M  V30 2 C 4.3929 2.1752 0.0 0
M  V30 3 N 4.3929 0.7741 0.0 0
M  V30 4 C 3.1776 2.8796 0.0 0
M  V30 5 C 3.0576 0.0000 0.0 0
M  V30 6 Fe 9.0142 8.0389 0.0 0 CHG=2 VAL=10
M  V30 7 C 7.7331 4.1104 0.0 0 VAL=5
M  V30 8 C 5.6082 2.8796 0.0 0 CHG=-1 VAL=4
M  V30 9 C 10.1947 4.1104 0.0 0 VAL=5
M  V30 10 C 8.9407 0.7122 0.0 0 VAL=5
M  V30 11 C 12.3312 2.8796 0.0 0 VAL=5
M  V30 12 C 12.4047 13.2717 0.0 0 CHG=-1 VAL=4
M  V30 13 C 5.6856 13.2717 0.0 0 VAL=5
M  V30 14 C 7.8066 12.0370 0.0 0 VAL=5
M  V30 15 C 10.2721 12.0370 0.0 0 VAL=5
M  V30 16 C 9.0142 15.4352 0.0 0 VAL=5
M  V30 17 C 2.6396 5.7089 0.0 0
M  V30 18 C 3.9556 6.4752 0.0 0
M  V30 19 C 1.3237 6.4752 0.0 0
M  V30 20 C 3.9556 8.0118 0.0 0
M  V30 21 C 5.2715 5.7089 0.0 0
M  V30 22 C 1.3237 8.0118 0.0 0
M  V30 23 C 2.6396 8.7781 0.0 0
M  V30 24 C 5.2715 8.7781 0.0 0
M  V30 25 C 6.5875 6.4752 0.0 0
M  V30 26 C 6.5875 8.0118 0.0 0
M  V30 27 C 2.6396 3.2782 0.0 0
M  V30 28 C 2.6396 1.7533 0.0 0
M  V30 29 C 1.3198 4.0407 0.0 0
M  V30 30 C 1.3198 0.9947 0.0 0
M  V30 31 C 0.0000 3.2782 0.0 0
M  V30 32 C 0.0000 1.7533 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 17
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 8
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 2 7 9
M  V30 20 1 8 10
M  V30 21 1 9 11
M  V30 22 2 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 1 17 18
M  V30 29 2 17 19
M  V30 30 2 18 20
M  V30 31 1 18 21
M  V30 32 1 19 22
M  V30 33 1 20 23
M  V30 34 1 20 24
M  V30 35 2 21 25
M  V30 36 2 22 23
M  V30 37 2 24 26
M  V30 38 1 25 26
M  V30 39 2 27 28
M  V30 40 1 27 29
M  V30 41 1 28 30
M  V30 42 2 29 31
M  V30 43 2 30 32
M  V30 44 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 860294-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 860268-18-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13991493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Re,SFe,
RP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene
[(RC, Sfe,Rp)-19]: A solution of (Re, SFe, Rp)-7 (633 mg, 1.25 mmol) and
40% methylamine aqueous solution (3.0 mL) in THF (10 mL) and MeOH (2.5
mL) was stirred for 3 days at 40°C, and concentrated. The residue was
dissolved in Et2O (20 mL), washed with brine (10 mL), dried (Na2SO4), and
evaporated under reduced pressure. The crude product was purified by
chromatography (SiO2, hexane- EtOAc-Et3N = 85:10:5) to give the title
compound (537 mg, 90%) as orange crystals. (Re,SFe,
RP)-2-[(1-N-Methylamino)ethyl]-1-[(1-naphthyl)phenylphosphino]ferrocene
[(RC, Sfe,Rp)-19], yield (537 mg, 90%) 1H NMR(CDCl3, 400.13 MHz): δ 1.45
(d, 3H, J= 6.5 Hz); 1.83 (s, 3H); 3.82 (m, 1H); 3.97 (m, 1H); 4.07 (s,
5H); 3 4.35 (t, 1H, J= 2.5 Hz); 4.53 (m, 1H); 7.20 (m, 1H); 7.30-7.36 (m,
5H); 7.40 (m, 1H); 7.56 ~ 7.61 (m, 2H); 7.78 (t, 2H, J= 8.2 Hz), 8.38 (m,
1H). 31P NMR (CDCl3, 162 MHz): δ -32.25.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of ferrocene-based chiral phosphines or arsines
as transformation catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068478 A1 2005-07-28

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]acetamide
C12H22ClNO
866422-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 6.1600 5.3347 0.0 0
M  V30 3 C 6.9300 6.6685 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 Cl 8.4700 6.6685 0.0 0
M  V30 6 C 1.5400 5.3347 0.0 0
M  V30 7 C 2.3100 6.6685 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0 CFG=2
M  V30 11 C 2.3100 4.0011 0.0 0 CFG=2
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0 CFG=2
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 11 6 CFG=1
M  V30 9 1 14 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-N-[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]acetamide
C13H26N2O
119330-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 C 6.6684 4.6200 0.0 0
M  V30 4 O 5.3347 2.3100 0.0 0
M  V30 5 N 8.0021 3.8500 0.0 0
M  V30 6 C 9.3358 4.6200 0.0 0
M  V30 7 C 1.3336 6.1600 0.0 0
M  V30 8 C 0.0000 6.9300 0.0 0
M  V30 9 C 2.6674 6.9300 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0 CFG=2
M  V30 12 C 1.3336 4.6200 0.0 0 CFG=2
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 1.3336 1.5400 0.0 0 CFG=2
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 12 7 CFG=1
M  V30 10 1 15 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866422-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 119330-03-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8873829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM L-Menthol as new scaffold for designing chiral phase-transfer catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Sanjeev; Sobhia, Masilamani Elizabeth; Ramachandran, Uma
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2005), 16(15), 2599-2605

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-N-[(4-fluorophenyl)methyl]-5-pyrimidinamine
C11H8Cl2FN3
867151-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 Cl 4.6200 0.0000 0.0 0
M  V30 4 Cl 0.0000 2.6674 0.0 0
M  V30 5 F 13.0900 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 N 2.3100 1.3338 0.0 0
M  V30 10 N 2.3100 4.0011 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 C 10.7800 2.6674 0.0 0
M  V30 16 C 10.7800 5.3349 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 7
M  V30 5 1 4 11
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N5-[(4-fluorophenyl)methyl]-N4-methyl-4,5-pyrimidinediamine
C12H12ClFN4
867151-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 4.6200 1.3338 0.0 0
M  V30 4 C 3.8500 0.0000 0.0 0
M  V30 5 Cl 0.0000 4.0011 0.0 0
M  V30 6 F 13.0900 5.3347 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 N 2.3100 2.6674 0.0 0
M  V30 11 N 2.3100 5.3347 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 10.7800 6.6685 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 5 12
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867151-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867151-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6638794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N5-Benzyl-2-chloro-N4-methylpyrimidine-4,5-diamine (4a); Typical
Procedure To a solution of 3a (200 mg, 0.79 mmol) in EtOH (3 mL) were
added 0.1 M aq HCl (5 mL) and methylamine (33 weight% in EtOH, 1 mL, 7.9
mmol). The mixture was heated at reflux for 1 h and concentrated under
reduced pressure until crystals appeared in the flask (2 mL). The
crystals were collected by filtration and washed with water to afford 4a.
2-Chloro-N5-(4-fluorobenzyl)-N4-methylpyrimidine-4,5-diamine (4e) From 3e
(170 mg, 0.62 mmol) 4e (150 mg, 90%) was obtained as an off-white solid.
1H NMR (250 MHz, DMSO-d6): δ = 2.85 (d, J = 4.5 Hz, 3 H, CH3NH), 4.25 (d,
J = 5.4 Hz, 2 H, CH2), 5.42 (t, J = 5.4 Hz, 1 H, NHCH2), 7.18 (m, 4 H,
H-c, H-e, H-6, NHCH3), 7.39 (dd, J = 5.7, 8.4 Hz, 2 H, H-b, H-f). 13C NMR
(62.5 MHz, DMSO-d6): δ = 27.4 (CH3), 45.6 (CH2), 115.0 (d, JC-F .2 Hz,
C-c, C-e), 126.9 (C-5), 129.4 (d, JC-F 1 Hz, C-b, C-f), 131.8 (C-6),
134.5 (d, JC-F 0 Hz, C-a), 147.0 (C-2), 154.4 (C-4), 161.0 (d, JC-F 3.0
Hz, C-d).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general and facile route to new trisubstituted purin-8-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gaulon, Catherine; Dijkstra, Harmen P.; Springer, Caroline J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (13), 2227-2233

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-N-(2-phenylethyl)-5-pyrimidinamine
C12H11Cl2N3
867151-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 Cl 9.3360 0.0000 0.0 0
M  V30 5 Cl 12.0033 4.6201 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 C 9.3360 1.5400 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 N 10.6697 2.3101 0.0 0
M  V30 10 N 9.3360 4.6201 0.0 0
M  V30 11 C 10.6697 3.8501 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 12
M  V30 5 1 4 7
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N4-methyl-N5-(2-phenylethyl)-4,5-pyrimidinediamine
C13H15ClN4
867151-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 N 2.6673 0.7700 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 Cl 0.0000 5.3901 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 N 1.3337 3.0801 0.0 0
M  V30 11 N 2.6673 5.3901 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 10.6697 5.3901 0.0 0
M  V30 17 C 12.0033 3.0801 0.0 0
M  V30 18 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 8
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 867151-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867151-59-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10907220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N5-Benzyl-2-chloro-N4-methylpyrimidine-4,5-diamine (4a); Typical
Procedure To a solution of 3a (200 mg, 0.79 mmol) in EtOH (3 mL) were
added 0.1 M aq HCl (5 mL) and methylamine (33 weight% in EtOH, 1 mL, 7.9
mmol). The mixture was heated at reflux for 1 h and concentrated under
reduced pressure until crystals appeared in the flask (2 mL). The
crystals were collected by filtration and washed with water to afford 4a.
2-Chloro-N4-methyl-N5-(2-phenylethyl)pyrimidine-4,5-diamine (4g) From 3g
(200 mg, 0.74 mmol) 4g (176 mg, 90%) was obtained as a pale yellow solid.
1H NMR (250 MHz, DMSO-d6): δ = 2.85 (d, J = 4.4 Hz, 3 H, CH3NH), 2.87 (t,
J = 7.7 Hz, 2 H, CH2Ph), 3.25 (td, J = 7.7, 5.2 Hz, 2 H, CH2NH), 4.96 (t,
J = 5.2 Hz, 1 H, NHCH2), 7.06-7.41 (m, 7 H, Ph, H-6, NHCH3). 13C NMR
(62.5 MHz, DMSO-d6): δ = 27.5 (CH3), 34.3 (CH2Ph), 44.4 (CH2NH), 126.1
(p-Ph), 127.3 (C-5), 128.2 (o-Ph), 128.7 (m- Ph), 131.2 (C-6), 139.4
(n-Ph), 147.0 (C-2), 154.2 (C-4).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general and facile route to new trisubstituted purin-8-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gaulon, Catherine; Dijkstra, Harmen P.; Springer, Caroline J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (13), 2227-2233

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromophthalic anhydride
C8H3BrO3
86-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 Br 7.2706 3.9844 0.0 0
M  V30 4 C 3.4206 2.6508 0.0 0
M  V30 5 C 2.6506 3.9844 0.0 0
M  V30 6 C 2.3902 1.5064 0.0 0
M  V30 7 C 4.9606 2.6508 0.0 0
M  V30 8 C 1.1444 3.6643 0.0 0
M  V30 9 C 3.4206 5.3182 0.0 0
M  V30 10 O 0.9834 2.1327 0.0 0
M  V30 11 C 5.7306 3.9844 0.0 0
M  V30 12 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methyl-1H-isoindole-1,3(2H)-dione
C9H6BrNO2
90224-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 0.0000 2.7106 0.0 0
M  V30 4 Br 7.9110 4.2506 0.0 0
M  V30 5 C 3.9099 3.4806 0.0 0
M  V30 6 C 3.9099 1.9406 0.0 0
M  V30 7 C 2.4452 3.9564 0.0 0
M  V30 8 C 5.2435 4.2506 0.0 0
M  V30 9 C 2.4452 1.4647 0.0 0
M  V30 10 C 5.2435 1.1706 0.0 0
M  V30 11 N 1.5400 2.7106 0.0 0
M  V30 12 C 6.5772 3.4806 0.0 0
M  V30 13 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-90-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90224-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-21748776
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bright near-infrared chemiluminescent dyes: Phthalhydrazides conjugated
with fluorescent BODIPYs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Guanglei; Hirano, Takashi; Yamada, Koji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2020), 178108339

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5-fluoro-2-pyridinamine
C5H4BrFN2
869557-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 F 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N3-methyl-2,3-pyridinediamine
C6H8FN3
1452561-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 F 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869557-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1452561-51-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39981746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridines and imidazopyrazines as modulators of the
NLPR3 inflammasome pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molette, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024023266 A1 2024-02-01

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,7-Dichloroquinoline
C9H5Cl2N
86-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.0010 0.0 0
M  V30 2 Cl 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-methyl-4-quinolinamine
C10H9ClN2
21875-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 Cl 8.4702 2.6673 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 C 6.1601 1.3337 0.0 0
M  V30 9 N 3.8501 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21875-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14489880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro antitubercular activity of a series of quinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Souza, Marcus V. N.; Pais, Karla C.; Kaiser, Carlos R.; Peralta,
Monica A.; Ferreira, Marcelle de L.; Lourenco, Maria C. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(4), 1474-1480

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Bis[(2-ethoxy-2-oxoacetyl)amino]benzoic acid
C15H16N2O8
869957-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 6.6685 0.0 0
M  V30 2 C 4.6201 6.6685 0.0 0
M  V30 3 C 3.8501 8.0023 0.0 0
M  V30 4 O 3.8501 5.3348 0.0 0
M  V30 5 O 2.3101 8.0023 0.0 0
M  V30 6 O 4.6201 9.3360 0.0 0
M  V30 7 C 1.5400 9.3360 0.0 0
M  V30 8 C 0.0000 9.3360 0.0 0
M  V30 9 N 9.2402 6.6685 0.0 0
M  V30 10 C 10.7802 6.6685 0.0 0
M  V30 11 C 11.5503 8.0023 0.0 0
M  V30 12 O 11.5503 5.3348 0.0 0
M  V30 13 O 13.0903 8.0023 0.0 0
M  V30 14 O 10.7802 9.3360 0.0 0
M  V30 15 C 13.8603 9.3360 0.0 0
M  V30 16 C 15.4003 9.3360 0.0 0
M  V30 17 C 6.1601 1.3337 0.0 0
M  V30 18 O 6.9302 0.0000 0.0 0
M  V30 19 O 4.6201 1.3337 0.0 0
M  V30 20 C 6.9302 5.3348 0.0 0
M  V30 21 C 8.4702 5.3348 0.0 0
M  V30 22 C 6.1601 4.0012 0.0 0
M  V30 23 C 9.2402 4.0012 0.0 0
M  V30 24 C 6.9302 2.6675 0.0 0
M  V30 25 C 8.4702 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 24
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Quinoxalinecarboxylic acid, 1,2,3,4-tetrahydro-2,3-dioxo-, compd. with meth...
C9H6N2O4.CH5N
1843240-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 3.0800 0.0 0
M  V30 2 O 9.3360 3.8501 0.0 0
M  V30 3 O 8.0023 1.5400 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 O 0.0000 6.1601 0.0 0
M  V30 6 C 4.0012 3.8501 0.0 0
M  V30 7 C 4.0012 5.3901 0.0 0
M  V30 8 C 5.3348 3.0800 0.0 0
M  V30 9 N 2.6675 3.0800 0.0 0
M  V30 10 C 5.3348 6.1601 0.0 0
M  V30 11 N 2.6675 6.1601 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 C 6.6685 5.3901 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 3.8980 0.0000 0.0 0
M  V30 17 N 5.4380 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 13
M  V30 5 2 5 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869957-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1843240-53-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28347447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CuII bis(oxamato) end-grafted poly(amidoamine) dendrimers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruehlig, Karoline; Mothes, Robert; Aliabadi, Azar; Kataev, Vladislav;
Buechner, Bernd; Buschbeck, Roy; Rueffer, Tobias; Lang, Heinrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2016), 45(19), 7960-7979

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)propyl]-2-(diphenylphosphino)-, (2R)-
C27H27FeO2P
871827-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.9824 6.1595 0.0 0
M  V30 2 C 3.1831 2.7159 0.0 0
M  V30 3 O 3.1831 1.6320 0.0 0
M  V30 4 C 2.2398 3.2609 0.0 0
M  V30 5 C 2.2398 1.0870 0.0 0
M  V30 6 C 1.2996 2.7159 0.0 0
M  V30 7 C 1.2996 1.6320 0.0 0
M  V30 8 O 2.2398 0.0000 0.0 0
M  V30 9 Fe 6.7554 7.2525 0.0 0 CHG=2 VAL=10
M  V30 10 C 5.7642 4.2131 0.0 0 VAL=5
M  V30 11 C 4.1233 3.2609 0.0 0 CHG=-1 VAL=4
M  V30 12 C 7.6717 4.2131 0.0 0 VAL=5
M  V30 13 C 6.6985 1.5840 0.0 0 VAL=5
M  V30 14 C 9.3216 3.2609 0.0 0 VAL=5
M  V30 15 C 9.3785 11.3009 0.0 0 CHG=-1 VAL=4
M  V30 16 C 4.1832 11.3009 0.0 0 VAL=5
M  V30 17 C 5.8241 10.3457 0.0 0 VAL=5
M  V30 18 C 7.7316 10.3457 0.0 0 VAL=5
M  V30 19 C 6.7554 12.9748 0.0 0 VAL=5
M  V30 20 C 2.0422 5.6175 0.0 0
M  V30 21 C 2.0422 4.4377 0.0 0
M  V30 22 C 1.0211 6.2074 0.0 0
M  V30 23 C 1.0211 3.8508 0.0 0
M  V30 24 C 0.0000 5.6175 0.0 0
M  V30 25 C 0.0000 4.4377 0.0 0
M  V30 26 C 2.9824 7.2465 0.0 0
M  V30 27 C 4.0035 7.8334 0.0 0
M  V30 28 C 1.9643 7.8364 0.0 0
M  V30 29 C 4.0065 9.0162 0.0 0
M  V30 30 C 1.9613 9.0132 0.0 0
M  V30 31 C 2.9854 9.6031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 11
M  V30 7 1 3 5
M  V30 8 1 4 6
M  V30 9 1 5 7
M  V30 10 2 5 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 9 15
M  V30 17 1 9 16
M  V30 18 1 9 17
M  V30 19 1 9 18
M  V30 20 1 9 19
M  V30 21 1 10 11
M  V30 22 2 10 12
M  V30 23 1 11 13
M  V30 24 1 12 14
M  V30 25 2 13 14
M  V30 26 1 15 18
M  V30 27 1 15 19
M  V30 28 1 16 17
M  V30 29 2 16 19
M  V30 30 2 17 18
M  V30 31 2 20 21
M  V30 32 1 20 22
M  V30 33 1 21 23
M  V30 34 2 22 24
M  V30 35 2 23 25
M  V30 36 1 24 25
M  V30 37 2 26 27
M  V30 38 1 26 28
M  V30 39 1 27 29
M  V30 40 2 28 30
M  V30 41 2 29 31
M  V30 42 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-(diphenylphosphino)-2-[(1R)-1-(methylamino)propyl]-, (1R)-
C26H28FeNP
871827-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 P 8.1412 12.7906 0.0 0
M  V30 2 C 3.3909 16.0572 0.0 0 CFG=2
M  V30 3 C 2.1713 16.7602 0.0 0
M  V30 4 N 4.6105 16.7602 0.0 0
M  V30 5 C 0.9516 16.0572 0.0 0
M  V30 6 C 5.9506 15.9873 0.0 0
M  V30 7 Fe 3.3909 7.2945 0.0 0 CHG=2 VAL=10
M  V30 8 C 6.7624 12.4993 0.0 0 CHG=-1 CFG=1 VAL=4
M  V30 9 C 3.3909 14.6473 0.0 0 CFG=2 VAL=5
M  V30 10 C 4.6416 11.2719 0.0 0 CFG=2 VAL=5
M  V30 11 C 0.0777 12.4993 0.0 0 CFG=1 VAL=5
M  V30 12 C 2.1907 11.2719 0.0 0 CFG=2 VAL=5
M  V30 13 C 0.0000 2.1557 0.0 0 CHG=-1 VAL=4
M  V30 14 C 6.6886 2.1557 0.0 0 VAL=5
M  V30 15 C 4.5678 3.3870 0.0 0 VAL=5
M  V30 16 C 2.1130 3.3870 0.0 0 VAL=5
M  V30 17 C 3.3171 0.0000 0.0 0 VAL=5
M  V30 18 C 9.3609 13.4936 0.0 0
M  V30 19 C 9.3609 15.0240 0.0 0
M  V30 20 C 10.6854 12.7285 0.0 0
M  V30 21 C 10.6854 15.7892 0.0 0
M  V30 22 C 12.0099 13.4936 0.0 0
M  V30 23 C 12.0099 15.0240 0.0 0
M  V30 24 C 8.1412 11.3807 0.0 0
M  V30 25 C 6.8129 10.6155 0.0 0
M  V30 26 C 9.4619 10.6155 0.0 0
M  V30 27 C 6.8129 9.0890 0.0 0
M  V30 28 C 9.4619 9.0890 0.0 0
M  V30 29 C 8.1412 8.3238 0.0 0
M  V30 30 H 4.2765 12.6314 0.0 0
M  V30 31 H 2.5558 12.6314 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 2 3
M  V30 5 1 2 4 CFG=1
M  V30 6 1 2 9
M  V30 7 1 3 5
M  V30 8 1 4 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 13
M  V30 15 1 7 14
M  V30 16 1 7 15
M  V30 17 1 7 16
M  V30 18 1 7 17
M  V30 19 1 8 9
M  V30 20 1 8 10
M  V30 21 2 9 11
M  V30 22 2 10 12
M  V30 23 1 10 30 CFG=1
M  V30 24 1 11 12
M  V30 25 1 12 31 CFG=1
M  V30 26 1 13 16
M  V30 27 1 13 17
M  V30 28 1 14 15
M  V30 29 2 14 17
M  V30 30 2 15 16
M  V30 31 2 18 19
M  V30 32 1 18 20
M  V30 33 1 19 21
M  V30 34 2 20 22
M  V30 35 2 21 23
M  V30 36 1 22 23
M  V30 37 2 24 25
M  V30 38 1 24 26
M  V30 39 1 25 27
M  V30 40 2 26 28
M  V30 41 2 27 29
M  V30 42 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 2 8 9 10 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 871827-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871827-80-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26021813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ferrocene-based chiral phosphine-triazines: a new family of highly
efficient P,N ligands for asymmetric catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Xiang-Ping; Chen, Hui-Lin; Zheng, Zhuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2005), 347(4), 541-548

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3-(phenylsulfonyl)[1,2,3]triazolo[1,5-a]quinazoline
C15H9ClN4O2S
872197-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.9857 4.5603 0.0 0 VAL=6
M  V30 2 O 7.6655 3.0539 0.0 0
M  V30 3 O 8.3059 6.0667 0.0 0
M  V30 4 Cl 4.0012 0.0000 0.0 0
M  V30 5 N 4.0012 4.6201 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 N 4.3213 6.1264 0.0 0
M  V30 9 C 6.4792 4.8805 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 N 5.8529 6.2873 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 9.4920 4.2402 0.0 0
M  V30 19 C 9.9679 2.7754 0.0 0
M  V30 20 C 10.5226 5.3846 0.0 0
M  V30 21 C 11.4743 2.4553 0.0 0
M  V30 22 C 12.0289 5.0644 0.0 0
M  V30 23 C 12.5048 3.5997 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 18
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 13
M  V30 15 2 10 14
M  V30 16 1 11 14
M  V30 17 2 11 15
M  V30 18 1 12 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(phenylsulfonyl)[1,2,3]triazolo[1,5-a]quinazolin-5-amine
C16H13N5O2S
892291-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.9857 5.3304 0.0 0 VAL=6
M  V30 2 O 8.3059 6.8367 0.0 0
M  V30 3 O 7.6655 3.8239 0.0 0
M  V30 4 N 4.0012 0.7700 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 N 4.0012 5.3901 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 N 4.3213 6.8964 0.0 0
M  V30 10 C 6.4792 5.6505 0.0 0
M  V30 11 N 5.3348 3.0801 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 N 5.8529 7.0574 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 0.0000 3.0801 0.0 0
M  V30 19 C 9.4920 5.0102 0.0 0
M  V30 20 C 10.5226 6.1546 0.0 0
M  V30 21 C 9.9679 3.5455 0.0 0
M  V30 22 C 12.0289 5.8344 0.0 0
M  V30 23 C 11.4743 3.2253 0.0 0
M  V30 24 C 12.5048 4.3697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 19
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 2 9 14
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 1 12 15
M  V30 18 2 12 16
M  V30 19 1 13 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 872197-91-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892291-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3591744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for solution phase parallel
synthesis of substituted 5-amino-3- arylsulfonyl-[1,2,3]triazolo[1,
5-a]quinazolines 3{1-14,1-60}. To a mixture of 5-chloro-PSTQ 1{1-14} (1
mmol) and TEA (1 mL) in DMF (2mL) amine 2{1-60} (1.1 mmol) was added. The
resulting mixture was heated for 1 h at 100-120 °C then cooled to room
temperature and water (10 mL) was added. The resulting precipitate was
separated and crystallized from MeOH.
N-Methyl-3-(phenylsulfonyl)-[1,2,3]triazolo[1,5-a]quinazolin-5-amine
3{1,2}. ESI-MS m/z 340; 1H NMR (DMSO-d6, 400 MHz) δ 9.00 (d, J= 4.4 Hz,
1H), 8.39 (d, J= 8.0 Hz, 1H), 8.35 (d, J= 8.0 Hz, 1H), 8.12 (d, J= 7.2
Hz, 2H), 7.97 (t, J= 7.6 Hz, 1H), 7.73 (t, J= 8.0 Hz, 1H), 7.65 (m, 3H),
3.12 (d, J= 7.6 Hz, 3H); 13C NMR (DMSO-d6, 75 MHz) δ 156.18, 141.66,
140.51, 134.47, 133.42, 132.60, 131.31, 129.20, 128.10, 127.00, 124.61,
115.37, 111.77, 28.26.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution phase parallel synthesis of substituted
3-phenylsulfonyl-[1,2,3]triazolo[1,5-a]quinazolines: selective serotonin
5-HT6 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivachtchenko, Alexandre V.; Golovina, Elena S.; Kadieva, Madina G.;
Koryakova, Angela G.; Kovalenko, Sergiy M.; Mitkin, Oleg D.; Okun, Ilya
M.; Ravnyeyko, Irina M.; Tkachenko, Sergey E.; Zaremba, Oleg V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2010), 12(4), 445-452

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methylphenyl)sulfonyl]-1H-indole-3-acetamide
C17H16N2O3S
872404-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 5.2308 0.0 0 VAL=6
M  V30 2 O 6.1048 6.5645 0.0 0
M  V30 3 O 4.5648 3.8972 0.0 0
M  V30 4 C 10.6374 4.1037 0.0 0
M  V30 5 C 11.2639 5.5107 0.0 0
M  V30 6 N 12.7954 5.6716 0.0 0
M  V30 7 O 10.3587 6.7565 0.0 0
M  V30 8 C 0.0000 8.3109 0.0 0
M  V30 9 N 6.6684 4.4608 0.0 0
M  V30 10 C 6.8295 2.9293 0.0 0
M  V30 11 C 8.0754 5.0873 0.0 0
M  V30 12 C 8.3358 2.6091 0.0 0
M  V30 13 C 5.7990 1.7849 0.0 0
M  V30 14 C 9.1058 3.9428 0.0 0
M  V30 15 C 8.8117 1.1444 0.0 0
M  V30 16 C 6.2748 0.3202 0.0 0
M  V30 17 C 7.7813 0.0000 0.0 0
M  V30 18 C 4.0011 6.0008 0.0 0
M  V30 19 C 2.6675 5.2308 0.0 0
M  V30 20 C 4.0011 7.5409 0.0 0
M  V30 21 C 1.3337 6.0008 0.0 0
M  V30 22 C 2.6675 8.3109 0.0 0
M  V30 23 C 1.3337 7.5409 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 18
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-[[1-[(4-methylphenyl)sulfonyl]-1H-indol-3-yl]methyl]urea
C18H19N3O3S
872405-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 5.2309 0.0 0 VAL=6
M  V30 2 O 4.5648 3.8972 0.0 0
M  V30 3 O 6.1048 6.5645 0.0 0
M  V30 4 C 10.6375 4.1037 0.0 0
M  V30 5 N 11.2638 5.5107 0.0 0
M  V30 6 C 12.7955 5.6716 0.0 0
M  V30 7 N 13.4219 7.0786 0.0 0
M  V30 8 O 13.7006 4.4257 0.0 0
M  V30 9 C 14.9534 7.2395 0.0 0
M  V30 10 C 0.0000 8.3109 0.0 0
M  V30 11 N 6.6685 4.4609 0.0 0
M  V30 12 C 6.8294 2.9293 0.0 0
M  V30 13 C 8.0755 5.0873 0.0 0
M  V30 14 C 8.3359 2.6091 0.0 0
M  V30 15 C 5.7990 1.7849 0.0 0
M  V30 16 C 9.1059 3.9428 0.0 0
M  V30 17 C 8.8118 1.1444 0.0 0
M  V30 18 C 6.2749 0.3202 0.0 0
M  V30 19 C 7.7813 0.0000 0.0 0
M  V30 20 C 4.0012 6.0009 0.0 0
M  V30 21 C 2.6673 5.2309 0.0 0
M  V30 22 C 4.0012 7.5409 0.0 0
M  V30 23 C 1.3337 6.0009 0.0 0
M  V30 24 C 2.6673 8.3109 0.0 0
M  V30 25 C 1.3337 7.5409 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 20
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 872404-92-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 872405-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28118831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3240-34-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the DIB-Promoted Hofmann
Rearrangement of 1-Protected Acetamide 2 A mixture of 1 mmol of
1-protected indole-3-acetamide 2 and 1.2 equiv of DIB were stirred in
10mL of solvent as indicated in Table 1 in the presence of an appropriate
alcohol (5 equiv) at room temperature for 4-30 h. After completion of the
reaction (checked by TLC), the solvent was removed under vacuum. The
residue was purified by chromatography on silica gel to give alkyl
carbamate 3. 3l. Purification by chromatography on silica gel (ethyl
acetate/petroleum ether 2:1) afforded a white solid, yield 90%. Mp:
170°C. IR: 970,1171,1369,1619,2924, 3328cm-1; 1H NMR (400MHz, CDCl3) δ
2.34 (s, 3H), 2.76 (s, 3H), 4.48 (d,J = 5.2 Hz, 2H), 4.50 (s, br, 1H),
4.70 (s, br, 1H), 7.21 (d, J = 8.0Hz, 2H), 7.25 (d, J = 0.8 Hz, 1H), 7.32
(t, J = 5.6 Hz, 1H), 7.48 (s, 1H), 7.56 (d, J = 8.0Hz, 1H), 7.75 (d, J =
8.4 Hz, 2H), 7.95 (d, J = 8.0 Hz, 1H); 13C NMR (400MHz, CDCl3) δ 21.5,
27.3, 35.7, 113.6, 119.8, 120.5, 123.3, 123.8, 125.0, 126.8, 129.5,
129.9, 135.1, 135.3, 145.0, 158.5; EI-MS: m/z (%) 357 (29, M+), 202 (30),
145 (100); HRMS calcd. for C18H19N3NaO3S: 380.1039; found 380.1032.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Alkyl Carbamate of 1-Protected Indole-3-methylamine as a
Precursor of Indole-3-methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Hao; Chen, Wei; Wang, Yin; Qin, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2005), 35(21), 2735-2748

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[[(3R,4R)-4-(4-chlorophenyl)-1-methyl-3-piperidinyl]methyl]thio]ace...
C16H22ClNO2S
872837-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 S 6.9300 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 O 10.0100 8.0021 0.0 0
M  V30 6 O 10.0100 5.3347 0.0 0
M  V30 7 C 11.5500 8.0021 0.0 0
M  V30 8 C 5.3900 0.0000 0.0 0
M  V30 9 Cl 0.0000 9.3358 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0 CFG=2
M  V30 11 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 3.0800 1.3336 0.0 0
M  V30 15 N 4.6200 1.3336 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6684 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.0000 6.6684 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 15
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[[(3R,4R)-4-(4-Chlorophenyl)-1-methyl-3-piperidinyl]methyl]thio]-N-methyla...
C16H23ClN2OS
872837-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 S 6.9300 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 N 10.0100 8.0021 0.0 0
M  V30 6 O 10.0100 5.3347 0.0 0
M  V30 7 C 11.5500 8.0021 0.0 0
M  V30 8 C 5.3900 0.0000 0.0 0
M  V30 9 Cl 0.0000 9.3358 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0 CFG=2
M  V30 11 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 C 3.0800 1.3336 0.0 0
M  V30 15 N 4.6200 1.3336 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 3.0800 6.6684 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.0000 6.6684 0.0 0
M  V30 21 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 15
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 872837-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 872837-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11207075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
2-[[(3S,4R)-4-(4-Chlorophenyl)-1-methylpiperidin-3-yl]-
methylsulfanyl]-N-methylacetamide ((-)-trans-5b). (-)- trans-4 (124 mg,
0.378 mmol) was dissolved in a 2.0Msolution of methylamine in MeOH (5.0
mL). The resulting mixture was stirred at room temperature for 24 h. The
solvent was then evaporated under vacuum. The residue was purified by
preparative TLC using EtOAc/Et3N (10/1) as the developing solvent to
afford (-)-trans-5b as a white solid (88.5 mg, 72%). Compounds (+)-cis-5b
and (-)-cis-5b were prepared by the same general procedure described for
(-)-trans-5b.
2-[(3R,4R)-4-(4-Chlorophenyl)-1-methylpiperidin-3-ylmethylsulfanyl]-
N-methylacetamide ((+)-cis-5b). Yield 90%; colorless oil; [α]25 D +81°(c
0.35, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.30 (d, J = 8.31 Hz, 2H), 7.09
(d, J = 8.3 Hz, 2H), 6.90 (s, 1H), 3.21-3.16 (m, 1H), 3.05-2.99 (m, 3H),
2.90- 2.82 (m, 1H), 2.78-2.67 (m, 4H), 2.29 (s, 3H), 2.05-1.85 (m, 5H),
1.73-1.61 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 168.0, 142.4, 132.5, 128.7,
58.3, 56.4, 46.5, 43.2, 40.5, 36.3, 30.1, 26.8, 25.1; MS (ESI) 327.1
[MH+]; HRMS calculated for C16H24ClN2- OS+ [MH+] 327.1298, found
327.1295.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Further Structure-Activity Relationship Studies of Piperidine-Based
Monoamine Transporter Inhibitors: Effects of Piperidine Ring
Stereochemistry on Potency. Identification of Norepinephrine Transporter
Selective Ligands and Broad-Spectrum Transporter Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Rong; Kurome, Toru; Giberson, Kelly M.; Johnson, Kenneth M.;
Kozikowski, Alan P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(25), 7970-7979

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyclopropyl-2,4-difluoro-5-[[5-(1-methylethyl)-6-[5-(methylsulfonyl)-1,3,4-...
C22H21F2N7O4S
873091-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2841 6.8584 0.0 0
M  V30 2 C 9.8195 7.3342 0.0 0
M  V30 3 C 12.4286 7.8888 0.0 0
M  V30 4 N 8.2638 5.5412 0.0 0
M  V30 5 F 6.7238 8.2087 0.0 0
M  V30 6 S 18.3139 5.8527 0.0 0 VAL=6
M  V30 7 C 19.8454 5.6916 0.0 0
M  V30 8 O 18.4748 7.3843 0.0 0
M  V30 9 O 18.1529 4.3212 0.0 0
M  V30 10 C 3.6437 2.8738 0.0 0
M  V30 11 N 2.1037 2.8738 0.0 0
M  V30 12 O 4.4137 1.5400 0.0 0
M  V30 13 F 2.1037 5.5412 0.0 0
M  V30 14 C 10.5738 4.2075 0.0 0
M  V30 15 C 11.6043 5.3519 0.0 0
M  V30 16 N 11.3438 2.8738 0.0 0
M  V30 17 C 9.0338 4.2075 0.0 0
M  V30 18 C 13.0112 4.7256 0.0 0
M  V30 19 C 12.8501 3.1940 0.0 0
M  V30 20 N 10.5738 1.5400 0.0 0
M  V30 21 N 8.2638 2.8738 0.0 0
M  V30 22 C 9.0338 1.5400 0.0 0
M  V30 23 C 14.3449 5.4956 0.0 0
M  V30 24 O 15.7517 4.8693 0.0 0
M  V30 25 N 14.5058 7.0271 0.0 0
M  V30 26 C 16.7823 6.0137 0.0 0
M  V30 27 N 16.0123 7.3473 0.0 0
M  V30 28 C 6.7238 5.5412 0.0 0
M  V30 29 C 5.9537 4.2075 0.0 0
M  V30 30 C 5.9537 6.8748 0.0 0
M  V30 31 C 4.4137 4.2075 0.0 0
M  V30 32 C 4.4137 6.8748 0.0 0
M  V30 33 C 3.6437 5.5412 0.0 0
M  V30 34 C 1.3337 1.5400 0.0 0
M  V30 35 C 1.3337 0.0000 0.0 0
M  V30 36 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 17
M  V30 5 1 4 28
M  V30 6 1 5 30
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 6 26
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 31
M  V30 14 1 11 34
M  V30 15 1 13 33
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 2 18 19
M  V30 24 1 18 23
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 2 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyclopropyl-2,4-difluoro-5-[[6-[5-(methylamino)-1,3,4-oxadiazol-2-yl]-5-(1-...
C22H22F2N8O2
1017281-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.8163 3.4495 0.0 0
M  V30 2 C 11.7858 2.3051 0.0 0
M  V30 3 C 14.3227 3.1293 0.0 0
M  V30 4 N 9.5420 3.0800 0.0 0
M  V30 5 F 9.5420 0.0000 0.0 0
M  V30 6 N 18.4014 7.8353 0.0 0
M  V30 7 C 19.8082 7.2089 0.0 0
M  V30 8 C 4.2073 3.0800 0.0 0
M  V30 9 N 2.8737 2.3100 0.0 0
M  V30 10 O 4.2073 4.6200 0.0 0
M  V30 11 F 4.2073 0.0000 0.0 0
M  V30 12 C 10.8758 5.3900 0.0 0
M  V30 13 C 12.3404 4.9142 0.0 0
M  V30 14 N 10.8758 6.9300 0.0 0
M  V30 15 C 9.5420 4.6200 0.0 0
M  V30 16 C 13.2456 6.1600 0.0 0
M  V30 17 C 12.3404 7.4059 0.0 0
M  V30 18 N 9.5420 7.7000 0.0 0
M  V30 19 N 8.2084 5.3900 0.0 0
M  V30 20 C 8.2084 6.9300 0.0 0
M  V30 21 C 14.7856 6.1600 0.0 0
M  V30 22 O 15.6908 7.4059 0.0 0
M  V30 23 N 15.6908 4.9142 0.0 0
M  V30 24 C 17.1554 6.9300 0.0 0
M  V30 25 N 17.1554 5.3900 0.0 0
M  V30 26 C 8.2084 2.3100 0.0 0
M  V30 27 C 6.8747 3.0800 0.0 0
M  V30 28 C 8.2084 0.7700 0.0 0
M  V30 29 C 5.5411 2.3100 0.0 0
M  V30 30 C 6.8747 0.0000 0.0 0
M  V30 31 C 5.5411 0.7700 0.0 0
M  V30 32 C 1.5400 3.0800 0.0 0
M  V30 33 C 0.7700 4.4137 0.0 0
M  V30 34 C 0.0000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 4 15
M  V30 5 1 4 26
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 29
M  V30 12 1 9 32
M  V30 13 1 11 31
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 17
M  V30 22 1 16 21
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 873091-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1017281-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8528943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, SAR, and evaluation of
4-[2,4-difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based
VEGFR-2 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Zhen-wei; Wei, Donna; Borzilleri, Robert M.; Qian, Ligang; Kamath,
Amrita; Mortillo, Steven; Wautlet, Barri; Henley, Benjamin J.;
Jeyaseelan, Robert; Tokarski, John; Hunt, John T.; Bhide, Rajeev S.;
Fargnoli, Joseph; Lombardo, Louis J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(4), 1354-1358

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[Bis(methylthio)methylene]-3-methyl-2-thioxo-4-thiazolidinone
C7H9NOS4
874500-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 S 1.3337 3.0801 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 3.0175 5.6422 0.0 0
M  V30 7 C 6.2949 6.3388 0.0 0
M  V30 8 S 7.9700 3.4372 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 4.1621 4.6116 0.0 0
M  V30 11 S 5.4080 2.4537 0.0 0
M  V30 12 N 5.6684 4.9318 0.0 0
M  V30 13 C 6.4384 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 12
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3-Methyl-5-[(methylamino)(methylthio)methylene]-2-thioxo-4-thiazolidinone
C7H10N2OS3
2098933-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 N 1.3337 3.0801 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 3.0175 5.6422 0.0 0
M  V30 7 C 6.2949 6.3388 0.0 0
M  V30 8 S 7.9700 3.4372 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 4.1621 4.6116 0.0 0
M  V30 11 S 5.4080 2.4537 0.0 0
M  V30 12 N 5.6684 4.9318 0.0 0
M  V30 13 C 6.4384 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 12
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 874500-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098933-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-17300008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, stereoselective, optimization study, optimized
on solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of rhodanine-derived enaminones in aqueous medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Devi, N. S.; Devi, Nirada
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2017), 47(13), 1209-1213

